{
    "0": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 11,
            "WhatReliabilityReliable": 0,
            "WhatReliabilityUnreliable": 11,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 3,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 6,
            "Who": 12,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 2,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 0,
            "TitleTitle-StanceDisagree": 1,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 3,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nAnte el brote del coronavirus que ha afectado a muchos países del mundo, no solo en la salud de sus habitantes, sino también en su economía, en China se anunció que científicos de Egipto han descubierto una vacuna que permite la sanación de los enfermos de tan terrible mal.\n\n<BREAK>\n\nNosotros tratamos el asunto con toda la seriedad necesaria, pues esta pandemia la están enfrentando muchos países e incluso varios de éstos han cerrado sus fronteras aéreas para no permitir que aviones aterricen en sus territorios, como Estados Unidos, Guatemala, Rusia y otros más.\n\n<BREAK>\n\nAquí el mensaje nos que nos mandaron para que el mundo entero pueda tener una esperanza para no solo combatir al coronavirus, sino para sanar a las personas que ya están contagiadas.\n\n<BREAK>\n\nEsperamos no fallar a nuestra sociedad con esta noticia que, como decimos, podría salvar al mundo.\n\n<BREAK>\n\nHace unas horas, China anunció oficialmente el éxito del suero egipcio que el doctor Hala, Ministro de Salud de Egipto, presentó al Ministerio de Salud de China para tratar el virus Corona, que resultó ser 100% efectivo en más de siete casos que han sido curados, por lo que China anunciará que los médicos egipcios han demostrado al mundo que son fabricantes.\n\n<BREAK>\n\nLa vida se ha convertido en un suero 100% egipcio, el derecho de exportar a todos los países del mundo, a estos a precios establecidos por el Ministro de Salud de Egipto, lo que será un auge económico en la historia de la medicina egipcia, pero es posible vender este remedio que pagará las deudas de Egipto y Egipto será otra China económicamente en el futuro cercano, por una bandera árabe.\n\n<BREAK>\n\nDe hecho, Egipto se convertirá en uno de los primeros países del mundo en medicina.\n",
        "TITLE": "EGIPTO DESCUBRE LA VACUNA CONTRA EL CORONAVIRUS Y AFIRMA QUE SIETE PERSONAS CONTAGIADAS SE HAN SANADO",
        "ID": "10-Morelosmagazzine",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "EGIPTO DESCUBRE LA VACUNA CONTRA EL CORONAVIRUS Y AFIRMA QUE SIETE PERSONAS CONTAGIADAS SE HAN SANADO",
                "text_en": "EGYPT DISCOVERS THE VACCINE AGAINST CORONAVIRUS AND AFIRMS THAT SEVEN CONTAGIED PERSONS HAVE BEEN HEALED",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "EGIPTO",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EGYPT"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "DESCUBRE LA VACUNA CONTRA EL CORONAVIRUS",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "DISCOVERS THE VACCINE AGAINST CORONAVIRUS"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "SIETE PERSONAS CONTAGIADAS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "SEVEN CONTAGIED PERSONS"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "SE HAN SANADO",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "HAVE BEEN HEALED"
                    }
                ],
                "evidences": [
                    {
                        "value": "It is free of charge as a part of the Coronavirus Vaccine for Free initiative and for digital solutions -they are also launching an online registration portal (concurrently with Lebanon) that will allow citizens and healthcare workers to keep records of their vaccinations. Though Egypt's portal does not make its methods and privacy protocols clear on its website, Lebanon's ministry of health has assured that the platform protects privacy and has been tested for safety. The vaccine will be free of cost for all Streets (2021) . Egypt plans on acquiring a total of 4.5 million doses by June and has already vaccinated 149K individuals as of 4th April 2021. Egypt also plans on manufacturing the Sinopharm vaccine in its own facilities, and a negotiation deal with the pharmaceutical is in the works. Citizens can register through an online portal and opt for the vaccine. Egypt also received 800,000+ doses of the AstraZeneca vaccine from the COVAX facility Organization (2021a).",
                        "score": 0.6299999952
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.913305819
                    }
                ]
            },
            {
                "text": "Ante el brote del coronavirus que ha afectado a muchos países del mundo, no solo en la salud de sus habitantes, sino también en su economía, en China se anunció que científicos de Egipto han descubierto una vacuna que permite la sanación de los enfermos de tan terrible mal.",
                "text_en": "In the face of the outbreak of the coronavirus that has affected many countries of the world, not only in the health of its inhabitants, but also in its economy, it was announced in China that Egyptian scientists have discovered a vaccine that allows the healing of the sick of such terrible evil.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en China",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in China"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se anunció que científicos de Egipto han descubierto una vacuna que permite la sanación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "announced that Egyptian scientists have discovered a vaccine that allows healing"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "científicos de Egipto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "scientists from Egypt"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "de los enfermos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the sick"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esperamos no fallar a nuestra sociedad con esta noticia que, como decimos, podría salvar al mundo.",
                "text_en": "We hope not to fail our society with this news that, as we say, could save the world.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esta noticia que, como decimos, podría salvar al mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "this news that, as we say, could save the world"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hace unas horas, China anunció oficialmente el éxito del suero egipcio que el doctor Hala, Ministro de Salud de Egipto, presentó al Ministerio de Salud de China para tratar el virus Corona, que resultó ser 100% efectivo en más de siete casos que han sido curados, por lo que China anunciará que los médicos egipcios han demostrado al mundo que son fabricantes.",
                "text_en": "A few hours ago, China officially announced the success of the Egyptian serum that Dr. Hala, Minister of Health of Egypt, presented to the Ministry of Health of China to treat the Corona virus, which turned out to be 100% effective in more than seven cases that have been cured, so China will announce that Egyptian doctors have shown the world that they are manufacturers.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hace unas horas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "A few hours ago"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "China",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "China"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "anunció oficialmente el éxito del suero egipcio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "officially announced the success of the Egyptian serum"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el doctor Hala, Ministro de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Hala, Minister of Health"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Egipto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Egypt"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "presentó al Ministerio de Salud de China para tratar el virus Corona",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "presented to the Ministry of Health of China to treat Corona virus"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Ministerio de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "China",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "China"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "resultó ser 100% efectivo en más de siete casos que han sido curados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "turned out to be 100% effective in more than seven cases that have been cured"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "China",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "China"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "anunciará que los médicos egipcios han demostrado al mundo que son fabricantes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "announce that Egyptian doctors have shown the world that they are manufacturers"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los médicos egipcios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Egyptian doctors"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La vida se ha convertido en un suero 100% egipcio, el derecho de exportar a todos los países del mundo, a estos a precios establecidos por el Ministro de Salud de Egipto, lo que será un auge económico en la historia de la medicina egipcia, pero es posible vender este remedio que pagará las deudas de Egipto y Egipto será otra China económicamente en el futuro cercano, por una bandera árabe.",
                "text_en": "Life has become a 100% Egyptian serum, the right to export to all countries of the world, to these at prices set by the Minister of Health of Egypt, which will be an economic boom in the history of Egyptian medicine, but it is possible to sell this remedy that will pay Egypt's debts and Egypt will be another China economically in the near future, by an Arab flag.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vida se ha convertido en un suero 100% egipcio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Life has become a 100% Egyptian serum"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Egipto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Egypt"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "será otra China económicamente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "will be another China economically"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "China",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "China"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en el futuro cercano",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the near future"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De hecho, Egipto se convertirá en uno de los primeros países del mundo en medicina.",
                "text_en": "In fact, Egypt will become one of the first countries in the world in medicine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Egipto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Egypt"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se convertirá en uno de los primeros países del mundo en medicina",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "become one of the first countries in the world in medicine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "del mundo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the world"
                    }
                ],
                "evidences": [
                    {
                        "value": "As one of the largest countries and markets in the Arab world, Egypt is potentially a high-growth country. Certainly, reforms over the past few years have borne fruit, at least for the well connected. But revolt has changed everything and economic reform will not be easy.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9887298942
                    }
                ]
            }
        ]
    },
    "1": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 6,
            "WhatReliabilityUnreliable": 4,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 4,
            "WhoReliabilityReliable": 3,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 10,
            "WhereReliabilityReliable": 10,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 3,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 4,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nMéxico es uno de los países del mundo que ha conocido un mayor exceso de mortalidad el año pasado: 160.000 fallecimientos que, hasta ahora, la intoxicación mediática ha atribuido a la pandemia, aunque lentamente empiezan a aparecer factores muchos más peliagudos que conciernen al dinero y el destino en el que se invierte.\n\n<PARAGRAPH>\n\nUn estudio científico identifica como principal causa de muerte en México la situación que se vive en los hospitales y, en concreto, la saturación hospitalaria y la falta de camas con ventilación asistida para los enfermos graves.\n\n<PARAGRAPH>\n\nEl 45 por ciento de los pacientes “con coronavirus” que murieron en México, deberían haber ingresado en las unidades de cuidados intensivos, pero no lo hicieron por falta de camas con ventilación mecánica.\n\n<PARAGRAPH>\n\nPor lo tanto, es evidente que una parte importante del exceso de mortalidad se pudo evitar.\n\n<BREAK>\n\nNo se debe a “causas naturales” sino políticas, económicas y sociales.\n\n<PARAGRAPH>\n\nLa carencia de camas ventiladas no afecta sólo a los pacientes “con coronavirus” sino a todos aquellos con saturación de oxígeno por debajo del 80 por ciento.\n\n<PARAGRAPH>\n\nEl estudio ha sido realizado por investigadores mexicanos del Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán” y lo ha publicado la revista científica Plos One (*).\n\n<PARAGRAPH>\n\nLa tasa de mortalidad en México se adjudica principalmente a la disponibilidad de camas con ventilación mecánica en unidades de cuidados intensivos, lo que sugiere que el hacinamiento fue uno de los principales factores que contribuyeron a la mortalidad hospitalaria.\n\n<PARAGRAPH>\n\nLa disponibilidad de camas con ventilación mecánica en México por cada 100.000 habitantes era de 1.5, lo que representa la mitad de las estimadas para China, un 10 por ciento de las de Italia y entre 0.04 y 0.05 por ciento para la capacidad de Alemania y Estados Unidos, respectivamente.\n\n<PARAGRAPH>\n\nLa escasa disponibilidad de camas en cuidados intensivos se está traduciendo en una demora en la admisión de pacientes y, como consecuenncia de ello, un incremento en la tasa de mortalidad.\n\n<PARAGRAPH>\n\nLa investigación concluye sobre la necesidad de atender con urgencia el problema de saturación hospitalaria del sistema de salud público, así como crear nuevas unidades de cuidados intensivos.\n\n<PARAGRAPH>\n\n(*) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0245772\n\n<PARAGRAPH>\n",
        "TITLE": "La principal causa de la muerte en México es la saturación hospitalaria",
        "ID": "NF_NF_1841_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "La principal causa de la muerte en México es la saturación hospitalaria",
                "text_en": "The main cause of death in Mexico is hospital saturation",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La principal causa de la muerte en México es la saturación hospitalaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The main cause of death in Mexico is hospital saturation"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en México",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Mexico"
                    }
                ],
                "evidences": [
                    {
                        "value": "The COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to remain a serious global health emergency, particularly in the Americas. The Pan-American Health Organization (Organización Panamericana de Salud, OPS) estimated in August 2020 that while the region accounts for approximately 13% of the global population, it has accounted for around 64% of the reported deaths (United Nations Organization, 2020). As of October, the United States, Brazil, and Mexico, represented the countries with the first, second, and fourth highest total reported deaths worldwide. Combined these three nations accounted for over 440,000 deaths (41% of total deaths worldwide). Mexico has experienced a particularly high rate of death as a percentage of confirmed infected population at 10% (Johns Hopkins Csse, 2020) . Furthermore, it is estimated that COVID-19 will be the number one cause of death in Mexico by the end of 2020 (IHME, 2020) . Perhaps more concerning is the likelihood that these are underreported figures and that the full extent of the infection and related death is even greater (Lau et al., 2020) .",
                        "score": 0.6200000048
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.6084943414
                    }
                ]
            },
            {
                "text": "México es uno de los países del mundo que ha conocido un mayor exceso de mortalidad el año pasado: 160.000 fallecimientos que, hasta ahora, la intoxicación mediática ha atribuido a la pandemia, aunque lentamente empiezan a aparecer factores muchos más peliagudos que conciernen al dinero y el destino en el que se invierte.",
                "text_en": "Mexico is one of the countries in the world that has known a greater excess of mortality last year: 160,000 deaths that, so far, media poisoning has attributed to the pandemic, although many more dangerous factors are slowly emerging that concern the money and the destiny in which it is invested.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "México",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mexico"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es uno de los países del mundo que ha conocido un mayor exceso de mortalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is one of the countries in the world that has known the greatest excess of mortality"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el año pasado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last year"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "empiezan a aparecer factores muchos más peliagudos que conciernen al dinero y el destino en el que se invierte",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Many more dangerous factors are emerging that concern the money and the destination in which it is invested"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un estudio científico identifica como principal causa de muerte en México la situación que se vive en los hospitales y, en concreto, la saturación hospitalaria y la falta de camas con ventilación asistida para los enfermos graves.",
                "text_en": "A scientific study identifies as the main cause of death in Mexico the situation in hospitals and, in particular, hospital saturation and the lack of beds with assisted ventilation for serious patients.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Un estudio científico identifica como principal causa de muerte en México la situación que se vive",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "A scientific study identifies the situation as the main cause of death in Mexico"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en México",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Mexico"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los hospitales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in hospitals"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "la saturación hospitalaria y la falta de camas con ventilación asistida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "hospital saturation and lack of beds with assisted ventilation"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los enfermos graves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the seriously ill"
                    }
                ],
                "evidences": [
                    {
                        "value": "The COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to remain a serious global health emergency, particularly in the Americas. The Pan-American Health Organization (Organización Panamericana de Salud, OPS) estimated in August 2020 that while the region accounts for approximately 13% of the global population, it has accounted for around 64% of the reported deaths (United Nations Organization, 2020). As of October, the United States, Brazil, and Mexico, represented the countries with the first, second, and fourth highest total reported deaths worldwide. Combined these three nations accounted for over 440,000 deaths (41% of total deaths worldwide). Mexico has experienced a particularly high rate of death as a percentage of confirmed infected population at 10% (Johns Hopkins Csse, 2020) . Furthermore, it is estimated that COVID-19 will be the number one cause of death in Mexico by the end of 2020 (IHME, 2020) . Perhaps more concerning is the likelihood that these are underreported figures and that the full extent of the infection and related death is even greater (Lau et al., 2020) .",
                        "score": 0.6299999952
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8842564821
                    }
                ]
            },
            {
                "text": "El 45 por ciento de los pacientes “con coronavirus” que murieron en México, deberían haber ingresado en las unidades de cuidados intensivos, pero no lo hicieron por falta de camas con ventilación mecánica.",
                "text_en": "Forty-five percent of patients “with coronaviruses” who died in Mexico should have been admitted to intensive care units, but did not do so due to a lack of beds with mechanical ventilation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El 45 por ciento de los pacientes “con coronavirus” que murieron",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "45 percent of patients “with coronavirus” who died"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en México",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Mexico"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deberían haber ingresado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They should have come in."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las unidades de cuidados intensivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in intensive care units"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por falta de camas con ventilación mecánica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to lack of beds with mechanical ventilation"
                    }
                ],
                "evidences": [
                    {
                        "value": "Data on deaths in patients <65 years old without any underlying conditions (comorbidities) were available for France, Italy, Mexico, Netherlands, Sweden, Georgia, and New York City. As shown in Table 4 , the proportion of these deaths ranged from 0.7-3.6% of all COVID-19 deaths with the exception of Mexico that had a much higher percentage (17.7%). Excluding Mexico, the highest proportions were in France, Sweden, and Georgia. France data were based on deaths for which electronic death certificates were available, and completeness of death certificate information is unknown. 11 Data on Sweden were based on death counts that included also probable deaths without laboratory confirmation; moreover, only cardiovascular disease, hypertension, diabetes, and pulmonary disease were counted as comorbidities in this assessment, so it is possible that additional patients may have had other comorbidities. 15 The lowest percentage (0.65% of all COVID-19 deaths) was seen in New York City. Similarly low percentages (0.7% of all COVID-19 deaths) were seen in Italy and Netherlands based on more detailed medical chart review. In Italy, this review is done on a subset of the deaths (n=917 as of April 2).",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9914346337
                    }
                ]
            },
            {
                "text": "Por lo tanto, es evidente que una parte importante del exceso de mortalidad se pudo evitar.",
                "text_en": "It is therefore clear that a significant part of the excess mortality could be avoided.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es evidente que una parte importante del exceso de mortalidad se pudo evitar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "it is clear that a significant part of the excess mortality could be avoided"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No se debe a “causas naturales” sino políticas, económicas y sociales.",
                "text_en": "It is not due to “natural causes” but to political, economic and social causes.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "se debe a “causas naturales” sino políticas, económicas y sociales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is due to “natural causes” but political, economic and social"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El estudio ha sido realizado por investigadores mexicanos del Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán” y lo ha publicado la revista científica Plos One (*).",
                "text_en": "The study has been carried out by Mexican researchers from the National Institute of Medical Sciences and Nutrition “Salvador Zubiran” and has been published by the scientific journal Plos One (*).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El estudio ha sido realizado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The study has been carried out"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "investigadores mexicanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mexican researchers"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "National Institute of Medical Sciences and Nutrition “Salvador Zubiran”"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la revista científica Plos One",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the scientific journal Plos One"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La disponibilidad de camas con ventilación mecánica en México por cada 100.000 habitantes era de 1.5, lo que representa la mitad de las estimadas para China, un 10 por ciento de las de Italia y entre 0.04 y 0.05 por ciento para la capacidad de Alemania y Estados Unidos, respectivamente.",
                "text_en": "The availability of mechanical ventilation beds in Mexico for every 100,000 inhabitants was 1.5, representing half of the estimated for China, 10 percent for Italy and 0.04 to 0.05 percent for Germany and the United States, respectively.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La disponibilidad de camas con ventilación mecánica en México por cada 100.000 habitantes era de 1.5",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The availability of mechanical ventilation beds in Mexico per 100,000 inhabitants was 1.5"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en México",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Mexico"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por cada 100.000 habitantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "per 100,000 population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La escasa disponibilidad de camas en cuidados intensivos se está traduciendo en una demora en la admisión de pacientes y, como consecuenncia de ello, un incremento en la tasa de mortalidad.",
                "text_en": "The limited availability of beds in intensive care is leading to a delay in the admission of patients and, as a result, an increase in the mortality rate.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "La escasa disponibilidad de camas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The low availability of beds"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en cuidados intensivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in intensive care"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "incremento en la tasa de mortalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "increase in mortality rate"
                    }
                ],
                "evidences": [
                    {
                        "value": "It is important to acknowledge that capacity has been considered only with regard to the number of beds within intensive care, and not the size or quality of clinical workforce. If the higher volumes of patients being looked after, as produced here through scenarios in which more beds are converted to intensive care specification, are not met with proportionate increases in the numbers of suitably-qualified doctors and nurses, then poorer patient outcomes (i.e. greater P adm d ) and longer lengths of stay may result [39] . Further research is thus required to investigate and incorporate the effect of workforce size and skill-mix on these model parameters. On the demand side, these parameters may also be affected by the possible implementation of an intensive care triage policy, which would result in a different case-mix admitted to intensive care. Additional modelling may thus be needed to understand the effects of rejecting intensive care admissions from patient cohorts known to have negligible survival likelihood, in the interests of maintaining available beds for those known to have more favourable chances. If those patients less likely to benefit from admission are triaged-out (as considered in [6, 40] ), then modelling would need to capture the different outcome and length of stay distributions for the new patient cohort. Ultimately, such a policy could potentially reduce further the total deaths over and above those considered in this study.",
                        "score": 0.5799999833
                    },
                    {
                        "value": "The lack of hospital beds has been attributed to a set of important cuts in the financing of public health over the last years that also result in a reduction of hospital beds both in general and in the intensive care units on the whole territory.",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9435363412
                    },
                    {
                        "label": "neutral",
                        "score": 0.9979304075
                    }
                ]
            },
            {
                "text": "La investigación concluye sobre la necesidad de atender con urgencia el problema de saturación hospitalaria del sistema de salud público, así como crear nuevas unidades de cuidados intensivos.",
                "text_en": "The research concludes on the need to urgently address the problem of hospital saturation in the public health system, as well as to create new intensive care units.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La investigación concluye sobre la necesidad de atender con urgencia el problema de saturación hospitalaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The research concludes on the need to urgently address the problem of hospital saturation"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "del sistema de salud público",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the public health system"
                    }
                ],
                "evidences": [
                    {
                        "value": "In all the potentially recommended scenarios, the hospital saturation level was handled with regard to both intensity and duration. Although we demonstrate here that several criteria may be considered simultaneously for decision-making and that hospital saturation and the associated mortality increased risk cannot justify an endless strict lockdown, public health remains the most important criterion in the short term, and the scenarios contribute to its optimization. Hospital saturation is not only a public health issue but also a key political risk of lockdown policy rejection (2) .",
                        "score": 0.6299999952
                    },
                    {
                        "value": "Therefore, most public health policies initially consisted of NPIs aimed at \"flattening the curve\" (ranging from physical distancing to school closures and full lockdowns) to avoid hospital saturation and triage of incoming patients in the intensive care unit (ICU). However, the benefits of the strictest interventions (curfews and lockdowns) to limit hospital saturation have to be balanced with the subsequent economic (1), social and medical consequences, such as reduced access to care for cancer patients (2) and consultations for heart attack and myocardial infarctions (3).",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9732781053
                    },
                    {
                        "label": "neutral",
                        "score": 0.9982736111
                    }
                ]
            }
        ]
    },
    "2": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 14,
            "WhatReliabilityReliable": 14,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 6,
            "Who": 7,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 4,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 12,
            "HowReliabilityReliable": 11,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 1,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 3,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 3,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "04/11/2021-19:11:13\n\n\n<TEXT>\n\nLa lucha contra la pandemia del coronavirus podrá dar un salto exponencial gracias a un tratamiento antiviral.\n\n<PARAGRAPH>\n\nLos investigadores de la Universidad de Nottingham, en Reino Unido, han descubierto una nueva propiedad antiviral de un fármaco que podría tener importantes implicaciones en la forma en que se gestionen las futuras epidemias/pandemias, incluido el COVID-19, según publican en la revista ‘Virus’.\n\n<PARAGRAPH>\n\nEl estudio muestra que la tapsigargina es un prometedor antiviral de amplio espectro, altamente eficaz contra el virus COVID-19 (SARS-CoV-2), un coronavirus del resfriado común, el virus respiratorio sincitial (RSV) y el virus de la gripe A.\n\n<PARAGRAPH>\n\nDado que las infecciones víricas respiratorias agudas causadas por diferentes virus son clínicamente indistinguibles en la presentación, un amplio espectro eficaz que pueda dirigirse a diferentes tipos de virus al mismo tiempo podría mejorar significativamente el tratamiento clínico.\n\n<PARAGRAPH>\n\nUn antiviral de este tipo podría estar disponible para uso comunitario para controlar la infección activa y su propagación.\n\n<PARAGRAPH>\n\nEl estudio es un proyecto de colaboración dirigido por el profesor Kin-Chow Chang y expertos de la Universidad de Nottingham (en las Facultades de Medicina y Ciencias Veterinarias, Biociencias, Farmacia, Medicina y Química) y colegas de la Agencia de Sanidad Animal y Vegetal (APHA), la Universidad Agrícola de China y el Instituto Pirbright.\n\n<PARAGRAPH>\n\nEn este innovador estudio, el equipo de expertos descubrió que el antiviral derivado de plantas, en pequeñas dosis, desencadena una respuesta inmune innata antiviral altamente eficaz de amplio espectro centrada en el huésped contra tres tipos principales de virus respiratorios humanos, incluido el COVID-19.\n\n<PARAGRAPH>\n\nEl estudio estudios con células y animales ha revelado que la tapsigargina un antiviral prometedor porque es eficaz contra la infección viral cuando se usa antes o durante una infección activa capaz de evitar que un virus haga nuevas copias de sí mismo en las células durante al menos 48 horas después de una sola exposición de 30 minutos.\n\n<PARAGRAPH>\n\nAdemás, es estable en pH ácido, como se encuentra en el estómago, y por lo tanto puede tomarse por vía oral, por lo que podría administrarse sin necesidad de inyecciones o ingreso hospitalario; no es sensible a la resistencia a virus y es al menos varios cientos de veces más eficaces que las opciones antivirales actuales.\n\n<PARAGRAPH>\n\nAsimismo, es tan eficaz para bloquear la infección combinada con coronavirus y el virus de la gripe A como en la infección por un solo virus.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Investigadores británicos descubren un posible tratamiento antiviral para COVID-19 - Periodista Digital",
        "ID": "11_NF_04-11-2021_21-02-57_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Investigadores británicos descubren un posible tratamiento antiviral para COVID-19 - Periodista Digital",
                "text_en": "British researchers discover possible antiviral treatment for COVID-19 - Digital Journalist",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Investigadores británicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "British researchers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "descubren un posible tratamiento antiviral para COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "discover possible antiviral treatment for COVID-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El estudio muestra que la tapsigargina es un prometedor antiviral de amplio espectro, altamente eficaz contra el virus COVID-19",
                "text_en": "The study shows that tapsigargin is a promising broad-spectrum antiviral, highly effective against the COVID-19 virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la tapsigargina es un prometedor antiviral de amplio espectro, altamente eficaz contra el virus COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "tapsigargin is a promising broad-spectrum antiviral, highly effective against the COVID-19 virus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La lucha contra la pandemia del coronavirus podrá dar un salto exponencial gracias a un tratamiento antiviral.",
                "text_en": "The fight against the coronavirus pandemic can take an exponential leap thanks to antiviral treatment.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La lucha contra la pandemia del coronavirus podrá dar un salto exponencial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The fight against the coronavirus pandemic can take an exponential leap"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "gracias a un tratamiento antiviral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thanks to antiviral treatment"
                    }
                ],
                "evidences": [
                    {
                        "value": "As we can see from study result, Coronavirus Pandemic has significant impacts on social and economic life. In forecasting future socio-economic indicators, we will have to make adjustments to the black swan effect, which is Coronavirus Pandemic.",
                        "score": 0.5400000215
                    },
                    {
                        "value": "Keywords: Coronavirus, SARS Coronavirus, Pandemic. . The coronavirus pandemic brought a new challenge to developing countries because equipment like respirators are not readily available for import. This scenario requires straightforward mechanisms to reveal which areas demand more attention from policymakers to receive investments and reallocated materials (Noronha, 2020) . The study of hospital structure is crucial to provide treatment for infected people, avoid deaths, and prevent the collapse of the health network due to the coronavirus pandemic. The aim of this study was to create a new indicator, called the COVID Index, to analyze how the hospital structure has responded to the coronavirus pandemic in the Brazilian microregions.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.991584897
                    },
                    {
                        "label": "neutral",
                        "score": 0.939357698
                    }
                ]
            },
            {
                "text": "Los investigadores de la Universidad de Nottingham, en Reino Unido, han descubierto una nueva propiedad antiviral de un fármaco que podría tener importantes implicaciones en la forma en que se gestionen las futuras epidemias/pandemias, incluido el COVID-19, según publican en la revista ‘Virus’.",
                "text_en": "Researchers at the University of Nottingham in the United Kingdom have discovered a new antiviral property of a drug that could have important implications for how future epidemics/pandemies, including COVID-19, are managed, as published in the magazine ‘Virus’.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los investigadores de la Universidad de Nottingham",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Researchers at the University of Nottingham"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han descubierto una nueva propiedad antiviral de un fármaco que podría tener importantes implicaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have discovered a new antiviral property of a drug that could have important implications"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en la forma en que se gestionen las futuras epidemias/pandemias, incluido el COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "how future epidemics/pandemies, including COVID-19, are managed"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la revista ‘Virus’",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the magazine ‘Virus’"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El estudio muestra que la tapsigargina es un prometedor antiviral de amplio espectro, altamente eficaz contra el virus COVID-19 (SARS-CoV-2), un coronavirus del resfriado común, el virus respiratorio sincitial (RSV) y el virus de la gripe A.",
                "text_en": "The study shows that tapsigargin is a promising broad-spectrum antiviral, highly effective against the COVID-19 virus (SARS-CoV-2), a common cold coronavirus, syncitial respiratory virus (SVR) and influenza A virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El estudio muestra que la tapsigargina es un prometedor antiviral de amplio espectro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The study shows that tapsigargin is a promising broad-spectrum antiviral"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "eficaz contra el virus COVID-19 (SARS-CoV-2), un coronavirus del resfriado común, el virus respiratorio sincitial (RSV) y el virus de la gripe A",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "effective against the COVID-19 virus (SARS-CoV-2), a common cold coronavirus, syncytial respiratory virus (SVR) and influenza A virus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Dado que las infecciones víricas respiratorias agudas causadas por diferentes virus son clínicamente indistinguibles en la presentación, un amplio espectro eficaz que pueda dirigirse a diferentes tipos de virus al mismo tiempo podría mejorar significativamente el tratamiento clínico.",
                "text_en": "Since acute respiratory viral infections caused by different viruses are clinically indistinguishable in presentation, an effective broad spectrum that can target different types of viruses at the same time could significantly improve clinical treatment.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las infecciones víricas respiratorias agudas causadas por diferentes virus son clínicamente indistinguibles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "acute respiratory viral infections caused by different viruses are clinically indistinguishable"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por diferentes virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by different viruses"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "un amplio espectro eficaz que pueda dirigirse a diferentes tipos de virus al mismo tiempo podría mejorar significativamente el tratamiento clínico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "an effective broad spectrum that can target different types of viruses at the same time could significantly improve clinical treatment"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "al mismo tiempo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the same time"
                    }
                ],
                "evidences": [
                    {
                        "value": "In conclusion, the data generated from this study have expanded the knowledge of the epidemiology of respiratory viral infections in children in Hong Kong. The management of children with severe acute respiratory infections in hospital, and surveillance for respiratory viral infections in the community could be greatly enhanced with the use of multiplex PCR assays.",
                        "score": 0.5500000119
                    },
                    {
                        "value": "Virus families often use conserved strategies to evade the cellular RNA decay machinery. Therefore, perhaps researchers can develop effective, broad-spectrum antivirals to disarm these strategies and destabilize viral RNAs. Future research in this burgeoning field will likely uncover novel mechanisms of the regulation of host and viral gene expression and facilitate new methods for treating viral diseases.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.999158144
                    },
                    {
                        "label": "neutral",
                        "score": 0.9992226362
                    }
                ]
            },
            {
                "text": "Un antiviral de este tipo podría estar disponible para uso comunitario para controlar la infección activa y su propagación.",
                "text_en": "Such an antiviral may be available for community use to control active infection and its spread.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "podría estar disponible para uso comunitario para controlar la infección activa y su propagación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "may be available for community use to control active infection and its spread"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "para uso comunitario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for Community use"
                    }
                ],
                "evidences": [
                    {
                        "value": "The timely availability of HIV antiviral therapy for pre-exposure and post-exposure to high-risk populations (sex workers, men who have sex with men) is also essential to decrease the viral load and prevalence of HIV in the community.",
                        "score": 0.5600000024
                    },
                    {
                        "value": "As NA facilitates viral release through the cleavage of HA, targeting of NA by next generation vaccines would still allow HA-mediated viral entry into host cells and potential adaptation of IAV. This could lead to mutations conferring resistance against clinically important antiviral drugs such as oseltamivir, a neuraminidase inhibitor (NAI). Conformational changes in the NA protein can prevent the binding of NAIs and reduce efficacy. NAIs are a common clinically available antiviral drugs to treat influenza and antiviral resistance has already been observed in circulating IAV [117] [118] [119] . Some studies suggest that there has been limited transmission of antiviral resistant IAV within the community to date, with only 1% of H1N1pdm strains containing known drug resistance mutations during the 2010/11 season [120] . Most IAV sequences with antiviral resistance mutation NA-H275Y identified in this study were from individuals who had been treated with oseltamivir prior to sample collection. As such, it is important to investigate if enhanced NA-directed immune pressure across a population alongside oseltamivir usage could drive further IAV adaptation within the community.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9949107766
                    },
                    {
                        "label": "neutral",
                        "score": 0.9800644517
                    }
                ]
            },
            {
                "text": "El estudio es un proyecto de colaboración dirigido por el profesor Kin-Chow Chang y expertos de la Universidad de Nottingham (en las Facultades de Medicina y Ciencias Veterinarias, Biociencias, Farmacia, Medicina y Química) y colegas de la Agencia de Sanidad Animal y Vegetal (APHA), la Universidad Agrícola de China y el Instituto Pirbright.",
                "text_en": "The study is a collaborative project led by Professor Kin-Chow Chang and experts from the University of Nottingham (in the Faculties of Veterinary Medicine and Sciences, Biosciences, Pharmacy, Medicine and Chemistry) and colleagues from the Animal and Plant Health Agency (APHA), the Agricultural University of China and the Pirbright Institute.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El estudio es un proyecto de colaboración dirigido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The study is a targeted collaboration project"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el profesor Kin-Chow Chang",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Professor Kin-Chow Chang"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "expertos de la Universidad de Nottingham (en las Facultades de Medicina y Ciencias Veterinarias, Biociencias, Farmacia, Medicina y Química)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "experts from the University of Nottingham (in the Faculties of Medicine and Veterinary Sciences, Biosciences, Pharmacy, Medicine and Chemistry)"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "colegas de la Agencia de Sanidad Animal y Vegetal (APHA), la Universidad Agrícola de China y el Instituto Pirbright",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "colleagues from the Animal and Plant Health Agency (APHA), the Agricultural University of China and Pirbright Institute"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En este innovador estudio, el equipo de expertos descubrió que el antiviral derivado de plantas, en pequeñas dosis, desencadena una respuesta inmune innata antiviral altamente eficaz de amplio espectro centrada en el huésped contra tres tipos principales de virus respiratorios humanos, incluido el COVID-19.",
                "text_en": "In this innovative study, the expert team found that plant-derived antiviral, in small doses, triggers a highly effective broad-spectrum host-centered innate antiviral immune response against three main types of human respiratory viruses, including COVID-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el equipo de expertos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the team of experts"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en pequeñas dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in small doses"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desencadena una respuesta inmune innata antiviral altamente eficaz de amplio espectro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "triggers a highly effective innate antiviral response of broad spectrum"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el huésped",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the guest"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "contra tres tipos principales de virus respiratorios humanos, incluido el COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "against three main types of human respiratory viruses, including COVID-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El estudio estudios con células y animales ha revelado que la tapsigargina un antiviral prometedor porque es eficaz contra la infección viral cuando se usa antes o durante una infección activa capaz de evitar que un virus haga nuevas copias de sí mismo en las células durante al menos 48 horas después de una sola exposición de 30 minutos.",
                "text_en": "Studies with cells and animals have revealed that tapsigargin a promising antiviral because it is effective against viral infection when used before or during an active infection able to prevent a virus from making new copies of itself in cells for at least 48 hours after a single exposure of 30 minutes.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estudios con células y animales ha revelado que la tapsigargina un antiviral prometedor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "cell and animal studies have revealed that tapsigargin a promising antiviral"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con células y animales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with cells and animals"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque es eficaz contra la infección viral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because it is effective against viral infection"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando se usa antes o durante una infección activa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when used before or during an active infection"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "evitar que un virus haga nuevas copias de sí mismo en las células durante al menos 48 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "prevent a virus from making new copies of itself in cells for at least 48 hours"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las células",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in cells"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "después de una sola exposición de 30 minutos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after a single 30-minute exposure"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, es estable en pH ácido, como se encuentra en el estómago, y por lo tanto puede tomarse por vía oral, por lo que podría administrarse sin necesidad de inyecciones o ingreso hospitalario; no es sensible a la resistencia a virus y es al menos varios cientos de veces más eficaces que las opciones antivirales actuales.",
                "text_en": "In addition, it is stable in acid pH, as it is found in the stomach, and can therefore be taken orally, so it could be given without needing injections or hospital admission; it is not sensitive to virus resistance and is at least several hundred times more effective than current antiviral options.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "es estable en pH ácido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is stable in acid pH"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puede tomarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "may be taken"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por vía oral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "oral use"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin necesidad de inyecciones o ingreso hospitalario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "no need for injections or hospital admission"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "varios cientos de veces",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "several hundred times"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "más eficaces que las opciones antivirales actuales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more effective than current antiviral options"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Asimismo, es tan eficaz para bloquear la infección combinada con coronavirus y el virus de la gripe A como en la infección por un solo virus.",
                "text_en": "It is also as effective in blocking infection combined with coronavirus and influenza A virus as it is in infection with a single virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es tan eficaz para bloquear la infección combinada con coronavirus y el virus de la gripe A como en la infección por un solo virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is as effective in blocking infection combined with coronavirus and influenza A virus as in single virus infection"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "3": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 14,
            "WhatReliabilityReliable": 14,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 16,
            "WhoReliabilityReliable": 14,
            "WhoReliabilityUnreliable": 2,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 11,
            "WhoRoleTarget": 3,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 2,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLa Agencia Europea del Medicamento (EMA) ha calificado como segura a la vacuna de AstraZenea tras los casos de trombosis acontecidos en algunas personas que se habían inoculado la dosis.\n\n<BREAK>\n\nPor ello muchos países ha reanudado las vacunaciones, aunque con matices.\n\n<BREAK>\n\nAl menos en Italia, donde se establece que los que no quieran la vacuna de AstraZeneca podrán recibir otra.\n\n<PARAGRAPH>\n\nEn concreto, el presidente del Consejo Superior de Sanidad, Franco Locatelli, ha informado que los italianos que la rechacen podrán esperar a recibir otra vacuna diferente.\n\n<PARAGRAPH>\n\nEllo se ha establecido porque, a raíz de los acontecimientos pasados sobre las personas que han sufrido trombosis, aunque se está estudiando, pero se ha demostrado que no hay relación de estos episodios con las dosis suministradas con la vacuna de AstraZeneca, muchas personas se han preocupado por ello.\n\n<PARAGRAPH>\n\nLo que está claro es que, aunque los médicos, la  EMA y la OMS confían en esta vacuna se ha producido una situación compleja que tiene que ver con la falta de confianza por parte de la población.\n\n<BREAK>\n\nRecordemos que hay muchas personas que ya han recibido una primera dosis y están a la espera de la segunda y que ahora no saben si ponérsela o no.\n\n<PARAGRAPH>\n\nItalia reanudó el viernes 19 de marzo la vacunación con AstraZeneca, tras unos días en suspensión, de la misma forma que lo hicieron otros países, incluido España.\n\n<PARAGRAPH>\n\nSe espera que en breve también nuestro país vuelva a vacunar con las dosis de Oxford.\n\n<BREAK>\n\nTodo apunta que será el miércoles 24 de marzo.\n\n<PARAGRAPH>\n\nCasos de trombosis\n\n<PARAGRAPH>\n\nEl Consejo Superior de Sanidad, Franco Locatelli, recordó que la información que analizó la EMA hace referencia a veinte millones de personas que han sido vacunadas con AstraZeneca en la Unión Europea y el Reino Unido.\n\n<BREAK>\n\nY de estas se han detectado 25 casos de trombosis.\n\n<PARAGRAPH>\n\nEn concreto se trata de siete de coagulación intravascular diseminada y de 18 de trombosis venosa cerebral.\n\n<PARAGRAPH>\n\nHay más reacciones que vienen de Italia, pues el primer ministro italiano, Mario Draghi, aseguró que se vacunará con el fármaco británico en cuanto pueda.\n\n<PARAGRAPH>\n\nPara dar ejemplo y acabar con la mala fama que está teniendo esta vacuna, el mismo Boris Johnson también ha dicho que se vacuna con la de Oxford, si bien Reino Unido no ha parado de vacunar con AstraZeneca.\n\n<PARAGRAPH>\n\nPor el momento desconocemos si otros países harán como Italia que ha determinado que los que no quieran la vacuna de AstraZeneca podrán recibir otra.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Los italianos que no quieran la vacuna de AstraZeneca podrán recibir otra",
        "ID": "NF_04-11-2021_21-13-10_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Los italianos que no quieran la vacuna de AstraZeneca podrán recibir otra",
                "text_en": "Italians who do not want the AstraZeneca vaccine will be able to receive another vaccine",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los italianos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Italians"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no quieran la vacuna de AstraZeneca podrán recibir otra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "do not want the AstraZeneca vaccine you will be able to receive another"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Agencia Europea del Medicamento (EMA) ha calificado como segura a la vacuna de AstraZenea tras los casos de trombosis acontecidos en algunas personas que se habían inoculado la dosis.",
                "text_en": "The European Medicines Agency (EMA) has rated the AstraZenea vaccine as safe following cases of thrombosis in some people who had inoculated the dose.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Europea del Medicamento (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha calificado como segura a la vacuna de AstraZenea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has qualified the AstraZenea vaccine as safe"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por ello muchos países ha reanudado las vacunaciones, aunque con matices.",
                "text_en": "That is why many countries have resumed vaccinations, albeit with nuances.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchos países",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "many countries"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha reanudado las vacunaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has resumed vaccinations"
                    }
                ],
                "evidences": [
                    {
                        "value": "Additionally, the work in pharmacies should be organized in such a way that the staff authorized to administer vaccinations are present for most of the time of the pharmacy hours. Studies show that convenient access to vaccinations is the main reason behind increased vaccination coverage rates [20, 25, 45, 46] . Thus, the model enabling pharmacists to conduct vaccinations should give patients the opportunity to receive vaccinations at any time. Signing up for vaccinations or the possibility to conduct vaccinations only during certain hours apply in the countries (e.g., Sweden and Finland) where, despite no possibility to conduct vaccinations in pharmacies, this service must not be provided directly by pharmacists but by additional employed authorized staff.",
                        "score": 0.5799999833
                    },
                    {
                        "value": "Bacillus Calmette-Guérin (BCG) vaccination policies have been in place in many countries across the world starting from widely differing start dates. We would like to estimate the percentage of the population in each country that has received a BCG vaccine in their lifetime. For this purpose we need the age demographics of each country as well as the dates when BCG vaccinations became/stopped being mandatory.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9963508844
                    },
                    {
                        "label": "neutral",
                        "score": 0.9735196829
                    }
                ]
            },
            {
                "text": "Al menos en Italia, donde se establece que los que no quieran la vacuna de AstraZeneca podrán recibir otra.",
                "text_en": "At least in Italy, where it is established that those who do not want the AstraZeneca vaccine will be able to receive another.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se establece que los que no quieran la vacuna de AstraZeneca podrán recibir otra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it is established that those who do not want the AstraZeneca vaccine will be able to receive another"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En concreto, el presidente del Consejo Superior de Sanidad, Franco Locatelli, ha informado que los italianos que la rechacen podrán esperar a recibir otra vacuna diferente.",
                "text_en": "In particular, the president of the Higher Health Council, Franco Locatelli, has reported that Italians who reject it will be able to wait for another vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el presidente del Consejo Superior de Sanidad, Franco Locatelli",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the president of the Higher Council of Health, Franco Locatelli"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha informado que los italianos que la rechacen podrán esperar a recibir otra vacuna diferente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has informed that Italians who reject it will be able to wait to receive another vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los italianos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italians"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ello se ha establecido porque, a raíz de los acontecimientos pasados sobre las personas que han sufrido trombosis, aunque se está estudiando, pero se ha demostrado que no hay relación de estos episodios con las dosis suministradas con la vacuna de AstraZeneca, muchas personas se han preocupado por ello.",
                "text_en": "This has been established because, following past events on people who have experienced thrombosis, although being studied, but it has been shown that there is no relationship between these episodes and the doses provided with the AstraZeneca vaccine, many people have been concerned about this.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchas personas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "many people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han preocupado por ello",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have been concerned about this"
                    }
                ],
                "evidences": [
                    {
                        "value": "Regarding COVID-19 vaccine related neurovascular thrombosis, the similar pathobiological process is possible. Vaccine might induce abnormal immune response and further cause problem [14, 15] . The underlying plays important role in determining occurrence of thrombotic event. As already noted, hyperviscosity and stasis might occur after COVID-19 vaccination. A patient with underlying neurological problem usually has a high blood viscosity, hence, that patient might have an increased risk of COVID-19 vaccination related neurovascular thrombosis. According to a recent study, the safety interval for thrombosis development is narrower in a vaccine recipient with underlying neurological disease [23] . It is recommended for a closed monitoring of possible thrombosis in a COVID-19 vaccine recipient who has an underlying neurological disease [23] .",
                        "score": 0.6399999857
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9618220329
                    }
                ]
            },
            {
                "text": "Lo que está claro es que, aunque los médicos, la  EMA y la OMS confían en esta vacuna se ha producido una situación compleja que tiene que ver con la falta de confianza por parte de la población.",
                "text_en": "What is clear is that, although doctors, the EMA and the WHO rely on this vaccine, there has been a complex situation that has to do with the lack of trust on the part of the population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los médicos, la  EMA y la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "physicians, the EMA and the WHO"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "confían en esta vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "trust in this vaccine"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha producido una situación compleja",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there has been a complex situation"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la falta de confianza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "lack of confidence"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "population"
                    }
                ],
                "evidences": [
                    {
                        "value": "Engagement and communication were further, additional predictors of vaccine willingness. False information about the virus, most likely to emerge from social media, has been shown to be negatively associated with COVID-19 health protective behaviour 38 , including vaccine willingness 20 where vaccine uptake, and choice of vaccine, has been particularly politically contentious. Polling data collected co-temporaneous to our Hungarian study showed political divisions between those willing to vaccinate with a Hungarian government approved vaccine (including Russian and Chinese vaccines at that time not approved by the European Medicines Agency(EMA)) and those on the political left more likely to endorse the EMA recommended Pfizer or Moderna vaccines 51 .",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9945793152
                    }
                ]
            },
            {
                "text": "Italia reanudó el viernes 19 de marzo la vacunación con AstraZeneca, tras unos días en suspensión, de la misma forma que lo hicieron otros países, incluido España.",
                "text_en": "Italy resumed vaccination with AstraZeneca on Friday, March 19, after a few days in suspension, just as other countries, including Spain, did.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reanudó el viernes 19 de marzo la vacunación con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He resumed vaccination with AstraZeneca on Friday, March 19th."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el viernes 19 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Friday, 19 March"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo hicieron",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They did."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "otros países, incluido España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "other countries, including Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Consejo Superior de Sanidad, Franco Locatelli, recordó que la información que analizó la EMA hace referencia a veinte millones de personas que han sido vacunadas con AstraZeneca en la Unión Europea y el Reino Unido.",
                "text_en": "The Higher Health Council, Franco Locatelli, recalled that the information analysed by the EMA refers to 20 million people who have been vaccinated with AstraZeneca in the European Union and the United Kingdom.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Consejo Superior de Sanidad, Franco Locatelli",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Higher Health Council, Franco Locatelli"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recordó que la información que analizó la EMA hace referencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recalled that the information analysed by the EMA refers to"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a veinte millones de personas que han sido vacunadas con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "20 million people who have been vaccinated with AstraZeneca"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Unión Europea y el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the European Union and the United Kingdom"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y de estas se han detectado 25 casos de trombosis.",
                "text_en": "And of these, 25 cases of thrombosis have been detected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han detectado 25 casos de trombosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "25 cases of thrombosis have been detected"
                    }
                ],
                "evidences": [
                    {
                        "value": "The European Medicine Agency (EMA) has examined eight cases of thrombosis associated with thrombocytopenia in individuals who got vaccinated Janssen's COVID-19 vaccine in the U.S. These extremely rare forms of thrombosis (with thrombocytopenia) involved venous thrombosis, mostly in odd locations including splanchnic vein thrombosis, cerebral venous sinus thrombosis, and arterial thrombosis along with a lethal consequence in one case. Within three weeks of vaccination, all cases were observed in individuals aged below 60, mostly in females. These cases were strikingly similar to those reported with AstraZeneca's COVID-19 vaccine, Vaxzevria. In terms of mechanism, the vaccine is considered to induce an immune response resulting in HIT-like disorder. In this stage, the pathophysiological mechanism is not well defined, and it is difficult to identify particular risk factors. Healthcare practitioners should know the clinical aspects of thromboembolism and thrombocytopenia to be able to provide treatments to patients at the earliest according to the available guidelines. Thrombosis associated with thrombocytopenia also necessitates specialized clinical management. For diagnosing and treating this disorder, healthcare practitioners should refer to relevant guidelines and/or consult specialists (e.g., hematologists and coagulation specialists) (Irani et al., 2019) .",
                        "score": 0.6399999857
                    },
                    {
                        "value": "In this nationwide analysis of hospitalizations for viral pneumonias, thrombosis occurred in 5% of cases. Although substantial, this is significantly lower than thrombosis observed in patients hospitalized with COVID-19. Investigations into mechanisms of thrombosis and risk reduction strategies in COVID-19 and other viral respiratory infections are necessary. ",
                        "score": 0.6499999762
                    },
                    {
                        "value": "Thrombosis plays a pivotal role in COVID-19 associated clinical outcomes. There is increasing evidence supporting the impact of thrombosis on disease worsening, tissue damage, and deaths. A recent study aimed to assess and compare throm-botic risks between COVID-19 patients having respiratory distress syndrome and non-COVID-19 ARDS patients (46) . A total of 64 thrombotic events in 150 patients (mainly pulmonary embolisms, hemodialysis fistula circuit clotting, etc.) were observed, and significantly more thrombotic complications were present among COVID-19 associated respiratory distress syndrome patients when compared to non-COVID-19 ARDS patients, despite regular anticoagulant therapy (46) .",
                        "score": 0.6600000262
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9978466034
                    },
                    {
                        "label": "neutral",
                        "score": 0.9991143346
                    },
                    {
                        "label": "neutral",
                        "score": 0.9659609795
                    }
                ]
            },
            {
                "text": "En concreto se trata de siete de coagulación intravascular diseminada y de 18 de trombosis venosa cerebral.",
                "text_en": "Specifically, these are seven of diffused intravascular coagulation and 18 of cerebral venous thrombosis.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de siete de coagulación intravascular diseminada y de 18 de trombosis venosa cerebral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of seven diffused intravascular coagulation and 18 cerebral venous thrombosis"
                    }
                ],
                "evidences": [
                    {
                        "value": "When analysing a study of 361 subjects, in which 39.8% had a BMI of 25-30 kg/m 2 and 24.1% a BMI of higher than or equal to 30 kg/m 2 , disseminated intravascular coagulation (DIC) was seen in 8 patients (2.1%). Seven (88%) patients with over-disseminated intravascular coagulation (DIC) died during hospitalisation [18] . It can be assumed that the increased inflammatory state associated with obesity might have been a factor in the development of this complication.",
                        "score": 0.5400000215
                    },
                    {
                        "value": "In our mixed methods scoping review, we were able to identify clinical evidence of a COVID-19-related coagulopathy. We found evidence of ARDS, sepsis and disseminated intravascular coagulation in cases with thromboembolic complications. However we also found evidence of cases where ARDS, sepsis or disseminated intravascular coagulation had either not been confirmed or else had been excluded. Since ARDS, sepsis and disseminated intravascular coagulation have well-established causal links with thromboembolic events ARDS, disseminated intravascular coagulation and sepsis are likely to account for a subset of the thromboembolic events seen in COVID-19. Given the evidence for additional mechanisms associated with coagulopathy, we can demonstrate more generally that COVID-19 is a polycoagulopathy mediated by multiple coagulation mechanisms (MCM's).",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9979288578
                    },
                    {
                        "label": "neutral",
                        "score": 0.9391178489
                    }
                ]
            },
            {
                "text": "Hay más reacciones que vienen de Italia, pues el primer ministro italiano, Mario Draghi, aseguró que se vacunará con el fármaco británico en cuanto pueda.",
                "text_en": "There are more reactions coming from Italy, as Italian Prime Minister Mario Draghi assured that he will be vaccinated with the British drug as soon as he can.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el primer ministro italiano, Mario Draghi",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italian Prime Minister Mario Draghi"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aseguró que se vacunará con el fármaco británico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "assured that he will be vaccinated with the British drug"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en cuanto pueda",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "as soon as possible."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por el momento desconocemos si otros países harán como Italia que ha determinado que los que no quieran la vacuna de AstraZeneca podrán recibir otra.",
                "text_en": "For the moment we do not know whether other countries will do like Italy that has determined that those who do not want the AstraZeneca vaccine will be able to receive another.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Por el momento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "For the moment"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desconocemos si otros países harán como Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "we do not know if other countries will do like Italy"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "otros países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "other countries"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "4": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 14,
            "WhatReliabilityReliable": 4,
            "WhatReliabilityUnreliable": 10,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 13,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 8,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 3,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 12,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 6,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEl Ministerio de Sanidad de Sánchez 24 horas antes de que Boris Johnson dijera que la cepa británica es un 30% más letal: «No agrava la enfermedad»\n\n<PARAGRAPH>\n\nVaya por delante y algún periodista con dos dedos de frente tendría que reflexionar sobre ello, que en los medios de comunicación españoles y esto incluye desde cadenas de televisión a periódicos nacionales, se dice y escribe ‘cepa británica’, en referencia a la contagiosa variedad de coronavirus que salió de allí, pero nadie se atreve ni se ha osado hablar de ‘peste china’ para hacer alusión a la pandemia que salió de Wuhan.\n\n<PARAGRAPH>\n\nEs un detalle, casi nimio, pero ayuda a entender la tremenda estupidez y la ovina actitud de buena parte del periodismo español.\n\n<PARAGRAPH>\n\nY ahora al tema que nos ocupa, que es mucho más relevante porque vuelven a morir ciudadanos como moscas.\n\n<PARAGRAPH>\n\nEl Ministerio de Sanidad de Salvador Illa ha tardado más de un mes en realizar un informe sobre la cepa británica que ha sido desmontado por el mismísimo Boris Johnson en menos de 24 horas.\n\n<PARAGRAPH>\n\nA media tarde, el departamento de Illa, que está pensando más en las elecciones catalanas que en hacer frente a la pandemia, hacía público un documento en el que, a grandes rasgos, aseguraba que la cepa británica «es más transmisible», pero «no tiene mayor riesgo» de causar una enfermedad grave.\n\n<PARAGRAPH>\n\nPues bien: horas después, el primer ministro británico aseguraba que «nos han informado que, además de propagarse más rápidamente, ahora hay evidencias científicas de que la nueva variante, descubierta por primera vez en Londres y el sureste de Inglaterra, puede ligarse a un mayor grado de mortalidad».\n\n<PARAGRAPH>\n\nEse mayor grado de mortalidad se cifra en un 30%, de modo que el estudio del Ministerio de Sanidad que asegura que la cepa británica «no tiene mayor riesgo» de causar enfermedad grave ha quedado absolutamente en entredicho nada más ver la luz.\n\n<BREAK>\n\nO sea, que ha durado lo que un caramelo a la puerta de un colegio.\n\n<PARAGRAPH>\n\nSi ésta es la eficacia de los estudios de Sanidad, que Dios nos coja confesados, como dicen en OKdiario.\n\n<PARAGRAPH>\n\nVamos a ver: si se tarda un mes en elaborar un estudio sobre los riegos de la nueva cepa, lo que no puede ser es que el documento esté lleno de lugares comunes y obviedades.\n\n<BREAK>\n\nPara decir que «es más transmisible, pero no tiene mayor riesgo de enfermedad» no hacía falta tomarse tanto tiempo.\n\n<BREAK>\n\nEso es lo que se aseguraba sobre la nueva variante a finales de diciembre.\n\n<PARAGRAPH>\n\nEl problema está en que ese «estudio» del Ministerio de Sanidad es un corte y pega carente de hondura, un churro desde el punto de vista técnico y profesional.\n\n<PARAGRAPH>\n\nBoris Johnson ha triturado el informe del departamento de Salvador Illa en un santiamén.\n\n<BREAK>\n\nPor decirlo suavemente, lo ha dejado desnudo de argumentos.\n\n<PARAGRAPH>\n\nAunque, en realidad, argumentos no tenía ninguno.\n\n<PARAGRAPH>\n",
        "TITLE": "Coronavirus: estamos en manos de un Gobierno irresponsable trufado de ‘expertos’ incompetentes",
        "ID": "NF_04-11-2021_20-54-08_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Coronavirus: estamos en manos de un Gobierno irresponsable trufado de ‘expertos’ incompetentes",
                "text_en": "Coronavirus: We are in the hands of an irresponsible government of incompetent ‘experts’",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estamos en manos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We're in hands."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un Gobierno irresponsable trufado de ‘expertos’ incompetentes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "an irresponsible trufated government of incompetent ‘experts’"
                    }
                ],
                "evidences": [
                    {
                        "value": "Keyword choice depended on country-specific factors relevant to the U.K. The name officially recognised by WHO is Coronavirus Disease 2019 [7] ; the RSV for 'Coronavirus' (virus) was used for analyses as this is the name used in U.K. government press releases and by the National Health Service (NHS) (Supplementary Table S2 ). Data on Coronavirus 'Virus', was used as this includes data allowing for spelling variations and assesses semantic meaning of searching. 'Handwashing' (search term) was purposely chosen as being the term used in a Department of Health media campaign run in March 2020 [8] . Google does not provide data for 'handwashing' as a topic. Similarly, 'face mask' is the wording used in official press releases and thus was chosen for analyses. Data on 'face mask' as a 'search term' was used as it correlated better with case numbers than that for 'topic' (Supplementary Table S3 ).",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8533684015
                    }
                ]
            },
            {
                "text": "El Ministerio de Sanidad de Sánchez 24 horas antes de que Boris Johnson dijera que la cepa británica es un 30% más letal: «No agrava la enfermedad»",
                "text_en": "Sánchez's Ministry of Health 24 hours before Boris Johnson said that the British strain is 30% more lethal: \"It does not aggravate the disease\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Ministerio de Sanidad de Sánchez",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The Ministry of Health of Sánchez"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "24 horas antes de que Boris Johnson dijera que la cepa británica es un 30% más letal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "24 hours before Boris Johnson said the British strain is 30% more lethal"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Boris Johnson",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Boris Johnson"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No agrava la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Does not aggravate the disease"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Vaya por delante y algún periodista con dos dedos de frente tendría que reflexionar sobre ello, que en los medios de comunicación españoles y esto incluye desde cadenas de televisión a periódicos nacionales, se dice y escribe ‘cepa británica’, en referencia a la contagiosa variedad de coronavirus que salió de allí, pero nadie se atreve ni se ha osado hablar de ‘peste china’ para hacer alusión a la pandemia que salió de Wuhan.",
                "text_en": "Go ahead and some journalist with two fingers of front would have to reflect on it, which in the Spanish media and this includes from television channels to national newspapers, it is said and written ‘British strain’, in reference to the contagious variety of coronavirus that came out of there, but no one dares or dares to speak of ‘Chinese pest’ to allude to the pandemic that came out of Wuhan.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "algún periodista con dos dedos de frente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "some journalist with two fingers in front"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tendría que reflexionar sobre ello",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I'd have to think about it."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los medios de comunicación españoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Spanish media"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es un detalle, casi nimio, pero ayuda a entender la tremenda estupidez y la ovina actitud de buena parte del periodismo español.",
                "text_en": "It is a detail, almost insignificant, but it helps to understand the tremendous stupidity and the sheep attitude of much of Spanish journalism.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ayuda a entender la tremenda estupidez y la ovina actitud",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "helps to understand the tremendous stupidity and the sheep attitude"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "buena parte del periodismo español",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "much of Spanish journalism"
                    }
                ],
                "evidences": [
                    {
                        "value": "Media plays a crucial role in creating a globally informed society, and journalism carries the responsibility of playing that role. It is exactly that professional attitude is an important quality that separates true journalist from writers of the news or facts, as it was reflected in the words of the Minister of Defense of the Spanish Government, Margarita Robles: \"Journalism is more necessary than ever and citizens value its public service role. They are the oxygen of democracy, their role as informants, and public opinion makers makes them essential. For this reason, at this time is when it is more necessary for the media to exercise journalism responsibly, providing information of general and proven interest.\" 1 The digital transformation of the media. A compromised quality?",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.99545151
                    }
                ]
            },
            {
                "text": "Y ahora al tema que nos ocupa, que es mucho más relevante porque vuelven a morir ciudadanos como moscas.",
                "text_en": "And now to the issue before us, which is much more relevant because citizens like flies are dying again.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "al tema que nos ocupa, que es mucho más relevante",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the issue at hand, which is much more relevant"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque vuelven a morir ciudadanos como moscas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because citizens die again like flies"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Ministerio de Sanidad de Salvador Illa ha tardado más de un mes en realizar un informe sobre la cepa británica que ha sido desmontado por el mismísimo Boris Johnson en menos de 24 horas.",
                "text_en": "Salvador Illa's Ministry of Health has taken more than a month to produce a report on the British strain that has been disassembled by Boris Johnson himself in less than 24 hours.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Ministerio de Sanidad de Salvador Illa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The Ministry of Health of Salvador Illa"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha tardado más de un mes en realizar un informe sobre la cepa británica que ha sido desmontado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has taken more than a month to make a report on the British strain that has been disassembled"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el mismísimo Boris Johnson",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Boris Johnson himself"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en menos de 24 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in less than 24 hours"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A media tarde, el departamento de Illa, que está pensando más en las elecciones catalanas que en hacer frente a la pandemia, hacía público un documento en el que, a grandes rasgos, aseguraba que la cepa británica «es más transmisible», pero «no tiene mayor riesgo» de causar una enfermedad grave.",
                "text_en": "In the middle of the afternoon, the department of Illa, which is thinking more of the Catalan elections than of dealing with the pandemic, made public a document in which, in general, it ensured that the British strain \"is more transmissible\", but \"has no greater risk\" of causing a serious disease.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "A media tarde",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Mid-afternoon"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el departamento de Illa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the department of Illa"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aseguraba que la cepa británica «es más transmisible», pero «no tiene mayor riesgo» de causar una enfermedad grave",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "claimed that the British strain ‘is more transmissible’, but ‘has no greater risk’ of causing a serious disease"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pues bien: horas después, el primer ministro británico aseguraba que «nos han informado que, además de propagarse más rápidamente, ahora hay evidencias científicas de que la nueva variante, descubierta por primera vez en Londres y el sureste de Inglaterra, puede ligarse a un mayor grado de mortalidad».",
                "text_en": "Well: hours later, the British Prime Minister assured us that “we have been informed that, in addition to spreading more quickly, there is now scientific evidence that the new variant, first discovered in London and southeastern England, can be linked to a higher degree of mortality.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "horas después",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "hours later"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el primer ministro británico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the British Prime Minister"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "más rápidamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "faster"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Londres y el sureste de Inglaterra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "London and South East England"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puede ligarse a un mayor grado de mortalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "may be linked to a higher degree of mortality"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ese mayor grado de mortalidad se cifra en un 30%, de modo que el estudio del Ministerio de Sanidad que asegura que la cepa británica «no tiene mayor riesgo» de causar enfermedad grave ha quedado absolutamente en entredicho nada más ver la luz.",
                "text_en": "The higher mortality rate is 30%, so the study by the Ministry of Health, which ensures that the British strain ‘has no greater risk’ of causing serious disease, is absolutely at stake as soon as it sees the light.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el estudio del Ministerio de Sanidad que asegura que la cepa británica «no tiene mayor riesgo» de causar enfermedad grave ha quedado absolutamente en entredicho",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the study by the Ministry of Health which ensures that the British strain ‘has no greater risk’ of causing serious disease has been absolutely questioned"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Vamos a ver: si se tarda un mes en elaborar un estudio sobre los riegos de la nueva cepa, lo que no puede ser es que el documento esté lleno de lugares comunes y obviedades.",
                "text_en": "Let's see: if it takes a month to prepare a study on the irrigations of the new strain, what can't be is that the document is full of common places and obviations.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el documento esté lleno de lugares comunes y obviedades",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the document is full of common places and obviations"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Eso es lo que se aseguraba sobre la nueva variante a finales de diciembre.",
                "text_en": "That is what was assured about the new variant at the end of December.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se aseguraba sobre la nueva variante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was secured on the new variant"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a finales de diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "end of December"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El problema está en que ese «estudio» del Ministerio de Sanidad es un corte y pega carente de hondura, un churro desde el punto de vista técnico y profesional.",
                "text_en": "The problem is that this \"study\" of the Ministry of Health is a cut and paste lacking in depth, a churro from a technical and professional point of view.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El problema está en que ese «estudio» del Ministerio de Sanidad es un corte y pega carente de hondura",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The problem is that this \"study\" of the Ministry of Health is a cut and paste without depth"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "desde el punto de vista técnico y profesional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from a technical and professional point of view"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Boris Johnson ha triturado el informe del departamento de Salvador Illa en un santiamén.",
                "text_en": "Boris Johnson shredded Salvador Illa's department report in no time.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Boris Johnson",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Boris Johnson"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha triturado el informe",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "shredded the report."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "departamento de Salvador Illa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "department of Salvador Illa"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en un santiamén",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in a jiffy"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aunque, en realidad, argumentos no tenía ninguno.",
                "text_en": "Although, actually, I didn't have any arguments.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "argumentos no tenía ninguno",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I didn't have any arguments."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "5": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 2,
            "Body": 0,
            "Conclusion": 1,
            "What": 12,
            "WhatReliabilityReliable": 4,
            "WhatReliabilityUnreliable": 8,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 2,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 18,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 8,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 1,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 1,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 7,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 5,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 2,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 8,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nUnos 90 voluntarios de entre 18 y 30 años serán inoculados con la variante británica, en un estudio aprobado por un comité de ética\n\n<PARAGRAPH>\n\nReino Unido está dispuesto a vencer al COVID-19 y empleará una investigación a fondo de la enfermedad en sus propios ciudadanos.\n\n<PARAGRAPH>\n\nLa nación iniciará en las próximas semanas pruebas clínicas para comprobar la efectividad de fármacos y vacunas contra la COVID-19 en las que se infectará a personas sanas, informó el Ministerio de Empresa, Energía y Estrategia Industrial.\n\n<PARAGRAPH>\n\nEl ministerio dice que el Reino Unido será el primer país del mundo que efectúe este tipo de estudios en esta pandemia, después de que hayan sido aprobados por un comité de ética.\n\n<PARAGRAPH>\n\nA partir de marzo, en torno a 90 voluntarios de entre 18 y 30 años, que serán compensados por su participación, serán inoculados de manera segura y controlada para determinar, en una primera fase, la cantidad mínima de virus requerida para que se genere infección, lo que facilitará después probar vacunas y fármacos.\n\n<PARAGRAPH>\n\nCuando se haya determinado ese dato, la intención es administrar vacunas consideradas seguras a un pequeño grupo de voluntarios a los que se infectará con el virus, a fin de comprobar la reacción inmune y que esto sirva para afinar y acelerar los ensayos de los preparados a mayor escala.\n\n<PARAGRAPH>\n\nLa variante del virus con la que se infectará inicialmente a los voluntarios, que están ahora siendo reclutados, será la que circula en el Reino Unido desde marzo de 2020 y que se ha demostrado que es de bajo riesgo para adultos jóvenes sanos, se señala en la nota.\n\n<PARAGRAPH>\n\nEl ensayo tiene una inversión de 45 millones de dólares por parte del gobierno.\n\n<BREAK>\n\nLos investigadores también están colaborando estrechamente con las autoridades sanitarias para garantizar que el estudio no afecte a la capacidad del sistema hospitalario de atender a los pacientes durante la pandemia.\n\n<PARAGRAPH>\n\n“Aunque el desarrollo de las vacunas ha avanzado de forma muy positiva, queremos encontrar las mejores y más eficaces vacunas para su uso a largo plazo.\n\n<BREAK>\n\nEstos estudios de desafío en humanos se llevarán a cabo aquí en el Reino Unido y ayudarán a acelerar el conocimiento de los científicos sobre cómo el coronavirus afecta a las personas y, en última instancia, podría impulsar el rápido desarrollo de vacunas”, dijo Kwasi Kwarteng, Secretario de Estado de Estrategia Empresarial, Energética y Industrial.\n\n<PARAGRAPH>\n\nLos estudios donde se infecta a personas sanas -en lugar de esperar a que se contagien de forma natural, como se ha hecho hasta ahora en el desarrollo de las vacunas anticovid- se usan ya para la generación de vacunas y tratamientos contra enfermedades como la malaria, fiebre tifoidea, resfriado común, gripe o norovirus.\n\n<PARAGRAPH>\n",
        "TITLE": "Reino Unido infectará con COVID a ciudadanos para probar fármacos y vacunas",
        "ID": "NF_04-11-2021_22-15-46_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Reino Unido infectará con COVID a ciudadanos para probar fármacos y vacunas",
                "text_en": "UK will infect citizens with COVID to test drugs and vaccines",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "infectará",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "will infect"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con COVID",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with COVID"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a ciudadanos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "citizens"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "probar fármacos y vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "testing drugs and vaccines"
                    }
                ],
                "evidences": [
                    {
                        "value": "Recombinant adenoviral vectors expressing SARS-CoV-2 spike protein/RBD A number of other institutions/companies in China, UK, Russia, and USA developed recombinant adenoviral vector expressing the COVID-19 genes as vaccines. China has a version based on the human adenovirus vector (rAd5 backbone). United Kingdom (Oxford University) has a version (code name AZD1222) that is based on a simian adenoviral vector. A multinational company also has a similar vaccine based on Ad26 backbone (code name Ad.26.CoV2.S or JNJ-78436725), which have data suggesting that one dose may be enough. Russia has a COVID-19 vaccine (code name Sputnik V) that uses two recombinant adenovirus backbone, with one dose using the rAd5 and the other dose using the rAd26 to reduce the interference by the host immunity against the 98 In this phase 2 trial, the vaccine was found to induce significant immune responses in the majority of the recipients after a single immunization. No data from their phase 3 study are available at the time that this review was prepared.",
                        "score": 0.5600000024
                    },
                    {
                        "value": "Our finding of 23% of UK HCWs being SARS-CoV-2 vaccine hesitant is in keeping with a recent systematic review of COVID-19 vaccine uptake, which found an average acceptance of 57% (range 28%-78%) across countries and occupation groups [8] . Many smaller SARS-CoV-2 vaccine hesitancy studies have been conducted outside the UK with common predictors of vaccine hesitancy being female sex, nonmedical occupation, lack of influenza vaccination and lower perceived risk of COVID-19 [6, 7, [40] [41] [42] . Vaccine hesitancy amongst female HCWs, in particular, is an important finding given that females make up a significant proportion of the UK healthcare workforce and further work to understand this is urgently required. There is conflicting evidence regarding the effect of age and previous COVID-19 on SARS-CoV-2 vaccine hesitancy [40,43À45] . Importantly, only two studies, both conducted in the US, examined the impact of ethnicity on SARS-CoV-2 vaccine hesitancy after adjustment for confounders, with both finding that Black ethnic groups were more likely to be hesitant compared to White HCWs [44, 45] . Whilst data on vaccine hesitancy in UK HCWs are limited, recent work examining vaccine uptake amongst hospital staff in the UK found that 35¢5% of HCWs had not been vaccinated; vaccination rates were highest amongst White HCWs and, in-line with our findings, lowest among Black ethnic groups [12] .",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9940652847
                    },
                    {
                        "label": "neutral",
                        "score": 0.9713826776
                    }
                ]
            },
            {
                "text": "Unos 90 voluntarios de entre 18 y 30 años serán inoculados con la variante británica, en un estudio aprobado por un comité de ética",
                "text_en": "About 90 volunteers aged between 18 and 30 will be inoculated with the British variant, in a study approved by an ethics committee",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Unos 90 voluntarios de entre 18 y 30 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "About 90 volunteers aged between 18 and 30"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "serán inoculados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "shall be inoculated"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la variante británica",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with the British variant"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un estudio aprobado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in an approved study"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un comité de ética",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "an ethics committee"
                    }
                ],
                "evidences": [
                    {
                        "value": "In total, 23 healthy volunteers (6 female and 17 male), aged 18 to 30 years, were recruited for this study at the Eye Center, Renmin Hospital of Wuhan University between July 2020 and August 2020.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9597833157
                    }
                ]
            },
            {
                "text": "Reino Unido está dispuesto a vencer al COVID-19 y empleará una investigación a fondo de la enfermedad en sus propios ciudadanos.",
                "text_en": "The United Kingdom is ready to beat COVID-19 and will employ in-depth research on the disease in its own citizens.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está dispuesto a vencer al COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is willing to beat COVID-19"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "empleará una investigación a fondo de la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "use an in-depth investigation of the disease"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en sus propios ciudadanos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in their own citizens"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La nación iniciará en las próximas semanas pruebas clínicas para comprobar la efectividad de fármacos y vacunas contra la COVID-19 en las que se infectará a personas sanas, informó el Ministerio de Empresa, Energía y Estrategia Industrial.",
                "text_en": "The nation will begin clinical trials in the coming weeks to check the effectiveness of drugs and vaccines against COVID-19 in which healthy people will be infected, the Ministry of Enterprise, Energy and Industrial Strategy reported.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La nación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The nation"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las próximas semanas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the coming weeks"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pruebas clínicas para comprobar la efectividad de fármacos y vacunas contra la COVID-19",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "clinical trials to check the effectiveness of drugs and vaccines against COVID-19"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en las que se infectará a personas sanas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in which healthy people will be infected"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Empresa, Energía y Estrategia Industrial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Enterprise, Energy and Industrial Strategy"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El ministerio dice que el Reino Unido será el primer país del mundo que efectúe este tipo de estudios en esta pandemia, después de que hayan sido aprobados por un comité de ética.",
                "text_en": "The ministry says that the UK will be the first country in the world to carry out such studies in this pandemic, after they have been approved by an ethics committee.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "será el primer país del mundo que efectúe este tipo de estudios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "will be the first country in the world to carry out such studies"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en esta pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in this pandemic"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "después de que hayan sido aprobados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after they have been approved"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por un comité de ética",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by an ethics committee"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A partir de marzo, en torno a 90 voluntarios de entre 18 y 30 años, que serán compensados por su participación, serán inoculados de manera segura y controlada para determinar, en una primera fase, la cantidad mínima de virus requerida para que se genere infección, lo que facilitará después probar vacunas y fármacos.",
                "text_en": "Starting in March, around 90 volunteers between 18 and 30 years of age, who will be compensated for their participation, will be safely and controlled to determine, in a first phase, the minimum amount of virus required to generate infection, which will then facilitate the testing of vaccines and drugs.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "A partir de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "From March"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en torno a 90 voluntarios de entre 18 y 30 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "around 90 volunteers aged between 18 and 30"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "serán inoculados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "shall be inoculated"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de manera segura y controlada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in a safe and controlled manner"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cuando se haya determinado ese dato, la intención es administrar vacunas consideradas seguras a un pequeño grupo de voluntarios a los que se infectará con el virus, a fin de comprobar la reacción inmune y que esto sirva para afinar y acelerar los ensayos de los preparados a mayor escala.",
                "text_en": "When this data has been established, the intention is to deliver vaccines considered safe to a small group of volunteers who will be infected with the virus, in order to check the immune reaction and that this serves to fine-tune and accelerate trials of preparations on a larger scale.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la intención es administrar vacunas consideradas seguras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the intention is to administer vaccines considered safe"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un pequeño grupo de voluntarios a los que se infectará con el virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a small group of volunteers who will be infected with the virus"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a fin de comprobar la reacción inmune",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to check the immune reaction"
                    }
                ],
                "evidences": [
                    {
                        "value": "Beliefs and concerns about COVID-19 vaccines were the strongest predictor of intended vaccine uptake. This is in keeping with evidence from an earlier study conducted between September and October 2020 (prior to the UK COVID-19 vaccination programme commencing) which found that beliefs around the efficacy, development, risks and importance of COVID-19 vaccines strongly predicted intention to accept a vaccine. 15 Our study also found beliefs and concerns around COVID-19 illness consistently predict vaccination intention. Our analysis was not able to consider structural reasons that determine vaccination intention beyond the role of missing work and education. Specifically, we did not measure conspiratorial beliefs and views of healthcare and medicine which have been previously found to predict vaccination intention to some degree.",
                        "score": 0.5600000024
                    },
                    {
                        "value": "The purpose of vaccination is to protect individuals from infection and transmission. Although the emergency use authorization for some of the COVID-19 vaccines has been approved by the Food and Drug Administration in the US and the Department of Health and Human Services of each country, the vaccines' efficacy and side effects have not yet been comprehensively discussed, although popular media and politicians have made many unsubstantiated claims. Therefore, in the current meta-analysis, we provide systematic and comprehensive data regarding the vaccines' safety, efficacy, and immunogenicity against SARS-CoV-2. Here, we mainly focused on available RCTs publications on the safety, efficacy, and immunogenicity of COVID-19 vaccines.",
                        "score": 0.6200000048
                    },
                    {
                        "value": "Despite the uncertainties in efficacy and safety, vaccines are expected to be the single most effective intervention to bring the COVID-19 pandemic to a resolution. To achieve fair and equitable access to vaccines, ethical principles should be upheld to overcome vaccination nationalism and, at the same time, to guarantee efficient access for individuals/countries in greater need (17-18). The moral imperative for equitable access to vaccines ultimately also serves the utilitarian purpose of selfprotection by vaccinating others.",
                        "score": 0.6600000262
                    },
                    {
                        "value": "This is a study of two experimental vaccines for prevention of avian influenza (\"bird flu\"). \"Experimental\" means that the study vaccines have not been approved by the Food and Drug Administration (FDA) for preventing of avian influenza infection. The FDA allows their use in research only. It is not known if the vaccines work. The plan is to enroll about 30 people in this study. The main purpose of this study is to see if the experimental vaccines are safe and whether there are any side effects. We also want to study immune responses to these vaccines.",
                        "score": 0.5600000024
                    },
                    {
                        "value": "Since the COVID-19 pandemic emerged and spread on a large scale, scientists around the world continue to engage relentless efforts to develop SARS-CoV-2 vaccines, including spike-based DNA/RNA vaccines, inactivated virus vaccines, live attenuated virus vaccines, recombinant viral-vectored vaccines, and protein subunit vaccines. Vaccine design considerations include the selection of antigens, vaccine platforms, and vaccination routes and regimens. The main purpose of developing a SARS-CoV-2 vaccine is to generate a sustained memory humoral immune response and to produce specific NAbs to prevent the entry of SARS-CoV-2 into host cells. We propose that vaccines designed to elicit specific NAbs will be effective in preventing SARS-CoV-2 infections.",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9981814623
                    },
                    {
                        "label": "neutral",
                        "score": 0.9954633117
                    },
                    {
                        "label": "neutral",
                        "score": 0.9983520508
                    },
                    {
                        "label": "neutral",
                        "score": 0.9956768155
                    },
                    {
                        "label": "neutral",
                        "score": 0.9993853569
                    }
                ]
            },
            {
                "text": "La variante del virus con la que se infectará inicialmente a los voluntarios, que están ahora siendo reclutados, será la que circula en el Reino Unido desde marzo de 2020 y que se ha demostrado que es de bajo riesgo para adultos jóvenes sanos, se señala en la nota.",
                "text_en": "The variant of the virus with which volunteers will initially be infected, who are now being recruited, will be the one circulating in the United Kingdom since March 2020 and which has been shown to be of low risk to healthy young adults, is noted in the note.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "variante del virus con la que se infectará inicialmente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "variant of the virus with which you will initially become infected"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los voluntarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to volunteers"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in the United Kingdom"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde marzo de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since March 2020"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El ensayo tiene una inversión de 45 millones de dólares por parte del gobierno.",
                "text_en": "The trial has an investment of $45 million from the government.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El ensayo tiene una inversión de 45 millones de dólares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The trial has an investment of 45 million dollars"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los investigadores también están colaborando estrechamente con las autoridades sanitarias para garantizar que el estudio no afecte a la capacidad del sistema hospitalario de atender a los pacientes durante la pandemia.",
                "text_en": "Researchers are also working closely with health authorities to ensure that the study does not affect the ability of the hospital system to care for patients during the pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los investigadores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Investigators"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están colaborando estrechamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are working closely together"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las autoridades sanitarias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "health authorities"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estos estudios de desafío en humanos se llevarán a cabo aquí en el Reino Unido y ayudarán a acelerar el conocimiento de los científicos sobre cómo el coronavirus afecta a las personas y, en última instancia, podría impulsar el rápido desarrollo de vacunas”, dijo Kwasi Kwarteng, Secretario de Estado de Estrategia Empresarial, Energética y Industrial.",
                "text_en": "These human challenge studies will be carried out here in the UK and will help accelerate scientists’ knowledge of how coronavirus affects people and ultimately could boost rapid vaccine development,” said Kwasi Kwarteng, Secretary of State for Business, Energy and Industrial Strategy.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estos estudios de desafío en humanos se llevarán a cabo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "These human challenge studies will be carried out"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "aquí en el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "here in the United Kingdom"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Kwasi Kwarteng, Secretario de Estado de Estrategia Empresarial, Energética y Industrial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Kwasi Kwarteng, Secretary of State for Business, Energy and Industrial Strategy"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los estudios donde se infecta a personas sanas -en lugar de esperar a que se contagien de forma natural, como se ha hecho hasta ahora en el desarrollo de las vacunas anticovid- se usan ya para la generación de vacunas y tratamientos contra enfermedades como la malaria, fiebre tifoidea, resfriado común, gripe o norovirus.",
                "text_en": "Studies where healthy people are infected - rather than waiting for them to become infected naturally, as has been done so far in the development of anti-covid vaccines - are already used for the generation of vaccines and treatments for diseases such as malaria, typhoid fever, common cold, flu or norovirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los estudios donde se infecta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Studies where you become infected"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a personas sanas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to healthy people"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "la generación de vacunas y tratamientos contra enfermedades como la malaria, fiebre tifoidea, resfriado común, gripe o norovirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the generation of vaccines and treatments for diseases such as malaria, typhoid fever, common cold, flu or norovirus"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "6": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 13,
            "WhatReliabilityReliable": 12,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 7,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 1,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 4,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 7,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nYa todos hemos oído hablar del concepto de fatiga pandémica y es que estamos bastante cansado de esta situación que nos ha tocado vivir ligada a la pandemia de la Covid.\n\n<BREAK>\n\nLa Sociedad Española de Neumología y Cirugía Torácica (SEPAR) la asocia a los problemas de sueño.“La fatiga pandémica conlleva un aspecto negativo y es que la ciudadanía deja de buscar información relacionada con la COVID-19 y, además, se produce una relajación con las medidas necesarias para prevenirla.\n\n<BREAK>\n\nMuchas personas dejan de cumplir las medidas como hacían al principio”, advierte la Dra.\n\n<BREAK>\n\nOlga Mediano, neumóloga y coordinadora del Área de Apnea del Sueño de SEPAR.Actualmente, en torno al 30% de la población tiene confirmado alguno de estos síntomas de la fatiga pandémica.\n\n<BREAK>\n\n“Aunque afecta a toda la población, no lo hace por igual en todos los colectivos.\n\n<BREAK>\n\nLos adolescentes y jóvenes se encuentran más afectados por la fatiga pandémica porque tienen menor tolerancia a las restricciones relativas a no salir y a otras normas que hay que cumplir”.Y está relacionado con el sueño porque, al estar en casa, algunas personas no tienen la obligación de levantarse para ir a trabajar u otra ocupación.\n\n<BREAK>\n\nA veces resulta complicado controlar el horario para levantarse, dormir la siesta o irse a la cama ni los horarios de las comidas, al no salir o comer solos.Según SEPAR, la falta de exposición a la luz solar también afecta, pues al no salir a la calle, la melatonina -hormona que produce la glándula pineal del cerebro y que este produce para ayudar a conciliar el sueño- no se regula bien.La melatonina ayuda a estar despiertos o dormidos.\n\n<BREAK>\n\nAl levantarse, salir a la calle y con la exposición a la luz solar, se inhibe y estamos despiertos.\n\n<BREAK>\n\nY, durante la noche, se activa y nos ayuda a quedarnos dormidos.Mientras que la Sociedad también da a conocer que el insomnio es el otro gran trastorno consecuencia de muchas de las patologías y problemas relacionados con la pandemia.Pues se duerme peor porque muchas personas se encuentran sometidas a una gran ansiedad y depresión al tener problemas económicos, laborales, de conciliación o familiares enfermos, entre otros, y no son capaces de quedarse dormidas cuando regresan a casa.También se despiertan antes de hora y no son capaces de volver a dormirse, de modo que padecen insomnio de despertar precoz.\n\n<BREAK>\n\nDe ahí que surjan problemas de sueño y se asocien directamente a la fatiga pandémica ",
        "TITLE": "Los problemas de sueño se asocian a la fatiga pandémica",
        "ID": "NF_04-11-2021_21-37-27_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Los problemas de sueño se asocian a la fatiga pandémica",
                "text_en": "Sleep problems are associated with pandemic fatigue",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los problemas de sueño se asocian a la fatiga pandémica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sleep problems are associated with pandemic fatigue"
                    }
                ],
                "evidences": [
                    {
                        "value": "It appears, however, that the occurrence of a new more contagious wave of COVID-19 is spreading faster than the first outbreak in spring 2020 according to top scientists [19, 29] . Member States across the WHO European Region are reporting emerging pandemic fatigue in their populations. Pandemic fatigue is an expected and natural reaction to the prolonged nature of this crisis and the associated inconvenience and hardship. It poses a serious threat to efforts to control the spread of the virus, see [30] for a Policy framework for reinvigorating the public to prevent the pandemic.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9987402558
                    }
                ]
            },
            {
                "text": "Ya todos hemos oído hablar del concepto de fatiga pandémica y es que estamos bastante cansado de esta situación que nos ha tocado vivir ligada a la pandemia de la Covid.",
                "text_en": "We have all heard of the concept of pandemic fatigue, and we are quite tired of this situation which has been linked to the Covid pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hemos oído hablar del concepto de fatiga pandémica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We've heard of the concept of pandemic fatigue."
                    }
                ],
                "evidences": [
                    {
                        "value": "The Wave 2 survey also included some additional questions about respondents' vaccination status and their experience of 'pandemic fatigue'. Pandemic fatigue -as a specific form of 'behavioural fatigue' (Harvey, 2020 )refers to a decreased compliance with pandemic-related restrictions, mainly as a function of the amount of time that restrictions are being imposed. Other factors also influence pandemic fatigue, such as the perceived severity of COVID-19 (MacIntyre et al., 2021) and the extent of economic and psychological sacrifices that the restrictions entail (Lilleholt et al., 2020) . To identify respondents' levels of pandemic fatigue, we use the 6-item Pandemic Fatigue Scale developed by Lilleholt et al., (2020) . The wording of each item in the scale can be found in the Supplementary Methods. With regards to vaccinations, respondents were asked to indicate whether they had had both vaccinations, one vaccination, or no vaccinations.",
                        "score": 0.75
                    },
                    {
                        "value": "In our study, 34.40% of the participants reported that the level of precautions they take has decreased in comparison to measures they took at the onset of the pandemic. Such a tendency is not only a threat to individuals' health but also to the general public. Our findings may be interpreted as that regardless of the restrictions imposed by governments, the biopsychosocial nature of humans should be taken into account in fighting against COVID-19. Such an approach is important as merely focusing individual or broader context may be limited in addressing pandemic fatigue. Considering the Ecological System Theory, we provided implications for both individuals and governments related to pandemic fatigue. First, while governments predominantly focus on preventing the spread of the pandemic by ordering restrictions, such as lockdowns and reduced shopping hours, in addition to those precautions, we suggest legislators take the psychological factors (e.g., pandemic fatigue) into account when fighting against COVID-19. One way to achieve this could be to make mental health services to the public more accessible and affordable. Increased access to mental health services may help individuals to have a psychologically more balanced approach toward COVID-19. Additionally, many countries are in some type of restriction and lockdown (e.g., full-lockdown, lockdown during certain hours). Governments can establish scientific criteria for imposition of and lifting restrictions. For example, based on scientific studies and experiences in other states, legislators can identify a certain number of daily coronavirus cases to impose and lift partial or full restrictions, including lockdowns, closures of schools, and businesses. This approach could increase predictability and may reduce pandemic fatigue, as uncertainty would be decreased.",
                        "score": 0.5
                    },
                    {
                        "value": "First, fear of COVID-19 was a significant predictor of pandemic fatigue. As participants' coronavirus fear increased, they tended to experience greater levels of pandemic fatigue. This predictive relationship may be explained by our initial hypothesis that individuals with higher levels of coronavirus fear may feel overwhelmed. This situation may manifest itself as pandemic fatigue, which may lead to decreased compliance with regulations.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9547163844
                    },
                    {
                        "label": "entailment",
                        "score": 0.7354084849
                    },
                    {
                        "label": "neutral",
                        "score": 0.9986108541
                    }
                ]
            },
            {
                "text": "La Sociedad Española de Neumología y Cirugía Torácica (SEPAR) la asocia a los problemas de sueño.“La fatiga pandémica conlleva un aspecto negativo y es que la ciudadanía deja de buscar información relacionada con la COVID-19 y, además, se produce una relajación con las medidas necesarias para prevenirla.",
                "text_en": "The Spanish Society of Pneumology and Thoracic Surgery (SEPAR) associates it with sleep problems.“Pandemic fatigue carries a negative aspect and is that the citizenry stops looking for information related to COVID-19 and, in addition, there is a relaxation with the necessary measures to prevent it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Sociedad Española de Neumología y Cirugía Torácica (SEPAR)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Spanish Society of Pneumology and Thoracic Surgery (SEPAR)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la asocia a los problemas de sueño",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "associated with sleep problems"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Muchas personas dejan de cumplir las medidas como hacían al principio”, advierte la Dra.",
                "text_en": "Many people fail to comply with the measures as they did at the beginning,” warns Dr.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Muchas personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Many people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dejan de cumplir las medidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "no longer comply with the measures"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al principio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the beginning"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Olga Mediano, neumóloga y coordinadora del Área de Apnea del Sueño de SEPAR.Actualmente, en torno al 30% de la población tiene confirmado alguno de estos síntomas de la fatiga pandémica.",
                "text_en": "Olga Mediano, pneumologist and coordinator of the SEPAR Dream Apnea Area. Currently, around 30% of the population has confirmed some of these symptoms of pandemic fatigue.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Olga Mediano, neumóloga y coordinadora del Área de Apnea del Sueño de SEPAR",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Olga Mediano, pneumologist and coordinator of the SEPAR Dream Apnea Area"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Actualmente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Currently"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en torno al 30% de la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "around 30% of the population"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tiene confirmado alguno de estos síntomas de la fatiga pandémica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have confirmed any of these symptoms of pandemic fatigue"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los adolescentes y jóvenes se encuentran más afectados por la fatiga pandémica porque tienen menor tolerancia a las restricciones relativas a no salir y a otras normas que hay que cumplir”.Y está relacionado con el sueño porque, al estar en casa, algunas personas no tienen la obligación de levantarse para ir a trabajar u otra ocupación.",
                "text_en": "Teenagers and young people are more affected by pandemic fatigue because they have less tolerance for non-exit restrictions and other standards to be met.\"And it is related to sleep because, at home, some people are not obliged to get up to go to work or other occupation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los adolescentes y jóvenes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Adolescents and young people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se encuentran más afectados por la fatiga pandémica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are more affected by pandemic fatigue"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque tienen menor tolerancia a las restricciones relativas a no salir y a otras normas que hay que cumplir",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because they have less tolerance for non-exit restrictions and other standards to be met"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está relacionado con el sueño",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is related to sleep"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque, al estar en casa, algunas personas no tienen la obligación de levantarse para ir a trabajar u otra ocupación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because, being at home, some people do not have the obligation to get up to go to work or other occupation"
                    }
                ],
                "evidences": [
                    {
                        "value": "Mediation analysis showed that the effects of pandemic fatigue on nurses' mental health, sleep quality and job contentment were partially mediated by resilience. Resilience seems to decrease the negative effects of pandemic fatigue on nurses' sleep quality, mental health and job contentment. This result provides additional knowledge concerning the mediating effect of resilience on the relationship between pandemic fatigue and nurse well-being. It was rather expected, as resilient individuals have been shown to more effectively handle stress, anxiety and other mental health issues during the pandemic compared to non-resilient individuals (Labrague & de los Santos, 2020; Roberts et al., 2021; Yoruk & Guler, 2021) . This leads to better sleep quality and, possibly, increased job contentment. Resilience, or an individual's ability to rebound from traumatic or highly distressful events (Cooper et al., 2020) , has been recognized as an important protective factor against various mental and psychological stressors, such as disease outbreaks (Pollock et al., 2020) .",
                        "score": 0.5899999738
                    },
                    {
                        "value": "Means, frequencies and standard deviations were used to present the descriptive data. Further, correlations between key study variables were analysed by ANOVA, Pearson's correlation coefficient (r) and independent t-test. Multiple regression analyses were conducted to determine the predictors of pandemic fatigue and the effects of pandemic fatigue on mental health, sleep quality and job contentment. The mediating effect of resilience on the relationships between pandemic fatigue and the outcome variables was examined using hierarchical regression analysis. The level of statistical significance was set at p < .05. ",
                        "score": 0.5400000215
                    },
                    {
                        "value": "Since the World Health Organisation published its report on pandemic fatigue 35 , several authors have investigated this topic. Reicher and Drury propose that the non-adherence to the confinement measures is not due to pandemic fatigue, but rather due to structural weaknesses in our society, such us the inability to effectively self-isolate 36 . Conversely, other authors have written about the psychological, physical and economic impact of the pandemic on people, which has led to the emergence of the pandemic fatigue in different countries in the world [37] [38] [39] [40] [41] [42] .",
                        "score": 0.6000000238
                    },
                    {
                        "value": "Considering evidence of COVID-19 pandemic fatigue and its consequences in decreasing motivation to adhere recommended protective behaviors (WHO, 2020a), it seems that in addition to addressing contributing factors to pandemic fatigue, paying attention to the elements that can increase these motivations might also be helpful. Cultural considerations can be regarded as a part of a multifactorial action plan (WHO, 2020a) and holistic approach to reduce the pandemic fatigue. In fact, among the elements that affect pandemic fatigue and motivation to comply with recommendations, in addition to regulations, are cultural norms and values (WHO, 2020a) that are related to the social and spiritual context of individuals.",
                        "score": 0.5799999833
                    },
                    {
                        "value": "The Wave 2 survey also included some additional questions about respondents' vaccination status and their experience of 'pandemic fatigue'. Pandemic fatigue -as a specific form of 'behavioural fatigue' (Harvey, 2020 )refers to a decreased compliance with pandemic-related restrictions, mainly as a function of the amount of time that restrictions are being imposed. Other factors also influence pandemic fatigue, such as the perceived severity of COVID-19 (MacIntyre et al., 2021) and the extent of economic and psychological sacrifices that the restrictions entail (Lilleholt et al., 2020) . To identify respondents' levels of pandemic fatigue, we use the 6-item Pandemic Fatigue Scale developed by Lilleholt et al., (2020) . The wording of each item in the scale can be found in the Supplementary Methods. With regards to vaccinations, respondents were asked to indicate whether they had had both vaccinations, one vaccination, or no vaccinations.",
                        "score": 0.6800000072
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "entailment",
                        "score": 0.8775861263
                    },
                    {
                        "label": "neutral",
                        "score": 0.995780468
                    },
                    {
                        "label": "neutral",
                        "score": 0.979849577
                    },
                    {
                        "label": "entailment",
                        "score": 0.9255974293
                    },
                    {
                        "label": "neutral",
                        "score": 0.9826016426
                    }
                ]
            },
            {
                "text": "A veces resulta complicado controlar el horario para levantarse, dormir la siesta o irse a la cama ni los horarios de las comidas, al no salir o comer solos.Según SEPAR, la falta de exposición a la luz solar también afecta, pues al no salir a la calle, la melatonina -hormona que produce la glándula pineal del cerebro y que este produce para ayudar a conciliar el sueño- no se regula bien.La melatonina ayuda a estar despiertos o dormidos.",
                "text_en": "Sometimes it is difficult to control the time to get up, sleep naps or go to bed or the meal schedules, not going out or eating alone.According to SEPAR, the lack of exposure to sunlight also affects, because by not going out on the street, melatonin -hormone that produces the pineal gland of the brain and that it produces to help fall asleep - is not well regulated.Melatonin helps to be awake or asleep.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "SEPAR",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "SEPAR"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la falta de exposición a la luz solar también afecta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "lack of exposure to sunlight also affects"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "pues al no salir a la calle, la melatonina -hormona que produce la glándula pineal del cerebro y que este produce para ayudar a conciliar el sueño- no se regula bien",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Since melatonin - a hormone that produces the pineal gland of the brain and that produces to help fall asleep - is not well regulated because it does not go out into the street."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a la calle",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the street"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La melatonina ayuda a estar despiertos o dormidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Melatonin helps to be awake or asleep"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Al levantarse, salir a la calle y con la exposición a la luz solar, se inhibe y estamos despiertos.",
                "text_en": "When we get up, go out into the street and with exposure to sunlight, it inhibits and we are awake.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la exposición a la luz solar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with exposure to sunlight"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se inhibe y estamos despiertos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's inhibited and we're awake."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y, durante la noche, se activa y nos ayuda a quedarnos dormidos.Mientras que la Sociedad también da a conocer que el insomnio es el otro gran trastorno consecuencia de muchas de las patologías y problemas relacionados con la pandemia.Pues se duerme peor porque muchas personas se encuentran sometidas a una gran ansiedad y depresión al tener problemas económicos, laborales, de conciliación o familiares enfermos, entre otros, y no son capaces de quedarse dormidas cuando regresan a casa.También se despiertan antes de hora y no son capaces de volver a dormirse, de modo que padecen insomnio de despertar precoz.",
                "text_en": "And, during the night, it activates and helps us to fall asleep.While the Society also announces that insomnia is the other major disorder resulting from many of the pathologies and problems related to the pandemic.It sleeps worse because many people are subjected to great anxiety and depression because they have economic, work, conciliation or sick family problems, among others, and are unable to fall asleep when they return home.They also wake up early and are unable to go back to sleep, so they suffer insomnia from early awakening.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante la noche",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the night"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se activa y nos ayuda a quedarnos dormidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It activates and helps us fall asleep"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Sociedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Society"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el insomnio es el otro gran trastorno consecuencia de muchas de las patologías y problemas relacionados con la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "insomnia is the other major disorder resulting from many of the pathologies and problems related to the pandemic"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "se duerme peor porque muchas personas se encuentran sometidas a una gran ansiedad y depresión al tener problemas económicos, laborales, de conciliación o familiares enfermos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "sleeps worse because many people are subjected to great anxiety and depression because they have economic, work, conciliation or sick family problems"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De ahí que surjan problemas de sueño y se asocien directamente a la fatiga pandémica ",
                "text_en": "Hence sleep problems arise and are directly associated with pandemic fatigue.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "surjan problemas de sueño y se asocien directamente a la fatiga pandémica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "sleep problems arise and are directly associated with pandemic fatigue"
                    }
                ],
                "evidences": [
                    {
                        "value": "Sleep problems were significantly more prevalent and severe among the individuals in the lowest income quartile (overall, 82%; severe, 35%) than among the highest income quartile (overall, 68%; severe, 16%) (p < .0001). Sleep problems also varied slightly but significantly according to household size (p = .01).",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9940043092
                    }
                ]
            }
        ]
    },
    "7": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 17,
            "WhatReliabilityReliable": 5,
            "WhatReliabilityUnreliable": 11,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 23,
            "WhoReliabilityReliable": 17,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 6,
            "WhereReliabilityReliable": 5,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 8,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 5,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 4,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 2,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 21,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n\"Uno encantado de su vacua cháchara y el otro con gesto contrito y eterna cara de circunstancias; incapaces ambos de transmitir la menor confianza\"\n\n<PARAGRAPH>\n\nEscalofrío fue el sentimiento que sintió buena parte de la población al escuchar la última imbecilidad de Fernando Simón en rueda de prensa.\n\n<BREAK>\n\nEl resto, solo sintieron risa floja.\n\n<PARAGRAPH>\n\nIgnacio Camacho es quien pone la palabra correcto al sentimiento en su columna en el diario ABC este 13 de enero de 2021.\n\n<BREAK>\n\nBajo título En buenas manos, el articulista define al dúo Illa-Simón como se merecen el ministro de Sanidad y el portavoz de la pandemia en España, en tono de chanza.\n\n<PARAGRAPH>\n\n«Fue inevitable el escalofrío», comienza Camacho, «la misma inflexión de la voz, casi las mismas palabras, hasta el mismo o similar jersey».\n\n<BREAK>\n\nY es que nadie olvida aquel primer vaticinio de Simón que le perseguirá hasta el fin de sus días en un cargo público.\n\n<PARAGRAPH>\n\nY es que el Director del Centro de Coordinación de Alertas y Emergencias Sanitarias se ha vuelto a coronar diciendo algo que no necesitaba decir, y de paso, echándole la culpa a los ciudadanos del aumento de contagios.\n\n<PARAGRAPH>\n\nUn portavoz imposible de tomar en serio, convertido en motivo de cachondeo y befa, con la reputación destruida a los ojos de la nación entera.\n\n<PARAGRAPH>\n\nTermina con Simón, Camacho, para introducir al ministro ‘saliente’ y definirlos como pareja de televisiva de sketch de Nochevieja:\n\n<PARAGRAPH>\n\nPoco pueden esperar de esta pareja como de mediocre comedia cinematográfica, uno encantado de su vacua cháchara y el otro con gesto contrito y eterna cara de circunstancias; incapaces ambos de transmitir la menor confianza.\n\n<BREAK>\n\nEn realidad, ejercen de lo que son: subalternos peones sin relevancia de un Ejecutivo instalado en la estrategia de no hacer nada.\n\n<PARAGRAPH>\n\nY el último palo:\n\n<PARAGRAPH>\n\nAsí el virus, el enemigo del año, cabalga otra vez desbocado sin que nadie dé la sensación de estar al mano.\n\n<BREAK>\n\nIIll a comunica el lento reparto de las vacunas como si fuera el encargado de una plataforma logística de Amazon y Simón reparte consejos paternales para que la población se ponga a resguardo.\n\n<PARAGRAPH>\n\n«No hay de qué preocuparse: estamos en buenas manos», ironiza el columnista para terminar.\n\n<PARAGRAPH>\n",
        "TITLE": "El escalofrío de Ignacio Camacho con la pareja cómica Simón-Illa: «No hay nadie al mando»",
        "ID": "NF_04-11-2021_21-26-15_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "El escalofrío de Ignacio Camacho con la pareja cómica Simón-Illa: «No hay nadie al mando»",
                "text_en": "The chill of Ignacio Camacho with the comic couple Simon-Illa: «There is no one in charge»",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El escalofrío",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The shiver"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ignacio Camacho",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ignacio Camacho"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la pareja cómica Simón-Illa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the comic couple Simon-Illa"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"Uno encantado de su vacua cháchara y el otro con gesto contrito y eterna cara de circunstancias; incapaces ambos de transmitir la menor confianza\"",
                "text_en": "\"One enchanted by his vacua cháchara and the other with contrite gesture and eternal face of circumstances; unable both to convey the least confidence\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "incapaces ambos de transmitir la menor confianza",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "unable to convey the least confidence"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ambos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Both"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Escalofrío fue el sentimiento que sintió buena parte de la población al escuchar la última imbecilidad de Fernando Simón en rueda de prensa.",
                "text_en": "Chill was the feeling that much of the population felt when they heard the last imbecility of Fernando Simón at a press conference.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Escalofrío fue el sentimiento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Chill was the feeling"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "buena parte de la población",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "large part of the population"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "al escuchar la última imbecilidad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "when listening to the last imbecility"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fernando Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fernando Simón"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en rueda de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at a press conference"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El resto, solo sintieron risa floja.",
                "text_en": "The rest, they just felt lazy laughter.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El resto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The rest"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "solo sintieron risa floja",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They just felt lazy laughter."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ignacio Camacho es quien pone la palabra correcto al sentimiento en su columna en el diario ABC este 13 de enero de 2021.",
                "text_en": "Ignacio Camacho is the one who puts the right word to feeling in his column in the ABC newspaper on January 13, 2021.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ignacio Camacho",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ignacio Camacho"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es quien pone la palabra correcto al sentimiento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's the one who puts the right word to the feeling."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su columna en el diario ABC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in his column in the ABC newspaper"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este 13 de enero de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "13 January 2021"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Bajo título En buenas manos, el articulista define al dúo Illa-Simón como se merecen el ministro de Sanidad y el portavoz de la pandemia en España, en tono de chanza.",
                "text_en": "Under the title In good hands, the writer defines the duo Illa-Simon as the minister of health and the spokesman for the pandemic in Spain deserve, in a tone of chanza.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Bajo título En buenas manos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Under Title In good hands"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el articulista",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the writer"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "define al dúo Illa-Simón como se merecen",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "defines the duo Illa-Simon as they deserve"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el ministro de Sanidad y el portavoz de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Minister of Health and the spokesman for the pandemic"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en tono de chanza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in tone of chanza"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Fue inevitable el escalofrío», comienza Camacho, «la misma inflexión de la voz, casi las mismas palabras, hasta el mismo o similar jersey».",
                "text_en": "\"The chill was inevitable,\" Camacho begins, \"the same inflection of the voice, almost the same words, up to the same or similar sweater.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Fue inevitable el escalofrío",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The chill was inevitable."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Camacho",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Camacho"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y es que nadie olvida aquel primer vaticinio de Simón que le perseguirá hasta el fin de sus días en un cargo público.",
                "text_en": "And it is that no one forgets the first prophecy of Simon that will persecute him until the end of his days in a public office.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nadie",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "No one."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "olvida aquel primer vaticinio de Simón que le perseguirá",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "forget that first prophecy of Simon that will persecute him"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Simon"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "hasta el fin de sus días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Until the end of his days"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un cargo público",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a public office"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y es que el Director del Centro de Coordinación de Alertas y Emergencias Sanitarias se ha vuelto a coronar diciendo algo que no necesitaba decir, y de paso, echándole la culpa a los ciudadanos del aumento de contagios.",
                "text_en": "The Director of the Health Alerts and Emergencies Coordination Center has again crowned himself with saying something he did not need to say, and in passing, blaming citizens for the increase in contagion.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Director del Centro de Coordinación de Alertas y Emergencias Sanitarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Director of the Health Alert and Emergency Coordination Centre"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha vuelto a coronar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has been crowned again"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "diciendo algo que no necesitaba decir",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "saying something I didn't need to say"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un portavoz imposible de tomar en serio, convertido en motivo de cachondeo y befa, con la reputación destruida a los ojos de la nación entera.",
                "text_en": "A spokesman impossible to take seriously, turned into a reason for horny and befa, with the reputation destroyed in the eyes of the entire nation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Un portavoz imposible de tomar en serio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "A spokesman impossible to take seriously"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "convertido en motivo de cachondeo y befa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "turned into a reason for horny and befa"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la reputación destruida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with reputation destroyed"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la nación entera",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the whole nation"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Termina con Simón, Camacho, para introducir al ministro ‘saliente’ y definirlos como pareja de televisiva de sketch de Nochevieja:",
                "text_en": "He ends with Simon Camacho to introduce the ‘outgoing’ minister and define them as a television couple for New Year’s Eve sketch:",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Camacho",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Camacho"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "definirlos como pareja de televisiva de sketch",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "define them as a sketch television couple"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "de Nochevieja",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "New Year's Eve"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Poco pueden esperar de esta pareja como de mediocre comedia cinematográfica, uno encantado de su vacua cháchara y el otro con gesto contrito y eterna cara de circunstancias; incapaces ambos de transmitir la menor confianza.",
                "text_en": "Little can be expected of this couple as mediocre cinematographic comedy, one enchanted by their vacua cháchara and the other with contrite gesture and eternal face of circumstances; unable both to convey the least confidence.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Poco pueden esperar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They can't wait."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "esta pareja",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This couple."
                    }
                ],
                "evidences": []
            },
            {
                "text": "En realidad, ejercen de lo que son: subalternos peones sin relevancia de un Ejecutivo instalado en la estrategia de no hacer nada.",
                "text_en": "In reality, they exercise what they are: subordinate pawns without relevance of an Executive installed in the strategy of doing nothing.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ejercen de lo que son: subalternos peones sin relevancia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "exercise what they are: subordinate labors without relevance"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ejercen de lo que son: subalternos peones sin relevancia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "exercise what they are: subordinate labors without relevance"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "subalternos peones sin relevancia de un Ejecutivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "subordinate labors without relevance of an Executive"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la estrategia de no hacer nada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the strategy of doing nothing"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en la estrategia de no hacer nada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the strategy of doing nothing"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así el virus, el enemigo del año, cabalga otra vez desbocado sin que nadie dé la sensación de estar al mano.",
                "text_en": "Thus the virus, the enemy of the year, rides again out of the way without anyone giving the feeling of being at hand.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el virus, el enemigo del año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the virus, the enemy of the year"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cabalga otra vez desbocado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Once again rides out of the way."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin que nadie dé la sensación de estar al mano",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "without anyone giving the feeling of being at hand"
                    }
                ],
                "evidences": []
            },
            {
                "text": "IIll a comunica el lento reparto de las vacunas como si fuera el encargado de una plataforma logística de Amazon y Simón reparte consejos paternales para que la población se ponga a resguardo.",
                "text_en": "IIll communicates the slow distribution of vaccines as if he were in charge of a logistic platform of Amazon and Simon distributes paternal advice for the population to be protected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "IIll a",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "IIll a"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "comunica el lento reparto de las vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "communicates the slow distribution of vaccines"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "como si fuera el encargado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Like I'm the manager."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "una plataforma logística de Amazon",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "an Amazon logistics platform"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Simon"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reparte consejos paternales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Gives Parental Advice"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«No hay de qué preocuparse: estamos en buenas manos», ironiza el columnista para terminar.",
                "text_en": "“There’s nothing to worry about: we’re in good hands,” the columnist ironically concludes.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estamos en buenas manos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We're in good hands."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el columnista",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the columnist"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "8": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 22,
            "WhatReliabilityReliable": 21,
            "WhatReliabilityUnreliable": 1,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 13,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 6,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 1,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 9,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 3,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nPor el momento, solo se administran las de Pfizer BioNtech, la única que ha autorizado la EMA\n\n<BREAK>\n\nApenas ha pasado un año desde que comenzaran las noticias de la expansión de un nuevo virus en China. \n\n<BREAK>\n\nEl SARS-CoV-2 se extendió muy rápido entre la población y dejó de ser epidemia para convertirse en pandemia.\n\n<BREAK>\n\nEl mundo se paralizó. \n\n<BREAK>\n\nLa mayoría de los países del mundo cerraron y pararon toda su maquinaria. \n\n<BREAK>\n\nTodos lo hicieron salvo los científicos. \n\n<BREAK>\n\nEstos no dejaron de buscar respuestas sobre el virus y una posible solución en forma de vacuna.\n\n<BREAK>\n\nEl 21 de diciembre de 2020, la Agencia Europea de Medicamentos (EMA) autorizó a Pfizer BioNtech a comercializar su vacuna contra el coronavirus. \n\n<BREAK>\n\nTodos los países de la Unión Europea adquirieron sus dosis contra este virus y empezó el proceso de inyección a la población.\n\n<BREAK>\n\nEn España, una mujer de una residencia de Guadalajara fue la primera que recibió las dosis de la vacuna. \n\n<BREAK>\n\nPosteriormente lo harán todos los residentes de centros de mayores, así como sus trabajadores. \n\n<BREAK>\n\nUn proceso que se espera que dure hasta marzo de 2021, momento en el que estarán vacunados 2'5 millones de personas.\n\n<BREAK>\n\nA medida que pase el tiempo llegarán más vacunas que se autorizarán por parte de la EMA, por lo que habrá más dosis disponibles para la población. \n\n<BREAK>\n\nPero, ¿son todas las vacunas iguales? ¿Hay diferencias entre una y otra?\n\n<BREAK>\n\nEstas son las diferencias que hay de las vacunas del coronavirus\n\n<BREAK>\n\nPor el momento, solo se ha aprobado, y por tanto solo se usa, la vacuna de Pfzier BioNtech. \n\n<BREAK>\n\nEste tipo de dosis se basan en el ARN mensajero. \n\n<BREAK>\n\nEsta es una tecnología nueva que nunca se usó en humanos, aunque lleva décadas en investigación. \n\n<BREAK>\n\nEl ARN mensajero consiste en mandar una serie de instrucciones en organismo para que reaccione y desarrolle el antígeno para protegerse del SARS-CoV-2. \n\n<BREAK>\n\nEn el caso del coronavirus, el antígeno es la proteína S.\n\n<BREAK>\n\nDel mismo modo, el ARN mensajero se basa la vacuna de Moderna. \n\n<BREAK>\n\nEsta se encuentra en estos momentos en evaluación por la EMA, por lo que en unas semanas se puede autorizar su uso en España. \n\n<BREAK>\n\nDesde Sanidad indican que pueden llegar aproximadamente ocho millones de dosis. \n\n<BREAK>\n\nABC informaba de que esta vacuna se espera que llegue para el 20 de enero.\n\n<BREAK>\n\nPor otro lado, otra de las que está en evaluación por las autoridades europeas es la de AstraZeneca/Oxford. \n\n<BREAK>\n\nTodavía no se han concretado cuántas dosis llegarán a España. \n\n<BREAK>\n\nA pesar de todo, Reino Unido la ha aprobado de forma reciente, por lo que su uso en el país británico será inmediato.\n\n<BREAK>\n\nA diferencia de las anteriores, la de AstraZeneca no es de ARNm, sino de vector viral no replicante (adenovirus de chimpancé). \n\n<BREAK>\n\nEste contiene una serie de genes que modifican el virus. \n\n<BREAK>\n\nEn este caso quiere modificar la proteína S.\n\n<BREAK>\n\n¿Y qué pasará en 2021? Por el momento, la Unión Europea solo tiene firmados contratos con otras empresas como Janssen (vector vírico), Sanofi (basado en proteína S del coronavirus) y Curevac (ARNm), cuyas dosis se esperan que lleguen a lo largo de 2021. \n\n<BREAK>\n\nAsimismo, la UE negocia un contrato con la empresa Novavax, que usa la proteína S.",
        "TITLE": "Pfizer, Moderna, AstraZeneca...Las diferencias entre las vacunas del coronavirus que llegarán a España",
        "ID": "11-Abc",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Pfizer, Moderna, AstraZeneca...Las diferencias entre las vacunas del coronavirus que llegarán a España",
                "text_en": "Pfizer, Moderna, AstraZeneca...The differences between the coronavirus vaccines that will arrive in Spain",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las diferencias entre las vacunas del coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Differences between coronavirus vaccines"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por el momento, solo se administran las de Pfizer BioNtech, la única que ha autorizado la EMA",
                "text_en": "For the time being, only Pfizer BioNtech, the only one authorised by the EMA, is administered.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Por el momento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For the moment"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "solo se administran las de Pfizer BioNtech",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "only Pfizer BioNtech is given"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la única que ha autorizado la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the only one authorised by the EMA"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El SARS-CoV-2 se extendió muy rápido entre la población y dejó de ser epidemia para convertirse en pandemia.",
                "text_en": "SARS-CoV-2 spread very quickly among the population and ceased to be an epidemic to become a pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El SARS-CoV-2 se extendió muy rápido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "SARS-CoV-2 spread very quickly"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dejó de ser epidemia para convertirse en pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ceased to be an epidemic to become a pandemic"
                    }
                ],
                "evidences": [
                    {
                        "value": "Global strategies focus on controlling SARS-CoV-2 by suppressing transmission of the virus and therapeutic intervention. According to current evidences, it has been suggested that SARS-CoV-2 can spread from person to person. However, understanding how, when, and environmental settings favoring SARS-CoV-2 spread is crucial to the development of effective infection prevention and control measures. SARS-CoV-2 possible modes of transmission includes droplet, airborne, fomite, fecal-oral, blood borne, mother to child, and animal-to-human transmission.",
                        "score": 0.6000000238
                    },
                    {
                        "value": "The seasonality of SARS-CoV-2 transmission is not yet fully understood. Globally, meteorological factors may play a role in SARS-CoV-2 spread. This role may result only in comparatively slower spread of SARS-CoV-2, but not stopped it (Bukhari et al., 2020) . On a worldwide scale, it was revealed that combination of temperature, relative humidity and wind speed can forecast the situation of COVID-19 pandemic .",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9797065258
                    },
                    {
                        "label": "neutral",
                        "score": 0.7798221707
                    }
                ]
            },
            {
                "text": "La mayoría de los países del mundo cerraron y pararon toda su maquinaria. ",
                "text_en": "Most countries in the world shut down and stopped all their machinery.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La mayoría de los países del mundo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Most countries in the world"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cerraron y pararon toda su maquinaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They shut down and stopped all their machinery."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Todos lo hicieron salvo los científicos. ",
                "text_en": "They all did it except the scientists.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los científicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "scientists"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estos no dejaron de buscar respuestas sobre el virus y una posible solución en forma de vacuna.",
                "text_en": "They did not stop looking for answers about the virus and a possible solution in the form of a vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no dejaron de buscar respuestas sobre el virus y una posible solución en forma de vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "did not stop looking for answers about the virus and a possible solution in the form of a vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El 21 de diciembre de 2020, la Agencia Europea de Medicamentos (EMA) autorizó a Pfizer BioNtech a comercializar su vacuna contra el coronavirus. ",
                "text_en": "On 21 December 2020, the European Medicines Agency (EMA) authorised Pfizer BioNtech to market its coronavirus vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El 21 de diciembre de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "On 21 December 2020"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea de Medicamentos (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "autorizó a Pfizer BioNtech a comercializar su vacuna contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "authorised Pfizer BioNtech to market its coronavirus vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer BioNtech",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer BioNtech"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Todos los países de la Unión Europea adquirieron sus dosis contra este virus y empezó el proceso de inyección a la población.",
                "text_en": "All the countries of the European Union acquired their doses against this virus and began the process of injection into the population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "empezó el proceso de inyección",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the injection process began"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A medida que pase el tiempo llegarán más vacunas que se autorizarán por parte de la EMA, por lo que habrá más dosis disponibles para la población. ",
                "text_en": "As time goes by, more vaccines will arrive that will be authorised by the EMA, making more doses available to the population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "A medida que pase el tiempo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "As time goes by"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llegarán más vacunas que se autorizarán",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more vaccines will arrive that will be authorised"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por parte de la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the EMA"
                    }
                ],
                "evidences": [
                    {
                        "value": "The coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulted in an unprecedented pandemic worldwide. The European Medicines Agency (EMA) and the US Food and Drug Administration have approved emergency use authorization for several COVID-19 vaccines before the completion of their clinical trials. Currently, EMA has approved four vaccines that are protective against SARS-CoV-2 [1, 2] . BNT162b2 (Pfizer/BioNTech, Mainz, Germany) [3] and mRNA-1273 (Moderna, Cambridge, MA, USA) [4] belong to the category of lipid nanoparticle (LNP)-formulated mRNA COVID-19 vaccines, while ChAdO×1 (University of Oxford/AstraZeneca, Oxford, UK) [5] and Ad26.COV2.S (Johnson & Johnson/Janssen, New Brunswick, NJ, USA) [6] belong to the category of adenovirus vector COVID-19 vaccines. Several adverse events, including ocular manifestations, have been reported after vaccination. In this study, we aimed to review all reported ocular side effects of the available COVID-19 vaccines.",
                        "score": 0.5799999833
                    },
                    {
                        "value": "To date, a variety of vaccines have been approved by the European Medicine Agency (EMA), under a conditional marketing authorisation due to the emergency situation, and many others are under development. These vaccines have different efficacy, understood as the percentage reduction in disease incidence, based on clinical trials (EMA, 2021) . The reported efficacy rates for vaccines requiring two doses are 94.6 and 93.6, respectively, for the Corminaty (Pfizer/BioNTech) and the COVID 19 Moderna (ModernaTX) vaccines and up to 60% for the Vaxzevria (Oxford-AstraZeneca AZD1222) vaccine (EMA, 2021) . The efficacy rate for the monodose Janssen vaccine (Johnson & Johnson) is up to 67% (EMA, 2021) .",
                        "score": 0.6200000048
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9982435703
                    },
                    {
                        "label": "neutral",
                        "score": 0.9684148431
                    }
                ]
            },
            {
                "text": "Estas son las diferencias que hay de las vacunas del coronavirus",
                "text_en": "These are the differences from the coronavirus vaccines.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estas son las diferencias que hay de las vacunas del coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "These are the differences from the coronavirus vaccines."
                    }
                ],
                "evidences": [
                    {
                        "value": "Developed countries have the infrastructure to distribute coronavirus vaccines fairly and equally, but developing countries, such as countries of South Asia, Central African countries, and other parts of the world, lack the infrastructure to facilitate the equal distribution of coronavirus vaccines. Therefore, there are more chances for unequal distribution; as Acharya et al. (2021) stated, countries should ensure that they have the needed infrastructure for broad vaccination campaigns.",
                        "score": 0.6000000238
                    },
                    {
                        "value": "Similar to DNA and protein subunit vaccines, most viral vector coronavirus vaccines target the S antigen. Numerous viral vectors have been used to develop SARS-CoV and MERS-CoV vaccines, which have been described in detail in previous review articles [74, 75] . In the following sections, we will highlight vaccines based on adenovirus, modified vaccinia virus Ankara and Venezuelan equine encephalitis virus, which are the most well studied viral vector platforms for coronavirus vaccines. We will also briefly introduce other recombinant viral platforms that are being actively developed for coronavirus vaccines.",
                        "score": 0.7400000095
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9962878227
                    },
                    {
                        "label": "neutral",
                        "score": 0.9967005849
                    }
                ]
            },
            {
                "text": "Por el momento, solo se ha aprobado, y por tanto solo se usa, la vacuna de Pfzier BioNtech. ",
                "text_en": "For the time being, only the Pfzier BioNtech vaccine has been approved and is therefore only used.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Por el momento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For the moment"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "solo se ha aprobado, y por tanto solo se usa, la vacuna de Pfzier BioNtech",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "only Pfzier BioNtech vaccine has been approved and is therefore only used."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este tipo de dosis se basan en el ARN mensajero. ",
                "text_en": "This type of dose is based on messenger RNA.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Este tipo de dosis se basan en el ARN mensajero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This type of dose is based on messenger RNA"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta es una tecnología nueva que nunca se usó en humanos, aunque lleva décadas en investigación. ",
                "text_en": "This is a new technology that has never been used in humans, although it has been in research for decades.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es una tecnología nueva que nunca se usó",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is a new technology that was never used"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en humanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in humans"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lleva décadas en investigación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He's been in research for decades."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Del mismo modo, el ARN mensajero se basa la vacuna de Moderna. ",
                "text_en": "Similarly, the messenger RNA is based on the Moderna vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el ARN mensajero se basa la vacuna de Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the messenger RNA is based on the Moderna vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta se encuentra en estos momentos en evaluación por la EMA, por lo que en unas semanas se puede autorizar su uso en España. ",
                "text_en": "This is currently being evaluated by the EMA, so in a few weeks it can be authorized to be used in Spain.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se encuentra en estos momentos en evaluación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is currently under evaluation"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en estos momentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Right now."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the EMA"
                    }
                ],
                "evidences": [
                    {
                        "value": "EMA is an instrument for assessing \"behavioral and cognitive processes in their natural settings\" [14] . From the technical perspective, EMA recording is feasible and well-supported. For example, in their survey on sleep selfmanagement apps [2] , Choi et al. list the recording of user-entered data as an important functionality, and stress that all investigated apps do support this functionality. However, next to the technical modalities, EMA relies also on selfdiscipline and adherence.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9949852228
                    }
                ]
            },
            {
                "text": "Por otro lado, otra de las que está en evaluación por las autoridades europeas es la de AstraZeneca/Oxford. ",
                "text_en": "On the other hand, another one that is being evaluated by the European authorities is that of AstraZeneca/Oxford.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "otra de las que está en evaluación por las autoridades europeas es la de AstraZeneca/Oxford",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "another one that is being evaluated by the European authorities is that of AstraZeneca/Oxford"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por las autoridades europeas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the European authorities"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A pesar de todo, Reino Unido la ha aprobado de forma reciente, por lo que su uso en el país británico será inmediato.",
                "text_en": "In spite of everything, the United Kingdom has recently approved it, so its use in the British country will be immediate.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la ha aprobado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "approved"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "de forma reciente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "recently"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A diferencia de las anteriores, la de AstraZeneca no es de ARNm, sino de vector viral no replicante (adenovirus de chimpancé). ",
                "text_en": "Unlike the above, AstraZeneca's is not of mRNA, but of non-replicant viral vector (chimpanzee adenovirus).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la de AstraZeneca no es de ARNm, sino de vector viral no replicante (adenovirus de chimpancé)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca's is not of mRNA, but of non-replicant viral vector (chimpanzee adenovirus)"
                    }
                ],
                "evidences": [
                    {
                        "value": "In contrast, the Chadox1 nCoV-19 vaccine developed by Oxford University and AstraZeneca is composed of a recombinant non-replicant chimpanzee adenovirus, which expresses the S protein of Sars-CoV-2 (39) . Different from the technology used for inactivated vaccines since the 1800's, this adenovirus platform was developed in 2012 (42) . The authors aimed to include an adenovirus in the vaccine that would not infect humans, in order to avoid its potential rejection by human antibodies. The chosen Chimpanzee adenovirus was phylogenetically related to the human adenovirus. The inventors deleted the region E1 of the chimpanzee adenovirus genome in order to render the virus defective and non-replicant, while the E3 region was excluded to increase the insert capacity. In addition, a bacterial artificial chromosome (BAC) containing a codon-optimized full-length spike protein of SARS-CoV-2 with a human tPA leader sequence (39) was added between the deleted E1 region and E4 to facilitate the genetic modifications. This approach has been reported to improve genetic stability (42) . However, additional modifications were needed to guarantee that the E4 region of the virus would express a human, instead of a simian protein, that would enable the virus recognition and propagation inside human cells in in vitro culture, for large-scale virus production (42) .",
                        "score": 0.5
                    },
                    {
                        "value": "The AstraZeneca vaccine (approved by Health Canada February 26, 2021) and the Janssen Ad26.COV2.S vaccine (approved by Health Canada on March 5, 2021) use a non-replicating adenovirus vector to deliver SARS-CoV-2 DNA encoding the spike protein to human cells, which uses the host machinery to produce viral spike protein (13) . The AstraZeneca vaccine is administered as two intramuscular injections between four and 12 weeks apart, while the Janssen vaccine is administered as a single intramuscular injection.",
                        "score": 0.6299999952
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9275702834
                    },
                    {
                        "label": "neutral",
                        "score": 0.6646939516
                    }
                ]
            },
            {
                "text": "Este contiene una serie de genes que modifican el virus. ",
                "text_en": "It contains a number of genes that modify the virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "contiene una serie de genes que modifican el virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "contains a series of genes that modify the virus"
                    }
                ],
                "evidences": [
                    {
                        "value": "Seneca Valley virus (SVV) is a single-stranded, positivesense RNA virus belonging to the species Senecavirus A in the genus Senecavirus in the family Picornaviridae [1, 2] . Although the species name Senecavirus A has been used in some publications as the virus name with an acronym of SVA, in fact the virus name is Seneca Valley virus. The SVV genome (approximately 7.3 kb) contains a single open reading frame (ORF) flanked by a long 5′ untranslated region (UTR; 668 nucleotides) and a short 3′ UTR (68 nucleotides) followed by a poly(A) tail. The polyprotein translated from the single ORF is predicted to be post-translationally processed into four structural proteins (VP4, VP2, VP3, and VP1) and seven nonstructural proteins (2A, 2B, 2C, 3A, 3B, 3C, and 3D) [2] .",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "entailment",
                        "score": 0.8599870801
                    }
                ]
            },
            {
                "text": "En este caso quiere modificar la proteína S.",
                "text_en": "In this case he wants to modify the S protein.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "quiere modificar la proteína S",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "wants to modify protein S"
                    }
                ],
                "evidences": [
                    {
                        "value": "To investigate post-translational modifications of SARS-CoV-2 S protein, we stably transfected S protein into HEK293T cells and inspected expression patterns upon administering various glycosyltransferase inhibitors. We noticed that some treatments shifted the molecular weight of S protein significantly upward (from 140 kDa to 180 kDa) (Figure 1a) , indicating that S protein is modified post-translationally. Interestingly, we observed that the molecular weight of S protein (Figure 1a, lanes 2-4) was reduced after treating with N-linked glycosyltransferase inhibitors, including tunicamycin, NGI-1, and 2-DG. However, O-GlcNAc-b-N-acetylglucosaminidase, O-GlcNAcase, and O-linked glycosyltransferase inhibitors did not affect the molecular weight of S protein (Figure 1a, lanes 7-9) . Moreover, treatment of S protein with PNGase F (to remove both complex and hybrid N-linked glycans) but not Endo H (to remove hybrid N-linked glycans only) impaired glycostaining intensity, indicating that S protein is extensively modified by complex N-linked glycosylation (Figure 1b) .",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9303857088
                    }
                ]
            },
            {
                "text": "Asimismo, la UE negocia un contrato con la empresa Novavax, que usa la proteína S.",
                "text_en": "The EU also negotiates a contract with Novavax, which uses S protein.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EU"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "negocia un contrato",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "negotiates a contract"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "con la empresa Novavax",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with Novavax company"
                    }
                ],
                "evidences": [
                    {
                        "value": "NVX-CoV2373 (Novavax) is engineered by using recombinant nanoparticle technology from the SARS-CoV-2 genetic sequence to generate the fulllength, prefusion spike (S) protein. This is united with an adjuvant (Matrix-M). Results of preclinical studies suggest that it binds efficiently with human receptors targeted by the virus. It is administered as a 2-dose series given 21 days apart. Considered efficacy original strain: 96.4%.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9996380806
                    }
                ]
            }
        ]
    },
    "9": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 7,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 8,
            "WhoReliabilityReliable": 8,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 7,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 6,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nEuropa Press\n\n<PARAGRAPH>\n\nBogotá, 31 de marzo _ RAM_ El viceministro de Salud Pública y Prestación de Servicios de Colombia, Luis Alexander Moscoso, ha celebrado este martes que el país ha llegado a dos millones de dosis de la vacuna contra el coronavirus aplicadas y avanza así a la «meta» de tres millones de inoculados para el 17 de abril.\n\n<PARAGRAPH>\n\nAsí lo ha aseverado Moscoso en una rueda de prensa desde Casa de Nariño, en la que ha indicado que alcanzar esta cifra «llena de alegría» y ha apuntado a la consolidación del Plan Nacional de Vacunación.\n\n<PARAGRAPH>\n\nEl presidente de Colombia, Iván Duque, ha asistido a la aplicación de la dosis con la que se alcanzaba los dos millones de dosis, que se ha administrado a Elizabeth Pérez Ramos, de 77 años, en el Hospital Universitario del Caribe, informa Radio Caracol.\n\n<PARAGRAPH>\n\nEn este contexto, Colombia ha confirmado este martes un aumento de casos con 7.952 nuevos positivos, que elevan el total a 2.397.731, según el último balance del Ministerio de Sanidad.\n\n<PARAGRAPH>\n\nLos fallecidos a causa de la pandemia han ascendido hasta 63.255, con 176 decesos en la última jornada, frente a un total de 2.279.840 personas que han logrado superar la enfermedad.\n\n<PARAGRAPH>\n\nEn la actualidad, el país tiene 46.423 casos activos.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Colombia alcanza dos millones de dosis de la vacuna contra el coronavirus aplicadas",
        "ID": "NF_04-11-2021_21-06-05_www_eje21_com_co",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Colombia alcanza dos millones de dosis de la vacuna contra el coronavirus aplicadas",
                "text_en": "Colombia reaches two million doses of the coronavirus vaccine applied",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "alcanza dos millones de dosis de la vacuna contra el coronavirus aplicadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reaches 2 million doses of the coronavirus vaccine applied"
                    }
                ],
                "evidences": [
                    {
                        "value": "On 17 February 2021, the national COVID-19 vaccination plan started in Colombia, with the arrival, on previous days, of the first doses of the Pfizer-BioNTech (New York, NY, USA) COVID-19 vaccine (BNT162b2). Nevertheless, so far, up to 15 March 2021, only 913,961 doses have been applied, mainly in healthcare workers and the population ≥80-year-old. Colombia has a population of 51,049,498 people, with approximately 1.8 physicians per 1000 people (2021).",
                        "score": 0.6600000262
                    },
                    {
                        "value": "At present, all provinces and cities in China are actively popularizing the new vaccine, advocating that citizens receive inoculation as soon as possible. The Coronavirus vaccine in China has been approved and administered to individuals from 18 years to over 100 years of age with a total of 2.2 billion doses of the Coronavirus vaccine administered nationwide, and 1.04 billion people have received a complete cycle of the vaccination. Among multiple vaccines, the Sinovac Coronavirus vaccine has been seen to have a wide coverage rate, and attention has also been given to the analysis of possible adverse events. Based inactivated vaccine are pain and swelling at the injection site, and less severe reactions such as fever or allergic reaction [5] . The most common adverse event in the phase I and II clinical trials of Coronavirus vaccine was pain at the injection site, with a severity rating of one recovered within 48 h post vaccine [6, 7] . At present, there is no report on other adverse events from receiving the Sinovac Coronavirus vaccine.",
                        "score": 0.6000000238
                    },
                    {
                        "value": "In August 2020, Russia registered the world's first vaccine based on a human adenoviral vector-based platform Sputnik V. After the third phase of clinical trials, vaccine efficacy was measured at 91.6% (95% CI: 85.6, 95.2) (Logunov et al., 2021) . The mass vaccination in Russia started in January 2021. On April 23, Deputy Prime Minister Tatyana Golikova, at a meeting with Vladimir Putin, said that more than 11.1 million Russians received at least one dose of the coronavirus vaccine, both doses received 6.8 million (4.7% of the total population).",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9948911667
                    },
                    {
                        "label": "neutral",
                        "score": 0.8779540062
                    },
                    {
                        "label": "neutral",
                        "score": 0.7504957914
                    }
                ]
            },
            {
                "text": "Bogotá, 31 de marzo _ RAM_ El viceministro de Salud Pública y Prestación de Servicios de Colombia, Luis Alexander Moscoso, ha celebrado este martes que el país ha llegado a dos millones de dosis de la vacuna contra el coronavirus aplicadas y avanza así a la «meta» de tres millones de inoculados para el 17 de abril.",
                "text_en": "Bogotá, March 31 _ RAM_ Colombia's Deputy Minister of Public Health and Services Delivery, Luis Alexander Moscoso, celebrated on Tuesday that the country has reached two million doses of the coronavirus vaccine applied and thus advances to the \"target\" of three million inoculated by April 17.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El viceministro de Salud Pública y Prestación de Servicios de Colombia, Luis Alexander Moscoso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Vice Minister of Public Health and Service Delivery of Colombia, Luis Alexander Moscoso"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha celebrado este martes que el país ha llegado a dos millones de dosis de la vacuna contra el coronavirus aplicadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has celebrated this Tuesday that the country has reached two million doses of the vaccine against the coronavirus applied"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este martes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Tuesday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así lo ha aseverado Moscoso en una rueda de prensa desde Casa de Nariño, en la que ha indicado que alcanzar esta cifra «llena de alegría» y ha apuntado a la consolidación del Plan Nacional de Vacunación.",
                "text_en": "This is what Moscoso said at a press conference from Casa de Nariño, in which he indicated that reaching this figure \"full of joy\" and aimed at consolidating the National Vaccination Plan.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Moscoso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mossus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una rueda de prensa desde Casa de Nariño",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at a press conference from Casa de Nariño"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha indicado que alcanzar esta cifra «llena de alegría» y ha apuntado a la consolidación del Plan Nacional de Vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has indicated that reaching this figure \"full of joy\" and has pointed to the consolidation of the National Vaccination Plan"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El presidente de Colombia, Iván Duque, ha asistido a la aplicación de la dosis con la que se alcanzaba los dos millones de dosis, que se ha administrado a Elizabeth Pérez Ramos, de 77 años, en el Hospital Universitario del Caribe, informa Radio Caracol.",
                "text_en": "The president of Colombia, Iván Duque, has attended the application of the dose with which the two million doses were reached, which has been given to Elizabeth Pérez Ramos, 77, at the University Hospital of the Caribbean, reports Radio Caracol.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El presidente de Colombia, Iván Duque",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The President of Colombia, Iván Duque"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha asistido a la aplicación de la dosis con la que se alcanzaba los dos millones de dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has attended the application of the dose with which the two million doses were reached"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a Elizabeth Pérez Ramos, de 77 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Elizabeth Pérez Ramos, 77"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Hospital Universitario del Caribe",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the Caribbean University Hospital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En este contexto, Colombia ha confirmado este martes un aumento de casos con 7.952 nuevos positivos, que elevan el total a 2.397.731, según el último balance del Ministerio de Sanidad.",
                "text_en": "In this context, Colombia has confirmed on Tuesday an increase in cases with 7,952 new positives, bringing the total to 2,397,731, according to the latest report of the Ministry of Health.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha confirmado este martes un aumento de casos con 7.952 nuevos positivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has confirmed this Tuesday an increase of cases with 7,952 new positives"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este martes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Tuesday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los fallecidos a causa de la pandemia han ascendido hasta 63.255, con 176 decesos en la última jornada, frente a un total de 2.279.840 personas que han logrado superar la enfermedad.",
                "text_en": "Those killed by the pandemic have risen to 63,255, with 176 deaths in the last day, compared to a total of 2,279,840 people who have managed to overcome the disease.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los fallecidos a causa de la pandemia han ascendido hasta 63.255",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Those killed by the pandemic have risen to 63,255"
                    }
                ],
                "evidences": [
                    {
                        "value": "The third wave of the pandemic pushed the excess mortality back into the positive range from week 8 onward and continued until week 28. During this period, 51,100 people would have died in Hungary without the pandemic, whereas 64,500 people actually died. In the third wave of the pandemic, the excess mortality was therefore 13,400 people, which was an increase of 26%.",
                        "score": 0.6399999857
                    },
                    {
                        "value": "The second wave of the pandemic reached Hungary in week 36 of 2020 and lasted until week 3 of 2021. Without the pandemic, 52,500 people would have died during this period, whereas 67,700 people actually died. Therefore, during the second wave, the excess mortality in Hungary was 15,200 people, an increase of 29% as compared with the estimated mortality.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.9757053256
                    },
                    {
                        "label": "entailment",
                        "score": 0.9503807425
                    }
                ]
            },
            {
                "text": "En la actualidad, el país tiene 46.423 casos activos.",
                "text_en": "Currently, the country has 46,423 active cases.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En la actualidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "At present"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tiene 46.423 casos activos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has 46,423 active cases"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "10": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 14,
            "WhatReliabilityReliable": 14,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 8,
            "WhoReliabilityReliable": 8,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 7,
            "WhyReliabilityReliable": 7,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 5,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 5,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nFigueras dice que son  \"una trampa para osos, porque es un sitio donde entra y sale mucha gente\".\n\n<BREAK>\n\nTodavía hay una cantidad muy grande de incertidumbres acerca de la Covid-19, pero los científicos llevan estudiando el comportamiento del virus desde que apareció. \n\n<BREAK>\n\nEn este tiempo, las advertencias han ido dirigidas a evitar tocar superficies en espacios públicos o a tratar de no permanecer demasiado tiempo en espacios cerrados o sin ventilación. \n\n<BREAK>\n\nAhora, un científico del Consejo Superior de Investigaciones Científicas (CSIC), señala un nuevo espacio donde el riesgo de contagio del virus puede ser especialmente alto: los ascensores. \n\n<BREAK>\n\nConcretamente, Antonio Figueras los ha descrito como \"una trampa para osos, porque es un sitio donde entra y sale mucha gente, pero el aire no se renueva\". \n\n<BREAK>\n\nAsí lo declaraba en una entrevista en 'Liarla Pardo', en la que recomendó evitar mezclarse más de una persona en un mismo ascensor \"porque están expuestos a un aire muy enrarecido\".\n\n<BREAK>\n\nEso sí, hay que ser conscientes de que los sitios cerrados siempre serán más peligrosos en cuanto a riesgo de contagio; pero no por ello hay que olvidar que la posibilidad de infectarse puede darse en los lugares más abiertos y ventilados, si no se toman las precauciones necesarias. \n\n<BREAK>\n\n\"Lo que está claro es que hay un porcentaje elevado de situaciones en las que no sabemos por qué nos contagiamos, pero también es cierto que uno se da cuenta de que bajamos la guardia porque estamos extremadamente cansados\", concluye el científico al mismo medio. ",
        "TITLE": "Un científico del CSIC señala que el peligro de contagiarse en los ascensores: \"Son trampas para osos\"",
        "ID": "12-20minutos",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Un científico del CSIC señala que el peligro de contagiarse en los ascensores: \"Son trampas para osos\"",
                "text_en": "A CSIC scientist points out that the danger of getting infected in elevators: \"They are bear traps\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Un científico del CSIC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A CSIC scientist"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "señala que el peligro de contagiarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "points out that the danger of getting infected"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los ascensores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in elevators"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Son trampas para osos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're bear traps."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Figueras dice que son  \"una trampa para osos, porque es un sitio donde entra y sale mucha gente\".",
                "text_en": "Figueras says they're \"a bear trap, because it's a place where a lot of people come in and out.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Figueras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Figs"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "una trampa para osos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a bear trap"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque es un sitio donde entra y sale mucha gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Because it's a place where a lot of people come in and out."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mucha gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a lot of people"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Todavía hay una cantidad muy grande de incertidumbres acerca de la Covid-19, pero los científicos llevan estudiando el comportamiento del virus desde que apareció. ",
                "text_en": "There are still a very large number of uncertainties about Covid-19, but scientists have been studying the behavior of the virus since it appeared.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay una cantidad muy grande de incertidumbres acerca de la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There is a very large amount of uncertainty about the Covid-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los científicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "scientists"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llevan estudiando el comportamiento del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have been studying the behavior of the virus"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde que apareció",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ever since he showed up."
                    }
                ],
                "evidences": []
            },
            {
                "text": "En este tiempo, las advertencias han ido dirigidas a evitar tocar superficies en espacios públicos o a tratar de no permanecer demasiado tiempo en espacios cerrados o sin ventilación. ",
                "text_en": "At this time, warnings have been aimed at avoiding touching surfaces in public spaces or trying not to stay too long in closed spaces or without ventilation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "evitar tocar superficies",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "avoid touching surfaces"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en espacios públicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in public spaces"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no permanecer demasiado tiempo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "not to stay too long"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en espacios cerrados o sin ventilación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in enclosed or non-ventilated spaces"
                    }
                ],
                "evidences": [
                    {
                        "value": "From the list of misdeeds shown in Table 1 , one can notice that the marking scheme not only penalises those households committing neighbourhood nuisances in public housing estates (e.g. littering and spitting in communal areas, and noise nuisances), but also restricts the misuse of the public housing resources (e.g. using the housing units as food factories or stores) and illegal activities (e.g. illegal gambling). For twelve prescribed misdeeds, prior warnings are given before point allotment with the purpose of encouraging timely rectification by perpetrators. For the other 16 misdeeds, points are allotted immediately without prior warnings because these wrong-doings affect the hygienic conditions and public safety in the housing estates in a more severe and acute manner (Hong Kong Housing Authority, 2010).",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9982403517
                    }
                ]
            },
            {
                "text": "Ahora, un científico del Consejo Superior de Investigaciones Científicas (CSIC), señala un nuevo espacio donde el riesgo de contagio del virus puede ser especialmente alto: los ascensores. ",
                "text_en": "Now, a scientist from the Higher Council for Scientific Research (CSIC) points to a new space where the risk of infection of the virus can be especially high: elevators.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un científico del Consejo Superior de Investigaciones Científicas (CSIC)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a scientist of the Higher Council for Scientific Research (CSIC)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "señala un nuevo espacio donde el riesgo de contagio del virus puede ser especialmente alto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "points to a new space where the risk of infection of the virus can be especially high"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "los ascensores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "elevators"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Concretamente, Antonio Figueras los ha descrito como \"una trampa para osos, porque es un sitio donde entra y sale mucha gente, pero el aire no se renueva\". ",
                "text_en": "Specifically, Antonio Figueras has described them as \"a bear trap, because it is a place where many people enter and leave, but the air is not renewed.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Antonio Figueras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Antonio Figueras"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "una trampa para osos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a bear trap"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque es un sitio donde entra y sale",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Because it's a place where he comes in and out."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mucha gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a lot of people"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "el aire no se renueva",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the air is not renewed"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así lo declaraba en una entrevista en 'Liarla Pardo', en la que recomendó evitar mezclarse más de una persona en un mismo ascensor \"porque están expuestos a un aire muy enrarecido\".",
                "text_en": "He stated this in an interview in 'Liarla Pardo', in which he recommended avoiding mixing more than one person in the same elevator \"because they are exposed to a very rare air\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una entrevista en 'Liarla Pardo'",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an interview on 'Liarla Pardo'"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recomendó evitar mezclarse más de una persona",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recommended avoiding mixing more than one person"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un mismo ascensor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the same elevator"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque están expuestos a un aire muy enrarecido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because they are exposed to a very rare air"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Eso sí, hay que ser conscientes de que los sitios cerrados siempre serán más peligrosos en cuanto a riesgo de contagio; pero no por ello hay que olvidar que la posibilidad de infectarse puede darse en los lugares más abiertos y ventilados, si no se toman las precauciones necesarias. ",
                "text_en": "However, we must be aware that closed sites will always be more dangerous in terms of the risk of contagion, but we must not forget that the possibility of infection can occur in the most open and ventilated places, if the necessary precautions are not taken.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los sitios cerrados siempre serán más peligrosos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "closed sites will always be more dangerous"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "riesgo de contagio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "risk of contagion"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "posibilidad de infectarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "possibility of becoming infected"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los lugares más abiertos y ventilados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the most open and ventilated places"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "no se toman las precauciones necesarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the necessary precautions are not taken"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"Lo que está claro es que hay un porcentaje elevado de situaciones en las que no sabemos por qué nos contagiamos, pero también es cierto que uno se da cuenta de que bajamos la guardia porque estamos extremadamente cansados\", concluye el científico al mismo medio. ",
                "text_en": "\"What is clear is that there is a high percentage of situations in which we don't know why we get infected, but it is also true that one realizes that we lower our guard because we are extremely tired,\" concludes the scientist in the same medium.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay un porcentaje elevado de situaciones en las que no sabemos por qué nos contagiamos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There is a high percentage of situations where we don't know why we get it."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "bajamos la guardia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We let our guard down."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque estamos extremadamente cansados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Because we're extremely tired."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el científico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the scientist"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al mismo medio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the same medium"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "11": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 6,
            "WhatReliabilityReliable": 6,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 3,
            "WhoReliabilityReliable": 3,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 2,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 15,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 15,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nEl riesgo de rebrote ha aumentado en 4 puntos y se sitúa en 212.\n\nCataluña ha administrado la vacuna del covid a un total de 692.801 personas.\n\n<PARAGRAPH>\n\nLa propagación del coronavirus vuelve a reactivarse en Cataluña, ya que el riesgo de rebrote (EPG), que mide el crecimiento exponencial de la pandemia, ha aumentado en 4 puntos y se sitúa en 212, tras dos días seguidos estancado en 208, y vuelven a aumentar los pacientes ingresados en las UCI. \n\n<PARAGRAPH>\n\nSegún los datos epidemiológicos actualizados este jueves por el Departamento de Salud, los ingresos hospitalarios han bajado, al pasar de los 1.393 registrados este miércoles a los 1.378 de este jueves, 15 menos. \n\n<PARAGRAPH>\n\nLa velocidad de propagación de la enfermedad (Rt) ha vuelto a crecer y alcanza la cifra de 1,09 -el miércoles y el martes fue de 1,08-, lo que significa que cada 100 infectados contagian de media a 109 personas, e indica una expansión del virus que hace temer a las autoridades sanitarias una cuarta ola de la pandemia. \n\n<PARAGRAPH>\n\nTambién ha aumentado la incidencia acumulada de positivos por cada 100.000 habitantes a 14 días (IA14), al situarse en 196 casos, mientras que en los dos últimos días la cifra había sido de 193.\n\n<PARAGRAPH>\n\nVacunación\n\n<PARAGRAPH>\n\nDel total de personas vacunadas con la primera dosis, 508.457 son de la provincia de Barcelona, 61.726 de Girona, 47.449 de Lleida y 73.759 de Tarragona; y 58.654 del total son personas usuarias de residencias catalanas.\n\n<PARAGRAPH>\n\n",
        "TITLE": "El crecimiento del virus se activa en Cataluña y aumentan los pacientes en la UCI",
        "ID": "F_04-11-2021_20-48-39_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "El crecimiento del virus se activa en Cataluña y aumentan los pacientes en la UCI",
                "text_en": "The growth of the virus is activated in Catalonia and increases patients in the ICU",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El crecimiento del virus se activa en Cataluña y aumentan los pacientes en la UCI",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The growth of the virus is activated in Catalonia and increases patients in the ICU"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la UCI",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the ICU"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El riesgo de rebrote ha aumentado en 4 puntos y se sitúa en 212.",
                "text_en": "The risk of rebound has increased by 4 points and is 212 points.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El riesgo de rebrote ha aumentado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The risk of regrowth has increased"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cataluña ha administrado la vacuna del covid a un total de 692.801 personas.",
                "text_en": "Catalonia has administered the covid vaccine to a total of 692,801 people.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha administrado la vacuna del covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has administered the covid vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a un total de 692.801 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a total of 692,801 persons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La propagación del coronavirus vuelve a reactivarse en Cataluña, ya que el riesgo de rebrote (EPG), que mide el crecimiento exponencial de la pandemia, ha aumentado en 4 puntos y se sitúa en 212, tras dos días seguidos estancado en 208, y vuelven a aumentar los pacientes ingresados en las UCI. ",
                "text_en": "The spread of the coronavirus is reactivated in Catalonia, as the risk of regrowth (EPG), which measures the exponential growth of the pandemic, has increased by 4 points and is at 212 points, after two consecutive days stagnating at 208, and patients admitted to ICUs are increasing again.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La propagación del coronavirus vuelve a reactivarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Propagation of the coronavirus reactivates"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que el riesgo de rebrote (EPG), que mide el crecimiento exponencial de la pandemia, ha aumentado en 4 puntos y se sitúa en 212",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as the risk of regrowth (GEP), which measures the exponential growth of the pandemic, has increased by 4 points and stands at 212 points"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según los datos epidemiológicos actualizados este jueves por el Departamento de Salud, los ingresos hospitalarios han bajado, al pasar de los 1.393 registrados este miércoles a los 1.378 de este jueves, 15 menos. ",
                "text_en": "According to epidemiological data updated this Thursday by the Department of Health, hospital admissions have dropped, from the 1,393 registered this Wednesday to the 1,378 this Thursday, 15 less.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "egún los datos epidemiológicos actualizados este jueves por el Departamento de Salud, los ingresos hospitalarios han bajado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "according to the epidemiological data updated this Thursday by the Department of Health, hospital admissions have dropped"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Thursday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Departamento de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Department of Health"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La velocidad de propagación de la enfermedad (Rt) ha vuelto a crecer y alcanza la cifra de 1,09 -el miércoles y el martes fue de 1,08-, lo que significa que cada 100 infectados contagian de media a 109 personas, e indica una expansión del virus que hace temer a las autoridades sanitarias una cuarta ola de la pandemia. ",
                "text_en": "The rate of spread of the disease (Rt) has grown again, reaching 1.09 – on Wednesday and Tuesday it was 1.08 – which means that every 100 infected people average 109 people, and indicates an expansion of the virus that makes health authorities fear a fourth wave of the pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La velocidad de propagación de la enfermedad (Rt) ha vuelto a crecer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The rate of spread of the disease (Rt) has grown again"
                    }
                ],
                "evidences": [
                    {
                        "value": "Individuals in cluster i get in physical proximity of another in cluster j at a certain rate, the rate is much higher if i = j, than when i = j. Only a fraction of these contacts spread the disease. We consider that disease spread rate φ i,j is the product of the rate at which an individual in cluster i gets in physical contact with another in cluster j and fraction of contacts between susceptibles and infectious individuals that spread the disease to the susceptibles. Rate of an event is the expected duration between successive occurrences of the event. Typically, φ i,i would be much higher than φ i,j for all i = j. Analogously, opinion spread rate α i,j is the product of the rate at which an individual in cluster i exchanges opinions with another in cluster j and fraction of such exchanges that change cooperativity.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "In conclusion, β may be interpreted as the average number of people a member of the population comes into contact with over one day, and 1 g is the average number of days an infective individual remains infective. [0, 1] denoting exposed individuals. This is a general model for diseases where individuals only become infective after a non-negligible period of time from exposure. It is assumed that an individual's evolution from being exposed to being infective follows a Poisson process with arrival rate Z 2 R >0 . Thus, 1 Z is the average number of days it takes an exposed individual to become infective.",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9547056556
                    },
                    {
                        "label": "contradiction",
                        "score": 0.781752646
                    }
                ]
            }
        ]
    },
    "12": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 3,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 7,
            "WhoReliabilityReliable": 4,
            "WhoReliabilityUnreliable": 3,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 2,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 1,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 2,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 11,
            "Key-Verb": 0,
            "Orthotypography": 2,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 16,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nHace varios días nos hacíamos eco de lo que estaba sucediendo en Chile y que, bajo nuestro punto de vista, demuestra muchas cosas, ninguna buena, sobre la vacuna.\n\n<BREAK>\n\nEn un país con casi 19 millones de habitantes, el 45% de la población ya ha sido vacunado y en estos momentos están atravesando por una situación sanitaria dramática.\n\n<PARAGRAPH>\n\nEn estos momentos, en Chile se están produciendo más de 8.000 contagios diarios y las UCI están saturadas.\n\n<BREAK>\n\nEn nuestra opinión, la situación está más que clara: son las proias vacunas las que, con sus efectos secundarios, han provocado la situación que se está viviendo en aquel país actualmente.\n\n<PARAGRAPH>\n\nPueden venir expertos, el Papa, o el televisivo doctor Cesar Carballo a intentar convencernos de lo contrario, pero nos da igual, nosotros lo tenemos claro y eso es lo que está provocando esa dramática situación.\n\n<PARAGRAPH>\n\nPero ahora llega Lo País en su línea habitual y nos cuenta lo siguiente para justificar esa situación: “La presente oleada ha sido superior al pico de la primera, registrado en junio, y se ha escalado hasta esas cifras mucho más rápidamente.\n\n<BREAK>\n\nLa excesiva confianza de los ciudadanos, derivada precisamente de la rápida campaña de vacunación, y que esta arrancase cuando las nuevas variantes ya estaban presentes en el país se apuntan como causas del aumento de casos“.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nEs decir, la culpa es de la gente, como siempre, y de múltiples variantes que ya estaban presentes.\n\n<BREAK>\n\nA ver, esperen, lo de la gente ya lo tomamos como normal, porque eso es lo que habitualmente se dice en estas situaciones, pero, ¿qué les parece la batallita de las nuevas variantes? Es que es muy fuerte porque todo esto nos lleva a preguntarnos: ENTONES, ¿PARA QUÉ LA VACUNA? No sirve para las “cepas” antiguas, tampoco sirven para las nuevas.\n\n<BREAK>\n\nNo evitan que contagies, no evita que te contagies, ¿entonces cual es la conclusión? Que para lo único que sirve es para meter gente en los hospitales y que se produzcan nuevas olas.\n\n<PARAGRAPH>\n\nPero claro, siervos de los fabricantes de vacunas, como Lo País, nunca van a culpar a la vacuna de marras.\n\n<BREAK>\n\nEso ni se les ocurre, no sea que no cobren…\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Lo País no deja de sorprendernos: Esta es su explicación para justificar la dramática situación sanitaria de Chile y no echar la culpa a la vacuna",
        "ID": "NF_04-11-2021_20-35-55_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Lo País no deja de sorprendernos: Esta es su explicación para justificar la dramática situación sanitaria de Chile y no echar la culpa a la vacuna",
                "text_en": "Lo País never ceases to surprise us: This is his explanation to justify the dramatic health situation in Chile and not to blame the vaccine",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Lo País",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Lo País"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "explicación para justificar la dramática situación sanitaria de Chile y no echar la culpa a la vacuna",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "explanation to justify Chile’s dramatic health situation and not blame the vaccine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Chile",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Chile"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hace varios días nos hacíamos eco de lo que estaba sucediendo en Chile y que, bajo nuestro punto de vista, demuestra muchas cosas, ninguna buena, sobre la vacuna.",
                "text_en": "Several days ago we echoed what was happening in Chile and which, from our point of view, shows many things, no good, about the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hace varios días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Several days ago"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Chile",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Chile"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "demuestra muchas cosas, ninguna buena, sobre la vacuna",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "shows many things, no good, about the vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En un país con casi 19 millones de habitantes, el 45% de la población ya ha sido vacunado y en estos momentos están atravesando por una situación sanitaria dramática.",
                "text_en": "In a country with nearly 19 million inhabitants, 45 per cent of the population has already been vaccinated and are currently experiencing a dramatic health situation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En un país con casi 19 millones de habitantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In a country with almost 19 million inhabitants"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 45% de la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "45% of the population"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya ha sido vacunado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has already been vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En estos momentos, en Chile se están produciendo más de 8.000 contagios diarios y las UCI están saturadas.",
                "text_en": "At present, more than 8,000 infections are occurring daily in Chile and ICUs are saturated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En estos momentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Right now."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Chile",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Chile"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se están produciendo más de 8.000 contagios diarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "More than 8,000 infections are occurring daily"
                    }
                ],
                "evidences": [
                    {
                        "value": "In Chile, the first confirmed case was registered on the 3 March 2020, and the first lockdown was established during the final week of March in seven municipalities of the Metropolitan Region. Currently, Chile reports more than 25,000 deaths, and more than 1.17 million infections.",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9971271157
                    }
                ]
            },
            {
                "text": "En nuestra opinión, la situación está más que clara: son las proias vacunas las que, con sus efectos secundarios, han provocado la situación que se está viviendo en aquel país actualmente.",
                "text_en": "In our view, the situation is more than clear: it is the proios vaccines that, with their side effects, have caused the situation that is currently being experienced in that country.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "son las proias vacunas las que, con sus efectos secundarios, han provocado la situación que se está viviendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It is the proias vaccines that, with their side effects, have caused the situation that is being experienced."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con sus efectos secundarios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with its side effects"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en aquel país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in that country"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "actualmente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "currently"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pueden venir expertos, el Papa, o el televisivo doctor Cesar Carballo a intentar convencernos de lo contrario, pero nos da igual, nosotros lo tenemos claro y eso es lo que está provocando esa dramática situación.",
                "text_en": "Experts may come, the Pope, or TV doctor Cesar Carballo to try to convince us otherwise, but we don't care, we are clear and that is what is causing this dramatic situation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "expertos, el Papa, o el televisivo doctor Cesar Carballo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "experts, the Pope, or the television doctor Cesar Carballo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "intentar convencernos de lo contrario",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "try to convince us otherwise"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero ahora llega Lo País en su línea habitual y nos cuenta lo siguiente para justificar esa situación: “La presente oleada ha sido superior al pico de la primera, registrado en junio, y se ha escalado hasta esas cifras mucho más rápidamente.",
                "text_en": "But now Lo País arrives in his usual line and tells us the following to justify that situation: “The present wave has been higher than the peak of the first, recorded in June, and has climbed to those figures much faster.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Lo País",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Lo País"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La presente oleada ha sido superior al pico de la primera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The present wave has been higher than the peak of the first"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en junio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in June"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La excesiva confianza de los ciudadanos, derivada precisamente de la rápida campaña de vacunación, y que esta arrancase cuando las nuevas variantes ya estaban presentes en el país se apuntan como causas del aumento de casos“.",
                "text_en": "The excessive confidence of citizens, derived precisely from the rapid vaccination campaign, and that this would start when the new variants were already present in the country are pointed out as causes of the increase in cases“.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "La excesiva confianza de los ciudadanos, derivada precisamente de la rápida campaña de vacunación, y que esta arrancase cuando las nuevas variantes ya estaban presentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The excessive confidence of the citizens, derived precisely from the rapid vaccination campaign, and that this would start when the new variants were already present"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the country"
                    }
                ],
                "evidences": [
                    {
                        "value": "Although the precise cause of these trends is unknown, we hypothesize that a relatively successful early vaccination campaign in the region coupled with a reasonable percentage of the population with natural immunity acquired by prior infection with Gamma contributed to the decreasing case rate around the time of introduction of the Delta variant. In contrast, when Gamma dominated transmission, the observed increasing in the number of cases would have been attributed to a relatively naïve population to infection with any SARS-CoV-2 variant. This epidemiological scenario of rapid switching of new variants without an increase in the number of cases seems not to be uncommon and has also been observed elsewhere [16] [17] [18] [19] [20] .",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.939959228
                    }
                ]
            },
            {
                "text": "A ver, esperen, lo de la gente ya lo tomamos como normal, porque eso es lo que habitualmente se dice en estas situaciones, pero, ¿qué les parece la batallita de las nuevas variantes? Es que es muy fuerte porque todo esto nos lleva a preguntarnos: ENTONES, ¿PARA QUÉ LA VACUNA? No sirve para las “cepas” antiguas, tampoco sirven para las nuevas.",
                "text_en": "Let's see, wait, we already take people as normal, because that's what is usually said in these situations, but, what do you think of the batallite of the new variants? It's that it's very strong because all this leads us to ask ourselves: FEELS, WHAT FOR THE VACUNA? It doesn't work for the old \"strains,\" neither do they serve the new ones.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo de la gente ya lo tomamos como normal",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We already take people as normal."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque eso es lo que habitualmente se dice",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because that's what you usually say."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en estas situaciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in these situations"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No evitan que contagies, no evita que te contagies, ¿entonces cual es la conclusión? Que para lo único que sirve es para meter gente en los hospitales y que se produzcan nuevas olas.",
                "text_en": "They don't stop you from contagion, they don't stop you from contaging, so what's the conclusion? That all it's good for is to get people into hospitals and make new waves.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "para lo único que sirve es para meter",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The only thing it's good for is to get in."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "gente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "people"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los hospitales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in hospitals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero claro, siervos de los fabricantes de vacunas, como Lo País, nunca van a culpar a la vacuna de marras.",
                "text_en": "But of course, servants of vaccine manufacturers, like Lo País, will never blame the brown vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "siervos de los fabricantes de vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "servants of vaccine manufacturers"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Lo País",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Lo País"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nunca van a culpar a la vacuna de marras",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're never gonna blame the brown vaccine."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "13": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 11,
            "WhatReliabilityReliable": 5,
            "WhatReliabilityUnreliable": 6,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 9,
            "WhoReliabilityReliable": 4,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 6,
            "WhenReliabilityReliable": 6,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 2,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 3,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 4,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 1,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 3,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 7,
            "Key-Verb": 0,
            "Orthotypography": 2,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 10,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLo del doctor César Carballo, que nos tuvo engañados a algunos al principio de la pandemia, es de lo más descarado y vendido al discurso oficial que hemos visto nunca, él y solo él sabrá a cambio de qué.\n\n<BREAK>\n\nResulta que, tras descubrir Iker Jiménez su faceta televisiva, que debe ser superior a su respeto por el Juramento Hipocrático, Carballo se ha convertido en un defensor a ultranza de las restricciones que se están ordenando con la excusa del virus y cómo no, de las vacunas.\n\n<PARAGRAPH>\n\nY en su defensa a ultranza de las vacunas, Carballo ha perdido todo el pudor y lo justifica todo, incluso de una forma obscena y absolutamente descarada.\n\n<BREAK>\n\nVean, por ejemplo, lo que ha publicado hoy en su cuenta de Twitter.\n\n<BREAK>\n\nHa publicado la radiografía de, en teoría, un hombre vacunado con Pfizer y que ha recibido su segunda dosis el día 26 de marzo.\n\n<PARAGRAPH>\n\nLlega Carballo, el “magnífico”, y nos cuenta que este hombre ha acudido al médico, suponemos que a él, porque tiene “debilidad, antígeno + y neumonia bilateral”, pero ojo, no crean que Carballo lo hace para denunciar que esto sea motivado por la vacuna, no, nos cuenta que es que, como no han pasado 7 días desde la segunda dosis, al hombre que padece todo esto no le ha dado tiempo a “levantar inmunidad”.\n\n<BREAK>\n\n¿Pero no habíamos quedado que la vacuna no garantizaba la inmunidad, que aún se podía contagiar y ser contagiado y que, además, todavía tenía que usar mascarillas y mantener las distancias de seguridad?\n\n<PARAGRAPH>\n\nY otra cosa habría que decirle a Carballo, o mucho nos equivocamos, o desde el 26 de marzo a hoy, día 5 de abril han pasado ¡¡11 días!! Pero atentos, porque también juega con las palabras y el “listo” dice “última dosis” para referirse a la dosis del 26 de marzo.\n\n<BREAK>\n\nMenudo morro que tiene Carballo.\n\n<PARAGRAPH>\n\nDesde la trinchera: >80 años, vacunado con Pfizer, última dosis 26/3, viene por debilidad, antígeno + y neumonia bilateral.\n\n<BREAK>\n\nExplicacion=todavía no ha dado tiempo con la 2° dosis a levantar inmunidad.\n\n<BREAK>\n\nNo se asegura protección hasta 7 días de la segunda dosis!!Aprendamos.\n\n<BREAK>\n\npic.twitter.com/vp2Ihr7sk4\n\n<PARAGRAPH>\n\n— Cesar Carballo (@ccarballo50) April 5, 2021\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "El televisivo doctor vendedor del discurso oficial, César Carballo, justifica de una forma vergonzosa la neumonía de un paciente vacunado el 26 de marzo",
        "ID": "NF_04-11-2021_21-45-32_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "El televisivo doctor vendedor del discurso oficial, César Carballo, justifica de una forma vergonzosa la neumonía de un paciente vacunado el 26 de marzo",
                "text_en": "The television doctor salesman of the official speech, César Carballo, justifies in a shameful way the pneumonia of a patient vaccinated on 26 March",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El televisivo doctor vendedor del discurso oficial, César Carballo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The TV doctor salesman of the official speech, César Carballo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "justifica de una forma vergonzosa la neumonía",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "justifies pneumonia in a shameful way"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de una forma vergonzosa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in a shameful way"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un paciente vacunado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "one patient vaccinated"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 26 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 26 March"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo del doctor César Carballo, que nos tuvo engañados a algunos al principio de la pandemia, es de lo más descarado y vendido al discurso oficial que hemos visto nunca, él y solo él sabrá a cambio de qué.",
                "text_en": "Dr. César Carballo, who had us fooled at the beginning of the pandemic, is one of the most brazen and sold to the official speech we have ever seen, he and only he will know in exchange for what.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "doctor César Carballo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. César Carballo"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al principio de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the beginning of the pandemic"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es de lo más descarado y vendido al discurso oficial",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is most brazen and sold to the official speech"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Resulta que, tras descubrir Iker Jiménez su faceta televisiva, que debe ser superior a su respeto por el Juramento Hipocrático, Carballo se ha convertido en un defensor a ultranza de las restricciones que se están ordenando con la excusa del virus y cómo no, de las vacunas.",
                "text_en": "It turns out that, after discovering Iker Jiménez's television facet, which must be superior to his respect for the Hippocratic Oath, Carballo has become an extreme defender of the restrictions that are being ordered with the excuse of the virus and of course not, of vaccines.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Carballo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Carballo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha convertido en un defensor a ultranza de las restricciones que se están ordenando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has become an outspoken defender of the restrictions being ordered"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la excusa del virus y cómo no, de las vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with the excuse of the virus and of course, of the vaccines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y en su defensa a ultranza de las vacunas, Carballo ha perdido todo el pudor y lo justifica todo, incluso de una forma obscena y absolutamente descarada.",
                "text_en": "And in his defense to the extreme of vaccines, Carballo has lost all modesty and justifies everything, even in an obscene and absolutely brazen way.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Carballo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Carballo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha perdido todo el pudor y lo justifica todo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has lost all modesty and justifies everything"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de una forma obscena y absolutamente descarada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in an obscene and absolutely brazen way"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Vean, por ejemplo, lo que ha publicado hoy en su cuenta de Twitter.",
                "text_en": "See, for example, what you posted today on your Twitter account.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo que ha publicado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "what you have published"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su cuenta de Twitter",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on your Twitter account"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ha publicado la radiografía de, en teoría, un hombre vacunado con Pfizer y que ha recibido su segunda dosis el día 26 de marzo.",
                "text_en": "He has published the X-ray of, in theory, a man vaccinated with Pfizer and who received his second dose on March 26.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un hombre vacunado con Pfizer",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a man vaccinated with Pfizer"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha recibido su segunda dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you have received your second dose"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el día 26 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 26 March"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Llega Carballo, el “magnífico”, y nos cuenta que este hombre ha acudido al médico, suponemos que a él, porque tiene “debilidad, antígeno + y neumonia bilateral”, pero ojo, no crean que Carballo lo hace para denunciar que esto sea motivado por la vacuna, no, nos cuenta que es que, como no han pasado 7 días desde la segunda dosis, al hombre que padece todo esto no le ha dado tiempo a “levantar inmunidad”.",
                "text_en": "Carballo arrives, the “magnificent”, and tells us that this man has come to the doctor, we assume that to him, because he has “weakness, antigen + and bilateral pneumonia”, but eye, do not believe that Carballo does it to denounce that this is motivated by the vaccine, no, he tells us that, since it has not been 7 days since the second dose, the man who suffers from all this has not given time to “lift immunity”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Carballo, el “magnífico”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Carballo, the “magnificent”"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "este hombre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "this man"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha acudido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has come"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al médico",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the doctor"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque tiene “debilidad, antígeno + y neumonia bilateral”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because it has “weakness, antigen + and bilateral pneumonia”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y otra cosa habría que decirle a Carballo, o mucho nos equivocamos, o desde el 26 de marzo a hoy, día 5 de abril han pasado ¡¡11 días!! Pero atentos, porque también juega con las palabras y el “listo” dice “última dosis” para referirse a la dosis del 26 de marzo.",
                "text_en": "And another thing would have to be told Carballo, or a lot of us were wrong, or from March 26 to today, April 5th have passed 11 days! But attentive, because he also plays with the words and the “ready” says “last dose” to refer to the dose of March 26th.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a Carballo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a Carballo"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde el 26 de marzo a hoy, día 5 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from 26 March to today, 5 April"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque también juega con las palabras",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because he also plays with words"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dice “última dosis” para referirse a la dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "says “last dose” to refer to dose"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "26 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "26 March"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desde la trinchera: >80 años, vacunado con Pfizer, última dosis 26/3, viene por debilidad, antígeno + y neumonia bilateral.",
                "text_en": "From the trench: >80 years, vaccinated with Pfizer, last dose 26/3, comes from weakness, antigen + and bilateral pneumonia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Desde la trinchera",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "From the trench"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vacunado con Pfizer, última dosis 26/3",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer vaccine, last dose 26/3"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "viene por debilidad, antígeno + y neumonia bilateral",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "comes from weakness, antigen + and bilateral pneumonia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Explicacion=todavía no ha dado tiempo con la 2° dosis a levantar inmunidad.",
                "text_en": "Explanation=has not yet given time with the 2nd dose to lift immunity.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "no ha dado tiempo con la 2° dosis a levantar inmunidad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has not given time with the 2nd dose to lift immunity"
                    }
                ],
                "evidences": [
                    {
                        "value": "Image 3: Zoomed out look at image 2 : Evaluating an extended time frame with the same variables as above. Projected population immunity based on reasonable estimates of the variables, decay rate of the default regimen is 1.5% per month and the decay rate of one dose efficacy wanes by 10% faster. Even if it takes 10 years to have the second dose available, the second dose deferred strategy would clearly increase population immunity relative to the default strategy.",
                        "score": 0.6399999857
                    },
                    {
                        "value": "Increasing population immunity is key in preventing unnecessary loss of life and harm to the economy. Implementing a deferred second dose strategy appears to maximize the effect of the vaccine supply, leading to a significant increase in population immunity and the associated reduction in loss of life. By modelling various decay rates, we can be reassured that given the data available to us at this time, it is both rational and prudent to deviate from the manufacturers trial designs, which neither considered optimal distribution for the benefit of the population nor evaluated the effect of spacing on long term efficacy. Indeed, the benefit of the increased population immunity of the proposed deferred second dose regimen vastly outweighed the speculative risk of increased decay rates for one dose efficacy. Evaluation of immunity decay rates as shown in this model strongly support implementation of the proposed deferred second dose strategy, along with continued evaluation of one dose efficacy decay rates.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.889706552
                    },
                    {
                        "label": "neutral",
                        "score": 0.9893493652
                    }
                ]
            },
            {
                "text": "No se asegura protección hasta 7 días de la segunda dosis!!Aprendamos.",
                "text_en": "No protection is guaranteed for up to 7 days of the second dose!!Let's learn.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No se asegura protección",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "No protection is ensured"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "hasta 7 días de la segunda dosis",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "up to 7 days of the second dose"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "14": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 11,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 4,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 2,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 11,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 3,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLa cantidad de información que los medios alternativos están publicando con noticias que desmontan por completo el discurso oficial por el que se están manteniendo activas las restricciones adoptadas con la excusa del virus son tantas, que a los voceros y comisionistas del discurso oficial les va a resultar cada vez más difícil mantenerla oculta.\n\n<PARAGRAPH>\n\nNingún gran medio lo ha publicado pero el pasado día 24 de marzo, el Tribunal Administrativo de Viena ha declarado como no apto el TEST PCR para el diagnóstico del virus en Austria.\n\n<BREAK>\n\nEs decir, no sirve de nada.\n\n<BREAK>\n\nLa sentencia, dictada tras una denuncia realizada por el FPÖ (Partido de la Libertad de Austria), cita a expertos y estudios reconocidos internacionalmente y a la Organización Mundial de la Salud, el tribunal consideró que las definiciones de la enfermedad eran erróneas y que una prueba PCR para el diagnóstico de Covid-19 no era adecuada.\n\n<PARAGRAPH>\n\nEn sus motivaciones para la sentencia, el tribunal dice, entre otras cosas, lo siguiente:\n\n<PARAGRAPH>\n\nSegún las definiciones del Ministro de Salud, “Definición de caso Covid-19” del 23 de diciembre de 2020, un “caso confirmado” 1) es cualquier persona con evidencia de ácido nucleico específico del SARS-CoV-2 (prueba de PCR, nota ), independientemente de la manifestación clínica o 2) cualquier persona con evidencia de antígeno específico de SARS-CoV que cumpla con los criterios clínicos o 3) cualquier persona con evidencia de antígeno específico de SARS-CoV que cumpla con los criterios epidemiológicos.\n\n<BREAK>\n\nPor tanto, ninguno de los tres “casos confirmados” definidos por el Ministro de Salud cumple los requisitos del concepto de la OMS de “persona enferma / infectada”.\n\n<BREAK>\n\nLa OMS se niega a confiar únicamente en la prueba de PCR (caso confirmado 1) (…)\n\n<PARAGRAPH>\n\nEl Servicio de Salud de la ciudad de Viena utiliza las palabras “número de casos”, “resultados de las pruebas”, “eventos de casos” y “número de infecciones”.\n\n<BREAK>\n\nEsta confusión de términos no hace justicia a una evaluación científica de la situación epidémica.\n\n<BREAK>\n\n(…) Para la OMS el factor decisivo es el número de personas infectadas / enfermas y no las que dieron positivo u otros “números de casos”.\n\n<PARAGRAPH>\n\nEs una pena que con tantas pruebas como van apareciendo que demuestran que, en estos momentos, nos encontramos con una farsa, haya personas que no se quieren dar por enteradas a estas alturas de la película.\n\n<PARAGRAPH>\n\nLa sentencia es la número VGW-103/048/3227/2021-2 del Tribunal Administrativo de Viena.\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Que no se entere nadie pero un tribunal austriaco ha declarado el TEST PCR como no válido para diagnosticar el virus",
        "ID": "NF_04-11-2021_21-34-32_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Que no se entere nadie pero un tribunal austriaco ha declarado el TEST PCR como no válido para diagnosticar el virus",
                "text_en": "Don't let anyone know, but an Austrian court has declared the TEST PCR as invalid for diagnosing the virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un tribunal austriaco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "an Austrian court"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha declarado el TEST PCR como no válido para diagnosticar el virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has declared PCR TEST as invalid for diagnosing the virus"
                    }
                ],
                "evidences": [
                    {
                        "value": "Les unités NC d'Île-de-France ont enregistré 75 % du total des cas COVID+ des patients dialysés chez NC (voir ci-dessous). La cellule de crise a évoqué l'intérêt d'un dépistage de masse par test PCR à l'ensemble des patients sur la notion qu'il existait de nombreux patients dialysés COVID+ asymptomatiques. Il s'agissait, entre autres, de l'expérience de NC en Catalogne qui a été publiée depuis [11] . Les néphrologues en charge de ces patients ont prescrit des tests PCR systématiques à plus de 400 patients asymptomatiques au cours de la deuxième quinzaine d'avril 2020. Dans une seule unité, deux de ces patients ont eu un test positif (0,005 %). Tous les autres patients ont eu un résultat négatif, en contradiction avec les résultats déjà publiés. Un dépistage sérologique systématique des anticorps anti-SARS-CoV2 a également été conduit dans l'unité d'Île-de-France, la plus touchée en juin 2020 (18 % des patients contaminés), dans laquelle par ailleurs un test PCR systématique avait été proposé aux patients. Sur 70 patients, 9 avaient eu un diagnostic de COVID (PCR+ chez 6 ; scanner thoracique positif chez 3 autres patients ayant soit une PCR négative (2), soit un refus du test PCR (1)) ; tous ces patients ont eu une sérologie positive. Tous les autres patients qui n'avaient pas eu de symptômes de COVID (61 patients) et une PCR négative (59 patients, deux ayant refusé le test PCR) ont un résultat négatif de la sérologie.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9829363823
                    }
                ]
            },
            {
                "text": "La cantidad de información que los medios alternativos están publicando con noticias que desmontan por completo el discurso oficial por el que se están manteniendo activas las restricciones adoptadas con la excusa del virus son tantas, que a los voceros y comisionistas del discurso oficial les va a resultar cada vez más difícil mantenerla oculta.",
                "text_en": "The amount of information that the alternative media are publishing with news that completely dismantles the official discourse by which the restrictions adopted under the virus excuse are being kept active are so many, that it will be increasingly difficult for the spokespersons and commissioners of the official discourse to keep it hidden.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La cantidad de información que los medios alternativos están publicando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The amount of information that alternative media are publishing"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con noticias que desmontan por completo el discurso oficial",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with news that completely dismantles the official discourse"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los voceros y comisionistas del discurso oficial",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the spokespersons and commissioners of the official speech"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "les va a resultar cada vez más difícil mantenerla oculta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're going to find it harder and harder to keep it hidden."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ningún gran medio lo ha publicado pero el pasado día 24 de marzo, el Tribunal Administrativo de Viena ha declarado como no apto el TEST PCR para el diagnóstico del virus en Austria.",
                "text_en": "No major media outlets have published it, but on 24 March last, the Vienna Administrative Tribunal declared the PCR STET unfit for the diagnosis of the virus in Austria.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado día 24 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last day of March 24"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Tribunal Administrativo de Viena",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Vienna Administrative Tribunal"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha declarado como no apto el TEST PCR para el diagnóstico del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has declared that PCR STET is not suitable for the diagnosis of the virus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Austria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Austria"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es decir, no sirve de nada.",
                "text_en": "I mean, it's no use.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no sirve de nada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It's no use."
                    }
                ],
                "evidences": []
            },
            {
                "text": "La sentencia, dictada tras una denuncia realizada por el FPÖ (Partido de la Libertad de Austria), cita a expertos y estudios reconocidos internacionalmente y a la Organización Mundial de la Salud, el tribunal consideró que las definiciones de la enfermedad eran erróneas y que una prueba PCR para el diagnóstico de Covid-19 no era adecuada.",
                "text_en": "The judgement, issued following a complaint made by the Austrian Freedom Party (FPÖ), cites internationally recognized experts and studies and the World Health Organization, the court considered that the definitions of the disease were wrong and that a PCR test for the diagnosis of Covid-19 was not adequate.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "dictada tras una denuncia realizada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "following a complaint lodged"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "FPÖ (Partido de la Libertad de Austria)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "FPÖ (Austrian Freedom Party)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cita a expertos y estudios reconocidos internacionalmente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "cites internationally recognized experts and studies"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Organización Mundial de la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the World Health Organization"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el tribunal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the court"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "consideró que las definiciones de la enfermedad eran erróneas y que una prueba PCR para el diagnóstico de Covid-19 no era adecuada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "considered that the definitions of the disease were wrong and that a PCR test for the diagnosis of Covid-19 was not adequate"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por tanto, ninguno de los tres “casos confirmados” definidos por el Ministro de Salud cumple los requisitos del concepto de la OMS de “persona enferma / infectada”.",
                "text_en": "Therefore, none of the three “confirmed cases” defined by the Minister of Health meets the requirements of the WHO concept of “ill/infected person”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ninguno de los tres “casos confirmados” definidos por el Ministro de Salud cumple los requisitos del concepto de la OMS de “persona enferma / infectada”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "none of the three “confirmed cases” defined by the Minister of Health meets the requirements of the WHO concept of “ill/infected person”"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministro de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Minister of Health"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La OMS se niega a confiar únicamente en la prueba de PCR (caso confirmado 1) (…)",
                "text_en": "WHO refuses to rely solely on the PCR test (confirmed case 1) (...)",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se niega a confiar únicamente en la prueba de PCR",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "refuses to rely solely on the PCR test"
                    }
                ],
                "evidences": []
            },
            {
                "text": "(…) Para la OMS el factor decisivo es el número de personas infectadas / enfermas y no las que dieron positivo u otros “números de casos”.",
                "text_en": "(...) For WHO the decisive factor is the number of people infected/diseased and not those who gave positive or other “numbers of cases”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el factor decisivo es el número de personas infectadas / enfermas y no las que dieron positivo u otros “números de casos”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the decisive factor is the number of people infected/diseased and not those who tested positive or other “numbers of cases”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es una pena que con tantas pruebas como van apareciendo que demuestran que, en estos momentos, nos encontramos con una farsa, haya personas que no se quieren dar por enteradas a estas alturas de la película.",
                "text_en": "It is a pity that with so many evidences as they appear that show that, at the moment, we find ourselves with a farce, there are people who do not want to be heard at this point in the film.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con tantas pruebas como van apareciendo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with as many proofs as they appear"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en estos momentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Right now."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos encontramos con una farsa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We run into a farce."
                    }
                ],
                "evidences": []
            },
            {
                "text": "La sentencia es la número VGW-103/048/3227/2021-2 del Tribunal Administrativo de Viena.",
                "text_en": "The judgment is VGW-103/048/3227/2021-2 of the Vienna Administrative Tribunal.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La sentencia es la número VGW-103/048/3227/2021-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The judgment is the number VGW-103/048/3227/2021-2"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Tribunal Administrativo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Administrative Tribunal"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Viena",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Vienna"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "15": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 30,
            "WhatReliabilityReliable": 19,
            "WhatReliabilityUnreliable": 11,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 20,
            "WhoReliabilityReliable": 16,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 20,
            "WhenReliabilityReliable": 18,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 6,
            "WhereReliabilityReliable": 5,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 2,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 16,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 5,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 7,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nDecía que no habría en España más que 'unos casos' de Covid, desaconsejó las mascarillas y pronosticó que la curva de contagios descendería rápidamente\n\n<PARAGRAPH>\n\nTiene más cara que espalda Fernando Simón.\n\n<PARAGRAPH>\n\nEl ‘experto‘ que nunca da una y hasta se sumó a los que hace un años instaban a la gente a aglomerarse en el aquelarre de las manifestaciones feministas, echa ahora la culpa de la tercera ola de coronavirus a los ciudadanos españoles.\n\n<PARAGRAPH>\n\nNo debería ser necesario recordar a la gente que el 31 de enero de 2020, cuando se detectó en España el primer caso de contagio por coronavirus, un turista alemán en la Gomera, Simón se puso estupendo y afirmó rotundo: «No hay que alarmarse, quizá haya aquí algún caso».\n\n<PARAGRAPH>\n\nPues hemos tenidos millones y más de 80.000 muertos.\n\n<PARAGRAPH>\n\nTampoco deberíamos evocar que en febrero de 2021, el doctor que parecía este jueves haber dormido en el coche, no veía necesarias las mascarillas.\n\n<BREAK>\n\nY que en abril ya las recomendaba, aunque no obligaba.\n\n<PARAGRAPH>\n\nOpinión que volvió a cambiar en mayo, cuando ya eran obligatorias.\n\n<PARAGRAPH>\n\nY por si fuera poco, el pasado 15 de octubre, Simón vaticinaba muy alegre un descenso de la curva «en los próximos días», una tendencia que no solo no se confirmó, sino que varió drásticamente al día siguiente: el 16 de octubre nuestro país batió su récord de contagios en toda la pandemia con 15.186 nuevos casos.\n\n<PARAGRAPH>\n\nPues este tipo, que en ocasiones da la impresión de acudir ‘alegre‘ a las ruedas de prensa pero que ejerce como director del Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES), tuvo la cara este 14 de enero de 2021 de descargar  en la sufriente ciudadanía toda la responsabilidad en el aumento de los contagios que está viviendo España en los últimos días.\n\n<PARAGRAPH>\n\nEn su opinión, la causa es, por encima de todo y casi en exclusiva, de su comportamiento durante la Navidad.\n\n<PARAGRAPH>\n\n«Los hemos pasado, quizá, mejor de lo que debíamos haberlo hecho en Navidades.\n\n<BREAK>\n\nPues ahora tenemos que asumir lo que va a suceder».\n\n<PARAGRAPH>\n\n«Sí, vamos a pasar unas semanas duras.\n\n<BREAK>\n\nNo sé cuándo va a llegar el pico de esta nueva fase.\n\n<BREAK>\n\nSí que es posible que no estemos muy lejos de él.\n\n<BREAK>\n\nDependerá de si las medidas de las comunidades empiezan a tener efecto.\n\n<BREAK>\n\nDe si nosotros, todos, una vez pasadas las festividades, hemos retomado las buenas costumbres y hemos vuelto de nuevo a ser conscientes de la importancia que tiene nuestra labor en el control de la epidemia.\n\n<BREAK>\n\nSi eso es así, es posible que al principio de la semana que viene estemos viendo un descenso».\n\n<PARAGRAPH>\n\nSalvar la Navidad le está saliendo muy caro a España.\n\n<PARAGRAPH>\n\nEste lunes, el Ministerio de Sanidad notificó 61.422 nuevos casos, la cifra más alta en un lunes desde el inicio de la pandemia, aunque la infranotificación en la primera ola desvirtúa la comparación.\n\n<PARAGRAPH>\n\nAdemás, sumó 401 fallecimientos.\n\n<BREAK>\n\nLa incidencia acumulada a 14 días está en 435,62 casos por 100.000 habitantes.\n\n<PARAGRAPH>\n\nY seguirá creciendo en los próximos días porque «la incidencia a siete días está muy encima de la mitad», indicó Simón.\n\n<BREAK>\n\nLa ocupación de las UCI por pacientes de covid-19 ya es del 26,13%, con dos comunidades por encima del 40% y otras tres por encima del 35%.\n\n<PARAGRAPH>\n\nA principios de diciembre, Sanidad y las comunidades autónomas acordaron rebajar las restricciones durante esas fechas.\n\n<PARAGRAPH>\n\nAunque unos días después el empeoramiento de la situación les hizo recular (solo un poco), en general, las autoridades no se atrevieron a sacrificar las reuniones familiares para evitar un inicio de 2021 peor de lo que ya se esperaba.\n\n<BREAK>\n\nEligieron abrir la mano, y las consecuencias las estamos viendo.\n\n<PARAGRAPH>\n\nHay que tener eso en cuenta a la hora de analizar el aumento de los contagios, que obviamente tiene su origen en los encuentros familiares y sociales de las últimas semanas.\n\n<PARAGRAPH>\n\nPero tampoco hay que obviar el mensaje que las autoridades, nacionales y autonómicas, lanzaron a sus ciudadanos con sus medidas.\n\n<BREAK>\n\nPuede que Simón, que dirige el equipo de expertos en salud pública que guía las actuaciones y recomendaciones del Ministerio de Sanidad, no estuviera de acuerdo con esas medidas.\n\n<BREAK>\n\nSi es así, no lo dijo en la rueda de prensa de este lunes, en la que señaló a los ciudadanos como los responsables.\n\n<PARAGRAPH>\n\n«Yo tiendo a ser, quizás, más optimista de lo que debiera.\n\n<BREAK>\n\nY creo que la población va a aplicar correctamente las medidas en estos días, va a ser consciente de lo que ha pasado en Navidades y de lo que ahora tenemos que hacer para dar un paso atrás en la transmisión por culpa de lo que hicimos en las Navidades».\n\n<PARAGRAPH>\n\n«No estoy juzgando.\n\n<BREAK>\n\nObviamente eran festividades y todo el mundo tenía necesidad de un periodo de relajación, pero eso tiene sus consecuencias».\n\n<PARAGRAPH>\n\nEl director del CCAES cree que la variante británica, de la que se han detectado unos 70 casos, está teniendo un impacto marginal en España.\n\n<PARAGRAPH>\n\nPor ese motivo, descartó que esté influyendo de manera significativa en la actual evolución de la pandemia.\n\n<PARAGRAPH>\n\n«No podemos pensar que esto es un problema asociado a una variante del virus.\n\n<BREAK>\n\nPuede tener un pequeño impacto, pero de ninguna manera podemos achacarlo a una variante del virus.\n\n<BREAK>\n\nEs un problema del comportamiento que hemos tenido estos días».\n\n<PARAGRAPH>\n\n«El problema no es la cepa británica, es nuestro comportamiento».\n\n<PARAGRAPH>\n\n«Las medidas de control son las mismas.\n\n<BREAK>\n\nSi la cepa es más transmisible, es verdad que hay que aplicarlos un poco mejor.\n\n<BREAK>\n\nY en ningún momento pretender que la evolución de la epidemia en España, si cambia, cambia por culpa de esa cepa.\n\n<BREAK>\n\nSi cambia, cambiará por culpa de nuestro comportamiento y las medidas de control que todos conocemos y sabemos aplicar».\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Fernando Simón, el ‘experto’ que no acertó ni una, culpa a los españoles de la tercera ola de coronavirus",
        "ID": "NF_04-11-2021_21-01-47_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Fernando Simón, el ‘experto’ que no acertó ni una, culpa a los españoles de la tercera ola de coronavirus",
                "text_en": "Fernando Simón, the ‘expert’ who did not hit one, blames the Spaniards for the third wave of coronavirus",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fernando Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fernando Simón"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "culpa a los españoles de la tercera ola de coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "blames the Spaniards for the third wave of coronavirus"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los españoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Spanish"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Decía que no habría en España más que 'unos casos' de Covid, desaconsejó las mascarillas y pronosticó que la curva de contagios descendería rápidamente",
                "text_en": "He said that there would be only 'a few cases' of Covid in Spain, discouraged the masks and predicted that the contagion curve would rapidly descend.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Decía que no habría en España más que 'unos casos' de Covid",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He said there would be nothing in Spain but 'a few cases' of Covid"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tiene más cara que espalda Fernando Simón.",
                "text_en": "It's more expensive than Fernando Simón's back.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Tiene más cara que espalda",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's got more face than back."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fernando Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fernando Simón"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El ‘experto‘ que nunca da una y hasta se sumó a los que hace un años instaban a la gente a aglomerarse en el aquelarre de las manifestaciones feministas, echa ahora la culpa de la tercera ola de coronavirus a los ciudadanos españoles.",
                "text_en": "The ‘expert’ who never gives one and even joined those who a few years ago urged people to gather in the coven of feminist demonstrations, now blames the third wave of coronavirus on Spanish citizens.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El ‘experto‘",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The ‘expert’"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el aquelarre de las manifestaciones feministas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the coven of feminist demonstrations"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "echa ahora la culpa de la tercera ola de coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "now blames the third wave of coronavirus"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los ciudadanos españoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Spanish citizens"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No debería ser necesario recordar a la gente que el 31 de enero de 2020, cuando se detectó en España el primer caso de contagio por coronavirus, un turista alemán en la Gomera, Simón se puso estupendo y afirmó rotundo: «No hay que alarmarse, quizá haya aquí algún caso».",
                "text_en": "It should not be necessary to remind people that on January 31, 2020, when the first case of contagion by coronavirus was detected in Spain, a German tourist in La Gomera, Simon got great and said emphatically: \"We should not be alarmed, perhaps there is some case here\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 31 de enero de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 31 January 2020"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un turista alemán",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a German tourist"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Gomera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in La Gomera"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Simon"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se puso estupendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It got great."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pues hemos tenidos millones y más de 80.000 muertos.",
                "text_en": "Well, we've had millions and more than 80,000 dead.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hemos tenidos millones y más de 80.000 muertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We've had millions and more than 80,000 dead."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tampoco deberíamos evocar que en febrero de 2021, el doctor que parecía este jueves haber dormido en el coche, no veía necesarias las mascarillas.",
                "text_en": "Nor should we recall that in February 2021, the doctor who seemed to have slept in the car this Thursday, saw no need for masks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en febrero de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in February 2021"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el doctor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the doctor"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "parecía este jueves haber dormido en el coche",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It seemed this Thursday to have slept in the car."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Thursday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no veía necesarias las mascarillas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "I didn't see any need for masks."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y que en abril ya las recomendaba, aunque no obligaba.",
                "text_en": "And that in April he already recommended them, although he did not force them.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in April"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las recomendaba",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recommended"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Opinión que volvió a cambiar en mayo, cuando ya eran obligatorias.",
                "text_en": "Opinion that changed again in May, when they were already mandatory.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Opinión que volvió a cambiar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Opinion that changed again"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en mayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in May"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y por si fuera poco, el pasado 15 de octubre, Simón vaticinaba muy alegre un descenso de la curva «en los próximos días», una tendencia que no solo no se confirmó, sino que varió drásticamente al día siguiente: el 16 de octubre nuestro país batió su récord de contagios en toda la pandemia con 15.186 nuevos casos.",
                "text_en": "And if that were not enough, on 15 October, Simon was very happy to predict a descent of the curve \"in the next few days\", a trend that was not only not confirmed, but changed dramatically the next day: on 16 October our country broke its record of contagion throughout the pandemic with 15,186 new cases.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado 15 de octubre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last October 15th"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Simon"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vaticinaba muy alegre un descenso de la curva",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I was very happy for a descent of the curve."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "«en los próximos días»,",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "‘in the next few days’,"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 16 de octubre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 16 October"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nuestro país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "our country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "batió su récord de contagios en toda la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "broke his record of contagion throughout the pandemic"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con 15.186 nuevos casos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "15,186 new cases"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pues este tipo, que en ocasiones da la impresión de acudir ‘alegre‘ a las ruedas de prensa pero que ejerce como director del Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES), tuvo la cara este 14 de enero de 2021 de descargar  en la sufriente ciudadanía toda la responsabilidad en el aumento de los contagios que está viviendo España en los últimos días.",
                "text_en": "For this type, which sometimes gives the impression of going ‘joyful‘ to press conferences but exercising as director of the Center for the Coordination of Health Alerts and Emergencies (CCAES), had the face on January 14, 2021 to download into the suffering citizenry all the responsibility in the increase of the contagions that Spain is experiencing in recent days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "este tipo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This guy."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este 14 de enero de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "14 January 2021"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "descargar  en la sufriente ciudadanía toda la responsabilidad en el aumento de los contagios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the burden of responsibility on the suffering citizenry in the increase of the contagion"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la sufriente ciudadanía",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Suffering citizenship"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En su opinión, la causa es, por encima de todo y casi en exclusiva, de su comportamiento durante la Navidad.",
                "text_en": "In his opinion, the cause is, above all and almost exclusively, his behavior during Christmas.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "su comportamiento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "your behavior"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante la Navidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during Christmas"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Sí, vamos a pasar unas semanas duras.",
                "text_en": "\"Yes, we are going to spend a few hard weeks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vamos a pasar unas semanas duras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We're gonna spend a few tough weeks."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Dependerá de si las medidas de las comunidades empiezan a tener efecto.",
                "text_en": "It will depend on whether community measures are starting to take effect.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Dependerá de si las medidas de las comunidades empiezan a tener efecto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It will depend on whether community measures are starting to take effect."
                    }
                ],
                "evidences": [
                    {
                        "value": "These measures may consist of a mixture of border controls designed to reduce the risk of cases being seeded into the population, and community measures designed to enhance surveillance and reduce the potential for transmission.",
                        "score": 0.5600000024
                    },
                    {
                        "value": "On the other hand, it is important to consider who leads community development, because development leaders have an impact on the direction, scope, focus, and process of community engagement as a means of promoting community wellbeing as an outcome of development. To further explore that aspect, we focus on three types of community development that Matarrita-Cascante and Brennan (2012, p. 289) suggest: \"imposed,\" \"directed,\" and \"self-help\" community development. \"Imposed\" community development occurs when governments or private developers generate improvements to make life or community living conditions better but without community involvement; \"directed\" community development applies where functional and structural improvements occur via governmental and/or non-governmental organizations, through community exchange, providing residents with some information and voice; finally, \"self-help\" community development applies where community benefits are associational, with high levels of capacity-building and with residents directing change (Harrow & Jung, 2016; Matarrita-Cascante & Brennan, 2012) . The well-being of a geographically bounded community is, however, central to community development, whether community development is \"imposed,\" \"directed,\" or \"self-help\"-based, and whether community well-being is defined narrowly (e.g. limiting the dimensions to be addressed) or more broadly (e.g. addressing all or a majority of the dimensions) (Foell & Pitzer, 2020) .",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9970001578
                    },
                    {
                        "label": "neutral",
                        "score": 0.9818584919
                    }
                ]
            },
            {
                "text": "De si nosotros, todos, una vez pasadas las festividades, hemos retomado las buenas costumbres y hemos vuelto de nuevo a ser conscientes de la importancia que tiene nuestra labor en el control de la epidemia.",
                "text_en": "Whether we, all of us, once the holidays have passed, have resumed good habits and have again become aware of the importance of our work in controlling the epidemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nosotros, todos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "us, all of us."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "una vez pasadas las festividades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Once the festivities have passed"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hemos vuelto de nuevo a ser conscientes de la importancia que tiene nuestra labor en el control de la epidemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We have once again become aware of the importance of our work in controlling the epidemic."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si eso es así, es posible que al principio de la semana que viene estemos viendo un descenso».",
                "text_en": "If that is the case, we may be seeing a descent at the beginning of next week.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al principio de la semana que viene",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the beginning of next week"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estemos viendo un descenso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We're seeing a descent."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este lunes, el Ministerio de Sanidad notificó 61.422 nuevos casos, la cifra más alta en un lunes desde el inicio de la pandemia, aunque la infranotificación en la primera ola desvirtúa la comparación.",
                "text_en": "On Monday, the Ministry of Health reported 61,422 new cases, the highest figure on a Monday since the beginning of the pandemic, although the undernotification in the first wave distorts the comparison.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This Monday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "notificó 61.422 nuevos casos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reported 61,422 new cases"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, sumó 401 fallecimientos.",
                "text_en": "In addition, it added 401 deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sumó 401 fallecimientos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "totaled 401 deaths"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y seguirá creciendo en los próximos días porque «la incidencia a siete días está muy encima de la mitad», indicó Simón.",
                "text_en": "And it will continue to grow in the coming days because \"the incidence of seven days is far above half,\" said Simon.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "seguirá creciendo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It'll keep growing."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los próximos días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the next few days"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque «la incidencia a siete días está muy encima de la mitad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because \"the incidence at seven days is far above half"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Simon"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A principios de diciembre, Sanidad y las comunidades autónomas acordaron rebajar las restricciones durante esas fechas.",
                "text_en": "In early December, Health and the Autonomous Communities agreed to reduce restrictions during those dates.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "A principios de diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Early December"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad y las comunidades autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health and the Autonomous Communities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "acordaron rebajar las restricciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "agreed to lower restrictions"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante esas fechas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during those dates"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aunque unos días después el empeoramiento de la situación les hizo recular (solo un poco), en general, las autoridades no se atrevieron a sacrificar las reuniones familiares para evitar un inicio de 2021 peor de lo que ya se esperaba.",
                "text_en": "Although a few days later the worsening of the situation made them regulate (just a little bit), in general, the authorities did not dare sacrifice family reunions to avoid a start of 2021 worse than was already expected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "unos días después",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a few days later"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las autoridades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "authorities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se atrevieron a sacrificar las reuniones familiares",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "did not dare to sacrifice family reunions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hay que tener eso en cuenta a la hora de analizar el aumento de los contagios, que obviamente tiene su origen en los encuentros familiares y sociales de las últimas semanas.",
                "text_en": "That must be taken into account when analyzing the increase in contagion, which obviously has its origin in the family and social encounters of the last few weeks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el aumento de los contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "increased contagion"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "en los encuentros familiares y sociales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at family and social meetings"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "las últimas semanas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the last few weeks"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si es así, no lo dijo en la rueda de prensa de este lunes, en la que señaló a los ciudadanos como los responsables.",
                "text_en": "If so, he did not say so at this Monday's press conference, in which he pointed out citizens as responsible.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la rueda de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the press conference"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "señaló a los ciudadanos como los responsables",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "pointed out citizens as responsible"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los ciudadanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "citizens"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y creo que la población va a aplicar correctamente las medidas en estos días, va a ser consciente de lo que ha pasado en Navidades y de lo que ahora tenemos que hacer para dar un paso atrás en la transmisión por culpa de lo que hicimos en las Navidades».",
                "text_en": "And I think people are going to apply the measures correctly these days, they're going to be aware of what happened at Christmas and what we have to do now to take a step back in broadcasting because of what we did at Christmas.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "population"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "va a aplicar correctamente las medidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will implement the measures correctly"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en estos días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "these days"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«No estoy juzgando.",
                "text_en": "«I am not judging.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No estoy juzgando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "I'm not judging."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Obviamente eran festividades y todo el mundo tenía necesidad de un periodo de relajación, pero eso tiene sus consecuencias».",
                "text_en": "Obviously they were festivities and everyone needed a period of relaxation, but that has its consequences.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "todo el mundo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "everyone"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tenía necesidad de un periodo de relajación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "I needed a period of relaxation."
                    }
                ],
                "evidences": []
            },
            {
                "text": "«No podemos pensar que esto es un problema asociado a una variante del virus.",
                "text_en": "\"We cannot think that this is a problem associated with a variant of the virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No podemos pensar que esto es un problema asociado a una variante del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We cannot think that this is a problem associated with a variant of the virus."
                    }
                ],
                "evidences": []
            },
            {
                "text": "«El problema no es la cepa británica, es nuestro comportamiento».",
                "text_en": "\"The problem is not the British strain, it's our behavior.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El problema no es la cepa británica, es nuestro comportamiento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The problem isn't the British strain, it's our behavior."
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Las medidas de control son las mismas.",
                "text_en": "‘The control measures are the same.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las medidas de control son las mismas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The control measures are the same"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y en ningún momento pretender que la evolución de la epidemia en España, si cambia, cambia por culpa de esa cepa.",
                "text_en": "And at no time do you pretend that the evolution of the epidemic in Spain, if it changes, changes because of that strain.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la evolución de la epidemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the evolution of the epidemic"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si cambia, cambiará por culpa de nuestro comportamiento y las medidas de control que todos conocemos y sabemos aplicar».",
                "text_en": "If it changes, it will change because of our behavior and the control measures that we all know and know how to apply.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por culpa de nuestro comportamiento y las medidas de control",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because of our behavior and control measures"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "16": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 16,
            "WhatReliabilityReliable": 16,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 13,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 6,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 5,
            "WhyReliabilityReliable": 5,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 9,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 9,
            "WhoRoleSubject": 12,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 5,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 5,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nMaría Neira asegura que las vacunas están contribuyendo en reducir los casos severos y muertes por coronavirus\n\n<PARAGRAPH>\n\nLas vacunas están siendo efectivas en la reducción de severidad y mortalidad de casos de coronavirus, también con las nuevas variantes, y además están contribuyendo a la disminución de la transmisión del virus.\n\n<BREAK>\n\nEs el mensaje esperanzador que este viernes ha lanzado Maria Neira, directora del departamento de Salut Pública y del Ambiente de la Organización Mundial de la Salud (OMS) en una entrevista radiofónica en El món a Rac1. \n\n<PARAGRAPH>\n\nPor todo ello, Neira urge a acelerar la vacunación con todas las inoculaciones posibles para frenar la expansión del Covid-19 y alcanzar el 70% de población europea protegida en verano, un objetivo que ve posible : \"Se puede conseguir con una estrategia clara\" de vacunación. \n\n<PARAGRAPH>\n\nSi bien en los últimos días se ha registrado un aumento de los contagios en Europa, la experta se ha mostrado esperanzada, aunque prudente, en que no se produzca un aumento de muertes por covid: \"Ya no se espera un repunte de la mortalidad por coronavirus\". \n\n<PARAGRAPH>\n\nTodas las esperanzas están puestas en la vacunación.\n\n<BREAK>\n\nY por ello, si una manera de “acelerar” las vacunas pasa por revisar licencias “son soluciones a las que hay que dar espacio porque necesitamos multiplicar la vacunación”, ha asegurado Neira.\n\n<BREAK>\n\nY no sólo en Europa, sino en todo el mundo, ha puntualizado. \n\n<PARAGRAPH>\n\nEn este sentido, la experta ha augurado que en las próximas semanas vamos a tener “buenas noticias” en relación con la disponibilidad de más y nuevas vacunas.\n\n<BREAK>\n\nLa Agencia Europea del Medicamento decidirá el 11 de marzo si aprueba la vacuna Janssen (de la farmacéutica Johnson&Johnson) y también está analizando las de CureVac y Sputnik V. \n\n<PARAGRAPH>\n\nPrecisamente, sobre el fármaco ruso, Neira ha asegurado que \"todas las vacunas tienen derecho a ser analizadas\" y que si bien les falta mucha información sobre la Sputnik V, cada día obtienen más datos.\n\n<BREAK>\n\nCon todo, ha enfatizado que la OMS mantiene los mismos estándares de calidad para todas las candidatas a vacuna contra la covid. \n\n<PARAGRAPH>\n\nPor el momento, y según los datos publicados por el departament de Salut de la Generalitat, Catalunya mantiene la tendencia a la baja de los datos epidemiológicos, que mejoran cerca de un 4% respecto a los anunciados el pasado jueves.\n\n<BREAK>\n\nDel 23 de febrero al 1 de marzo se han registrado 8.572 positivos, cerca de 300 menos que el pasado jueves.\n\n<BREAK>\n\nEn las últimas 24 horas se han sumado al total 1.581 positivos, elevando la cifra a 563.617.Mientras el riesgo de rebrote, la positividad y la incidencia acumulada se reducen; y la velocidad de contagio se mantiene en 0,92, el dato negativo se encuentra este viernes en las ucis.\n\n<BREAK>\n\nLos pacientes en planta han descendido a 1.605, 32 menos en 24 horas, aunque los graves en unidades de cuidados intensivos han subido 18 según los notificados el pasado jueves (522 en total).\n\n<PARAGRAPH>\n\nA pesar de la aprobación de nuevas vacunas, Neira ha puntualizado que “otra cosa es la velocidad de vacunación”.\n\n<BREAK>\n\nPor eso la experta de la OMS ha urgido a vacunar de forma “más acelerada” porque se ha demostrado que hacerlo reduce la mortalidad, la severidad de los casos e incluso la transmisión también en las nuevas variantes.\n\n<PARAGRAPH>\n\nEn cuanto la indicación de aplicar la vacuna de AstraZeneca a los menores de 55 años, como mantiene el Gobierno español, Neira considera que no es necesaria porque \"la opinión de la OMS\" es que el fármaco desarrollado también por la universidad de Oxford se puede usar en personas mayores de 65 años. \n\n<PARAGRAPH>\n",
        "TITLE": "La directora de Salud Pública de la OMS: \"No se espera un repunte de la mortalidad\" por la covid",
        "ID": "F_04-11-2021_21-36-01_www_lavanguardia_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La directora de Salud Pública de la OMS: \"No se espera un repunte de la mortalidad\" por la covid",
                "text_en": "WHO Director of Public Health: \"There is no expectation of an upturn in mortality\" by covid",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La directora de Salud Pública de la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO Director of Public Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No se espera un repunte de la mortalidad\" por la covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There is no expectation of an upturn in mortality\" from covid"
                    }
                ],
                "evidences": []
            },
            {
                "text": "María Neira asegura que las vacunas están contribuyendo en reducir los casos severos y muertes por coronavirus",
                "text_en": "María Neira assures that vaccines are helping to reduce severe cases and deaths from coronaviruses",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "María Neira",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "María Neira"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "asegura que las vacunas están contribuyendo en reducir los casos severos y muertes por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ensures that vaccines are helping to reduce severe cases and deaths from coronaviruses"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las vacunas están siendo efectivas en la reducción de severidad y mortalidad de casos de coronavirus, también con las nuevas variantes, y además están contribuyendo a la disminución de la transmisión del virus.",
                "text_en": "Vaccines are being effective in reducing the severity and mortality of coronavirus cases, also with the new variants, and are also contributing to the reduction of virus transmission.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las vacunas están siendo efectivas en la reducción de severidad y mortalidad de casos de coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Vaccines are being effective in reducing severity and mortality of coronavirus cases"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "contribuyendo a la disminución de la transmisión del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "contributing to reduced transmission of the virus"
                    }
                ],
                "evidences": [
                    {
                        "value": "Protein-subunit vaccines. Two trials assessing protein-subunit vaccines reported vaccine efficacy on symptomatic COVID-19 participants. Meta-analysis (RE) showed that protein-subunit vaccines versus placebo may result in a large reduction of symptomatic COVID-19 participants, but the confidence interval was compatible with no effect (efficacy, 77% [95% CI −5% ",
                        "score": 0.5099999905
                    },
                    {
                        "value": "We consider that due to the emergence of new SARS-CoV-2 variants in countries with limited access to vaccines, the redesign SARS-CoV-2 vaccines based on these new variants is highly recommended.",
                        "score": 0.5699999928
                    },
                    {
                        "value": "The vaccines are expected to protect subjects against new virus variants and effective at preventing severe respiratory disease and death. An update of vaccine composition may be necessary in order to maintain high efficacy against new variants. Furthermore, the revaccination schedule may also be essential if variants develop that are potentially different from the original coronavirus that the vaccines were produced against. Another variant, B.1.1.7, revealed in the UK, has been reported to have a high mortality rate and faster transmission speed. New variants reported in various countries can decrease the efficiency of the current COVID-19 vaccines. If the pandemic persists, the mutations of coronavirus will increase, and humanity must struggle for vaccination and worldwide distribution [13] .",
                        "score": 0.8000000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9944196343
                    },
                    {
                        "label": "neutral",
                        "score": 0.9979522228
                    },
                    {
                        "label": "neutral",
                        "score": 0.9936500192
                    }
                ]
            },
            {
                "text": "Es el mensaje esperanzador que este viernes ha lanzado Maria Neira, directora del departamento de Salut Pública y del Ambiente de la Organización Mundial de la Salud (OMS) en una entrevista radiofónica en El món a Rac1. ",
                "text_en": "It is the hopeful message that Maria Neira, director of the Department of Public Health and the Environment of the World Health Organization (WHO) launched this Friday in a radio interview in El mon a Rac1.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Es el mensaje esperanzador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's the hopeful message."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Friday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Maria Neira",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Maria Neira"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "departamento de Salut Pública y del Ambiente de la Organización Mundial de la Salud (OMS)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Department of Public Health and the Environment of the World Health Organization (WHO)"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una entrevista radiofónica en El món a Rac1",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a radio interview in El mon a Rac1"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por todo ello, Neira urge a acelerar la vacunación con todas las inoculaciones posibles para frenar la expansión del Covid-19 y alcanzar el 70% de población europea protegida en verano, un objetivo que ve posible : \"Se puede conseguir con una estrategia clara\" de vacunación. ",
                "text_en": "Therefore, Neira urges to speed up vaccination with all possible inoculations in order to stop the expansion of Covid-19 and reach 70% of the European protected population in summer, a goal that she sees possible: \"It can be achieved with a clear strategy\" of vaccination.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Neira",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Neira"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "urge a acelerar la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "urge to speed up vaccination"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con todas las inoculaciones posibles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with all possible inoculations"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si bien en los últimos días se ha registrado un aumento de los contagios en Europa, la experta se ha mostrado esperanzada, aunque prudente, en que no se produzca un aumento de muertes por covid: \"Ya no se espera un repunte de la mortalidad por coronavirus\". ",
                "text_en": "Although in recent days there has been an increase in contagion in Europe, the expert has been hopeful, albeit cautious, that there will not be an increase in covid deaths: \"There is no longer expected to be an upturn in coronavirus mortality\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los últimos días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last few days"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha registrado un aumento de los contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There has been an increase in contagion"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Europa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Europe"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la experta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the expert"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Ya no se espera un repunte de la mortalidad por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There is no longer expected to be an upturn in coronavirus mortality"
                    }
                ],
                "evidences": [
                    {
                        "value": "The rapid spread of the Coronavirus (COVID- 19) has led the World Health Organization (WHO) to declare the outbreak a pandemic in March 2020. The epidemic started in the Hubei province of China, around the turn of the 2019/20, spreading thereafter to the entire country and to almost the entire world [1] . In late February 2020, early March, contagion spread rapidly first throughout Europe and then through the US. In response to the growth of infections [2] and in particular to the exponential increase in deaths, most of Europe has been put under lockdown, with the US adopting similar measures. The toll on economic activity is considerable. Restaurants are closed or empty, only 10% of the normal number of flights operate, investment plans are being delayed, etc. Discounting the negative economic impact of epidemic containment policies [3] , financial markets have become extremely volatile.",
                        "score": 0.5799999833
                    },
                    {
                        "value": "In the province of Brescia, in the North of Italy, censed foreign born people account for 12.1% of the population (1, 200 ,000 province population) 5 , while undocumented migrants are estimated to be 8.8% of the foreigners. The presence of foreigners in Brescia is higher than at national level, where migrants represent 8.4% of the resident population 6 . Since March 2020 Brescia became one of the provinces most affected by the Coronavirus disease (COVID-19) epidemic in Europe, with a contagion rate of 8.2% (up to 10th May 2021) 7 . It was one of the very first Italian areas to implement contagion control measures in the early epidemic, including the interruption of the majority of outpatient consultations, screening and diagnostic services, as well as dedicated migrant health clinics, due to the reallocation of health resources.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9990183115
                    },
                    {
                        "label": "neutral",
                        "score": 0.9974600673
                    }
                ]
            },
            {
                "text": "Todas las esperanzas están puestas en la vacunación.",
                "text_en": "All hopes are set on vaccination.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Todas las esperanzas están puestas en la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "All hopes are set on vaccination"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y por ello, si una manera de “acelerar” las vacunas pasa por revisar licencias “son soluciones a las que hay que dar espacio porque necesitamos multiplicar la vacunación”, ha asegurado Neira.",
                "text_en": "And so, if a way to “accelerate” vaccines goes by reviewing licenses “they are solutions that need to be given space because we need to multiply vaccination,” Neira said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "una manera de “acelerar” las vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a way to “accelerate” vaccines"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "revisar licencias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "review licenses"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque necesitamos multiplicar la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because we need to multiply vaccination"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Neira",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Neira"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En este sentido, la experta ha augurado que en las próximas semanas vamos a tener “buenas noticias” en relación con la disponibilidad de más y nuevas vacunas.",
                "text_en": "In this sense, the expert has predicted that in the coming weeks we will have “good news” regarding the availability of more and new vaccines.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la experta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the expert"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las próximas semanas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the coming weeks"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vamos a tener “buenas noticias”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "we’re going to have “good news”"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la disponibilidad de más y nuevas vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "availability of more and new vaccines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Agencia Europea del Medicamento decidirá el 11 de marzo si aprueba la vacuna Janssen (de la farmacéutica Johnson&Johnson) y también está analizando las de CureVac y Sputnik V. ",
                "text_en": "The European Medicines Agency will decide on 11 March whether to approve the Janssen vaccine (from the Johnson&Johnson pharmaceutical company) and is also analysing those from CureVac and Sputnik V.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Europea del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "decidirá el 11 de marzo si aprueba la vacuna Janssen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "decide on 11 March whether to approve the Janssen vaccine"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 11 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 11 March"
                    }
                ],
                "evidences": [
                    {
                        "value": "The European Medicines Agency (EMA) issued a conditional marketing authorization on 21 December 2020 of the Comirnaty (BNT162b2) vaccine by BioNTech, in collaboration with Pfizer, on 6 January 2021, the mRNA-1273 vaccine by Moderna Biotech, on 29 January 2021 Vaxzevria (previously AstraZeneca) by AstraZeneca in collaboration with the University of Oxford, and finally on 11 March 2021, the Janssen vaccine by Johnson & Johnson [99] . Companies are testing the vaccine's efficacy against new virus variants [100] . Notwithstanding, the information released at such an early stage does not answer critical questions about whether the vaccine can prevent the most severe cases or quell the coronavirus pandemic. The question also remains if it can protect people from infection or prevent those showing very mild disease symptoms from spreading the virus. Last but not least, a critical unanswered question is how long the vaccine's response will last, especially in light of omnipresent reports about the possibility of re-infection [101] .",
                        "score": 0.5600000024
                    },
                    {
                        "value": "The development of a safe and effective vaccine for COVID-19 has been a major global challenge. To date, there are 12 approved vaccines for emergency use or with full authorization; many more are in development. On 11 December 2020, the Food and Drug Administration (FDA) issued the first EUA for \"tozinameran\", the COVID-19 vaccine produced by Pfizer-BioNTech. The U.S.A. has approved a second COVID-19 vaccine, the \"mRNA-1273\" manufactured by Moderna. The European Medicines Agency (EMA) approved the Pfizer-BioNTech COVID-19 vaccine on 21 December 2020. The EMA authorized Moderna's vaccine distribution on 6 January 2021. \"AZD1222\", developed by Oxford University and AstraZeneca, is the third COVID-19 vaccine that EMA has recommended for authorization. On 28 February 2021, the FDA recommended the use of another vaccine produced by Janssen Pharmaceuticals and Johnson & Johnson. EMA approved the COVID-19 Vaccine Janssen on 11 March 2021.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9890931845
                    },
                    {
                        "label": "neutral",
                        "score": 0.9991146922
                    }
                ]
            },
            {
                "text": "Por el momento, y según los datos publicados por el departament de Salut de la Generalitat, Catalunya mantiene la tendencia a la baja de los datos epidemiológicos, que mejoran cerca de un 4% respecto a los anunciados el pasado jueves.",
                "text_en": "At the moment, and according to data published by the Department of Salut de la Generalitat, Catalonia maintains the downward trend of epidemiological data, which improves by about 4% compared to those announced last Thursday.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Catalunya",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mantiene la tendencia a la baja de los datos epidemiológicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "maintains the downward trend in epidemiological data"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last Thursday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Del 23 de febrero al 1 de marzo se han registrado 8.572 positivos, cerca de 300 menos que el pasado jueves.",
                "text_en": "From 23 February to 1 March there were 8,572 positives, nearly 300 less than last Thursday.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Del 23 de febrero al 1 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "From 23 February to 1 March"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han registrado 8.572 positivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "8,572 positives have been registered"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los pacientes en planta han descendido a 1.605, 32 menos en 24 horas, aunque los graves en unidades de cuidados intensivos han subido 18 según los notificados el pasado jueves (522 en total).",
                "text_en": "The patients in the plant have dropped to 1,605, 32 less in 24 hours, although the severe ones in intensive care units have risen 18 according to those reported last Thursday (522 in total).",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los pacientes en planta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Patients in plant"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han descendido a 1.605",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have gone down to 1,605"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por eso la experta de la OMS ha urgido a vacunar de forma “más acelerada” porque se ha demostrado que hacerlo reduce la mortalidad, la severidad de los casos e incluso la transmisión también en las nuevas variantes.",
                "text_en": "That is why the WHO expert has urged vaccination in a “faster” way because it has been shown that doing so reduces mortality, the severity of cases and even transmission in the new variants.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la experta de la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the WHO expert"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha urgido a vacunar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has urged to vaccinate"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma “más acelerada”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more “faster”"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque se ha demostrado que hacerlo reduce la mortalidad, la severidad de los casos e incluso la transmisión también en las nuevas variantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because it has been shown that doing so reduces mortality, the severity of cases and even transmission also in new variants"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En cuanto la indicación de aplicar la vacuna de AstraZeneca a los menores de 55 años, como mantiene el Gobierno español, Neira considera que no es necesaria porque \"la opinión de la OMS\" es que el fármaco desarrollado también por la universidad de Oxford se puede usar en personas mayores de 65 años. ",
                "text_en": "As for the indication of applying the AstraZeneca vaccine to children under 55 years of age, as the Spanish Government maintains, Neira considers that it is not necessary because \"the opinion of the WHO\" is that the drug developed also by Oxford University can be used in people over 65 years of age.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los menores de 55 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to persons under 55 years of age"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Neira",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Neira"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "considera que no es necesaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "considers that it is not necessary"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque \"la opinión de la OMS\" es que el fármaco desarrollado también por la universidad de Oxford se puede usar en personas mayores de 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because \"the WHO opinion\" is that the drug also developed by Oxford University can be used in people over 65 years of age."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "17": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 17,
            "WhatReliabilityReliable": 16,
            "WhatReliabilityUnreliable": 1,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 5,
            "Who": 2,
            "WhoReliabilityReliable": 2,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 0,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nJusto este mes de marzo se cumple un año desde que empezó la pandemia, y está claro que desde ese momento hemos aprendido múltiples cosas que hasta entonces, no sabíamos.\n\n<BREAK>\n\nHemos tenido que afrontar retos, readaptar nuestra rutina e incorporar nuevos hábitos a nuestros días -cómo el de llevar mascarilla o el de lavarnos las manos con frecuencia.\n\n<BREAK>\n\nYa conocemos los diversos tipos de cubrebocas, pero ¿qué son las mascarillas KF94?\n\n<PARAGRAPH>\n\nAhora que ha pasado un tiempo prudencial desde la implementación de las mascarillas, ya estamos más informados y tenemos claro cuales son las buenas prácticas y los malos hábitos a evitar en relación a su uso, pero es cierto que todavía hay algunos datos que siguen confundiendo a mucha gente, el más común: los distintos tipos de mascarillas.\n\n<PARAGRAPH>\n\nEs por eso que en este artículo intentaremos aclarar un poco la información que todos deberíamos saber sobre las mascarillas KF94, ya que al parecer este diseño con una estructura en pico similar a las KN95, es el menos conocido ¡aunque también uno de las más eficaces!\n\n<PARAGRAPH>\n\nLa versión coreana de las mascarillas FFP2\n\n<PARAGRAPH>\n\nEfectivamente, el modelo KF94 es el nombre con el que en Corea se conocen las mascarillas FFP2 españolas, las KN95 chinas o las N95 estadounidenses, y es que si nos paramos a analizar la nomenclatura de estas mascarillas que presentan un diseño a medio camino entre las FFP2 y las quirúrgicas, podremos darnos cuenta de que ‘KF’ significa korean filter (filtro coreano) y el 94 indica el porcentaje de partículas de polvo, virus u otras sustancias de un tamaño medio de 0,4 μm que este modelo es capaz de bloquear.\n\n<PARAGRAPH>\n\n¿Sabías que contienen cuatro capas protectoras?\n\n<PARAGRAPH>\n\nA demás de contar con una banda en horizontal que promete mejorar el ajuste y la filtración, este tipo de mascarillas desechables con cuatro capas y con un clip nasal metálico están creadas con un material no tejido similar al de las FFP2 o KN95 y es una de las opciones más recomendadas para aquellos que ya están contagiados por el SARS-CoV-2.\n\n<PARAGRAPH>\n\nSe ha demostrado que este tipo de cubrebocas no permite la salida de ninguna partícula del virus, mientras que en la quirúrgica puede escaparse por los laterales porque su ajuste no es tan bueno.\n\n<PARAGRAPH>\n\nY es que es muy interesante saber que las mascarillas KF94 son aptas para usarse en entornos cerrados con gran afluencia de gente (como en el transporte público, o en contacto con pacientes COVID-19 positivos) y que lo más importante a tener en cuenta, es que no podemos reutilizarlas ni siquiera desinfectándolas, pues en el proceso podríamos dañar su tejido y afectar a su efectividad.\n\n<PARAGRAPH>\n\nAhora que sabes esto pues, solo debes comparar bien las opciones a tu alcance y escoger la mascarilla que más se adapte a tu estilo de vida o a tus circunstancias, pero siempre teniendo en cuenta que es importante comprarlas en establecimientos como farmacias o supermercados y que debes fijarte muy bien en su etiquetado (que debe incluir el marcado CE, seguido de los cuatro dígitos del organismo notificado, el informe del organismo notificado y un test report del país de origen).\n\n<PARAGRAPH>\n\n",
        "TITLE": "¿Qué son las mascarillas KF94 y cuáles son sus características?",
        "ID": "5_NF_04-11-2021_21-12-05_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "¿Qué son las mascarillas KF94 y cuáles son sus características?",
                "text_en": "What are KF94 masks and what are their characteristics?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mascarillas KF94",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "KF94 masks"
                    }
                ],
                "evidences": [
                    {
                        "value": "When comparing the types of KF94 masks, the total FFs for general-fitting and tight-fitting of masks A, B, and C (median, IQR) were 4 (3-8), 39 (21-69), 3 (2-5), and 27 (8-83), 125 (67-189), and 9 (5-23), respectively. The type B mask with adjustable ear-loop length had a significantly higher FF, while the vertical 2-fold type C mask had a significantly lower FF in both wearing methods ( Table 3) .",
                        "score": 0.6800000072
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9379953742
                    }
                ]
            },
            {
                "text": "Justo este mes de marzo se cumple un año desde que empezó la pandemia, y está claro que desde ese momento hemos aprendido múltiples cosas que hasta entonces, no sabíamos.",
                "text_en": "Just this month of March marks a year since the pandemic began, and it is clear that from that moment we have learned many things that until then, we did not know.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este mes de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this month of March"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se cumple un año desde que empezó la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "one year since the pandemic began"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ya conocemos los diversos tipos de cubrebocas, pero ¿qué son las mascarillas KF94?",
                "text_en": "We already know the different types of mouth covers, but what are KF94 masks?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las mascarillas KF94",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "KF94 masks"
                    }
                ],
                "evidences": [
                    {
                        "value": "When comparing the types of KF94 masks, the total FFs for general-fitting and tight-fitting of masks A, B, and C (median, IQR) were 4 (3-8), 39 (21-69), 3 (2-5), and 27 (8-83), 125 (67-189), and 9 (5-23), respectively. The type B mask with adjustable ear-loop length had a significantly higher FF, while the vertical 2-fold type C mask had a significantly lower FF in both wearing methods ( Table 3) .",
                        "score": 0.5699999928
                    },
                    {
                        "value": "In this study, we demonstrated that an adequate face seal cannot be achieved with ear-looptype KF94 masks. However, our results suggest that selected adjustable models of ear-looptype FFRs modified using a clip can provide significantly improved respiratory protection over general ear-loop masks. Therefore, if the FFRs labeled according to their own national regulations are of the ear-loop type, a modified fitting, such as using clips or adjusting the earloop length, is indicated to increase the mask-face seal. In addition, to improve the respiratory protection of HCWs during the COVID-19 pandemic, it is important to choose a suitable FFR for each individual and teach them how to wear the mask tightly through a fit test in advance.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9682011604
                    },
                    {
                        "label": "neutral",
                        "score": 0.9940294027
                    }
                ]
            },
            {
                "text": "Ahora que ha pasado un tiempo prudencial desde la implementación de las mascarillas, ya estamos más informados y tenemos claro cuales son las buenas prácticas y los malos hábitos a evitar en relación a su uso, pero es cierto que todavía hay algunos datos que siguen confundiendo a mucha gente, el más común: los distintos tipos de mascarillas.",
                "text_en": "Now that a reasonable time has passed since the implementation of the masks, we are already more informed and we are clear what good practices and bad habits are to avoid in relation to their use, but it is true that there are still some data that continue to confuse many people, the most common: the different types of masks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estamos más informados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We're more informed."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay algunos datos que siguen confundiendo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There are some data that continue to confuse"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a mucha gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to many people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los distintos tipos de mascarillas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the different types of masks"
                    }
                ],
                "evidences": [
                    {
                        "value": "Before the COVID-19 outbreak, 18.29% of the 645 HCWs had previous experience in medical rescue, and only 0.9% were inexperienced in the proper procedure for wearing masks. Medical surgical masks were the most common type of masks (61.09%) used by the HCWs during their daily work in the East-West Lake Fangcang shelter hospital, followed by disposable medical masks (27.60%) and medical protective masks (10.23%). Notably, particulate protection masks were also used (1.09%) ( Table 2 ). Only approximately one-third of the HCWs (35.50%) wore multiple masks. Among them, 65.07% used medical protective masks together with medical surgical masks, and 15.72% used a double layer of medical surgical masks, while 1.31% used particulate protection masks together with disposable medical masks or medical protective masks ( Figure 2 ). About half of the HCWs (54.26%) changed their masks every 4 h, 36.43% every 6-8 h and 9.31% of HCWs changed their masks every 12 h or even longer. Most HCWs (90.69%) entered inpatient areas no more than four times a week, while others entered 5-6 times (8.53%) or more than six times (0.78%).",
                        "score": 0.5299999714
                    },
                    {
                        "value": "The most common type of mask in our study was surgical mask (63.8%). The same finding reported by Gunasegaram et al. [19, 20] and Tam et al. [18] . This can be questionable because the WHO and CDC did not recommend the use of surgical masks in general population [2, 26] . In contrast, they recommended using cloth masks in public setting. This type of masks can be easily manufactured or made at home and reused after washing [27] and it is more affordable than other masks. Besides, we found that the types of face masks were differently used among the age groups. Filtered masks were used higher by older pedestrians while younger people used cloth face masks much higher than the older pedestrians. People in higher age groups usually fill more risk of COVID-19 so they may be use more frequently filtered masks with the purpose of their higher protection. A Survey of the Healthcare Workers in Afghanistan showed that Participants had access to one-layer medical masks produced inside Afghanistan 378 (41%), medical masks 451 (49%), N95 masks 206 (22%) [28] .",
                        "score": 0.7200000286
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9995875955
                    },
                    {
                        "label": "neutral",
                        "score": 0.9987877011
                    }
                ]
            },
            {
                "text": "Es por eso que en este artículo intentaremos aclarar un poco la información que todos deberíamos saber sobre las mascarillas KF94, ya que al parecer este diseño con una estructura en pico similar a las KN95, es el menos conocido ¡aunque también uno de las más eficaces!",
                "text_en": "That is why in this article we will try to clarify a little bit the information that we should all know about the KF94 masks, since apparently this design with a peak structure similar to the KN95, is the least known though also one of the most effective!",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las mascarillas KF94",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "KF94 masks"
                    }
                ],
                "evidences": [
                    {
                        "value": "The KF94 masks use ear loops instead of an elastic head-band as in N95s. In our pilot tests, most of KF94 masks failed to fit properly when undergoing the occupational safety and health administration (OSHA) fit test protocol. The general fitting applied through ear loops may be weaker than a head-band, and this can be a severe concern that hinders mask fitting. Some people who wear ear-loop masks apply a mask clip that connects the ear loops behind the head to reduce pain around the ears. The use of this clip may also increase tension on the entire mask through additional tension on the ear loops; thus, it was reasoned that using a clip may improve the face seal of ear-loop-type masks.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9956089854
                    }
                ]
            },
            {
                "text": "Efectivamente, el modelo KF94 es el nombre con el que en Corea se conocen las mascarillas FFP2 españolas, las KN95 chinas o las N95 estadounidenses, y es que si nos paramos a analizar la nomenclatura de estas mascarillas que presentan un diseño a medio camino entre las FFP2 y las quirúrgicas, podremos darnos cuenta de que ‘KF’ significa korean filter (filtro coreano) y el 94 indica el porcentaje de partículas de polvo, virus u otras sustancias de un tamaño medio de 0,4 μm que este modelo es capaz de bloquear.",
                "text_en": "Indeed, model KF94 is the name with which Spanish FFP2 masks, Chinese KN95s or US N95s are known in Korea, and it is that if we stop to analyze the nomenclature of these masks that present a half-way design between FFP2 and surgical ones, we can realize that ‘KF’ means Korean filter and 94 indicates the percentage of particles of dust, viruses or other substances of an average size of 0.4 μm that this model is capable of blocking.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el modelo KF94 es el nombre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "model KF94 is the name"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Corea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Korea"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las mascarillas FFP2 españolas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spanish FFP2 masks"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las KN95 chinas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Chinese KN95"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las N95 estadounidenses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the US N95"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Sabías que contienen cuatro capas protectoras?",
                "text_en": "Did you know they contain four protective layers?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "contienen cuatro capas protectoras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "contain four protective layers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se ha demostrado que este tipo de cubrebocas no permite la salida de ninguna partícula del virus, mientras que en la quirúrgica puede escaparse por los laterales porque su ajuste no es tan bueno.",
                "text_en": "It has been shown that this type of mouth cover does not allow the release of any particles of the virus, while in surgery it can escape through the sides because its adjustment is not so good.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Se ha demostrado que este tipo de cubrebocas no permite la salida de ninguna partícula del virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It has been shown that this type of mouth cover does not allow the release of any particles of the virus."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la quirúrgica puede escaparse por los laterales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the surgical can escape through the sides"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque su ajuste no es tan bueno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Because your fit isn't that good."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y es que es muy interesante saber que las mascarillas KF94 son aptas para usarse en entornos cerrados con gran afluencia de gente (como en el transporte público, o en contacto con pacientes COVID-19 positivos) y que lo más importante a tener en cuenta, es que no podemos reutilizarlas ni siquiera desinfectándolas, pues en el proceso podríamos dañar su tejido y afectar a su efectividad.",
                "text_en": "And it is very interesting to know that KF94 masks are suitable for use in closed environments with a large influx of people (such as in public transport, or in contact with positive COVID-19 patients) and that the most important thing to keep in mind is that we cannot reuse them or even disinfect them, because in the process we could damage their tissue and affect their effectiveness.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las mascarillas KF94 son aptas para usarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "KF94 masks are suitable for use"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en entornos cerrados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in closed environments"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "con gran afluencia de gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with a large influx of people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no podemos reutilizarlas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We can't reuse them."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "podríamos dañar su tejido y afectar a su efectividad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We could damage her tissue and affect her effectiveness."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ahora que sabes esto pues, solo debes comparar bien las opciones a tu alcance y escoger la mascarilla que más se adapte a tu estilo de vida o a tus circunstancias, pero siempre teniendo en cuenta que es importante comprarlas en establecimientos como farmacias o supermercados y que debes fijarte muy bien en su etiquetado (que debe incluir el marcado CE, seguido de los cuatro dígitos del organismo notificado, el informe del organismo notificado y un test report del país de origen).",
                "text_en": "Now that you know this, you only have to compare the options well at your disposal and choose the mask that best suits your lifestyle or circumstances, but always bearing in mind that it is important to buy them in establishments such as pharmacies or supermarkets and that you should look very closely at their labeling (which must include the CE marking, followed by the four digits of the notified body, the report of the notified body and a test report from the country of origin).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "escoger la mascarilla que más se adapte a tu estilo de vida o a tus circunstancias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "choosing the mask that best suits your lifestyle or your circumstances"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "fijarte muy bien en su etiquetado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "look very closely at its labeling"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "18": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 15,
            "WhatReliabilityReliable": 15,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 15,
            "WhoReliabilityReliable": 15,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 13,
            "WhereReliabilityReliable": 13,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 4,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nEl hospital, gracias a varias donaciones, ha habilitado una biblioteca y zonas de juegos para aliviar las convalecencias. \n\n<PARAGRAPH>\n\nEl hospital Enfermera Isabel Zendal está a punto de cumplir dos meses abierto.\n\n<BREAK>\n\nDos meses en los que ha estado rodeado de diversas polémicas pero sin dejar de trabajar: desde que se puso en funcionamiento, más de 1.700 pacientes han pasado por sus instalaciones, levantadas entre julio y noviembre de 2020 en el barrio de Valdebebas. \n\n<PARAGRAPH>\n\nLa convalecencia de muchos pacientes en este centro ha sido muy complicada, en una unidad de cuidados intensivos o en las llamadas de cuidados respiratorios intermedios, una concepción novedosa nacida de la experiencia de los profesionales sanitarios que llevan 11 meses eternos luchando contra la Covid-19.\n\n<PARAGRAPH>\n\nPero la estancia del grueso de personas que ha estado en el Zendal ha sido en las camas de hospitalización o convencionales.\n\n<BREAK>\n\nEn la mayoría de los casos, con autonomía para moverse y siempre con consciencia, a pesar de sufrir en ocasiones elevados picos de fiebre.\n\n<BREAK>\n\nEso lleva a que los días de ingreso, enfermos y sin posibilidad de salir del centro ni de recibir visitas de familiares o amigos, se hagan eternos en no pocas ocasiones.\n\n<PARAGRAPH>\n\nLa mayoría de pacientes pueden dar paseos por dentro de los pabellones.\n\n<BREAK>\n\nTambién tienen sus teléfonos móviles con ellos y algunos tienen tabletas u ordenadores y con ellos pueden doblegar al aburrimiento mientras vencen a la Covid-19.\n\n<BREAK>\n\nPero aun con esas ventanas al mundo que son los dispositivos electrónicos, sigue habiendo necesidad de llenar las horas, y de ahí nacieron hace unas semanas unas iniciativas de entretenimiento más tradicionales que no dejan de crecer y que son posibles gracias a la solidaridad de muchas personas. \n\n<PARAGRAPH>\n\nVarias empresas, asociaciones, parroquias e incluso algunos particulares, han enviado desde revistas, juegos de mesa, libros o pasatiempos al hospital Isabel Zendal. Por ejemplo, parroquias de la diócesis de Getafe enviaron al hospital de Valdebebas libros, revistas y juegos de mesa.\n\n<BREAK>\n\nLa Fundación Pequeño Deseo envío pasatiempos, que también llegaron desde otra asociación sin ánimo de lucro.\n\n<BREAK>\n\nVarias familiares del Colegio Andel de Alcorcón remitieron libros, revistas y pasatiempos.\n\n<BREAK>\n\nEl Corte Inglés donó tableros de ajedrez, de parchís, bingos y cartas.\n\n<BREAK>\n\nTambién mesas y sillas, que se han habilitado como puntos de ocio en los laterales de los pabellones.\n\n<PARAGRAPH>\n\nLa lectura también es otro de los pasatiempos más cultivados en el Zendal.\n\n<BREAK>\n\nLa revista Hola manda ejemplares todas las semanas, el Colegio Pío Baroja de Madrid donó clásicos de la literatura y la Consejería de Cultura envío varias cajas de libros que llevaban dentro entradas para el teatro.\n\n<BREAK>\n\nOtras donaciones han llegado de editoriales, como BookBank Agencia Literaria, y de negocios privados, como la clínica dental Federico Herrero Climent.\n\n<PARAGRAPH>\n\nLa solidaridad también llega desde los propios trabajadores del hospital un celador y una auxiliar administrativa llevaron varias cajas de libros para entretener a los pacientes.\n\n<BREAK>\n\nTodos se dispusieron en una sala que se habilitó como biblioteca gracias a la donación de mobiliario de la empresa Eurest. \n\n<PARAGRAPH>\n\nMensajes de ánimo en los manteles y donaciones al Banco de Alimentos\n\n<PARAGRAPH>\n\n\"Muchos ciudadanos se han estado poniendo en contacto con las trabajadoras sociales del Zendal para ver cómo pueden colaborar\", indican a 20minutos desde el hospital.\n\n<BREAK>\n\nLa solidaridad, al fin y al cabo, parece ser contagiosa en circunstancias adversas como la actual. Y es que más allá del entretenimiento de pacientes, en otros ámbitos también se están llevando a cabo iniciativas con una clara impronta filantrópica.\n\n<PARAGRAPH>\n\nEn el marco del movimiento Grow Food Banks, puesto en marcha por Compass Group, se dona un kilo de comida al Banco de Alimentos por cada paciente que sea curado de la Covid-19 en el Zendal.\n\n<BREAK>\n\nDe momento, ya se han superado el millar de altas médicas.\n\n<PARAGRAPH>\n\nAdemás, la empresa Eurest, que sirve los menús de los pacientes ingresados, ha estado acompañando las comidas de cartas redactadas por los hijos de los empleados de la empresa, como una vía más para tratar de levantar el ánimo a las personas que están siendo tratadas en el hospital.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Dentro del Zendal: paseos y juegos de mesa, los otros 'tratamientos' para sobrellevar la odisea del coronavirus",
        "ID": "F_04-11-2021_20-40-17_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Dentro del Zendal: paseos y juegos de mesa, los otros 'tratamientos' para sobrellevar la odisea del coronavirus",
                "text_en": "Inside the Zendal: rides and board games, the other 'treatments' to cope with the odyssey of the coronavirus",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Zendal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Zendal"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "otros 'tratamientos' para sobrellevar la odisea del coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "other 'treatments' to cope with the odyssey of the coronavirus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El hospital, gracias a varias donaciones, ha habilitado una biblioteca y zonas de juegos para aliviar las convalecencias. ",
                "text_en": "The hospital, thanks to several donations, has provided a library and playgrounds to relieve convalescence.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "El hospital",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The hospital"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "gracias a varias donaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thanks to several donations"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha habilitado una biblioteca y zonas de juegos para aliviar las convalecencias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has enabled a library and playgrounds to relieve convalescence"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El hospital Enfermera Isabel Zendal está a punto de cumplir dos meses abierto.",
                "text_en": "Nurse Isabel Zendal Hospital is about to be open for two months.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "El hospital Enfermera Isabel Zendal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Nurse Isabel Zendal Hospital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Dos meses en los que ha estado rodeado de diversas polémicas pero sin dejar de trabajar: desde que se puso en funcionamiento, más de 1.700 pacientes han pasado por sus instalaciones, levantadas entre julio y noviembre de 2020 en el barrio de Valdebebas. ",
                "text_en": "Two months in which he has been surrounded by various polemics but still working: since it was put into operation, more than 1,700 patients have passed through its facilities, erected between July and November 2020 in the neighborhood of Valdebebas.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "más de 1.700 pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more than 1,700 patients"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han pasado por sus instalaciones, levantadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have passed through their facilities, raised"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "entre julio y noviembre de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "between July and November 2020"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el barrio de Valdebebas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the neighborhood of Valdebebas"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La convalecencia de muchos pacientes en este centro ha sido muy complicada, en una unidad de cuidados intensivos o en las llamadas de cuidados respiratorios intermedios, una concepción novedosa nacida de la experiencia de los profesionales sanitarios que llevan 11 meses eternos luchando contra la Covid-19.",
                "text_en": "The convalescence of many patients in this center has been very complicated, in an intensive care unit or in the so-called intermediate respiratory care, a novel conception born of the experience of healthcare professionals who have been fighting Covid-19 for 11 eternal months.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La convalecencia de muchos pacientes en este centro ha sido muy complicada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The convalescence of many patients in this center has been very complicated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchos pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "many patients"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en este centro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in this center"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una unidad de cuidados intensivos o en las llamadas de cuidados respiratorios intermedios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an intensive care unit or in intermediate respiratory care calls"
                    }
                ],
                "evidences": [
                    {
                        "value": "J o u r n a l P r e -p r o o f 16 Our study has limitations, including the reduced number of samples from patients at acute disease (n=58) relative to those during convalescence (n=83), indeed for some parameters only 30 acute samples were examined. Furthermore, disease severity in the acute group did not match that in the convalescent group; the latter contained more severe patients (acute=22.4%; convalescence=49.4%). In addition, only 14 patients were followed longitudinally from acute disease into convalescence, our study would have been significantly enhanced if we could have followed more individual patients. Our study would have been further enhanced were it possible to examine convalescent patients at later time-points, for example 9 months and 1 year. would like to thank the following for technical and scientific discussions; the Lydia Becker",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9946098328
                    }
                ]
            },
            {
                "text": "Pero la estancia del grueso de personas que ha estado en el Zendal ha sido en las camas de hospitalización o convencionales.",
                "text_en": "But the stay of the bulk of people who have been in Zendal has been in hospital beds or conventional.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la estancia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stay"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "grueso de personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "bulk of people"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Zendal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Zendal"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las camas de hospitalización o convencionales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in hospital beds or conventional beds"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En la mayoría de los casos, con autonomía para moverse y siempre con consciencia, a pesar de sufrir en ocasiones elevados picos de fiebre.",
                "text_en": "In most cases, with autonomy to move and always conscious, despite sometimes suffering high fever peaks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con autonomía para moverse y siempre con consciencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with autonomy to move and always with consciousness"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La mayoría de pacientes pueden dar paseos por dentro de los pabellones.",
                "text_en": "Most patients can take walks inside the pavilions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La mayoría de pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Most patients"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pueden dar paseos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They can take walks."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "por dentro de los pabellones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "inside the pavilions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero aun con esas ventanas al mundo que son los dispositivos electrónicos, sigue habiendo necesidad de llenar las horas, y de ahí nacieron hace unas semanas unas iniciativas de entretenimiento más tradicionales que no dejan de crecer y que son posibles gracias a la solidaridad de muchas personas. ",
                "text_en": "But even with those windows to the world that are electronic devices, there is still a need to fill the hours, and from there were born a few weeks ago more traditional entertainment initiatives that do not stop growing and that are possible thanks to the solidarity of many people.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hace unas semanas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A few weeks ago"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "unas iniciativas de entretenimiento más tradicionales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more traditional entertainment initiatives"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "gracias a la solidaridad de muchas personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thanks to the solidarity of many people"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchas personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "many people"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Varias empresas, asociaciones, parroquias e incluso algunos particulares, han enviado desde revistas, juegos de mesa, libros o pasatiempos al hospital Isabel Zendal. Por ejemplo, parroquias de la diócesis de Getafe enviaron al hospital de Valdebebas libros, revistas y juegos de mesa.",
                "text_en": "Several companies, associations, parishes and even some individuals have sent from magazines, board games, books or hobbies to the Isabel Zendal hospital. For example, parishes in the diocese of Getafe sent books, magazines and board games to the hospital in Valdebebas.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Varias empresas, asociaciones, parroquias e incluso algunos particulares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Various companies, associations, parishes and even some individuals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han enviado desde revistas, juegos de mesa, libros o pasatiempos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have sent from magazines, board games, books or hobbies"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al hospital Isabel Zendal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Isabel Zendal Hospital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La lectura también es otro de los pasatiempos más cultivados en el Zendal.",
                "text_en": "Reading is also another of the most cultivated pastimes in Zendal.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La lectura también es otro de los pasatiempos más cultivados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Reading is also another of the most cultivated pastimes"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Zendal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Zendal"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Otras donaciones han llegado de editoriales, como BookBank Agencia Literaria, y de negocios privados, como la clínica dental Federico Herrero Climent.",
                "text_en": "Other donations have come from publishers, such as BookBank Literary Agency, and from private businesses, such as the Federico Herrero Climent dental clinic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Otras donaciones han llegado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Other donations have arrived"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "editoriales, como BookBank Agencia Literaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "editorials, such as BookBank Agencia Literaria"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "negocios privados, como la clínica dental Federico Herrero Climent",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "private businesses, such as the Federico Herrero Climent dental clinic"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La solidaridad también llega desde los propios trabajadores del hospital un celador y una auxiliar administrativa llevaron varias cajas de libros para entretener a los pacientes.",
                "text_en": "Solidarity also comes from the hospital's own workers a warder and an administrative assistant brought several boxes of books to entertain patients.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "celador y una auxiliar administrativa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "warder and an administrative assistant"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llevaron varias cajas de libros para entretener",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "took several boxes of books to entertain"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Mensajes de ánimo en los manteles y donaciones al Banco de Alimentos",
                "text_en": "Messages of encouragement on tablecloths and donations to the Food Bank",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Mensajes de ánimo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Messages of encouragement"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los manteles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on tablecloths"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "donaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "donations"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Banco de Alimentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Food Bank"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"Muchos ciudadanos se han estado poniendo en contacto con las trabajadoras sociales del Zendal para ver cómo pueden colaborar\", indican a 20minutos desde el hospital.",
                "text_en": "\"Many citizens have been getting in touch with Zendal's social workers to see how they can collaborate,\" they tell 20 minutes from the hospital.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Muchos ciudadanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Many citizens"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han estado poniendo en contacto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They've been getting in touch."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las trabajadoras sociales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Social workers"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Zendal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Zendal"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "colaborar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "collaborate"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, la empresa Eurest, que sirve los menús de los pacientes ingresados, ha estado acompañando las comidas de cartas redactadas por los hijos de los empleados de la empresa, como una vía más para tratar de levantar el ánimo a las personas que están siendo tratadas en el hospital.",
                "text_en": "In addition, the Eurest company, which serves the patient's inpatient menus, has been accompanying the letter meals written by the children of the company's employees, as one more way to try to raise the spirits of people who are being treated in the hospital.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la empresa Eurest",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the company Eurest"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha estado acompañando las comidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He's been accompanying the meals."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de cartas redactadas por los hijos de los empleados de la empresa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of letters drawn up by the children of the employees of the company"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los hijos de los empleados de la empresa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the children of the employees of the company"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "19": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 15,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 8,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 17,
            "WhoReliabilityReliable": 11,
            "WhoReliabilityUnreliable": 6,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 7,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 6,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 11,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 4,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 5,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nCastilla-La Mancha ha impuesto, tras el Estado de Alarma, un régimen de visitas y estancia en residencias de la tercera edad que impone a sus residentes un régimen análogo al de las prisiones españolas y que ha sido avalado por el Tribunal Superior de Justicia.\n\n<PARAGRAPH>\n\nSegún la nota difundida por el gobierno manchego, se ha estipulado que las personas alojadas en estos centros no podrán salir de ellos y las visitas a las residencias se podrán «autorizar» (se utiliza ese término) tras haber completado la vacunación a residentes y trabajadores.\n\n<PARAGRAPH>\n\nAparte, tanto la persona que acuda a la visita, como la persona residente no han de presentar ningún cuadro clínico compatible con la infección por coronavirus y por cada visita podrán acudir dos personas, siendo la duración máxima de la reunión de 60 minutos de manera cronometrada.\n\n<PARAGRAPH>\n\nEn ese contexto, los ancianos solo podrán tener dos visitas a la semana, que se podrán incrementar atendiendo a circunstancias concretas; las visitas deberán realizarse preferentemente en espacio exterior del edificio, y si no fuera posible, se habilitará un espacio específico.\n\n<BREAK>\n\nAdemás durante el tiempo de las visitas se podrá llevar a cabo un paseo terapéutico que solo podrá hacerse por los alrededores del centro.\n\n<PARAGRAPH>\n\nEn caso de tratarse de una visita por una situación de acompañamiento en los momentos finales de la vida, podrán asistir a la visita el número de personas que autorice la residencia.\n\n<PARAGRAPH>\n\nPero esta medida no es nueva, ya que en prácticamente todas las residencias españolas se ha establecido un régimen penitenciario donde las personas alojadas no tienen contacto con el exterior, y donde los visitantes (los que lo hacían) han estado obligados a sentarse a 1 metro de distancia, o con mamparas que se interponían, sin poder abrazarse ni tocarse durante una visita que estaba cronometrada por el personal que hace de carcelero.\n\n<PARAGRAPH>\n\nLa reclusión de los ancianos con la excusa del coronavirus, que han quedado aparcados en los últimos años de su vida a la espera de la muerte, ha convertido la soledad en una cuestión cotidiana para el resto de la sociedad, que está mirando para otro lado en algo que es una bomba de relojería para la salud mental de la población mayor.\n\n<PARAGRAPH>\n\nLa soledad y el aislamiento son riesgos graves para la salud de la tercera edad.\n\n<BREAK>\n\nSi bien esta realidad era conocida antes del confinamiento, es razonable imaginar que este porcentaje ha aumentado durante el transcurso de su reclusión de estos últimos meses, con restricciones aún más estrictas para esta franja de la población.\n\n<PARAGRAPH>\n\nIncluso antes del confinamiento, millones de ancianos en toda España luchaban contra sentimientos de soledad, aislamiento y falta de compañía regular.\n\n<PARAGRAPH>\n\nLa ausencia de visitas y la obligación de permanecer en sus habitaciones con la televisión como único contacto externo son las únicas «vías de escape» que se les ha dado a la tercera edad, con el supuesto objetivo de protegerlos, pero lo cierto es que el coronavirus ha sido la excusa perfecta para recluir y abandonar, a la espera de la muerte, a quien nada producía y normalmente estorbaba.\n\n<PARAGRAPH>\n\nEn síntesis, se está produciendo un genocidio tolerado por toda la sociedad.\n\n<PARAGRAPH>\n",
        "TITLE": "Castilla-La Mancha impone un régimen penitenciario en los centros de mayores, avalado por los tribunales",
        "ID": "NF_NF_1473_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Castilla-La Mancha impone un régimen penitenciario en los centros de mayores, avalado por los tribunales",
                "text_en": "Castilla-La Mancha imposes a prison regime in the institutions of the elderly, endorsed by the courts",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Castilla-La Mancha",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Castilla-La Mancha"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "impone un régimen penitenciario",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "imposes a prison regime"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los centros de mayores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the centres of the elderly"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "avalado por los tribunales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "endorsed by the courts"
                    }
                ],
                "evidences": [
                    {
                        "value": "The term \"prison\" is used in this article in the usual UK sense, meaning an establishment tasked with the custodial care of those accused of crimes awaiting trial or sentence, and those who have been sentenced to terms of imprisonment (or youth custody for young offenders). This includes a wide range of institutions, including the equivalents of jails and also the equivalents of federal penitentiaries, as exist in the US. Prisons are not homogenous environments, but they all involve compulsory detention and associated restrictions on liberty. They vary not only in terms of their physical environments and facilities, but also their populations: for example, a city-centre Victorian prison such as HMP Preston, is populated mainly by remand prisoners and experiences a high level of prisoner turnover (\"churn\") and an unstable and ever-changing population, with security appropriate to holding Category B prisoners. This can be contrasted with long-term training prisons and contrasted again with the highest security \"dispersal\" prisons (such as HMP Long Lartin) and prisons operating under open conditions (such as HMP Kirkham). Some prisons have higher proportionate numbers of older offenders as a reflection of their specialist status as exemplified by HMP Wymott and its high population of sex offenders. All prisons in England and Wales are subject to the same inspection regime but these same inspection reports illuminate differences between establishments.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9764556289
                    }
                ]
            },
            {
                "text": "Castilla-La Mancha ha impuesto, tras el Estado de Alarma, un régimen de visitas y estancia en residencias de la tercera edad que impone a sus residentes un régimen análogo al de las prisiones españolas y que ha sido avalado por el Tribunal Superior de Justicia.",
                "text_en": "Castilla-La Mancha has imposed, after the State of Alarm, a regime of visits and stay in nursing homes that imposes on its residents a regime similar to that of Spanish prisons and that has been endorsed by the High Court of Justice.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Castilla-La Mancha",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Castilla-La Mancha"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha impuesto, tras el Estado de Alarma, un régimen de visitas y estancia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has imposed, after the State of Alarm, a regime of visits and stay"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras el Estado de Alarma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after the State of Alarm"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en residencias de la tercera edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in old-age residences"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "impone a sus residentes un régimen análogo al de las prisiones españolas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "imposes on its residents a regime similar to that of Spanish prisons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según la nota difundida por el gobierno manchego, se ha estipulado que las personas alojadas en estos centros no podrán salir de ellos y las visitas a las residencias se podrán «autorizar» (se utiliza ese término) tras haber completado la vacunación a residentes y trabajadores.",
                "text_en": "According to the note issued by the Manchego government, it has been stipulated that people staying in these centers will not be able to leave them and visits to the residences can be \"authorized\" (this term is used) after having completed the vaccination of residents and workers.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas alojadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the persons who have been accommodated"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en estos centros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in these centres"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no podrán salir de ellos y las visitas a las residencias se podrán «autorizar»",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "may not leave them and visits to residences may be ‘authorised’."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras haber completado la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after vaccination has been completed"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a residentes y trabajadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to residents and workers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aparte, tanto la persona que acuda a la visita, como la persona residente no han de presentar ningún cuadro clínico compatible con la infección por coronavirus y por cada visita podrán acudir dos personas, siendo la duración máxima de la reunión de 60 minutos de manera cronometrada.",
                "text_en": "In addition, both the person attending the visit and the resident person are not required to present any clinical picture compatible with the infection by coronavirus and for each visit two people will be able to attend, being the maximum duration of the meeting of 60 minutes in a timed manner.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "tanto la persona que acuda a la visita, como la persona residente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "both the person who comes to visit, and the resident person"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a la visita",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the visit"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no han de presentar ningún cuadro clínico compatible con la infección por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "do not have any clinical symptoms compatible with coronavirus infection"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En ese contexto, los ancianos solo podrán tener dos visitas a la semana, que se podrán incrementar atendiendo a circunstancias concretas; las visitas deberán realizarse preferentemente en espacio exterior del edificio, y si no fuera posible, se habilitará un espacio específico.",
                "text_en": "In this context, the elderly may only have two visits per week, which may be increased according to specific circumstances; visits should preferably take place in the outer space of the building, and if this is not possible, a specific space will be provided.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los ancianos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the elderly"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "solo podrán tener dos visitas a la semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "You can only have two visits a week"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en espacio exterior del edificio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in outer space of the building"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además durante el tiempo de las visitas se podrá llevar a cabo un paseo terapéutico que solo podrá hacerse por los alrededores del centro.",
                "text_en": "In addition, during the time of the visits a therapeutic walk can be carried out that can only be done around the center.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante el tiempo de las visitas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the time of the visits"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se podrá llevar a cabo un paseo terapéutico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a therapeutic walk can be carried out"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "por los alrededores del centro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "around the center"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En caso de tratarse de una visita por una situación de acompañamiento en los momentos finales de la vida, podrán asistir a la visita el número de personas que autorice la residencia.",
                "text_en": "In the case of a visit due to an accompanying situation at the end of life, the number of persons authorising residence may attend the visit.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "En caso de tratarse de una visita por una situación de acompañamiento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In case of a visit due to an accompanying situation"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los momentos finales de la vida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the final moments of life"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "podrán asistir a la visita",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "may attend the visit"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el número de personas que autorice la residencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the number of persons authorising residence"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero esta medida no es nueva, ya que en prácticamente todas las residencias españolas se ha establecido un régimen penitenciario donde las personas alojadas no tienen contacto con el exterior, y donde los visitantes (los que lo hacían) han estado obligados a sentarse a 1 metro de distancia, o con mamparas que se interponían, sin poder abrazarse ni tocarse durante una visita que estaba cronometrada por el personal que hace de carcelero.",
                "text_en": "But this measure is not new, as in practically all Spanish residences a prison regime has been established where the persons accommodated have no contact with the outside, and where the visitors (those who did) have been forced to sit 1 meter away, or with screens that stood in the way, without being able to hug or touch each other during a visit that was timed by the prison staff.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en prácticamente todas las residencias españolas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in virtually all Spanish residences"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha establecido un régimen penitenciario",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a prison system has been established"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas alojadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the persons who have been accommodated"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante una visita",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during a visit"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "cronometrada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "timed"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por el personal que hace de carcelero",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by the staff who act as a jailer"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La reclusión de los ancianos con la excusa del coronavirus, que han quedado aparcados en los últimos años de su vida a la espera de la muerte, ha convertido la soledad en una cuestión cotidiana para el resto de la sociedad, que está mirando para otro lado en algo que es una bomba de relojería para la salud mental de la población mayor.",
                "text_en": "The confinement of the elderly under the excuse of the coronavirus, which has been parked in the last years of their life awaiting death, has turned loneliness into a daily issue for the rest of society, which is looking the other way into something that is a time bomb for the mental health of the elderly population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La reclusión",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Imprisonment"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los ancianos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the elderly"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "con la excusa del coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with the excuse of the coronavirus"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los últimos años de su vida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the last years of his life"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a la espera de la muerte",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "waiting for death"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el resto de la sociedad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the rest of the society"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está mirando para otro lado en algo que es una bomba de relojería para la salud mental",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's looking the other way at something that's a time bomb for mental health."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población mayor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the largest population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La soledad y el aislamiento son riesgos graves para la salud de la tercera edad.",
                "text_en": "Loneliness and isolation are serious risks to the health of the elderly.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La soledad y el aislamiento son riesgos graves para la salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Loneliness and isolation are serious health risks"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la tercera edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the elderly"
                    }
                ],
                "evidences": [
                    {
                        "value": "Knowledge about an association between informal caregiving and loneliness/social isolation may be of particular importance to target individuals at risk for increased loneliness or social isolation scores. Avoiding loneliness or social isolation may assist in maintaining health status of informal caregivers.",
                        "score": 0.5899999738
                    },
                    {
                        "value": "Knowledge about an association between informal caregiving and loneliness orsocial isolation may be of particular importance to target individuals at risk for increased self-reports of loneliness or social isolation. Avoiding or responding to loneliness or social isolation may assist in maintaining health status of informal caregivers.",
                        "score": 0.6399999857
                    },
                    {
                        "value": "We measured loneliness and social isolation prior to the assessment of deficits in healthy aging. However, this prospective design does not rule out the possibility that prior disability and disease might cause loneliness and social isolation. To refine our inference, we limited our measurement of loneliness and social isolation to the first two assessments and conducted analysis of incident disability and chronic disease during the interval between the second assessment of loneliness and social isolation and follow-up in 2016. We included all participants from the main analysis, regardless of whether they were free of any disability or disease at baseline. During follow-up of 2-6 years, 13% of participants (N=1,219) reported one or more incident ADL disabilities, 13% (N=1,235) reported one or more incident IADL disabilities, and 24% (N=2,266) reported one or more incident chronic diseases (Supplemental Figure 1 ). Comparing intermittent and persistent exposure phenotypes . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
                        "score": 0.6800000072
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.990598619
                    },
                    {
                        "label": "neutral",
                        "score": 0.9884676337
                    },
                    {
                        "label": "neutral",
                        "score": 0.9928124547
                    }
                ]
            },
            {
                "text": "Si bien esta realidad era conocida antes del confinamiento, es razonable imaginar que este porcentaje ha aumentado durante el transcurso de su reclusión de estos últimos meses, con restricciones aún más estrictas para esta franja de la población.",
                "text_en": "While this reality was known before confinement, it is reasonable to imagine that this percentage has increased during the course of his detention in recent months, with even stricter restrictions on this segment of the population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es razonable imaginar que este porcentaje ha aumentado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is reasonable to imagine that this percentage has increased"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "durante el transcurso de su reclusión de estos últimos meses",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "during the course of his detention in recent months"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "con restricciones aún más estrictas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with even stricter restrictions"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "esta franja de la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this segment of the population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Incluso antes del confinamiento, millones de ancianos en toda España luchaban contra sentimientos de soledad, aislamiento y falta de compañía regular.",
                "text_en": "Even before confinement, millions of elderly people throughout Spain fought against feelings of loneliness, isolation and lack of regular company.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Incluso antes del confinamiento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Even before confinement"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "millones de ancianos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "millions of elderly"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en toda España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "luchaban contra sentimientos de soledad, aislamiento y falta de compañía regular",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "struggle against feelings of loneliness, isolation and lack of regular company"
                    }
                ],
                "evidences": [
                    {
                        "value": "Moreover, while we were conducting the present investigation, other research articles were published on the effects of self-isolation due to COVID-19 on older adults' well-being and loneliness, further confirming the relevance of the topic. Online surveys conducted in Spain and Israel showed that a negative self-perception of aging was associated with loneliness and psychological distress [39, 40] . Interestingly, the study conducted in Spain, including 1310 participants aged between 18 and 88 years, showed an inverse association between chronological age and both loneliness and distress, suggesting better coping abilities in aged individuals [39] . A longitudinal observational study showed that US older adults experienced increased depressive symptoms and loneliness than prior to the COVID-19 pandemic [41] . Conversely, in a large Swedish cohort evaluated annually for 5 years, no changes in loneliness were detected [42] .",
                        "score": 0.6399999857
                    },
                    {
                        "value": "In this context, the purpose of this research is to understand the experience of elderly people aged over 60 in Spain during one of the hardest confinements in Europe, with the use of the Internet and ICT as tools to address social isolation, loneliness and distance from their love ones. Accordingly, three research questions (RQ) are addressed:",
                        "score": 0.6700000167
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9950102568
                    },
                    {
                        "label": "neutral",
                        "score": 0.9980921149
                    }
                ]
            },
            {
                "text": "La ausencia de visitas y la obligación de permanecer en sus habitaciones con la televisión como único contacto externo son las únicas «vías de escape» que se les ha dado a la tercera edad, con el supuesto objetivo de protegerlos, pero lo cierto es que el coronavirus ha sido la excusa perfecta para recluir y abandonar, a la espera de la muerte, a quien nada producía y normalmente estorbaba.",
                "text_en": "The absence of visits and the obligation to stay in their rooms with television as the only external contact are the only \"exhaustive routes\" given to the elderly, with the supposed aim of protecting them, but the truth is that the coronavirus has been the perfect excuse to detain and abandon, pending death, whom nothing produced and usually interfered with.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el coronavirus ha sido la excusa perfecta para recluir y abandonar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the coronavirus has been the perfect excuse to lock up and abandon"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a la espera de la muerte",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "waiting for death"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a quien nada producía y normalmente estorbaba",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to whom nothing produced and usually interfered"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En síntesis, se está produciendo un genocidio tolerado por toda la sociedad.",
                "text_en": "In short, a genocide tolerated by society as a whole is taking place.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se está produciendo un genocidio tolerado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a tolerated genocide is taking place"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por toda la sociedad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "throughout society"
                    }
                ],
                "evidences": [
                    {
                        "value": "(a) Killing members of the group (b) Causing serious bodily or mental harm to members of the group (c) Deliberately inflicting on the group conditions of life calculated to bring about its physical destruction in whole or in part (d) Imposing measures intended to prevent births within the group (e) Forcibly transferring children of the group to another group The We Charge Genocide petition, first authored in 1951 and then taken up again recently, posited that the USA is committing the crime of genocide against African Americans. As stated in We Charge Genocide (Patterson, 1952) , just because genocide does not succeed in the total destruction of a race of people does not mean it is not happening. Intent in the definition of genocide needs to be reconceptualized to consider Galtung's (1969) notion that violence is embedded into the structures of society and may not have an identifiable perpetrator. Genocide comes in many forms and it is no less genocidal, by definition, to cause serious bodily or mental harm to members of a group by neglect and deprivation of fundamental human needs through public school closures than it is to kill members of the group.",
                        "score": 0.6299999952
                    },
                    {
                        "value": "The UN \"Convention on the Prevention and Punishment of the Crime of Genocide\" (https://treaties.un.org/doc/publication/unts/volume%2078/volume-78-i-1021-english.pdf) defines one form of genocide as \"the deliberate infliction on the group conditions of life calculated to bring about its physical destruction in whole or in part.\" It is hard to imagine that someone somewhere would implement measures to reduce the number of older people, considering them overly burdensome during pandemics. However, unintentional \"gerocide\" may be based on the negligence of the interests and rights of these people.",
                        "score": 0.6600000262
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9984663725
                    },
                    {
                        "label": "neutral",
                        "score": 0.9971401691
                    }
                ]
            }
        ]
    },
    "20": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 16,
            "WhatReliabilityReliable": 16,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 14,
            "WhoReliabilityReliable": 14,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 6,
            "WhenReliabilityReliable": 6,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 4,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 9,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 9,
            "WhoRoleSubject": 12,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nLos vaivenes con el fármaco y las imprecisas comunicaciones oficiales provocan incertidumbre entre los que acuden a recibir la inyección\n\n<PARAGRAPH>\n\nMinutos antes de las diez de la mañana, Jesús Rodríguez, de 64 años, encabeza la cola para vacunarse de la covid este jueves en el Centro Cultural Miguel Delibes, de Valladolid.\n\n<BREAK>\n\n“¡Estamos hasta las narices!”, exclama, por la falta de información oficial.\n\n<BREAK>\n\nUn escueto comunicado de la Junta de Castilla y León en la noche del miércoles señalaba que “en las próximas horas, a medida que sea factible”, se retomaría, aunque solo para las personas de entre 60 y 65 años, la vacunación con AstraZeneca, suspendida esa mañana por “precaución”.\n\n<BREAK>\n\nEn la fila, en la que se mezclan personas citadas anteriormente para este jueves y otras a las que les cancelaron el miércoles y que se han pasado a informarse, hay una mezcla de resignación, desconcierto e indignación.\n\n<BREAK>\n\nRodríguez comenta que muchos acudieron a primera hora y se encontraron con el centro cerrado, por lo que se marcharon pensando que no se vacunaría.\n\n<PARAGRAPH>\n\nEl corrillo formado junto al acceso saluda a una enfermera que acarrea una bolsa de vacunas; ella sonríe y pide calma: “Tranquilos, que ahora os atendemos”.\n\n<BREAK>\n\nRafael Álvarez y sus colegas de fila le dicen: “Te vamos a aplaudir a ti”.\n\n<BREAK>\n\nMenos loas recibe la consejera de Sanidad, Verónica Casado, impulsora de la interrupción del uso de AstraZeneca: “Es un desastre”.\n\n<PARAGRAPH>\n\nLas puertas de la gran sala de vacunación habilitada se abren a las 10.22.\n\n<BREAK>\n\nEl vigilante de seguridad toma la temperatura y ejerce de orientador ante la falta de personal institucional que asista a los pacientes.\n\n<BREAK>\n\nA su letanía de “hola, qué hay, buenos días” tiene que añadir respuestas para los rangos de edad que se vacunarán y el dato de que van a vacunar a los de la jornada anterior y los del jueves.\n\n<BREAK>\n\nAsimismo, polivalente, anima a los recelosos.\n\n<BREAK>\n\nUna señora murmura “ay, qué miedo”.\n\n<BREAK>\n\nÉl contesta con un “no se preocupe”, y sigue dando la vez a las personas que piden su turno al mismo tiempo que atiende a los despistados que no saben si les toca a ellos por fin.\n\n<BREAK>\n\nCuando reciben la noticia, se apresuran a llamar o escribir a sus allegados.\n\n<BREAK>\n\nEl boca a boca se ha convertido, en la era de la información, en la forma más eficaz de que una población sepa si la van a inmunizar contra un virus mortífero.\n\n<PARAGRAPH>\n\nYolanda Villafáñez, de 63, sale del Delibes ya vacunada y corre apurada hacia su perro, Gustavo, que ha permanecido fuera ladrando junto a la fila.\n\n<BREAK>\n\nUna vez lo tranquiliza, critica que las decisiones de la Consejería de Sanidad la han “asustado” y que ha accedido a inmunizarse porque ha preguntado por curiosidad y le han confirmado que seguía el proceso: “Si me lo pienso, no entro”.\n\n<PARAGRAPH>\n\nLa caprichosa primavera de Valladolid muestra un crisol de estilos bajo el engañoso sol.\n\n<BREAK>\n\nUn hombre abre su paraguas mientras unos metros más allá Gregorio Muñoz, de 64, luce pantorrillas.\n\n<BREAK>\n\n“¡Hay que refrescar las piernas!”, bromea, aunque se pone serio para denunciar “la incertidumbre”, un trastorno que los hace sentirse “como monigotes” porque nadie se ha parado a precisarles el porqué de las cosas.\n\n<BREAK>\n\nAdolfo Morales, un año mayor, amaga con el alzamiento de una población hastiada: “Somos demasiado civilizados, es una gran falta de respeto”.\n\n<BREAK>\n\nNo hace falta que Verónica Casado “se ponga de rodillas”, pero sí reclama “explicaciones” sobre el miedo creado hacia los trombos y los efectos de una vacuna que cree necesaria.\n\n<BREAK>\n\nCastilla y León fue el único territorio que suspendió la vacunación con AstraZeneca hasta que, horas después, la Agencia Europea del Medicamento (EMA, en sus siglas en inglés), confirmó que existen riesgos “muy raros” de trombos, pero que los beneficios superan con mucho el peligro.\n\n<PARAGRAPH>\n\nIncluso la “precaución” que esgrimió la Junta encuentra detractores en el personal sanitario.\n\n<BREAK>\n\nAmada Pérez, de 64 años, trabaja en el gremio y alcanza a comprender que se actúe con prudencia hacia un fármaco, pero cree que el panorama es el que es “y se genera desconcierto”.\n\n<BREAK>\n\nPérez, conciliadora, expresa que “la intención era buena” pero el resultado de tanto carrusel de medidas acaba provocando una “incertidumbre” indeseable en estos momentos.\n\n<BREAK>\n\nEn un rato recibirá la inyección, que no le hace mucha ilusión pero “es lo que toca”.\n\n<BREAK>\n\n“Estoy mentalizada”, dice.\n\n<PARAGRAPH>\n\nAquellos que se han vacunado salen del Miguel Delibes con un peso menos encima, pero no precisamente contentos.\n\n<BREAK>\n\nJesús Rodríguez, que se pone parsimoniosamente su camisa, jersey y cazadora tras pasar por manos de las enfermeras, destaca que los sanitarios han admitido que no sabían nada sobre si iban a continuar vacunando o no.\n\n<BREAK>\n\n“Lo que han hecho no tiene justificación”, proclama, con la esperanza de que el cabreo se le pase en las 12 semanas que tiene que aguardar hasta la siguiente dosis.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Castilla y León retoma la vacunación con AstraZeneca entre el desconcierto y la indignación: “Es un desastre”",
        "ID": "F_04-11-2021_22-10-21_elpais_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Castilla y León retoma la vacunación con AstraZeneca entre el desconcierto y la indignación: “Es un desastre”",
                "text_en": "Castilla y León resumes vaccination with AstraZeneca between confusion and indignation: “It’s a disaster”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Castilla y León"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "retoma la vacunación con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "resume vaccination with AstraZeneca"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "entre el desconcierto y la indignación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "between confusion and indignation"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los vaivenes con el fármaco y las imprecisas comunicaciones oficiales provocan incertidumbre entre los que acuden a recibir la inyección",
                "text_en": "The fluctuations with the drug and the imprecise official communications cause uncertainty among those who come to receive the injection",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los vaivenes con el fármaco y las imprecisas comunicaciones oficiales provocan incertidumbre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Vaivens with the drug and inaccuracies official communications cause uncertainty"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los que acuden a recibir la inyección",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "those who come to receive the injection"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Minutos antes de las diez de la mañana, Jesús Rodríguez, de 64 años, encabeza la cola para vacunarse de la covid este jueves en el Centro Cultural Miguel Delibes, de Valladolid.",
                "text_en": "Minutes before ten in the morning, Jesús Rodríguez, 64, heads the queue to get vaccinated from covid this Thursday at the Miguel Delibes Cultural Center in Valladolid.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Minutos antes de las diez de la mañana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Minutes before 10:00 in the morning"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Jesús Rodríguez, de 64 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Jesús Rodríguez, 64 years old"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "encabeza la cola para vacunarse de la covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "head the tail to vaccinate from the covid"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Thursday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Centro Cultural Miguel Delibes, de Valladolid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Cultural Center Miguel Delibes, Valladolid"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“¡Estamos hasta las narices!”, exclama, por la falta de información oficial.",
                "text_en": "“We’re up to our noses!” he exclaims, for lack of official information.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "exclama",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "exclaims"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la falta de información oficial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "lack of official information"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un escueto comunicado de la Junta de Castilla y León en la noche del miércoles señalaba que “en las próximas horas, a medida que sea factible”, se retomaría, aunque solo para las personas de entre 60 y 65 años, la vacunación con AstraZeneca, suspendida esa mañana por “precaución”.",
                "text_en": "A brief statement from the Junta de Castilla y León on Wednesday night pointed out that “in the next few hours, as it becomes feasible”, vaccination with AstraZeneca, suspended that morning for “precaution”, would be resumed, although only for people between 60 and 65 years of age.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Junta de Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Junta de Castilla y León"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la noche del miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Wednesday night"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se retomaría, aunque solo para las personas de entre 60 y 65 años, la vacunación con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccination with AstraZeneca would be resumed, although only for people between 60 and 65 years of age."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "solo para las personas de entre 60 y 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "only for persons aged 60 to 65"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "suspendida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Suspended"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "esa mañana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "that morning"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por “precaución”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "“precaution”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En la fila, en la que se mezclan personas citadas anteriormente para este jueves y otras a las que les cancelaron el miércoles y que se han pasado a informarse, hay una mezcla de resignación, desconcierto e indignación.",
                "text_en": "In the row, in which people quoted above are mixed for this Thursday and others who were cancelled on Wednesday and who have been informed, there is a mixture of resignation, bewilderment and indignation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay una mezcla de resignación, desconcierto e indignación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There is a mixture of resignation, bewilderment and indignation"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Menos loas recibe la consejera de Sanidad, Verónica Casado, impulsora de la interrupción del uso de AstraZeneca: “Es un desastre”.",
                "text_en": "Less loas receives Health Advisor Veronica Married, a driving force behind the interruption of the use of AstraZeneca: “It’s a disaster.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la consejera de Sanidad, Verónica Casado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Health Counselor, Veronica Married"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "impulsora de la interrupción del uso de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "booster of interruption of use of AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El vigilante de seguridad toma la temperatura y ejerce de orientador ante la falta de personal institucional que asista a los pacientes.",
                "text_en": "The security guard takes the temperature and acts as a guide in the absence of institutional staff to assist patients.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El vigilante de seguridad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The security guard"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "toma la temperatura y ejerce de orientador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "takes the temperature and acts as a guide"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la falta de personal institucional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "lack of institutional staff"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Yolanda Villafáñez, de 63, sale del Delibes ya vacunada y corre apurada hacia su perro, Gustavo, que ha permanecido fuera ladrando junto a la fila.",
                "text_en": "Yolanda Villafáñez, 63, leaves the already vaccinated Delibes and runs in a hurry towards her dog, Gustavo, who has remained outside barking next to the line.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Yolanda Villafáñez, de 63",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Yolanda Villafáñez, 63"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sale del Delibes ya vacunada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Gets out of the already vaccinated Delibes"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "del Delibes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of Delibes"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un hombre abre su paraguas mientras unos metros más allá Gregorio Muñoz, de 64, luce pantorrillas.",
                "text_en": "A man opens his umbrella while a few meters beyond Gregorio Muñoz, 64, looks calfs.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gregorio Muñoz, de 64",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Gregorio Muñoz, 64"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“¡Hay que refrescar las piernas!”, bromea, aunque se pone serio para denunciar “la incertidumbre”, un trastorno que los hace sentirse “como monigotes” porque nadie se ha parado a precisarles el porqué de las cosas.",
                "text_en": "“You have to refresh your legs!” he jokes, although he gets serious about denouncing “uncertainty,” a disorder that makes you feel “like monkeys” because no one has stopped to tell you why of things.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se pone serio para denunciar “la incertidumbre”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "gets serious about denouncing “uncertainty”"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque nadie se ha parado a precisarles el porqué de las cosas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because no one has stopped to tell them why of things"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Adolfo Morales, un año mayor, amaga con el alzamiento de una población hastiada: “Somos demasiado civilizados, es una gran falta de respeto”.",
                "text_en": "Adolfo Morales, a year older, is tingling with the uprising of a tired population: “We are too civilized, it is a great lack of respect.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Adolfo Morales, un año mayor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Adolfo Morales, one year older"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No hace falta que Verónica Casado “se ponga de rodillas”, pero sí reclama “explicaciones” sobre el miedo creado hacia los trombos y los efectos de una vacuna que cree necesaria.",
                "text_en": "Veronica Married does not need to “get down on her knees,” but she does demand “explanations” about the fear created towards thrombi and the effects of a vaccine she believes necessary.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reclama “explicaciones” sobre el miedo creado hacia los trombos y los efectos de una vacuna que cree necesaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "calls for “explanations” about the fear created towards thrombi and the effects of a vaccine that it believes necessary"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Castilla y León fue el único territorio que suspendió la vacunación con AstraZeneca hasta que, horas después, la Agencia Europea del Medicamento (EMA, en sus siglas en inglés), confirmó que existen riesgos “muy raros” de trombos, pero que los beneficios superan con mucho el peligro.",
                "text_en": "Castilla y León was the only territory that stopped vaccination with AstraZeneca until, hours later, the European Medicines Agency (EMA), confirmed that there are “very rare” risks of thrombi, but that the benefits far outweigh the danger.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Castilla y León"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue el único territorio que suspendió la vacunación con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was the only territory that stopped vaccination with AstraZeneca"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "horas después",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "hours later"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "confirmó que existen riesgos “muy raros” de trombos, pero que los beneficios superan con mucho el peligro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "confirmed that there are “very rare” risks of thrombus, but that the benefits far outweigh the risk"
                    }
                ],
                "evidences": [
                    {
                        "value": "The very low level of willingness to get vaccinated with a vector vaccine, especially AstraZeneca, also requires a comment. The reason for the above might be the fact that during the period of the distribution of the survey, there were media reports that the preparation increases the risk of getting vein thrombosis [31] . Consequently, within a few days, vaccination with AstraZeneca was temporarily suspended, e.g., in Germany, Austria and Norway [31] . On the day before the finalisation of the collection of the data for this study, the European Medicines Agency (EMA) issued a statement regarding the above-mentioned formulation according to which the process of vaccination was to be continued and that there was no dependence between the risk of getting thrombosis and vaccination with AstraZeneca [32] . What is more, the approval of another type of vector vaccine, Johnson & Johnson, was published a week before the end of stage II of the study and the process of vaccination with the product has not started in Poland yet [9] .",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9969214201
                    }
                ]
            },
            {
                "text": "Jesús Rodríguez, que se pone parsimoniosamente su camisa, jersey y cazadora tras pasar por manos de las enfermeras, destaca que los sanitarios han admitido que no sabían nada sobre si iban a continuar vacunando o no.",
                "text_en": "Jesús Rodríguez, who puts on his shirt, sweater and hunter after passing by the nurses, points out that the doctors have admitted that they did not know anything about whether they were going to continue to vaccinate or not.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Jesús Rodríguez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Jesús Rodríguez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "destaca que los sanitarios han admitido que no sabían nada sobre si iban a continuar vacunando o no",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "highlights that the health care providers have admitted that they knew nothing about whether or not they were going to continue to vaccinate"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health care services"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Lo que han hecho no tiene justificación”, proclama, con la esperanza de que el cabreo se le pase en las 12 semanas que tiene que aguardar hasta la siguiente dosis.",
                "text_en": "“What they have done has no justification,” he proclaims, hoping that the anger will pass him in the 12 weeks he has to wait until the next dose.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esperanza de que el cabreo se le pase",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "hope he's pissed off."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las 12 semanas que tiene que aguardar hasta la siguiente dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the 12 weeks you have to wait until the next dose"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "21": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 9,
            "WhatReliabilityReliable": 9,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 12,
            "WhoReliabilityReliable": 12,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 1,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nLondres, 3 abr (Reuters) – Reguladores británicos informaron el jueves de que identificaron 30 casos de eventos raros de coagulación sanguínea tras el uso de la vacuna COVID-19 de AstraZeneca, 25 más de los que habían reportado previamente.\n\n<PARAGRAPH>\n\nLa Agencia Reguladora de Medicamentos y Productos Sanitarios (MHRA) dijo que no había recibido ningún informe de eventos de coagulación tras el uso de la vacuna fabricada por BioNTech SE y Pfizer Inc.\n\n<PARAGRAPH>\n\nEl viernes, el organismo regulador de los medicamentos dijo al Financial Times y a The Guardian que siete receptores de la vacuna de AstraZeneca habían muerto tras los raros eventos de coagulación de la sangre.\n\n<BREAK>\n\nReuters no pudo confirmar inmediatamente la cifra de la MHRA fuera del horario de oficina.\n\n<PARAGRAPH>\n\nEl MHRA, la Agencia Europea del Medicamento y la Organización Mundial de la Salud han reiterado que los beneficios de la vacuna en la prevención de la COVID-19 superan con creces cualquier posible riesgo de coágulos sanguíneos.\n\n<PARAGRAPH>\n\nAlgunos países están restringiendo el uso de la vacuna de AstraZeneca, mientras que otros han reanudado las inoculaciones, mientras continúan las investigaciones sobre los informes de los raros, y a veces graves, coágulos de sangre.\n\n<PARAGRAPH>\n\nEl 18 de marzo, el organismo regulador de medicamentos del Reino Unido había dicho que habían ocurrido cinco casos de un raro coágulo cerebral entre 11 millones de vacunas administradas.\n\n<PARAGRAPH>\n\nEl jueves, el organismo elevó la cifra a 22 informes de trombosis del seno venoso cerebral, una dolencia de coagulación cerebral extremadamente rara, y 8 informes de otros eventos de coagulación asociados a un nivel bajo de plaquetas en la sangre, de un total de 18,1 millones de dosis administradas.\n\n<PARAGRAPH>\n",
        "TITLE": "Regulador británico halla 30 casos de coágulos sanguíneos tras uso de vacuna de AstraZeneca",
        "ID": "NF_04-11-2021_21-50-02_www_eje21_com_co",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Regulador británico halla 30 casos de coágulos sanguíneos tras uso de vacuna de AstraZeneca",
                "text_en": "British regulator finds 30 cases of blood clots after use of AstraZeneca vaccine",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Regulador británico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "British Regulator"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "halla 30 casos de coágulos sanguíneos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "found 30 cases of blood clots"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras uso de vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after use of AstraZeneca vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Londres, 3 abr (Reuters) – Reguladores británicos informaron el jueves de que identificaron 30 casos de eventos raros de coagulación sanguínea tras el uso de la vacuna COVID-19 de AstraZeneca, 25 más de los que habían reportado previamente.",
                "text_en": "London, 3 Apr (Reuters) – British regulators reported Thursday that they identified 30 cases of rare blood clotting events following the use of the AstraZeneca COVID-19 vaccine, 25 more than they had previously reported.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Reguladores británicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "British regulators"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Thursday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "identificaron 30 casos de eventos raros de coagulación sanguínea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "30 rare blood clotting events identified"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras el uso de la vacuna COVID-19 de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "following the use of the AstraZeneca COVID-19 vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Agencia Reguladora de Medicamentos y Productos Sanitarios (MHRA) dijo que no había recibido ningún informe de eventos de coagulación tras el uso de la vacuna fabricada por BioNTech SE y Pfizer Inc.",
                "text_en": "The Regulatory Agency for Medicines and Health Products (MHRA) said it had not received any reports of coagulation events following the use of the vaccine manufactured by BioNTech SE and Pfizer Inc.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Reguladora de Medicamentos y Productos Sanitarios (MHRA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Regulatory Agency for Medicines and Health Products (MHRA)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dijo que no había recibido ningún informe de eventos de coagulación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "said he had not received any reports of coagulation events"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras el uso de la vacuna fabricada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after use of the manufactured vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "BioNTech SE y Pfizer Inc",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "BioNTech SE and Pfizer Inc"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El viernes, el organismo regulador de los medicamentos dijo al Financial Times y a The Guardian que siete receptores de la vacuna de AstraZeneca habían muerto tras los raros eventos de coagulación de la sangre.",
                "text_en": "On Friday, the drug regulator told the Financial Times and The Guardian that seven AstraZeneca vaccine recipients had died after the rare blood clotting events.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Friday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el organismo regulador de los medicamentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the regulatory body for medicinal products"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Financial Times y a The Guardian",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Financial Times and the Guardian"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "siete receptores de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "seven AstraZeneca vaccine recipients"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "habían muerto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They were dead."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras los raros eventos de coagulación de la sangre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after rare blood clotting events"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Reuters no pudo confirmar inmediatamente la cifra de la MHRA fuera del horario de oficina.",
                "text_en": "Reuters could not immediately confirm the MHRA figure outside office hours.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Reuters",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Reuters"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no pudo confirmar inmediatamente la cifra de la MHRA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "could not immediately confirm the MHRA figure"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "fuera del horario de oficina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "outside office hours"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El MHRA, la Agencia Europea del Medicamento y la Organización Mundial de la Salud han reiterado que los beneficios de la vacuna en la prevención de la COVID-19 superan con creces cualquier posible riesgo de coágulos sanguíneos.",
                "text_en": "MHRA, the European Medicines Agency and the World Health Organization have reiterated that the benefits of the vaccine in preventing COVID-19 far outweigh any potential risk of blood clots.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El MHRA, la Agencia Europea del Medicamento y la Organización Mundial de la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "MHRA, the European Medicines Agency and the World Health Organization"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han reiterado que los beneficios de la vacuna en la prevención de la COVID-19 superan con creces cualquier posible riesgo de coágulos sanguíneos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have reiterated that the benefits of the vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Algunos países están restringiendo el uso de la vacuna de AstraZeneca, mientras que otros han reanudado las inoculaciones, mientras continúan las investigaciones sobre los informes de los raros, y a veces graves, coágulos de sangre.",
                "text_en": "Some countries are restricting the use of the AstraZeneca vaccine, while others have resumed inoculations, as research continues on reports of rare, and sometimes severe, blood clots.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Algunos países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Some countries"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están restringiendo el uso de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are restricting the use of the AstraZeneca vaccine"
                    }
                ],
                "evidences": [
                    {
                        "value": "Vaccines developed in high-income countries have been enormously successful in reducing the global burden of infectious diseases, saving perhaps 2.5 million lives per year, but even for successful cases, like the rotavirus vaccine, global implementation may take a decade or more. For unincentivized vaccines, the delays are even more profound, as both the supply of a vaccine from DCVMNs and vaccine demand from countries with the high disease burdens have to be generated in order for impact to be manifest. A number of poverty-associated infectious diseases, whose burden is greatest in LMICs, would benefit from appropriate levels of support for vaccine development -GAS, iNTS, schistosomiasis, shigella, to name a few.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9990371466
                    }
                ]
            },
            {
                "text": "El 18 de marzo, el organismo regulador de medicamentos del Reino Unido había dicho que habían ocurrido cinco casos de un raro coágulo cerebral entre 11 millones de vacunas administradas.",
                "text_en": "On 18 March, the UK drug regulator had said that five cases of a rare brain clot had occurred among 11 million vaccines administered.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El 18 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "March 18"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el organismo regulador de medicamentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the regulatory body for medicinal products"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "había dicho que habían ocurrido cinco casos de un raro coágulo cerebral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had said that five cases of a rare brain clot had occurred"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "entre 11 millones de vacunas administradas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "11 million vaccines administered"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El jueves, el organismo elevó la cifra a 22 informes de trombosis del seno venoso cerebral, una dolencia de coagulación cerebral extremadamente rara, y 8 informes de otros eventos de coagulación asociados a un nivel bajo de plaquetas en la sangre, de un total de 18,1 millones de dosis administradas.",
                "text_en": "On Thursday, the body raised the number to 22 reports of cerebral venous sinus thrombosis, an extremely rare cerebral coagulation condition, and 8 reports of other coagulation events associated with a low level of platelets in the blood, out of a total of 18.1 million doses administered.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Thursday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el organismo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the body"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "elevó la cifra a 22 informes de trombosis del seno venoso cerebral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "raised the number to 22 reports of cerebral venous sinus thrombosis"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "22": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 14,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 9,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 2,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 1,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 2,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 4,
            "WhoRoleTarget": 3,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 4,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 5,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nEn el mes de agosto, el 80 por ciento de las personas que han muerto “por covid” en Escocia se habían vacunado, según los datos oficiales del Instituto Escocés de Salud Pública (PHS, Public Health Scotland).\n\n<BREAK>\n\nEl programa de vacunación contra el coronavirus es, pues, un fracaso.\n\n<BREAK>\n\nLas vacunas no previenen la circulación del virus, lo cual es algo que ya estaba admitido, y aumentan el riesgo de hospitalización y muerte, en lugar de reducirlo.\n\n<PARAGRAPH>\n\nComo los demás organismos públicos, el PHS presenta las cifras de manera que el asunto quede convenientemente tapado.\n\n<BREAK>\n\nEn lugar de hacer un balance semana a semana, incluyen las muertes hasta el 29 de diciembre del año pasado.\n\n<BREAK>\n\nSegún esos datos, hubo 3.102 muertes en la población no vacunada, 279 muertes en la población parcialmente vacunada y 298 muertes en la población totalmente vacunada.\n\n<BREAK>\n\nParece, pues, que la mayoría de las muertes “por covid” se producen en la población no vacunada.\n\n<BREAK>\n\nEn cosecuencia, las vacunas previenen las hospitalizaciones y muertes “por covid”, como era de esperar.\n\n<PARAGRAPH>\n\nSin embargo, esos datos incluyen el momento cumbre de la llamada “segunda ola”, cuando sólo el 9 por ciento de la población había recibido una dosis y sólo el 0,1 por ciento de la población total estaba totalmente vacunada.\n\n<BREAK>\n\nDe ahí resulta que la mayor parte de los muertos y hospitalizados no estaban vacunados.\n\n<PARAGRAPH>\n\nPero el análisis tiene que ser mucho más fino, recurriendo a los informes más recientes en los que la mayor parte de la población ya está vacunada.\n\n<BREAK>\n\nDe esa manera se deduce que entre el 5 y el 26 de agosto de este año el número de muertes atribuidas al “covid” ha sido el siguiente:\n\n<PARAGRAPH>\n\nEsto significa que en agosto de este año la población no vacunada representó sólo el 20 por ciento de las muertes atribuidas al “covid”, mientras que la población totalmente vacunada representó el 75 por ciento.\n\n<PARAGRAPH>\n\nEntre el 19 y el 26 de agosto de este año el número de muertes atribuidas al “covid” se distribuye de la siguiente manera:\n\n<PARAGRAPH>\n\nLos porcentajes son, pues, aún más mayores: el 86 por ciento de las muertes “por covid” corresponden a personas vacunadas contra el “covid”.\n\n<PARAGRAPH>\n\nLa conclusión es que, en lugar de reducir el riesgo de muerte “por covid”, las vacunas lo aumentan en un 566 por ciento.\n\n<PARAGRAPH>\n\n—https://theexpose.uk/2021/09/08/exclusive-80-percent-of-covid-19-deaths-in-august-were-people-who-had-been-vaccinated/\n\n<PARAGRAPH>\n",
        "TITLE": "El 80 por ciento de las muertes atribuidas al ‘covid’ en Escocia son de personas vacunadas",
        "ID": "NF_NF_1107_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "El 80 por ciento de las muertes atribuidas al ‘covid’ en Escocia son de personas vacunadas",
                "text_en": "80 percent of the deaths attributed to ‘covid’ in Scotland are from vaccinated people",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El 80 por ciento de las muertes atribuidas al ‘covid’",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "80 percent of deaths attributed to ‘covid’"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Escocia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Scotland"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas vacunadas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "people vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el mes de agosto, el 80 por ciento de las personas que han muerto “por covid” en Escocia se habían vacunado, según los datos oficiales del Instituto Escocés de Salud Pública (PHS, Public Health Scotland).",
                "text_en": "By August, 80 percent of people who have died “for covid” in Scotland had been vaccinated, according to official data from the Scottish Institute of Public Health (PHS, Public Health Scotland).",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En el mes de agosto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the month of August"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 80 por ciento de las personas que han muerto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "80% of people who have died"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por covid",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "per covid"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Escocia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Scotland"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se habían vacunado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "had been vaccinated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Instituto Escocés de Salud Pública (PHS, Public Health Scotland)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Scottish Institute of Public Health (PHS, Public Health Scotland)"
                    }
                ],
                "evidences": [
                    {
                        "value": "Population data on the spread of lab-confirmed cases and deaths across the UK (devolved countries) and regions in England are shown in Fig. 2 . Up to 12th August there were 472 cases and 70 deaths per 10 0,0 0 0 population in the UK. The number of cases was maximal in England, although cases per 10 0,0 0 0 population was highest in Wales. The proportion of deaths-to-cases of COVID-19 is most pronounced in England (16%) with 75 deaths per 10 0,0 0 0 population, followed in descending order by Scotland (13%) with 352 deaths per 10 0,0 0 0 population. Wales and Northern Ireland both reported a proportion of deaths-to-cases of 9%; although Wales had more deaths per 10 0,0 0 0 population than Scotland [27] . Between 10th April to 7th August June 10th, 14,120 deaths in England were reported in care homes [33] .",
                        "score": 0.6600000262
                    },
                    {
                        "value": "As of August 2020, more than 800,000 deaths worldwide have been attributed to COVID-19, of which > 41,000 have been in the United Kingdom and 2494 in Scotland [1] . People with MND (pwMND) may be particularly vulnerable. We completed a population-based analysis of the Scottish MND Register, CARE-MND [2] and a clinician survey, to measure the impact of the pandemic on (1) diagnostic rate, (2) mortality rate, and, (3) delivery of services.",
                        "score": 0.6299999952
                    },
                    {
                        "value": "Our estimates make no adjustment for the ongoing COVID-19 pandemic which has particularly affected people aged 75 or over who accounted for 76% of the 3,546 COVIDrelated deaths registered in Scotland by 17 May 2020. 19 Excess deaths relating to, but not directly caused by, COVID-19 have also occurred. The long-term consequences of the virus",
                        "score": 0.6200000048
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8293730021
                    },
                    {
                        "label": "neutral",
                        "score": 0.9993512034
                    },
                    {
                        "label": "neutral",
                        "score": 0.9976658821
                    }
                ]
            },
            {
                "text": "El programa de vacunación contra el coronavirus es, pues, un fracaso.",
                "text_en": "The vaccination programme against coronavirus is therefore a failure.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El programa de vacunación contra el coronavirus es, pues, un fracaso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The vaccination programme against coronavirus is therefore a failure."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las vacunas no previenen la circulación del virus, lo cual es algo que ya estaba admitido, y aumentan el riesgo de hospitalización y muerte, en lugar de reducirlo.",
                "text_en": "Vaccines do not prevent the circulation of the virus, which is something that was already admitted, and increase the risk of hospitalization and death, rather than reducing it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Las vacunas no previenen la circulación del virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Vaccines do not prevent the circulation of the virus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aumentan el riesgo de hospitalización y muerte",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "increase the risk of hospitalization and death"
                    }
                ],
                "evidences": [
                    {
                        "value": "By and large, regulation of the full vaccine life cycle has yet to be established in China. Typically, there are five phases of vaccine regulation: development, registration, production, circulation, and vaccination. The Vaccines Circulation Regulation focuses solely on circulation and vaccination, without touching on the development, registration and monitoring aspects. The main subject of the Infectious Diseases Prevention Law is to prevent and control the spread of infectious diseases. However, despite the huge scope of its responsibilities, its provisions only mention that ''vaccines used for prophylactic vaccination shall conform to the quality standards of the State.\"",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9959833622
                    }
                ]
            },
            {
                "text": "Como los demás organismos públicos, el PHS presenta las cifras de manera que el asunto quede convenientemente tapado.",
                "text_en": "Like the other public bodies, the PHS presents the figures so that the matter is conveniently covered up.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el PHS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the PHS"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "presenta las cifras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "presents the figures"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de manera que el asunto quede convenientemente tapado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "so that the matter is conveniently covered up"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En lugar de hacer un balance semana a semana, incluyen las muertes hasta el 29 de diciembre del año pasado.",
                "text_en": "Instead of taking a week-to-week balance, they include deaths until December 29, last year.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "incluyen las muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "including deaths"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "hasta el 29 de diciembre del año pasado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "until December 29 of last year"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según esos datos, hubo 3.102 muertes en la población no vacunada, 279 muertes en la población parcialmente vacunada y 298 muertes en la población totalmente vacunada.",
                "text_en": "According to these data, there were 3,102 deaths in the unvaccinated population, 279 deaths in the partially vaccinated population and 298 deaths in the fully vaccinated population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hubo 3.102 muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There were 3,102 deaths"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en la población no vacunada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the unvaccinated population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Parece, pues, que la mayoría de las muertes “por covid” se producen en la población no vacunada.",
                "text_en": "It seems, therefore, that most of the deaths “by covid” occur in the unvaccinated population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la mayoría de las muertes “por covid” se producen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "most deaths “by covid” occur"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "per covid"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en la población no vacunada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the unvaccinated population"
                    }
                ],
                "evidences": [
                    {
                        "value": "However, the third key point in the report continues: 'the current average share of all COVID-19 deaths that were care home residents is 46% (based on 21 countries'. Now that we reconsidered this statement, we acknowledge that this exact percentage might be biased by the various approaches used to quantify deaths. Therefore, in the introduction of our manuscript we removed this exact percentage:",
                        "score": 0.6299999952
                    },
                    {
                        "value": "During May-August 2020, the percentage of COVID-19associated deaths occurring in the South increased from 23.4% in May to 62.7% in August, and in the West from 10.6% to 21.4%; the percentages occurring in the Northeast decreased from 44.2% in May to 4.0% in August, and in the Midwest declined from 21.8% to 11.8% ( Figure 1 ). The percentage of decedents aged ≥65 years decreased from 81.8% to 77.6%, and the percentage of deaths occurring in nursing homes or longterm care facilities decreased from 29.8% to 16.6% ( Figure 1 ).",
                        "score": 0.6800000072
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9975376129
                    },
                    {
                        "label": "neutral",
                        "score": 0.9984198809
                    }
                ]
            },
            {
                "text": "En cosecuencia, las vacunas previenen las hospitalizaciones y muertes “por covid”, como era de esperar.",
                "text_en": "In consequence, vaccines prevent hospitalizations and deaths “by covid”, as expected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las vacunas previenen las hospitalizaciones y muertes “por covid”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccines prevent hospitalizations and deaths “by covid”"
                    }
                ],
                "evidences": [
                    {
                        "value": "• Coronavirus Disease 2019 (COVID- 19) vaccination is one of the main strategies to control the COVID-19 pandemic and to avoid hospitalizations and deaths from COVID- 19 .",
                        "score": 0.6299999952
                    },
                    {
                        "value": "Differences in prevented Covid-19 cases, hospitalizations and deaths under 'mitigation' are illustrated in Figure 1 , with full details in the Appendix. . During the study period, in the 65 to 79 years cohort, a total of 4,282 symptomatic infections, 338 hospitalizations and 172 deaths were observed (Table 2) , compared to a total of 3,078 symptomatic infections, 854 hospitalizations and 764 COVID-19 related deaths observed in the 80 and more yo cohort (Table 3) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint",
                        "score": 0.6100000143
                    },
                    {
                        "value": "In summary, nationwide records of COVID-19 hospitalizations in Spain support that massive vaccination of people above 60-years-old precluded a fourth wave of COVID-19 hospitalizations after Easter time. The protective effect on COVID-19 hospitalizations was noticed shortly after the first dose of the current marketed vaccines.",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.930755794
                    },
                    {
                        "label": "neutral",
                        "score": 0.9413923621
                    },
                    {
                        "label": "neutral",
                        "score": 0.9985859394
                    }
                ]
            },
            {
                "text": "Sin embargo, esos datos incluyen el momento cumbre de la llamada “segunda ola”, cuando sólo el 9 por ciento de la población había recibido una dosis y sólo el 0,1 por ciento de la población total estaba totalmente vacunada.",
                "text_en": "However, these data include the peak of the so-called “second wave”, when only 9 percent of the population had received a dose and only 0.1 percent of the total population was fully vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el momento cumbre de la llamada “segunda ola”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the peak moment of the so-called “second wave”"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 9 por ciento de la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "9 per cent of the population"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "había recibido una dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had received a dose"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De ahí resulta que la mayor parte de los muertos y hospitalizados no estaban vacunados.",
                "text_en": "It turns out that most of the dead and hospitalized were not vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la mayor parte de los muertos y hospitalizados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "most of the dead and hospitalized"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no estaban vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "were not vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero el análisis tiene que ser mucho más fino, recurriendo a los informes más recientes en los que la mayor parte de la población ya está vacunada.",
                "text_en": "But the analysis has to be much finer, drawing on the most recent reports in which most of the population is already vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el análisis tiene que ser mucho más fino",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the analysis has to be much thinner."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "recurriendo a los informes más recientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "using the most recent reports"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto significa que en agosto de este año la población no vacunada representó sólo el 20 por ciento de las muertes atribuidas al “covid”, mientras que la población totalmente vacunada representó el 75 por ciento.",
                "text_en": "This means that in August of this year the unvaccinated population accounted for only 20 percent of the deaths attributed to “covid”, while the fully vaccinated population accounted for 75 percent.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en agosto de este año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in August of this year"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población no vacunada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the unvaccinated population"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "representó sólo el 20 por ciento de las muertes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "accounted for only 20 percent of deaths"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "atribuidas al “covid”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "assigned to “covid”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La conclusión es que, en lugar de reducir el riesgo de muerte “por covid”, las vacunas lo aumentan en un 566 por ciento.",
                "text_en": "The conclusion is that, instead of reducing the risk of death “by covid”, vaccines increase it by 566 percent.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "en lugar de reducir el riesgo de muerte “por covid”, las vacunas lo aumentan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Instead of reducing the risk of death “by covid”, vaccines increase the risk of death."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en un 566 por ciento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "566 percent"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "23": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 27,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 16,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 6,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 21,
            "WhoReliabilityReliable": 16,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 12,
            "WhenReliabilityReliable": 8,
            "WhenReliabilityUnreliable": 4,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 6,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 5,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 3,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 8,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 2,
            "QuoteAuthor-StanceUnknown": 6,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 11,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 0,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 1,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 7,
            "Key-Verb": 0,
            "Orthotypography": 13,
            "Figure": 7,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 27,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nFuente original: https://healthimpactnews.com/2021/53-dead-in-gibraltar-in-10-days-after-experimental-pfizer-mrna-covid-injections-started/\n\n<BREAK>\n\nA Kevin Rushworth reported:\n\n<BREAK>\n\nResidentes de Gibraltar se han puesto en contacto conmigo y me han dicho que 53 personas han muerto en 10 días inmediatamente después del lanzamiento de las inyecciones de ARNm COVID de Pfizer, y lo han calificado de «masacre».\n\n<BREAK>\n\nLos informes de los medios locales confirman las muertes, pero culpan a COVID y no a las inyecciones de COVID.\n\n<BREAK>\n\nSin embargo, antes del lanzamiento de las inyecciones, se informa que solo 16 personas en total murieron “por COVID” desde el comienzo de la “pandemia” hace aproximadamente un año.\n\n<BREAK>\n\nEl primer lote de inyecciones experimentales de ARNm COVID de Pfizer fue administrado por los militares el 9 de enero, según el UK Defense Journal:\n\n<BREAK>\n\nUn avión de transporte británico A400M Atlas ha entregado las primeras dosis de la vacuna Pfizer COVID19 a Gibraltar.\n\n<BREAK>\n\nSegún un comunicado del Gobierno de Gibraltar:\n\n<BREAK>\n\n“El Gobierno de Su Majestad de Gibraltar se complace en anunciar que la primera entrega de la vacuna Pfizer / BioNTech COVID-19 el sábado 9 de enero de 2021. \n\n<BREAK>\n\nA su llegada, la vacuna se llevará inmediatamente directamente a los congeladores dedicados en el sótano del Hospital St Bernard. y se mantiene a -75 grados centígrados.\n\n<BREAK>\n\nEsta primera entrega está siendo proporcionada a Gibraltar por el Gobierno del Reino Unido como parte de su programa para abastecer a los Territorios de Ultramar, por lo que la metodología de entrega es la misma que en el Reino Unido.\n\n<BREAK>\n\nSe recibirán 5850 dosis de la vacuna en esta primera entrega. \n\n<BREAK>\n\nLa segunda entrega de la vacuna se espera para fines de enero. \n\n<BREAK>\n\nEl objetivo es haber vacunado a todos los mayores de 70 años con al menos una dosis a mediados de febrero, asumiendo que las vacunas lleguen según lo previsto ”.\n\n<BREAK>\n\nEl programa de vacunación para el público en Gibraltar comenzará el lunes 11 de enero y tendrá lugar en el antiguo Centro de Atención Primaria del ICC.\n\n<BREAK>\n\nExpatica.com informó que las inyecciones comenzaron el 9 de enero y que para la noche del domingo 10 de enero se habían administrado 5,847 dosis.\n\n<BREAK>\n\nGibraltar comenzó a implementar su programa de vacunación el 9 de enero con la vacuna Pfizer y el domingo por la noche había administrado 5.847 dosis, que cubren alrededor del 17 por ciento de la población. \n\n<BREAK>\n\nEl Gobierno de Gibraltar informó que a partir del 10 de enero, solo un día después de que comenzaran las inyecciones, 4 personas murieron inmediatamente:\n\n<BREAK>\n\nEs con profundo pesar que el Gobierno confirme la muerte de cuatro residentes de Gibraltar por COVID-19. \n\n<BREAK>\n\nEsto eleva el número total de muertes relacionadas con COVID-19 en Gibraltar a 16.\n\n<BREAK>\n\nEl primero fue un residente masculino de Servicios Residenciales para Ancianos, de entre 90 y 95 años, que murió anoche de neumonía COVID-19 con septicemia. \n\n<BREAK>\n\nEsto se registrará en las estadísticas de hoy como una muerte por COVID-19.\n\n<BREAK>\n\nEl segundo era un hombre, de 70 a 75 años, que también era paciente de cáncer en el momento de su muerte. \n\n<BREAK>\n\nEl paciente falleció hoy de neumonitis COVID-19. \n\n<BREAK>\n\nEsto se registrará en las estadísticas de hoy como una muerte por COVID-19.\n\n<BREAK>\n\nLa tercera era una residente de Servicios Residenciales para Ancianos, de entre 90 y 95 años, que falleció hoy de septicemia por COVID-19. \n\n<BREAK>\n\nEsto se registrará en las estadísticas de hoy como una muerte por COVID-19.\n\n<BREAK>\n\nLa cuarta era una mujer de 95 a 100 años, que murió hoy de neumonitis COVID-19. \n\n<BREAK>\n\nEsto se registrará en las estadísticas de hoy como una muerte por COVID-19.\n\n<BREAK>\n\nEn lugar de detener de inmediato el programa de «vacunación» de COVID, el ministro principal, Fabián Picardo, afirmó que las «vacunas» trajeron «un alivio genuino y la esperanza de un mañana mejor».\n\n<BREAK>\n\nEl Ministro Principal, Fabián Picardo, dijo: ‘Estoy extremadamente triste por la noticia de hoy de la pérdida de cuatro miembros de nuestra comunidad por COVID-19. \n\n<BREAK>\n\nMis pensamientos y mi más sentido pésame están con los familiares y amigos de los fallecidos.\n\n<BREAK>\n\n“La conmoción de sus muertes el mismo día en que comenzó el programa de vacunación de Gibraltar es particularmente dolorosa .\n\n<BREAK>\n\n‘No estamos fuera de peligro todavía. \n\n<BREAK>\n\nEl lanzamiento de la vacuna nos brinda un alivio genuino y la esperanza de un mañana mejor. \n\n<BREAK>\n\nPero hasta que podamos vacunar a todos, la mejor manera de proteger a sus seres queridos es quedarse en casa. \n\n<BREAK>\n\nRecuerde también que la vacuna tarda algunas semanas en comenzar a ofrecer protección contra COVID-19, por lo que incluso cuando esté vacunado, debe tener el mayor cuidado.\n\n<BREAK>\n\nEso significa, por ahora, seguir en casa, usar una máscara si tiene que salir por razones esenciales y lavarse las manos bien y con frecuencia.\n\n<BREAK>\n\n‘Insto a todos a que registren su interés en recibir la vacuna utilizando el formulario en línea exclusivo de la GHA, disponible en https://www.gha.gi/covid-19-vaccination-interest-form/. \n\n<BREAK>\n\nYa lo he hecho, y espero ansiosamente mi turno en la fila. \n\n<BREAK>\n\nPor ahora, nos centraremos con razón en proteger a nuestros trabajadores de primera línea más vulnerables y valiosos, cuyos continuos e incansables esfuerzos nos han llevado a este punto en el que podemos mirar hacia el futuro con esperanza ‘. \n\n<BREAK>\n\nSí, «masacre» es el término correcto aquí, y otro funcionario del gobierno aparentemente culpable de asesinato en masa.\n\n<BREAK>\n\n¿Ves el patrón desarrollándose aquí? Inyecte primero a los ancianos, obsérvelos morir por inyección letal y luego échele la culpa al virus, mientras anima a todos los demás a recibir la “vacuna” para protegerse.\n\n<BREAK>\n\nLo triste es que esto realmente está funcionando. \n\n<BREAK>\n\nLa gente no se resiste. \n\n<BREAK>\n\nLas multitudes no se están levantando para proteger a los indefensos y encarcelar a los tiranos asesinos.\n\n<BREAK>\n\nEstán obedeciendo a su gobierno siendo “buenos ciudadanos” y usando sus máscaras, practicando el distanciamiento social y quedándose en casa, tal como se les dice que hagan.\n\n<BREAK>\n\nRescata a los que se llevan a la muerte; reprime a los que se tambalean hacia la matanza.\n\n<BREAK>\n\nSi dices: «Pero no sabíamos nada de esto», ¿no lo percibe el que pesa el corazón? ¿No lo sabe el que guarda tu vida? ¿No pagará a cada uno según lo que haya hecho? (Proverbios 24: 11-12)",
        "TITLE": "53 muertos en Gibraltar en 10 días después de que comenzaran las inyecciones experimentales de ARNm COVID de Pfizer",
        "ID": "7-Periodistasporlaverdad",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "53 muertos en Gibraltar en 10 días después de que comenzaran las inyecciones experimentales de ARNm COVID de Pfizer",
                "text_en": "53 dead in Gibraltar within 10 days of the start of experimental injections of Pfizer COVID mRNA",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "53 muertos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "53 dead"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Gibraltar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Gibraltar"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en 10 días después de que comenzaran las inyecciones experimentales de ARNm COVID de Pfizer",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "within 10 days of the start of experimental injections of Pfizer's mRNA COVID"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Residentes de Gibraltar se han puesto en contacto conmigo y me han dicho que 53 personas han muerto en 10 días inmediatamente después del lanzamiento de las inyecciones de ARNm COVID de Pfizer, y lo han calificado de «masacre».",
                "text_en": "Residents of Gibraltar have contacted me and told me that 53 people have died in 10 days immediately after the launch of Pfizer's COVID mRNA injections, and have described it as 'massacre'.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Residentes de Gibraltar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Residents of Gibraltar"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "me han dicho que 53 personas han muerto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I've been told that 53 people have died."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "53 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "53 persons"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en 10 días inmediatamente después del lanzamiento de las inyecciones de ARNm COVID de Pfizer",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "within 10 days immediately after the launch of the injections of Pfizer's mRNA COVID"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo han calificado de «masacre»",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "have described it as “massacre”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los informes de los medios locales confirman las muertes, pero culpan a COVID y no a las inyecciones de COVID.",
                "text_en": "Local media reports confirm deaths, but blame COVID and not COVID injections.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los informes de los medios locales confirman las muertes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Local media reports confirm deaths"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "culpan a COVID y no a las inyecciones de COVID",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "blame COVID and not COVID injections"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sin embargo, antes del lanzamiento de las inyecciones, se informa que solo 16 personas en total murieron “por COVID” desde el comienzo de la “pandemia” hace aproximadamente un año.",
                "text_en": "However, prior to the launch of the injections, only 16 people are reported to have died “by COVID” since the start of “pandemy” about a year ago.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "antes del lanzamiento de las inyecciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "before the injections are launched"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "16 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "16 persons"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "murieron",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're dead."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "“por COVID”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "“by COVID”"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde el comienzo de la “pandemia” hace aproximadamente un año",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "from the beginning of “pandemy” about a year ago"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El primer lote de inyecciones experimentales de ARNm COVID de Pfizer fue administrado por los militares el 9 de enero, según el UK Defense Journal:",
                "text_en": "The first batch of experimental injections of Pfizer's COVID mRNA was administered by the military on January 9, according to the UK Defense Journal:",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El primer lote de inyecciones experimentales de ARNm COVID de Pfizer fue administrado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The first batch of experimental injections of Pfizer COVID mRNA was administered"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los militares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Military personnel"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 9 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 9 January"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "UK Defense Journal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "UK Defense Journal"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un avión de transporte británico A400M Atlas ha entregado las primeras dosis de la vacuna Pfizer COVID19 a Gibraltar.",
                "text_en": "A British transport aircraft A400M Atlas has delivered the first doses of the Pfizer COVID19 vaccine to Gibraltar.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Un avión de transporte británico A400M Atlas ha entregado las primeras dosis de la vacuna Pfizer COVID19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A British transport aircraft A400M Atlas has delivered the first doses of the Pfizer COVID19 vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gibraltar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Gibraltar"
                    }
                ],
                "evidences": [
                    {
                        "value": "[29] Pfizer and BioNTech, \"\"FDA Briefing Document: Pfizer-BioNTech COVID-19 Vaccine/Cumulative Incidence Curves for the First COVID-19 Occurrence After Dose 1, Dose 1 All-Available Efficacy Population\",\" Vaccines and Related Biological Products Advisory Committee Meeting (December 10, 2020).",
                        "score": 0.5600000024
                    },
                    {
                        "value": "Mainstays of the AT and AAR force are the Hercules, TriStar and C-17s based at Brize Norton (Oxon). The A330 Voyager entered service in April 2012 and will gradually supplant the TriStar tankers and the Vickers VC-10 jetliners (the latter of which were retired in Sept. 2013) as part of the Future Strategic Tanker Aircraft programme. The A400M Atlas entered operational service in Sept. 2015 to replace the Hercules fleet, which is due to be withdrawn from service by 2022.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9974562526
                    },
                    {
                        "label": "neutral",
                        "score": 0.9984148741
                    }
                ]
            },
            {
                "text": "Según un comunicado del Gobierno de Gibraltar:",
                "text_en": "According to a statement by the Government of Gibraltar:",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "un comunicado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a statement"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gobierno de Gibraltar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government of Gibraltar"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El programa de vacunación para el público en Gibraltar comenzará el lunes 11 de enero y tendrá lugar en el antiguo Centro de Atención Primaria del ICC.",
                "text_en": "The vaccination programme for the public in Gibraltar will begin on Monday, 11 January, and will take place at the former ICC Primary Care Centre.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "programa de vacunación para el público",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccination programme for the public"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Gibraltar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Gibraltar"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el lunes 11 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Monday, 11 January"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el antiguo Centro de Atención Primaria del ICC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the former ICC Primary Care Centre"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Gibraltar comenzó a implementar su programa de vacunación el 9 de enero con la vacuna Pfizer y el domingo por la noche había administrado 5.847 dosis, que cubren alrededor del 17 por ciento de la población. ",
                "text_en": "Gibraltar began implementing its vaccination program on January 9 with the Pfizer vaccine and on Sunday night it had administered 5,847 doses, covering about 17 percent of the population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gibraltar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Gibraltar"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "comenzó a implementar su programa de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "started implementing its vaccination program"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 9 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 9 January"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la vacuna Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with Pfizer vaccine"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el domingo por la noche",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Sunday night"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "había administrado 5.847 dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "5 847 doses had been administered"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Gobierno de Gibraltar informó que a partir del 10 de enero, solo un día después de que comenzaran las inyecciones, 4 personas murieron inmediatamente:",
                "text_en": "The Government of Gibraltar reported that as of 10 January, only one day after the start of the injections, four people died immediately:",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno de Gibraltar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Government of Gibraltar"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir del 10 de enero, solo un día después de que comenzaran las inyecciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from January 10, only one day after the injections began"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "4 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "4 persons"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "murieron inmediatamente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "died immediately."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto eleva el número total de muertes relacionadas con COVID-19 en Gibraltar a 16.",
                "text_en": "This brings the total number of COVID-19-related deaths in Gibraltar to 16.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esto eleva el número total de muertes relacionadas con COVID-19 en Gibraltar a 16",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This brings the total number of COVID-19-related deaths in Gibraltar to 16"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Gibraltar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Gibraltar"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En lugar de detener de inmediato el programa de «vacunación» de COVID, el ministro principal, Fabián Picardo, afirmó que las «vacunas» trajeron «un alivio genuino y la esperanza de un mañana mejor».",
                "text_en": "Instead of immediately stopping the COVID 'vaccination' programme, Chief Minister Fabián Picardo said that 'vaccines' brought 'genuine relief and hope for a better tomorrow'.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el ministro principal, Fabián Picardo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the chief minister, Fabián Picardo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "afirmó que las «vacunas» trajeron «un alivio genuino y la esperanza de un mañana mejor»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "said that \"vaccines\" brought \"genuine relief and hope for a better tomorrow\""
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Ministro Principal, Fabián Picardo, dijo: ‘Estoy extremadamente triste por la noticia de hoy de la pérdida de cuatro miembros de nuestra comunidad por COVID-19. ",
                "text_en": "Chief Minister Fabián Picardo said: ‘I am extremely saddened by today’s news of the loss of four members of our community by COVID-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Ministro Principal, Fabián Picardo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Chief Minister, Fabián Picardo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estoy extremadamente triste",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "I'm extremely sad."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la noticia de hoy de la pérdida de cuatro miembros de nuestra comunidad por COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for today's news of the loss of four members of our community by COVID-19"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "cuatro miembros de nuestra comunidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "four members of our community"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“La conmoción de sus muertes el mismo día en que comenzó el programa de vacunación de Gibraltar es particularmente dolorosa .",
                "text_en": "“The shock of their deaths on the very day that Gibraltar’s vaccination program began is particularly painful.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La conmoción de sus muertes el mismo día en que comenzó el programa de vacunación de Gibraltar es particularmente dolorosa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The shock of their deaths on the same day that Gibraltar's vaccination programme began is particularly painful"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el mismo día en que comenzó el programa de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on the same day as the vaccination program began"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Gibraltar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Gibraltar"
                    }
                ],
                "evidences": [
                    {
                        "value": "Parallels in the management of modern-day yellow fever vaccination and travel by the International Health Regulations are made to that of emerging COVID-19 vaccination passport programmes. 18 The nineteenth century yellow fever countermeasures in Gibraltar are equally comparable. Gibraltar, now a British Overseas Territory, was one of the first nations in the world to complete the COVID-19 vaccination of their adult population, those who have been vaccinated were issued cards. As of March 2021, Gibraltar was preparing a COVID-19 passport valid for the EU and UK. In January 2020, in outskirts of Shijiazhuang in China, there was a rush to build an encampment to quarantine 4000 people, who may have come in contact with a person infected with COVID-19.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9843185544
                    }
                ]
            },
            {
                "text": "‘No estamos fuera de peligro todavía. ",
                "text_en": "‘We are not out of danger yet.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No estamos fuera de peligro todavía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We're not out of danger yet."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero hasta que podamos vacunar a todos, la mejor manera de proteger a sus seres queridos es quedarse en casa. ",
                "text_en": "But until we can vaccinate everyone, the best way to protect their loved ones is to stay home.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la mejor manera de proteger",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the best way to protect"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a sus seres queridos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to their loved ones"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "quedarse en casa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stay at home"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en casa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at home"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Recuerde también que la vacuna tarda algunas semanas en comenzar a ofrecer protección contra COVID-19, por lo que incluso cuando esté vacunado, debe tener el mayor cuidado.",
                "text_en": "Remember also that it takes a few weeks for the vaccine to start providing protection against COVID-19, so even when you are vaccinated, you should be most careful.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la vacuna tarda algunas semanas en comenzar a ofrecer protección contra COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vaccine takes a few weeks to start offering protection against COVID-19"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando esté vacunado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when you are vaccinated"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "debe tener el mayor cuidado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "You should be most careful."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Eso significa, por ahora, seguir en casa, usar una máscara si tiene que salir por razones esenciales y lavarse las manos bien y con frecuencia.",
                "text_en": "That means, for now, staying at home, wearing a mask if you have to leave for essential reasons and washing your hands well and often.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "seguir en casa, usar una máscara si tiene que salir por razones esenciales y lavarse las manos bien y con frecuencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stay at home, wear a mask if you have to leave for essential reasons and wash your hands well and often"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por ahora, nos centraremos con razón en proteger a nuestros trabajadores de primera línea más vulnerables y valiosos, cuyos continuos e incansables esfuerzos nos han llevado a este punto en el que podemos mirar hacia el futuro con esperanza ‘. ",
                "text_en": "For now, we will rightly focus on protecting our most vulnerable and valuable front-line workers, whose continuous and tireless efforts have led us to this point where we can look to the future with hope.’",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos centraremos con razón en proteger",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We will rightly focus on protecting"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a nuestros trabajadores de primera línea más vulnerables y valiosos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to our most vulnerable and valuable front-line workers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sí, «masacre» es el término correcto aquí, y otro funcionario del gobierno aparentemente culpable de asesinato en masa.",
                "text_en": "Yes, \"massacre\" is the right term here, and another government official apparently guilty of mass murder.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "«masacre» es el término correcto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "‘massacre’ is the correct term"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "otro funcionario del gobierno",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "other government official"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "culpable",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Guilty"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "de asesinato en masa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "of mass murder"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Ves el patrón desarrollándose aquí? Inyecte primero a los ancianos, obsérvelos morir por inyección letal y luego échele la culpa al virus, mientras anima a todos los demás a recibir la “vacuna” para protegerse.",
                "text_en": "Do you see the pattern developing here? Inject the elderly first, watch them die by lethal injection and then blame the virus, while encouraging everyone else to receive the “vaccine” to protect themselves.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Inyecte primero a los ancianos, obsérvelos morir por inyección letal y luego échele la culpa al virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Inject the elderly first, watch them die by lethal injection and then blame the virus"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los ancianos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the elderly"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por inyección letal",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by lethal injection"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo triste es que esto realmente está funcionando. ",
                "text_en": "The sad thing is that this is really working.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esto realmente está funcionando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This is really working."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las multitudes no se están levantando para proteger a los indefensos y encarcelar a los tiranos asesinos.",
                "text_en": "The crowds are not rising up to protect the defenseless and imprison the murderous tyrants.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Las multitudes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The crowds"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se están levantando para proteger a los indefensos y encarcelar a los tiranos asesinos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're not getting up to protect the defenseless and imprison the murderous tyrants."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los indefensos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the defenseless"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los tiranos asesinos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the murderous tyrants"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Están obedeciendo a su gobierno siendo “buenos ciudadanos” y usando sus máscaras, practicando el distanciamiento social y quedándose en casa, tal como se les dice que hagan.",
                "text_en": "They are obeying their government by being “good citizens” and wearing their masks, practicing social distancing and staying at home, as they are told to do.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Están obedeciendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're obeying"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "su gobierno",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "your government"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "siendo “buenos ciudadanos” y usando sus máscaras, practicando el distanciamiento social y quedándose en casa, tal como se les dice que hagan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "being “good citizens” and wearing their masks, practicing social distancing and staying at home, as they are told to do"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "24": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 16,
            "WhatReliabilityReliable": 16,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 25,
            "WhoReliabilityReliable": 24,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 1,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 1,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 6,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 6,
            "WhoRoleSubject": 18,
            "WhoRoleTarget": 7,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nEl Gobierno de Madrid es el único que en el Consejo Interterritorial de Salud votó en contra de suspender el uso de esta vacuna en menores de 60 años\n\n<PARAGRAPH>\n\nEl Gobierno de la Comunidad de Madrid ha justificado este miércoles su oposición a suspender el uso de la vacuna de AstraZeneca en menores de 60 años —en este momento del proceso de vacunación, la mayoría de ellos es personal esencial, como docentes o policías— con el argumento de que esa decisión, adoptada con su único voto en contra en el Consejo Interterritorial de Salud, “no está basada en las conclusiones del Comité para la Evaluación de Riesgos en Farmacovigilancia Europeo (PRAC)”.\n\n<PARAGRAPH>\n\nEl Gobierno central y las autonomías volvieron el miércoles a revisar la estrategia de inmunización contra el coronavirus con este medicamento después de que la Agencia Europea del Medicamento (EMA, por sus siglas en inglés) encontrase “posibles vínculos” entre los casos de trombos y la administración de la vacuna.\n\n<BREAK>\n\nAunque la Agencia Europea del Medicamento concluyó que los beneficios siguen siendo mayores que los riesgos y evitó fijar una limitación de edad, Sanidad propuso, tras reunirse con sus homólogos europeos, limitar su uso en este grupo de edad apelando al “principio de precaución”.\n\n<BREAK>\n\nSegún fuentes presentes en la reunión del Consejo Interterritorial, la inmensa mayoría de las autonomías fueron favorables a las propuestas del ministerio.\n\n<BREAK>\n\nSolo el País Vasco y Ceuta se abstuvieron, y la Comunidad de Madrid se posicionó en contra.\n\n<PARAGRAPH>\n\n“No obstante, por precaución y a la espera de una comunicación oficial del ministerio, la Consejería de Sanidad procederá a anular la cita a las personas que tenían que ir a vacunarse” este jueves por la tarde, ha precisado un portavoz de este departamento.\n\n<BREAK>\n\n“Son un total de 600 personas, entre profesores, bomberos y otro personal de emergencias, así como miembros de las Fuerzas y Cuerpos de Seguridad del Estado, que estaban todavía pendientes de vacunar”, ha añadido.\n\n<PARAGRAPH>\n\nEl Ejecutivo regional, sin embargo, no ha detallado cuál será su decisión definitiva después de este jueves.\n\n<BREAK>\n\nHasta la fecha, la Comunidad de Madrid ha recibido 452.500 dosis de la vacuna de AstraZeneca, que ha empleado mayoritariamente en vacunar a policías, profesores y profesionales de protección civil.\n\n<PARAGRAPH>\n\n“Lo que no se puede hacer es cambiar de criterio, dar palos de ciego y crear inseguridad constantemente”, ha dicho la presidenta regional, Isabel Díaz Ayuso, en una entrevista en Onda Madrid.\n\n<BREAK>\n\n“Lo que no se puede es cambiar a mitad de la partida cuando tantísima gente ya está vacunada, cuando ya por fin empieza a ver un poco de claridad en qué vacunas son, para qué grupos, y volver a cambiar otra vez”.\n\n<PARAGRAPH>\n\nLa dirigente del PP también ha anunciado que próximamente se vacunará en 10 hospitales públicos, que se unirán a los centros de vacunación instalados en el hospital Enfermera Isabel Zendal, en el Wanda Metropolitano y el antiguo Palacio de los Deportes (que abre sus puertas el viernes).\n\n<BREAK>\n\nAdemás, ha dicho Díaz Ayuso, cuando haya vacunas suficientes también se abrirán los centros de salud durante los fines de semana.\n\n<BREAK>\n\nEn total, la Comunidad de Madrid espera vacunar a 290.000 personas esta semana, más de 50.000 al día, ha dicho la presidenta regional.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Ayuso, sobre AstraZeneca: “No se puede cambiar de criterio, dar palos de ciego y crear inseguridad”",
        "ID": "F_04-11-2021_20-55-34_elpais_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Ayuso, sobre AstraZeneca: “No se puede cambiar de criterio, dar palos de ciego y crear inseguridad”",
                "text_en": "Ayuso, on AstraZeneca: “You can’t change your mind, beat the blind and create insecurity”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ayuso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ayuso"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Gobierno de Madrid es el único que en el Consejo Interterritorial de Salud votó en contra de suspender el uso de esta vacuna en menores de 60 años",
                "text_en": "The Government of Madrid is the only one that voted in the Interterritorial Health Council against suspending the use of this vaccine in children under 60 years of age.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Government of Madrid"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es el único que en el Consejo Interterritorial de Salud votó en contra de suspender el uso de esta vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is the only one who in the Interterritorial Health Council voted against suspending the use of this vaccine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Consejo Interterritorial de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the Interterritorial Health Council"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en menores de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in children under 60 years of age"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Gobierno de la Comunidad de Madrid ha justificado este miércoles su oposición a suspender el uso de la vacuna de AstraZeneca en menores de 60 años —en este momento del proceso de vacunación, la mayoría de ellos es personal esencial, como docentes o policías— con el argumento de que esa decisión, adoptada con su único voto en contra en el Consejo Interterritorial de Salud, “no está basada en las conclusiones del Comité para la Evaluación de Riesgos en Farmacovigilancia Europeo (PRAC)”.",
                "text_en": "The Government of the Community of Madrid has justified on Wednesday its opposition to suspend the use of AstraZeneca vaccine in children under 60 years of age — at this time in the vaccination process, most of them are essential personnel, as teachers or police officers — on the grounds that this decision, taken with its sole vote against in the Interterritorial Health Council, “is not based on the conclusions of the Committee for the Evaluation of Risks in European Pharmacovigilance (PRAC)”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno de la Comunidad de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Government of the Community of Madrid"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha justificado este miércoles su oposición a suspender el uso de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has justified this Wednesday its opposition to suspend the use of the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Wednesday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en menores de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in children under 60 years of age"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "no está basada en las conclusiones del Comité para la Evaluación de Riesgos en Farmacovigilancia Europeo (PRAC)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is not based on the conclusions of the Committee for the Evaluation of Risks in European Pharmacovigilance (PRAC)"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Comité para la Evaluación de Riesgos en Farmacovigilancia Europeo (PRAC)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Committee for the Evaluation of Risks in European Pharmacovigilance (PRAC)"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Gobierno central y las autonomías volvieron el miércoles a revisar la estrategia de inmunización contra el coronavirus con este medicamento después de que la Agencia Europea del Medicamento (EMA, por sus siglas en inglés) encontrase “posibles vínculos” entre los casos de trombos y la administración de la vacuna.",
                "text_en": "The central government and autonomies again reviewed the coronavirus immunization strategy with this medicine on Wednesday after the European Medicines Agency (EMA) found “possible links” between thrombus cases and vaccine administration.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno central y las autonomías",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Central government and self-government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "volvieron el miércoles a revisar la estrategia de inmunización contra el coronavirus con este medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "back on Wednesday to review the immunization strategy against coronavirus with this medication"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Wednesday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "encontrase “posibles vínculos” entre los casos de trombos y la administración de la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "finding “possible links” between thrombus cases and vaccine administration"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aunque la Agencia Europea del Medicamento concluyó que los beneficios siguen siendo mayores que los riesgos y evitó fijar una limitación de edad, Sanidad propuso, tras reunirse con sus homólogos europeos, limitar su uso en este grupo de edad apelando al “principio de precaución”.",
                "text_en": "Although the European Medicines Agency concluded that the benefits are still greater than the risks and avoided setting an age limitation, Health proposed, after meeting with its European counterparts, limiting its use in this age group by appealing to the “precautionary principle”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "concluyó que los beneficios siguen siendo mayores que los riesgos y evitó fijar una limitación de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "concluded that the benefits are still higher than the risks and avoided setting an age limit"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras reunirse con sus homólogos europeos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after meeting with their European counterparts"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "homólogos europeos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "European counterparts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "limitar su uso en este grupo de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "limit its use in this age group"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "principio de precaución",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "precautionary principle"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según fuentes presentes en la reunión del Consejo Interterritorial, la inmensa mayoría de las autonomías fueron favorables a las propuestas del ministerio.",
                "text_en": "According to sources present at the meeting of the Interterritorial Council, the vast majority of the autonomies were in favour of the ministry's proposals.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la inmensa mayoría de las autonomías",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vast majority of autonomies"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fueron favorables a las propuestas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "were in favour of the proposals"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del ministerio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Solo el País Vasco y Ceuta se abstuvieron, y la Comunidad de Madrid se posicionó en contra.",
                "text_en": "Only the Basque Country and Ceuta abstained, and the Community of Madrid stood against it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el País Vasco y Ceuta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Basque Country and Ceuta"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se abstuvieron",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "abstained"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Comunidad de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Community of Madrid"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se posicionó en contra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stood against"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“No obstante, por precaución y a la espera de una comunicación oficial del ministerio, la Consejería de Sanidad procederá a anular la cita a las personas que tenían que ir a vacunarse” este jueves por la tarde, ha precisado un portavoz de este departamento.",
                "text_en": "“However, as a precaution and pending an official communication from the ministry, the Department of Health will proceed to cancel the appointment to the people who had to go to get vaccinated” this Thursday afternoon, a spokesman for this department said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por precaución y a la espera de una comunicación oficial del ministerio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as a precaution and awaiting official communication from the Ministry"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Consejería de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Department of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "procederá a anular la cita",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "proceed to cancel the appointment"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las personas que tenían que ir a vacunarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to people who had to go to get vaccinated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un portavoz de este departamento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a spokesman for this department"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Ejecutivo regional, sin embargo, no ha detallado cuál será su decisión definitiva después de este jueves.",
                "text_en": "The regional executive, however, has not detailed what its final decision will be after this Thursday.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Ejecutivo regional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Regional Executive"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no ha detallado cuál será su decisión definitiva",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has not detailed what its final decision will be"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hasta la fecha, la Comunidad de Madrid ha recibido 452.500 dosis de la vacuna de AstraZeneca, que ha empleado mayoritariamente en vacunar a policías, profesores y profesionales de protección civil.",
                "text_en": "To date, the Community of Madrid has received 452,500 doses of the AstraZeneca vaccine, which it has used mostly to vaccinate police, teachers and civil protection professionals.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Comunidad de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Community of Madrid"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha recibido 452.500 dosis de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you have received 452,500 doses of the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "policías, profesores y profesionales de protección civil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Police, teachers and civil protection professionals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Lo que no se puede hacer es cambiar de criterio, dar palos de ciego y crear inseguridad constantemente”, ha dicho la presidenta regional, Isabel Díaz Ayuso, en una entrevista en Onda Madrid.",
                "text_en": "“What you can’t do is change your mind, beat the blind and create insecurity constantly,” said regional president Isabel Díaz Ayuso in an interview in Onda Madrid.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "crear inseguridad constantemente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "constantly create insecurity"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la presidenta regional, Isabel Díaz Ayuso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the regional president, Isabel Díaz Ayuso"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una entrevista en Onda Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an interview in Onda Madrid"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La dirigente del PP también ha anunciado que próximamente se vacunará en 10 hospitales públicos, que se unirán a los centros de vacunación instalados en el hospital Enfermera Isabel Zendal, en el Wanda Metropolitano y el antiguo Palacio de los Deportes (que abre sus puertas el viernes).",
                "text_en": "The PP leader has also announced that she will soon be vaccinated in 10 public hospitals, which will join the vaccination centers installed at Nurse Isabel Zendal Hospital, in the Metropolitan Wanda and the former Sports Palace (which opens on Friday).",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La dirigente del PP",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The PP leader"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha anunciado que próximamente se vacunará",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "announced that he will be vaccinated soon"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "próximamente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Soon"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en 10 hospitales públicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in 10 public hospitals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En total, la Comunidad de Madrid espera vacunar a 290.000 personas esta semana, más de 50.000 al día, ha dicho la presidenta regional.",
                "text_en": "In total, the Community of Madrid hopes to vaccinate 290,000 people this week, more than 50,000 a day, said the regional president.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Comunidad de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Community of Madrid"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "espera vacunar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "wait to vaccinate"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a 290.000 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "290,000 persons"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "esta semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this week"
                    }
                ],
                "evidences": [
                    {
                        "value": "This paper is focused on two regions in Spain. Castilla-Leon is the largest Community in Spain by area and is located in the northwest part of Spain, with a population of 2.5 million. The Community of Madrid is located in the central part of Spain and has a population of around 6.8 million, and it is home of the capital of the country, Madrid City, with 3.3 million inhabitants.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9988969564
                    }
                ]
            }
        ]
    },
    "25": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 17,
            "WhatReliabilityReliable": 17,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 17,
            "WhoReliabilityReliable": 17,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 12,
            "WhenReliabilityReliable": 12,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 4,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 3,
            "WhoRoleSubject": 12,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nLa Agencia Europea del Medicamento (EMA) recibió este martes una solicitud oficial de la farmacéutica filial de la estadounidense Johnson & Johnson\n\n<PARAGRAPH>\n\nLa Agencia Europea del Medicamento (EMA) recibió este martes una solicitud oficial de la farmacéutica Janssen, filial de la estadounidense Johnson & Johnson.\n\n<BREAK>\n\nEl objetivo es estudiar la posibilidad de que la Comisión Europea le dé una licencia de uso condicional de su vacuna contra la covid-19 en la Unión Europea.\n\n<PARAGRAPH>\n\nEl regulador europeo, que aprobó hasta ahora a las vacunas de Pfizer/BioNTech, Moderna y AstraZeneca, estudiará esta petición \"según un calendario acelerado\".\n\n<BREAK>\n\nEn diciembre ya empezó a analizar en tiempo real los datos sobre la eficacia, la seguridad y la calidad de la vacuna de Janssen contra el SARS-CoV-2.\n\n<PARAGRAPH>\n\nEl comité de medicamentos humanos (CHMP) espera poder concluir el análisis de todo el paquete de datos de este antídoto \"a mediados de marzo\", concretamente esperan dar luz verde el 8 de marzo.  La condición es que la información presentada por la empresa sea siempre \"lo suficientemente completa y sólida\" como para aceptar su uso en todos los países europeos al mismo tiempo y en las mismas condiciones.\n\n<PARAGRAPH>\n\nEl pasado 1 de diciembre, el CHMP comenzó lo que se conoce como una “revisión continua” del fármaco.\n\n<BREAK>\n\nSe trata de una herramienta que permite analizar los datos de laboratorio y los clínicos a medida que vayan estando disponibles: los ingredientes, el proceso de producción, los ensayos en animales y la información preliminar de los ensayos en personas.\n\n<PARAGRAPH>\n\nDurante esa fase, la EMA también evaluó los datos de la calidad y los de estudios de laboratorio para determinar cómo funciona la vacuna a la hora de desencadenar la producción de anticuerpos y células inmunes que atacan el virus, además de los datos de seguridad clínica sobre el vector viral del fármaco.\n\n<PARAGRAPH>\n\nActualmente, los científicos europeos están analizando datos adicionales sobre la eficacia y la seguridad de este antídoto.\n\n<BREAK>\n\nTambién la calidad.\n\n<BREAK>\n\nEn el caso de que concluyan que “sus beneficios superan sus riesgos”, la EMA recomendará a la Comisión que emita una autorización de comercialización condicional que permita a la farmacéutica usar su vacuna de la covid-19 en la UE bajo ciertos compromisos.\n\n<PARAGRAPH>\n\nCon la de Janssen, son ya cuatro las solicitudes para una licencia condicional que recibe la EMA desde que estalló la pandemia a principios de 2020.\n\n<BREAK>\n\nLas otras tres lograron su autorización condicional el 21 de diciembre (Pfizer), el 6 de enero (Moderna) y el 29 de enero (AstraZeneca).\n\n<BREAK>\n\nYa están siendo utilizadas en las campañas de vacunación en la UE.\n\n<PARAGRAPH>\n\nEstas farmacéuticas, como ocurrirá con Janssen en el caso de conseguir pasar el escrutinio de la EMA, se han comprometido a seguir analizando durante los próximos años los datos de los ensayos clínicos que han llevado a cabo.\n\n<BREAK>\n\nAdemás, se responsabilizan a vigilar las campañas de vacunación en los diferentes países europeos para detectar cualquier efecto secundario nuevo.\n\n<PARAGRAPH>\n\nAsimismo, La EMA pidió el pasado día 10 a todos los desarrolladores de vacunas contra la covid-19 que investiguen si sus antídotos pueden ofrecer protección suficiente contra las nuevas mutaciones del SARS-CoV-2, como las detectadas en Reino Unido, Sudáfrica y Brasil.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Janssen pide a la UE la aprobación de la vacuna de una sola dosis que acelerará la inmunización",
        "ID": "4_F_04-11-2021_21-15-55_www_lavanguardia_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Janssen pide a la UE la aprobación de la vacuna de una sola dosis que acelerará la inmunización",
                "text_en": "Janssen asks the EU to approve a single-dose vaccine that will speed up immunization",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Janssen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Janssen"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EU"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aprobación de la vacuna de una sola dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "single-dose vaccine approval"
                    }
                ],
                "evidences": [
                    {
                        "value": "Oxford/AstraZeneca vaccine requires two doses, while the Janssen vaccine is authorized for use as a single dose vaccine. At present, only the Janssen vaccine has EUA for use in the U.S for individuals aged 18 years or older. [45] . 2%], all of which generally resolve within a day or two. The severity of these symptoms is noted to be considerably less than the mRNAbased vaccines. On rare occasions, Janssen vaccine can cause radiculitis and Guillain-Barre syndrome. Other rare, albeit serious, potentially life-threatening cases of thrombosis with thrombocytopenia syndrome (TTS) have been noted following the Janssen COVID-19 vaccine [46] . Interestingly, all the 15 reported cases (after 7.98 million vaccine doses) have been reported in females. Pregnancy, hormone therapy, or birth control pills are pre-existing risk factors for thrombosis [47] . Therefore, it is advisable to counsel women younger than 50 years old about the increased risk of thrombosis with the Janssen vaccine [48] . The salient features of the Moderna, Pfizer-BioNTech, and Janssen vaccines are summarized in Table 1 . ",
                        "score": 0.6700000167
                    },
                    {
                        "value": "Gegen SARS-CoV-2 sind in der EU bisher vier Impfstoffe zugelassen. Es handelt sich dabei um zwei mRNA-Impfstoffe (Comirnaty der Firma BioNTech/Pfizer und Spikevax der Firma Moderna) sowie zwei vektorbasierte Impfstoffe (Vaxzevria der Firma AstraZeneca und COVID-19 Vaccine Janssen der Firma Janssen Cilag International). Die COVID-19 Vaccine Janssen ist derzeit als einmalige Impfung zugelassen, die Wirksamkeit eines 2-Dosen-Schemas ist derzeit unter Prüfung [20] .",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9725571871
                    },
                    {
                        "label": "neutral",
                        "score": 0.98810184
                    }
                ]
            },
            {
                "text": "La Agencia Europea del Medicamento (EMA) recibió este martes una solicitud oficial de la farmacéutica filial de la estadounidense Johnson & Johnson",
                "text_en": "The European Medicines Agency (EMA) received an official application on Tuesday from the US subsidiary pharmaceutical company Johnson & Johnson",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Europea del Medicamento (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recibió este martes una solicitud oficial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "received an official request this Tuesday"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este martes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Tuesday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la farmacéutica filial de la estadounidense Johnson & Johnson",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the pharmaceutical subsidiary of the American Johnson & Johnson"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Agencia Europea del Medicamento (EMA) recibió este martes una solicitud oficial de la farmacéutica Janssen, filial de la estadounidense Johnson & Johnson.",
                "text_en": "The European Medicines Agency (EMA) received an official application on Tuesday from the pharmaceutical company Janssen, a subsidiary of Johnson & Johnson.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Europea del Medicamento (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recibió este martes una solicitud oficial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "received an official request this Tuesday"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este martes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Tuesday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la farmacéutica Janssen, filial de la estadounidense Johnson & Johnson",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the pharmaceutical company Janssen, subsidiary of the American Johnson & Johnson"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El objetivo es estudiar la posibilidad de que la Comisión Europea le dé una licencia de uso condicional de su vacuna contra la covid-19 en la Unión Europea.",
                "text_en": "The aim is to explore the possibility of the European Commission giving you a conditional use license for your covid-19 vaccine in the European Union.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Comisión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Commission"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "una licencia de uso condicional de su vacuna contra la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a conditional use license for your covid-19 vaccine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Unión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the European Union"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El regulador europeo, que aprobó hasta ahora a las vacunas de Pfizer/BioNTech, Moderna y AstraZeneca, estudiará esta petición \"según un calendario acelerado\".",
                "text_en": "The European regulator, who so far approved Pfizer/BioNTech, Moderna and AstraZeneca vaccines, will study this petition \"according to an accelerated schedule\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El regulador europeo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European regulator"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estudiará esta petición",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will consider this request"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En diciembre ya empezó a analizar en tiempo real los datos sobre la eficacia, la seguridad y la calidad de la vacuna de Janssen contra el SARS-CoV-2.",
                "text_en": "In December, it began to analyze in real time the data on the efficacy, safety and quality of the Janssen vaccine against SARS-CoV-2.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "December"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "empezó a analizar en tiempo real los datos sobre la eficacia, la seguridad y la calidad de la vacuna de Janssen contra el SARS-CoV-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "started to analyze in real time data on the efficacy, safety and quality of Janssen vaccine against SARS-CoV-2"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El comité de medicamentos humanos (CHMP) espera poder concluir el análisis de todo el paquete de datos de este antídoto \"a mediados de marzo\", concretamente esperan dar luz verde el 8 de marzo.  La condición es que la información presentada por la empresa sea siempre \"lo suficientemente completa y sólida\" como para aceptar su uso en todos los países europeos al mismo tiempo y en las mismas condiciones.",
                "text_en": "The Human Medicines Committee (CHMP) hopes to be able to complete the analysis of the entire data package of this antidote \"in mid-March\", specifically expect to give the green light on 8 March. The condition is that the information presented by the company is always \"complete and solid enough\" to accept its use in all European countries at the same time and under the same conditions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El comité de medicamentos humanos (CHMP)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Human Medicines Committee (CHMP)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "espera poder concluir el análisis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "hopes to be able to conclude the analysis"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "\"a mediados de marzo\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "\"in mid-March\""
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la información presentada por la empresa sea siempre \"lo suficientemente completa y sólida\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the information submitted by the company is always \"complete and solid enough\""
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la empresa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the company"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en todos los países europeos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in all European countries"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "al mismo tiempo y en las mismas condiciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the same time and under the same conditions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El pasado 1 de diciembre, el CHMP comenzó lo que se conoce como una “revisión continua” del fármaco.",
                "text_en": "On December 1, the CHMP began what is known as a “continuous review” of the drug.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El pasado 1 de diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last December 1st"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el CHMP",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the CHMP"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "“revisión continua” del fármaco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "“continuous review” of the drug"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se trata de una herramienta que permite analizar los datos de laboratorio y los clínicos a medida que vayan estando disponibles: los ingredientes, el proceso de producción, los ensayos en animales y la información preliminar de los ensayos en personas.",
                "text_en": "It is a tool that allows analysis of laboratory and clinical data as they become available: ingredients, production process, animal trials and preliminary data from human trials.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "analizar los datos de laboratorio y los clínicos a medida que vayan estando disponibles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "analyze laboratory and clinical data as they become available"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Durante esa fase, la EMA también evaluó los datos de la calidad y los de estudios de laboratorio para determinar cómo funciona la vacuna a la hora de desencadenar la producción de anticuerpos y células inmunes que atacan el virus, además de los datos de seguridad clínica sobre el vector viral del fármaco.",
                "text_en": "During this phase, the EMA also evaluated quality data and those from laboratory studies to determine how the vaccine works when triggering the production of antibodies and immune cells that attack the virus, in addition to clinical safety data on the viral vector of the drug.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Durante esa fase",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "During this phase"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "evaluó los datos de la calidad y los de estudios de laboratorio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "evaluated quality data and those from laboratory studies"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "determinar cómo funciona la vacuna a la hora de desencadenar la producción de anticuerpos y células inmunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "determine how the vaccine works when triggering the production of antibodies and immune cells"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "los datos de seguridad clínica sobre el vector viral del fármaco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "clinical safety data on the viral vector of the drug"
                    }
                ],
                "evidences": [
                    {
                        "value": "In the EMA product information report of the AstraZeneca COVID-19 vaccine, the overall safety was based on pooled data of 23,745 participants from the United Kingdom (UK), Brazil and South Africa. The data after the first and second dose were not analyzed separately (about half were vaccinated with one dose), and the time after the vaccination is underreported as well in the EMA report [9] . The injection site tiredness was the most commonly reported local SE (63.7%) in the EMA report, although it was not solicited in this study's questionnaire. Injection site pain was found more frequently in our European sample (72.8%) compared to the EMA report (54.2%). Moreover, injection site swelling (10.9%) and injection site redness (10.9%) were solicited in our study; however, they were not reported by the manufacturer. Compared with the CDC report on Pfizer-BioNTech COVID-19 vaccine, the injection site redness and swelling were slightly more prevalent among our participants who received the AstraZeneca vaccine [29] .",
                        "score": 0.5199999809
                    },
                    {
                        "value": "In infection research recombinant MVA viruses serve as candidate vaccines compatible with clinical use and industrial-scale production (for review see Volz, 2016 Adv Virus Res, in press) . The data quality required before initiating clinical trials include evaluation of the phenotypic properties of the vaccine virus preparations (European Medicines Agency. 2010. Guideline on quality, non-clinical and clinical aspects of live recombinant viral vectored vaccines. EMA/CHMP/VWP/141697/2009).",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9953393936
                    },
                    {
                        "label": "neutral",
                        "score": 0.9733434916
                    }
                ]
            },
            {
                "text": "Actualmente, los científicos europeos están analizando datos adicionales sobre la eficacia y la seguridad de este antídoto.",
                "text_en": "European scientists are currently analysing additional data on the efficacy and safety of this antidote.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los científicos europeos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "European scientists"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están analizando datos adicionales sobre la eficacia y la seguridad de este antídoto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are analysing additional data on the efficacy and safety of this antidote"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Con la de Janssen, son ya cuatro las solicitudes para una licencia condicional que recibe la EMA desde que estalló la pandemia a principios de 2020.",
                "text_en": "With Janssen's, there are already four applications for a conditional license that the EMA has received since the pandemic broke out in early 2020.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "son ya cuatro las solicitudes para una licencia condicional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There are already four applications for a conditional license"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde que estalló la pandemia a principios de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since the pandemic broke out in early 2020"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las otras tres lograron su autorización condicional el 21 de diciembre (Pfizer), el 6 de enero (Moderna) y el 29 de enero (AstraZeneca).",
                "text_en": "The other three obtained their conditional authorization on 21 December (Pfizer), 6 January (Modern) and 29 January (AstraZeneca).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las otras tres lograron su autorización condicional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The other three obtained their conditional authorization."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 21 de diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 21 December"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 6 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 6 January"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 29 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 29 January"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ya están siendo utilizadas en las campañas de vacunación en la UE.",
                "text_en": "They are already being used in vaccination campaigns in the EU.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están siendo utilizadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are being used"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las campañas de vacunación en la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in vaccination campaigns in the EU"
                    }
                ],
                "evidences": [
                    {
                        "value": "The Commission's assertive role in providing EU-wide medical countermeasures throughout 2021 served as a sketch of the first vague contours of an EHU in action-and the emergence of a comprehensive post-Westphalian health governance structure. The Commission's EU-wide procurement of Covid-19 vaccines, their collective approval through the EMA, the build-up of EU-wide capacities for the production of these vaccines, and their adaption to new variants of the virus underscored that such an international health crisis could be successfully tackled through a post-Westphalian governance structure with the Commission at the head. These medical countermeasures have helped to keep vaccine nationalism among EU member states at a minimum, avoiding aggravating the health crisis even further, and has put the EU and EU member states into the lead with respect to global vaccination efforts. At the global level, neither WHO nor its global coordination mechanisms, such as the COVAX vaccine facility, have been able to ease vaccine nationalism among governments worldwide, thus exacerbating the crisis.",
                        "score": 0.5
                    },
                    {
                        "value": "On 21 December 2020, the European Medicines Agency (EMA) announced their decision on the conditional marketing authorization for the first coronavirus disease 2019 vaccine in the European Union (EU) [1] . This decision allowed the implementation of vaccination programs against COVID-19 in the EU Member States. According to the EU Vaccines Strategy, the EU Member States launched the joint purchase of COVID-19 vaccines to secure supplies and facilitate the rollout of vaccines [2] . The European Commission has signed the Advance Purchase Agreements with individual COVID-19 vaccine producers on behalf of Member States, wherein the volume of orders was proportional to the number of inhabitants of individual EU Member States [3] . According to the EU Vaccines Strategy, by summer 2021, Member States should have vaccinated a minimum of 70% of the entire adult population, in order to achieve herd immunity [2] [3] [4] . While vaccine deliveries depended on the EU Agreements, the organization of COVID-19 vaccination programs, methods of promotion as well as priority groups for COVID-19 vaccination differed between EU Member States [2, 4] .",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9966486096
                    },
                    {
                        "label": "neutral",
                        "score": 0.9891520739
                    }
                ]
            },
            {
                "text": "Estas farmacéuticas, como ocurrirá con Janssen en el caso de conseguir pasar el escrutinio de la EMA, se han comprometido a seguir analizando durante los próximos años los datos de los ensayos clínicos que han llevado a cabo.",
                "text_en": "These pharmaceuticals, as will happen with Janssen in the case of passing the EMA scrutiny, have undertaken to continue to analyze over the next few years the data from the clinical trials they have carried out.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Estas farmacéuticas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "These pharmaceuticals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han comprometido a seguir analizando durante los próximos años los datos de los ensayos clínicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "committed to further analysing clinical trial data over the next few years"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante los próximos años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over the next few years"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, se responsabilizan a vigilar las campañas de vacunación en los diferentes países europeos para detectar cualquier efecto secundario nuevo.",
                "text_en": "In addition, they are responsible for monitoring vaccination campaigns in different European countries to detect any new side effects.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se responsabilizan a vigilar las campañas de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are responsible for monitoring vaccination campaigns"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los diferentes países europeos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the different European countries"
                    }
                ],
                "evidences": [
                    {
                        "value": "Historically, vaccination campaigns and, in particular, the one against the ongoing pandemic represent the most efficient cornerstone in achieving potential public health goals [12] . Reduction of pressure on the healthcare system, reduction of overall COVID-19 severity and mortality, re-opening of society, and disease eradication are four main potential targets related to COVID-19 vaccination campaign. Notwithstanding, the strategy behind vaccination campaigns requires efficient and effective planning, coordination, and cooperation between the national and regional health bodies, allowing a unified and centralized response to the country's immunization plan.",
                        "score": 0.5899999738
                    },
                    {
                        "value": "For example, data from the University of Oxford's Our World Data database [18] show that 80 out of 189 countries have started their internal vaccination campaigns, which raises the debate on the central reasons for this non-equal distribution and highlights the importance of the country's engagement in enabling access to immunization. Thus, this study aimed to identify the determinants that influence access to the SARS-CoV-2 vaccine by different countries and, consequently, public health during the Covid-19 epidemic.",
                        "score": 0.5899999738
                    },
                    {
                        "value": "Collective Responsibility, i.e., the willingness to protect others by getting vaccinated, are the 472 strongest predictors of COVID-19 vaccination intention. This suggests that campaigns targeted at 473 increasing vaccination intention among young adults will likely be most successful when focused 474 on enhancing the levels of both Confidence and Collective Responsibility. Smaller negative links 475 are present between vaccination intention and Complacency, Constraints, and Calculation. 476 Psychological profiles underlying COVID-19 vaccination intention 477 We show that psychological profiles indeed play an important role in explaining vaccination 478 intention. As vaccination campaigns will most likely be most successful when targeted at 479",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9944116473
                    },
                    {
                        "label": "neutral",
                        "score": 0.9992464781
                    },
                    {
                        "label": "neutral",
                        "score": 0.9313674569
                    }
                ]
            },
            {
                "text": "Asimismo, La EMA pidió el pasado día 10 a todos los desarrolladores de vacunas contra la covid-19 que investiguen si sus antídotos pueden ofrecer protección suficiente contra las nuevas mutaciones del SARS-CoV-2, como las detectadas en Reino Unido, Sudáfrica y Brasil.",
                "text_en": "In addition, the EMA asked on the 10th of last day all covid-19 vaccine developers to investigate whether their antidotes can provide sufficient protection against new SARS-CoV-2 mutations, such as those detected in the UK, South Africa and Brazil.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The EMA"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado día 10",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last day 10"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a todos los desarrolladores de vacunas contra la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to all developers of covid-19 vaccines"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "investiguen si sus antídotos pueden ofrecer protección suficiente contra las nuevas mutaciones del SARS-CoV-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "investigate whether your antidotes can provide sufficient protection against new SARS-CoV-2 mutations"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Sudáfrica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "South Africa"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Brazil"
                    }
                ],
                "evidences": [
                    {
                        "value": "Gamaleya, CanSino Biologics were approved and used in clinical settings. These vaccines were reported to induce robust humoral and cellular immune responses, similar to those reported for mRNA vaccines [32] . Therefore, this type of vaccine may be effective against new SARS-CoV-2 variants such as those isolated in India, Brazil, South Africa, and UK. Another advantage this vaccine modality has over mRNA vaccines is its stability, which makes it easier to handle and store.",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9955193996
                    }
                ]
            }
        ]
    },
    "26": {
        "DATA": {
            "Title": 1,
            "Subtitle": 2,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 9,
            "WhatReliabilityReliable": 9,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 12,
            "WhoReliabilityReliable": 12,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 0,
            "WhereReliabilityReliable": 0,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 4,
            "WhoRoleTarget": 8,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nEl fármaco llegará a España este fin de semana y comenzará a aplicarse a los profesionales sanitarios y sociosanitarios en activo no incluidos en la primera fase de vacunación\n\n<BREAK>\n\n— Las sorpresas positivas de la vacuna de AstraZeneca a la espera de resultados concluyentes sobre su eficacia en mayores de 55 años\n\n<BREAK>\n\nLa Comisión de Salud Pública ha decidido que la vacuna de AstraZeneca se administrará solo a la población comprendida entre los 18 y los 55 años de edad, según ha podido confirmar elDiario.es. \n\n<BREAK>\n\nSanidad ya había anunciado este miércoles que los mayores de 80 no iban a recibir esta vacuna desarrollada en colaboración con la Universidad de Oxford.\n\n<BREAK>\n\nA las personas de este grupo de edad –mayores de 80 años– solo se les inyectarán vacunas de otro tipo, las denominadas de 'ARN mensajero', cuya eficacia sí ha sido probada.\n\n<BREAK>\n\nLa razón para dejar fuera de la aplicación de la vacuna de AstraZeneca a los más mayores es que durante las pruebas no fueron lo suficientemente representativas las muestras de población de esas edades, por lo que no se tienen garantías de que el fármaco sea lo bastante efectivo en ciudadanos de esas franjas de edad.\n\n<BREAK>\n\nPor este mismo motivo ayer jueves Sanidad ya había decidido también no administrar a mayores de 65 años la vacuna de AstraZeneca. \n\n<BREAK>\n\nQueda la duda de qué vacuna recibirán los mayores de 55 años, si también serán las llamadas de 'ARN mensajero', como la de Moderna o Pfizer, o nuevas vacunas todavía por aprobar.\n\n<BREAK>\n\nEspaña sigue así la estela de otros países del entorno europeo, como Alemania y Francia, que ya han descartado la aplicación de la vacuna. \n\n<BREAK>\n\nLa llegada de las vacunas a España se produce tras su reciente autorización de comercialización para adultos mayores de 18 años por parte Agencia Europea del Medicamento (EMA) y la aprobación de la Comisión Europea.\n\n<BREAK>\n\nEstos cambios en el plan desencadenarán novedades en cuanto a los grupos prioritarios de inmunización, que hasta ahora eran los residentes y trabajadores de residencias y los sanitarios de primera línea. \n\n<BREAK>\n\nEn la sesión de este jueves de la Comisión de Salud Pública se ha acordado que la vacuna de AstraZeneca, que comienza a llegar este fin de semana, se inyectará en primer lugar a los profesionales sanitarios y sociosanitarios en activo no incluidos en los anteriores grupos (2 y 3).\n\n<BREAK>\n\nDel mismo modo, se ha aprobado que el intervalo recomendado en su administración sea de, 10 a 12 semanas, entre la primera y segunda dosis, tal y como adelantó la ministra de Sanidad, Carolina Darias.",
        "TITLE": "Sanidad no administrará la vacuna de AstraZeneca a mayores de 55 años",
        "ID": "15-Eldiario",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Sanidad no administrará la vacuna de AstraZeneca a mayores de 55 años",
                "text_en": "Health will not administer the AstraZeneca vaccine to people over 55 years of age",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no administrará la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you will not administer the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a mayores de 55 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 55 years of age"
                    }
                ],
                "evidences": [
                    {
                        "value": "The question about what preparation the vaccinated respondents were with was answered by 1577 people out of 1657 respondents (80 people did not answer this question). Most of the subjects from group zero, as expected, were vaccinated with the preparation of the company Pfizer 94.9% (1497), AstraZeneca 3.9% (61) and Moderna 1.2% (19) . When asked with the option to add another proposed answer about the possibility of choosing a vaccine preparation, 90.2% (1429) would choose the Pfizer vaccine, 3.8% (60) Moderna, 1.3% (20) AstraZeneca. This question was answered by 1585 respondents out of 1657 people who filled out the questionnaire. There were also responses that \"I would get vaccinated with any single-dose vaccine\" (12), or \"it didn't matter\" (35). When asked what technology the vaccine against COVID-19 is based on, 1595 respondents were answered that the Pfizer and Moderna vaccine is an mRNA vaccine on the S protein, and vaccination with this preparation in this technology marked 89.3% (1425). The previous question shows that 1513 people were vaccinated with these preparations. The AstraZeneca vaccine is a vector vaccine based on the adenovirus S protein, and vaccination with the preparation obtained in this technology was indicated by 68 people (4.3%) in this question, while in the closed question about vaccination with AstraZeneca preparation, 61 people indicated vaccination with this preparation. In addition, 6.4% of people, or 102 people, do not know what technology the vaccine was based on. A total of 1596 people answered this question, while 1602 people were vaccinated, so 6 people abstained from answering.",
                        "score": 0.5500000119
                    },
                    {
                        "value": "The European Medicines Agency (EMA) has conditionally authorized for marketing the vaccine AstraZeneca to prevent COVID-19 in people aged >18 years on 29 January 2021. Combined results from four clinical trials in the United Kingdom, Brazil, and South Africa demonstrated that this vaccine was safe and effective to prevent the disease. These studies involved around 24,000 people altogether, who received either the vaccine or were given a control injection (i.e., a dummy injection or another non-COVID vaccine), with an overall efficacy of about 70% [68] . As most of the participants in these studies were between 18 and 55 years old, there were not enough results in older participants to provide information for how well the vaccine will work in this group. However, after secondary analyses, the vaccine was considered safe also in people aged >60 and <80.",
                        "score": 0.6899999976
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "entailment",
                        "score": 0.4856559038
                    },
                    {
                        "label": "neutral",
                        "score": 0.99909091
                    }
                ]
            },
            {
                "text": "El fármaco llegará a España este fin de semana y comenzará a aplicarse a los profesionales sanitarios y sociosanitarios en activo no incluidos en la primera fase de vacunación",
                "text_en": "The drug will arrive in Spain this weekend and will begin to apply to healthcare professionals and active health partners not included in the first phase of vaccination",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "comenzará a aplicarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will begin to be implemented"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los profesionales sanitarios y sociosanitarios en activo no incluidos en la primera fase de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health professionals and active health-care partners not included in the first stage of vaccination"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Comisión de Salud Pública ha decidido que la vacuna de AstraZeneca se administrará solo a la población comprendida entre los 18 y los 55 años de edad, según ha podido confirmar elDiario.es. ",
                "text_en": "The Public Health Commission has decided that the AstraZeneca vaccine will only be given to the population aged between 18 and 55 years, as confirmed by the Journal.es.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Comisión de Salud Pública",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Public Health Commission"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha decidido que la vacuna de AstraZeneca se administrará",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has decided that the AstraZeneca vaccine will be administered"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la población comprendida entre los 18 y los 55 años de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "population aged 18 to 55"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A las personas de este grupo de edad –mayores de 80 años– solo se les inyectarán vacunas de otro tipo, las denominadas de 'ARN mensajero', cuya eficacia sí ha sido probada.",
                "text_en": "People in this age group – over 80 years of age – will only be injected with vaccines of another type, the so-called 'messaging RNA', whose efficacy has been proven.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "A las personas de este grupo de edad –mayores de 80 años–",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "To people in this age group – over 80 years –"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "solo se les inyectarán vacunas de otro tipo, las denominadas de 'ARN mensajero'",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "only other vaccines, known as messenger RNAs, will be injected."
                    }
                ],
                "evidences": [
                    {
                        "value": "We identified for each vaccine the total number of ADRs reported in the study period and selected those related to thrombotic events, Table 1 shows the distribution of thrombotic ADRs according to the age group and sex. Overall, the age group <65 was more prevalent among the thrombotic ADRs of adenoviral vector vaccines than among those of mRNA vaccines and the prevalence of female sex was approximately 55% for the four vaccines. CVT events were observed for all vaccines, a lower reporting rate of unusual site thrombosis ADRs was observed for the mRNA compared to the adenoviral vaccines ( Table 2) . CVT events alongside with thrombocytopenia have been reported for all vaccines, ranging from 3-5% to 31-44% for mRNA and adenoviral vaccines, respectively.",
                        "score": 0.5699999928
                    },
                    {
                        "value": "The Italian authorities have used the following vaccination strategy, reserving the mRNA vaccines for health personnel and the population over 80 years old, and the administration of the COVID-19 Vaccine AstraZeneca for law enforcement personnel, school personnel and the population between 70 and 80 years old [9] . A strategy for monitoring adverse events of vaccines is based on the collaboration of local and national health structures, assisted by Italian Medicines Agency (AIFA) [10, 11] . On 15 March 2021, AIFA has decided to suspend temporarily the use of the AstraZeneca Covid19 vaccine throughout the country as a precaution, pending the rulings of the European Medicines Agency (EMA). This decision was taken in line with similar measures adopted by other European countries due to the death of some vaccinated people [10]. On 18 March 2021, EMA's safety committee concluded its preliminary review about thromboembolic events in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting [12] . The Committee confirmed that:",
                        "score": 0.5799999833
                    },
                    {
                        "value": "Investigating explicit vaccination scenarios, we assume that 80% of people getting offered vaccination accept this offer. Since, as of now, none of the available vaccines has been approved for people younger than 16 years, this corresponds to a vaccine uptake of roughly 70% of the overall population (for European demographics). We model the delivery and administration of all doses to be completed within 32 weeks (13), which is comparable to the increasing vaccination rate in the European Union. We investigate two scenarios: that the average vaccine efficacy against transmission is 80%, in line with reported values for current vaccines against the wild type and the widely dominant B.1.1.7 variant (32-34), or 40%, a possible scenario for partially immune-escaping variants.",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9591137171
                    },
                    {
                        "label": "neutral",
                        "score": 0.8985509872
                    },
                    {
                        "label": "neutral",
                        "score": 0.9917634726
                    }
                ]
            },
            {
                "text": "La razón para dejar fuera de la aplicación de la vacuna de AstraZeneca a los más mayores es que durante las pruebas no fueron lo suficientemente representativas las muestras de población de esas edades, por lo que no se tienen garantías de que el fármaco sea lo bastante efectivo en ciudadanos de esas franjas de edad.",
                "text_en": "The reason for leaving out the application of the AstraZeneca vaccine to the older ones is that during the tests population samples of those ages were not sufficiently representative, so there is no guarantee that the drug is effective enough in citizens of these age groups.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dejar fuera de la aplicación de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "leave out the application of the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los más mayores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the older ones"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante las pruebas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during testing"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "durante las pruebas no fueron lo suficientemente representativas las muestras de población de esas edades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "population samples of these ages were not sufficiently representative during the tests"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se tienen garantías de que el fármaco sea lo bastante efectivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there is no guarantee that the drug is effective enough"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en ciudadanos de esas franjas de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in citizens of these age groups"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por este mismo motivo ayer jueves Sanidad ya había decidido también no administrar a mayores de 65 años la vacuna de AstraZeneca. ",
                "text_en": "For the same reason yesterday, Sanidad had decided not to give AstraZeneca vaccine to over 65 years old.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya había decidido también no administrar a mayores de 65 años la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had also decided not to give AstraZeneca vaccine to adults over 65 years of age"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a mayores de 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 65 years of age"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En la sesión de este jueves de la Comisión de Salud Pública se ha acordado que la vacuna de AstraZeneca, que comienza a llegar este fin de semana, se inyectará en primer lugar a los profesionales sanitarios y sociosanitarios en activo no incluidos en los anteriores grupos (2 y 3).",
                "text_en": "At this Thursday's session of the Public Health Committee it has been agreed that the AstraZeneca vaccine, which begins to arrive this weekend, will be injected first to health professionals and active health partners not included in the previous groups (2 and 3).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se inyectará en primer lugar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you will be injected first"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los profesionales sanitarios y sociosanitarios en activo no incluidos en los anteriores grupos (2 y 3)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health professionals and active health partners not included in the above groups (2 and 3)"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Del mismo modo, se ha aprobado que el intervalo recomendado en su administración sea de, 10 a 12 semanas, entre la primera y segunda dosis, tal y como adelantó la ministra de Sanidad, Carolina Darias.",
                "text_en": "Similarly, it has been approved that the recommended dosing interval is 10 to 12 weeks between the first and second doses, as anticipated by the Minister of Health, Carolina Darias.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha aprobado que el intervalo recomendado en su administración sea de, 10 a 12 semanas, entre la primera y segunda dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The recommended dosing interval of 10 to 12 weeks between the first and second doses has been approved."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la ministra de Sanidad, Carolina Darias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Minister of Health, Carolina Darias"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "27": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 14,
            "WhatReliabilityReliable": 14,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 14,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 1,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 8,
            "WhenReliabilityReliable": 8,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 6,
            "HowReliabilityReliable": 6,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 3,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 2,
            "Figure": 4,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nEl Consell no varía la mayoría de las restricciones pero amplía a seis los consumidores en terrazas y a dos los núcleos en espacios privados\n\n<PARAGRAPH>\n\nLa Generalitat valenciana ha acordado mantener la mayoría de restricciones vigentes en la comunidad en lo que respecto al cierre perimetral de la autonomía, el toque de queda a las 22.00 y el cierre de la hostelería a las 18.00.\n\n<BREAK>\n\nLa reunión interdepartamental para la lucha contra la pandemia ha decidido este jueves relajar únicamente las medidas referentes al número de personas permitidas para reuniones en espacios públicos, que pasa de cuatro a seis, tanto en mesas de terrazas como para la práctica de deporte en la calle, y de uno a dos los núcleos familiares en el ámbito privado.\n\n<BREAK>\n\nTambién se flexibilizarán las condiciones para visitar las residencias de mayores inmunizadas porque, salvo algunas excepciones, el 100% de sus usuarios y trabajadores están vacunados.\n\n<BREAK>\n\nEstas nuevas medidas entrarán en vigor el próximo 12 de abril.\n\n<PARAGRAPH>\n\nEl objetivo es, según ha indicado el presidente de la Generalitat, Ximo Puig, estabilizar la buenos datos epidemiológicos que mantienen a la Comunidad valenciana con la incidencia acumulada más baja de España y Europa.\n\n<BREAK>\n\n“Es lo que aconseja el sentido común”, ha justificado Puig que ha apelado a la “cautela”.\n\n<BREAK>\n\nEn el caso de que los se consoliden, Puig ha prometido avanzar en la flexibilización de las restricciones y ha reiterado que “no durarán ni un día más del necesario”.\n\n<PARAGRAPH>\n\nHasta entonces la próxima revisión, el 25 de abril, se mantienen las restricciones actuales: cierre de la hostelería a las seis de la tarde, dos horas antes que el de los comercios no esenciales, con terrazas al 100% de su capacidad e interiores al 30%.\n\n<BREAK>\n\nTambién sigue el toque de queda a las 22 horas.\n\n<PARAGRAPH>\n\nOtro de los argumentos para mantener las restricciones ha sido la tasa de hospitalizados, que se ha reducido a la mitad en tres semanas y la bajada “drástica” de la mortalidad por coronavirus, porque “en los últimos 23 días ha muerto la tercera parte de las personas que en los 23 anteriores”, según ha señalado Puig.\n\n<PARAGRAPH>\n\nPor su parte, la consellera de Sanidad, Ana Barceló, ha confirmado que no hay ninguna citación para vacunar a menores de 60 años con AstraZeneca y ha pedido “tranquilidad” a las personas a las que ya se les ha inoculado porque hay de margen hasta el mes de junio para que los técnicos determinen si es necesaria la segunda dosis ya que estudios actuales cifran la inmunización con solo la primera inyección en un 76%.\n\n<PARAGRAPH>\n\nBarceló, en la rueda de prensa tras la reunión de la mesa interdepartamental, ha corroborado que esta semana no había ninguna cita para vacunar a nadie menor de 60 años con AstraZeneca y, tras el acuerdo de ayer del Consejo Interterritorial de suspender la inoculación por debajo de esa edad, tampoco se llamará a las personas de grupos esenciales en este tramo que quedaban pendientes de ser inoculados.\n\n<BREAK>\n\nEl colectivo de Fuerzas y Cuerpos de Seguridad y de centros docentes han sido los principales colectivos a los que ya se les ha administrado la primera dosis vacuna de AstraZeneca.\n\n<PARAGRAPH>\n\n",
        "TITLE": "La Comunidad Valenciana mantiene el cierre perimetral y la limitación horaria para la hostelería",
        "ID": "F_04-11-2021_20-47-19_elpais_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La Comunidad Valenciana mantiene el cierre perimetral y la limitación horaria para la hostelería",
                "text_en": "The Valencian Community maintains the perimeter closure and the time limit for hospitality",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Comunidad Valenciana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Valencian Community"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mantiene el cierre perimetral y la limitación horaria para la hostelería",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "keeps the perimeter closure and time limitation for the hotel"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Consell no varía la mayoría de las restricciones pero amplía a seis los consumidores en terrazas y a dos los núcleos en espacios privados",
                "text_en": "The Council does not vary most of the restrictions but extends to six consumers on terraces and two cores in private spaces",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Consell",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Consell"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "amplía a seis los consumidores en terrazas y a dos los núcleos en espacios privados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "expands to six the consumers on terraces and to two the cores in private spaces"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en terrazas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on terraces"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en espacios privados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in private spaces"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Generalitat valenciana ha acordado mantener la mayoría de restricciones vigentes en la comunidad en lo que respecto al cierre perimetral de la autonomía, el toque de queda a las 22.00 y el cierre de la hostelería a las 18.00.",
                "text_en": "The Valencian Generalitat has agreed to maintain the majority of restrictions in force in the community regarding the perimeter closure of the autonomy, the curfew at 22.00 and the closure of the hotel at 18.00.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Generalitat valenciana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Valencian Generalitat"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha acordado mantener la mayoría de restricciones vigentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "agreed to maintain most existing restrictions"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la comunidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the community"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "cierre perimetral de la autonomía, el toque de queda a las 22.00 y el cierre de la hostelería a las 18.00",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the perimeter closure of the autonomy, the curfew at 22.00 and the closure of the hotel shop at 18.00"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La reunión interdepartamental para la lucha contra la pandemia ha decidido este jueves relajar únicamente las medidas referentes al número de personas permitidas para reuniones en espacios públicos, que pasa de cuatro a seis, tanto en mesas de terrazas como para la práctica de deporte en la calle, y de uno a dos los núcleos familiares en el ámbito privado.",
                "text_en": "The interdepartmental meeting to combat the pandemic has decided this Thursday to relax only the measures regarding the number of people allowed for meetings in public spaces, which goes from four to six, both at terrace tables and for the practice of sports in the street, and from one to two the family centers in the private sphere.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La reunión interdepartamental para la lucha contra la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The interdepartmental meeting to combat the pandemic"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha decidido este jueves relajar únicamente las medidas referentes al número de personas permitidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has decided this Thursday to relax only the measures regarding the number of people allowed"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Thursday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "reuniones en espacios públicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "meetings in public spaces"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el ámbito privado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the private sector"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También se flexibilizarán las condiciones para visitar las residencias de mayores inmunizadas porque, salvo algunas excepciones, el 100% de sus usuarios y trabajadores están vacunados.",
                "text_en": "The conditions for visiting residences of immunized older persons will also be relaxed because, with some exceptions, 100 per cent of their users and workers are vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se flexibilizarán las condiciones para visitar las residencias de mayores inmunizadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the conditions for visiting the residences of the elderly immunized will be relaxed"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "el 100% de sus usuarios y trabajadores están vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "100% of its users and workers are vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estas nuevas medidas entrarán en vigor el próximo 12 de abril.",
                "text_en": "These new measures will enter into force on 12 April.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estas nuevas medidas entrarán en vigor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "These new measures will enter into force"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el próximo 12 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on April 12"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El objetivo es, según ha indicado el presidente de la Generalitat, Ximo Puig, estabilizar la buenos datos epidemiológicos que mantienen a la Comunidad valenciana con la incidencia acumulada más baja de España y Europa.",
                "text_en": "The objective is, according to the president of the Generalitat, Ximo Puig, to stabilize the good epidemiological data that keep the Valencian Community with the lowest accumulated incidence in Spain and Europe.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el presidente de la Generalitat, Ximo Puig",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the president of the Generalitat, Ximo Puig"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estabilizar la buenos datos epidemiológicos que mantienen a la Comunidad valenciana con la incidencia acumulada más baja",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stabilize the good epidemiological data that keep the Valencian Community with the lowest cumulative incidence"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Europa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Europe"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Es lo que aconseja el sentido común”, ha justificado Puig que ha apelado a la “cautela”.",
                "text_en": "“It’s what common sense advises,” Puig has justified that he has appealed to the “cautela.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Puig",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Puig"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha apelado a la “cautela”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has appealed to the “cautela”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el caso de que los se consoliden, Puig ha prometido avanzar en la flexibilización de las restricciones y ha reiterado que “no durarán ni un día más del necesario”.",
                "text_en": "In the event that they are consolidated, Puig has promised to move forward in the relaxation of the restrictions and has reiterated that “they will not last one day longer than necessary”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Puig",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Puig"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha prometido avanzar en la flexibilización de las restricciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has promised to move forward in the easing of restrictions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hasta entonces la próxima revisión, el 25 de abril, se mantienen las restricciones actuales: cierre de la hostelería a las seis de la tarde, dos horas antes que el de los comercios no esenciales, con terrazas al 100% de su capacidad e interiores al 30%.",
                "text_en": "Until then the next review, on April 25, the current restrictions remain: closure of the hotel shop at six o'clock in the afternoon, two hours before that of the non-essential shops, with terraces at 100% of its capacity and interiors at 30%.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hasta entonces la próxima revisión, el 25 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Until then the next review, April 25"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se mantienen las restricciones actuales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the current restrictions are maintained"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "cierre de la hostelería",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "closure of the hotel"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a las seis de la tarde",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at six o'clock in the afternoon"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con terrazas al 100% de su capacidad e interiores al 30%",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with terraces at 100% of its capacity and interiors at 30%"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También sigue el toque de queda a las 22 horas.",
                "text_en": "It also follows curfew at 22 hours.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sigue el toque de queda",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Follow the curfew"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a las 22 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at 22 hours"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por su parte, la consellera de Sanidad, Ana Barceló, ha confirmado que no hay ninguna citación para vacunar a menores de 60 años con AstraZeneca y ha pedido “tranquilidad” a las personas a las que ya se les ha inoculado porque hay de margen hasta el mes de junio para que los técnicos determinen si es necesaria la segunda dosis ya que estudios actuales cifran la inmunización con solo la primera inyección en un 76%.",
                "text_en": "For its part, the health councillor, Ana Barceló, has confirmed that there is no summons to vaccinate children under the age of 60 with AstraZeneca and has asked for “quietness” from people who have already been inoculated because there is scope until June for technicians to determine if the second dose is necessary as current studies number immunization with only the first injection by 76%.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la consellera de Sanidad, Ana Barceló",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Consellera de Sanidad, Ana Barceló"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha confirmado que no hay ninguna citación para vacunar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "confirmed that there is no citation to vaccinate"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a menores de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to persons under 60 years of age"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with AstraZeneca"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha pedido “tranquilidad”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has asked for “quietness”"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las personas a las que ya se les ha inoculado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "people who have already been inoculated"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque hay de margen hasta el mes de junio para que los técnicos determinen si es necesaria la segunda dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because there is scope until June for technicians to determine if the second dose is necessary"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el mes de junio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the month of June"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los técnicos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "technicians"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Barceló, en la rueda de prensa tras la reunión de la mesa interdepartamental, ha corroborado que esta semana no había ninguna cita para vacunar a nadie menor de 60 años con AstraZeneca y, tras el acuerdo de ayer del Consejo Interterritorial de suspender la inoculación por debajo de esa edad, tampoco se llamará a las personas de grupos esenciales en este tramo que quedaban pendientes de ser inoculados.",
                "text_en": "Barceló, at the press conference following the meeting of the interdepartmental bureau, corroborated that this week there was no appointment to vaccinate anyone under 60 years of age with AstraZeneca and, following yesterday's agreement by the Interterritorial Council to suspend inoculation below that age, neither will the people of essential groups in this section who were still waiting to be inoculated be called.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Barceló",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Barceló"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la rueda de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the press conference"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras la reunión de la mesa interdepartamental",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after the meeting of the interdepartmental bureau"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha corroborado que esta semana no había ninguna cita para vacunar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has corroborated that this week there was no appointment to vaccinate"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "esta semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this week"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a nadie menor de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to anyone under 60 years of age"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El colectivo de Fuerzas y Cuerpos de Seguridad y de centros docentes han sido los principales colectivos a los que ya se les ha administrado la primera dosis vacuna de AstraZeneca.",
                "text_en": "The group of Security Forces and Corps and schools have been the main groups that have already been given the first vaccine dose of AstraZeneca.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El colectivo de Fuerzas y Cuerpos de Seguridad y de centros docentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The collective of Security Forces and Corps and educational institutions"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han sido los principales colectivos a los que ya se les ha administrado la primera dosis vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have already been given the first vaccine dose of AstraZeneca"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "28": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 1,
            "WhatReliabilityUnreliable": 9,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 10,
            "WhoReliabilityReliable": 4,
            "WhoReliabilityUnreliable": 6,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 0,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 2,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 9,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 5,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 5,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nUna de las personas que más están luchando para denunciar la verdad de todo lo que está sucediendo en el mundo con las virus y con las vacunas es la doctora argentina, Chinda Brandolino.\n\n<PARAGRAPH>\n\nComo la mayor parte de las personas a las que se nos pretende inocular esas “vacunas salvadoras” de las que no se quieren hacer responsables ni fabricantes ni gobiernos, no somos expertos virólogos, médicos o biólogos, Brandolino ha publicado un vídeo en el que explica en un lenguaje que todos podamos entender, en qué consisten y que peligros tienen esas vacunas que nos pretenden poner a todos bajo amenazas varias.\n\n<PARAGRAPH>\n\nSon muchas las advertencias que expertos valientes están haciendo sobre estos productos y una decisión personal de cada uno creerles o no.\n\n<BREAK>\n\nPero de lo que estamos completamente seguros es de que, quien más, quien menos, tiene sus dudas sobre los potingues en cuestión y que quieren que les digamos, ante la duda lo mejor sería no ponerse nada.\n\n<PARAGRAPH>\n\nPero esa es una decisión personal y libre que cada uno de nosotros debe tomar.\n\n<BREAK>\n\nNuestra intención al publicar este tipo de información es que conozcan otras opiniones que nunca se van a mostrar por televisión.\n\n<BREAK>\n\nQuien solo vea la televisión puede llegar a pensar que todo lo relacionado con las vacunas es perfecto porque todos los supuestos expertos a los que se les permite salir por televisión están obligados a decir lo mismo.\n\n<BREAK>\n\nPero vean como hay otros muchos que no opinan de la misma forma.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n",
        "TITLE": "La doctora Chinda Brandolino publica un fantástico vídeo explicando a la perfección cuáles son los peligros de las vacunas que nos pretenden poner",
        "ID": "NF_04-11-2021_21-22-49_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "La doctora Chinda Brandolino publica un fantástico vídeo explicando a la perfección cuáles son los peligros de las vacunas que nos pretenden poner",
                "text_en": "Dr. Chinda Brandolino publishes a fantastic video explaining perfectly what are the dangers of vaccines that we intend to put",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La doctora Chinda Brandolino",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Chinda Brandolino"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "publica un fantástico vídeo explicando a la perfección cuáles son los peligros de las vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "posts a fantastic video explaining perfectly what the dangers of vaccines are"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una de las personas que más están luchando para denunciar la verdad de todo lo que está sucediendo en el mundo con las virus y con las vacunas es la doctora argentina, Chinda Brandolino.",
                "text_en": "One of the people who are fighting the most to denounce the truth of everything that is happening in the world with viruses and vaccines is Argentina's doctor, Chinda Brandolino.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Una de las personas que más están luchando para denunciar la verdad de todo lo que está sucediendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "One of the people who are fighting the most to denounce the truth of everything that is happening"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el mundo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the world"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la doctora argentina, Chinda Brandolino",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Argentine doctor, Chinda Brandolino"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Como la mayor parte de las personas a las que se nos pretende inocular esas “vacunas salvadoras” de las que no se quieren hacer responsables ni fabricantes ni gobiernos, no somos expertos virólogos, médicos o biólogos, Brandolino ha publicado un vídeo en el que explica en un lenguaje que todos podamos entender, en qué consisten y que peligros tienen esas vacunas que nos pretenden poner a todos bajo amenazas varias.",
                "text_en": "As most of the people we are trying to inoculate these “saviour vaccines” for whom neither manufacturers nor governments want to be held accountable, we are not virologists, doctors or biologists, Brandolino has published a video explaining in a language that we can all understand, what they consist of and what dangers these vaccines have that aim to put us all under various threats.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se quieren hacer responsables",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They don't want to take responsibility."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ni fabricantes ni gobiernos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "neither manufacturers nor governments"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Brandolino",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Brandolino"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "que peligros tienen esas vacunas que nos pretenden poner",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "What dangers do those vaccines intend to put us in?"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a todos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to all"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "bajo amenazas varias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "under various threats"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Son muchas las advertencias que expertos valientes están haciendo sobre estos productos y una decisión personal de cada uno creerles o no.",
                "text_en": "There are many warnings that brave experts are making about these products and a personal decision of each to believe them or not.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "muchas las advertencias que expertos valientes están haciendo sobre estos productos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "many warnings that brave experts are making about these products"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "expertos valientes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "brave experts"
                    }
                ],
                "evidences": [
                    {
                        "value": "Factors that the group of experts rated higher than the consulted expert of the in-depth interview related to the impact that a frozen, composed product will have on food safety in comparison to a fresh, non-composed product (factors 1, 5 and 17). Group expert opinions were more profound (i.e., rated as a substantially increased risk), while the individual expert rated these factors merely as an increased risk. The latter compared those factors with other frozen products within the same company concluding that risks increased slightly (+1). Group experts compared the innovative stew product, in line with the task at hand, with a traditional table potato and thus came to a different conclusion regarding food safety risks related to the factors 1, 5 and 7 (+1.5 or +2). On the other hand, workshop participants expected considerable improvements in factors related to producers' behaviour (factors 11-13). This can be explained by the fact that a recall will harm a large-scale processor much more than a product which is marketed by relatively small-scale producers. The stew expert compared those factors with other frozen products within the same company concluding no change.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9941940904
                    }
                ]
            },
            {
                "text": "Pero de lo que estamos completamente seguros es de que, quien más, quien menos, tiene sus dudas sobre los potingues en cuestión y que quieren que les digamos, ante la duda lo mejor sería no ponerse nada.",
                "text_en": "But what we are absolutely certain of is that, who else, who less, has his doubts about the potingues in question and who want us to tell them, in the face of doubt, it would be best not to put anything on.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo mejor sería no ponerse nada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It would be best not to wear anything."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero esa es una decisión personal y libre que cada uno de nosotros debe tomar.",
                "text_en": "But that is a personal and free decision that each of us must make.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esa es una decisión personal y libre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "That's a personal and free decision."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "cada uno de nosotros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "each of us"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Nuestra intención al publicar este tipo de información es que conozcan otras opiniones que nunca se van a mostrar por televisión.",
                "text_en": "Our intention in publishing this type of information is to get to know other opinions that will never be shown on television.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Nuestra intención al publicar este tipo de información es que conozcan otras opiniones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Our intention in publishing this type of information is to get to know other opinions"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "nunca se van a mostrar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're never gonna show up."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "por televisión",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on television"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Quien solo vea la televisión puede llegar a pensar que todo lo relacionado con las vacunas es perfecto porque todos los supuestos expertos a los que se les permite salir por televisión están obligados a decir lo mismo.",
                "text_en": "Anyone who only watches television may think that everything related to vaccines is perfect because all so-called experts who are allowed to go on television are obliged to say the same thing.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Quien solo vea la televisión",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Whoever only watches TV"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puede llegar a pensar que todo lo relacionado con las vacunas es perfecto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "you may even think that everything related to vaccines is perfect."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque todos los supuestos expertos a los que se les permite salir por televisión están obligados a decir lo mismo.",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because all so-called experts who are allowed to go on television are obliged to say the same thing."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "todos los supuestos expertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "all so-called experts"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero vean como hay otros muchos que no opinan de la misma forma.",
                "text_en": "But see how there are many others who do not feel the same way.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "otros muchos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "many others"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no opinan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "they don't think"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de la misma forma",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the same way"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "29": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 23,
            "WhatReliabilityReliable": 22,
            "WhatReliabilityUnreliable": 1,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 10,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 5,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 2,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 3,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nLos científicos advierten de que aún no se conoce si esta nueva cepa es realmente más contagiosa\n\n<BREAK>\n\nEl primer ministro británico, Boris Johnson, ha decidido este sábado endurecer las restricciones navideñas en Londres debido a una nueva cepa del coronavirus detectada en la capital del Reino Unido y en zonas del sur y sureste de Inglaterra. \n\n<BREAK>\n\nSegún ha asegurado el equipo científico que asesora al Gobierno británico, esta nueva cepa tiene una mayor capacidad de transmisión (hasta un 70% más que la anterior) y eso significa que los contagios se producen con mayor rapidez, aunque los datos de los que se dispone hasta este momento no llevan a concluir que la variante produzca síntomas más graves de la enfermedad o una mayor mortalidad. \n\n<BREAK>\n\nSegún el Gobierno británico, hasta un 62% de los nuevos contagios registrados en la capital británica responden a la nueva variante, que se ha convertido en la dominante.\n\n<BREAK>\n\nEsta no es la primera nueva cepa preocupante detectada del SARS-CoV-2. \n\n<BREAK>\n\nEl Gobierno de Dinamarca ordenó en noviembre sacrificar a millones de visones tras la detección de una variante del coronavirus que se extendió entre las granjas de cría y después saltó a humanos. \n\n<BREAK>\n\nEsta variante del coronavirus tenía cuatro nuevas mutaciones, algunas de ellas en la parte más importante del patógeno: la proteína S que es esencial para que el SARS-CoV-2 pueda infectar y que es la diana de muchas de las vacunas que están en desarrollo. \n\n<BREAK>\n\nAún no se ha podido demostrar que estas nuevas cepas sean más contagiosas o infecciosas que las ya detectadas.\n\n<BREAK>\n\n“Que los virus muten para volverse más infecciosos no es sorprendente y que esto podría suceder con virus nuevos y emergentes se conoce desde hace algún tiempo”, ha dicho Paul Hunter, profesor de la Escuela de Medicina de Norwich, Universidad de East Anglia, al servicio de noticias científicas SMC. \n\n<BREAK>\n\n“Para mí, estos informes sobre la transmisibilidad de la nueva variante son aún más preocupantes de lo que había previsto”, añade. \n\n<BREAK>\n\nEl experto cree que es solo “cuestión de tiempo” que esta variante del virus se convierta en la dominante en el Reino Unido y que aparezca en otros países. \n\n<BREAK>\n\n“Esta nueva variante es muy preocupante y no se parece a nada que hayamos visto hasta ahora en la pandemia. \n\n<BREAK>\n\nLas nuevas restricciones anunciadas hoy son una respuesta totalmente justificada a la situación en rápido desarrollo”, ha dicho al mismo medio Jeffrey Barrett, director de la iniciativa Covid Genomics en el Wellcome Sanger Institute.\n\n<BREAK>\n\nLos virus mutan constantemente. \n\n<BREAK>\n\nLos científicos del Gobierno británico han identificado que hay 17 mutaciones vinculadas en el código genético del virus que parecen hacer que esta nueva cepa descubierta sea más infecciosa. \n\n<BREAK>\n\nSegún los investigadores, los cambios en la superficie del virus pueden permitir que se una a las células más fácilmente. \n\n<BREAK>\n\n“Sin embargo, todavía no hay evidencia de que el nuevo virus sea más o menos peligroso en términos de su capacidad para causar enfermedades. \n\n<BREAK>\n\nLamentablemente, tendremos que esperar y ver si las hospitalizaciones y las muertes aumentan o disminuyen para averiguarlo“, ha dicho Simon Clarke, profesor asociado de microbiología celular en la Universidad de Reading.\n\n<BREAK>\n\n“Esta variante se ha vuelto sin duda más prevalente en el sureste de Inglaterra”, ha dicho Daniel Altmann, inmunólogo del Imperial College de Londres. \n\n<BREAK>\n\n“Esta situación incrementa la urgencia de que todo el mundo se vacune cuanto antes”, ha añadido. \n\n<BREAK>\n\nA la espera de nuevas pruebas, el equipo científico que asesora al Gobierno británico sigue confiando en que las vacunas sean eficaces con esta nueva modalidad del virus. \n\n<BREAK>\n\n“Esta variante tiene algunas mutaciones preocupantes que nos obligan a reducir la transmisión imponiendo limitaciones sociales”, ha dicho Ravindra Gupta, microbiólogo de la Universidad de Cambridge. \n\n<BREAK>\n\n“Aún debemos entender el impacto real de estas mutaciones en la forma de comportarse del virus”, ha añadido.\n\n<BREAK>\n\nEs importante tener en cuenta que aún se desconoce el impacto real de estas nuevas cepas. \n\n<BREAK>\n\n“Solo la mitad de las 17 mutaciones detectadas están en la proteína S [la que el virus usa para entrar en células humanas]”, explica Fernando González Candelas, investigador de la fundación valenciana Fisabio. \n\n<BREAK>\n\n“En cualquier caso parece lo suficientemente seria para no dejarla sin mirar en profundidad y con urgencia”, añade.\n\n<BREAK>\n\nUna mutación es una errata en el libro de instrucciones del virus —su genoma— que contiene una secuencia de 30.000 letras genéticas cuyo orden es fundamental. \n\n<BREAK>\n\nCada vez que el virus hace una copia de sí mismo —y es capaz de hacer decenas de miles infectando una sola célula— pueden producirse errores de copia en su genoma. \n\n<BREAK>\n\nLa inmensa mayoría de estas erratas no tienen ningún efecto, pero algunas de ellas pueden darle al virus una mayor capacidad infectiva o de propagación, sobre todo si están en la proteína S.",
        "TITLE": "El enigma de la nueva variante del coronavirus detectada en Inglaterra",
        "ID": "8-Elpais",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "El enigma de la nueva variante del coronavirus detectada en Inglaterra",
                "text_en": "The enigma of the new variant of the coronavirus detected in England",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El enigma de la nueva variante del coronavirus detectada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The enigma of the new variant of the detected coronavirus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Inglaterra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in England"
                    }
                ],
                "evidences": [
                    {
                        "value": "The WGS results confirm reinfection with a different lineage 8 months after initial infection in the absence of significant immunocompromise. The reinfection was with the \"new variant\" VOC-202012/01. This variant has been recently identified in the UK, and is rapidly spreading, especially in London and the South East of England and South Wales and may be responsible for a surge in new cases here [1] . The \"new variant\" is characterized by numerous mutations in the spike region which causes diagnostic escape in PCR assays using the \"S\" gene as a target for amplification [1, 2] . The numerous spike region mutations also raise questions about possible immune escape and/or vaccine evasion and likelihood of reinfection.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9830841422
                    }
                ]
            },
            {
                "text": "Los científicos advierten de que aún no se conoce si esta nueva cepa es realmente más contagiosa",
                "text_en": "Scientists warn that it is not yet known whether this new strain is actually more contagious",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los científicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Scientists"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "advierten de que aún no se conoce si esta nueva cepa es realmente más contagiosa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "warn that it is not yet known if this new strain is really more contagious"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El primer ministro británico, Boris Johnson, ha decidido este sábado endurecer las restricciones navideñas en Londres debido a una nueva cepa del coronavirus detectada en la capital del Reino Unido y en zonas del sur y sureste de Inglaterra. ",
                "text_en": "British Prime Minister Boris Johnson has decided this Saturday to tighten the Christmas restrictions in London due to a new strain of the coronavirus detected in the capital of the UK and in areas of southern and south-eastern England.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El primer ministro británico, Boris Johnson",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "British Prime Minister Boris Johnson"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha decidido este sábado endurecer las restricciones navideñas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has decided this Saturday to tighten the Christmas restrictions"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este sábado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Saturday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Londres",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in London"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "debido a una nueva cepa del coronavirus detectada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to a new strain of the detected coronavirus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la capital del Reino Unido y en zonas del sur y sureste de Inglaterra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the capital of the United Kingdom and in areas of southern and south-eastern England"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según ha asegurado el equipo científico que asesora al Gobierno británico, esta nueva cepa tiene una mayor capacidad de transmisión (hasta un 70% más que la anterior) y eso significa que los contagios se producen con mayor rapidez, aunque los datos de los que se dispone hasta este momento no llevan a concluir que la variante produzca síntomas más graves de la enfermedad o una mayor mortalidad. ",
                "text_en": "According to the scientific team advising the British Government, this new strain has a higher transmission capacity (up to 70% more than the previous one) and this means that contagions occur faster, although the data available so far do not lead to the conclusion that the variant produces more severe symptoms of the disease or increased mortality.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esta nueva cepa tiene una mayor capacidad de transmisión (hasta un 70% más que la anterior)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this new strain has a higher transmission capacity (up to 70% more than the previous one)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los contagios se producen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Contagion occurs"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con mayor rapidez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "faster"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los datos de los que se dispone hasta este momento no llevan a concluir que la variante produzca síntomas más graves de la enfermedad o una mayor mortalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the data available so far do not lead to the conclusion that the variant produces more severe symptoms of the disease or increased mortality"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hasta este momento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Until this moment"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según el Gobierno británico, hasta un 62% de los nuevos contagios registrados en la capital británica responden a la nueva variante, que se ha convertido en la dominante.",
                "text_en": "According to the British Government, up to 62 per cent of the new infections registered in the British capital correspond to the new variant, which has become the dominant one.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Según el Gobierno británico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "According to the British Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hasta un 62% de los nuevos contagios registrados en la capital británica responden a la nueva variante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "up to 62% of the new infections registered in the British capital respond to the new variant"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la capital británica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the British capital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta no es la primera nueva cepa preocupante detectada del SARS-CoV-2. ",
                "text_en": "This is not the first newly detected worrying strain of SARS-CoV-2.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta no es la primera nueva cepa preocupante detectada del SARS-CoV-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This is not the first newly detected worrying strain of SARS-CoV-2"
                    }
                ],
                "evidences": [
                    {
                        "value": "The data from high throughput sequencing analysis has confirmed around 20 mutation events in the genome of SARS-CoV-2 collected in October 2020 over the first strain sequenced in January 2020 (Wuhan-Hu-1) (Fang et al., 2021) . The virus has been reported evolving at a rate of ∼1.1 × 10 −3 substitutions per site per year, corresponding to one substitution every 11 days approximately (Martin et al., 2021) . This contrasts with the mutations in the HIV occurring at a rate of ∼4 × 10 −3 substitutions per site per year (Andrews and Rowland-Jones, 2017) . Based on the aforementioned details, the US government interagency established a variant classification scheme that classifies SARS-CoV-2 variants into three distinct groups:",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8978464603
                    }
                ]
            },
            {
                "text": "El Gobierno de Dinamarca ordenó en noviembre sacrificar a millones de visones tras la detección de una variante del coronavirus que se extendió entre las granjas de cría y después saltó a humanos. ",
                "text_en": "The Danish Government ordered in November to sacrifice millions of minks following the detection of a variant of the coronavirus that spread between breeding farms and then jumped humans.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno de Dinamarca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Government of Denmark"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ordenó en noviembre sacrificar a millones de visones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ordered in November to sacrifice millions of minks"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en noviembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in November"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras la detección de una variante del coronavirus que se extendió",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after detection of a variant of the coronavirus that spread"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "las granjas de cría",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "farming farms"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aún no se ha podido demostrar que estas nuevas cepas sean más contagiosas o infecciosas que las ya detectadas.",
                "text_en": "It has not yet been demonstrated that these new strains are more contagious or infectious than those already detected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Aún no se ha podido demostrar que estas nuevas cepas sean más contagiosas o infecciosas que las ya detectadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It has not yet been possible to prove that these new strains are more contagious or infectious than those already detected."
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Que los virus muten para volverse más infecciosos no es sorprendente y que esto podría suceder con virus nuevos y emergentes se conoce desde hace algún tiempo”, ha dicho Paul Hunter, profesor de la Escuela de Medicina de Norwich, Universidad de East Anglia, al servicio de noticias científicas SMC. ",
                "text_en": "“That viruses mutate to become more infectious is not surprising and that this could happen with new and emerging viruses has been known for some time,” said Paul Hunter, professor at the Norwich School of Medicine, University of East Anglia, at the SMC scientific news service.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los virus muten para volverse más infecciosos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "viruses mutate to become more infectious"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esto podría suceder con virus nuevos y emergentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this could happen with new and emerging viruses"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Paul Hunter, profesor de la Escuela de Medicina de Norwich, Universidad de East Anglia, al servicio de noticias científicas SMC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Paul Hunter, professor at the Norwich School of Medicine, University of East Anglia, scientific news service SMC"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El experto cree que es solo “cuestión de tiempo” que esta variante del virus se convierta en la dominante en el Reino Unido y que aparezca en otros países. ",
                "text_en": "The expert believes that it is only “a question of time” that this variant of the virus becomes the dominant in the UK and appears in other countries.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El experto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The expert"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esta variante del virus se convierta en la dominante en el Reino Unido y que aparezca en otros países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this variant of the virus becomes the dominant in the United Kingdom and appears in other countries"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in the United Kingdom"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en otros países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in other countries"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las nuevas restricciones anunciadas hoy son una respuesta totalmente justificada a la situación en rápido desarrollo”, ha dicho al mismo medio Jeffrey Barrett, director de la iniciativa Covid Genomics en el Wellcome Sanger Institute.",
                "text_en": "The new restrictions announced today are a fully justified response to the rapidly developing situation,” said Jeffrey Barrett, director of the Covid Genomics initiative at the Wellcome Sanger Institute.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las nuevas restricciones anunciadas hoy son una respuesta totalmente justificada a la situación en rápido desarrollo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The new restrictions announced today are a fully justified response to the rapidly developing situation"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Jeffrey Barrett, director de la iniciativa Covid Genomics en el Wellcome Sanger Institute",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Jeffrey Barrett, director of the Covid Genomics initiative at the Wellcome Sanger Institute"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los virus mutan constantemente. ",
                "text_en": "Viruses mutate constantly.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los virus mutan constantemente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Viruses mutate constantly"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Sin embargo, todavía no hay evidencia de que el nuevo virus sea más o menos peligroso en términos de su capacidad para causar enfermedades. ",
                "text_en": "“However, there is still no evidence that the new virus is more or less dangerous in terms of its ability to cause disease.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no hay evidencia de que el nuevo virus sea más o menos peligroso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There's no evidence that the new virus is more or less dangerous."
                    }
                ],
                "evidences": [
                    {
                        "value": "In this work, we did simulation about the new virus COVID 19, which was very close to the real situation. Sure, there is no real data because the virus is still new, and there is not enough available data. Also, we tried to use the dynamics of the SIRD model to create a comprehensible picture on this new virus, and better understand its effects.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9981720448
                    }
                ]
            },
            {
                "text": "Lamentablemente, tendremos que esperar y ver si las hospitalizaciones y las muertes aumentan o disminuyen para averiguarlo“, ha dicho Simon Clarke, profesor asociado de microbiología celular en la Universidad de Reading.",
                "text_en": "Unfortunately, we will have to wait and see if hospitalizations and deaths increase or decrease to find out,” said Simon Clarke, associate professor of cell microbiology at Reading University.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Simon Clarke, profesor asociado de microbiología celular en la Universidad de Reading",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Simon Clarke, Associate Professor of Cell Microbiology at Reading University"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Esta variante se ha vuelto sin duda más prevalente en el sureste de Inglaterra”, ha dicho Daniel Altmann, inmunólogo del Imperial College de Londres. ",
                "text_en": "“This variant has undoubtedly become more prevalent in southeastern England,” said Daniel Altmann, an immunologist at Imperial College in London.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta variante se ha vuelto sin duda más prevalente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This variant has undoubtedly become more prevalent"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el sureste de Inglaterra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the southeast of England"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Daniel Altmann, inmunólogo del Imperial College de Londres",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Daniel Altmann, immunologist at Imperial College London"
                    }
                ],
                "evidences": [
                    {
                        "value": "Zhanwei Du, 1 Lin Wang, 1 T he United Kingdom has detected a variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent coronavirus disease (COVID-19), from samples initially collected in Kent on September 20 and London on September 21, 2020 (1). The variant was associated with increased transmissibility and includes deletions at amino acid sites 69 and 70 of the spike protein (2) . In mid-December, the UK government tightened measures in London and southeastern England to mitigate transmission of the fast-spreading virus variant (3). On January 5, 2021, England initiated a national lockdown that included closing all schools and nonessential businesses until mid-February (4). By December 20, restrictions for travelers from the United Kingdom had been implemented by ≈40 countries (5) . The new variant (501Y) has subsequently been reported worldwide, including in the United States (6), Spain, Sweden, and France, and might be spreading without detection in countries with limited virus sequencing capacity (5) .",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9810953736
                    }
                ]
            },
            {
                "text": "A la espera de nuevas pruebas, el equipo científico que asesora al Gobierno británico sigue confiando en que las vacunas sean eficaces con esta nueva modalidad del virus. ",
                "text_en": "Pending further testing, the scientific team advising the British Government continues to trust that vaccines will be effective with this new virus modality.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el equipo científico que asesora al Gobierno británico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the scientific team advising the British Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sigue confiando en que las vacunas sean eficaces con esta nueva modalidad del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "continues to hope that vaccines will be effective with this new form of virus"
                    }
                ],
                "evidences": [
                    {
                        "value": "Currently, there is no such vaccine for COVID-19 although some are in clinical trials. The vaccines available in today's world are mainly that activates the immune system but molecular vaccines have a separate principle. Molecular vaccines use the shRNA-plasmids for silencing the 5 viral RNA before it starts to produce viral protein molecules. Molecular vaccines have an advantage over other currently available vaccines as they may be used as a treatment module for viral infections as well. Moreover, if one can choose a target site on the viral genome that is common to other viruses while selecting the shRNA sequence then, that nanoconjugate will become the common vaccine for wide variety of viruses. Further, the use of shRNA makes a stable knockdown of the cell line so it have better efficacy than small interfering RNAs (siRNAs) (8) . These advantages of the molecular vaccine may become the most upcoming new modality of vaccination in today's world.",
                        "score": 0.5
                    },
                    {
                        "value": "In fairness I find it funny, this idea that the UK developed a vaccine. I mean it's true the vaccine is being developed in the UK, but most people I've interacted with in the vaccine trials have been foreigners and migrants. Obviously, the British government is funding some of it, there's some British people involved, but this idea that the British population should have got given the right to more vaccines because it just happened to be done here seems a bit farfetched to me (CQI-0404).",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9979991317
                    },
                    {
                        "label": "neutral",
                        "score": 0.9983924031
                    }
                ]
            },
            {
                "text": "Es importante tener en cuenta que aún se desconoce el impacto real de estas nuevas cepas. ",
                "text_en": "It is important to note that the actual impact of these new strains is still unknown.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aún se desconoce el impacto real de estas nuevas cepas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The actual impact of these new strains is still unknown."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una mutación es una errata en el libro de instrucciones del virus —su genoma— que contiene una secuencia de 30.000 letras genéticas cuyo orden es fundamental. ",
                "text_en": "A mutation is a mistake in the virus's instruction book — its genome — which contains a sequence of 30,000 genetic letters whose order is fundamental.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Una mutación es una errata en el libro de instrucciones del virus —su genoma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A mutation is a mistake in the virus's instruction book — its genome"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "contiene una secuencia de 30.000 letras genéticas cuyo orden es fundamental",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "contains a sequence of 30,000 genetic letters whose order is fundamental"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La inmensa mayoría de estas erratas no tienen ningún efecto, pero algunas de ellas pueden darle al virus una mayor capacidad infectiva o de propagación, sobre todo si están en la proteína S.",
                "text_en": "The vast majority of these errors have no effect, but some of them may give the virus greater infective or spreading capacity, especially if they are in protein S.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La inmensa mayoría de estas erratas no tienen ningún efecto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The vast majority of these errors have no effect"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "algunas de ellas pueden darle al virus una mayor capacidad infectiva o de propagación, sobre todo si están en la proteína S",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "some of them may give the virus greater infective or propagation capacity, especially if they are in protein S"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "30": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 14,
            "WhatReliabilityReliable": 8,
            "WhatReliabilityUnreliable": 6,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 12,
            "WhoReliabilityReliable": 11,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 6,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 9,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 12,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 9,
            "Key-Verb": 0,
            "Orthotypography": 3,
            "Figure": 5,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 17,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEn los últimos tiempos parece que las evidencias de que se están haciendo las cosas rematadamente mal con esto del virus quedan totalmente eclipsadas con lo que digan gobiernos como el de Pedro Sánchez, lo que se diga por las televisiones o lo que digan médicos vendidos al discurso oficial como muchos de los que sufrimos en España y que deberían ser sentados delante de un juez de forma inmediata.\n\n<PARAGRAPH>\n\nPero la manipulación no solo llega hasta ese punto, llega hasta extremos en los que se trata de silenciar lo que ocurre en otros lugares del mundo, solo porque tiran por tierra las versiones oficiales con las que se nos intente engañar y manipular aquí, para mentenernos aterrados con esta gran farsa.\n\n<PARAGRAPH>\n\nUn claro ejemplo de ello es lo publicado recientemente por el digital Zero Hedge.\n\n<BREAK>\n\nTal y como se informa en uno de sus artículos, los estados de Texas y Mississippi han asistido a un espectacular descenso de los contagios y las hospitalizaciones tras la eliminación de la obligatoriedad del uso de mascarillas y la vuelta a la normalidad, no a la nueva normalidad.\n\n<PARAGRAPH>\n\nEn el caso de Texas, la tasa de positividad de la prueba fue del 4,95 por cient, que es la más baja que ha visto el estado desde el inicio de la pandemia.\n\n<BREAK>\n\nSegún el Departamento de Servicios de Salud del Estado de Texas, el domingo se informaron unos 1,900 nuevos casos de virus , que es el número diario más bajo que ha visto el estado desde principios de junio.\n\n<PARAGRAPH>\n\nLos datos de los Centros para el Control y la Prevención de Enfermedades de EE.\n\n<BREAK>\n\nUU.\n\n<BREAK>\n\nhan mostrado que el promedio móvil de siete días de casos en Texas ha caído al nivel más bajo desde mediados de junio.\n\n<BREAK>\n\nSegún los CDC, Texas ha tenido un promedio de 3.783 casos diarios al 27 de marzo.\n\n<PARAGRAPH>\n\nSegún datos del Departamento de Servicios de Salud del Estado de Texas (DSHS), hasta el sábado 3.104 pacientes de COVID-19 se encontraban en hospitales de todo el estado.\n\n<BREAK>\n\nLos datos muestran que el estado no ha registrado un número tan bajo desde el 19 de septiembre, cuando hubo 3.081 hospitalizaciones.\n\n<PARAGRAPH>\n\nEn el caso de Mississippi, ha experimentado una caída en los casos de virus y las hospitalizaciones.\n\n<BREAK>\n\nSegún datos de los CDC, hasta el sábado Mississippi registraba un promedio de 254 casos diarios, lo que representa una disminución con respecto al mes anterior, donde el estado promediaba alrededor de 520.\n\n<PARAGRAPH>\n\nSegún el departamento de salud del estado, Mississippi también ha eperimentado una caída en las hospitalizaciones por COVID-19, informando 238 pacientes hospitalizados con infecciones confirmadas el viernes pasado, que es el más bajo que ha visto el estado desde mayo.\n\n<PARAGRAPH>\n\nY ahora, después de leer todo esto, piensen en la situación en la que nos encontramos en España y en gran parte de Europa.\n\n<BREAK>\n\nAquí las restricciones siguen vigentes y la locura absoluta campa a sus anchas.\n\n<BREAK>\n\nTengan en cuenta que, además, en el caso de España nos vamos acercando al 9 de mayo, día en el que, en teoría, finaliza el estado de alarma, y este gobierno que preside Sánchez anda como loco por mantener ese estado de alarma de forma perenne infundiendo terror a la población.\n\n<BREAK>\n\nTenemos que dejar de permitir todo esto.\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Espectacular descenso de los contagios y hospitalizaciones en Texas y Mississippi tras eliminar la obligatoriedad del uso de mascarillas",
        "ID": "NF_04-11-2021_21-56-59_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Espectacular descenso de los contagios y hospitalizaciones en Texas y Mississippi tras eliminar la obligatoriedad del uso de mascarillas",
                "text_en": "Spectacular decrease in contagions and hospitalizations in Texas and Mississippi after eliminating the mandatory use of masks",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Espectacular descenso de los contagios y hospitalizaciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Spectacular decrease in contagion and hospitalizations"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Texas y Mississippi",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Texas and Mississippi"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras eliminar la obligatoriedad del uso de mascarillas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after eliminating the mandatory use of masks"
                    }
                ],
                "evidences": [
                    {
                        "value": "Reluctance to abide by mandatory masking edicts in public venues and classrooms became politicized early in the course of the pandemic as advice from the Centers for Disease Control and public health experts originally discouraged masks for people not showing symptoms. 79 Concerned about a possible shortage of masks, experts including Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and Dr. Jerome Adams, former surgeon general argued that face masks should be reserved for front-line medical workers. 80 When the message changed and some school districts and government authorities began mask mandates, protests erupted arguing that mask requirements impinged on personal freedom. 81 In states such as Florida, Texas and Arizona, state leaders banned mask mandates for schools, while the University System of Georgia regents warned of disciplinary action for faculty members requiring COVID mitigation measures such as distance learning or mandatory masks in classrooms. 82, 83 In each such case, the anti-mask position was backed by a Republican governor and/or Republican-dominated legislature arguing that such mandates impinge on parental rights to make decisions about the health care of their children. 84 The announcement by President Biden on September 10, 2021, that employers with 100 workers or more require their employees to get vaccinations or weekly COVID testing, was met with sharp criticism from Republicans who saw this move as \"unconstitutional,\" \"un-American\" and \"an assault on freedom and liberty.\" [85] [86] [87] At the same time, the chair of the Democratic National Committee, Jaime Harrison, enthusiastically supported this mandate, stating that the Democrats are \"moving forward with protecting the American people\" while the Republican response is \"crazy.\" 88 ",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9958872199
                    }
                ]
            },
            {
                "text": "En los últimos tiempos parece que las evidencias de que se están haciendo las cosas rematadamente mal con esto del virus quedan totalmente eclipsadas con lo que digan gobiernos como el de Pedro Sánchez, lo que se diga por las televisiones o lo que digan médicos vendidos al discurso oficial como muchos de los que sufrimos en España y que deberían ser sentados delante de un juez de forma inmediata.",
                "text_en": "In recent times it seems that the evidence that things are being done completely wrong with this virus is totally eclipsed by what governments like Pedro Sánchez say, what is said by television or what doctors say sold to the official discourse like many of those we suffer in Spain and that they should be seated in front of a judge immediately.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En los últimos tiempos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "In recent times"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se están haciendo las cosas rematadamente mal con esto del virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "You're doing things completely wrong with this virus thing."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pedro Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pedro Sánchez"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "médicos vendidos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "doctors sold"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero la manipulación no solo llega hasta ese punto, llega hasta extremos en los que se trata de silenciar lo que ocurre en otros lugares del mundo, solo porque tiran por tierra las versiones oficiales con las que se nos intente engañar y manipular aquí, para mentenernos aterrados con esta gran farsa.",
                "text_en": "But manipulation not only goes so far, it goes so far as to silence what is happening in other parts of the world, only because they throw down the official versions with which we are tried to deceive and manipulate here, to keep us terrified by this great farce.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se trata de silenciar lo que ocurre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It's about silencing what's going on."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en otros lugares del mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in other parts of the world"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque tiran por tierra las versiones oficiales con las que se nos intente engañar y manipular aquí",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because they're throwing down the official versions with which we're being tricked and manipulated here."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un claro ejemplo de ello es lo publicado recientemente por el digital Zero Hedge.",
                "text_en": "A clear example of this is the recent release by the digital Zero Hedge.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "el digital Zero Hedge",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the digital Zero Hedge"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tal y como se informa en uno de sus artículos, los estados de Texas y Mississippi han asistido a un espectacular descenso de los contagios y las hospitalizaciones tras la eliminación de la obligatoriedad del uso de mascarillas y la vuelta a la normalidad, no a la nueva normalidad.",
                "text_en": "As reported in one of its articles, the states of Texas and Mississippi have witnessed a dramatic decline in contagions and hospitalizations following the elimination of the mandatory use of masks and the return to normality, not the new normality.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los estados de Texas y Mississippi",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the states of Texas and Mississippi"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han asistido a un espectacular descenso de los contagios y las hospitalizaciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "have witnessed a dramatic decline in contagion and hospitalizations"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras la eliminación de la obligatoriedad del uso de mascarillas y la vuelta a la normalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after the elimination of the obligatory use of masks and the return to normality"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el caso de Texas, la tasa de positividad de la prueba fue del 4,95 por cient, que es la más baja que ha visto el estado desde el inicio de la pandemia.",
                "text_en": "In the case of Texas, the test positivity rate was 4.95 percent, which is the lowest the state has seen since the beginning of the pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En el caso de Texas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the case of Texas"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la tasa de positividad de la prueba fue del 4,95 por cient",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the positivity rate of the test was 4.95 per cent"
                    }
                ],
                "evidences": [
                    {
                        "value": "The rate of test positivity in pediatric patients varies. In a study conducted in Texas, the test positivity rate was 7.3%, while it was found to be 4% in the first peak period of the pandemic in England [15, 16] . In this study, the test positivity rate was 19.9%. The higher test positivity rates may have been due to the existence of guidelines that enable better diagnosis of the disease and more selective testing of this process already existed.",
                        "score": 0.6499999762
                    },
                    {
                        "value": "We first used phylogenetic analyses of the sequence data to identify genetically related B.1.1.7 sequences within states. Based on the criteria of: (1) having sequenced identical B.1.1.7 genomes from multiple individuals within a state, and; (2) limiting our analysis to states with at least 10 B.1.1.7 genomes available for comparison, we found phylogenetic evidence for community B. Our collective clinical diagnostic laboratories performed 639,013 TaqPath COVID-19 RT-PCR tests from November 2020 through January 2021 across 5 states: Illinois (336,869 tests), Connecticut (192, 760) , New Jersey (52,725), New York (35,515), and Texas (11,144). The SARS-CoV-2 test positivity rate varied across the states and months, but all were high (range = 6-23%; Figure 3A ; Data S1). Among the positive tests, the frequency of SGTF results increased during January in all states except Texas, where we had the least amount of TaqPath data ( Figure 3B) . While rates of SGTF increased to 0.6-2% during January 2021 in Illinois, Connecticut, New Jersey, and New York, this should be seen as a maximum potential frequency of B.1.1.7 within the tested populations, and not an absolute frequency. In the US, a second SARS-CoV-2 lineage, B.1.375, also has the spike gene Δ69/70 HV deletion that causes SGTF, and has a higher frequency than B.1.1.7 in many states from December 2020 to January 2021 (Larsen and Worobey, 2020; Moreno et al., 2021) . In fact, from 254 SGTF samples tested at Yale University (from Connecticut, New Jersey, Illinois, and New York) as of January 31st, 2021, only 37 (15%) were identified as B.1.1.7 through sequencing. In contrast, the percentage SGTF identified as B.1.1.7 in Florida and California were significantly higher (Washington et al., 2021) . Thus, SGTF data may be currently more helpful for monitoring trends in some states than others. Overall, while such indirect measures should be interpreted carefully, the combination of recent SGTF increases and the genetic relatedness of B.1.1.7 sequences suggests that community transmission of B.1.1.7 has become established and is on the rise in several US states. ",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.9959486127
                    },
                    {
                        "label": "neutral",
                        "score": 0.9834337234
                    }
                ]
            },
            {
                "text": "Según el Departamento de Servicios de Salud del Estado de Texas, el domingo se informaron unos 1,900 nuevos casos de virus , que es el número diario más bajo que ha visto el estado desde principios de junio.",
                "text_en": "According to the Texas State Department of Health Services, some 1,900 new cases of viruses were reported on Sunday, which is the lowest daily number the state has seen since the beginning of June.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Departamento de Servicios de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Department of Health Services"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Estado de Texas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "State of Texas"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el domingo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Sunday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se informaron unos 1,900 nuevos casos de virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Some 1,900 new cases of viruses were reported"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según los CDC, Texas ha tenido un promedio de 3.783 casos diarios al 27 de marzo.",
                "text_en": "According to the CDC, Texas has had an average of 3,783 cases per day as of March 27.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Texas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Texas"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha tenido un promedio de 3.783 casos diarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has had an average of 3,783 cases per day"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al 27 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as at 27 March"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según datos del Departamento de Servicios de Salud del Estado de Texas (DSHS), hasta el sábado 3.104 pacientes de COVID-19 se encontraban en hospitales de todo el estado.",
                "text_en": "According to data from the Texas State Department of Health Services (DSHS), up to Saturday, 3,104 patients with COVID-19 were in hospitals across the state.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Departamento de Servicios de Salud del Estado de Texas (DSHS)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Texas State Department of Health Services (DSHS)"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hasta el sábado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "until Saturday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "3.104 pacientes de COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "3,104 patients with COVID-19"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se encontraban",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "they were"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en hospitales de todo el estado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in hospitals all over the state"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los datos muestran que el estado no ha registrado un número tan bajo desde el 19 de septiembre, cuando hubo 3.081 hospitalizaciones.",
                "text_en": "The data show that the state has not registered such a low number since September 19, when there were 3,081 hospitalizations.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el estado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "status"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no ha registrado un número tan bajo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He hasn't registered such a low number."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde el 19 de septiembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since 19 September"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el caso de Mississippi, ha experimentado una caída en los casos de virus y las hospitalizaciones.",
                "text_en": "In the case of Mississippi, he has experienced a fall in cases of viruses and hospitalizations.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Mississippi",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mississippi"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha experimentado una caída en los casos de virus y las hospitalizaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has experienced a fall in virus cases and hospitalizations"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según datos de los CDC, hasta el sábado Mississippi registraba un promedio de 254 casos diarios, lo que representa una disminución con respecto al mes anterior, donde el estado promediaba alrededor de 520.",
                "text_en": "According to CDC data, up to Saturday Mississippi recorded an average of 254 cases per day, a decrease from the previous month, where the state averaged about 520.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hasta el sábado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "until Saturday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Mississippi",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mississippi"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "registraba un promedio de 254 casos diarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "averaged 254 cases per day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según el departamento de salud del estado, Mississippi también ha eperimentado una caída en las hospitalizaciones por COVID-19, informando 238 pacientes hospitalizados con infecciones confirmadas el viernes pasado, que es el más bajo que ha visto el estado desde mayo.",
                "text_en": "According to the state's health department, Mississippi has also experienced a fall in COVID-19 hospitalizations, reporting 238 hospitalized patients with confirmed infections last Friday, which is the lowest the state has seen since May.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Mississippi",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mississippi"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "también ha eperimentado una caída en las hospitalizaciones por COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has also experienced a fall in COVID-19 hospitalizations"
                    }
                ],
                "evidences": [
                    {
                        "value": "As of September 13, 2020, Mississippi and Louisiana reported a cumulative of 87,805 and 154,955 cases, respectively [5] . Louisiana became an epicenter among southern states as early as April and was the third highest in per capita reported cases in the US [6] . Mississippi had a more steady increase in the number of cases but had the second highest COVID-19 hospitalization rate in the nation by early June [7] . The emergence of COVID-19 cases and scientific and medical uncertainty of disease surveillance urged public health officials and state/local governments to identify and implement interventions to slow the spread of disease [8] . Nonpharmaceutical public health interventions (NPI) such as social distancing and isolation have been shown to be simple and cost-effective ways to control respiratory infections [9] . The Center for Disease Control and Prevention has also identified NPIs as one of the best ways to control pandemic illnesses when vaccines are not yet available [10] . By early April, both Mississippi and Louisiana issued stay-at-home orders and stated guidelines that included mask mandates, restrictions for nonessential businesses, and social distancing to slow the spread of COVID-19. Stay-at-home orders (referred to as \"shelter\" at home in Louisiana) in both states directed residents to stay at or shelter at home and limit movements outside of their homes beyond essential needs. There is still much too be learned about medical experiences related to the pandemic as well as attitudes and other factors related to stay-at-home order adherence. Additionally, it is critically to understand the factors related to state-at-home order adherence to better inform intervention and policy design. The purpose of this study was to describe COVID-19 related symptoms and medical care experienced in the first six months of the pandemic as well as stay-at-home order adherence, and attitudes related to COVID-19 risk and social distancing among a diverse sample of adults in the Deep South, specifically in the states of Louisiana and Mississippi. Additionally, we determined predictors of stay-at-home order adherence.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9781022668
                    }
                ]
            },
            {
                "text": "Aquí las restricciones siguen vigentes y la locura absoluta campa a sus anchas.",
                "text_en": "Here the restrictions are still in force and the absolute madness is at large.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Aquí",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Here."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las restricciones siguen vigentes y la locura absoluta campa a sus anchas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the restrictions are still in force and the absolute madness runs wide"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tengan en cuenta que, además, en el caso de España nos vamos acercando al 9 de mayo, día en el que, en teoría, finaliza el estado de alarma, y este gobierno que preside Sánchez anda como loco por mantener ese estado de alarma de forma perenne infundiendo terror a la población.",
                "text_en": "Please note that, in the case of Spain, we are approaching the 9th of May, the day when, in theory, the state of alarm ends, and this government presided over by Sánchez is crazy to keep that state of alarm perennially infusing terror to the population.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el caso de España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the case of Spain"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al 9 de mayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as at 9 May"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "este gobierno que preside Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this government that presides Sánchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "anda como loco",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's crazy."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por mantener ese estado de alarma de forma perenne",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for keeping that state of alarm perennially"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "infundiendo terror a la población",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Infusing terror to the population"
                    }
                ],
                "evidences": [
                    {
                        "value": "As COVID-19 is becoming a global health crisis, it has been announced as pandemic by World Health Organization (WHO, Geneva, Switzerland) on 11 March [1]. Three days after, being one of the most infected countries, Spanish prime minister Pedro Sanchez declared state of alarm. This is the second time that Spain declared a national lockdown, so the influence of the pandemic on Spain is substantial. As the situation of the pandemic became stable, the Spanish government announced a 4-step plan for the transition to a new normality on 3 May (Plan para la transición hacia una nueva normalidad), signaling that the pandemic is gradually becoming under control.",
                        "score": 0.6200000048
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9973938465
                    }
                ]
            }
        ]
    },
    "31": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 19,
            "WhatReliabilityReliable": 19,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 25,
            "WhoReliabilityReliable": 25,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 11,
            "WhenReliabilityReliable": 11,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 6,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 6,
            "WhoRoleSubject": 15,
            "WhoRoleTarget": 9,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 4,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLa Generalitat combinará a partir de entonces los primeros pinchazos al colectivo de entre 70 y 79 años con las segundas de los más mayores\n\n<PARAGRAPH>\n\nCataluña busca acelerar la vacunación de los mayores de 80 años.\n\n<BREAK>\n\nLa subdirectora general de Promoción de la Salud de la Generalitat, Carmen Cabezas, adelantó este lunes que el gobierno autonómico prevé que a mediados de abril ya habrá inyectado al menos una dosis de la vacuna contra la covid-19 a toda la población de este colectivo.\n\n<BREAK>\n\n“En las dos próximas semanas recibiremos más dosis, y la previsión es que todo el colectivo haya recibido un pinchazo, como mínimo”, aseguró.\n\n<PARAGRAPH>\n\nA partir de entonces, empezará el turno de las personas que se encuentran entre los 70 y los 79 años, y el departamento de Salud combinará las primeras dosis de este franja de edad, con la segunda de los mayores de 80 aprovechando las tres semanas de espera requeridas en los viales de Pizer entre los dos pinchazos.\n\n<BREAK>\n\nEl Govern ya anunció la semana pasada que confía en haber vacunado a todos los ancianos más mayores a mediados de mayo.\n\n<BREAK>\n\nPara esta franja de edad, está estipulado el uso de las vacunas desarrolladas por las compañías Pfizer y Moderna, puesto que el fármaco de AstraZeneca solo puede administrarse hasta los 65 años.\n\n<PARAGRAPH>\n\nEn relación a esto, Cabezas pidió “que se saque la limitación por edad” que afecta a esta última vacuna.\n\n<BREAK>\n\nUna semana después de que el Gobierno del Estado retrasara el tope de los 55 a los 65 años, ahora la responsable del proceso de vacunación en Cataluña reclama que se elimine cualquier límite.\n\n<BREAK>\n\n“En el Reino Unido ya no se está aplicando esta limitación y las tasas de efectividad son muy buenas en personas mayores, que tienen 70 u 80 años.\n\n<BREAK>\n\nEsta vacuna se tendría que usar para todas las edades”, sentenció.\n\n<BREAK>\n\nEn una entrevista concedida a Catalunya Ràdio, Cabezas anunció que desde la Generalitat este asunto “se está tratando con el ministerio” y recordó que “Cataluña siempre lo ha pedido”.\n\n<PARAGRAPH>\n\nCabezas también aseguró que el cumplimiento del plan de vacunación dependerá de que las farmacéuticas cumplan con los plazos de entrega, ya que, según Cabezas, “el problema está en que hasta ahora se han recibido muy pocas dosis”.\n\n<BREAK>\n\nCataluña recibirá a partir del próximo 5 de abril las vacunas de AstraZeneca pendientes que no han llegado esta semana, aunque Salud aún no tiene el número de dosis confirmado.\n\n<PARAGRAPH>\n\nLa responsable del proceso de vacunación en Cataluña quiso trasladar un mensaje de tranquilidad a quienes ya tengan una cita programada para vacunarse, que no estarán afectados por el retraso en la vacunación de AstraZeneca.\n\n<BREAK>\n\nSegún Cabezas, el plan de vacunación “avanza con fluidez” y puso en valor “el trabajo de la atención primaria” para llevarlo a cabo.\n\n<PARAGRAPH>\n\nExpansión del virus\n\n<PARAGRAPH>\n\nLas previsiones del Govern llegan en un escenario de expansión del virus en Cataluña.\n\n<BREAK>\n\nAumentan los contagios, la velocidad de propagación del virus, el riesgo de rebrote y el número de personas hospitalizadas.\n\n<PARAGRAPH>\n\nSegún los datos epidemiológicos actualizados el lunes por el Departamento de Salud, hay 1.474 pacientes con covid hospitalizados, 89 más que la víspera, de los que 403 están graves en la UCI, siete más, en el segundo día consecutivo en el que sube la presión asistencial en los hospitales.\n\n<PARAGRAPH>\n\nLa velocidad de propagación de la enfermedad (Rt) sigue creciendo y ayer se situó en 1,13, dos centésimas más que el balance anterior.\n\n<BREAK>\n\nLa cifra indica una expansión del virus lenta pero constante cuando se ha iniciado la Semana Santa, que conllevará un aumento de la movilidad y de las interacciones sociales.\n\n<PARAGRAPH>\n\nLa incidencia acumulada de casos por cada 100.000 habitantes a 14 días (IA14) también empeora y se situó en 215, cuatro casos más que el domingo, mientras que el riesgo de rebrote, índice que mide el crecimiento potencial de la pandemia, es de 242 puntos, ocho más.\n\n<BREAK>\n\nLa positividad, es decir, el porcentaje de positivos en pruebas PCR y test de antígenos, se sitúa en 5,50%, ocho centésimas más que el día anterior y por encima del 5% que la OMS señala como umbral de control de la epidemia.\n\n<PARAGRAPH>\n\nEl aumento de los indicadores preocupa a los expertos.\n\n<BREAK>\n\nEl investigador Daniel López Codina, miembro del BioComSC, el grupo de investigación de la UPC experto en la proyección de la epidemia, señaló el lunes en TV3 que el incremento de la movilidad permitida a inicios de Semana Santa “es uno de los temas peligrosos”, ya que “cuando hay un aumento de movilidad, hay un aumento de contactos y un incremento de los contagios”.\n\n<PARAGRAPH>\n\nEl científico indicó que la incógnita reside en hasta donde llegará este crecimiento que ahora mismo se ve en la Rt, y que en unas semanas se verá “un crecimiento de las hospitalizaciones y de los pacientes críticos”.\n\n<PARAGRAPH>\n",
        "TITLE": "Cataluña prevé haber administrado la primera dosis a todos los mayores de 80 años a mediados de abril",
        "ID": "F_04-11-2021_21-50-53_elpais_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Cataluña prevé haber administrado la primera dosis a todos los mayores de 80 años a mediados de abril",
                "text_en": "Catalonia expects to have administered the first dose to all those over 80 by mid-April",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "prevé haber administrado la primera dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "plan to have given the first dose"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a todos los mayores de 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to all persons over 80 years of age"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a mediados de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mid-April"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Generalitat combinará a partir de entonces los primeros pinchazos al colectivo de entre 70 y 79 años con las segundas de los más mayores",
                "text_en": "From then on, the Generalitat will combine the first punctures to the group between 70 and 79 years old with the second ones of the oldest.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Generalitat",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Generalitat"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "combinará a partir de entonces los primeros pinchazos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will then combine the first punctures"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al colectivo de entre 70 y 79 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the group between 70 and 79 years old"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con las segundas de los más mayores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with the second of the oldest"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cataluña busca acelerar la vacunación de los mayores de 80 años.",
                "text_en": "Catalonia seeks to accelerate vaccination for those over 80 years of age.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "busca acelerar la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "seeks to speed up vaccination"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "de los mayores de 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of those over 80 years of age"
                    }
                ],
                "evidences": [
                    {
                        "value": "Influenza vaccination coverage rates fall a long way short from the 75% target proposed by the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC). For the 2020-21 influenza vaccination campaign in Catalonia and Spain, the goal has been set to achieve or exceed 75% of vaccinations in people aged over 65 and in healthcare professionals, and 60% in pregnant women and people with a high risk for complications [6, 9] .",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9933193922
                    }
                ]
            },
            {
                "text": "La subdirectora general de Promoción de la Salud de la Generalitat, Carmen Cabezas, adelantó este lunes que el gobierno autonómico prevé que a mediados de abril ya habrá inyectado al menos una dosis de la vacuna contra la covid-19 a toda la población de este colectivo.",
                "text_en": "The deputy director general of Health Promotion of the Generalitat, Carmen Cabezas, said this Monday that the autonomous government previews that by mid-April it will have already injected at least one dose of the vaccine against covid-19 to the entire population of this collective.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La subdirectora general de Promoción de la Salud de la Generalitat, Carmen Cabezas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Deputy Director General of Health Promotion of the Generalitat, Carmen Cabezas"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el gobierno autonómico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the autonomous government"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a mediados de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mid-April"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "inyectado al menos una dosis de la vacuna contra la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "injected at least one dose of covid-19 vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a toda la población de este colectivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the entire population of this group"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“En las dos próximas semanas recibiremos más dosis, y la previsión es que todo el colectivo haya recibido un pinchazo, como mínimo”, aseguró.",
                "text_en": "“In the next two weeks we will receive more doses, and the forecast is that the whole group has received at least one puncture,” he said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En las dos próximas semanas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the next two weeks"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recibiremos más dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "we will receive more doses"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A partir de entonces, empezará el turno de las personas que se encuentran entre los 70 y los 79 años, y el departamento de Salud combinará las primeras dosis de este franja de edad, con la segunda de los mayores de 80 aprovechando las tres semanas de espera requeridas en los viales de Pizer entre los dos pinchazos.",
                "text_en": "From then on, the turn of people between the ages of 70 and 79 will begin, and the Health Department will combine the first doses of this age range, with the second of those over 80 taking advantage of the three weeks of waiting required in the Pizer vials between the two punctures.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el departamento de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Department of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "combinará las primeras dosis de este franja de edad, con la segunda",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "combine the first doses of this age group with the second"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "de los mayores de 80",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of those over 80"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "aprovechando las tres semanas de espera requeridas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "taking advantage of the three weeks of waiting required"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Govern ya anunció la semana pasada que confía en haber vacunado a todos los ancianos más mayores a mediados de mayo.",
                "text_en": "The Govern already announced last week that he hopes to have vaccinated all the older elderly in mid-May.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Govern",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Govern"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "anunció la semana pasada que confía en haber vacunado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "announced last week that he trusts to have vaccinated"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "la semana pasada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last week"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a todos los ancianos más mayores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to all older elders"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a mediados de mayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mid-May"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para esta franja de edad, está estipulado el uso de las vacunas desarrolladas por las compañías Pfizer y Moderna, puesto que el fármaco de AstraZeneca solo puede administrarse hasta los 65 años.",
                "text_en": "For this age group, the use of vaccines developed by the companies Pfizer and Moderna is stipulated, since the drug of AstraZeneca can only be administered up to the age of 65.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Para esta franja de edad, está estipulado el uso de las vacunas desarrolladas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For this age group, the use of developed vaccines is stipulated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las compañías Pfizer y Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the companies Pfizer and Moderna"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "puesto que el fármaco de AstraZeneca solo puede administrarse hasta los 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since AstraZeneca drug can only be given up to 65 years of age"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una semana después de que el Gobierno del Estado retrasara el tope de los 55 a los 65 años, ahora la responsable del proceso de vacunación en Cataluña reclama que se elimine cualquier límite.",
                "text_en": "One week after the government of the State delayed the ceiling from 55 to 65 years of age, now the person responsible for the vaccination process in Catalonia demands that any limit be removed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la responsable del proceso de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the person responsible for the vaccination process"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reclama que se elimine cualquier límite",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "calls for any limit to be removed"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“En el Reino Unido ya no se está aplicando esta limitación y las tasas de efectividad son muy buenas en personas mayores, que tienen 70 u 80 años.",
                "text_en": "“This limitation is no longer being applied in the UK and the rates of effectiveness are very good in older people, who are 70 or 80 years old.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya no se está aplicando esta limitación y las tasas de efectividad son muy buenas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This limitation is no longer being applied and the rates of effectiveness are very good"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en personas mayores, que tienen 70 u 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in older persons, who are 70 or 80 years old"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cabezas también aseguró que el cumplimiento del plan de vacunación dependerá de que las farmacéuticas cumplan con los plazos de entrega, ya que, según Cabezas, “el problema está en que hasta ahora se han recibido muy pocas dosis”.",
                "text_en": "Cabezas also assured that compliance with the vaccination plan will depend on pharmaceuticals meeting delivery deadlines, as according to Cabezas, “the problem is that so far very few doses have been received.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cabezas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Heads"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aseguró que el cumplimiento del plan de vacunación dependerá de que las farmacéuticas cumplan con los plazos de entrega",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "assured that compliance with the vaccination plan will depend on pharmaceuticals complying with delivery deadlines"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las farmacéuticas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pharmaceuticals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cataluña recibirá a partir del próximo 5 de abril las vacunas de AstraZeneca pendientes que no han llegado esta semana, aunque Salud aún no tiene el número de dosis confirmado.",
                "text_en": "Catalonia will receive as of April 5 the pending AstraZeneca vaccines that have not arrived this week, although Health still does not have the confirmed dose number.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recibirá a partir del próximo 5 de abril las vacunas de AstraZeneca pendientes que no han llegado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will receive as of April 5 the vaccines of AstraZeneca pending that have not arrived"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir del próximo 5 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from the next 5th of April"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "esta semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this week"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La responsable del proceso de vacunación en Cataluña quiso trasladar un mensaje de tranquilidad a quienes ya tengan una cita programada para vacunarse, que no estarán afectados por el retraso en la vacunación de AstraZeneca.",
                "text_en": "The person responsible for the vaccination process in Catalonia wanted to convey a message of tranquility to those who already have a scheduled appointment to get vaccinated, who will not be affected by the delay in the vaccination of AstraZeneca.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La responsable del proceso de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The person responsible for the vaccination process"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "quiso trasladar un mensaje de tranquilidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "wanted to convey a message of tranquility"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a quienes ya tengan una cita programada para vacunarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to those who already have a scheduled appointment to get vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según Cabezas, el plan de vacunación “avanza con fluidez” y puso en valor “el trabajo de la atención primaria” para llevarlo a cabo.",
                "text_en": "According to Cabezas, the vaccination plan “advances smoothly” and put in value “the work of primary care” to carry it out.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cabezas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Heads"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el plan de vacunación “avanza con fluidez”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vaccination plan “progresses smoothly”"
                    }
                ],
                "evidences": [
                    {
                        "value": "We compare different scenarios to assess the effect of mass vaccination campaigns with different paces, in the presence of varying profiles of the reproduction number R 0 over time, due to specific SARS-CoV-2 variants and/or restrictions. We consider four effective vaccination schedules (Extended Data Fig. 4) , obtained by modulating linearly the speed of the four phases, T1-T4, of Italy's vaccination plan 28 and yielding a different fraction of immunized people Letters NATuRE MEDICINE within January 2022: absent (0%), slow (47%), medium (64%) and fast (90%). We also consider five different time profiles of R 0 : constant R 0 = 1.27 (high transmission); Open-Close periodic R 0 with average value of 1.1, in which 1-month Openings (R 0 = 1.27: leaving schools and shops open, wearing face masks and keeping physical distance) alternate with 1-month Closures (R 0 = 0.9: closing schools, shops, restaurants and entertainment places), starting with an Opening phase; constant R 0 = 1.1; Close-Open periodic R 0 with average value of 1.1, in which 1-month Closures alternate with 1-month Openings, starting with a Closure phase; constant R 0 = 0.9 (eradication).",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9625241756
                    }
                ]
            },
            {
                "text": "Según los datos epidemiológicos actualizados el lunes por el Departamento de Salud, hay 1.474 pacientes con covid hospitalizados, 89 más que la víspera, de los que 403 están graves en la UCI, siete más, en el segundo día consecutivo en el que sube la presión asistencial en los hospitales.",
                "text_en": "According to epidemiological data updated on Monday by the Department of Health, there are 1,474 patients with covid hospitalized, 89 more than the previous day, of whom 403 are severe in the ICU, seven more, on the second consecutive day on which hospital care pressure rises.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Monday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Departamento de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Department of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay 1.474 pacientes con covid hospitalizados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There are 1,474 patients with covid hospitalized"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La velocidad de propagación de la enfermedad (Rt) sigue creciendo y ayer se situó en 1,13, dos centésimas más que el balance anterior.",
                "text_en": "The rate of spread of the disease (Rt) continues to grow and yesterday stood at 1.13, two hundredths more than the previous balance.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La velocidad de propagación de la enfermedad (Rt) sigue creciendo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The rate of spread of the disease (Rt) continues to grow"
                    }
                ],
                "evidences": [
                    {
                        "value": "Individuals in cluster i get in physical proximity of another in cluster j at a certain rate, the rate is much higher if i = j, than when i = j. Only a fraction of these contacts spread the disease. We consider that disease spread rate φ i,j is the product of the rate at which an individual in cluster i gets in physical contact with another in cluster j and fraction of contacts between susceptibles and infectious individuals that spread the disease to the susceptibles. Rate of an event is the expected duration between successive occurrences of the event. Typically, φ i,i would be much higher than φ i,j for all i = j. Analogously, opinion spread rate α i,j is the product of the rate at which an individual in cluster i exchanges opinions with another in cluster j and fraction of such exchanges that change cooperativity.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8998776078
                    }
                ]
            },
            {
                "text": "La cifra indica una expansión del virus lenta pero constante cuando se ha iniciado la Semana Santa, que conllevará un aumento de la movilidad y de las interacciones sociales.",
                "text_en": "The figure indicates a slow but steady expansion of the virus at the start of Holy Week, which will lead to increased mobility and social interactions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La cifra indica una expansión del virus lenta pero constante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The figure indicates a slow but steady expansion of the virus"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando se ha iniciado la Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when Holy Week has begun"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El aumento de los indicadores preocupa a los expertos.",
                "text_en": "The increase in indicators is of concern to experts.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El aumento de los indicadores preocupa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The increase in indicators is a matter of concern"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los expertos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "experts"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El investigador Daniel López Codina, miembro del BioComSC, el grupo de investigación de la UPC experto en la proyección de la epidemia, señaló el lunes en TV3 que el incremento de la movilidad permitida a inicios de Semana Santa “es uno de los temas peligrosos”, ya que “cuando hay un aumento de movilidad, hay un aumento de contactos y un incremento de los contagios”.",
                "text_en": "Researcher Daniel López Codina, member of the BioComSC, the UPC research group expert in the projection of the epidemic, said Monday on TV3 that the increase in mobility allowed at the beginning of Easter “is one of the dangerous issues”, since “when there is an increase in mobility, there is an increase in contacts and an increase in infections”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El investigador Daniel López Codina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Investigator Daniel López Codina"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Monday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en TV3",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on TV3"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el incremento de la movilidad permitida a inicios de Semana Santa “es uno de los temas peligrosos”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the increase of the mobility allowed at the beginning of Holy Week “is one of the dangerous issues”"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que “cuando hay un aumento de movilidad, hay un aumento de contactos y un incremento de los contagios”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because “when there is an increase in mobility, there is an increase in contacts and an increase in contagions”"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "32": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 24,
            "WhatReliabilityReliable": 24,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 7,
            "Who": 12,
            "WhoReliabilityReliable": 9,
            "WhoReliabilityUnreliable": 3,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 9,
            "WhereReliabilityReliable": 9,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 11,
            "HowReliabilityReliable": 10,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 2,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nDesconfía de quien asegura que su bar, hotel o restaurante está libre de coronavirus. Nadie puede garantizar un espacio seguro 100%. Todos quieren tener este reclamo merketiniano, pero es imposible, sencillamente, porque el virus no se ve\n\n<PARAGRAPH>\n\n¿Qué pensarían ustedes si yo les dijera que en Torremolinos han abierto el primer restaurante «libre de resfriados»? Probablemente me tomarían por loca.\n\n<BREAK>\n\nCualquiera con dos dedos de frente caería en la cuenta de que, en el mismo momento en que un camarero esté resfriado o de que uno de los clientes entre por la puerta estornudando o toque la barra con las manos sucias, la posibilidad de contagio existe.\n\n<PARAGRAPH>\n\nSin embargo, hace una semana la noticia del primer restaurante «covid free» acaparó titulares en los informativos sin que nadie pusiera el grito en el cielo.\n\n<BREAK>\n\nY desde entonces, otros muchos se han subido al carro de lo imposible.\n\n<BREAK>\n\nSí, de lo imposible.\n\n<BREAK>\n\nPorque es imposible garantizar un espacio «libre de coronavirus» desde el mismo instante en que una criaturita del Señor pone el pie en él.\n\n<BREAK>\n\nEntre otras cosas, porque el virus, como la procesión, va por dentro.\n\n<PARAGRAPH>\n\nUna oportunidad de negocio\n\n<PARAGRAPH>\n\nPor si, tras dos meses cerrados, la crisis dentro del sector hostelero no fuera ya suficiente, como buitres carroñeros unas cuantas empresas se han lanzado a ofrecer todo tipo de «sellos de calidad» con precios que llegan hasta los 4000 euros.\n\n<BREAK>\n\nAl parecer, es fácil caer en la trampa.\n\n<BREAK>\n\nEl reclamo marketiniano del sello «covid free» es potente y todos quieren ser los primeros en garantizar que su bar, hotel o restaurante es un espacio seguro.\n\n<BREAK>\n\n¿Quién no querría invertir en garantizar la seguridad de sus clientes ante tanta incertidumbre? ¿Quién no querría diferenciarse de la competencia?\n\n<PARAGRAPH>\n\nEstas empresas han encontrado en el miedo el salvoconducto perfecto para poder colar sus productos.\n\n<BREAK>\n\nY hablo de sus productos porque las desgracias nunca vienen solas: entre las prácticas que se implementan con algunos de estos sellos está la instalación de dispositivos de ozono que, como ya comentamos la semana pasada desde estas páginas, no sólo no garantizan la eliminación del bicho sino que además pueden entrañar riesgos.\n\n<BREAK>\n\nEl negocio es redondo.\n\n<PARAGRAPH>\n\nNo está todo perdido: guías de buenas prácticas\n\n<PARAGRAPH>\n\nPor suerte, no todo está perdido y frente a estos cuestionables reclamos que existen otras iniciativas dignas de mención.\n\n<BREAK>\n\nEntre tanto oportunismo y mercadería, existen profesionales sanitarios que han decidido ayudar al sector de la hostelería, no sólo de una forma rigurosa y ética, sino también gratuita.\n\n<BREAK>\n\nEstos profesionales sanitarios también merecen el aplauso de las ocho porque con su trabajo ayudan a la prevención de nuevos contagios.\n\n<BREAK>\n\nEs el caso de la Plataforma granadina COVID19, un proyecto impulsado de forma conjunta por los Colegios Oficiales de Farmacéuticos y de Veterinarios de Granada.\n\n<BREAK>\n\nAl frente del mismo está un equipo 16 profesionales expertos en Salud Pública, miembros del Cuerpo Superior Facultativo de Instituciones Sanitarias de la Junta de Andalucía y del Ayuntamiento de Granada.\n\n<BREAK>\n\nEn definitiva, son los mismos inspectores que antes de la pandemia se ocupaban del cumplimiento de la normativa en bares y restaurantes los que ahora se han remangado poniéndose a disposición del sector para ayudarles en esta difícil etapa.\n\n<BREAK>\n\nEl curso sobre buenas prácticas, que se realizará a través de una plataforma online, tiene dos objetivos muy claros.\n\n<BREAK>\n\nEl primero, que los empresarios y trabajadores identifiquen y analicen los riesgos propios de sus establecimientos.\n\n<BREAK>\n\nEl segundo, que puedan implementar las mejores prácticas en el servicio, instalaciones y personal para hacer frente al coronavirus.\n\n<BREAK>\n\nY todo desde el rigor y la ciencia, sin necesidad de invertir en máquinas de ozono ni prometer que tu bar se convertirá en un quirófano.\n\n<PARAGRAPH>\n\nSiete medidas para los bares y restaurantes\n\n<PARAGRAPH>\n\nEstas son siete de las medidas aconsejadas dentro de las guías de buenas prácticas para bares y restaurantes.\n\n<BREAK>\n\nAunque algunas de ellas son nuevas, otras muchas son de toda la vida y a partir de ahora conviene prestarles más atención:\n\n<PARAGRAPH>\n\n1.\n\n<BREAK>\n\nLos manteles serán preferentemente de un solo uso.\n\n<PARAGRAPH>\n\n2.\n\n<BREAK>\n\nNo habrá vinagreras ni otros elementos compartidos que vayan de mesa en mesa.\n\n<BREAK>\n\nSi necesitas aceite o queso rallado se servirá en monodosis o te lo servirá el camarero.\n\n<PARAGRAPH>\n\n3.\n\n<BREAK>\n\nLas cartas serán virtuales (es la era del código QR), con pizarras o cantadas por el camarero.\n\n<PARAGRAPH>\n\n4.\n\n<BREAK>\n\nSe recomienda una limpieza de los baños, al menos, seis veces al día.\n\n<PARAGRAPH>\n\n5.\n\n<BREAK>\n\nSe aconseja extremar la precaución con la orientación de los flujos de los aires acondicionados: pueden mover corrientes de aire y favorecer el desplaza-miento del virus.\n\n<PARAGRAPH>\n\n6.\n\n<BREAK>\n\nAdiós (esperemos que definitivo, porque esto ya estaba prohibido) a los pinchos y tapas dispuestos sobre la barra.\n\n<BREAK>\n\nLas vitrinas también deberán estar tapadas por la parte del camarero.\n\n<PARAGRAPH>\n\n7.\n\n<BREAK>\n\nNo se aconsejan los equipos e instalaciones de ozono en los locales hasta que no se conozca su eficacia debido a que requieren un manejo profesional.\n\n<PARAGRAPH>\n\nEstos son sólo algunos de los ejemplos de las medidas que encontraremos en bares y restaurantes, junto a las ya clásicas medidas de distancia de seguridad e higiene (que no por clásicas han dejado de ser importantes).\n\n<BREAK>\n\nY ante los cursos y certificaciones para el sector hostelero que ahora saldrán de debajo de las piedras, ¡importante! los certificados podrán acreditar que los trabajadores se han formado y disponen de los conocimientos para dar un buen servicio, pero desconfía de quien garantiza que su local está libre de coronavirus porque, sencillamente, cuando tú mismo entres en él ya no lo está.\n\n<BREAK>\n\nResumiendo, y como diría mi madre, ni covid fri, ni covid fra.\n\n<PARAGRAPH>\n\nConforme a los criterios de\n\n<PARAGRAPH>\n\nSaber más\n\n<PARAGRAPH>\n\n- Ciencia y Salud- Coronavirus- Covid 19\n\n<PARAGRAPH>\n\n",
        "TITLE": "El sello \"covid free\" y otros timos de la estampita",
        "ID": "5_F_04-11-2021_21-27-40_www_elmundo_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "El sello \"covid free\" y otros timos de la estampita",
                "text_en": "The label \"covid free\" and other stamp scams",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sello \"covid free\" y otros timos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "label \"covid free\" and other scams"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desconfía de quien asegura que su bar, hotel o restaurante está libre de coronavirus. Nadie puede garantizar un espacio seguro 100%. Todos quieren tener este reclamo merketiniano, pero es imposible, sencillamente, porque el virus no se ve",
                "text_en": "Trust anyone who ensures that your bar, hotel or restaurant is free of coronavirus. No one can guarantee a 100% safe space. Everyone wants to have this Merketinian claim, but it is simply impossible because the virus is not seen",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Nadie",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "No one."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puede garantizar un espacio seguro 100%",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "can guarantee a 100% safe space"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque el virus no se ve",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because the virus can't be seen"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cualquiera con dos dedos de frente caería en la cuenta de que, en el mismo momento en que un camarero esté resfriado o de que uno de los clientes entre por la puerta estornudando o toque la barra con las manos sucias, la posibilidad de contagio existe.",
                "text_en": "Anyone with two front fingers would realize that, at the same time that a waiter has a cold or that one of the customers enters through the door sneezing or touching the bar with dirty hands, the possibility of contagion exists.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la posibilidad de contagio existe",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the possibility of contagion exists"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sin embargo, hace una semana la noticia del primer restaurante «covid free» acaparó titulares en los informativos sin que nadie pusiera el grito en el cielo.",
                "text_en": "A week ago, however, news of the first covid free restaurant caught headlines in the news without anyone shouting in the sky.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hace una semana",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a week ago."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la noticia del primer restaurante «covid free» acaparó titulares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the news of the first restaurant \"covid free\" has caught headlines"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los informativos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the press"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Porque es imposible garantizar un espacio «libre de coronavirus» desde el mismo instante en que una criaturita del Señor pone el pie en él.",
                "text_en": "Because it is impossible to guarantee a space \"free of coronavirus\" from the very moment a little creature of the Lord sets foot in it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es imposible garantizar un espacio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it is impossible to guarantee a space"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "«libre de coronavirus»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "‘coronavirus-free’"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Entre otras cosas, porque el virus, como la procesión, va por dentro.",
                "text_en": "Among other things, because the virus, like the procession, goes inside.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque el virus, como la procesión, va por dentro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Because the virus, like the procession, goes inside"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por si, tras dos meses cerrados, la crisis dentro del sector hostelero no fuera ya suficiente, como buitres carroñeros unas cuantas empresas se han lanzado a ofrecer todo tipo de «sellos de calidad» con precios que llegan hasta los 4000 euros.",
                "text_en": "In case, after two months closed, the crisis within the hotel sector was not enough, as scavengers vultures a few companies have launched to offer all kinds of \"quality labels\" with prices up to 4000 euros.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "unas cuantas empresas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a few companies"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han lanzado a ofrecer todo tipo de «sellos de calidad»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have launched to offer all kinds of ‘quality labels’"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con precios que llegan hasta los 4000 euros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with prices that reach up to 4000 euros"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Al parecer, es fácil caer en la trampa.",
                "text_en": "Apparently, it's easy to fall into the trap.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es fácil caer en la trampa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's easy to fall into the trap"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El reclamo marketiniano del sello «covid free» es potente y todos quieren ser los primeros en garantizar que su bar, hotel o restaurante es un espacio seguro.",
                "text_en": "The marketinian claim of the covid free label is powerful and everyone wants to be the first to ensure that their bar, hotel or restaurant is a safe space.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "todos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "all"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "garantizar que su bar, hotel o restaurante es un espacio seguro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ensure that your bar, hotel or restaurant is a safe space"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estas empresas han encontrado en el miedo el salvoconducto perfecto para poder colar sus productos.",
                "text_en": "These companies have found in fear the perfect safe conduct to be able to strain their products.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Estas empresas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "These companies"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han encontrado en el miedo el salvoconducto perfecto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have found in fear the perfect safe conduct"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y hablo de sus productos porque las desgracias nunca vienen solas: entre las prácticas que se implementan con algunos de estos sellos está la instalación de dispositivos de ozono que, como ya comentamos la semana pasada desde estas páginas, no sólo no garantizan la eliminación del bicho sino que además pueden entrañar riesgos.",
                "text_en": "And I talk about their products because misfortunes never come alone: among the practices that are implemented with some of these seals is the installation of ozone devices that, as we mentioned last week from these pages, not only do not guarantee the removal of the bug but can also involve risks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "la instalación de dispositivos de ozono",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "installation of ozone devices"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por suerte, no todo está perdido y frente a estos cuestionables reclamos que existen otras iniciativas dignas de mención.",
                "text_en": "Fortunately, not everything is lost and in the face of these questionable claims that there are other initiatives worth mentioning.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "otras iniciativas dignas de mención",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "other noteworthy initiatives"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Entre tanto oportunismo y mercadería, existen profesionales sanitarios que han decidido ayudar al sector de la hostelería, no sólo de una forma rigurosa y ética, sino también gratuita.",
                "text_en": "Meanwhile opportunism and merchandise, there are health professionals who have decided to help the hospitality sector, not only in a rigorous and ethical way, but also free of charge.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "profesionales sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health professionals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han decidido ayudar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They've decided to help."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al sector de la hostelería",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the hospitality sector"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de una forma rigurosa y ética",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a rigorous and ethical manner"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "también gratuita",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "also free"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es el caso de la Plataforma granadina COVID19, un proyecto impulsado de forma conjunta por los Colegios Oficiales de Farmacéuticos y de Veterinarios de Granada.",
                "text_en": "This is the case of the Granada Platform COVID19, a project jointly promoted by the Official Colleges of Pharmacists and Veterinaries of Granada.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Plataforma granadina COVID19, un proyecto impulsado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Grenadian platform COVID19, a project powered by"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma conjunta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "jointly"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los Colegios Oficiales de Farmacéuticos y de Veterinarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Official Colleges of Pharmacists and Veterinaries"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Granada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Grenada"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El curso sobre buenas prácticas, que se realizará a través de una plataforma online, tiene dos objetivos muy claros.",
                "text_en": "The course on good practice, which will be conducted through an online platform, has two very clear objectives.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "curso sobre buenas prácticas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "good practice course"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a través de una plataforma online",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "through an online platform"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El primero, que los empresarios y trabajadores identifiquen y analicen los riesgos propios de sus establecimientos.",
                "text_en": "The first is for employers and workers to identify and analyse the risks inherent in their establishments.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "empresarios y trabajadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "employers and workers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "identifiquen y analicen los riesgos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "identify and analyse risks"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "establecimientos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "establishments"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El segundo, que puedan implementar las mejores prácticas en el servicio, instalaciones y personal para hacer frente al coronavirus.",
                "text_en": "The second is that they can implement best practices in the service, facilities and personnel to cope with the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "implementar las mejores prácticas en el servicio, instalaciones y personal para hacer frente al coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "implement best practices in the service, facilities and personnel to cope with the coronavirus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "servicio, instalaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "service, facilities"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "staff"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Siete medidas para los bares y restaurantes",
                "text_en": "Seven measures for bars and restaurants",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "medidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "measures"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "los bares y restaurantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "bars and restaurants"
                    }
                ],
                "evidences": [
                    {
                        "value": "Zug: From July 13 onward the canton has required clubs, bars and restaurants to gather contact details of their guests. By July 13 the canton has limited the maximum number of guests in restaurants and events to 30. On August 22 Zug introduced a number of additional measures: events with more than 100 attendees were only allowed if distancing could be maintained or masks worn. At the same time measures for bars and clubs were relaxed (100 people were allowed indoors). On October 10, Zug made a face-mask ",
                        "score": 0.5
                    },
                    {
                        "value": "Level 1: No Intervention No Intervention Level 2: Close schools All schools are closed. Level 3: Close schools, bars, and restaurants; and ban large events In addition to school closures, all bars' and restaurants' dine-in services are closed, only allowing for take-out options. Also, large gatherings are banned. Level 4: Close schools, bars, and restaurants; ban large events; and close nonessential businesses",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8350067139
                    },
                    {
                        "label": "neutral",
                        "score": 0.9878734946
                    }
                ]
            },
            {
                "text": "Estas son siete de las medidas aconsejadas dentro de las guías de buenas prácticas para bares y restaurantes.",
                "text_en": "These are seven of the recommended measures within the good practice guides for bars and restaurants.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "medidas aconsejadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recommended measures"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "bares y restaurantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "bars and restaurants"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los manteles serán preferentemente de un solo uso.",
                "text_en": "The tablecloths shall preferably be of one use only.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "manteles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "tablecloths"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de un solo uso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "single use"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No habrá vinagreras ni otros elementos compartidos que vayan de mesa en mesa.",
                "text_en": "There shall be no vinaigrators or other shared elements that go from table to table.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No habrá vinagreras ni otros elementos compartidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There will be no vinaigrators or other shared elements"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si necesitas aceite o queso rallado se servirá en monodosis o te lo servirá el camarero.",
                "text_en": "If you need oil or grated cheese, it will be served in monodose or served by the waiter.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "se servirá en monodosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will be served in single dose"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las cartas serán virtuales (es la era del código QR), con pizarras o cantadas por el camarero.",
                "text_en": "The cards will be virtual (it is the age of the QR code), with slates or sung by the waiter.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cartas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "cards"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "virtuales (es la era del código QR), con pizarras o cantadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "virtual (it is the age of the QR code), with slates or sung"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el camarero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the waiter"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se recomienda una limpieza de los baños, al menos, seis veces al día.",
                "text_en": "It is recommended to clean the bathrooms at least six times a day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "limpieza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "cleaning"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "baños",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "bathrooms"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "seis veces al día",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "six times a day"
                    }
                ],
                "evidences": [
                    {
                        "value": "Sodium hypochlorite should be freshly prepared every day, and it should not be used on metal surfaces as it is corrosive. 11 Bathrooms & toilets, including the faucets, soap dispenser, doorknobs etc. should be cleaned twice a day. First with detergent and then with hypochlorite solution wearing appropriate PPE and the toilet should be flushed while the seats are covered by the lid to prevent any aerosolization. 12 Holding the flush handle with a tissue while cleaning the toilets is also recommended.",
                        "score": 0.6299999952
                    },
                    {
                        "value": "Only 14/34 (41.2%) guidelines made recommendations with reference to dental clinic bathrooms. The main recommendations were to provide supplies for hand hygiene (14/34, 41.2%), to install hand washing and coughing guidance posters and signs, to maintain social distancing (8/34, 23.5%), and to ensure frequent disinfection of bathrooms (4/34, 11.8%).",
                        "score": 0.5199999809
                    },
                    {
                        "value": "Poor environment such as unhygienic facilities, dirty bathrooms and persistent water shortages were viewed as unsupportive. . Less than half of the students (46.5%) reported that the bathrooms they regularly used at university always had a bin to dispose of their used menstrual products, although most (54.1%) indicated that clean running water and soap were always available for handwashing. Around half of the students indicated that, most of the time, bathrooms had enough privacy (43.6%), functional toilets (47.4%), locks on doors (47.3%) and toilet paper (51.4%) and were clean and sanitary (43.9%) ( Table 3 ).",
                        "score": 0.5
                    },
                    {
                        "value": "Less than half of the students (46.5%) reported that the bathrooms they regularly used at university always had a bin to dispose of their used menstrual products, although most (54.1%) indicated that clean running water and soap were always available for handwashing. Around half of the students indicated that, most of the time, bathrooms had enough privacy (43.6%), functional toilets (47.4%), locks on doors (47.3%) and toilet paper (51.4%) and were clean and sanitary (43.9%) ( Table 3 ).",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9991726279
                    },
                    {
                        "label": "neutral",
                        "score": 0.9242539406
                    },
                    {
                        "label": "neutral",
                        "score": 0.9735190272
                    },
                    {
                        "label": "neutral",
                        "score": 0.9986115694
                    }
                ]
            },
            {
                "text": "Estos son sólo algunos de los ejemplos de las medidas que encontraremos en bares y restaurantes, junto a las ya clásicas medidas de distancia de seguridad e higiene (que no por clásicas han dejado de ser importantes).",
                "text_en": "These are just some of the examples of the measures that we will find in bars and restaurants, along with the already classic distance measures of safety and hygiene (which not by classics have ceased to be important).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "clásicas medidas de distancia de seguridad e higiene",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "classic distance safety and hygiene measures"
                    }
                ],
                "evidences": [
                    {
                        "value": "Improved knowledge of the effect of social distancing measures, such as limitations on the serving of alcohol, may be important for stopping the spread of the virus in both bartenders and waiters, and the general population. It might also be important knowledge to owners of restaurants and bars, to protect their workers.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9962489009
                    }
                ]
            },
            {
                "text": "Y ante los cursos y certificaciones para el sector hostelero que ahora saldrán de debajo de las piedras, ¡importante! los certificados podrán acreditar que los trabajadores se han formado y disponen de los conocimientos para dar un buen servicio, pero desconfía de quien garantiza que su local está libre de coronavirus porque, sencillamente, cuando tú mismo entres en él ya no lo está.",
                "text_en": "And before the courses and certifications for the hospitality sector that will now come out from under the stones, important! the certificates will be able to prove that the workers have been trained and have the knowledge to provide a good service, but it is distrustful of those who guarantee that their place is free of coronavirus because, simply, when you enter it yourself it is no longer.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desconfía de quien garantiza que su local está libre de coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "distrust of those who guarantee that their premises are free of coronavirus"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "quien garantiza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "who guarantees"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "local",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "local"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque, sencillamente, cuando tú mismo entres en él ya no lo está",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because, quite simply, when you enter it yourself it is no longer"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "tú mismo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "You yourself."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "él",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "him."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Resumiendo, y como diría mi madre, ni covid fri, ni covid fra.",
                "text_en": "In short, and as my mother would say, neither covid fri, nor covid fra.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ni covid fri, ni covid fra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "neither covid fri, nor covid fra"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "33": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 30,
            "WhatReliabilityReliable": 12,
            "WhatReliabilityUnreliable": 18,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 21,
            "WhoReliabilityReliable": 17,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 7,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 13,
            "WhereReliabilityReliable": 11,
            "WhereReliabilityUnreliable": 2,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 7,
            "HowReliabilityReliable": 4,
            "HowReliabilityUnreliable": 3,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 1,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 16,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 8,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLas comunidades autónomas no pueden legislar sobre la vacunación obligatoria\n\n<PARAGRAPH>\n\nEl pasado 23 de febrero se ha consumado la anunciada tropelía de la aprobación con la mayoría absoluta del PP de Galicia de la Ley de Salud de Galicia, acuñada por algunos como Ley “Auschwitz”.\n\n<BREAK>\n\nEspero que la fecha elegida no tenga una connotación con el fascismo.\n\n<BREAK>\n\nDesde luego, la tiene con el autoritarismo.\n\n<BREAK>\n\nSe han pasado por el arco del triunfo la Constitución Española, los Convenios Internacionales firmados por España, los Derechos Humanos y un sin fin de normas, además de atribuirse funciones y competencias que sólo le corresponden al gobierno central, actuando de facto como un reino de taifas.\n\n<BREAK>\n\nEn definitiva, el Estado de Derecho.\n\n<BREAK>\n\nEs una reproducción de la Ley 3/2020, de 3 de diciembre, de Salud de Aragón.\n\n<BREAK>\n\nTal para cual.\n\n<BREAK>\n\nAmbas son  un asalto a la libertad con esquela incluida del atentado contra los derechos fundamentales y libertades públicas de los gallegos, aragoneses y del resto de españoles que osen visitar sus feudos.\n\n<BREAK>\n\nCentrándonos, en la ley gallega, la portavoz del PP aseguró que esta ley ofrece “más seguridad jurídica”.\n\n<BREAK>\n\nHasta donde sé, la seguridad jurídica es la suma de certeza, legalidad, jerarquía e interdicción de la arbitrariedad (TC).\n\n<BREAK>\n\nLo contrario a la reforma ¡Qué felonía y traición a los derechos de un pueblo tan noble! De nada han servido las sorprendentes llamadas de los portavoces de PSGA y BNGA, que calificaron la reforma como un disparate, dado que restringe derechos y libertades, además de ser una norma totalitaria, cuando los gallegos están sufriendo las medidas más duras y restrictivas de España.\n\n<PARAGRAPH>\n\nEsa “seguridad jurídica” sólo debe existir en la imaginación del PPGA, a modo de existencia de un ente que tiene en sí mismo el principio de la acción y su fin.\n\n<BREAK>\n\nVamos una entelequia.\n\n<BREAK>\n\nUna Ley que, saltándose los derechos fundamentales y humanos previstos en la CE y Tratados Internacionales, permite la prohibición o restricción del derecho de reunión; prohibición de la movilidad; cierres perimetrales; intervención de empresas y bienes; hospitalizaciones y tratamientos forzosos; internamientos en lugares por definir y la vacunación obligatoria, entre otras barbaridades.\n\n<BREAK>\n\nTambién, atribuye la condición de autoridad o agente a quien carece de la misma.\n\n<BREAK>\n\nEs decir, legaliza “la policía de balcón”, como los confidentes de la Stasi de Ceaucescu o la Cheka de Lenin.\n\n<BREAK>\n\nEsa “seguridad jurídica”, sólo puede estar en el mito de la santa compaña.\n\n<BREAK>\n\nEn el miedo a la muerte que propagan interesadamente cada minuto.\n\n<BREAK>\n\nSon medidas propias del feudalismo y del totalitarismo.\n\n<BREAK>\n\nSon los excrementos de la libertad.\n\n<BREAK>\n\nSe trata de dos despropósitos legislativos, contra los que ya se han presentado querellas criminales por delitos de prevaricación, odio y contra los derechos fundamentales y libertades públicas.\n\n<BREAK>\n\nA tal respecto, la Dra.\n\n<BREAK>\n\nNatalia Prego ha dicho “La aprobación de la Ley de Salud de Galicia es una ignominia al pueblo gallego”.\n\n<PARAGRAPH>\n\nY, precisamente, un día después de que el Parlamento de Galicia haya aprobado la reforma de la Ley de Salud, la Fiscalía del Tribunal Supremo en un Dictamen ha censurado la vacunación obligatoria.\n\n<BREAK>\n\nEn este sentido, la Fiscalía ha concluido que “En tanto la ley no establezca la obligación de vacunarse, no cabe invocar razones genéricas de salud pública o específicamente basadas en la especial vulnerabilidad de determinados grupos de personas”.\n\n<BREAK>\n\nTambién señala que “ni en el marco de la legislación sanitaria ordinaria, ni en el de la normativa excepcional contenida o dictada al amparo del R.D.\n\n<BREAK>\n\n926/2020, por el que se declara el estado de alarma, ni en las disposiciones que lo aplican y desarrollan, se ha establecido por ahora con carácter obligatorio la vacunación de la ciudadanía…”.\n\n<BREAK>\n\nLa decisión, señala el dictamen, corresponde a la persona afectada, que puede prestar o negar su  consentimiento.\n\n<BREAK>\n\nTambién hace referencia a la justificación de una limitación temporal del derecho a la libre circulación, que debe ir acompañada de la acreditación suficiente de un riesgo específico, como estar contagiado o haber estado en contacto con un enfermo.\n\n<PARAGRAPH>\n\nEn el mismo sentido, se pronunció la Subdirección General de Recursos Humanos de la Dirección General de la Policía, que con fecha 22 de febrero envió una Circular a los policías diciéndoles: “Conocido es que la vacunación es un acto voluntario  en todo el territorio nacional, (…)”.\n\n<PARAGRAPH>\n\nSi no fuera bastante, el propio PP de Galicia publicó, después de aprobar la reforma de su Ley de Salud, que “su aprobación no hace que la vacuna sea obligatoria.\n\n<BREAK>\n\nEsa decisión no compete a la Xunta de Galicia” ¿Lo entienden? ¿Feijoó ahora lo ha entendido y reconoce que no tienen competencia, ni para la obligatoriedad de la vacuna, ni para el resto de las medidas si no están avaladas por el gobierno central? Es un virtuoso de la estrategia engañosa.\n\n<BREAK>\n\nUn ejemplo de dictador benevolente a ojos de buen cubero.\n\n<BREAK>\n\nPero, no se olviden, que la ley sigue en vigor.\n\n<BREAK>\n\nTodo ello, a pesar de que recientemente el Consejo de Europa ya prohibió la vacunación obligatoria y la discriminación de los no vacunados en la Resolución “Vacunas Covid-19: Consideraciones éticas, legales y prácticas”, aprobada con fecha 27/01/2021 (7.3.1 y 7.3.2).\n\n<PARAGRAPH>\n\nPero, les da igual, han volteado la libertad.\n\n<BREAK>\n\nLa han matado y publicado su esquela de asfixia al ciudadano libre.\n\n<BREAK>\n\nComo decía Ignacio Ruiz-Quintano en su columna de ABC “En teoría una comunidad autónoma no podría legislar sobre la vacunación obligatoria, pero en la práctica si podría hacerlo –dice el constitucionalista Blanco Valdés, un Hugo Preuss de Feijoó.\n\n<BREAK>\n\nPreuss pasa por “padre” de Weimar y Blanco podría pasar por “padre” de Breogan, la taifa de Feijoo, cuya política covidiana (pruebas rectales, vacunas obligatorias) parece hija adulterina del decisionismo de Franco (¡aquel decreto del 44!) (…).\n\n<BREAK>\n\nCon la teoría de la Constitución y con la práctica de nuestro cojonudismo.\n\n<BREAK>\n\nLo llaman moderación, que <<nada hay más moderado que los modales de los atados al poder con pactos secretos de inmoralidad política>>”.\n\n<BREAK>\n\nAl final, lo que haces hoy es el resultado de lo que pasará mañana.\n\n<PARAGRAPH>\n",
        "TITLE": "El asalto a la libertad",
        "ID": "NF_04-11-2021_21-11-40_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "El asalto a la libertad",
                "text_en": "The Assault on Freedom",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El asalto a la libertad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The Assault on Freedom"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las comunidades autónomas no pueden legislar sobre la vacunación obligatoria",
                "text_en": "Autonomous communities cannot legislate on compulsory vaccination",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Las comunidades autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Autonomous Communities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no pueden legislar sobre la vacunación obligatoria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "cannot legislate on compulsory vaccination"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El pasado 23 de febrero se ha consumado la anunciada tropelía de la aprobación con la mayoría absoluta del PP de Galicia de la Ley de Salud de Galicia, acuñada por algunos como Ley “Auschwitz”.",
                "text_en": "On February 23, the announced trope of approval with the absolute majority of the Galician PP of the Galician Health Law, coined by some as the “Auschwitz” Law, was completed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El pasado 23 de febrero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last February 23rd"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha consumado la anunciada tropelía de la aprobación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the announced tropel of approval has been completed"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la mayoría absoluta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with the absolute majority"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "PP",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "PP"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Galicia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Galicia"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por algunos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by some"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Espero que la fecha elegida no tenga una connotación con el fascismo.",
                "text_en": "I hope that the chosen date does not have a connotation with fascism.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la fecha elegida no tenga una connotación con el fascismo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the chosen date does not have a connotation with fascism"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desde luego, la tiene con el autoritarismo.",
                "text_en": "Of course, he has it with authoritarianism.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la tiene con el autoritarismo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has it with authoritarianism"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se han pasado por el arco del triunfo la Constitución Española, los Convenios Internacionales firmados por España, los Derechos Humanos y un sin fin de normas, además de atribuirse funciones y competencias que sólo le corresponden al gobierno central, actuando de facto como un reino de taifas.",
                "text_en": "The Spanish Constitution, the International Conventions signed by Spain, Human Rights and an endless array of norms have passed through the arch of triumph, in addition to attributing functions and competences that correspond only to the central government, acting de facto as a kingdom of taifas.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Se han pasado por el arco del triunfo la Constitución Española, los Convenios Internacionales firmados por España, los Derechos Humanos y un sin fin de normas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The Spanish Constitution, the International Conventions signed by Spain, Human Rights and an endless array of norms have passed through the arch of triumph."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al gobierno central",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the central government"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es una reproducción de la Ley 3/2020, de 3 de diciembre, de Salud de Aragón.",
                "text_en": "It is a reproduction of Law 3/2020, of 3 December, of Health of Aragon.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Es una reproducción de la Ley 3/2020, de 3 de diciembre, de Salud de Aragón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It is a reproduction of Law 3/2020, of 3 December, of Health of Aragon"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "3 de diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "3 December"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Aragón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Aragon"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ambas son  un asalto a la libertad con esquela incluida del atentado contra los derechos fundamentales y libertades públicas de los gallegos, aragoneses y del resto de españoles que osen visitar sus feudos.",
                "text_en": "Both are an assault on freedom, including the violation of the fundamental rights and public freedoms of Galicians, Aragonese and other Spaniards who dare to visit their fiefdoms.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Ambas son  un asalto a la libertad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Both are an assault on freedom"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con esquela incluida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with esquela included"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "del atentado contra los derechos fundamentales y libertades públicas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "violation of fundamental rights and public freedoms"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los gallegos, aragoneses y del resto de españoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Galicians, Aragonese and the rest of Spaniards"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Centrándonos, en la ley gallega, la portavoz del PP aseguró que esta ley ofrece “más seguridad jurídica”.",
                "text_en": "Focusing on Galician law, the PP spokesman said that this law offers “more legal certainty.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la portavoz del PP",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the PP spokesman"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aseguró que esta ley ofrece “más seguridad jurídica”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "assured that this law offers “more legal certainty”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo contrario a la reforma ¡Qué felonía y traición a los derechos de un pueblo tan noble! De nada han servido las sorprendentes llamadas de los portavoces de PSGA y BNGA, que calificaron la reforma como un disparate, dado que restringe derechos y libertades, además de ser una norma totalitaria, cuando los gallegos están sufriendo las medidas más duras y restrictivas de España.",
                "text_en": "The opposite of the reform What a felony and betrayal of the rights of such a noble people! The surprising calls of PSGA and BNGA spokesmen, who called the reform a nonsense, have served nothing, since it restricts rights and freedoms, besides being a totalitarian norm, when Galicians are suffering the harshest and most restrictive measures in Spain.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los portavoces de PSGA y BNGA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "PSGA and BNGA spokespersons"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "calificaron la reforma como un disparate",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They called the reform a nonsense."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "dado que restringe derechos y libertades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since it restricts rights and freedoms"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esa “seguridad jurídica” sólo debe existir en la imaginación del PPGA, a modo de existencia de un ente que tiene en sí mismo el principio de la acción y su fin.",
                "text_en": "Such “legal security” must exist only in the PPGA’s imagination, as an entity that has in itself the principle of action and its end.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esa “seguridad jurídica” sólo debe existir",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Such “legal certainty” should only exist"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la imaginación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the imagination"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del PPGA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the PPGA"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una Ley que, saltándose los derechos fundamentales y humanos previstos en la CE y Tratados Internacionales, permite la prohibición o restricción del derecho de reunión; prohibición de la movilidad; cierres perimetrales; intervención de empresas y bienes; hospitalizaciones y tratamientos forzosos; internamientos en lugares por definir y la vacunación obligatoria, entre otras barbaridades.",
                "text_en": "A law that, with the exception of the fundamental and human rights provided for in the EC and International Treaties, allows the prohibition or restriction of the right of assembly; prohibition of mobility; perimeter closures; intervention of companies and property; hospitalizations and forced treatment; placements in places to be defined and compulsory vaccination, among other barbarities.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Una Ley que, saltándose los derechos fundamentales y humanos previstos en la CE y Tratados Internacionales, permite la prohibición o restricción del derecho",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "A law which, by disregarding the fundamental and human rights provided for in the EC and International Treaties, allows the prohibition or restriction of the right"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "saltándose los derechos fundamentales y humanos previstos en la CE y Tratados Internacionales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "ignoring the fundamental and human rights provided for in the EC and International Treaties"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en lugares por definir",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in places to be defined"
                    }
                ],
                "evidences": [
                    {
                        "value": "Right now, the temptation is very strong to do \"whatever is necessary\" (Sevastopulo et al. 2020) . Undoubtedly, in times of crisis there is an increased need for governments to monitor and control the public, which might make it necessary to limit individual freedom. Such decisionism characterizes many emergencies. Constitutions and human rights, however, are designed with such crises in mind. Furthermore, the International Covenant on Civil and Political Rights (ICCPR) and on the European level the European Convention on Human Rights (ECHR), are prepared to deal with such situations. Considering such developments from a formal perspective, it is useful to take a look at the legal and institutional framework of the Council of Europe (CoE). This international organization administers and controls one of the most important international human rights treaties guaranteeing individual freedoms, the European Convention on Human Rights (ECHR). The CoE has established procedures and case-law for times of crisis like the current one (Mokhtar 2004 ). Furthermore, Article 4 of the ICCPR is similarly worded and beyond that requires state parties to report to all other parties via the UN Secretariat. Certain rights such as the right to life (except in respect of deaths resulting from lawful acts of war), the prohibition of torture and other forms of ill-treatment, the prohibition of slavery or servitude, and the rule of no punishment without law are non-derogable. However, many other rights are subject to derogation, including particularly the right to privacy, freedom of expression, the freedom of movement, as well as the freedom of assembly and association. Such derogations may only be of temporary nature (Zwitter 2012) . Both of these legal frameworks allow states for some flexibility by enabling them to temporarily derogate from some rights.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "Germany, in contrast, took a position more extreme then did France and adopted the territorial criterion applied in the common law. German legislation denied access to court, first and foremost, to any enemy alien dwelling outside Germany and to any corporation located beyond German borders, irrespective of whether in enemy or neutral territory (However, like England, the exercise of the right to defend oneself as a respondent was retained). 12 Germany's Chancellor received broad authority to set individual exceptions. Due to the territorial test, French or English subjects residing in Germany during the war, and French or English corporations operating primarily from German soil, or having branches in Germany, were awarded the option of access to court. 13 Although the civil law rule is in general more liberal than the common law rule, in practice differences are not significant. Most of the civil law states enacted during WWI special legislation banned any governmental or private trade with the enemy. Enemy aliens were not allowed to sue, even if the contract or the commercial relation were signed before the outbreak of the war. This approach was maintained during WWII. 14 An absolute prohibition was in tort law. Most of the civil law states, similarly to the UK and the US, enacted legislation providing strict immunity for the state from enemy aliens' war damages claims (Hogg and Monahan 2000; Frulli 2003; Engle 2005; Hofmann and Riemann 2004) . 15 In public claims regarding the war's conduct, the rule was even stricter (McNair 1915).",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9959003329
                    },
                    {
                        "label": "neutral",
                        "score": 0.9215521216
                    }
                ]
            },
            {
                "text": "También, atribuye la condición de autoridad o agente a quien carece de la misma.",
                "text_en": "It also attributes the status of authority or agent to those who lack it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "atribuye la condición de autoridad o agente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "assigns the status of authority or agent"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a quien carece de la misma",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to those who lack it"
                    }
                ],
                "evidences": [
                    {
                        "value": "The empirical research on epistemic authority (Kruglanski, 1989; Kruglanski, et al., 2005) focused mainly on the selection processes in which individuals choose model figures to serve as epistemic authorities for them, but did not examine the actual social behavior of these authority figures. The epistemic authority is a hypothetical figure, a symbolic relevant role holder. In real life settings, people continuously observe their chosen epistemic authorities and interact with them. Therefore, some selected figures might have higher chances of attaining stability in their status, whereas others might lose their privileged status in the eyes of their followers. The well-known term \"clay feet\" reflects disappointment with selected idols following the accumulation of social information.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9919335246
                    }
                ]
            },
            {
                "text": "Son medidas propias del feudalismo y del totalitarismo.",
                "text_en": "They are measures typical of feudalism and totalitarianism.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Son medidas propias del feudalismo y del totalitarismo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "These are measures typical of feudalism and totalitarianism."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Son los excrementos de la libertad.",
                "text_en": "They're the excrement of freedom.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Son los excrementos de la libertad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're the excrement of freedom."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se trata de dos despropósitos legislativos, contra los que ya se han presentado querellas criminales por delitos de prevaricación, odio y contra los derechos fundamentales y libertades públicas.",
                "text_en": "These are two legislative misdemeanours, against which criminal charges have already been brought for offences of prevarication, hatred and against fundamental rights and public freedoms.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya se han presentado querellas criminales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Criminal complaints have already been filed"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por delitos de prevaricación, odio y contra los derechos fundamentales y libertades públicas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for offences of prevarication, hatred and against fundamental rights and public freedoms"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Natalia Prego ha dicho “La aprobación de la Ley de Salud de Galicia es una ignominia al pueblo gallego”.",
                "text_en": "Natalia Prego has said “The adoption of the Galician Health Law is a disgrace to the Galician people.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Natalia Prego",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Natalia Prego"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La aprobación de la Ley de Salud de Galicia es una ignominia al pueblo gallego",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The adoption of the Galician Health Law is a disgrace to the Galician people"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Galicia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Galicia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y, precisamente, un día después de que el Parlamento de Galicia haya aprobado la reforma de la Ley de Salud, la Fiscalía del Tribunal Supremo en un Dictamen ha censurado la vacunación obligatoria.",
                "text_en": "And, precisely one day after the Galician Parliament approved the reform of the Health Law, the Supreme Court's Public Prosecutor's Office in an Opinion has censored compulsory vaccination.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Galicia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Galicia"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Fiscalía del Tribunal Supremo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Office of the Public Prosecutor of the Supreme Court"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en un Dictamen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an opinion"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha censurado la vacunación obligatoria",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has censored compulsory vaccination"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También señala que “ni en el marco de la legislación sanitaria ordinaria, ni en el de la normativa excepcional contenida o dictada al amparo del R.D.",
                "text_en": "It also states that “neither under ordinary health legislation nor under exceptional regulations contained or issued under the R.D.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "ni en el marco de la legislación sanitaria ordinaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "or in the framework of ordinary health legislation"
                    }
                ],
                "evidences": []
            },
            {
                "text": "926/2020, por el que se declara el estado de alarma, ni en las disposiciones que lo aplican y desarrollan, se ha establecido por ahora con carácter obligatorio la vacunación de la ciudadanía…”.",
                "text_en": "926/2020, declaring the state of alarm, nor in the provisions that apply it and develop it, the vaccination of the citizenry has been established for the time being on a mandatory basis ...”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las disposiciones que lo aplican y desarrollan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the implementing and implementing provisions"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha establecido por ahora con carácter obligatorio la vacunación de la ciudadanía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vaccination of the citizenry has been established for the time being on a compulsory basis"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "por ahora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For now"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con carácter obligatorio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on a mandatory basis"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el mismo sentido, se pronunció la Subdirección General de Recursos Humanos de la Dirección General de la Policía, que con fecha 22 de febrero envió una Circular a los policías diciéndoles: “Conocido es que la vacunación es un acto voluntario  en todo el territorio nacional, (…)”.",
                "text_en": "In the same vein, the Subdirectorate General of Human Resources of the General Directorate of the Police, who on 22 February sent a Circular to the police saying: “I know that vaccination is a voluntary act throughout the national territory, (...)”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Subdirección General de Recursos Humanos de la Dirección General de la Policía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sub-Directorate-General for Human Resources of the Police Directorate-General"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "con fecha 22 de febrero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "dated 22 February 2007"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "envió una Circular",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "sent a Circular"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los policías",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the police"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la vacunación es un acto voluntario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccination is a voluntary act"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en todo el territorio nacional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout the national territory"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si no fuera bastante, el propio PP de Galicia publicó, después de aprobar la reforma de su Ley de Salud, que “su aprobación no hace que la vacuna sea obligatoria.",
                "text_en": "If not enough, the PP of Galicia itself published, after approving the reform of its Health Law, that “its approval does not make the vaccine compulsory.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el propio PP",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the PP itself"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Galicia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Galicia"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de aprobar la reforma de su Ley de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after passing the reform of its Health Act"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "su aprobación no hace que la vacuna sea obligatoria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "its approval does not make the vaccine compulsory"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esa decisión no compete a la Xunta de Galicia” ¿Lo entienden? ¿Feijoó ahora lo ha entendido y reconoce que no tienen competencia, ni para la obligatoriedad de la vacuna, ni para el resto de las medidas si no están avaladas por el gobierno central? Es un virtuoso de la estrategia engañosa.",
                "text_en": "This decision does not belong to the Xunta de Galicia” Do you understand it? Did you now understand it and recognize that you have no competence, neither for the obligatory vaccination, nor for the rest of the measures if they are not endorsed by the central government? It is a virtuous of the misleading strategy.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Feijoó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Feijoó"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ahora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Now"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reconoce que no tienen competencia",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "recognizes that they have no competence"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "si no están avaladas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "if they're not backed up."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por el gobierno central",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the central government"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un ejemplo de dictador benevolente a ojos de buen cubero.",
                "text_en": "An example of a benevolent dictator in the eyes of a good cubero.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Un ejemplo de dictador benevolente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "An example of a benevolent dictator"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero, no se olviden, que la ley sigue en vigor.",
                "text_en": "But, don't forget, the law is still in force.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la ley sigue en vigor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the law is still in force"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Todo ello, a pesar de que recientemente el Consejo de Europa ya prohibió la vacunación obligatoria y la discriminación de los no vacunados en la Resolución “Vacunas Covid-19: Consideraciones éticas, legales y prácticas”, aprobada con fecha 27/01/2021 (7.3.1 y 7.3.2).",
                "text_en": "All this, despite the fact that the Council of Europe has recently banned compulsory vaccination and discrimination against non-vaccinated persons in the Resolution “Vacunas Covid-19: Ethical, legal and practical considerations”, adopted on 27/01/2021 (7.3.1 and 7.3.2).",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Consejo de Europa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Council of Europe"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "prohibió la vacunación obligatoria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "prohibited compulsory vaccination"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Resolución “Vacunas Covid-19: Consideraciones éticas, legales y prácticas”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Resolution “Vacunas Covid-19: Ethical, legal and practical considerations”"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "con fecha 27/01/2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "dated 27/01/2021"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero, les da igual, han volteado la libertad.",
                "text_en": "But they don't care, they've turned freedom around.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han volteado la libertad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They've turned freedom upside down."
                    }
                ],
                "evidences": []
            },
            {
                "text": "La han matado y publicado su esquela de asfixia al ciudadano libre.",
                "text_en": "She has been killed and published by her suffocation scheme for the free citizen.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La han matado y publicado su esquela de asfixia",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "She's been killed and published by her suffocation skeleton."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al ciudadano libre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the free citizen"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Como decía Ignacio Ruiz-Quintano en su columna de ABC “En teoría una comunidad autónoma no podría legislar sobre la vacunación obligatoria, pero en la práctica si podría hacerlo –dice el constitucionalista Blanco Valdés, un Hugo Preuss de Feijoó.",
                "text_en": "As Ignacio Ruiz-Quintano said in his ABC column “In theory an autonomous community could not legislate on compulsory vaccination, but in practice if it could do so,” says constitutionalist Blanco Valdés, a Hugo Preuss de Feijoó.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ignacio Ruiz-Quintano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ignacio Ruiz-Quintano"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su columna de ABC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in your ABC column"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una comunidad autónoma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "an autonomous community"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no podría legislar sobre la vacunación obligatoria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "could not legislate on compulsory vaccination"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo llaman moderación, que <<nada hay más moderado que los modales de los atados al poder con pactos secretos de inmoralidad política>>”.",
                "text_en": "They call it moderation, that nothing is more moderate than the manners of those bound to power with secret covenants of political immorality>>.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nada hay más moderado que los modales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "There is nothing more moderate than manners"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los atados al poder",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "those bound to power"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con pactos secretos de inmoralidad política",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with secret covenants of political immorality"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "34": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 11,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 13,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 7,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nEn base a los resultados arrojados por clínicos de fase III realizados por la compañía anglo-sueca en su laboratorio de Estados Unidos, AstraZeneca afirma que su vacuna tiene una efectividad del 79% y no aumenta el riesgo de coágulos.\n\n<BREAK>\n\nTras la polémica generada en las últimas semanas después de que se detectaron trombos y problemas de coagulación, la Agencia Europea de Medicamentos (EMA) concluyó que no existen riesgos.\n\n<BREAK>\n\nEn España, Sanidad y las Autonomías deciden hoy si se utilizará en mayores de 55 años.No aumenta el riesgo de trombos, afirma AstraZenecaSegún los resultados del estudio comunicados por el laboratorio de la compañía, la vacuna tendría un 79% de efectividad en la población general, un 100% de efectividad para prevenir formas graves de COVID-19 y no aumentaría el riesgo de trombos.Los ensayos de fase III implementados por la farmacéutica AstraZeneca y la Universidad de Oxford se realizaron con 32.449 participantes.\n\n<BREAK>\n\nEl 20% tenía más de 65 años y el 60% tenía los problemas de salud que se relacionan con una forma grave de COVID-19, como obesidad, diabetes y problemas cardíacos.\n\n<BREAK>\n\nSin embargo, no ha habido evidencias de un aumento en los problemas cardiovasculares, especialmente trombosis.¿Reanudarán la vacunación de AstraZeneca?Los principales países de la Unión Europea, como Alemania, Italia, Francia y España, reanudarán la vacunación después que la Agencia Europea de Medicamentos (EMA) revisara la vacuna y concluyera que no está asociada a un mayor riesgo de coágulos.Pero corresponde a cada uno de los países decidir si se reanuda la vacunación, cuándo y en qué grupos se administrará.\n\n<BREAK>\n\nEn España, la vacunación se reanudará el miércoles.El Consejo Interterritorial de Salud se reúne hoy lunes en una sesión extraordinaria para llegar a un acuerdo sobre si extender la vacunación de AstraZeneca a los mayores de 55 años.\n\n<BREAK>\n\nEs de destacar que, según la farmacéutica, la eficacia de su fármaco aumenta hasta un 80% en el grupo de los mayores de 65 años.Este es uno de los argumentos de la Ponencia de Vacunas del Ministerio de Sanidad para ampliar la inmunización a la franja de entre los 55 y los 65 años, como se está utilizando en otros países de la UE.En Francia, por ejemplo, se ha decidido se administrará únicamente la vacuna de AstraZeneca a los mayores de 55 años.\n\n<BREAK>\n\nUna de las razones de mayor peso es que, pese a la pérdida de confianza, en este grupo de edad no hay constancia de trombosis.Comparte esta noticia en tus redes y déjanos tus comentarios.",
        "TITLE": "Coronavirus: AstraZeneca afirma que su vacuna es 79% efectiva",
        "ID": "NF_04-11-2021_21-27-56_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Coronavirus: AstraZeneca afirma que su vacuna es 79% efectiva",
                "text_en": "Coronavirus: AstraZeneca claims its vaccine is 79% effective",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "afirma que su vacuna es 79% efectiva",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "claims that his vaccine is 79% effective"
                    }
                ],
                "evidences": [
                    {
                        "value": "On March 15th 2021, several European countries, including Italy, temporarily suspended the use of the COVID-19 vaccine developed by AstraZeneca, following sparse reports of serious side effects. Figure 6 reports the emotional profiles of \"vaccine\" and \"astrazeneca\" in popular tweets gathered in the next few days after the suspension. In comparison with the popular perceptions observed in December 2020 and in January 2021, as summarised in Figure 2 , the temporary suspension of the AstraZeneca vaccine had drastic effects over social discourse in the Italian twittersphere but not in the English one.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.999325633
                    }
                ]
            },
            {
                "text": "En base a los resultados arrojados por clínicos de fase III realizados por la compañía anglo-sueca en su laboratorio de Estados Unidos, AstraZeneca afirma que su vacuna tiene una efectividad del 79% y no aumenta el riesgo de coágulos.",
                "text_en": "Based on the results of Phase III clinicians performed by the Anglo-Swedish company in its laboratory in the United States, AstraZeneca states that its vaccine has an effectiveness of 79% and does not increase the risk of clots.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "En base a los resultados arrojados por clínicos de fase III",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Based on results from phase III clinicians"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su laboratorio de Estados Unidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in his laboratory in the United States"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "afirma que su vacuna tiene una efectividad del 79% y no aumenta el riesgo de coágulos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "claims that your vaccine has an effectiveness of 79% and does not increase the risk of clots"
                    }
                ],
                "evidences": [
                    {
                        "value": "Vaccine effectiveness against more severe outcomes were higher when compared to symptomatic infection. For the 65-79 yo cohort VE varied between 89% (AstraZeneca vaccines) and 95% (mRNA vaccines). For the 80 and more yo cohort, mRNA VE against hospitalizations was estimated at 76%. Due to small size of the group exposed among 80 or more years old population VE against hospitalizations for AstraZeneca vaccine was not estimated.",
                        "score": 0.5899999738
                    },
                    {
                        "value": "Previously, the heterologous prime-boost regimens have been extensively applied in the (human immunodeficiency virus) HIV vaccination. It has been reported that heterologous prime-boost vaccines can yield intensive and extensive immune responses. 7 The Oxford/AstraZeneca vaccine (ChAdOx1 nCoV19 adenovirus-based vector-vaccine) and Pfizer BioNTech (BNT162b2, COVID-19 mRNA vaccine) and Moderna vaccines (BNT162b2 or mRNA-1273 mRNAbased vaccines) are among the most commonly distributed vaccines worldwide. These vaccines have shown an excellent immunogenic response and remarkably effective specific immune response for preventing infection with the SARS-CoV-2 virus. 8 An efficacy of 63% for the AstraZeneca vaccine, 95% for Pfizer BioNTech vaccine, and 94% for the Moderna vaccine have been reported against COVID-19, [9] [10] [11] although the surveillance and analysis of vaccine effectiveness against new SARS-CoV-2 variants continues.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9909632802
                    },
                    {
                        "label": "neutral",
                        "score": 0.9995641112
                    }
                ]
            },
            {
                "text": "Tras la polémica generada en las últimas semanas después de que se detectaron trombos y problemas de coagulación, la Agencia Europea de Medicamentos (EMA) concluyó que no existen riesgos.",
                "text_en": "Following the controversy in recent weeks after thrombus and clotting problems were detected, the European Medicines Agency (EMA) concluded that there are no risks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las últimas semanas después de que se detectaron trombos y problemas de coagulación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last few weeks after thrombus and clotting problems were detected"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea de Medicamentos (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "concluyó que no existen riesgos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "concluded that there are no risks"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En España, Sanidad y las Autonomías deciden hoy si se utilizará en mayores de 55 años.No aumenta el riesgo de trombos, afirma AstraZenecaSegún los resultados del estudio comunicados por el laboratorio de la compañía, la vacuna tendría un 79% de efectividad en la población general, un 100% de efectividad para prevenir formas graves de COVID-19 y no aumentaría el riesgo de trombos.Los ensayos de fase III implementados por la farmacéutica AstraZeneca y la Universidad de Oxford se realizaron con 32.449 participantes.",
                "text_en": "In Spain, Health and Autonomy decide today if it will be used in older than 55 years.The risk of thrombus does not increase, says AstraZenecaAccording to the results of the study reported by the company's laboratory, the vaccine would be 79% effective in the general population, 100% effective in preventing severe forms of COVID-19 and would not increase the risk of thrombus.The phase III trials implemented by the pharmaceutical company AstraZeneca and the University of Oxford were conducted with 32,449 participants.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Spain"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad y las Autonomías",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health and Autonomy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deciden hoy si se utilizará",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "decide today if it will be used"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en mayores de 55 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in over 55 years of age"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los ensayos de fase III implementados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Phase III trials implemented"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la farmacéutica AstraZeneca y la Universidad de Oxford",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the pharmaceutical company AstraZeneca and the University of Oxford"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "32.449 participantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "32,449 participants"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sin embargo, no ha habido evidencias de un aumento en los problemas cardiovasculares, especialmente trombosis.¿Reanudarán la vacunación de AstraZeneca?Los principales países de la Unión Europea, como Alemania, Italia, Francia y España, reanudarán la vacunación después que la Agencia Europea de Medicamentos (EMA) revisara la vacuna y concluyera que no está asociada a un mayor riesgo de coágulos.Pero corresponde a cada uno de los países decidir si se reanuda la vacunación, cuándo y en qué grupos se administrará.",
                "text_en": "However, there has been no evidence of an increase in cardiovascular problems, especially thrombosis.Will AstraZeneca vaccination resume?The main European Union countries, such as Germany, Italy, France and Spain, will resume vaccination after the European Medicines Agency (EMA) revises the vaccine and concludes that it is not associated with an increased risk of clots.But it is up to each country to decide whether to resume vaccination, when and in which groups it will be administered.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "o ha habido evidencias de un aumento en los problemas cardiovasculares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "or there has been evidence of an increase in cardiovascular problems"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los principales países de la Unión Europea, como Alemania, Italia, Francia y España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The main countries of the European Union, such as Germany, Italy, France and Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reanudarán la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "resume vaccination"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea de Medicamentos (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la Agencia Europea de Medicamentos (EMA) revisara la vacuna y concluyera que no está asociada a un mayor riesgo de coágulos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency (EMA) will review the vaccine and conclude that it is not associated with an increased risk of clots"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En España, la vacunación se reanudará el miércoles.El Consejo Interterritorial de Salud se reúne hoy lunes en una sesión extraordinaria para llegar a un acuerdo sobre si extender la vacunación de AstraZeneca a los mayores de 55 años.",
                "text_en": "In Spain, vaccination will resume on Wednesday.The Interterritorial Health Council meets today Monday in an extraordinary session to reach an agreement on whether to extend the vaccination of AstraZeneca to those over the age of 55.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la vacunación se reanudará",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccination will resume"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Wednesday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Consejo Interterritorial de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Interterritorial Health Council"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se reúne",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "meets"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hoy lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "today Monday"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en una sesión extraordinaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an extraordinary session"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es de destacar que, según la farmacéutica, la eficacia de su fármaco aumenta hasta un 80% en el grupo de los mayores de 65 años.Este es uno de los argumentos de la Ponencia de Vacunas del Ministerio de Sanidad para ampliar la inmunización a la franja de entre los 55 y los 65 años, como se está utilizando en otros países de la UE.En Francia, por ejemplo, se ha decidido se administrará únicamente la vacuna de AstraZeneca a los mayores de 55 años.",
                "text_en": "It should be noted that, according to the pharmaceutical company, the effectiveness of your drug increases to 80% in the group of those over 65 years of age.This is one of the arguments of the Vaccines Paper of the Ministry of Health to extend immunization to the range between 55 and 65 years of age, as it is being used in other EU countries.In France, for example, it has been decided that only the AstraZeneca vaccine will be given to those over 55 years of age.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la eficacia de su fármaco aumenta hasta un 80%",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the efficacy of your drug increases up to 80%"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en el grupo de los mayores de 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the group of those over 65 years of age"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En Francia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In France"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha decidido se administrará únicamente la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It has been decided that only AstraZeneca vaccine will be administered"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los mayores de 55 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 55 years of age"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una de las razones de mayor peso es que, pese a la pérdida de confianza, en este grupo de edad no hay constancia de trombosis.Comparte esta noticia en tus redes y déjanos tus comentarios.",
                "text_en": "One of the most important reasons is that, despite the loss of confidence, there is no evidence of thrombosis in this age group.Share this news in your networks and leave us your comments.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en este grupo de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in this age group"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "en este grupo de edad no hay constancia de trombosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in this age group there is no evidence of thrombosis"
                    }
                ],
                "evidences": [
                    {
                        "value": "Given that solid organ damage secondary to thrombosis and hypoxic injury are a hallmark of COVID-19 infection, it is not surprising that numerous reports have detailed both arterial and venous thrombosis of the extremities in patients with COVID-19. A large study of 3,334 patients including 829 ICU and 2,505 non-ICU patients assessing all types of thrombosis found an overall arterial thrombosis rate of 11.1%, with systemic thromboembolism in 1.0% (86) and deep venous thrombosis in 3.9% (86) . These numbers likely underestimate the true incidence of thrombosis. Surveillance imaging of COVID-19 positive patients with bilateral leg ultrasound found the rate of deep venous thrombosis as high as 65% -69% (87, 88) .",
                        "score": 0.5099999905
                    },
                    {
                        "value": "Sixty-one (95.3%) patients were identified with at least one thrombotic event ( Table 2 ). More than one-third (35.9%) of these patients had two or more sites of thrombosis. The most common site of thrombosis was the brain (68.8%), with CVT in 59.4% of patients with thrombosis, the middle cerebral artery thrombosis in 7.8%, and other arterial cerebral ischaemic attack in 3.1%. Thirteen patients (20.3%) had pulmonary embolism, and one patient (1.6%) had pulmonary artery thrombosis. Gastrointestinal involvement was also common (25.0%). Other sites of thrombosis included deep vein (4.7%), internal jugular vein (4.7%), and inferior vena cava (3.1%) thrombosis. Twenty-one patients (32.8%) presented with haemorrhage. Among patients with haemorrhage, 57.1% had intracerebral haemorrhage (ICH), followed by subarachnoid haemorrhage (SAH) and adrenal haemorrhage, each at 14.3%. In three cases, the location of haemorrhage was not specified.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "Thrombosis in COVID-19 is an important part of the clinical picture that needs to be considered. Ultrasound is one of the most common methods to help clinicians to detect thrombosis. Some reported thrombosis described in COVID-19 was found by CTPA or at autopsy [15] [16] [17] [18] . Almost all the reports have focused on the severe or critically ill patients; little attention has been paid to those with mild to moderate disease [19] .",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9337896705
                    },
                    {
                        "label": "neutral",
                        "score": 0.9769333005
                    },
                    {
                        "label": "neutral",
                        "score": 0.9739397168
                    }
                ]
            }
        ]
    },
    "35": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 13,
            "WhatReliabilityReliable": 6,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 13,
            "WhoReliabilityReliable": 11,
            "WhoReliabilityUnreliable": 2,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 6,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 5,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 11,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 7,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 6,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 13,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nDos días, exactamente han pasado dos días desde que Sánchez compareciera en rueda de prensa en la Moncloa afirmando que a España llegarían, entre abril y septiembre, un total de 87 millones de vacunas para darnos cuenta de que las mentiras de Sánchez hacen bueno ese refrán que dice que “la mentira tiene las patas muy cortas”.\n\n<PARAGRAPH>\n\nY es que la Unión Europea acaba de comunicar que llegarán al continente en el segundo trimestre: 360 millones de dosis.\n\n<BREAK>\n\nA España le corresponderían alrededor de 36 millones de vacunas de esta remesa.\n\n<BREAK>\n\nEsto implica que, para que se cumpla la promesa de Sánchez, deberán llegar 51 millones de dosis solo en el tercer trimestre, aunque el presidente señaló en rueda de prensa que para este trimestre llegarían 48 millones de dosis.\n\n<PARAGRAPH>\n\nPor tanto, España tendría que recibir entre julio y septiembre tres veces más vacunas que las que han aterrizado en nuestro país entre enero y marzo (9,6 millones de dosis).\n\n<PARAGRAPH>\n\nEs decir, la Unión Europea es incapaz de garantizar una cifra pero Sánchez, que es muy listo, sí y todo para mentir una vez más.\n\n<BREAK>\n\nY no es que nosotros queramos que lleguen esas vacunas, nada más lejos de la realidad porque no queremos ni una, pero es importante dejar claro que Sánchez miente una vez más y provoca que la Unión Europea tenga que salir de inmediato a desmentirle.\n\n<PARAGRAPH>\n\nLo de este hombre con la mentira ya es absolutamente patológica y nos lleva a preguntarnos si habrá dicho alguna verdad en su vida.\n\n<BREAK>\n\n¿Recuerdan que otra de las cosas que ha dicho ha sido que no tiene intención de ampliar el estado de alarma más allá del 9 de mayo? No le hagan ni caso, está en plena campaña electoral en Madrid.\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "La Unión Europea tiene que salir al paso para aclarar una nueva mentira de Pedro Sánchez, lo del presimiente con la mentira ya es patológico",
        "ID": "NF_04-11-2021_21-25-15_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "La Unión Europea tiene que salir al paso para aclarar una nueva mentira de Pedro Sánchez, lo del presimiente con la mentira ya es patológico",
                "text_en": "The European Union has to step up to clarify a new lie by Pedro Sánchez, the prescient with the lie is already pathological",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Unión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European Union"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tiene que salir al paso para aclarar una nueva mentira",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "You have to step up to clear up a new lie."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pedro Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pedro Sánchez"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Dos días, exactamente han pasado dos días desde que Sánchez compareciera en rueda de prensa en la Moncloa afirmando que a España llegarían, entre abril y septiembre, un total de 87 millones de vacunas para darnos cuenta de que las mentiras de Sánchez hacen bueno ese refrán que dice que “la mentira tiene las patas muy cortas”.",
                "text_en": "Two days, exactly two days have passed since Sanchez appeared at a press conference in Moncloa, saying that between April and September, a total of 87 million vaccines would arrive in Spain to realize that Sanchez’s lies make good that saying that “the lie has very short legs”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sanchez"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en rueda de prensa en la Moncloa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at a press conference at the Moncloa"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llegarían, entre abril y septiembre, un total de 87 millones de vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Between April and September, a total of 87 million vaccines would arrive"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "entre abril y septiembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "between April and September"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "darnos cuenta de que las mentiras",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "realize that lies"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sanchez"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y es que la Unión Europea acaba de comunicar que llegarán al continente en el segundo trimestre: 360 millones de dosis.",
                "text_en": "The European Union has just announced that they will arrive on the continent in the second quarter: 360 million doses.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Unión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Union"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "acaba de comunicar que llegarán al continente en el segundo trimestre: 360 millones de dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "just reported that they will arrive in the continent in the second trimester: 360 million doses"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al continente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the continent"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en el segundo trimestre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the second quarter"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A España le corresponderían alrededor de 36 millones de vacunas de esta remesa.",
                "text_en": "Spain would have some 36 million vaccines for this consignment.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "A España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "To Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "le corresponderían alrededor de 36 millones de vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "would correspond to approximately 36 million vaccines"
                    }
                ],
                "evidences": [
                    {
                        "value": "At a time when cases of the Delta variant are rising sharply worldwide and countries are lifting restrictions, it is key to know the concerns and doubts that people have about vaccination. In a recent survey of 1,050 subjects conducted in Spain between March 17 and 18, most Spaniards (52%) responded that the Vaxzevria vaccine was unsafe, twice as many as a month ago (25%). However, the perception of the safety of the other three vaccines administered in Spain, Pfizer-BioNTech, Moderna, and Janssen, increased. The same attitude was recorded in Italy, France, and Germany (12) . After the resumption of vaccination with Vaxzevria in Spain, official data showed that only 1% refused to receive it (12) . However, there have been more consultations in primary care centers about the effects of the vaccines, although these seem to dissipate after the information provided by health professionals. Thus, it is important to provide as much transparency as possible, generating a climate of trust between government, healthcare professionals, and regular citizens to be vaccinated.",
                        "score": 0.5299999714
                    },
                    {
                        "value": "The quick and effective development of vaccines against COVID-19 has played an important role in the control of the pandemic [1] and represents one of the most meritorious and relevant advances of the history of science [2] . As of October 2021, the European Medicines Agency (EMA) has authorized the use of four vaccines against COVID-19 in Spain: BNT162b2 (Comirnaty ® ), mRNA-1273 (Moderna ® ), AZD1222 (Vaxzevria ® ), and Ad26.COV2.s (Janssen ® ). Although all these vaccines have proven their efficacy and safety, several studies during 2021 have reported adverse events in clinical series and post-authorization trials [3] [4] [5] .",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9952110648
                    },
                    {
                        "label": "neutral",
                        "score": 0.9764475226
                    }
                ]
            },
            {
                "text": "Esto implica que, para que se cumpla la promesa de Sánchez, deberán llegar 51 millones de dosis solo en el tercer trimestre, aunque el presidente señaló en rueda de prensa que para este trimestre llegarían 48 millones de dosis.",
                "text_en": "This means that, in order for Sánchez's promise to be fulfilled, 51 million doses will have to arrive in the third quarter alone, although the president said in a press conference that 48 million doses would arrive for this quarter.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deberán llegar 51 millones de dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "must reach 51 million doses"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "solo en el tercer trimestre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "only in the third quarter"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el presidente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the President"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en rueda de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at a press conference"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este trimestre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this quarter"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llegarían 48 millones de dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "48 million doses would arrive"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por tanto, España tendría que recibir entre julio y septiembre tres veces más vacunas que las que han aterrizado en nuestro país entre enero y marzo (9,6 millones de dosis).",
                "text_en": "Therefore, between July and September, Spain would have to receive three times more vaccines than those that have landed in our country between January and March (9.6 million doses).",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tendría que recibir entre julio y septiembre tres veces más vacunas que las que han aterrizado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "would have to receive three times more vaccines between July and September than those that have landed"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "entre julio y septiembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from July to September"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en nuestro país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in our country"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "entre enero y marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "between January and March"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es decir, la Unión Europea es incapaz de garantizar una cifra pero Sánchez, que es muy listo, sí y todo para mentir una vez más.",
                "text_en": "That is to say, the European Union is unable to guarantee a figure but Sanchez, who is very smart, yes and all to lie once again.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Unión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Union"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es incapaz de garantizar una cifra",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is unable to guarantee a figure"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sanchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mentir una vez más",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "lie one more time"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y no es que nosotros queramos que lleguen esas vacunas, nada más lejos de la realidad porque no queremos ni una, pero es importante dejar claro que Sánchez miente una vez más y provoca que la Unión Europea tenga que salir de inmediato a desmentirle.",
                "text_en": "And it is not that we want those vaccines to arrive, nothing further than reality because we do not want one, but it is important to make it clear that Sanchez is lying once again and causes the European Union to have to go out immediately to deny him.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no es que nosotros queramos que lleguen esas vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It's not that we want those vaccines to arrive."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nosotros",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "us."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque no queremos ni una",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because we don't want one."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sanchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "miente una vez más",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "lie one more time"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo de este hombre con la mentira ya es absolutamente patológica y nos lleva a preguntarnos si habrá dicho alguna verdad en su vida.",
                "text_en": "This man with the lie is already absolutely pathological and leads us to wonder if he has said any truth in his life.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "este hombre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "this man"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos lleva a preguntarnos si habrá dicho alguna verdad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "leads us to wonder if he has told any truth"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en su vida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in your life"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "36": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 27,
            "WhatReliabilityReliable": 2,
            "WhatReliabilityUnreliable": 25,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 7,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 8,
            "Who": 19,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 6,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 2,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 3,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 8,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 6,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 3,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 9,
            "WhoRoleTarget": 9,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 11,
            "Key-Verb": 0,
            "Orthotypography": 32,
            "Figure": 5,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 48,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nUna excelente noticia.\n\n<BREAK>\n\nÚLTIMA HORA\n\n<BREAK>\n\nNO son necesarios los Respiradores, ventiladores, ni La Unidad de Cuidados Intensivos\"\n\n<BREAK>\n\nÚLTIMA HORA INTERNACIONAL ECUADOR\n\n<BREAK>\n\nEN ECUADOR POR FIN LA CURA PARA EL CORONAVIRUS\n\n<BREAK>\n\nLos médicos ecuatorianos, dirigidos por el Doctor Jacinto Pichamaluco, desobedecieron la ley mundial de la salud OMS, de no hacer autopsias en los muertos del Coronavirus y ellos confirmaron que NO es un VIRUS sino una BACTERIA la que produce la muerte. \n\n<BREAK>\n\nEsta hace que se formen coágulos en la sangre y causa la muerte del paciente.\n\n<BREAK>\n\nEcuador derrota al llamado Covid-19, que no es otra cosa que “Coagulación intravascular diseminada” (Trombosis)\n\n<BREAK>\n\nY la forma como combatirlo, o sea su curación, es con los “antibióticos, anti-inflamatorios y anticoagulantes”. \n\n<BREAK>\n\nASPIRINA, lo que indica que se había estado tratando mal a esta enfermedad.\n\n<BREAK>\n\nEsta sensacional noticia para el mundo la han producido médicos ecuatorianos al realizar autopsias a cadáveres producto del Covid-19.\n\n<BREAK>\n\nAlgo más, según patólogos ecuatorianos. \n\n<BREAK>\n\n“Nunca se necesitaron los ventiladores, ni de la unidad de cuidados intensivos”.\n\n<BREAK>\n\nPor lo tanto, en Ecuador se inició el cambio de los protocolos ECUADOR SE REVELA Y LEVANTARIA LA LLAMADA pandemia mundial por la OMS. \n\n<BREAK>\n\nEsta curación ya los Chinos lo sabían y no informaron POR HACER NEGOCIO.\n\n<BREAK>\n\nFuente: Ministerio de Salud de ECUADOR.\n\n<BREAK>\n\nCOMPARTIR QUE SE ENTERE TODO EL MUNDO QUE NOS HAN ENGAÑADO Y ASESINADO A NUESTROS MAYORES!! @Ecuadorrevelacurardelcovid19\n\n<BREAK>\n\nOJO ALERTA\n\n<BREAK>\n\nTransmitan esta Información a toda su familia, vecindad, conocidos, amigos, colegas, compañeros de trabajo y su entorno en general:\n\n<BREAK>\n\nSi Llegan a Contraer El Covid-19, el cual “No es Un Virus” Como nos han hecho creer, sino “Una Bacteria”, amplificada con Radiación Electromagnética 5G que produce también Inflamación e Hipoxia.\n\n<BREAK>\n\nVan a hacer lo Siguiente:\n\n<BREAK>\n\nDeben tomar:\n\n<BREAK>\n\nAspirina de 81 mg o 100 mg y Apronax o Paracetamol, Ibuprofno de 400mg ¿Porqué?:\n\n<BREAK>\n\nPorque se ha demostrado que el Covid-19 lo que hace es coagular la sangre, haciendo que la persona haga cuadro de trombosis y la sangre no fluya y no oxigene el corazón y los pulmones y la persona fallezca rapidamente por no poder respirar.\n\n<BREAK>\n\nEn Ecuador mandaron al carajo el protocolo de la OMS Hicieron autopsias, las venas estaban dilatadas y la sangre coagulada, todas las venas y arterias llenas de trombos, impidiendo que la sangre fluya normalmente y lleve oxígeno a todos los organos, principalmente al cerebro, corazón y pulmones y acabe muriendo el paciente, ya sabiendo este diagnóstico el Ministerio de Salud de Italia cambio inmediatamente los Protocolos de tratamiento contra el Covid-19, y comenzó a administrar a sus pacientes positivos Aspirina de 100mg y Apronax, resultado: los pacientes comenzaron a recuperarse y presentar mejorias y el Ministerio de Salud dio de alta y mando a sus casas a más de 14.000 pacientes en un solo dia.\n\n<BREAK>\n\nURGENTE:\n\n<BREAK>\n\nTransmitan esta información y haganlo viral, aquí en nuestro Pais nos han mentido, con esto de pandemia.\n\n<BREAK>\n\nLo Único que dicen todos los días son Datos y ESTADÍSTICAS pero No Informan sobre esto para salvar a los Ciudadanos Pero Italia se salto la norma, porque ya estaban desbordados y en caos grave de muertes diarias, Ahora La OMS, Será Demandada Mundialmente , por Encubrir Tantas Muertes y el colapso de las Economías de Muchos Países del Mundo,\n\n<BREAK>\n\nAhora se entiende porque la orden de INCINERAR o enterrar inmediatamente los cuerpos sin hacersele autopsia, y los etiquetaban de altamente contaminantes,\n\n<BREAK>\n\nEstá en nuestras manos llevar la verdad y la esperanza de salvar muchas vidas,.\n\n<BREAK>\n\nDIFUNDIR EN TODAS LAS REDES URGENTE!!! Por eso, el Gel Anti Bacterial funciona y El Dióxido de Cloro ,\n\n<BREAK>\n\nVamos A Salvar Vidas Compartiendo Esta Gran Información",
        "TITLE": "En Ecuador por fin encuentran la cura al Coronavirus",
        "ID": "6-Chihuahuaes",
        "VALUE": "Fake",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "En Ecuador por fin encuentran la cura al Coronavirus",
                "text_en": "In Ecuador finally find the cure to Coronavirus",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En Ecuador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Ecuador"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "encuentran la cura al Coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "find the cure to the Coronavirus"
                    }
                ],
                "evidences": [
                    {
                        "value": "Ecuador, suffered arguably one of the worst COVID-19 scenario during the first stage of the pandemic in the region, with a death toll that is 15 times higher than its official tally of coronavirus related deaths (Ortiz-Prado, Diaz, et al., 2020) . No mathematical estimations were given prior the arrival of COVID-19 in the country, neither any study is available in Ecuador regarding previous outbreaks. In this sense, the aim of this model is to provide the evidence of the transmission dynamics of SARS-CoV-2 in Ecuador in order to track the evolution of COVID-19 pandemic in a continuous way and to evaluate the development of public health policies in Ecuador.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9919935465
                    }
                ]
            },
            {
                "text": "NO son necesarios los Respiradores, ventiladores, ni La Unidad de Cuidados Intensivos\"",
                "text_en": "There is no need for Breathers, fans, or the Intensive Care Unit.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "NO son necesarios los Respiradores, ventiladores, ni La Unidad de Cuidados Intensivos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "There is no need for respirators, fans, or the Intensive Care Unit."
                    }
                ],
                "evidences": []
            },
            {
                "text": "EN ECUADOR POR FIN LA CURA PARA EL CORONAVIRUS",
                "text_en": "IN ECUADOR BY END CURE FOR CORONAVIRUS",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "EN ECUADOR",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "IN ECUADOR"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "LA CURA PARA EL CORONAVIRUS",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "CURE FOR CORONAVIRUS"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los médicos ecuatorianos, dirigidos por el Doctor Jacinto Pichamaluco, desobedecieron la ley mundial de la salud OMS, de no hacer autopsias en los muertos del Coronavirus y ellos confirmaron que NO es un VIRUS sino una BACTERIA la que produce la muerte. ",
                "text_en": "Ecuadorean doctors, led by Dr. Jacinto Pichamaluco, disobeyed the WHO global health law, not to perform autopsies on the dead of the Coronavirus and they confirmed that it is NOT a VIRUS but a BACTERIA that causes death.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los médicos ecuatorianos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ecuadorian doctors"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Doctor Jacinto Pichamaluco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Jacinto Pichamaluco"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desobedecieron la ley mundial de la salud OMS, de no hacer autopsias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "disobeyed the WHO global health law, not to perform autopsies"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en los muertos del Coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the dead of the Coronavirus"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ellos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "confirmaron que NO es un VIRUS sino una BACTERIA la que produce la muerte",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "confirmed that it is NOT a VIRUS but a BACTERIA that produces death"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta hace que se formen coágulos en la sangre y causa la muerte del paciente.",
                "text_en": "It causes clots to form in the blood and causes the patient to die.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "se formen coágulos en la sangre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "clots form in the blood"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ecuador derrota al llamado Covid-19, que no es otra cosa que “Coagulación intravascular diseminada” (Trombosis)",
                "text_en": "Ecuador defeats the so-called Covid-19, which is nothing other than “Disseminated intravascular coagulation” (Trombosis)",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ecuador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ecuador"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "derrota al llamado Covid-19, que no es otra cosa que “Coagulación intravascular diseminada” (Trombosis)",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "defeating the so-called Covid-19, which is nothing but “distinguished intravascular coagulation” (Trombosis)"
                    }
                ],
                "evidences": [
                    {
                        "value": "In South America, Brazil is the country with the highest number of COVID-19-confirmed cases followed by Ecuador. Although Brazil has two times the number of cases than Ecuador, it is important to analyze the prevalence of the disease in the context of the countries' population. While Brazil, with a population of 212,559,417, has a total of 1,549 confirmed cases (0.007%); Ecuador, with a population of 17,567,751, has 789 confirmed cases (0.004%) [3] [4] . The greater ratio of cases per population in Ecuador raises the concern about the efficacy of the containment measures and public health policies taken by the country.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9933377504
                    }
                ]
            },
            {
                "text": "Y la forma como combatirlo, o sea su curación, es con los “antibióticos, anti-inflamatorios y anticoagulantes”. ",
                "text_en": "And the way to combat it, that is to say its cure, is with “antibiotics, anti-inflammatory and anticoagulants”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con los “antibióticos, anti-inflamatorios y anticoagulantes”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with “antibiotics, anti-inflammatory and anticoagulants”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "ASPIRINA, lo que indica que se había estado tratando mal a esta enfermedad.",
                "text_en": "ASPIRINE, indicating that this disease had been treated badly.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se había estado tratando mal a esta enfermedad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "had been treating this disease badly"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta sensacional noticia para el mundo la han producido médicos ecuatorianos al realizar autopsias a cadáveres producto del Covid-19.",
                "text_en": "This sensational news for the world has been produced by Ecuadorian doctors when performing autopsies to corpses produced by Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "médicos ecuatorianos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Ecuadorian doctors"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "realizar autopsias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "perform autopsies"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "cadáveres producto del Covid-19",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "bodies derived from the Covid-19"
                    }
                ],
                "evidences": [
                    {
                        "value": "The objective of our case series study was to present the histopathological findings following whole-body autopsies in COVID-19 inpatients. We present post-mortem examination data from 29 whole-body autopsies of COVID-19 deaths occurring in hospitals, in Lusaka, Zambia -the first large autopsy case series study from Africa.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "The so-called minimally invasive autopsies are only used to obtain selective findings. The individual pathomorphologic picture and cause of death cannot be fully determined. Therefore, SARS-CoV-2-infected bodies in Hamburg are always completely autopsied (opening of all three body cavities and dissection of all organs, including a dissection of the veins of the lower extremities). The autopsies are carried out by at least one forensic specialist and a resident. This ensures that the autopsies meet the standards for forensic autopsies.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9987242818
                    },
                    {
                        "label": "neutral",
                        "score": 0.9963337183
                    }
                ]
            },
            {
                "text": "“Nunca se necesitaron los ventiladores, ni de la unidad de cuidados intensivos”.",
                "text_en": "“The fans were never needed, nor the intensive care unit.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Nunca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Never"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se necesitaron los ventiladores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Fans were needed"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por lo tanto, en Ecuador se inició el cambio de los protocolos ECUADOR SE REVELA Y LEVANTARIA LA LLAMADA pandemia mundial por la OMS. ",
                "text_en": "In Ecuador, therefore, the change of the ECUADOR protocols was initiated. The WHO called for a global pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Ecuador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Ecuador"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se inició el cambio de los protocolos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the change of the protocols has begun"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta curación ya los Chinos lo sabían y no informaron POR HACER NEGOCIO.",
                "text_en": "This healing the Chinese already knew and didn't report for doing business.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los Chinos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The Chinese"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo sabían y no informaron",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They knew it and didn't report it."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "POR HACER NEGOCIO",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "FOR DOING BUSINESS"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Transmitan esta Información a toda su familia, vecindad, conocidos, amigos, colegas, compañeros de trabajo y su entorno en general:",
                "text_en": "Please transmit this Information to your entire family, neighborhood, acquaintances, friends, colleagues, coworkers and your environment in general:",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Transmitan esta Información",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Transmit this Information"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a toda su familia, vecindad, conocidos, amigos, colegas, compañeros de trabajo y su entorno en general",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to all your family, neighborhood, acquaintances, friends, colleagues, coworkers and your environment in general"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si Llegan a Contraer El Covid-19, el cual “No es Un Virus” Como nos han hecho creer, sino “Una Bacteria”, amplificada con Radiación Electromagnética 5G que produce también Inflamación e Hipoxia.",
                "text_en": "If they get to Contraer The Covid-19, which “is not a virus” As they have made us believe, but “A Bacteria”, amplified with 5G Electromagnetic Radiation that also produces Inflammation and Hipoxia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "“No es Un Virus” Como nos han hecho creer, sino “Una Bacteria”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "“It’s not a virus” As we have been made to believe, but “A Bacteria”"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "amplificada con Radiación Electromagnética 5G",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "amplified with 5G Electromagnetic Radiation"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "produce también Inflamación e Hipoxia",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "also causes inflammation and hypoxia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Porque se ha demostrado que el Covid-19 lo que hace es coagular la sangre, haciendo que la persona haga cuadro de trombosis y la sangre no fluya y no oxigene el corazón y los pulmones y la persona fallezca rapidamente por no poder respirar.",
                "text_en": "Because Covid-19 has been shown to coagulate the blood, causing the person to make a picture of thrombosis and the blood does not flow and does not oxygenate the heart and lungs and the person dies quickly for not being able to breathe.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha demostrado que el Covid-19 lo que hace es coagular la sangre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Covid-19 has been shown to coagulate blood."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "haciendo que la persona haga cuadro de trombosis y la sangre no fluya y no oxigene el corazón y los pulmones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "causing the person to have thrombosis and blood not to flow and not to oxygenate the heart and lungs"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la persona",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the person"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fallezca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "die"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por no poder respirar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for not being able to breathe"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En Ecuador mandaron al carajo el protocolo de la OMS Hicieron autopsias, las venas estaban dilatadas y la sangre coagulada, todas las venas y arterias llenas de trombos, impidiendo que la sangre fluya normalmente y lleve oxígeno a todos los organos, principalmente al cerebro, corazón y pulmones y acabe muriendo el paciente, ya sabiendo este diagnóstico el Ministerio de Salud de Italia cambio inmediatamente los Protocolos de tratamiento contra el Covid-19, y comenzó a administrar a sus pacientes positivos Aspirina de 100mg y Apronax, resultado: los pacientes comenzaron a recuperarse y presentar mejorias y el Ministerio de Salud dio de alta y mando a sus casas a más de 14.000 pacientes en un solo dia.",
                "text_en": "In Ecuador, they sent the WHO protocol to the fuck. They performed autopsies, the veins were dilated and the blood clotted, all veins and arteries filled with thrombus, preventing blood from flowing normally and bringing oxygen to all organs, mainly to the brain, heart and lungs and the patient ended up dying, already knowing this diagnosis the Italian Ministry of Health immediately changed the Covid-19 Treatment Protocols, and began to administer to its positive patients 100mg Aspirin and Aprox, result: patients began to recover and present improvements and the Ministry of Health discharged and sent more than 14,000 patients to their homes in one day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En Ecuador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Ecuador"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mandaron al carajo el protocolo de la OMS",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They sent WHO protocol to hell."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Hicieron autopsias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They did autopsies."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Salud de Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Ministry of Health of Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cambio inmediatamente los Protocolos de tratamiento contra el Covid-19",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "immediately change the Covid-19 Treatment Protocols"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "comenzó a administrar a sus pacientes positivos Aspirina de 100mg y Apronax",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "began to administer 100mg Aspirin and Apronax to its positive patients"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a sus pacientes positivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to its positive patients"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "comenzaron a recuperarse y presentar mejorias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "began to recover and present improvements"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dio de alta y mando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "discharge and command"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a sus casas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to their homes"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a más de 14.000 pacientes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to more than 14,000 patients"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en un solo dia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in one day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Transmitan esta información y haganlo viral, aquí en nuestro Pais nos han mentido, con esto de pandemia.",
                "text_en": "Pass on this information and do it viral, here in our country have lied to us, with this pandemic thing.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "aquí en nuestro Pais",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "here in our country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos han mentido",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We've been lied to."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo Único que dicen todos los días son Datos y ESTADÍSTICAS pero No Informan sobre esto para salvar a los Ciudadanos Pero Italia se salto la norma, porque ya estaban desbordados y en caos grave de muertes diarias, Ahora La OMS, Será Demandada Mundialmente , por Encubrir Tantas Muertes y el colapso de las Economías de Muchos Países del Mundo,",
                "text_en": "The only thing they say every day is Data and STATISTICS, but they don't report on this to save the citizens. But Italy skipped the norm, because they were already overwhelmed and in severe chaos of daily deaths, now the WHO, will be demanded worldwide, by covering up so many deaths and the collapse of the economies of many countries of the world,",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se salto la norma",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "skip the norm"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque ya estaban desbordados y en caos grave de muertes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because they were already overflowing and in severe chaos of deaths"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Será Demandada Mundialmente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Will Be Demanded Worldwide"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por Encubrir Tantas Muertes y el colapso de las Economías de Muchos Países del Mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by Covering So Many Deaths and the Collapse of the Economies of Many Countries of the World"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ahora se entiende porque la orden de INCINERAR o enterrar inmediatamente los cuerpos sin hacersele autopsia, y los etiquetaban de altamente contaminantes,",
                "text_en": "Now it is understood why the order to INCINER or immediately bury the bodies without autopsy, and labeled them as highly polluting,",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la orden de INCINERAR o enterrar inmediatamente los cuerpos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the order to INCINE or immediately bury the bodies"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin hacersele autopsia",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "without getting an autopsy."
                    }
                ],
                "evidences": []
            },
            {
                "text": "DIFUNDIR EN TODAS LAS REDES URGENTE!!! Por eso, el Gel Anti Bacterial funciona y El Dióxido de Cloro ,",
                "text_en": "DIFUNDIR ON ALL NETWORKS URGENT!!! That’s why the Anti-Bacterial Gel works and Chlorine Dioxide ,",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "DIFUNDIR EN TODAS LAS REDES URGENTE",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "DIFUNDIR IN ALL NETWORKS URGENT"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "EN TODAS LAS REDES",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ALL NETWORK"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el Gel Anti Bacterial funciona y El Dióxido de Cloro",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Anti-Bacterial Gel works and Chlorine Dioxide"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Vamos A Salvar Vidas Compartiendo Esta Gran Información",
                "text_en": "Let's Save Lives Sharing This Great Information",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Vamos A Salvar Vidas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Let's save lives"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Compartiendo Esta Gran Información",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Sharing This Great Information"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "37": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 14,
            "WhatReliabilityReliable": 14,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 7,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 0,
            "WhereReliabilityReliable": 0,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 5,
            "HowReliabilityReliable": 5,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 7,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 7,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 2,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nLa pandemia de covid-19 ha causado más de un millón de muertos y aún no existe un tratamiento realmente curativo, una ardua tarea a la que se dedican más de mil proyectos en todo el mundo, de forma paralela a las investigaciones para lograr una vacuna.\n\n<BREAK>\n\nRemdesivir, dexametosana, hidroxicloriquia o lopinavir son algunos medicamentos de los que nos hemos acostumbrado a oír hablar durante estos ocho meses de pandemia, vinculados al tratamiento de la covid-19, pero con resultados dispares.\n\n<BREAK>\n\nDe momento, no hay ningún fármaco que sea eficaz, aunque se han identificado algunos que pueden ayudar en el tratamiento y otros que \"no atacan al virus, pero ayudan a mejorar la situación clínica\" del enfermo, dice Adrián Velázquez-Campoy, investigador de la española Fundación Agencia Aragonesa para la Investigación y el Desarrollo (Araid).\n\n<BREAK>\n\nPero en estos meses muchas cosas han cambiado en el tratamiento, ahora se conoce mejor la enfermedad y su comportamiento clínico, lo que, señala Miguel Górgolas, del Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (Madrid), les permite adelantarse \"a eventuales complicaciones\".\n\n<BREAK>\n\nEn todo caso, es fundamental encontrar un tratamiento eficaz, ya sea a través del reposicionamiento de medicamentos que se usan para otras dolencias y que se demuestre que tienen efectos ante la covid-19 o con la investigación de fármacos específicos.\n\n<BREAK>\n\nUna guerra en dos frentes\n\n<BREAK>\n\nLa enfermedad se combate desde dos frentes, explica Velázquez-Campoy: atacar al virus cuando invade el organismo y evitar que nuestro sistema inmunológico se desborde, generando una tormenta de citoquinas, causada por una reacción excesiva del sistema inmunitario, que acaba atacando al organismo.\n\n<BREAK>\n\nEn la actualidad, se han dejado de usar fármacos como los antirretrovirales, la cloroquina y otros, que -señala Górgolas- \"han demostrado ser inútiles\". \n\n<BREAK>\n\n\"Y me atrevería a decir -añade-, han provocado más perjuicio que beneficio\"; además, los protocolos se han simplificado incluyendo solo los medicamentos que han demostrado eficacia.\n\n<BREAK>\n\nEntre ellos, el antiviral remdesivir, que acorta la hospitalización de los pacientes graves, o los corticosteroides, como la dexametasona, que actúan sobre la inflamación de los tejidos y disminuye la mortalidad en enfermos graves y muy graves, aunque, en ambos casos, \"la eficacia es limitada\".\n\n<BREAK>\n\nEl doctor no cree que \"en breve\" se disponga de una medicación que reduzca \"de forma significativa la mortalidad\". \n\n<BREAK>\n\nActualmente hay centenares de ensayos con diferentes moléculas, anticuerpos monoclonales, inmunomoduladores y, es \"muy probable\", que varios de ellos demuestren eficacia frente al placebo, pero duda de que \"esta eficacia aparezca en una gran mayoría de casos\".\n\n<BREAK>\n\nEn este sentido, señala que hay factores de riesgo y posiblemente otros genéticos que \"influyen significativamente en la evolución de la enfermedad y esto, no se va a poder solucionar con un fármaco 'milagroso', no ha sido así en ninguna infección viral similar\" a ésta.\n\n<BREAK>\n\nReposicionar fármacos\n\n<BREAK>\n\nEl método más rápido de encontrar un fármaco es intentar reposicionar los que ya se emplean para otras patologías, en ello trabaja la química Nuria Campillo, del español Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), usando el diseño computacional.\n\n<BREAK>\n\n\"Para no emplear más tiempo del necesario usamos el ordenador y programas específicos\" para enfrentar diferentes proteínas del virus o de la célula humana a una quimioteca de medicamentos, así se ve qué fármacos son capaces de unirse a dichas proteínas de forma virtual.\n\n<BREAK>\n\nDespués se evalúan frente al SARS-Cov-2 con el fin de comprobar que esos fármacos identificados con técnicas computacionales presentan actividad antiviral.\n\n<BREAK>\n\nHasta ahora, \"hay algunos bastante interesantes\" y se está pensando en pasar a ensayos clínicos, indica Campillo, que se muestra confiada en que, a través del reposicionamiento, se pueda hallar un fármaco eficaz.\n\n<BREAK>\n\nEsta búsqueda de medicinas que ya existen funciona desde múltiples frentes, desde evitar que el virus entre en la célula, a impedir su replicación, controlar la inflamación o minimizar el daño pulmonar.\n\n<BREAK>\n\nTambién en el CIB-CSIC, el equipo de Eduardo Rial analiza medicamentos contra el cáncer que frenen la replicación del SARS-Cov-2 en las células.\n\n<BREAK>\n\nLa investigación está aún en líneas celulares de bronquios y pulmones, explica Rial, quien tiene \"una gran esperanza en que alguno de estos antitumorales funcione\", aunque advierte de que estos procesos llevan tiempo.\n\n<BREAK>\n\nFormulación desde cero\n\n<BREAK>\n\nLa otra vía para encontrar medicamentos es la formulación específica desde cero, un proceso que puede llevar más de una década.\n\n<BREAK>\n\nEl equipo de Velázquez-Campoy ha identificado la quercetina, un falvonoide que hay en alimentos como la uva, la manzana, el hinojo o las alcaparras, en un proyecto que, por ahora, -destaca- está siendo financiado íntegramente por fundación NHA.\n\n<BREAK>\n\nAunque los trabajos están fase incipiente, han descubierto que \"in vitro\" la quercitina tiene un efecto inhibidor sobre dos proteínas del virus, 3CLPRO y PLPRO, que \"son esenciales para su replicación\".\n\n<BREAK>\n\nA este compuesto llegaron a través de un proyecto de cribado de cientos de moléculas, pero Velázquez-Campoy advierte de que tomar los alimentos donde se encuentra de forma natural o con suplementos dietéticos no sirve frente a la enfermedad.\n\n<BREAK>\n\nEn esta búsqueda de medicamentos la comunidad científica mundial se ha movilizado de forma \"impresionante, cada uno desde su enfoque particular\", destaca Rial, quien considera: \"Si muchos buscamos alguno dará con el bueno\".",
        "TITLE": "La ardua búsqueda de fármacos para combatir la covid-19",
        "ID": "6-Efe",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La ardua búsqueda de fármacos para combatir la covid-19",
                "text_en": "The arduous search for drugs to combat covid-19",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La ardua búsqueda de fármacos para combatir la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The arduous search for drugs to combat covid-19"
                    }
                ],
                "evidences": [
                    {
                        "value": "Identification of drugs-human protein interactions. To evaluate our candidate targets, we use all drugs and their corresponding target interactions reported in the Uniprot. These interactions contain 6,163 drugs and 2,898 protein targets. We also use 44 experimental unapproved drugs for COVID-19 treatment reported in DrugBank [18] . From these 44 drugs denoted as Covid-Drug, 27 drugs have no target information and the other 17 drugs have the drug target information. These 17 drugs can target 78 proteins in human cells. The second group of drugs denoted as Clinical-Drug contains 449 drugs as clinical trials for COVID-19 treatment reported in DrugBank [18] . From these 449 drugs, 328 drugs have target proteins in our PPI network. These 328 drugs can target 888 proteins in human cells.",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.7326964736
                    }
                ]
            },
            {
                "text": "La pandemia de covid-19 ha causado más de un millón de muertos y aún no existe un tratamiento realmente curativo, una ardua tarea a la que se dedican más de mil proyectos en todo el mundo, de forma paralela a las investigaciones para lograr una vacuna.",
                "text_en": "The covid-19 pandemic has caused more than a million deaths and there is still no really curative treatment, an arduous task to which more than a thousand projects around the world are dedicated, in parallel to research to achieve a vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aún no existe un tratamiento realmente curativo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There is no really curative treatment yet."
                    }
                ],
                "evidences": [
                    {
                        "value": "In the UK, there have been 152490 deaths (192 deaths/100000 population), 471045 hospital admissions, and 4717811 confirmed cases (7062 cases per 100000 population) due to COVID-19 pandemic between March 2020 to June 2021 [1] .",
                        "score": 0.6800000072
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9991930127
                    }
                ]
            },
            {
                "text": "De momento, no hay ningún fármaco que sea eficaz, aunque se han identificado algunos que pueden ayudar en el tratamiento y otros que \"no atacan al virus, pero ayudan a mejorar la situación clínica\" del enfermo, dice Adrián Velázquez-Campoy, investigador de la española Fundación Agencia Aragonesa para la Investigación y el Desarrollo (Araid).",
                "text_en": "At the moment, there is no drug that is effective, although some have been identified that can help in the treatment and others that \"do not attack the virus, but help improve the clinical situation\" of the patient, says Adrián Velázquez-Campoy, researcher at the Spanish Agency for Research and Development (Araid).",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "De momento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For the time being"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no hay ningún fármaco que sea eficaz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there is no drug that is effective"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han identificado algunos que pueden ayudar en el tratamiento y otros que \"no atacan al virus, pero ayudan a mejorar la situación clínica\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "some have been identified that can help in treatment and others that \"do not attack the virus, but help improve the clinical situation\""
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ayudan a mejorar la situación clínica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "help improve the clinical situation"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del enfermo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the patient"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Adrián Velázquez-Campoy, investigador de la española Fundación Agencia Aragonesa para la Investigación y el Desarrollo (Araid)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Adrián Velázquez-Campoy, researcher at the Spanish Agency for Research and Development (Araid)"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero en estos meses muchas cosas han cambiado en el tratamiento, ahora se conoce mejor la enfermedad y su comportamiento clínico, lo que, señala Miguel Górgolas, del Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (Madrid), les permite adelantarse \"a eventuales complicaciones\".",
                "text_en": "But in these months many things have changed in treatment, now the disease and its clinical behavior are better known, which, says Miguel Górgolas, of the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (Madrid), allows them to advance \"to possible complications\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se conoce mejor la enfermedad y su comportamiento clínico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the disease and its clinical behavior are better known"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Miguel Górgolas, del Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (Madrid)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Miguel Górgolas, Institute of Health Research-Fundación Jiménez Díaz (Madrid)"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En todo caso, es fundamental encontrar un tratamiento eficaz, ya sea a través del reposicionamiento de medicamentos que se usan para otras dolencias y que se demuestre que tienen efectos ante la covid-19 o con la investigación de fármacos específicos.",
                "text_en": "In any case, it is essential to find effective treatment, either through the repositioning of medicines used for other ailments and that it is shown that they have effects on covid-19 or through the research of specific drugs.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es fundamental encontrar un tratamiento eficaz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it is essential to find effective treatment"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "ya sea a través del reposicionamiento de medicamentos que se usan para otras dolencias y que se demuestre que tienen efectos ante la covid-19 o con la investigación de fármacos específicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "either through the repositioning of medicines that are used for other ailments and that are shown to have effects on covid-19 or by researching specific drugs"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En la actualidad, se han dejado de usar fármacos como los antirretrovirales, la cloroquina y otros, que -señala Górgolas- \"han demostrado ser inútiles\". ",
                "text_en": "At present, drugs such as antiretrovirals, chloroquine and others have been stopped, which, Górgolas points out, \"have proved to be useless.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En la actualidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "At present"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han dejado de usar fármacos como los antirretrovirales, la cloroquina y otros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have stopped using drugs such as antiretrovirals, chloroquine and others"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Górgolas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Gorgolas"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "han demostrado ser inútiles",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "proved useless."
                    }
                ],
                "evidences": []
            },
            {
                "text": "El doctor no cree que \"en breve\" se disponga de una medicación que reduzca \"de forma significativa la mortalidad\". ",
                "text_en": "The doctor does not believe that \"soon\" medication is available that \"significantly reduces mortality\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El doctor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The doctor"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no cree que \"en breve\" se disponga de una medicación que reduzca \"de forma significativa la mortalidad\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "does not believe that \"in the near future\" medication is available that \"significantly reduces mortality\""
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en breve",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "shortly"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma significativa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a significant way"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Actualmente hay centenares de ensayos con diferentes moléculas, anticuerpos monoclonales, inmunomoduladores y, es \"muy probable\", que varios de ellos demuestren eficacia frente al placebo, pero duda de que \"esta eficacia aparezca en una gran mayoría de casos\".",
                "text_en": "There are currently hundreds of trials with different molecules, monoclonal antibodies, immunomodulators and, \"very likely\", several of them demonstrate efficacy against placebo, but he doubts that \"this efficacy appears in a large majority of cases\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Actualmente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Currently"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay centenares de ensayos con diferentes moléculas, anticuerpos monoclonales, inmunomoduladores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There are hundreds of trials with different molecules, monoclonal antibodies, immunomodulators"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En este sentido, señala que hay factores de riesgo y posiblemente otros genéticos que \"influyen significativamente en la evolución de la enfermedad y esto, no se va a poder solucionar con un fármaco 'milagroso', no ha sido así en ninguna infección viral similar\" a ésta.",
                "text_en": "In this sense, he points out that there are risk factors and possibly other genetic factors that \"significantly influence the evolution of the disease and this, it will not be possible to solve with a 'miraculous' drug, it has not been so in any viral infection similar to this one\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "hay factores de riesgo y posiblemente otros genéticos que \"influyen significativamente en la evolución de la enfermedad y esto, no se va a poder solucionar con un fármaco 'milagroso'",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There are risk factors and possibly other genetic factors that \"significantly influence the evolution of the disease and this, will not be able to solve with a 'miraculous' drug."
                    }
                ],
                "evidences": []
            },
            {
                "text": "El método más rápido de encontrar un fármaco es intentar reposicionar los que ya se emplean para otras patologías, en ello trabaja la química Nuria Campillo, del español Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), usando el diseño computacional.",
                "text_en": "The fastest method of finding a drug is to try to reposition those already used for other pathologies, in this work the chemistry Nuria Campillo, of the Spanish Center for Biological Research Margarita Salas (CIB-CSIC), using the computational design.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El método más rápido de encontrar un fármaco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Fastest Method of Finding a Drug"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "reposicionar los que ya se emplean para otras patologías",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "repositioning those already used for other pathologies"
                    }
                ],
                "evidences": [
                    {
                        "value": "Drug repurposing is a promising, fast, and cost-effective method that can overcome traditional de novo drug discovery and development challenges of targeting various diseases and disorders. Drug repurposing, the process of identifying new uses for the existing or candidate drugs, is an effective strategy for drug discovery in multiple diseases, including infectious viral diseases.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8607771397
                    }
                ]
            },
            {
                "text": "La otra vía para encontrar medicamentos es la formulación específica desde cero, un proceso que puede llevar más de una década.",
                "text_en": "The other way to find drugs is specific formulation from scratch, a process that can take more than a decade.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La otra vía para encontrar medicamentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The other way to find medicines"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "la formulación específica desde cero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the specific formulation from scratch"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "proceso que puede llevar más de una década",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "process that can take more than a decade"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En esta búsqueda de medicamentos la comunidad científica mundial se ha movilizado de forma \"impresionante, cada uno desde su enfoque particular\", destaca Rial, quien considera: \"Si muchos buscamos alguno dará con el bueno\".",
                "text_en": "In this search for medicines the world scientific community has mobilized in an \"impressive way, each one from its particular focus,\" says Rial, who considers: \"If many we seek one we will find the good\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "En esta búsqueda de medicamentos la comunidad científica mundial se ha movilizado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In this search for medicines the world scientific community has mobilized"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la comunidad científica mundial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the global scientific community"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma \"impresionante, cada uno desde su enfoque particular\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an \"impressive way, each from its own particular approach\""
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Rial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Rial"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "38": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 1,
            "What": 10,
            "WhatReliabilityReliable": 2,
            "WhatReliabilityUnreliable": 8,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 10,
            "WhoReliabilityReliable": 4,
            "WhoReliabilityUnreliable": 6,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 9,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nAsí lo recoge la web norteamericana ‘Centipede Nation’ en un artículo que puedes leer en este enlace, y que recoge el testimonio de dos mujeres que hicieron pública su situación en redes sociales.\n\n<PARAGRAPH>\n\nLa primera se llama Tabatha Lauren y fue hospitalizada después de recibir la ‘vacuna’ de Johnson & Johnson, en la que afirmó que sus problemas “Comenzaron con dolor en el pecho, parálisis en el lado izquierdo. Me llevaron a toda prisa en ambulancia al [Centro Médico de la Universidad de Baylor] donde me hicieron numerosas exploraciones. He tenido alrededor de ocho convulsiones en los últimos dos días; nunca antes había tenido una convulsión. Encontraron un aneurisma cerebral de 3 mm. Actualmente estoy conectada a mi electroencefalograma para que puedan controlar mis convulsiones”.\n\n<PARAGRAPH>\n\nAsí lo publicó en su cuenta de Tik Tok, una cuenta que tras la publicación fue eliminada.\n\n<PARAGRAPH>\n\nJust awful.\n\n<BREAK>\n\nAn obviously young girl having fits and blood clots after J&J vax.\n\n<PARAGRAPH>\n\nI am seeing far too many of these for it to be a ‘very rare’ side effect.\n\n<PARAGRAPH>\n\nGov is lying and covering it up.\n\n<BREAK>\n\npic.twitter.com/yZIkgMWW8I\n\n<PARAGRAPH>\n\n— Penelope Pitstop (@Pen_stop) April 9, 2021\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nOtra mujer, que también recibió la vacuna de Johnson & Johnson relata hinchazón en su cabeza y otras reacciones.\n\n<BREAK>\n\nY hace referencia al intento de “adelgazar” la población mundial, algo de los que muchos hablan y otros, como Bill Gates, llevan años planteando.\n\n<PARAGRAPH>\n\n#democrats no longer need #Blackpeople as they have #IllegalAliens to replace us.\n\n<PARAGRAPH>\n\nSeems like they’re using that #vaccine to “thin the herd” #VAXTHEBLACKS #RIP #MidwinCharles pic.twitter.com/6sOnICLICb\n\n<PARAGRAPH>\n\n— B1SanDiego (@B1SanDiego1) April 7, 2021\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nComo siempre, que cada uno saque sus propias conclusiones.\n\n<BREAK>\n\nNosotros nos limitamos a hacernos eco de aquello sobre lo que no informan los medios que están todo el día diciendo que las vacunas son muy seguras…\n\n<PARAGRAPH>\n",
        "TITLE": "Varias mujeres cuentan los efectos secundarios que están sufriendo tras inyectarse la vacuna de Johnson & Johnson, que pretende aprobar ahora la UE",
        "ID": "NF_04-11-2021_21-38-56_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Varias mujeres cuentan los efectos secundarios que están sufriendo tras inyectarse la vacuna de Johnson & Johnson, que pretende aprobar ahora la UE",
                "text_en": "Several women tell of the side effects they are experiencing after injecting the Johnson & Johnson vaccine, which is now intended to be approved by the EU.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Varias mujeres",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Several women"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cuentan los efectos secundarios que están sufriendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "count the side effects they are suffering"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras inyectarse la vacuna de Johnson & Johnson",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after injecting the Johnson & Johnson vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EU"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así lo recoge la web norteamericana ‘Centipede Nation’ en un artículo que puedes leer en este enlace, y que recoge el testimonio de dos mujeres que hicieron pública su situación en redes sociales.",
                "text_en": "This is how the American website ‘Centipede Nation’ collects it in an article that you can read in this link, which collects the testimony of two women who made their situation public on social networks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la web norteamericana ‘Centipede Nation’",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the North American website ‘Centipede Nation’"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en este enlace",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in this link"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recoge el testimonio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Collects the Testimony"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "dos mujeres",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "two women"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en redes sociales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on social networks"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La primera se llama Tabatha Lauren y fue hospitalizada después de recibir la ‘vacuna’ de Johnson & Johnson, en la que afirmó que sus problemas “Comenzaron con dolor en el pecho, parálisis en el lado izquierdo. Me llevaron a toda prisa en ambulancia al [Centro Médico de la Universidad de Baylor] donde me hicieron numerosas exploraciones. He tenido alrededor de ocho convulsiones en los últimos dos días; nunca antes había tenido una convulsión. Encontraron un aneurisma cerebral de 3 mm. Actualmente estoy conectada a mi electroencefalograma para que puedan controlar mis convulsiones”.",
                "text_en": "The first is called Tabatha Lauren and was hospitalized after receiving Johnson & Johnson’s ‘vaccine’, in which she stated that her problems “started with chest pain, paralysis on the left side. I was rushed by ambulance to the Baylor University Medical Center where I had numerous scans. I have had about eight seizures in the last two days; I had never had a seizure before. They found a 3 mm brain aneurysm. I am currently connected to my electroencephalogram so that they can control my seizures.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Tabatha Lauren",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Tabatha Lauren"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue hospitalizada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was hospitalized"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de recibir la ‘vacuna’ de Johnson & Johnson",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after receiving Johnson & Johnson’s ‘vaccine’"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al [Centro Médico de la Universidad de Baylor]",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to [Baylor University Medical Center]"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "He tenido alrededor de ocho convulsiones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I've had about eight seizures."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los últimos dos días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last two days"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así lo publicó en su cuenta de Tik Tok, una cuenta que tras la publicación fue eliminada.",
                "text_en": "He posted it on his Tik Tok account, an account that was deleted after publication.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su cuenta de Tik Tok",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in your Tik Tok account"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras la publicación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after publication"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue eliminada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was eliminated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Otra mujer, que también recibió la vacuna de Johnson & Johnson relata hinchazón en su cabeza y otras reacciones.",
                "text_en": "Another woman, who also received the Johnson & Johnson vaccine, reports swelling in her head and other reactions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Otra mujer",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Another woman"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "relata hinchazón en su cabeza y otras reacciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "reports swelling in your head and other reactions"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su cabeza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in his head"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y hace referencia al intento de “adelgazar” la población mundial, algo de los que muchos hablan y otros, como Bill Gates, llevan años planteando.",
                "text_en": "And he refers to the attempt to “scale” the world’s population, something many people talk about and others, like Bill Gates, have been raising for years.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hace referencia al intento de “adelgazar”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "refers to the attempt to “sloop”"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población mundial",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "of the world ' s population"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Bill Gates",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Bill Gates"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llevan años planteando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They've been raising questions for years."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Como siempre, que cada uno saque sus propias conclusiones.",
                "text_en": "As always, let each one draw his own conclusions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "cada uno",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "each"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "saque sus propias conclusiones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "draw your own conclusions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Nosotros nos limitamos a hacernos eco de aquello sobre lo que no informan los medios que están todo el día diciendo que las vacunas son muy seguras…",
                "text_en": "We just echo what the media doesn't report all day saying vaccines are very safe...",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los medios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the media"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "diciendo que las vacunas son muy seguras",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "saying that vaccines are very safe"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "39": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 11,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 6,
            "WhoReliabilityReliable": 6,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 5,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 7,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 7,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nLa mayoría de las notificaciones corresponden a personas de entre 18 y 65 años y mayoritariamente a mujeres.\n\n<PARAGRAPH>\n\nFiebre, dolor en la zona de vacunación, cefalea, mareos, mialgia y artralgia son, hasta ahora, los acontecimientos adversos de las vacunas contra el coronavirus más frecuentemente notificados en España, según el 4º Informe de Farmacovigilancia sobre Vacunas Covid-19.\n\n<PARAGRAPH>\n\nHasta el 21 de marzo de 2021, según el trabajo elaborado por la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), se han administrado en España 6.125.119 dosis de vacunas frente a la Covid-19, habiéndose recibido 11.182 notificaciones de acontecimientos adversos, lo que correspondería a 183 notificaciones por cada 100.000 dosis administradas.\n\n<BREAK>\n\nEl 84% han sido comunicadas por profesionales sanitarios, y el 16% por ciudadanos.\n\n<PARAGRAPH>\n\nLa mayoría de las notificaciones corresponden a personas de entre 18 y 65 años (93%) y mayoritariamente a mujeres (82%).\n\n<BREAK>\n\nSe han notificado tres casos que incluyen acontecimientos de corta duración y que no revisten gravedad en lactantes cuyas madres se habían vacunado con la vacuna desarrollada por Moderna como, por ejemplo, diarrea, vómitos e irritabilidad.\n\n<PARAGRAPH>\n\nAsimismo, la AEMPS ha informado que con la vacuna de Pfizer puede aparecer una inflamación más extensa que la zona de inyección en la extremidad de administración de la vacuna.\n\n<BREAK>\n\nDe hecho, se encuentra en estudio la posible aparición de inflamación en zonas de la cara en las que se habían aplicado previamente inyecciones de relleno bajo la piel (por ejemplo, de ácido hialurónico).\n\n<PARAGRAPH>\n\nSobre la vacuna de AstraZeneca\n\n<PARAGRAPH>\n\nRespecto a la vacuna desarrollada por AstraZeneca, la AEMPS recuerda en el informe que no se considera que la administración de esta vacuna produzca un aumento del riesgo global de acontecimientos trombóticos.\n\n<BREAK>\n\nSin embargo, muy raramente se han presentado casos de trombosis de senos venosos cerebrales que pueden acompañarse de niveles bajos de plaquetas, que actualmente están en investigación.\n\n<BREAK>\n\nAdemás, se incluirán las reacciones alérgicas de anafilaxia e hipersensibilidad como reacciones adversas conocidas en la ficha técnica y el prospecto de esta vacuna.\n\n<PARAGRAPH>\n\nSe encuentra en estudio la potencial relación entre la aparición de trombocitopenia inmune y administración de las tres vacunas utilizadas hasta el momento.\n\n<BREAK>\n\nFinalmente, la AEMPS ha recordado que los eventos adversos que se notifican no significa que estén relacionados con la vacunación y, por tanto, \"no son reacciones adversas ni sirven para comparar el perfil de reacciones adversas de las diferentes vacunas\".\n\n<PARAGRAPH>\n\n",
        "TITLE": "Los principales efectos de las vacunas detectados en España hasta ahora",
        "ID": "F_04-11-2021_20-34-29_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Los principales efectos de las vacunas detectados en España hasta ahora",
                "text_en": "The main effects of vaccines detected in Spain so far",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los principales efectos de las vacunas detectados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The main effects of detected vaccines"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hasta ahora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Until now"
                    }
                ],
                "evidences": [
                    {
                        "value": "According to a study performed in Israel, COVID-19 vaccination is highly effective in preventing symptomatic and asymptomatic SARS-CoV-2 infections and COVID-19-related hospitalisations, and deaths (Haas et al., 2021) . The studies of VE performed in Spain, where around 80% of the population has already been vaccinated, have provided encouraging results so far. Thus, even though the vaccination campaign in Spain was carried out at a much slower speed than Israel, COVID-19 vaccination using mRNA vaccines in Spain has shown to be very effective in preventing infections, and COVID-19 hospitalisations and deaths in elderly long-term care facilities (LTCF) residents (Mazagatos et al., 2021) .",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.6302344799
                    }
                ]
            },
            {
                "text": "La mayoría de las notificaciones corresponden a personas de entre 18 y 65 años y mayoritariamente a mujeres.",
                "text_en": "The majority of notifications are for persons aged 18 to 65 and mostly for women.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mayoría de las notificaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "majority of notifications"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas de entre 18 y 65 años y mayoritariamente a mujeres",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "between 18 and 65 years of age and mostly women"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Fiebre, dolor en la zona de vacunación, cefalea, mareos, mialgia y artralgia son, hasta ahora, los acontecimientos adversos de las vacunas contra el coronavirus más frecuentemente notificados en España, según el 4º Informe de Farmacovigilancia sobre Vacunas Covid-19.",
                "text_en": "Fever, pain in the vaccination area, headache, dizziness, myalgia and arthralgia are, so far, the most frequently reported adverse events of coronavirus vaccines in Spain, according to the 4th Covid-19 Vaccine Pharmacovigilance Report.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Fiebre, dolor en la zona de vacunación, cefalea, mareos, mialgia y artralgia son, hasta ahora, los acontecimientos adversos de las vacunas contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fever, pain in the vaccination area, headache, dizziness, myalgia and arthralgia are, so far, adverse events of coronavirus vaccines"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hasta ahora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Until now"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    }
                ],
                "evidences": [
                    {
                        "value": "Although the efficacy and safety of this vaccine have been widely studied [7, 8] , several articles have reported adverse reactions to this vaccine in the general population [9] and in healthcare workers [3] [4] [5] . To date, no study has evaluated these adverse events in hospital workers in large sample-sized cohort in Spain, and the factors associated with these events are not clear to date. Coggins et al. suggested that women were more susceptible to report these events [5] , but this information contrasts with other studies that did not find any clear association.",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9965920448
                    }
                ]
            },
            {
                "text": "Hasta el 21 de marzo de 2021, según el trabajo elaborado por la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), se han administrado en España 6.125.119 dosis de vacunas frente a la Covid-19, habiéndose recibido 11.182 notificaciones de acontecimientos adversos, lo que correspondería a 183 notificaciones por cada 100.000 dosis administradas.",
                "text_en": "As of March 21, 2021, according to the work done by the Spanish Agency for Medicinal Products and Health Products (AEMPS), 6,125,119 doses of vaccines have been administered in Spain against Covid-19, with 11,182 reports of adverse events, corresponding to 183 notifications per 100,000 doses administered.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hasta el 21 de marzo de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Until 21 March 2021"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Spanish Agency for Medicines and Health Products (AEMPS)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han administrado en España 6.125.119 dosis de vacunas frente a la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Doses of Covid-19 vaccines have been administered in Spain 6.125.119"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "11.182 notificaciones de acontecimientos adversos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "11,182 reports of adverse events"
                    }
                ],
                "evidences": [
                    {
                        "value": "According to data obtained from the Ministry of Health at the time of writing this article, in Spain 39.9 million doses had been administered, with more than 24 million persons having received one dose (52.8%) and more than 16 million having completed the full vaccination schedule (35.4% of the population).",
                        "score": 0.6600000262
                    },
                    {
                        "value": "According to the 4 th Pharmacovigilance Report on COVID-19 Vaccines of the Spanish Agency for Medicines and Health Products (AEMPS), at the time of the latest data cut-off (March 21 st , 2021) a total of 6,125,119 doses of COVID-19 vaccines had been administered in Spain since the beginning of the vaccination campaign (December 27 th , 2020). A total of 4,136,963 people were vaccinated of which 67 % were women. Seventy nine percent of the administered doses corresponded to Comirnaty, 16 % to Vaxzevria and 5% to Moderna vaccine, and 11,182 adverse events were reported, 93 % in people between 18 and 65 years old (93 %) and mostly women (82 %) [38] . The most frequently reported events continue to be general disorders (fever, pain at the injection site), events of the central nervous system (headache, dizziness) and musculoskeletal (myalgia and arthralgia) ( Table 3 ). The report concluded that, after reviewing the available data, no hitherto unknown adverse reactions have been identified that may give cause for concern [38] . However, no information is available so far on potential long-term adverse events.",
                        "score": 0.8199999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.9822445512
                    },
                    {
                        "label": "neutral",
                        "score": 0.9601390362
                    }
                ]
            },
            {
                "text": "La mayoría de las notificaciones corresponden a personas de entre 18 y 65 años (93%) y mayoritariamente a mujeres (82%).",
                "text_en": "The majority of notifications are for persons aged 18 to 65 (93%) and mostly for women (82%).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La mayoría de las notificaciones corresponden",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Most notifications correspond"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a personas de entre 18 y 65 años (93%) y mayoritariamente a mujeres (82%)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons aged 18 to 65 (93%) and mostly women (82%)"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Asimismo, la AEMPS ha informado que con la vacuna de Pfizer puede aparecer una inflamación más extensa que la zona de inyección en la extremidad de administración de la vacuna.",
                "text_en": "In addition, AEMPS has reported that with the Pfizer vaccine there may be more extensive inflammation than the injection site at the end of the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la AEMPS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AEMPS"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la vacuna de Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with Pfizer vaccine"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puede aparecer una inflamación más extensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more extensive inflammation may occur"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la extremidad de administración de la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the end of administration of the vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Respecto a la vacuna desarrollada por AstraZeneca, la AEMPS recuerda en el informe que no se considera que la administración de esta vacuna produzca un aumento del riesgo global de acontecimientos trombóticos.",
                "text_en": "Regarding the vaccine developed by AstraZeneca, AEMPS recalls in the report that the administration of this vaccine is not considered to result in an increased overall risk of thrombotic events.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la AEMPS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AEMPS"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el informe",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the report"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se considera que la administración de esta vacuna produzca un aumento del riesgo global de acontecimientos trombóticos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "administration of this vaccine is not considered to result in an increased overall risk of thrombotic events"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se encuentra en estudio la potencial relación entre la aparición de trombocitopenia inmune y administración de las tres vacunas utilizadas hasta el momento.",
                "text_en": "The potential relationship between the occurrence of immune thrombocytopenia and the administration of the three vaccines used so far is being studied.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Se encuentra en estudio la potencial relación entre la aparición de trombocitopenia inmune y administración de las tres vacunas utilizadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The potential relationship between the occurrence of immune thrombocytopenia and the administration of the three vaccines used is being studied."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hasta el momento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "So far"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Finalmente, la AEMPS ha recordado que los eventos adversos que se notifican no significa que estén relacionados con la vacunación y, por tanto, \"no son reacciones adversas ni sirven para comparar el perfil de reacciones adversas de las diferentes vacunas\".",
                "text_en": "Finally, AEMPS has recalled that the reported adverse events do not mean that they are related to vaccination and therefore \"are not adverse reactions nor do they serve to compare the adverse reaction profile of the different vaccines\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la AEMPS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AEMPS"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los eventos adversos que se notifican no significa que estén relacionados con la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reported adverse events do not mean that they are related to vaccination"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no son reacciones adversas ni sirven para comparar el perfil de reacciones adversas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are not adverse reactions nor are they used to compare the adverse reaction profile"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "40": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 11,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 0,
            "WhoReliabilityReliable": 0,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 6,
            "WhenReliabilityReliable": 6,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 0,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nDesde que comenzaran los casos de Covid-19 en España y tras pasar por el un estado de alarma y un confinamiento, la mascarilla se ha convertido en un producto fundamental en todas las casas, ya que se debe utilizar de forma obligatoria en los espacios públicos. \n\n<BREAK>\n\nDe este modo, aunque se ha hablado mucho de ello, es importante saber cómo se utiliza de forma correcta la mascarilla, ya que es importante seguir una serie de recomendaciones para que su función de protección sea efectiva. \n\n<BREAK>\n\n¿Por qué no hay que tocar la mascarilla con las manos? \n\n<BREAK>\n\nDesde el principio, una de las principales indicaciones en cuanto al uso de mascarilla es, precisamente, no tocarla con las manos. \n\n<BREAK>\n\nEs por ello, que una de las muchas guías elaboradas por el Gobierno, en este caso, por el Ministerio de Consumo sobre qué tener en cuenta a la hora de comprar una mascarilla, indica varias cosas importantes. \n\n<BREAK>\n\nEn primer lugar, la mascarilla hay que ponérsela con las manos limpias, por lo que antes de colocarla hay que lavarse las manos. \n\n<BREAK>\n\nDespués, para ponérsela, hay que tocar únicamente las gomas y no la parte que cubre la boca. \n\n<BREAK>\n\nCuando la mascarilla está sobre la boca y la nariz, hay que tratar de no tocarla, ya que la zona exterior de la mascarilla es donde se acumulan las sustancias contaminantes y, al tocar esa zona con las manos, estas se contaminan también: \"Evita tocar la parte exterior de la mascarilla. \n\n<BREAK>\n\nSi lo haces, lávate las manos antes y después\", indica el documento. \n\n<BREAK>\n\nPor último, al quitarse la mascarilla, también hay que evitar tocarla con las manos y, posteriormente, meterla en una bolsa de basura desechable y volver a lavarse las manos. \n\n<BREAK>\n\nComo se aprecia, lavarse las manos es una de las principales recomendaciones sanitarias a la hora de evitar contagios por coronavirus, por lo que el uso de mascarilla debe ser una medida complementaria al lavado frecuente de manos y al mantenimiento de la distancia mínima entre personas.",
        "TITLE": "¿Por qué no deberías tocarte la mascarilla con la mano cuando la llevas puesta?",
        "ID": "9-20minutos",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "¿Por qué no deberías tocarte la mascarilla con la mano cuando la llevas puesta?",
                "text_en": "Why shouldn't you touch the mask with your hand when you're wearing it?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no deberías tocarte la mascarilla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "You shouldn't touch the mask."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la mano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with your hand"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando la llevas puesta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "When you're wearing it"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desde que comenzaran los casos de Covid-19 en España y tras pasar por el un estado de alarma y un confinamiento, la mascarilla se ha convertido en un producto fundamental en todas las casas, ya que se debe utilizar de forma obligatoria en los espacios públicos. ",
                "text_en": "Since the beginning of the Covid-19 cases in Spain and after passing through a state of alarm and confinement, the mask has become a fundamental product in all houses, since it must be used in public spaces.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Desde que comenzaran los casos de Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Since the Covid-19 cases began"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la mascarilla se ha convertido en un producto fundamental",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the mask has become a fundamental product"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en todas las casas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in all houses"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que se debe utilizar de forma obligatoria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since it must be used on a mandatory basis"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los espacios públicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in public spaces"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De este modo, aunque se ha hablado mucho de ello, es importante saber cómo se utiliza de forma correcta la mascarilla, ya que es importante seguir una serie de recomendaciones para que su función de protección sea efectiva. ",
                "text_en": "Thus, although much has been said about it, it is important to know how the mask is used correctly, as it is important to follow a number of recommendations so that its protection function is effective.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es importante saber cómo se utiliza de forma correcta la mascarilla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it is important to know how the mask is used correctly"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que es importante seguir una serie de recomendaciones para que su función de protección sea efectiva",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since it is important to follow up a number of recommendations so that its protection function is effective"
                    }
                ],
                "evidences": [
                    {
                        "value": "The use of a face mask-of various specifications according to the required degree of protection/function-is part of the PPE required in several professional activities, most noticeable in healthcare. One of the participants in this study, who works in healthcare, described her own experience in terms of the caring features of the face masks from medical to communal setting.",
                        "score": 0.6000000238
                    },
                    {
                        "value": "The main purpose of this review was to present different techniques in quality control and processing of face masks. These days, due to the COVID-19 consequences, public attention is drawn to face mask application for reducing death and infection. For this, productive information about face masks in terms of starting materials, primary and advance processing, mechanisms of filtration and related required application tests were considered.",
                        "score": 0.6499999762
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9934301972
                    },
                    {
                        "label": "neutral",
                        "score": 0.9950947762
                    }
                ]
            },
            {
                "text": "Desde el principio, una de las principales indicaciones en cuanto al uso de mascarilla es, precisamente, no tocarla con las manos. ",
                "text_en": "From the beginning, one of the main indications as to the use of mask is precisely not to touch it with your hands.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "una de las principales indicaciones en cuanto al uso de mascarilla es, precisamente, no tocarla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "one of the main indications as to the use of mask is, precisely, not to touch it"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con las manos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with your hands"
                    }
                ],
                "evidences": [
                    {
                        "value": "Since the first reviewer pointed out that coverage of masking was inadequate I decided to remove this as a major focus. I have attempted to look into this issue but there are too many confounders to arrive at a definitive conclusion (e.g., if maskwearing reduces other NPIs in some societies, that would reduce the effectiveness of masks) 2 . In general terms the fact that asymptomatic transmission is a factor indicates that mask wearing is likely to be effective, but I have found no definitive study to back this -though e.g. the Czech experience of having one of the lowest rates of infection in Europe while masking and becoming one of the worst when masking was dropped supports the case. For this reason, I prefer to make the focus asymptomatic transmission and dropped masking as an issue.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.918862164
                    }
                ]
            },
            {
                "text": "En primer lugar, la mascarilla hay que ponérsela con las manos limpias, por lo que antes de colocarla hay que lavarse las manos. ",
                "text_en": "First, the mask has to be put on with clean hands, so before placing it you have to wash your hands.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "antes de colocarla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "before placing it"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay que lavarse las manos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "You have to wash your hands."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Después, para ponérsela, hay que tocar únicamente las gomas y no la parte que cubre la boca. ",
                "text_en": "Then, to put it on, you have to touch only the gums and not the part that covers your mouth.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "para ponérsela",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to wear it"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay que tocar únicamente las gomas y no la parte que cubre la boca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "touch only the gums and not the part that covers the mouth"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cuando la mascarilla está sobre la boca y la nariz, hay que tratar de no tocarla, ya que la zona exterior de la mascarilla es donde se acumulan las sustancias contaminantes y, al tocar esa zona con las manos, estas se contaminan también: \"Evita tocar la parte exterior de la mascarilla. ",
                "text_en": "When the mask is over the mouth and nose, try not to touch it, because the outer area of the mask is where the contaminating substances accumulate and, when touching that area with the hands, they also become contaminated: \"Do not touch the outer part of the mask.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay que tratar de no tocarla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "You have to try not to touch her."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que la zona exterior de la mascarilla es donde se acumulan las sustancias contaminantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because the outer area of the mask is where contaminating substances accumulate"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si lo haces, lávate las manos antes y después\", indica el documento. ",
                "text_en": "If you do, wash your hands before and after,\" the document says.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lávate las manos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Wash your hands"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "antes y después",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "before and after"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por último, al quitarse la mascarilla, también hay que evitar tocarla con las manos y, posteriormente, meterla en una bolsa de basura desechable y volver a lavarse las manos. ",
                "text_en": "Finally, when removing the mask, you should also avoid touching it with your hands and then putting it in a disposable trash bag and washing your hands again.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al quitarse la mascarilla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when removing the mask"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay que evitar tocarla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "You have to avoid touching her."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con las manos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with your hands"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Como se aprecia, lavarse las manos es una de las principales recomendaciones sanitarias a la hora de evitar contagios por coronavirus, por lo que el uso de mascarilla debe ser una medida complementaria al lavado frecuente de manos y al mantenimiento de la distancia mínima entre personas.",
                "text_en": "As can be seen, washing hands is one of the main health recommendations when it comes to preventing contagion by coronavirus, so the use of mask should be a complementary measure to the frequent washing of hands and the maintenance of the minimum distance between people.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lavarse las manos es una de las principales recomendaciones sanitarias a la hora de evitar contagios por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "washing hands is one of the main health recommendations when it comes to preventing contagion by coronavirus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el uso de mascarilla debe ser una medida complementaria al lavado frecuente de manos y al mantenimiento de la distancia mínima entre personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the use of mask should be a complementary measure to the frequent washing of hands and the maintenance of the minimum distance between persons"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "41": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 7,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 12,
            "WhoReliabilityReliable": 12,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nBogotá, 08 de abril _ RAM_ Luego de que se reportaran al menos 86 casos de personas que manifestaron que, tras recibir la vacuna de AstraZeneca presentaron efectos adversos como la generación de coágulos en la sangre asociados a recuentos bajos de plaqueta, el Invima anunció que, igual que la Agencia Europea del Medicamento y la Organización Mundial de la Salud, considera que estos casos son mínimos frente al beneficio del inmunizante para contrarrestar la Covid-19.\n\n<PARAGRAPH>\n\n“Colombia, al igual que las agencias sanitarias del resto de las Américas, permitirá que se continúe utilizando esta vacuna en el marco de los planes de vacunación que adelanta el Gobierno Nacional y sugerirá a AstraZeneca que añada en la documentación de sus estudios esta información sobre los eventuales efectos adversos”, señaló Julio César Aldana, director del Invima.\n\n<PARAGRAPH>\n\nPor su parte, la farmacéutica aseguró que, dentro de la información con las advertencias suministrada a los países, al momento de solicitar la autorización para la comercialización de su vacuna, se estableció que el inmunizante se debe suministrar con precaución en personas con trombocitopenia, trastornos de coagulación o en quienes están recibiendo algún tratamiento de anticoagulante, debido al riesgo de sangrado o formación de hematomas.\n\n<PARAGRAPH>\n\nImportante anotar que, la Autorización para Uso de Emergencia a la farmacéutica AstraZeneca se la otorgó Colombia el 23 de febrero de este año.\n\n<BREAK>\n\nEsta vacuna además está siendo usada en otros 100 países.\n\n<PARAGRAPH>\n",
        "TITLE": "Invima avaló que en Colombia se siga usando la vacuna de AstraZeneca",
        "ID": "NF_04-11-2021_21-31-30_www_eje21_com_co",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Invima avaló que en Colombia se siga usando la vacuna de AstraZeneca",
                "text_en": "Invima endorsed the continued use of AstraZeneca vaccine in Colombia",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Invima",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Invima"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "avaló que en Colombia se siga usando la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "supported the continued use of the AstraZeneca vaccine in Colombia"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Colombia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Bogotá, 08 de abril _ RAM_ Luego de que se reportaran al menos 86 casos de personas que manifestaron que, tras recibir la vacuna de AstraZeneca presentaron efectos adversos como la generación de coágulos en la sangre asociados a recuentos bajos de plaqueta, el Invima anunció que, igual que la Agencia Europea del Medicamento y la Organización Mundial de la Salud, considera que estos casos son mínimos frente al beneficio del inmunizante para contrarrestar la Covid-19.",
                "text_en": "Bogotá, April 08 _ RAM_ After at least 86 cases were reported of people who said that, after receiving the AstraZeneca vaccine, they had adverse effects such as the generation of blood clots associated with low platelet counts, the Invima announced that, like the European Medicines Agency and the World Health Organization, it considers these cases to be minimal compared to the benefit of the immunizer to counteract Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "86 casos de personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "86 cases of persons"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras recibir la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after receiving the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "presentaron efectos adversos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "side effects"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Invima",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Invima"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Organización Mundial de la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the World Health Organization"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "considera que estos casos son mínimos frente al beneficio del inmunizante para contrarrestar la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "considers that these cases are minimal compared to the benefit of the immunizer to counteract Covid-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Colombia, al igual que las agencias sanitarias del resto de las Américas, permitirá que se continúe utilizando esta vacuna en el marco de los planes de vacunación que adelanta el Gobierno Nacional y sugerirá a AstraZeneca que añada en la documentación de sus estudios esta información sobre los eventuales efectos adversos”, señaló Julio César Aldana, director del Invima.",
                "text_en": "“Colombia, like the health agencies of the rest of the Americas, will allow this vaccine to continue to be used within the framework of the vaccination plans being carried out by the National Government and will suggest to AstraZeneca that this information on possible adverse effects be added in the documentation of its studies,” said Julio César Aldana, director of the Invima.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las agencias sanitarias del resto de las Américas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health agencies in the rest of the Americas"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "permitirá que se continúe utilizando esta vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "allow continued use of this vaccine"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en el marco de los planes de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "within the framework of vaccination plans"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Julio César Aldana, director del Invima",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Julio César Aldana, director of the Invima"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por su parte, la farmacéutica aseguró que, dentro de la información con las advertencias suministrada a los países, al momento de solicitar la autorización para la comercialización de su vacuna, se estableció que el inmunizante se debe suministrar con precaución en personas con trombocitopenia, trastornos de coagulación o en quienes están recibiendo algún tratamiento de anticoagulante, debido al riesgo de sangrado o formación de hematomas.",
                "text_en": "For her part, the pharmacist said that, within the information with the warnings provided to countries, at the time of requesting authorization for the marketing of their vaccine, it was established that the immunizer should be supplied with caution in people with thrombocytopenia, coagulation disorders or in those who are receiving anticoagulant treatment, due to the risk of bleeding or formation of hematomas.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la farmacéutica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pharmaceuticals"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al momento de solicitar la autorización para la comercialización de su vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the time of application for authorisation to place your vaccine on the market"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se estableció que el inmunizante se debe suministrar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it was established that the immunizer should be supplied"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con precaución",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with caution"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en personas con trombocitopenia, trastornos de coagulación o en quienes están recibiendo algún tratamiento de anticoagulante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in people with thrombocytopenia, coagulation disorders, or who are receiving anticoagulant treatment"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "debido al riesgo de sangrado o formación de hematomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to the risk of bleeding or bruising"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Importante anotar que, la Autorización para Uso de Emergencia a la farmacéutica AstraZeneca se la otorgó Colombia el 23 de febrero de este año.",
                "text_en": "Important to note, the Emergency Use Authorization to the pharmaceutical company AstraZeneca was granted by Colombia on February 23, this year.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la Autorización para Uso de Emergencia a la farmacéutica AstraZeneca se la otorgó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Emergency Use Authorisation to the pharmaceutical company AstraZeneca has been granted"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la farmacéutica AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the pharmaceutical company AstraZeneca"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 23 de febrero de este año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 23 February of this year"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta vacuna además está siendo usada en otros 100 países.",
                "text_en": "This vaccine is also being used in another 100 countries.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta vacuna además está siendo usada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This vaccine is also being used"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en otros 100 países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "100 additional countries"
                    }
                ],
                "evidences": [
                    {
                        "value": "S. Rautio outlined UNICEF's stockpiling strategies, priorities and forecasting, funding and contracting activities [8] . UNICEF procures around 2.5 billion doses of 40 WHO-prequalified vaccines and distributes these to around 100 countries, managing demand and reallocating supply to level-out fluctuations and avert crises. Since 2010, UNICEF has responded to around 300 humanitarian situations in 90 countries annually, with a peak in 2016 (Fig. 3) . For bivalent oral poliovirus vaccine (bOPV) in 2017, a rolling buffer of 150 million doses is maintained, with a further 115 million doses of bulk maintained by manufacturers, ready for delivery within 3 months. A unique challenge is presented by the OPV type 2 stockpile, established to support the Global Polio Eradication Initiative (GPEI) should type 2 outbreaks occur following the withdrawal of trivalent OPV. The same will apply to OPV types 1 and 3, to be secured after future bOPV cessation.",
                        "score": 0.6299999952
                    },
                    {
                        "value": "10. Progress toward securing future vaccine supply Y. Momeni (UNICEF) provided an update for 2017 (Fig. 6) , where around 100 countries were supplied 2.4 billion doses of vaccine through UNICEF, at a value of US$1.3 billion, reaching 45% of children under 5 years of age.",
                        "score": 0.6800000072
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9859785438
                    },
                    {
                        "label": "neutral",
                        "score": 0.9946517944
                    }
                ]
            }
        ]
    },
    "42": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 18,
            "WhatReliabilityReliable": 18,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 25,
            "WhoReliabilityReliable": 25,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 9,
            "WhenReliabilityReliable": 9,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 4,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 4,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 4,
            "WhoRoleSubject": 19,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLa Reina, presidenta de honor de la AECC,  participa en un foto con motivo del Día Mundial Contra el Cáncer\n\n<PARAGRAPH>\n\nEl foco está en los afectados por la covid, pero la pandemia y la crisis sanitaria está afectando también a los enfermos que sufren otras patologías.\n\n<BREAK>\n\nCon motivo del Día Mundial contra el Cáncer, la reina Letizia, ha intervenido, este jueves, en un foro en el que ha hecho un llamamiento para que los cargos públicos, los agentes sociales y la ciudadanía refuercen su atención a los enfermos con cáncer ante la pérdida que atención sufrida en los últimos meses  tras advertir que es una necesidad \"más urgente que nunca\".\n\n<PARAGRAPH>\n\n\"El enfermo de cáncer es vulnerable y lo es aún más en esta pandemia\", ha dicho la Reina, presidenta de honor de la Asociación Española Contra el Cáncer (AECC), entidad que ha organizado el encuentro, donde ha estado acompañada por la ministra de Sanidad, Carolina Darias, en el que ha sido su primer acto conjunto, y el presidente de la asociación Ramón Reyes.\n\n<PARAGRAPH>\n\nEn sus palabras, la Reina ha  recordado que ya antes de la crisis del coronavirus la situación socioeconómica de las personas con cáncer era ya delicada, pero un año después, \"el desafío es mayor. La necesidad de dar respuesta a la situación que viven los pacientes oncológicos es más urgente que nunca\", ha dicho en alusión a los problemas que este colectivo se han encontrado en los últimos meses, como retrasos en las revisiones, en los tratamientos y en el diagnóstico de la enfermedad.\n\n<PARAGRAPH>\n\nLa Reina, este jueves, a su llegada a la sede de la Asociación Española Contra el Cáncer, en Madrid\n\n<PARAGRAPH>\n\nPor ello, la Reina ha emplazado a los responsables de las distintas Administraciones, a los agentes sociales, a los medios de comunicación y a la sociedad en general a \"poner sobre la mesa este asunto\" al subrayar que es \"algo que no puede esperar\".\n\n<PARAGRAPH>\n\nTras la intervención de la reina, se han presentado en un vídeo las conclusiones de un estudio desarrollado por esta entidad en la que se destaca, demás de los problemas en la atención sanitaria al cáncer a causa de la covid-19, el agravamiento de la situación económica de las personas afectadas y sus familias.\n\n<PARAGRAPH>\n\nEl cáncer no se ha parado en tiempos de la covid-19.\n\n<BREAK>\n\nCada año, casi 280.000 personas son diagnosticadas de cáncer en nuestro país y más de 112.000 fallecen (300 personas cada día).\n\n<BREAK>\n\nSigue siendo un desafío económico, social y sanitario, no solo el momento presente sino también para los próximos años. La crisis provocada por esta pandemia no ha hecho sino agravar la situación de fragilidad de las personas con cáncer y sus familias como colectivo doblemente vulnerable, por el cáncer y por la covid. \n\n<PARAGRAPH>\n\nCon motivo del Día Mundial del Cáncer la AECC ha convocado el Foro para  reflexionar sobre cómo abordar esta vulnerabilidad sobrevenida.\n\n<BREAK>\n\nLa AECC es la primera entidad cuya presidencia de honor, en septiembre de 2010, asumió Letizia, aún princesa de Asturias, con carácter permanente y en la que participa activamente.  La asociación integra a pacientes, familiares, voluntarios y profesionales que trabajan unidos para prevenir, sensibilizar, apoyar y acompañar a las personas afectadas y financiar proyectos e investigación oncológica que permitan un mejor diagnóstico y tratamiento.\n\n<PARAGRAPH>\n",
        "TITLE": "Letizia alerta de que la atención al cáncer es más urgente que nunca",
        "ID": "F_04-11-2021_21-49-07_www_lavanguardia_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Letizia alerta de que la atención al cáncer es más urgente que nunca",
                "text_en": "Letizia warns that cancer care is more urgent than ever",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Letizia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Letizia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "alerta de que la atención al cáncer es",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "alert that cancer care is"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "más urgente que nunca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more urgent than ever"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Reina, presidenta de honor de la AECC,  participa en un foto con motivo del Día Mundial Contra el Cáncer",
                "text_en": "The Queen, president of honor of the AECC, participates in a photo on the occasion of World Cancer Day",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Reina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Queen"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la AECC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ECTA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "participa en un foto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "participate in a photo"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "con motivo del Día Mundial Contra el Cáncer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on the occasion of World Cancer Day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El foco está en los afectados por la covid, pero la pandemia y la crisis sanitaria está afectando también a los enfermos que sufren otras patologías.",
                "text_en": "The focus is on those affected by covid, but the pandemic and health crisis are also affecting patients suffering from other pathologies.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los afectados por la covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "those affected by covid"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la pandemia y la crisis sanitaria está afectando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the pandemic and the health crisis is affecting"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los enfermos que sufren otras patologías",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients suffering from other pathologies"
                    }
                ],
                "evidences": [
                    {
                        "value": "Although COVID-19 is a physical health crisis, the United Nations recognised early on that it had the potential of precipitating a major mental health crisis, especially for specific populations such as older adults [6] . Mental health has been a focus from the very onset of the pandemic-the sheer volume of loss, the trauma of covid survivors (especially those who were hospitalised or worse still, intubated), the sudden awareness of ageing and fear of mortality, forced social isolation, and induced helplessness, seemed to provide a fertile ground for precipitating prolonged periods of stress and anxiety with the threat of these transitory emotional states evolving into more enduring mental illness for all sections of the society, but more so for those deemed vulnerable.",
                        "score": 0.6800000072
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9925806522
                    }
                ]
            },
            {
                "text": "Con motivo del Día Mundial contra el Cáncer, la reina Letizia, ha intervenido, este jueves, en un foro en el que ha hecho un llamamiento para que los cargos públicos, los agentes sociales y la ciudadanía refuercen su atención a los enfermos con cáncer ante la pérdida que atención sufrida en los últimos meses  tras advertir que es una necesidad \"más urgente que nunca\".",
                "text_en": "On the occasion of World Cancer Day, Queen Letizia, this Thursday, spoke in a forum in which she called for public officials, social agents and citizens to strengthen their attention to cancer patients in the face of the loss of attention suffered in recent months after warning that it is a \"more urgent than ever\" need.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Con motivo del Día Mundial contra el Cáncer,",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "On the occasion of World Cancer Day,"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la reina Letizia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Queen Letizia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha intervenido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has intervened"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Thursday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un foro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a forum"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los cargos públicos, los agentes sociales y la ciudadanía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "public officials, social partners and citizenship"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "refuercen su atención",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "strengthen your attention"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los enfermos con cáncer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the sick with cancer"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ante la pérdida que atención sufrida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "before the loss of attention suffered"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los últimos meses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in recent months"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"El enfermo de cáncer es vulnerable y lo es aún más en esta pandemia\", ha dicho la Reina, presidenta de honor de la Asociación Española Contra el Cáncer (AECC), entidad que ha organizado el encuentro, donde ha estado acompañada por la ministra de Sanidad, Carolina Darias, en el que ha sido su primer acto conjunto, y el presidente de la asociación Ramón Reyes.",
                "text_en": "\"The cancer patient is vulnerable and is even more vulnerable in this pandemic,\" said the Queen, honorary president of the Spanish Association Against Cancer (AECC), an entity that has organized the meeting, where she has been accompanied by the Minister of Health, Carolina Darias, in which it has been her first joint act, and the president of the Ramón Reyes association.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El enfermo de cáncer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The cancer patient"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es vulnerable",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is vulnerable"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en esta pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in this pandemic"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Reina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Queen"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Asociación Española Contra el Cáncer (AECC)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Spanish Association Against Cancer (AECC)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "entidad que ha organizado el encuentro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "entity that has organized the meeting"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la ministra de Sanidad, Carolina Darias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Minister of Health, Carolina Darias"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el presidente de la asociación Ramón Reyes.",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the president of the Ramón Reyes association."
                    }
                ],
                "evidences": []
            },
            {
                "text": "En sus palabras, la Reina ha  recordado que ya antes de la crisis del coronavirus la situación socioeconómica de las personas con cáncer era ya delicada, pero un año después, \"el desafío es mayor. La necesidad de dar respuesta a la situación que viven los pacientes oncológicos es más urgente que nunca\", ha dicho en alusión a los problemas que este colectivo se han encontrado en los últimos meses, como retrasos en las revisiones, en los tratamientos y en el diagnóstico de la enfermedad.",
                "text_en": "In her words, the Queen recalled that already before the crisis of the coronavirus the socio-economic situation of people with cancer was already delicate, but a year later, \"the challenge is greater. The need to respond to the situation experienced by cancer patients is more urgent than ever,\" she said in reference to the problems that this group has encountered in recent months, such as delays in the reviews, in the treatments and in the diagnosis of the disease.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Reina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Queen"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ya antes de la crisis del coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "before the crisis of the coronavirus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la situación socioeconómica de las personas con cáncer era ya delicada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the socio-economic situation of people with cancer was already sensitive"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "problemas que este colectivo se han encontrado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "problems this group has encountered"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "este colectivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this collective"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los últimos meses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in recent months"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por ello, la Reina ha emplazado a los responsables de las distintas Administraciones, a los agentes sociales, a los medios de comunicación y a la sociedad en general a \"poner sobre la mesa este asunto\" al subrayar que es \"algo que no puede esperar\".",
                "text_en": "For this reason, the Queen has called on those responsible for the various administrations, the social partners, the media and society in general to \"put this issue on the table\" by stressing that it is \"something that cannot be expected\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Reina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Queen"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los responsables de las distintas Administraciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to those responsible for the various administrations"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "subrayar que es \"algo que no puede esperar\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stress that it is \"something that cannot wait\""
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tras la intervención de la reina, se han presentado en un vídeo las conclusiones de un estudio desarrollado por esta entidad en la que se destaca, demás de los problemas en la atención sanitaria al cáncer a causa de la covid-19, el agravamiento de la situación económica de las personas afectadas y sus familias.",
                "text_en": "Following the intervention of the Queen, the conclusions of a study carried out by this entity have been presented in a video highlighting, among others, the problems of health care for cancer due to covid-19, the worsening of the economic situation of the affected persons and their families.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Tras la intervención de la reina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "After the intervention of the Queen"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "conclusiones de un estudio desarrollado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "conclusions of a study carried out"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por esta entidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by this entity"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El cáncer no se ha parado en tiempos de la covid-19.",
                "text_en": "Cancer has not stopped in the time of covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El cáncer no se ha parado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The cancer hasn't stopped."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en tiempos de la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the time of covid-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cada año, casi 280.000 personas son diagnosticadas de cáncer en nuestro país y más de 112.000 fallecen (300 personas cada día).",
                "text_en": "Every year, almost 280,000 people are diagnosed with cancer in our country and more than 112,000 die (300 people every day).",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Cada año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Every year"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "casi 280.000 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Nearly 280,000 people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "son diagnosticadas de cáncer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are diagnosed with cancer"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en nuestro país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in our country"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sigue siendo un desafío económico, social y sanitario, no solo el momento presente sino también para los próximos años. La crisis provocada por esta pandemia no ha hecho sino agravar la situación de fragilidad de las personas con cáncer y sus familias como colectivo doblemente vulnerable, por el cáncer y por la covid. ",
                "text_en": "It remains an economic, social and health challenge, not only for the present moment but also for the coming years. The crisis caused by this pandemic has only aggravated the fragile situation of people with cancer and their families as a doubly vulnerable group, because of cancer and covid.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Sigue siendo un desafío económico, social y sanitario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It remains an economic, social and health challenge"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La crisis provocada por esta pandemia no ha hecho sino agravar la situación de fragilidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The crisis caused by this pandemic has only aggravated the fragile situation"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "de las personas con cáncer y sus familias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of people with cancer and their families"
                    }
                ],
                "evidences": [
                    {
                        "value": "This study proposes a conceptual framework to explain crisis development stages and crisis challenges. We provide insights into how small businesses in Macao have interpreted and responded to the COVID-19 pandemic. Due to the continual pandemic crisis, the borderline between the during-and post-crisis stages has blurred. The challenge of crisis termination has been reinterpreted as a \"normal\" stage (Välikangas and Lewin 2020), a new concept that deserves further research and discussion. However, some of the strategies followed in previous crises may still be useful for small firms; the uniqueness of the COVID-19 pandemic requires them to expand stakeholder engagement and develop new learning.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.999008894
                    }
                ]
            },
            {
                "text": "Con motivo del Día Mundial del Cáncer la AECC ha convocado el Foro para  reflexionar sobre cómo abordar esta vulnerabilidad sobrevenida.",
                "text_en": "On the occasion of World Cancer Day, the AECC has convened the Forum to reflect on how to address this emerging vulnerability.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Con motivo del Día Mundial del Cáncer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "On the occasion of World Cancer Day"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la AECC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ECTA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha convocado el Foro para  reflexionar sobre cómo abordar esta vulnerabilidad sobrevenida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "convened the Forum to reflect on how to address this emerging vulnerability"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La AECC es la primera entidad cuya presidencia de honor, en septiembre de 2010, asumió Letizia, aún princesa de Asturias, con carácter permanente y en la que participa activamente.  La asociación integra a pacientes, familiares, voluntarios y profesionales que trabajan unidos para prevenir, sensibilizar, apoyar y acompañar a las personas afectadas y financiar proyectos e investigación oncológica que permitan un mejor diagnóstico y tratamiento.",
                "text_en": "The AECC is the first entity whose honorary presidency, in September 2010, assumed Letizia, still princess of Asturias, on a permanent basis and in which it actively participates. The association integrates patients, family members, volunteers and professionals who work together to prevent, raise awareness, support and accompany the affected people and finance projects and oncology research that allow for a better diagnosis and treatment.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La AECC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The ECTA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es la primera entidad cuya presidencia de honor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is the first entity whose honorary presidency"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en septiembre de 2010",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as at September 2010"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Letizia, aún princesa de Asturias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Letizia, still princess of Asturias"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con carácter permanente y en la que participa activamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on a permanent basis and in which it actively participates"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La asociación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The partnership"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "integra a pacientes, familiares, voluntarios y profesionales que trabajan unidos para prevenir, sensibilizar, apoyar y acompañar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "integrates patients, family members, volunteers and professionals working together to prevent, raise awareness, support and accompany"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a pacientes, familiares, voluntarios y profesionales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to patients, family members, volunteers and professionals"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "43": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 8,
            "WhatReliabilityReliable": 8,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 10,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 3,
            "WhoRoleTarget": 3,
            "WhoRoleBoth": 4,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nDetectan doce pacientes asintomáticos y cuatro profesionales contagiados que se suman a los diez positivos derivados a otros centros\n\n<PARAGRAPH>\n\nEl Hospital de Sant Jaume i Santa Magdalena de Mataró (Maresme) ha llevado a cabo un cribado masivo a todos sus profesionales y pacientes tras detectar cinco casos positivos de coronavirus entre enfermos que no estaban en la unidad de la Covid-19, han informado fuentes del centro. \n\n<PARAGRAPH>\n\nTal y como han detallado desde el Consorci Sanitari del Maresme, el cribado se practicó el pasado jueves y ha concluido con doce pacientes asintomáticos y cuatro profesionales contagiados, que se suman a los diez positivos derivados de otros centros y residencias que permanecían ingresados en la unidad covid del Sant Jaume. \n\n<PARAGRAPH>\n\nTras realizar las pruebas, el conjunto de casos positivos ha sido trasladado a la tercera planta, que se ha sectorializado y a la que ha sido trasladada la unidad covid, que ha ampliado el número de personal destinado a la misma.\n\n<BREAK>\n\nCon estas medidas, el centro ha dado por controlado el brote, aunque repetirán las pruebas diagnósticas en unos días para controlar la evolución del mismo y descartar nuevos positivos. \n\n<PARAGRAPH>\n\nTambién en Mataró, en el centro sociosanitario Hestia Maresme, un positivo detectado la pasada semana en una de las plantas ha obligado a cribar a pacientes y profesionales, con el resultado de ocho personas contagiadas asintomáticas, cuatro con sintomatología leve y una con afectación respiratoria que ha sido derivada al hospital.\n\n<BREAK>\n\nFuentes del centro han explicado que, aunque en principio no esperan detectar más casos, seguirán haciendo cribados y pruebas PCR en los próximos días.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Hospital de Mataró: Cribaje masivo tras detectar cinco positivos de Covid-19",
        "ID": "F_04-11-2021_20-37-55_www_lavanguardia_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Hospital de Mataró: Cribaje masivo tras detectar cinco positivos de Covid-19",
                "text_en": "Mataró Hospital: Mass screening after detecting five Covid-19 positives",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Hospital de Mataró",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mataró Hospital"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Cribaje masivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mass screening"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras detectar cinco positivos de Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after detecting five Covid-19 positives"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Detectan doce pacientes asintomáticos y cuatro profesionales contagiados que se suman a los diez positivos derivados a otros centros",
                "text_en": "Twelve asymptomatic patients and four infected professionals are detected in addition to the ten positives derived from other centers.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Detectan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Detect"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "doce pacientes asintomáticos y cuatro profesionales contagiados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "12 asymptomatic patients and 4 professionals infected"
                    }
                ],
                "evidences": [
                    {
                        "value": "Underestimation of asymptomatic infections of COVID-19 has been suggested, as an increasing number of infected people have not traveled to epidemic hotspots or been linked to known COVID-19 patients (8) . Applying serological tests, Singapore identified the source of a cluster of 23 COVID-19 patients who tested negative on RT-PCR for SARS-CoV-2 (13) . In this study, we report nine asymptomatic patients identified via serological test in addition to 26 asymptomatic patients who were previously identified by the RT-PCR test. The nine asymptomatic patients had multiple negative RT-PCR test results, with the first RT-PCR test of these asymptomatic patients conducted almost immediately after their close contacts were identified as COVID-19 patients. Thus, a proportion of asymptomatic patients might have short viral shedding duration or may have viral nucleic acid loads that are undetectable on RT-PCR. According to a previous study, the interval from the first day of positive RT-PCR tests to the first day of continuous negative tests for the asymptomatic patient ranged from 1 to 21 days, with five asymptomatic patients having persistently negative RT-PCR test results 1 day after the date of diagnosis (5) . The results indicated the potential for the underestimation of the proportion of asymptomatic patients based on RT-PCR tests, which possibly identifies only those with longer viral shedding period. These results suggested that serological tests could serve as a more reliable method to estimate the asymptomatic proportion of COVID-19 patients.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.942732811
                    }
                ]
            },
            {
                "text": "El Hospital de Sant Jaume i Santa Magdalena de Mataró (Maresme) ha llevado a cabo un cribado masivo a todos sus profesionales y pacientes tras detectar cinco casos positivos de coronavirus entre enfermos que no estaban en la unidad de la Covid-19, han informado fuentes del centro. ",
                "text_en": "The Hospital de Sant Jaume i Santa Magdalena de Mataró (Maresme) has carried out a massive screening of all its professionals and patients after detecting five positive cases of coronaviruses among patients who were not in the Covid-19 unit, sources from the center have reported.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "El Hospital de Sant Jaume i Santa Magdalena de Mataró (Maresme)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Hospital de Sant Jaume i Santa Magdalena de Mataró (Maresme)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cribado masivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mass screening"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a todos sus profesionales y pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to all its professionals and patients"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras detectar cinco casos positivos de coronavirus entre enfermos que no estaban en la unidad de la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after detecting five positive cases of coronavirus among patients who were not in the Covid-19 unit"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la unidad de la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the unit of the Covid-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "fuentes del centro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "sources of the centre"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tal y como han detallado desde el Consorci Sanitari del Maresme, el cribado se practicó el pasado jueves y ha concluido con doce pacientes asintomáticos y cuatro profesionales contagiados, que se suman a los diez positivos derivados de otros centros y residencias que permanecían ingresados en la unidad covid del Sant Jaume. ",
                "text_en": "As detailed by the Consorci Sanitari del Maresme, screening was carried out last Thursday and has concluded with twelve asymptomatic patients and four infected professionals, who add to the ten positives derived from other centers and residences that remained in the covid unit of Sant Jaume.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el cribado se practicó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "screening was performed"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last Thursday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "doce pacientes asintomáticos y cuatro profesionales contagiados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "12 asymptomatic patients and 4 professionals infected"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "diez positivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ten positives"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "otros centros y residencias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "other centres and residences"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tras realizar las pruebas, el conjunto de casos positivos ha sido trasladado a la tercera planta, que se ha sectorializado y a la que ha sido trasladada la unidad covid, que ha ampliado el número de personal destinado a la misma.",
                "text_en": "After the tests, the set of positive cases has been transferred to the third floor, which has been sectoralized and to which the unit covid has been transferred, which has expanded the number of personnel assigned to it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "casos positivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "positive cases"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha sido trasladado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has been transferred"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a la tercera planta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the third floor"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Con estas medidas, el centro ha dado por controlado el brote, aunque repetirán las pruebas diagnósticas en unos días para controlar la evolución del mismo y descartar nuevos positivos. ",
                "text_en": "With these measures, the center has stopped the outbreak, although they will repeat the diagnostic tests in a few days to monitor the evolution of the outbreak and discard new positives.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Con estas medidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "With these measures"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el centro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the center"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha dado por controlado el brote",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has controlled the outbreak"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También en Mataró, en el centro sociosanitario Hestia Maresme, un positivo detectado la pasada semana en una de las plantas ha obligado a cribar a pacientes y profesionales, con el resultado de ocho personas contagiadas asintomáticas, cuatro con sintomatología leve y una con afectación respiratoria que ha sido derivada al hospital.",
                "text_en": "Also in Mataró, in the Hestia Maresme socio-sanitary center, a positive detected last week in one of the plants has forced to screen patients and professionals, with the result of eight people infected asymptomatic, four with mild symptomatology and one with respiratory involvement that has been derived to the hospital.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Mataró, en el centro sociosanitario Hestia Maresme",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Mataró, at the Hestia Maresme social health center"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un positivo detectado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a positive detected"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "la pasada semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last week"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una de las plantas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in one of the plants"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha obligado a cribar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "forced to screen"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a pacientes y profesionales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to patients and professionals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Fuentes del centro han explicado que, aunque en principio no esperan detectar más casos, seguirán haciendo cribados y pruebas PCR en los próximos días.",
                "text_en": "Sources from the centre have explained that, although they do not expect to detect any more cases in principle, they will continue to screen and test PCR in the coming days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fuentes del centro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sources of the centre"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "seguirán haciendo cribados y pruebas PCR",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "continue screening and PCR testing"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los próximos días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the next few days"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "44": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 15,
            "WhatReliabilityReliable": 8,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 6,
            "Who": 14,
            "WhoReliabilityReliable": 8,
            "WhoReliabilityUnreliable": 6,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 0,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 0,
            "WhereReliabilityReliable": 0,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 11,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 6,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nPara los que todavía sigan pensando que vivimos en una especie de países de cuentos de hadas y que a nuestros políticos les importa en lo más mínimo nuestra salud y los problemas que podamos tener a lo largo de nuestras vidas, la Agencia Europea del Medicamento les obliga, desde hoy, a realizar un aterrizaje forzoso desde esos lindos sueños y a poner los pies sobre la tierra.\n\n<PARAGRAPH>\n\nSegún publica Reuters, la Agencia Europea del Medicamento (EMA) “encuentra un posible vínculo entre la vacuna AstraZeneca y los coágulos de sangre raros”.\n\n<BREAK>\n\nAl parecer, los ministros de Sanidad de los países de la UE han sido informados y se les ha dicho que la decisión de la EMA sobre la seguridad de la vacuna tendrá implicaciones inmediatas para los planes de vacunación y requerirá una respuesta coordinada.\n\n<BREAK>\n\nDespués de esta comunicación de la EMA habrá una reunión de los ministros para concretar acciones sobre este asunto.\n\n<PARAGRAPH>\n\nPero no vayan a pensar que la cosa se queda solo en esto.\n\n<BREAK>\n\nA pesar de esa comunicación, la Directora Ejecutiva de la EMA, Emer Cooke, ha dicho que de todas formas, “el riesgo de mortalidad por COVID es mucho mayor que el riesgo de mortalidad por estos efectos secundarios raros”.\n\n<BREAK>\n\nEs decir, según esta individua la vacuna tiene riesgos pero considera que esos riesgos son menores que los de la enfermedad.\n\n<BREAK>\n\nQue se lo diga a las familias que han perdido ya a seres queridos que estaban sanos.\n\n<PARAGRAPH>\n\nSeñores, el tenderete se le está desmontando, poco a poco, a esta gentuza miserable.\n\n<BREAK>\n\nLos efectos secundarios de las vacunas son silenciados por los grandes medios de comunicación, pero solo pueden serlo hasta un punto.\n\n<BREAK>\n\nEn nuestra opinión, la vacuna de AstraZeneca, que ya se estaba vendiendo a los países a precio de coste, tiene los días contados y hagan lo que hagan los ministros esta tarde, si deciden seguir vacunando con AstraZeneca y hay alguien que, a estas alturas, permite que se la pongan es que está absolutamente loco.\n\n<PARAGRAPH>\n\nEsta es la prueba evidente de que las vacunas no son más que una experimentación y que toda la población del planeta somos sus conejillos de indias.\n\n<BREAK>\n\nSinceramente, hay que tener mucho valor para, a estas alturas y viendo lo que estamos viendo, ir a vacunarse tan tranquilo.\n\n<BREAK>\n\nEs muy fuerte la frase de Emer Cooke sobre los riesgos y esta mujer demuestra tener muy poca vergüenza.\n\n<PARAGRAPH>\n\nCOLABORA CON NOSOTROS CON PAYPAL\n\n<PARAGRAPH>\n\n",
        "TITLE": "¡Grandísimo escándalo! La EMA ve vínculos entre AstraZeneca y los coágulos y trombosis pero dice que “el riesgo de mortalidad por COVID es mucho mayor que el riesgo de mortalidad por estos efectos secundarios”",
        "ID": "11_NF_04-11-2021_22-12-36_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "¡Grandísimo escándalo! La EMA ve vínculos entre AstraZeneca y los coágulos y trombosis pero dice que “el riesgo de mortalidad por COVID es mucho mayor que el riesgo de mortalidad por estos efectos secundarios”",
                "text_en": "Great scandal! The EMA sees links between AstraZeneca and clots and thrombosis but says that “the risk of mortality from COVID is much higher than the risk of mortality from these side effects”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ve vínculos entre AstraZeneca y los coágulos y trombosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "see links between AstraZeneca and clots and thrombosis"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el riesgo de mortalidad por COVID es mucho mayor que el riesgo de mortalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the risk of mortality from VOCD is much higher than the risk of mortality"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por estos efectos secundarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to these side effects"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para los que todavía sigan pensando que vivimos en una especie de países de cuentos de hadas y que a nuestros políticos les importa en lo más mínimo nuestra salud y los problemas que podamos tener a lo largo de nuestras vidas, la Agencia Europea del Medicamento les obliga, desde hoy, a realizar un aterrizaje forzoso desde esos lindos sueños y a poner los pies sobre la tierra.",
                "text_en": "For those of us who still think that we live in a kind of fairytale country and that our politicians care in the least about our health and the problems we may have throughout our lives, the European Medicines Agency forces them, from today, to make a forced landing from those beautiful dreams and to set foot on the ground.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los que todavía sigan pensando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "those who still think"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a nuestros políticos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to our politicians"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "les importa en lo más mínimo nuestra salud",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They care in the least about our health."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "poner los pies sobre la tierra",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "put your feet on the ground"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según publica Reuters, la Agencia Europea del Medicamento (EMA) “encuentra un posible vínculo entre la vacuna AstraZeneca y los coágulos de sangre raros”.",
                "text_en": "According to Reuters, the European Medicines Agency (EMA) “finds a possible link between the AstraZeneca vaccine and rare blood clots.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "encuentra un posible vínculo entre la vacuna AstraZeneca y los coágulos de sangre raros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "find a possible link between the AstraZeneca vaccine and rare blood clots"
                    }
                ],
                "evidences": [
                    {
                        "value": "Norwegian health authorities suspended the use of the Oxford-AstraZeneca (Vaxevria, hereafter referred to as AstraZeneca) vaccine on March 11th, 2021, after sudden reports of severe and sometimes fatal thromboembolic events following vaccination were announced earlier the same day [1] . In these announcements, it became clear that the European Medicines Agency (EMA) had received reports of 30 similar events among the five million individuals in the European Economic Area who had received the AstraZeneca vaccine [2] . While it was still not known whether the thromboembolic events could be linked to the vaccine, the severe cases and fatalities among otherwise healthy individuals received much media attention in the days that followed.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9985492826
                    }
                ]
            },
            {
                "text": "Al parecer, los ministros de Sanidad de los países de la UE han sido informados y se les ha dicho que la decisión de la EMA sobre la seguridad de la vacuna tendrá implicaciones inmediatas para los planes de vacunación y requerirá una respuesta coordinada.",
                "text_en": "Health ministers from EU countries appear to have been informed and told that the EMA decision on vaccine safety will have immediate implications for vaccination plans and will require a coordinated response.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "implicaciones inmediatas para los planes de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "immediate implications for vaccination plans"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Después de esta comunicación de la EMA habrá una reunión de los ministros para concretar acciones sobre este asunto.",
                "text_en": "Following this communication from the EMA there will be a meeting of ministers to take action on this issue.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "habrá una reunión de los ministros para concretar acciones sobre este asunto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There will be a meeting of ministers to take action on this issue."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los ministros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A pesar de esa comunicación, la Directora Ejecutiva de la EMA, Emer Cooke, ha dicho que de todas formas, “el riesgo de mortalidad por COVID es mucho mayor que el riesgo de mortalidad por estos efectos secundarios raros”.",
                "text_en": "Despite this communication, the EMA Executive Director, Emer Cooke, has said that in any case, “the risk of mortality from COVID is much higher than the risk of mortality from these rare side effects.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Directora Ejecutiva de la EMA, Emer Cooke",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EMA Executive Director, Emer Cooke"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el riesgo de mortalidad por COVID es mucho mayor que el riesgo de mortalidad por estos efectos secundarios raros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the risk of mortality from VOCD is much higher than the risk of mortality from these rare side effects"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es decir, según esta individua la vacuna tiene riesgos pero considera que esos riesgos son menores que los de la enfermedad.",
                "text_en": "That is, according to this individual, the vaccine has risks but considers that these risks are lower than those of the disease.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "esta individua",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "this individual."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "considera que esos riesgos son menores que los de la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "considers that these risks are lower than those of the disease"
                    }
                ],
                "evidences": [
                    {
                        "value": "A candidate vaccine will be beneficial (i.e., decrease the daily risk of infection) if the risk of transmission after the introduction of the vaccine is lower than the current risk. To show which parameters the daily risk is most sensitive to, we used plots of PRCCs for each of the independent parameters. Parameters with PRCC > 0 increase a susceptible's daily risk as the parameter value increases, whereas parameters with PRCC < 0 decrease a susceptible's daily risk as the parameter value increases. 6 J o u r n a l P r e -p r o o f Figure 1 illustrates the degree of sensitivity of the daily risk of infection before the vaccine is introduced. At relatively low transmissibility levels, reducing contact with infected individuals (e c I ) is the most effective alternative to decrease the daily risk of infection. When the rate of transmission is moderate and there is no vaccine, wearing hazmat suits and reducing contact with the dead has a better protective impact. As the transmission rate rises, a higher proportion of use of those protection protocols becomes necessary. When the transmission probability is high and there is no vaccine available, all protection protocols are similar in terms of their efficacy, but none has a substantial effect on protecting against the virus. It is here that the introduction of a vaccine will benefit populations at risk the most.",
                        "score": 0.6800000072
                    },
                    {
                        "value": "Variables that may have an impact on not getting vaccinated or delaying it were assessed using multivariate logistic regression analysis. According to the regression result, it was demonstrated that being under the age of 50 increased the risk of not having a COVID-19 vaccine or deferring it by 1.85 times (95% CI: 1.08-3.18, p = 0.026). Gender was not identified to be a risk factor (p = 0.209). In comparison to the faculty members or doctors, the risk of not receiving a vaccine or postponement was detected to be higher by 1.78 times for nurses/midwives, by 3.42 times for administrative staff, 4.11 times for patient attendants/cleaners and by 2.96 times for those in the security guard/other group (p < 0.001). Suffering from COVID-19 disease compared to not acquiring it elevated the risk of not being immunized with a COVID-19 vaccine or delaying it by 2.36 times (p < 0.001). In contrast to those receiving the flu vaccine this year, those not receiving the flu vaccine were observed to have an increased risk of not taking a COVID-19 vaccine by 3.24 times (95% CI: 1.90-5.55, p < 0.001). It was revealed that the risk of not getting immunized with a COVID-19 vaccine or late administration was 6.61 times greater for those with vaccine hesitancy related to other vaccines (95% CI: 3.82-11.44, p < 0.001). In another regression model we created, adding separately the two questions measuring hesitancy for prior vaccines, it was shown that refusing a vaccine to be given to oneself or one's child considering it dangerous or ineffective resulted in not vaccinating or deferment with a 7.09 times greater risk, whereas delaying a vaccine previously recommended by the doctor led to an increased risk of 3.34 times (p < 0.001 and p = 0.003). The risk factors of the previous model were present in this model as well (Table 3) .",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.887871325
                    },
                    {
                        "label": "neutral",
                        "score": 0.9438334703
                    }
                ]
            },
            {
                "text": "Señores, el tenderete se le está desmontando, poco a poco, a esta gentuza miserable.",
                "text_en": "Gentlemen, the shopkeeper is slowly disassembled from this miserable scumbag.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "gentuza miserable",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Miserable rabble"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los efectos secundarios de las vacunas son silenciados por los grandes medios de comunicación, pero solo pueden serlo hasta un punto.",
                "text_en": "The side effects of vaccines are silenced by the mainstream media, but can only be to a point.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los efectos secundarios de las vacunas son silenciados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The side effects of vaccines are muted"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por los grandes medios de comunicación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by the major media"
                    }
                ],
                "evidences": [
                    {
                        "value": "H6. Participants' use of (a) mainstream media and (b) alternative media is positively related to their attitudes toward mainstream media and alternative media, respectively. . Results: All respondents agreed that it was important to remain up to date with global outbreaks. The main reason cited for following global outbreak news was as an early warning for serious epidemics. Mainstream media and specialist Internet sources such as the World Health Organization (n = 54/91; 59%), the Program for Monitoring Emerging Diseases (ProMED)-mail (n = 45/91; 49%) and the United States Centers for Disease Control and Prevention (n = 31/91; 34%) were the most common sources for global outbreak news; rapid intelligence services such as HealthMap were less common (n = 9/91; 10%). Only 51% (n = 46/91) of respondents thought that their sources of outbreak news were timely and sufficient for their needs.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9858594537
                    }
                ]
            },
            {
                "text": "En nuestra opinión, la vacuna de AstraZeneca, que ya se estaba vendiendo a los países a precio de coste, tiene los días contados y hagan lo que hagan los ministros esta tarde, si deciden seguir vacunando con AstraZeneca y hay alguien que, a estas alturas, permite que se la pongan es que está absolutamente loco.",
                "text_en": "In our opinion, the AstraZeneca vaccine, which was already being sold to countries at cost, has the days counted and do what the ministers do this afternoon, if they decide to continue to vaccinate with AstraZeneca and there is someone who, at this point, allows them to put it on is that he is absolutely crazy.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los ministros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deciden seguir vacunando con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "decide to continue vaccination with AstraZeneca"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "alguien",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Someone."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está absolutamente loco",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's absolutely crazy."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta es la prueba evidente de que las vacunas no son más que una experimentación y que toda la población del planeta somos sus conejillos de indias.",
                "text_en": "This is the obvious proof that vaccines are nothing more than experimentation and that the entire population of the planet are their guinea pigs.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta es la prueba evidente de que las vacunas no son más que una experimentación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This is the obvious proof that vaccines are nothing more than experimentation."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "toda la población del planeta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the entire population of the planet"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "somos sus conejillos de indias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We're his guinea pigs."
                    }
                ],
                "evidences": [
                    {
                        "value": "Pregnant sows are suitable models for evaluating the effectiveness of inactivated PEDV vaccines in target populations, such as neonatal piglets, because transfer of maternal antibodies to piglets via colostrum may play an important role in the development of protective immunity against PEDV in sucking piglets [26] . However, considerations of size of litter, housing, and reproduction have limited their use in vaccination experiment. And the correspondingly higher cost associated with housing and experimentation is needed. Therefore, in the present study, we used growing pigs to evaluate the protective efficacy of our experimental vaccines, because pigs of all ages are susceptible to PEDV infection [8] .",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9786072969
                    }
                ]
            },
            {
                "text": "Es muy fuerte la frase de Emer Cooke sobre los riesgos y esta mujer demuestra tener muy poca vergüenza.",
                "text_en": "Emer Cooke's phrase about the risks is very strong and this woman shows very little shame.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Emer Cooke",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Emer Cooke"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "demuestra tener muy poca vergüenza",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Shows very little shame"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "45": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 18,
            "WhatReliabilityReliable": 18,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 5,
            "Who": 9,
            "WhoReliabilityReliable": 8,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 3,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 7,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nAsimismo, no se han observado diferencias en los síntomas gastrointestinales —dolor abdominal, náuseas o diarrea—, dificultad para respirar o dolores de cabeza.\n\n<PARAGRAPH>\n\nNo son iguales, aunque todas son muy malas.\n\n<PARAGRAPH>\n\nLa variante británicadel coronavirus está cada vez más presente entre los nuevos contagios que se detectan en España.\n\n<BREAK>\n\nSi actualmente supone entre un 5% y un 8% de los casos, Sanidad prevé que a finales de febrero o a principios de marzo se convierta en la cepa predominante al abarcar el 50% de los casos activos en todo el país.\n\n<PARAGRAPH>\n\nDesde que fue identificada esta variante —denominada B.1.1.7— en el Reino Unido, los investigadores no han cesado de estudiar cómo puede repercutir en la eficacia de las vacunas así como en identificar sus síntomas.\n\n<PARAGRAPH>\n\nUn reciente estudio de la Oficina de Estadísticas Nacionales del Reino Unido (ONS, por sus siglas en inglés) ha publicado una serie de características compatibles con esta variante del virus más contagiosa y que se diferencian de la cepa ‘convencional’.\n\n<PARAGRAPH>\n\nSegún explican en el estudio, realizado en colaboración con la Universidad de Oxford, la Universidad de Manchester y la Sanidad pública británica, las mayores diferencias en los síntomas informados entre los positivos compatibles con la nueva variante y los que no son compatibles con la nueva variante del Reino Unido se encontraron en tos, dolor de garganta, fatiga y mialgia —dolor muscular—.\n\n<PARAGRAPH>\n\nLos investigadores apuntan que esta nueva variante «tiene cambios genéticos en el gen S» —proteína de la espícula que el virus utiliza para entrar en las células del huésped—.\n\n<BREAK>\n\nPara ello, las personas que participaron en este estudio tuvieron que indicar si habían experimentado una variedad de posibles síntomas en los siete días anteriores a la prueba y también, por separado, si sentían que tenían síntomas compatibles con la infección por Covid-19 en los últimos siete días.\n\n<PARAGRAPH>\n\nEn este sentido, el estudio indica que las personas con la variante británica del virus informaron en menor proporción de una pérdida del gusto y el olfato, síntoma clásico de la Covid convencional.\n\n<PARAGRAPH>\n\nAsimismo, no se han observado diferencias en los síntomas gastrointestinales —dolor abdominal, náuseas o diarrea—, dificultad para respirar o dolores de cabeza.\n\n<PARAGRAPH>\n\nEn concreto, un 35,11% de los sujetos analizados reconoció haber tenido tos, un 32,46% tuvo fatiga, un 25,03% ha padecido mialgia, y un 21,88% ha tenido dolor de garganta.\n\n<PARAGRAPH>\n\nLas muestras analizadas en este estudio fueron tomadas entre el 15 de noviembre y el 16 de enero, cuando esa variante no solo es la más dominante en el Reino Unido, sino que ya se ha extendido lo suficiente a otros países.\n\n<PARAGRAPH>\n\n",
        "TITLE": "¿Sabes qué síntomas tiene la cepa británica y sus diferencias con la Covid 'normal'?",
        "ID": "23_NF_04-11-2021_21-04-05_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "¿Sabes qué síntomas tiene la cepa británica y sus diferencias con la Covid 'normal'?",
                "text_en": "Do you know what symptoms the British strain has and its differences with the 'normal' Covid?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "síntomas tiene la cepa británica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "symptoms have the British strain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Asimismo, no se han observado diferencias en los síntomas gastrointestinales —dolor abdominal, náuseas o diarrea—, dificultad para respirar o dolores de cabeza.",
                "text_en": "Similarly, no differences have been observed in gastrointestinal symptoms — abdominal pain, nausea or diarrhea — or difficulty breathing or headaches.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se han observado diferencias en los síntomas gastrointestinales —dolor abdominal, náuseas o diarrea—, dificultad para respirar o dolores de cabeza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "no differences in gastrointestinal symptoms — abdominal pain, nausea or diarrhoea —, shortness of breath, or headaches have been observed"
                    }
                ],
                "evidences": [
                    {
                        "value": "In conclusion, our review found that gastrointestinal symptoms are common in children with COVID-19 with nearly a quarter of patients developing such symptoms. Diarrhoea, vomiting and abdominal pain were the main gastrointestinal symptoms. It is important for clinicians to be aware of the gastrointestinal manifestation of COVID-19.",
                        "score": 0.6800000072
                    },
                    {
                        "value": "In summary, the proportion of COVID-19 patients who experience gastrointestinal symptoms in the Wuhan area is relatively high. The most common gastrointestinal symptoms are inappetence and diarrhoea, and these are typically accompanied by moderate or high fever. Patients who experience gastrointestinal symptoms are more likely to suffer from severe pneumonia, which may help clinicians identify patients at high risk of COVID-19 and thus reduce the incidence of this condition. ",
                        "score": 0.6499999762
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9906796813
                    },
                    {
                        "label": "neutral",
                        "score": 0.9955631495
                    }
                ]
            },
            {
                "text": "La variante británicadel coronavirus está cada vez más presente entre los nuevos contagios que se detectan en España.",
                "text_en": "The British variant of the coronavirus is increasingly present among the new contagions detected in Spain.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La variante británicadel coronavirus está cada vez más presente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The British variant of the coronavirus is increasingly present"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si actualmente supone entre un 5% y un 8% de los casos, Sanidad prevé que a finales de febrero o a principios de marzo se convierta en la cepa predominante al abarcar el 50% de los casos activos en todo el país.",
                "text_en": "If it currently accounts for between 5% and 8% of cases, Health expects that by the end of February or the beginning of March it will become the predominant strain by covering 50% of active cases throughout the country.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a finales de febrero o a principios de marzo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "end of February or beginning of March"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cepa predominante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "predominant strain"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "al abarcar el 50% de los casos activos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "50 per cent of active cases"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en todo el país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "all over the country"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desde que fue identificada esta variante —denominada B.1.1.7— en el Reino Unido, los investigadores no han cesado de estudiar cómo puede repercutir en la eficacia de las vacunas así como en identificar sus síntomas.",
                "text_en": "Since this variant — referred to as B.1.1.7 — was identified in the United Kingdom, researchers have continued to study how it can impact on the effectiveness of vaccines and identify their symptoms.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "variante —denominada B.1.1.7",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "variant —named B.1.1.7"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in the United Kingdom"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los investigadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "researchers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no han cesado de estudiar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have not stopped studying"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un reciente estudio de la Oficina de Estadísticas Nacionales del Reino Unido (ONS, por sus siglas en inglés) ha publicado una serie de características compatibles con esta variante del virus más contagiosa y que se diferencian de la cepa ‘convencional’.",
                "text_en": "A recent study by the UK Bureau of National Statistics (ONS) has published a number of features that are compatible with this variant of the most contagious virus and differ from the ‘conventional’ strain.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Un reciente estudio de la Oficina de Estadísticas Nacionales del Reino Unido (ONS, por sus siglas en inglés) ha publicado una serie de características compatibles con esta variante del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A recent study by the UK Bureau of National Statistics (ONS) has published a number of features compatible with this variant of the virus."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Oficina de Estadísticas Nacionales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Office of National Statistics"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según explican en el estudio, realizado en colaboración con la Universidad de Oxford, la Universidad de Manchester y la Sanidad pública británica, las mayores diferencias en los síntomas informados entre los positivos compatibles con la nueva variante y los que no son compatibles con la nueva variante del Reino Unido se encontraron en tos, dolor de garganta, fatiga y mialgia —dolor muscular—.",
                "text_en": "As explained in the study, conducted in collaboration with the University of Oxford, the University of Manchester and British Public Health, the greatest differences in the symptoms reported between the positives compatible with the new variant and those not compatible with the new UK variant were found in cough, sore throat, fatigue and myalgia — muscle pain.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "realizado en colaboración",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "carried out in collaboration"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Universidad de Oxford",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "University of Oxford"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Universidad de Manchester",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "University of Manchester"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Sanidad pública británica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom Public Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tos, dolor de garganta, fatiga y mialgia —dolor muscular—",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "cough, sore throat, fatigue, and myalgia — muscle pain —"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los investigadores apuntan que esta nueva variante «tiene cambios genéticos en el gen S» —proteína de la espícula que el virus utiliza para entrar en las células del huésped—.",
                "text_en": "Researchers point out that this new variant \"has genetic changes in the S gene\"—a protein of the speculum that the virus uses to enter host cells.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los investigadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Investigators"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esta nueva variante «tiene cambios genéticos en el gen S»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this new variant \"has genetic changes in the S gene\""
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tiene cambios genéticos en el gen S",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has genetic changes in the S gene"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para ello, las personas que participaron en este estudio tuvieron que indicar si habían experimentado una variedad de posibles síntomas en los siete días anteriores a la prueba y también, por separado, si sentían que tenían síntomas compatibles con la infección por Covid-19 en los últimos siete días.",
                "text_en": "To do this, people who participated in this study had to indicate whether they had experienced a variety of possible symptoms in the seven days before the test and also, separately, whether they felt they had symptoms compatible with Covid-19 infection in the last seven days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas que participaron",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the persons who participated"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en este estudio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in this study"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tuvieron que indicar si habían experimentado una variedad de posibles síntomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had to indicate if they had experienced a variety of possible symptoms"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los siete días anteriores a la prueba",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the seven days preceding the test"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "si sentían que tenían síntomas compatibles con la infección por Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "if they felt they had symptoms compatible with Covid-19 infection"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los últimos siete días.",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last seven days."
                    }
                ],
                "evidences": []
            },
            {
                "text": "En este sentido, el estudio indica que las personas con la variante británica del virus informaron en menor proporción de una pérdida del gusto y el olfato, síntoma clásico de la Covid convencional.",
                "text_en": "In this sense, the study indicates that people with the British variant of the virus reported to a lesser extent a loss of taste and smell, a classic symptom of conventional Covid.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas con la variante británica del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "people with the British variant of the virus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "informaron en menor proporción de una pérdida del gusto y el olfato",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reported to a lesser extent a loss of taste and smell"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en menor proporción",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to a lesser extent"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Asimismo, no se han observado diferencias en los síntomas gastrointestinales —dolor abdominal, náuseas o diarrea—, dificultad para respirar o dolores de cabeza.",
                "text_en": "Similarly, no differences have been observed in gastrointestinal symptoms — abdominal pain, nausea or diarrhea — or difficulty breathing or headaches.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se han observado diferencias en los síntomas gastrointestinales —dolor abdominal, náuseas o diarrea—, dificultad para respirar o dolores de cabeza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "no differences in gastrointestinal symptoms — abdominal pain, nausea or diarrhoea —, shortness of breath, or headaches have been observed"
                    }
                ],
                "evidences": [
                    {
                        "value": "In conclusion, our review found that gastrointestinal symptoms are common in children with COVID-19 with nearly a quarter of patients developing such symptoms. Diarrhoea, vomiting and abdominal pain were the main gastrointestinal symptoms. It is important for clinicians to be aware of the gastrointestinal manifestation of COVID-19.",
                        "score": 0.6800000072
                    },
                    {
                        "value": "In summary, the proportion of COVID-19 patients who experience gastrointestinal symptoms in the Wuhan area is relatively high. The most common gastrointestinal symptoms are inappetence and diarrhoea, and these are typically accompanied by moderate or high fever. Patients who experience gastrointestinal symptoms are more likely to suffer from severe pneumonia, which may help clinicians identify patients at high risk of COVID-19 and thus reduce the incidence of this condition. ",
                        "score": 0.6499999762
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9906796813
                    },
                    {
                        "label": "neutral",
                        "score": 0.9955631495
                    }
                ]
            },
            {
                "text": "Las muestras analizadas en este estudio fueron tomadas entre el 15 de noviembre y el 16 de enero, cuando esa variante no solo es la más dominante en el Reino Unido, sino que ya se ha extendido lo suficiente a otros países.",
                "text_en": "The samples analysed in this study were taken between 15 November and 16 January, when this variant is not only the most dominant in the United Kingdom, but has already been sufficiently extended to other countries.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las muestras analizadas en este estudio fueron tomadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The samples analyzed in this study were taken"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "entre el 15 de noviembre y el 16 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from 15 November to 16 January"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la más dominante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the most dominant"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in the United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha extendido lo suficiente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's been extended long enough."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a otros países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to other countries"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "46": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 12,
            "WhatReliabilityReliable": 12,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 13,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 4,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 4,
            "WhoRoleSubject": 12,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 8,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nAgencia ANADOLU\n\n<PARAGRAPH>\n\nBogotá, 02 de abril _ RAM_ El Consejo Nacional de Secretarios de Salud de Brasil comunicó que durante el último día el país registró 3.769 fallecidos a causa del coronavirus.\n\n<PARAGRAPH>\n\nPor primera vez el promedio diario de muertes en Brasil por COVID-19 superó las 3.000 al llegar a 3.117, posicionando los últimos siete días de marzo como la peor semana de la pandemia en el país.\n\n<PARAGRAPH>\n\nDe acuerdo con las cifras publicadas por el Consejo Nacional de Secretarios de Salud (Conass), este 1 de abril se registraron a nivel nacional 91.097 nuevos contagios y 3.769 fallecidos por el virus, para un acumulado de 325.284 decesos.\n\n<PARAGRAPH>\n\nSi la cifra de óbitos diarios se mantiene por encima de los 3.000 en los próximos días, Brasil sumaría más de 330.000 muertes a causa del virus en menos de 48 horas y sobrepasaría los 350.000 en apenas una semana.\n\n<PARAGRAPH>\n\n“La Organización Mundial de la Salud (OMS) está sumamente preocupada con la situación de Brasil”, dijo a los medios de comunicación brasileños Mariangela Simao, la subdirectora general del Departamento de Acceso a Medicamentos, Vacunas y Productos Farmacéuticos de la OMS.\n\n<PARAGRAPH>\n\n“Brasil se encuentra en una situación muy grave, los hospitales están saturados, con la mayoría de las UCI llenas.\n\n<BREAK>\n\nMás de 6.000 personas están esperando cama en la UCI.\n\n<BREAK>\n\nEsta es una situación muy crítica.\n\n<BREAK>\n\nLa variante brasileña afecta gravemente a los jóvenes, entre 21 y 30 años, que además están hospitalizados y en la UCI”, agregó Maria Van Kerkhove, jefe de enfermedades emergentes y zoonosis de la OMS.\n\n<PARAGRAPH>\n\nEl miércoles 31 de marzo el país suramericano rompió un nuevo récord de muertes por COVID-19, alcanzando la cifra diaria de 3.869 fallecimientos.\n\n<PARAGRAPH>\n\nFrente a la situación, el recién posesionado ministro de Salud, Marcelo Queiroga, explicó en una rueda de prensa que “en estos días festivos no puede haber aglomeraciones innecesarias.\n\n<BREAK>\n\nEs importante llevar una máscara, mantener el aislamiento.\n\n<BREAK>\n\nEs importante hacerlo.\n\n<BREAK>\n\nNo se desean medidas extremas, así que hagamos esto”.\n\n<PARAGRAPH>\n\nSin embargo, el presidente Jair Bolsonaro mostró su rechazo a esta medida: “No vamos a resolver este problema quedándonos en casa.\n\n<BREAK>\n\nEsta política [el distanciamiento] se sigue adoptando, pero el espíritu de la misma era prepararse con camas de UCI, respiradores, para que la gente no perdiera la vida por falta de atención.\n\n<BREAK>\n\nNinguna nación puede sostenerse por mucho tiempo con este tipo de política y lo que realmente queremos es volver a la normalidad lo antes posible”, afirmó ante los medios.​​​​​​​\n\n<PARAGRAPH>\n",
        "TITLE": "Brasil registra por primera vez un promedio de más de 3.000 muertes diarias en los últimos siete días",
        "ID": "NF_04-11-2021_21-24-40_www_eje21_com_co",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Brasil registra por primera vez un promedio de más de 3.000 muertes diarias en los últimos siete días",
                "text_en": "Brazil records for the first time an average of more than 3,000 deaths per day in the last seven days",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Brazil"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "registra por primera vez un promedio de más de 3.000 muertes diarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "records for the first time an average of more than 3,000 deaths per day"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los últimos siete días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last seven days"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Bogotá, 02 de abril _ RAM_ El Consejo Nacional de Secretarios de Salud de Brasil comunicó que durante el último día el país registró 3.769 fallecidos a causa del coronavirus.",
                "text_en": "Bogotá, April 02 _ RAM_ The National Council of Health Secretaries of Brazil reported that on the last day the country recorded 3,769 deaths due to the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Consejo Nacional de Secretarios de Salud de Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The National Council of Health Secretaries of Brazil"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "comunicó que durante el último día el país registró 3.769 fallecidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reported that on the last day the country recorded 3,769 deaths"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a causa del coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because of the coronavirus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De acuerdo con las cifras publicadas por el Consejo Nacional de Secretarios de Salud (Conass), este 1 de abril se registraron a nivel nacional 91.097 nuevos contagios y 3.769 fallecidos por el virus, para un acumulado de 325.284 decesos.",
                "text_en": "According to figures published by the National Council of Health Secretaries (Conass), 91,097 new infections and 3,769 deaths from the virus were registered nationwide on 1 April for a cumulative of 325,284 deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Consejo Nacional de Secretarios de Salud (Conass)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "National Council of Health Secretaries (Conass)"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este 1 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "1 April"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se registraron a nivel nacional 91.097 nuevos contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There were 91,097 new infections at the national level"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si la cifra de óbitos diarios se mantiene por encima de los 3.000 en los próximos días, Brasil sumaría más de 330.000 muertes a causa del virus en menos de 48 horas y sobrepasaría los 350.000 en apenas una semana.",
                "text_en": "If the number of deaths per day remains above 3,000 in the next few days, Brazil would add more than 330,000 deaths from the virus in less than 48 hours and exceed 350,000 in just one week.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Brazil"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sumaría más de 330.000 muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "would add up to more than 330,000 deaths"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a causa del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "caused by the virus"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en menos de 48 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in less than 48 hours"
                    }
                ],
                "evidences": [
                    {
                        "value": "On December 31, 2019, the World Health Organization (WHO) was informed of a high incidence of pneumonia cases in the city of Wuhan, Hubei Province of China. On January 7, 2020, Chinese authorities confirmed the pneumonia outbreak was caused by a new type of virus, which belongs to a family known as Coronaviruses (1) . Some of the viruses in the Coronaviruses family already exist in Brazil, and are capable of causing a common cold; however, the coronavirus family also encompasses viruses like SARS and MERS that caused epidemics with a large number of deaths in 2004 and 2012, respectively. The new virus is believed to have been transmitted from another species of animal, bats are currently suspected, to humans (2) . On February 26, 2020, the first case of this disease was reported in Brazil, a 61-year-old man who had recently been abroad. Since then, the number of cases grew rapidly, and in early May, the virus death toll in Brazil was over 10,000, with over 600 deaths reported per day (3) .",
                        "score": 0.5600000024
                    },
                    {
                        "value": "Regarding the COVID-19 pandemic situation in 2021, Brazil is in second place on the global scale in the number of deaths and infected people, with 3251 deaths in a single day in March 2021, according to the Ministry of Health. In the same period, more than 12 million people were infected and there were over 420,000 deaths [1] . A Unifying Panel of COVID-19 in Rio de Janeiro monitoring deaths in favelas showed that there were 3396 deaths in the first three months of 2021 in these territories, accounting for more deaths than in 162 countries.",
                        "score": 0.7799999714
                    },
                    {
                        "value": "To this day, Brazil is the second most affected country with over 3.3 million people COVID-19 cases and over 107.000 deaths. Since the end of March, a partial lockdown has been conducted in most cities even in those without any cases or deaths yet, and, four months later, there is still a high number of daily new cases.",
                        "score": 0.6999999881
                    },
                    {
                        "value": "To beat the pandemic, Brazil needs to optimize the COVID-19 diagnosis through the SARS-CoV-2 identification using RT-PCR tests and adjust its policies to save lives. Brazil is in a crucial moment to minimize the impact of the illness on society by reducing the number of cases and thus, preventing deaths, mainly of the risk group populations. However, as widely announced, in Brazil the diagnosis using SARS-CoV-2 RT-PCR is still scarce and part of the material collected from patients was disposed of and many patients were not tested, regardless of the seriousness of the symptoms, due to errors of medical data records, improper conservation of the samples after collection and/or during transport, which compromised the quality of the material to be tested.. Moreover, the federal government, through the image of the president Jair Bolsonaro, has supported the end of the quarantine, while the number of deaths has grown in thousands every day and the cases have been expanding to the interior of the country.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.961464107
                    },
                    {
                        "label": "neutral",
                        "score": 0.9815289974
                    },
                    {
                        "label": "neutral",
                        "score": 0.9994204044
                    },
                    {
                        "label": "neutral",
                        "score": 0.9985660911
                    }
                ]
            },
            {
                "text": "“La Organización Mundial de la Salud (OMS) está sumamente preocupada con la situación de Brasil”, dijo a los medios de comunicación brasileños Mariangela Simao, la subdirectora general del Departamento de Acceso a Medicamentos, Vacunas y Productos Farmacéuticos de la OMS.",
                "text_en": "“The World Health Organization (WHO) is extremely concerned about the situation in Brazil,” Mariangela Simao, the deputy director general of the WHO Department of Access to Drugs, Vaccines and Pharmaceuticals, told the Brazilian media.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Organización Mundial de la Salud (OMS)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The World Health Organization (WHO)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está sumamente preocupada con la situación de Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is extremely concerned about the situation in Brazil"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Mariangela Simao, la subdirectora general del Departamento de Acceso a Medicamentos, Vacunas y Productos Farmacéuticos de la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mariangela Simao, Deputy Director-General, Department of Access to Drugs, Vaccines and Pharmaceutical Products, WHO"
                    }
                ],
                "evidences": [
                    {
                        "value": "The appearance of Covid-19 demonstrates a concern for Brazil, which has previously dealt with socioeconomic problems since the arrival of other endemic viral pathologies, such as dengue, Zika virus (ZIKV), and chikungunya in 2013 [8] . Zika virus was declared a national public health emergency by the Brazilian Ministry of Health in 2015 and a public health emergency of international concern by the World Health Organization (WHO) in 2016 [9, 10] . In January 2016, 30,000 cases of infection and 1118 suspected cases of microcephaly were registered, a consequence of vertical transmission caused by ZIKV [10] .",
                        "score": 0.5
                    },
                    {
                        "value": "Mauricio Zuma and Nisia T. Lima, of Bio-Manguinhos/Fiocruz, encouraged improved vaccine access, inequality reduction and strengthening of developing countries' industrial and technological capabilities, to enhance health for all. The Brazilian Health System focus on prevention of infectious diseases, by maximizing national immunization coverage, was highlighted by DCVMN President, Mahima Datla, as an example of health system strengthening through vaccination. The vital contribution of DCVMN members contribution to vaccine quality, availability and affordability was noted by Tedros Ghebreyesus, Director-General of the World Health Organization (WHO), via video. He recognized slow adoption of vaccines by some countries and acknowledged that collaboration with manufacturers is required to ensure that all children access lifesaving vaccines.",
                        "score": 0.6600000262
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "entailment",
                        "score": 0.9388129115
                    },
                    {
                        "label": "neutral",
                        "score": 0.9975242019
                    }
                ]
            },
            {
                "text": "“Brasil se encuentra en una situación muy grave, los hospitales están saturados, con la mayoría de las UCI llenas.",
                "text_en": "“Brazil is in a very serious situation, hospitals are saturated, with most ICUs full.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Brazil"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se encuentra en una situación muy grave",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you are in a very serious situation"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "los hospitales están saturados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Hospitals are saturated."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la mayoría de las UCI llenas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with most of the ICUs filled"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Más de 6.000 personas están esperando cama en la UCI.",
                "text_en": "More than 6,000 people are waiting for a bed in the ICU.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Más de 6.000 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "More than 6,000 people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están esperando cama",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're waiting for bed."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la UCI",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the ICU"
                    }
                ],
                "evidences": [
                    {
                        "value": "To highlight the associated implications for healthcare demand, we also modelled the daily occupancy of hospital beds and ICU beds by following the recommendations of the Centre for Disease Control's (CDC) working groups on COVID-19 modeling and assuming that 5% of infectious people require a hospital bed, and 14% of hospitalized people require an ICU bed in . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
                        "score": 0.5299999714
                    },
                    {
                        "value": "For the purposes of the telephonic survey, an ICU bed was defined as comprising a bed, a pulse oximeter, a mechanical ventilator, a suction machine and an anaesthesia provider in the vicinity. We determined that, based on our definition, there were 33 ICU beds in the whole country for a population of 33 million people (Table 1) .",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.99880445
                    },
                    {
                        "label": "neutral",
                        "score": 0.9886045456
                    }
                ]
            },
            {
                "text": "La variante brasileña afecta gravemente a los jóvenes, entre 21 y 30 años, que además están hospitalizados y en la UCI”, agregó Maria Van Kerkhove, jefe de enfermedades emergentes y zoonosis de la OMS.",
                "text_en": "The Brazilian variant seriously affects young people between the ages of 21 and 30, who are also hospitalized and in the ICU,” added Maria Van Kerkhove, WHO head of emerging diseases and zoonoses.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La variante brasileña afecta gravemente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Brazilian variant seriously affects"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los jóvenes, entre 21 y 30 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for young people between 21 and 30 years of age"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Maria Van Kerkhove, jefe de enfermedades emergentes y zoonosis de la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Maria Van Kerkhove, WHO Head of Emerging Diseases and Zoonoses"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El miércoles 31 de marzo el país suramericano rompió un nuevo récord de muertes por COVID-19, alcanzando la cifra diaria de 3.869 fallecimientos.",
                "text_en": "On Wednesday, March 31, the South American country broke a new record of deaths due to COVID-19, reaching the daily figure of 3,869 deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El miércoles 31 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Wednesday, 31 March"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el país suramericano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "South American country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "rompió un nuevo récord de muertes por COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "broke a new record of deaths by COVID-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Frente a la situación, el recién posesionado ministro de Salud, Marcelo Queiroga, explicó en una rueda de prensa que “en estos días festivos no puede haber aglomeraciones innecesarias.",
                "text_en": "Faced with the situation, the newly-possessed Minister of Health Marcelo Queiroga explained in a press conference that “on these holidays there can be no unnecessary agglomerations.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el recién posesionado ministro de Salud, Marcelo Queiroga",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the newly possessed Minister of Health, Marcelo Queiroga"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una rueda de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at a press conference"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en estos días festivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on these holidays"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no puede haber aglomeraciones innecesarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There can be no unnecessary agglomerations"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es importante llevar una máscara, mantener el aislamiento.",
                "text_en": "It's important to wear a mask, keep the insulation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Es importante llevar una máscara, mantener el aislamiento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's important to wear a mask, keep the insulation"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sin embargo, el presidente Jair Bolsonaro mostró su rechazo a esta medida: “No vamos a resolver este problema quedándonos en casa.",
                "text_en": "However, President Jair Bolsonaro showed his rejection of this measure: “We are not going to solve this problem by staying at home.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el presidente Jair Bolsonaro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "President Jair Bolsonaro"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mostró su rechazo a esta medida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "showed its rejection of this measure"
                    }
                ],
                "evidences": [
                    {
                        "value": "Our study draws attention to an important and hitherto neglected aspect of vaccination against COVID-19: vaccines produced in some countries may suffer greater rejection. Precisely, the acceptance or rejection of vaccines produced abroad is closely tied to the foreign policy preferences of sitting governments. In Brazil, President Jair Bolsonaro has been a firm critic of China since his inauguration in January 2019. That opposition has led him to openly criticize the vaccine developed by Sinovac Biotech, leading millions of Brazilians to now reject it. His stance has unduly put pressure on the Brazilian public health services and is undermining the campaign to get Brazilians vaccinated against COVID-19. In January 2021, however, the Brazilian drug agency (Agência Nacional de Vigiância Sanitária, Anvisa) approved the emergency use of Cor-onaVac and the Bolsonaro government finally signed a contract to buy 100 million doses of the Chinese vaccine after much pressure [14] .",
                        "score": 0.5299999714
                    },
                    {
                        "value": "Our study draws attention to an important and hitherto neglected aspect of vaccination against COVID-19: vaccines produced in some countries may suffer greater rejection. Precisely, the acceptance or rejection of vaccines produced abroad is closely tied to the foreign policy preferences of sitting governments. In Brazil, President Jair Bolsonaro has been a firm critic of China since his inauguration in January 2019. That opposition has led him to openly criticize the vaccine developed by Sinovac Biotech, leading millions of Brazilians to now reject it. His stance has unduly put pressure on the Brazilian public health services and is undermining the campaign to get Brazilians vaccinated against COVID-19. In January 2021, however, the Brazilian drug agency (Agência Nacional de Vigiância Sanitária, Anvisa) approved the emergency use of CoronaVac and the Bolsonaro government finally signed a contract to buy 100 million doses of the Chinese vaccine after much pressure [14] .",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9987743497
                    },
                    {
                        "label": "neutral",
                        "score": 0.9987646341
                    }
                ]
            }
        ]
    },
    "47": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 14,
            "WhatReliabilityReliable": 14,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 21,
            "WhoReliabilityReliable": 20,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 16,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nDesde Roma advierten que el laboratorio ha incumplido con sus entregas en Europa y se convirtió en el primer miembro de la UE en frenar exportaciones de los inoculantes\n\n<PARAGRAPH>\n\nItalia lanza un pulso a AstraZeneca por su incumplimiento en las entregas previstas para Europa.\n\n<PARAGRAPH>\n\nLa nación transalpina impidió la salida de un cargamento con 250.000 dosis de la vacuna de AstraZeneca, destinado a Australia, para evitar que dosis producidas en la Unión Europea sean exportadas a un tercer país mientras el fabricante incumple los volúmenes de suministro acordados con los países de la UE.\n\n<PARAGRAPH>\n\nEl contingente fue retenido por las autoridades italianas cuando iba a ser exportado, según informaron fuentes europeas, que no ha dado más detalles sobre el momento de la incautación.\n\n<PARAGRAPH>\n\nItalia se convirtió así en el primer país de la Unión Europea (UE) en tomar una decisión de este tipo, desde que Bruselas aprobó a finales de enero el mecanismo sobre el control de las exportaciones de los fármacos producidos en territorio comunitario.\n\n<PARAGRAPH>\n\nEl mismo habilitaba a los Estados miembro actuar ante la sospecha de que partidas que corresponderían a los socios del bloque estaban siendo desviadas a otros compradores en el exterior.\n\n<PARAGRAPH>\n\nItalia trasladó su decisión a la Comisión Europea (CE) la semana pasada y el Ejecutivo comunitario, que tiene la última palabra al respecto, no se opuso a la prohibición decretada por Roma.\n\n<PARAGRAPH>\n\nPrecisamente, el primer ministro italiano, Mario Draghi, conversó con la presidenta del Ejecutivo comunitario, Ursula Von der Leyen, sobre cómo acelerar la respuesta sanitaria europea contra el coronavirus, en relación a la campaña de vacunación.\n\n<PARAGRAPH>\n\nEl nuevo sistema surgió precisamente como reacción urgente al anuncio de AstraZeneca de que no podría repartir entre los 27 la cantidad de dosis que había prometido durante el primer trimestre, pero el sistema cubre todas aquellas vacunas de laboratorios con los que la UE ha firmado acuerdos anticipados de compra.\n\n<PARAGRAPH>\n\nAdemás, la UE sospecha que la farmacéutica AstraZeneca vendió al Reino Unido vacunas que le correspondían a los países de la UE.\n\n<BREAK>\n\nUnas insinuaciones que el laboratorio anglo-sueco rechazó.\n\n<PARAGRAPH>\n",
        "TITLE": "Italia retiene 250.000 vacunas de AstraZeneca destinadas a Australia",
        "ID": "NF_04-11-2021_21-41-16_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Italia retiene 250.000 vacunas de AstraZeneca destinadas a Australia",
                "text_en": "Italy retains 250,000 AstraZeneca vaccines destined for Australia",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "retiene 250.000 vacunas de AstraZeneca destinadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "retains 250,000 AstraZeneca vaccines destined"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a Australia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Australia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desde Roma advierten que el laboratorio ha incumplido con sus entregas en Europa y se convirtió en el primer miembro de la UE en frenar exportaciones de los inoculantes",
                "text_en": "From Rome they warn that the laboratory has failed with its deliveries in Europe and became the first EU member to stop inoculator exports",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Roma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Rome"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el laboratorio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the laboratory"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha incumplido con sus entregas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has failed with their deliveries"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Europa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Europe"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "primer miembro de la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "first EU member"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "en frenar exportaciones de los inoculantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in slowing down exports of inoculators"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Italia lanza un pulso a AstraZeneca por su incumplimiento en las entregas previstas para Europa.",
                "text_en": "Italy launches a pulse to AstraZeneca for its failure in the deliveries planned for Europe.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lanza un pulso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Throws a pulse"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a AstraZeneca"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por su incumplimiento en las entregas previstas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for non-compliance with planned deliveries"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Europa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Europe"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La nación transalpina impidió la salida de un cargamento con 250.000 dosis de la vacuna de AstraZeneca, destinado a Australia, para evitar que dosis producidas en la Unión Europea sean exportadas a un tercer país mientras el fabricante incumple los volúmenes de suministro acordados con los países de la UE.",
                "text_en": "The transalpine nation prevented the departure of a cargo containing 250,000 doses of the AstraZeneca vaccine, destined for Australia, in order to prevent doses produced in the European Union from being exported to a third country while the manufacturer fails to comply with the agreed supply volumes with EU countries.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La nación transalpina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Transalpine Nation"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "impidió la salida de un cargamento con 250.000 dosis de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "prevented the departure of a cargo with 250,000 doses of the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Australia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Australia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El contingente fue retenido por las autoridades italianas cuando iba a ser exportado, según informaron fuentes europeas, que no ha dado más detalles sobre el momento de la incautación.",
                "text_en": "The quota was retained by the Italian authorities when it was to be exported, according to European sources, which has not given more details about the time of seizure.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El contingente fue retenido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The contingent was retained"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las autoridades italianas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Italian authorities"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando iba a ser exportado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when it was to be exported"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "fuentes europeas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "European sources"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no ha dado más detalles sobre el momento de la incautación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has given no further details on the time of seizure"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Italia se convirtió así en el primer país de la Unión Europea (UE) en tomar una decisión de este tipo, desde que Bruselas aprobó a finales de enero el mecanismo sobre el control de las exportaciones de los fármacos producidos en territorio comunitario.",
                "text_en": "Italy thus became the first country in the European Union (EU) to take such a decision, since Brussels adopted the mechanism for the control of exports of drugs produced on Community territory at the end of January.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se convirtió así en el primer país de la Unión Europea (UE) en tomar una decisión de este tipo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thus became the first country in the European Union (EU) to take such a decision"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Italia trasladó su decisión a la Comisión Europea (CE) la semana pasada y el Ejecutivo comunitario, que tiene la última palabra al respecto, no se opuso a la prohibición decretada por Roma.",
                "text_en": "Italy forwarded its decision to the European Commission (EC) last week and the Community Executive, which has the last word on it, did not oppose the ban decreed by Rome.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "trasladó su decisión",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "moved his decision"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la Comisión Europea (CE)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the European Commission (EC)"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "la semana pasada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last week"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ejecutivo comunitario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Community Executive"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se opuso a la prohibición decretada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "did not object to the decreed ban"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Roma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Rome"
                    }
                ],
                "evidences": [
                    {
                        "value": "At EU level, a good alternative to fines would be the issuance of 'commitment decisions' 72 by the European Commission, in order to motivate the relevant firms to set lower prices in the future and offer conditions that are more convenient for consumers. The European Commission can issue 'commitment decisions' when it intends to adopt a decision requiring that an infringement be brought to an end, and the companies under investigation prefer to offer commitments in order to remove the European Commission's competition concerns as expressed in a preliminary assessment. 73 'Commitment decisions' may also be preferable if the case is not one where a fine would be appropriate or when efficiency reasons justify that, the Commission limits itself to making the commitments binding, and does not issue a formal prohibition decision. 74 The reasons why 'commitment decisions' could be a good remedy for excessive pricing under the current circumstances is that they can restore undistorted conditions of competition in the markets in a swift and effective manner, as the administrative process for commitment decisions is generally short. 75 'Commitment decisions' can be either behavioural or structural and can be limited in time, meaning that the European Commission is able to reassess them if a material change takes place in the meantime. 76 They do not establish an infringement and do not require any admission by the parties, as they only require commitment to future behaviour. 77 This can be an incentive for firms to pursue the commitment route, as they know that in this way they avoid any damage to their reputation as well as a formal finding of an infringement against them. In addition, the ECJ does not require a strict proportionality test for assessing the remedies imposed by the European Commission in a 'commitment decision' , as it would do in case of a prohibition decision. 78 If a firm does not comply with the 'commitment decision' , the European Commission is able to impose a fine up to 10 per cent of the firm's annual turnover without having to prove any violation of the competition rules. 79 From the viewpoint of the European Commission, this provision saves money and time. Moreover, the European Commission is able to impose periodic penalty payments of up to 5 per cent of the average daily turnover of a firm until it complies with the 'commitment decision' . 80",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9982825518
                    }
                ]
            },
            {
                "text": "Precisamente, el primer ministro italiano, Mario Draghi, conversó con la presidenta del Ejecutivo comunitario, Ursula Von der Leyen, sobre cómo acelerar la respuesta sanitaria europea contra el coronavirus, en relación a la campaña de vacunación.",
                "text_en": "The Italian Prime Minister, Mario Draghi, spoke with the president of the Community Executive, Ursula Von der Leyen, about how to accelerate the European health response against the coronavirus, in relation to the vaccination campaign.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el primer ministro italiano, Mario Draghi",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italian Prime Minister Mario Draghi"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la presidenta del Ejecutivo comunitario, Ursula Von der Leyen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the president of the community executive, Ursula Von der Leyen"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cómo acelerar la respuesta sanitaria europea contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "how to accelerate the European health response against coronavirus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El nuevo sistema surgió precisamente como reacción urgente al anuncio de AstraZeneca de que no podría repartir entre los 27 la cantidad de dosis que había prometido durante el primer trimestre, pero el sistema cubre todas aquellas vacunas de laboratorios con los que la UE ha firmado acuerdos anticipados de compra.",
                "text_en": "The new system emerged precisely as an urgent reaction to AstraZeneca's announcement that it would not be able to share the amount of doses it had promised during the first quarter among the 27 but the system covers all those laboratory vaccines with which the EU has signed early purchase agreements.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El nuevo sistema surgió",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The new system emerged"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "reacción urgente al anuncio de AstraZeneca de que no podría repartir entre los 27 la cantidad de dosis que había prometido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "urgent reaction to AstraZeneca's announcement that he would not be able to share the amount of dose he had promised among the 27"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante el primer trimestre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the first quarter"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, la UE sospecha que la farmacéutica AstraZeneca vendió al Reino Unido vacunas que le correspondían a los países de la UE.",
                "text_en": "In addition, the EU suspects that the pharmaceutical company AstraZeneca sold to the UK vaccines corresponding to the EU countries.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EU"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sospecha que la farmacéutica AstraZeneca vendió al Reino Unido vacunas que le correspondían",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "suspects that the pharmaceutical company AstraZeneca sold to the United Kingdom vaccines that corresponded to it"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la farmacéutica AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pharmaceutical company AstraZeneca"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the United Kingdom"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los países de la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to EU countries"
                    }
                ],
                "evidences": [
                    {
                        "value": "An initial idea of what a future EHU might look like was offered by the Commission's strategy in late 2020 to pursue an EU-wide approach to purchasing Covid-19 vaccines, with approvals being granted by the EMA rather than national medicines agencies. But mistakes made by the Commission in the procurement process with pharmaceutical companies (particularly with AstraZeneca) and initial difficulties in ramping up the production process led to an extremely slow vaccine rollout across the EU in the first few months of 2021, attracting considerable criticism from EU member states and WHO. As a solution to this problem, some member states resorted to nationalist behaviour and thus challenged the EU-wide approach coordinated by the Commission. Hungary and Slovakia, for instance, also relied on Russia's Sputnik V vaccine, although the EMA did not approve it (Martuscelli, 2021) . One should note, however, that many EU member states can also be blamed for the slow EU-wide vaccines rollout. A number of them administered significantly fewer vaccine doses than received by the Commission due to a lack of national preparation and planning and controversies about the efficacy and safety of the AstraZeneca vaccine, one of the principal vaccines (along with the Pfizer-BioNTech vaccine) administered initially by EU vaccination programmes (Hirsch and Deutsch, 2021) .",
                        "score": 0.5099999905
                    },
                    {
                        "value": "This new EU strategy follows a vaccination campaign that showed the EU to be dependent on extra-EU producers, i.e. the UK (Oxford-AstraZeneca) and the US (Pfi zer, in cooperation with the German company BioNTech, Moderna and Johnson & Johnson). Moreover, this external technological dependence has caused serious delays in the development of the vaccination campaign in the EU, with major implications for the spread of the infection and its consequences in terms of hospitalisations and human lives, but also in terms of delayed economic recovery due to later reopenings compared to global competitors.",
                        "score": 0.6200000048
                    },
                    {
                        "value": "The ChAdOx1 nCoV-19 vaccine, commonly known as the Oxford-AstraZeneca vaccine, Covishield, or Vaxzevira, is one of four vaccines that received conditional approval for the prevention of COVID-19 in the UK (November 2021) 1 2 The Oxford-AstraZeneca vaccine has been approved and licensed for use in over 170 countries, and approximately 1 billion doses have been administered globally as of late November 2021. 3 4 The vaccine makes use of a novel technology that relies on a chimpanzee adenovirus-vector (ChAdOx) to encode the production of the SARS-CoV-2 BMJ Global Health spike protein, which induces an immune response. 5 It is of particular importance in resource-limited settings as it does not require the same cold-chain management and is more affordable than the mRNA-based COVID-19 vaccines developed by Pfizer/BioNTech and Moderna. 6 Although the Oxford-AstraZeneca vaccine itself was developed in response to the COVID-19 pandemic, the underlying ChAdOx vaccine platform relies on two decades of research and development (R&D) by the Oxford Vaccine Group at the Jenner Institute, University of Oxford, led by Professor Sarah Gilbert (SG) and Professor Adrian Hill (AH). Vaccines using the ChAdOx technology have previously undergone clinical trials in human participants for other infectious diseases, including hepatitis C virus and malaria, where it has been shown to induce a powerful immune response during phase I clinical trials. 7 8 Before the emergence of SARS-CoV-2, the ChAdOx technology was being used to develop a vaccine for Middle East Respiratory Syndrome coronavirus (MERS-CoV), which is closely related to the novel coronavirus. 9 When the pandemic emerged, this ChAdOx1 MERS-CoV vaccine had already undergone its first clinical trials in non-human primates and humans (phase I) and was rapidly adapted to induce an immune response to SARS-CoV-2. 10 The resultant ChAdOx nCoV-19 vaccine was undergoing phase I/II clinical trials in NHS Trusts across the UK when a deal with biopharmaceutical company AstraZeneca was announced in late April 2020. [11] [12] [13] [14] Shortly after this, the UK government committed £65.5 million towards the commercialisation and manufacturing of the Oxford-AstraZeneca vaccine. 15 However, it is not known who funded the early stages of R&D into the ChAdOx technology at the University of Oxford.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.993961513
                    },
                    {
                        "label": "neutral",
                        "score": 0.9995214939
                    },
                    {
                        "label": "neutral",
                        "score": 0.999245286
                    }
                ]
            },
            {
                "text": "Unas insinuaciones que el laboratorio anglo-sueco rechazó.",
                "text_en": "Insinuations that the Anglo-Swedish laboratory rejected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Unas insinuaciones que el laboratorio anglo-sueco rechazó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Insinuations that the Anglo-Swedish laboratory rejected"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el laboratorio anglo-sueco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Anglo-Swedish laboratory"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "48": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 8,
            "WhatReliabilityUnreliable": 2,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 13,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 5,
            "WhyReliabilityReliable": 4,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 2,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 5,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n.Contraindicaciones de la vacuna contra el coronavirus: esto dicen los prospectos de Pfizer, Moderna y AstraZeneca.\n\n<PARAGRAPH>\n\nSiete personas han muerto en el Reino Unido a causa de unos raros coágulos de sangre después de recibir la vacuna de AstraZeneca contra la Covid-19, según pudo saber la BBC.\n\n<PARAGRAPH>\n\nLa Agencia Reguladora de Medicinas y Cuidados para la Salud (MHRA, en inglés) del Reino Unido señaló este viernes que identificaron 30 casos de unos raros coágulos de sangre entre los 18,1 millones de personas vacunadas con ese preparado hasta finales de marzo.\n\n<PARAGRAPH>\n\nEse organismo regulador puntualizó, no obstante, que los riesgos asociados a estos coágulos son \"muy pequeños\" y que la población debería aceptar la vacuna cuando sea ofrecida por la Sanidad.\n\n<PARAGRAPH>\n\nDe los 30 incidentes, 22 corresponden a trombos cerebrales venosos (CVST, por sus siglas en inglés) y ocho a otros problemas relacionados con la coagulación de sangre con bajas plaquetas.\n\n<PARAGRAPH>\n\nLa cadena BBC afirma este sábado que pudo saber de los reguladores que siete de estas personas vacunadas han fallecido y que prosiguen las investigaciones para determinar si es el preparado de AstraZeneca el responsable de causar estos trombos.\n\n<PARAGRAPH>\n\nEsta información sale a la luz después de que Alemania decidiera suspender el uso de AstraZeneca para las personas menores de 60 años ante el temor de un posible vínculo con coágulos.\n\n<PARAGRAPH>\n\nAdemás de este preparado, el Reino Unido está vacunando con el de Pfizer y más de 30 millones de personas ya han recibido al menos la primera de las dos dosis de una de estas vacunas.\n\n<PARAGRAPH>\n",
        "TITLE": "Reino Unido ha inyectado más de 18 millones de dosis de AstraZeneca y ha registrado siete muertos por coágulos",
        "ID": "F_04-11-2021_21-29-20_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Reino Unido ha inyectado más de 18 millones de dosis de AstraZeneca y ha registrado siete muertos por coágulos",
                "text_en": "United Kingdom has injected more than 18 million doses of AstraZeneca and recorded seven deaths from clots",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha inyectado más de 18 millones de dosis de AstraZeneca y ha registrado siete muertos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has injected more than 18 million doses of AstraZeneca and recorded seven deaths"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por coágulos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by clots"
                    }
                ],
                "evidences": []
            },
            {
                "text": ".Contraindicaciones de la vacuna contra el coronavirus: esto dicen los prospectos de Pfizer, Moderna y AstraZeneca.",
                "text_en": "Contraindications of the coronavirus vaccine: this is what the leaflets for Pfizer, Moderna and AstraZeneca say.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los prospectos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "package leaflets"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer, Moderna y AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer, Moderna and AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Siete personas han muerto en el Reino Unido a causa de unos raros coágulos de sangre después de recibir la vacuna de AstraZeneca contra la Covid-19, según pudo saber la BBC.",
                "text_en": "Seven people have died in the UK from rare blood clots after receiving AstraZeneca's Covid-19 vaccine, BBC reports.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Siete personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Seven people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han muerto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're dead."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in the United Kingdom"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a causa de unos raros coágulos de sangre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "due to rare blood clots"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "después de recibir la vacuna de AstraZeneca contra la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after receiving the AstraZeneca vaccine against Covid-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Agencia Reguladora de Medicinas y Cuidados para la Salud (MHRA, en inglés) del Reino Unido señaló este viernes que identificaron 30 casos de unos raros coágulos de sangre entre los 18,1 millones de personas vacunadas con ese preparado hasta finales de marzo.",
                "text_en": "The UK Health Care and Medicine Regulatory Agency (MHRA) said on Friday that they identified 30 cases of rare blood clots among 18.1 million people vaccinated with that preparation until the end of March.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Reguladora de Medicinas y Cuidados para la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Regulatory Agency for Medicine and Health Care"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Friday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "identificaron 30 casos de unos raros coágulos de sangre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "identified 30 cases of rare blood clots"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "vacunadas con ese preparado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccinated with that preparation"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ese organismo regulador puntualizó, no obstante, que los riesgos asociados a estos coágulos son \"muy pequeños\" y que la población debería aceptar la vacuna cuando sea ofrecida por la Sanidad.",
                "text_en": "This regulatory body pointed out, however, that the risks associated with these clots are \"very small\" and that the population should accept the vaccine when it is offered by Health.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ese organismo regulador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "That regulatory body"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los riesgos asociados a estos coágulos son \"muy pequeños\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the risks associated with these clots are \"very small\""
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "population"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "debería aceptar la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you should accept the vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por la Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for Health"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De los 30 incidentes, 22 corresponden a trombos cerebrales venosos (CVST, por sus siglas en inglés) y ocho a otros problemas relacionados con la coagulación de sangre con bajas plaquetas.",
                "text_en": "Of the 30 incidents, 22 relate to venous brain thrombus (CVST) and eight to other problems related to blood clotting with low platelets.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "De los 30 incidentes, 22 corresponden",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Of the 30 incidents, 22 relate"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a trombos cerebrales venosos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to venous brain thrombus"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "problemas relacionados con la coagulación de sangre con bajas plaquetas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "problems related to blood clotting with low platelets"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La cadena BBC afirma este sábado que pudo saber de los reguladores que siete de estas personas vacunadas han fallecido y que prosiguen las investigaciones para determinar si es el preparado de AstraZeneca el responsable de causar estos trombos.",
                "text_en": "BBC claims on Saturday that it was able to learn from regulators that seven of these vaccinated people have died and that investigations are continuing to determine whether AstraZeneca's preparation is responsible for causing these thrombi.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La cadena BBC",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The BBC Network"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este sábado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Saturday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "siete de estas personas vacunadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "seven of these people vaccinated"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han fallecido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have passed away"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta información sale a la luz después de que Alemania decidiera suspender el uso de AstraZeneca para las personas menores de 60 años ante el temor de un posible vínculo con coágulos.",
                "text_en": "This information comes to light after Germany decided to discontinue the use of AstraZeneca for people under 60 years of age in fear of a possible clot link.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta información sale a la luz",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This information comes to light"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de que Alemania decidiera suspender el uso de AstraZenec",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after Germany decided to suspend the use of AstraZenec"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Alemania",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Germany"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas menores de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons under 60 years of age"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ante el temor de un posible vínculo con coágulos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "fear of a possible bond with clots"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además de este preparado, el Reino Unido está vacunando con el de Pfizer y más de 30 millones de personas ya han recibido al menos la primera de las dos dosis de una de estas vacunas.",
                "text_en": "In addition to this preparation, the UK is vaccinating with Pfizer and more than 30 million people have already received at least the first of the two doses of one of these vaccines.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está vacunando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He's vaccinating."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con el de Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with that of Pfizer"
                    }
                ],
                "evidences": [
                    {
                        "value": "The NHS in England has rapidly responded to the availability of COVID-19 vaccines and administered a substantial number of doses in the first six weeks of the vaccination campaign. In our study 961,580 people had received at least one vaccine dose by January 13th, including 41.1% of eligible people over the age of 80. Over 80s from ethnic minority groups were substantially less likely to be vaccinated in the first weeks of the COVID-19 vaccination campaign, and similarly those living in more socioeconomically deprived areas generally had lower vaccine coverage. Among those over 80, people with pre-existing medical conditions were equally likely, or more likely, to have received a vaccine, across all groups of pre-existing medical problems, with two striking exceptions: vaccination was substantially lower among people with severe mental illnesses and learning disabilities. We observed substantial geographic variation in vaccination coverage between STPs. 17.6% (n=169,472) of people have received a second dose of the vaccine; at this stage of the vaccination campaign most received Pfizer-BioNtech , with only 6.8% receiving the AstraZeneca-Oxford vaccine.",
                        "score": 0.5799999833
                    },
                    {
                        "value": "In early 2020, more than 50 companies began development of the first vaccines against SARS-CoV-2. Of these, the Pfizer-BioNTech BNT162b2 6 vaccine was first approved for use in the UK on Dec 2, 2020, followed by the Oxford-AstraZeneca vaccine 7 on Dec 20, 2020, and the Moderna vaccine 8 on Jan 8, 2021, although only the Pfizer-BioNTech and Oxford-AstraZeneca vaccines were in widespread use in the UK by February, 2021. As of February, 2021, the UK had ordered 457 million doses of vaccines from eight different developers: 8, 9 100 million doses from Oxford-AstraZeneca, 40 million doses from Pfizer-BioNTech, 17 million doses from Moderna, 60 million doses from Novavax, 100 million doses from Valneva, 60 million doses from GSK-Sanofi Pasteur, 30 million doses from Janssen, and 50 million doses from CureVac. This amount is far more than any possible demand from the UK population, but mitigates for potential delays or failures from any single manufacturer. A continuing unknown with the potential vaccines is the degree to which they are effective against transmission, rather than simply preventing symptomatic infection (for further information see the appendix pp 1-2); this is a key uncertainty that we aimed to investigate in this study.",
                        "score": 0.7799999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.995747149
                    },
                    {
                        "label": "neutral",
                        "score": 0.998996079
                    }
                ]
            }
        ]
    },
    "49": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 9,
            "WhatReliabilityReliable": 9,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 14,
            "WhoReliabilityReliable": 14,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 6,
            "WhenReliabilityReliable": 6,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 3,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 6,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 4,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEn algunas zonas ya se ha comenzado a vacunar esta semana a personas de 70 a 79 años.El 81% de los mayores de 80 años ya tienen la primera dosis de la vacuna contra el coronavirus en Cataluña.\n\n<PARAGRAPH>\n\nLa subdirectora general de Promoción de la Salud de la Generalitat, Carmen Cabezas, ha previsto este viernes que a partir de la semana que viene se comience a citar \"de forma generalizada\" a personas de entre 70 y 79 años para recibir la vacuna del coronavirus, aunque ya hay personas de este colectivo que ya se han vacunado esta misma semana.\n\n<PARAGRAPH>\n\n\"En algunos puntos ya se está empezando a citar\", ha destacado Cabezas en declaraciones a Catalunya Ràdio recogidas por Europa Press, en las que ha concretado que se empezará por las personas \"más mayores\" de este grupo de edad.\n\n<PARAGRAPH>\n\nEn relación a la vacuna desarrollada por AstraZeneca, Cabezas ha celebrado que la Comisión de Salud Pública acordase el jueves seguir vacunando a personas de 60 a 65 años y que el siguiente colectivo a inmunizar con esta vacuna sea el de 66 a 69 años.\n\n<PARAGRAPH>\n\n\"Es una buena noticia\", ha reivindicado la subdirectora general de Promoción de la Salud, que ha reiterado que desde el departamento catalán consideran que no tendría que haber un límite de edad vinculado a esta vacuna.\n\n<PARAGRAPH>\n\nSobre las 200.000 personas menores de 60 años que están pendientes de recibir la segunda dosis de AstraZeneca, Cabezas ha defendido que tienen que estar tranquilas porque con una dosis ya tienen una \"protección muy importante\". Asimismo, ha precisado que se está estudiando \"con profundidad\" para determinar cómo se procederá con estas 200.000 personas y espera que la semana que viene lo puedan comunicar.\n\n<PARAGRAPH>\n\nAl ser preguntada por si se alcanzará el objetivo de tener el 30% de la población vacunada en junio y el 70% cuando finalice el verano, Cabezas ha dicho que están trabajando para que \"esto sea viable\" y ha destacado la llegada regular de cerca de 190.000 dosis de Pfizer cada lunes, así como 52.700 dosis de Moderna que han llegado este viernes.\n\n<PARAGRAPH>\n",
        "TITLE": "Cataluña citará masivamente a los mayores de 70 años para la vacuna a partir de la próxima semana",
        "ID": "F_04-11-2021_21-11-14_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Cataluña citará masivamente a los mayores de 70 años para la vacuna a partir de la próxima semana",
                "text_en": "Catalonia will quote massively those over 70 for the vaccine starting next week",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "citará masivamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will quote massively"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los mayores de 70 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 70 years of age"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir de la próxima semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from next week"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En algunas zonas ya se ha comenzado a vacunar esta semana a personas de 70 a 79 años.El 81% de los mayores de 80 años ya tienen la primera dosis de la vacuna contra el coronavirus en Cataluña.",
                "text_en": "In some areas, vaccinations have already started this week for people aged 70 to 79 years. 81% of those over 80 years of age already have the first dose of the coronavirus vaccine in Catalonia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En algunas zonas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In some areas"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya se ha comenzado a vacunar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has already started to vaccinate"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "esta semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this week"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a personas de 70 a 79 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to persons aged 70-79"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El 81% de los mayores de 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "81% of those over 80 years of age"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya tienen la primera dosis de la vacuna contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "already have the first dose of the coronavirus vaccine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    }
                ],
                "evidences": [
                    {
                        "value": "Regarding the influence of Spain's COVID-19 vaccine rollout, adult vaccination started on the 27 th of December 2021, and the coverage (full vaccination) went from 0.84% at the end of January 2021 to 17.53% at the end of the study period (see Supplementary Figure 2 in the Supplementary Material). Considering the age <69 years, which is the age-group of active employees, only 5.45% were fully vaccinated by the end of May 2021, while 23.52% had received at least the first dose of a vaccine. Moreover, essential workers, such as teachers and staff working in educational centers, were vaccinated with the Oxford/AstraZeneca© vaccine with a scheduled interval of 12 weeks between the first and the second dose. In particular, in Catalonia, the second dose of the vaccine began to be administered to essential workers on 27 th May 2021 (29) . Therefore, considering the rollout procedure, the incidence among children during the last part of the analyzed period was probably not affected by the vaccination of teachers and other school workers.",
                        "score": 0.6399999857
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9927364588
                    }
                ]
            },
            {
                "text": "La subdirectora general de Promoción de la Salud de la Generalitat, Carmen Cabezas, ha previsto este viernes que a partir de la semana que viene se comience a citar \"de forma generalizada\" a personas de entre 70 y 79 años para recibir la vacuna del coronavirus, aunque ya hay personas de este colectivo que ya se han vacunado esta misma semana.",
                "text_en": "The Deputy Director General of Health Promotion of the Generalitat, Carmen Cabezas, has scheduled this Friday that from next week people between 70 and 79 years of age will begin to be mentioned \"generally\" to receive the coronavirus vaccine, although there are already people from this group who have already been vaccinated this week.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La subdirectora general de Promoción de la Salud de la Generalitat, Carmen Cabezas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Deputy Director General of Health Promotion of the Generalitat, Carmen Cabezas"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Friday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se comience a citar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "starting to quote"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma generalizada\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a generalised manner\""
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a personas de entre 70 y 79 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to persons aged 70-79"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"En algunos puntos ya se está empezando a citar\", ha destacado Cabezas en declaraciones a Catalunya Ràdio recogidas por Europa Press, en las que ha concretado que se empezará por las personas \"más mayores\" de este grupo de edad.",
                "text_en": "\"In some points it is already beginning to mention\", Cabezas said in statements to Catalunya Ràdio collected by Europa Press, in which he has specified that it will start with the \"oldest\" people in this age group.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En algunos puntos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "At some points"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cabezas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Heads"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en declaraciones a Catalunya Ràdio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in statements to Catalunya Ràdio"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha concretado que se empezará",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has specified that it will start"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por las personas \"más mayores\" de este grupo de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the \"oldest\" people in this age group"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En relación a la vacuna desarrollada por AstraZeneca, Cabezas ha celebrado que la Comisión de Salud Pública acordase el jueves seguir vacunando a personas de 60 a 65 años y que el siguiente colectivo a inmunizar con esta vacuna sea el de 66 a 69 años.",
                "text_en": "In relation to the vaccine developed by AstraZeneca, Cabezas has celebrated that the Public Health Commission agreed on Thursday to continue to vaccinate people aged 60 to 65 and that the next group to immunize with this vaccine is 66 to 69 years.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cabezas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Heads"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Comisión de Salud Pública",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Public Health Commission"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "acordase el jueves seguir vacunando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "agree on Thursday to continue vaccinating"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Thursday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a personas de 60 a 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to persons aged 60 to 65"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"Es una buena noticia\", ha reivindicado la subdirectora general de Promoción de la Salud, que ha reiterado que desde el departamento catalán consideran que no tendría que haber un límite de edad vinculado a esta vacuna.",
                "text_en": "\"It's good news,\" claimed the deputy director general of Health Promotion, who has reiterated that from the Catalan department they believe that there should be no age limit linked to this vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la subdirectora general de Promoción de la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Deputy Director-General for Health Promotion"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "consideran que no tendría que haber un límite de edad vinculado a esta vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "consider that there should be no age limit linked to this vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sobre las 200.000 personas menores de 60 años que están pendientes de recibir la segunda dosis de AstraZeneca, Cabezas ha defendido que tienen que estar tranquilas porque con una dosis ya tienen una \"protección muy importante\". Asimismo, ha precisado que se está estudiando \"con profundidad\" para determinar cómo se procederá con estas 200.000 personas y espera que la semana que viene lo puedan comunicar.",
                "text_en": "About the 200,000 people under the age of 60 who are awaiting the second dose of AstraZeneca, Cabezas has argued that they have to be calm because with a dose they already have a \"very important protection.\" He has also specified that it is being studied \"in depth\" to determine how to proceed with these 200,000 people and hopes that next week they can communicate it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cabezas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Heads"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha defendido que tienen que estar tranquilas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has defended that they have to be calm"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con una dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with one dose"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya tienen una \"protección muy importante\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They already have a \"very important protection\""
                    }
                ],
                "evidences": []
            },
            {
                "text": "Al ser preguntada por si se alcanzará el objetivo de tener el 30% de la población vacunada en junio y el 70% cuando finalice el verano, Cabezas ha dicho que están trabajando para que \"esto sea viable\" y ha destacado la llegada regular de cerca de 190.000 dosis de Pfizer cada lunes, así como 52.700 dosis de Moderna que han llegado este viernes.",
                "text_en": "When asked whether the target of 30% of the vaccinated population will be reached by June and 70% by the end of the summer, Cabezas has said that they are working to make \"this feasible\" and has highlighted the regular arrival of about 190,000 doses of Pfizer every Monday, as well as 52,700 doses of Moderna that have arrived this Friday.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en junio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in June"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando finalice el verano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the end of the summer"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cabezas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Heads"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha dicho que están trabajando para que \"esto sea viable\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He said they're working to make \"this workable.\""
                    }
                ],
                "evidences": []
            }
        ]
    },
    "50": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 9,
            "WhatReliabilityReliable": 2,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 8,
            "WhoReliabilityReliable": 0,
            "WhoReliabilityUnreliable": 8,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 3,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 0,
            "WhereReliabilityReliable": 0,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 2,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 4,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 6,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nA pesar de que siga habiendo mucha gente que, cuando ve cosas como estas, se siga poniendo las manos en los ojos y en los oídos porque no quieren enterarse de nada, nosotros no nos cansaremos de seguir denunciando lo que le ha pasado a mucha gente poco después de ponerse la vacuna.\n\n<PARAGRAPH>\n\nEn este caso estamos hablando de una anciana que, justo en la misma noche en la que le pusieron la vacuna de Moderna, ya empezó a tener serios problemas hasta que a los quince días falleció.\n\n<BREAK>\n\nEl testimonio, quien cuenta todo lo que ha pasado es su propio nieto que, destrozado, habla muy claro de lo que él cree que le ha pasado a su abuela: “Han matado a mi abuela”.\n\n<PARAGRAPH>\n\nSeguimos diciendo lo mismo que decimos siempre, la vacunación es voluntaria y quien quiera vacunarse es tan libre de hacerlo como quien no quiera.\n\n<BREAK>\n\nPero a esos que se quieren vacunar y están convencidos por médicos televisivos como el doctor Carballo: ¿No les da que pensar que cada vez se produzcan más testimonios como estos? ¿Tan poco les importa jugar a la ruleta rusa y arriesgarse a sufrir consecuencias irreversibles?\n\n<PARAGRAPH>\n\nEscuchen, escuchen y mediten sobre ello.\n\n<PARAGRAPH>\n\nCOLABORA CON NOSOTROS CON PAYPAL\n\n<PARAGRAPH>\n\n",
        "TITLE": "Nuevo testimonio sobre las vacunas: \"Han matado a mi abuela\"",
        "ID": "NF_04-11-2021_20-40-28_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Nuevo testimonio sobre las vacunas: \"Han matado a mi abuela\"",
                "text_en": "New testimony about vaccinations: \"My grandmother has been killed\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Nuevo testimonio sobre las vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "New Testimony on Vaccines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A pesar de que siga habiendo mucha gente que, cuando ve cosas como estas, se siga poniendo las manos en los ojos y en los oídos porque no quieren enterarse de nada, nosotros no nos cansaremos de seguir denunciando lo que le ha pasado a mucha gente poco después de ponerse la vacuna.",
                "text_en": "Despite the fact that there are still many people who, when they see things like this, keep putting their hands in their eyes and ears because they don't want to know anything, we will not tire of continuing to denounce what has happened to many people shortly after getting the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mucha gente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a lot of people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se siga poniendo las manos en los ojos y en los oídos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "keep putting your hands in your eyes and ears"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque no quieren enterarse de nada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because they don't want to know anything."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nosotros",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "us."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no nos cansaremos de seguir denunciando lo que le ha pasado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We won't get tired of reporting what's happened to him anymore."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a mucha gente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to many people"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "poco después de ponerse la vacuna",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "shortly after getting the vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En este caso estamos hablando de una anciana que, justo en la misma noche en la que le pusieron la vacuna de Moderna, ya empezó a tener serios problemas hasta que a los quince días falleció.",
                "text_en": "In this case we are talking about an old woman who, just on the same night as she was given the Moderna vaccine, already began to have serious problems until she died within fifteen days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una anciana",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "an old woman"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "justo en la misma noche en la que le pusieron la vacuna de Moderna",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Just on the same night he got the Moderna vaccine."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya empezó a tener serios problemas hasta que a los quince días falleció",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He started to have serious problems until he died in the fortnight."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a los quince días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "at 15 days"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El testimonio, quien cuenta todo lo que ha pasado es su propio nieto que, destrozado, habla muy claro de lo que él cree que le ha pasado a su abuela: “Han matado a mi abuela”.",
                "text_en": "The testimony, who tells all that has happened is his own grandson who, shattered, speaks very clearly of what he thinks has happened to his grandmother: “They have killed my grandmother.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "su propio nieto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "his own grandson"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "habla muy claro de lo que él cree que le ha pasado a su abuela",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He speaks very clearly about what he thinks happened to his grandmother."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Han matado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They've killed."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a mi abuela",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to my grandmother"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Seguimos diciendo lo mismo que decimos siempre, la vacunación es voluntaria y quien quiera vacunarse es tan libre de hacerlo como quien no quiera.",
                "text_en": "We keep saying the same thing we always say, vaccination is voluntary and anyone who wants to get vaccinated is as free to do it as anyone who doesn't want to.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la vacunación es voluntaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccination is voluntary"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero a esos que se quieren vacunar y están convencidos por médicos televisivos como el doctor Carballo: ¿No les da que pensar que cada vez se produzcan más testimonios como estos? ¿Tan poco les importa jugar a la ruleta rusa y arriesgarse a sufrir consecuencias irreversibles?",
                "text_en": "But to those who want to be vaccinated and are convinced by television doctors like Dr. Carballo: Don't you think that more and more testimonies like these are produced? Do you care so little to play Russian roulette and risk irreversible consequences?",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a esos que se quieren vacunar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "those who want to be vaccinated"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están convencidos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're convinced."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "médicos televisivos como el doctor Carballo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "TV doctors like Dr. Carballo"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Escuchen, escuchen y mediten sobre ello.",
                "text_en": "Listen, listen and meditate on it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "escuchen y mediten sobre ello",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Listen and meditate on it"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "51": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 11,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 8,
            "WhoReliabilityReliable": 8,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 8,
            "WhenReliabilityReliable": 8,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 3,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 18,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 19,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nSanidad notifica 106 defunciones en las últimas 24 horas, mientras que los contagios descienden ligeramente (de 3.031 a 2.911). El número de nuevos brotes también se reduce de 71 a 61.\n\n<PARAGRAPH>\n\nLa Comunidad Valenciana ha superado los 100 fallecidos por coronavirus por tercer día consecutivo, con 106 defunciones en las últimas 24 horas.\n\n<BREAK>\n\nEl dato se sitúa ligeramente por debajo del de este miércoles (108) y algo por encima del día anterior (104) pero dobla los registrados el lunes y domingo (55 y 52, respectivamente).\n\n<PARAGRAPH>\n\nEl total de defunciones desde el inicio de la pandemia es de 5.796 personas: 677 en la provincia de Castellón, 2.156 en la de Alicante y 2.963 en la de Valencia.\n\n<PARAGRAPH>\n\nPor otro lado, se han registrado 2.911 casos nuevos casos de coronavirus confirmados por prueba PCR o a través de test de antígenos desde la última actualización, lo que sitúa la cifra total de positivos en 358.444 personas.\n\n<BREAK>\n\nEsto supone un descenso respecto al miércoles, en el que se notificaron 3.031 contagios.\n\n<PARAGRAPH>\n\nPor provincias, la distribución de nuevos positivos es la siguiente: 268 en Castellón (36.546 en total), 959 en Alicante (134.975 en total) y 1.684 en la provincia de Valencia (186.921 en total).\n\n<BREAK>\n\nSe ha reasignado un caso, con lo que el total de casos sin asignar en toda la Comunitat Valenciana se sitúa ahora en 2.\n\n<BREAK>\n\nEl nñumero de brotes nuevos ha pasado de 71 a 61.\n\n<PARAGRAPH>\n\nLee también Salvador Enguix Oliver\n\n<PARAGRAPH>\n\nEstas cifras confirman las palabras que el presidente de la Generalitat, Ximo Puig, ha dicho esta mañana en la sesión de control en las Cortes: que, aunque se está frenando la curva de la tercera ola en cuanto a contagios, \"la letalidad sigue siendo insoportable\".\n\n<PARAGRAPH>\n\nAsimismo, desde la última actualización se han registrado 3.829 altas a pacientes con coronavirus.\n\n<BREAK>\n\nDe esta forma, ya son 322.092 personas en la Comunidad Valenciana las que han superado la enfermedad desde que comenzó la pandemia.\n\n<BREAK>\n\nPor provincias, las altas se distribuyen del siguiente modo: 32.994 en Castellón, 119.899 en Alicante y 169.141 en Valencia, además de 58 no asignadas.\n\n<PARAGRAPH>\n\nLos hospitales valencianos tienen, actualmente, 2.806 personas ingresadas: 285 en la provincia de Castellón, con 50 pacientes en UCI; 1.144 en la provincia de Alicante, 208 de ellos en la UCI; y 1.377 en la provincia de Valencia, 303 de ellos en UCI.\n\n<PARAGRAPH>\n\nDe acuerdo con los datos registrados, en estos momentos hay 42.031 casos activos, lo que supone un 11,36% del total de positivos.\n\n<PARAGRAPH>\n\nLee también Salvador Enguix\n\n<PARAGRAPH>\n\nPor otra parte, la Comunidad Valenciana ha administrado un total de 210.530 dosis de la vacuna contra el coronavirus.\n\n<BREAK>\n\nPor provincias, 27.935 en Castellón, 78.472 en Alicante y 104.123 en Valencia.\n\n<BREAK>\n\nHan recibido las dos dosis de la vacuna 91.910 personas.\n\n<PARAGRAPH>\n\nFinalmente, desde la última actualización se ha registrado algún caso positivo en 158 residencias de mayores (15 en la provincia de Castellón, 51 en la provincia de Alicante y 92 en la provincia de Valencia), 36 centros de diversidad funcional (3 en la provincia de Castellón, 11 en la provincia de Alicante y 22 en la provincia de Valencia) y 8 centros de menores (5 en la provincia de Alicante y 3 en la provincia de Valencia).\n\n<PARAGRAPH>\n\n",
        "TITLE": "La Comunidad Valenciana supera los 100 fallecidos por covid por tercer día consecutivo",
        "ID": "F_04-11-2021_20-34-53_www_lavanguardia_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La Comunidad Valenciana supera los 100 fallecidos por covid por tercer día consecutivo",
                "text_en": "The Valencian Community exceeds 100 deaths by covid for the third consecutive day",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Comunidad Valenciana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Valencian Community"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "supera los 100 fallecidos por covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more than 100 deaths per covid"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por tercer día consecutivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the third consecutive day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sanidad notifica 106 defunciones en las últimas 24 horas, mientras que los contagios descienden ligeramente (de 3.031 a 2.911). El número de nuevos brotes también se reduce de 71 a 61.",
                "text_en": "Health reports 106 deaths in the last 24 hours, while contagions fall slightly (from 3,031 to 2,911). The number of new outbreaks is also reduced from 71 to 61.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "notifica 106 defunciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "notifies 106 deaths"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las últimas 24 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last 24 hours"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Comunidad Valenciana ha superado los 100 fallecidos por coronavirus por tercer día consecutivo, con 106 defunciones en las últimas 24 horas.",
                "text_en": "The Valencian Community has exceeded 100 deaths due to coronavirus for the third consecutive day, with 106 deaths in the last 24 hours.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Comunidad Valenciana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Valencian Community"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha superado los 100 fallecidos por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has exceeded 100 deaths per coronavirus"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por tercer día consecutivo, con 106 defunciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the third consecutive day, with 106 deaths"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las últimas 24 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last 24 hours"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El total de defunciones desde el inicio de la pandemia es de 5.796 personas: 677 en la provincia de Castellón, 2.156 en la de Alicante y 2.963 en la de Valencia.",
                "text_en": "The total number of deaths since the beginning of the pandemic is 5,796: 677 in the province of Castellón, 2,156 in Alicante and 2,963 in Valencia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El total de defunciones desde el inicio de la pandemia es de 5.796 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The total number of deaths since the beginning of the pandemic is 5,796"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde el inicio de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since the beginning of the pandemic"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la provincia de Castellón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the province of Castellón"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la de Alicante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Alicante"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la de Valencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Valencia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por otro lado, se han registrado 2.911 casos nuevos casos de coronavirus confirmados por prueba PCR o a través de test de antígenos desde la última actualización, lo que sitúa la cifra total de positivos en 358.444 personas.",
                "text_en": "On the other hand, 2,911 new cases of coronavirus confirmed by PCR or through antigen testing have been recorded since the last update, which puts the total number of positives at 358,444.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han registrado 2.911 casos nuevos casos de coronavirus confirmados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "2,911 confirmed new cases of coronavirus have been reported"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por prueba PCR o a través de test de antígenos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by PCR test or via antigen test"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde la última actualización",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since last update"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estas cifras confirman las palabras que el presidente de la Generalitat, Ximo Puig, ha dicho esta mañana en la sesión de control en las Cortes: que, aunque se está frenando la curva de la tercera ola en cuanto a contagios, \"la letalidad sigue siendo insoportable\".",
                "text_en": "These figures confirm the words that the president of the Generalitat, Ximo Puig, said this morning in the control session in the Cortes: that, although the curve of the third wave in terms of contagion is slowing down, \"lethality remains unbearable\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el presidente de la Generalitat, Ximo Puig",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the president of the Generalitat, Ximo Puig"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "esta mañana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this morning"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la sesión de control en las Cortes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the control session in the Courts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aunque se está frenando la curva de la tercera ola en cuanto a contagios, \"la letalidad sigue siendo insoportable",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Although the curve of the third wave is slowing down in terms of contagion, \"lethality remains unbearable."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Asimismo, desde la última actualización se han registrado 3.829 altas a pacientes con coronavirus.",
                "text_en": "Also, since the last update, 3,829 patients with coronavirus have been registered with discharges.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde la última actualización",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since last update"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han registrado 3.829 altas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "3,829 highs have been recorded"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a pacientes con coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to patients with coronavirus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De esta forma, ya son 322.092 personas en la Comunidad Valenciana las que han superado la enfermedad desde que comenzó la pandemia.",
                "text_en": "In this way, 322,092 people in the Valencian Community have overcome the disease since the beginning of the pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "322.092 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "322,092 persons"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Comunidad Valenciana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Valencian Community"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han superado la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have overcome the disease"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde que comenzó la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since the pandemic began"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por otra parte, la Comunidad Valenciana ha administrado un total de 210.530 dosis de la vacuna contra el coronavirus.",
                "text_en": "Moreover, the Valencian Community has administered a total of 210,530 doses of the coronavirus vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a Comunidad Valenciana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a Valencian Community"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha administrado un total de 210.530 dosis de la vacuna contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has administered a total of 210,530 doses of the coronavirus vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Han recibido las dos dosis de la vacuna 91.910 personas.",
                "text_en": "They have received both doses of the vaccine 91,910 people.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Han recibido las dos dosis de la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They've received both doses of the vaccine."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "91.910 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "91,910 persons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Finalmente, desde la última actualización se ha registrado algún caso positivo en 158 residencias de mayores (15 en la provincia de Castellón, 51 en la provincia de Alicante y 92 en la provincia de Valencia), 36 centros de diversidad funcional (3 en la provincia de Castellón, 11 en la provincia de Alicante y 22 en la provincia de Valencia) y 8 centros de menores (5 en la provincia de Alicante y 3 en la provincia de Valencia).",
                "text_en": "Finally, since the last update there have been some positive cases in 158 nursing homes (15 in the province of Castellón, 51 in the province of Alicante and 92 in the province of Valencia), 36 centres of functional diversity (3 in the province of Castellón, 11 in the province of Alicante and 22 in the province of Valencia) and 8 juvenile centres (5 in the province of Alicante and 3 in the province of Valencia).",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde la última actualización",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since last update"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha registrado algún caso positivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "some positive cases have been recorded"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en 158 residencias de mayores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in 158 nursing homes"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "36 centros de diversidad funcional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "36 functional diversity centres"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "8 centros de menores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "8 juvenile centres"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "52": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 12,
            "WhatReliabilityReliable": 3,
            "WhatReliabilityUnreliable": 9,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 3,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 7,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 2,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 6,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 1,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 1,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 4,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 5,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 10,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nSi tienes un paciente COVID y presenta dificultad para respirar, pon en práctica el drenaje postural.\n\n<BREAK>\n\nLos contagios por COVID-19 se están multiplicando día por día, esto a pesar de tener ya 10 meses de advertencias y recomendaciones por parte de las autoridades de los tres niveles de gobierno.\n\n<BREAK>\n\nLos hospitales están ya colapsando y es imposible brindar a cada paciente los cuidados necesarios, es por ello que muchas familias están optando por atender a sus familias desde casa.\n\n<BREAK>\n\nPero ahora conseguir tanques de oxígeno se está volviendo un gran problema, dado que el mercado no estaba preparado para enfrentar esta pandemia, en algunos establecimientos la demanda de tanques de oxígeno se ha vuelto una oportunidad para lucrar con el costo de este producto, en el mercado existen tanques que van desde los 4,500.00 hasta los 8,000 pesos en renta.\n\n<BREAK>\n\nPor ello en  caso de no poder conseguir oxígeno en hospitales o distribuidores comerciales, o simplemente la economía no te permite adquirirlo, no te asustes, en casa puedes poner en práctica las siguientes posiciones al paciente y de esta manera hacer un drenaje postural.\n\n<BREAK>\n\nEl drenaje postural “Es una forma para ayudar a tratar los problemas respiratorios debido a la inflamación y al exceso de mucosidad en las vías respiratorias de los pulmones”.\n\n<BREAK>\n\nEsta vieja técnica se ha desvanecido en el tiempo, desde que tenemos respiradores y otras máquinas.\n\n<BREAK>\n\nSi en casa tienes un familiar con los síntomas de COVID-19 y presenta dificultad para respirar, tenga en cuenta ésta técnica, no esperes a último momento.\n\n<BREAK>\n\nUn paciente con dificultad para respirar, es un paciente grave que requiere de atención inmediata.\n\n<BREAK>\n\nSi siente alguna dificultad para respirar o mucha mucosidad, inhale y exhale lentamente en esta posición, de 15 a 20 minutos, 3 veces al día o todo el tiempo que necesite.\n\n<BREAK>\n\nPero cuidado, no  lo haga con el estómago lleno, deje pasar algunas horas desde la último  ingesta de alimento.\n\n<BREAK>\n\nEsta práctica se realizó en  un hogar de ancianos en Vietnam (1.976) aplicaron está técnica, durante la epidemia de influenza. \n\n<BREAK>\n\nNingún anciano falleció, en comparación a otros asilos donde sí murieron un sinnúmero de pacientes.\n\n<BREAK>\n\nConoce  los síntomas o signos como: dificultad para respirar (dato de gravedad), fiebre (mayor a 38 grados), dolor de cabeza, tos, dolor de garganta, escurrimiento nasal, dolor de pecho, alteración del olfato o del sentido del gusto.\n\n<BREAK>\n\nRecuerda que para prevenir la transmisión, lavarse las manos de manera frecuente con agua y jabón o utilizar soluciones alcoholadas a 70%, usar cubreboca al salir de casa y mantener sana distancia entre personas (de 1.5 a dos metros).\n\n<BREAK>\n\nSi vives en el estado de Querétaro y presentas enfermedades respiratorias comunicarse al call center estatal 4421015205, para recibir orientación médica",
        "TITLE": "La importancia del drenaje postural en pacientes COVID-19",
        "ID": "15-Informativodequeretaro",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "La importancia del drenaje postural en pacientes COVID-19",
                "text_en": "The importance of postural drainage in patients COVID-19",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La importancia del drenaje postural",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The importance of postural drainage"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "pacientes COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients COVID-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si tienes un paciente COVID y presenta dificultad para respirar, pon en práctica el drenaje postural.",
                "text_en": "If you have a COVID patient and have difficulty breathing, practice postural drainage.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un paciente COVID",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "one patient COVID"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "presenta dificultad para respirar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you have difficulty breathing"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pon en práctica el drenaje postural",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "implement postural drainage"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los contagios por COVID-19 se están multiplicando día por día, esto a pesar de tener ya 10 meses de advertencias y recomendaciones por parte de las autoridades de los tres niveles de gobierno.",
                "text_en": "Contagions by COVID-19 are multiplying day by day, despite having already 10 months of warnings and recommendations by the authorities of the three levels of government.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los contagios por COVID-19 se están multiplicando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "COVID-19 contagions are multiplying"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "día por día",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "day by day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los hospitales están ya colapsando y es imposible brindar a cada paciente los cuidados necesarios, es por ello que muchas familias están optando por atender a sus familias desde casa.",
                "text_en": "Hospitals are already collapsing and it is impossible to provide each patient with the necessary care, which is why many families are choosing to care for their families from home.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Los hospitales están ya colapsando y es imposible brindar a cada paciente los cuidados necesarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Hospitals are already collapsing and it is impossible to provide each patient with the necessary care."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a cada paciente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to each patient"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchas familias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "many families"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están optando por atender a sus familias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "opting to care for their families"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "desde casa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from home"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por ello en  caso de no poder conseguir oxígeno en hospitales o distribuidores comerciales, o simplemente la economía no te permite adquirirlo, no te asustes, en casa puedes poner en práctica las siguientes posiciones al paciente y de esta manera hacer un drenaje postural.",
                "text_en": "Therefore in case you cannot get oxygen in hospitals or commercial distributors, or simply the economy does not allow you to acquire it, do not panic, at home you can put the following positions to the patient and in this way make a postural drainage.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en  caso de no poder conseguir oxígeno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in case of inability to obtain oxygen"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en casa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at home"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puedes poner en práctica las siguientes posiciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "you can implement the following positions"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al paciente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the patient"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El drenaje postural “Es una forma para ayudar a tratar los problemas respiratorios debido a la inflamación y al exceso de mucosidad en las vías respiratorias de los pulmones”.",
                "text_en": "Postural drainage “It is a way to help treat breathing problems due to inflammation and excess mucus in the airways of the lungs.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El drenaje postural “Es una forma para ayudar a tratar los problemas respiratorios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Postural Drainage “It’s a way to help treat breathing problems"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta vieja técnica se ha desvanecido en el tiempo, desde que tenemos respiradores y otras máquinas.",
                "text_en": "This old technique has vanished in time, since we have respirators and other machines.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta vieja técnica se ha desvanecido",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This old technique has vanished."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en el tiempo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in time"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "desde que tenemos respiradores y otras máquinas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since we have respirators and other machines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un paciente con dificultad para respirar, es un paciente grave que requiere de atención inmediata.",
                "text_en": "A patient with difficulty breathing is a severe patient who requires immediate attention.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Un paciente con dificultad para respirar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A patient with difficulty breathing"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es un paciente grave que requiere de atención inmediata",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is a severe patient requiring immediate attention"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si siente alguna dificultad para respirar o mucha mucosidad, inhale y exhale lentamente en esta posición, de 15 a 20 minutos, 3 veces al día o todo el tiempo que necesite.",
                "text_en": "If you experience any shortness of breath or a lot of mucus, breathe in and breathe out slowly in this position, 15 to 20 minutes, 3 times a day, or as long as you need.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Si siente alguna dificultad para respirar o mucha mucosidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "If you feel any shortness of breath or a lot of mucus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "inhale y exhale",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "inhale and exhale"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "lentamente en esta posición, de 15 a 20 minutos, 3 veces al día o todo el tiempo que necesite",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "slowly in this position, 15 to 20 minutes, 3 times a day or as long as you need"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta práctica se realizó en  un hogar de ancianos en Vietnam (1.976) aplicaron está técnica, durante la epidemia de influenza. ",
                "text_en": "This practice was carried out in a nursing home in Vietnam (1,976) applied this technique during the influenza epidemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta práctica se realizó",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This practice was carried out"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en  un hogar de ancianos en Vietnam",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in a nursing home in Vietnam"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante la epidemia de influenza",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "during the influenza epidemic"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ningún anciano falleció, en comparación a otros asilos donde sí murieron un sinnúmero de pacientes.",
                "text_en": "No elderly person died, compared to other homes where countless patients died.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ningún anciano",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "No old man"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "falleció",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He passed away."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Recuerda que para prevenir la transmisión, lavarse las manos de manera frecuente con agua y jabón o utilizar soluciones alcoholadas a 70%, usar cubreboca al salir de casa y mantener sana distancia entre personas (de 1.5 a dos metros).",
                "text_en": "Remember that to prevent transmission, wash your hands frequently with soap and water or use 70% alcohol solutions, use mouth cover when leaving home and keep healthy distance between people (1.5 to 2 meters).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "prevenir la transmisión",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "preventing transmission"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "lavarse las manos de manera frecuente con agua y jabón o utilizar soluciones alcoholadas a 70%, usar cubreboca al salir de casa y mantener sana distancia entre personas (de 1.5 a dos metros)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Wash your hands frequently with soap and water or use 70% alcohol solutions, use mouth cover when leaving home and maintain healthy distance between people (1.5 to 2 meters)"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al salir de casa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on leaving the house"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "53": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 18,
            "WhatReliabilityReliable": 13,
            "WhatReliabilityUnreliable": 5,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 19,
            "WhoReliabilityReliable": 14,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 13,
            "WhenReliabilityReliable": 10,
            "WhenReliabilityUnreliable": 3,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 8,
            "HowReliabilityReliable": 5,
            "HowReliabilityUnreliable": 3,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 4,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 3,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 18,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 3,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 13,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 17,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEn esos días y con dinero público, Irene Montero, la mujer de Pablo Iglesias, montaba carteles incitando a la gente a ir al aquelarre feminista en el que se contagio hasta la mujer de Sánchez\n\n<PARAGRAPH>\n\nY ahí sigue el ‘experto’ Fernando Simón, presentándose en las ruedas de prensa como si viniera de una noche de copas o de dormir en el coche y soltando sin ruborizarse nuevas predicciones.\n\n<BREAK>\n\nLa última, que llega el fin dela tercera ola de coronavirus.\n\n<PARAGRAPH>\n\nFue el 31 de enero de 2020 el controvertido director del Centro de Coordinación de Alertas y Emergencias Sanitarias dijo rotundo aquello de «España no tendrá, como mucho, más allá de algún caso diagnosticado».\n\n<PARAGRAPH>\n\nPasados 365 días de la metida de pata más espeluznante que se recuerda, en España hay más de 2,5 millones de contagios y suma la friolera de más de 80.000 muertos.\n\n<PARAGRAPH>\n\nTodas las comunidades autónomas están en alerta extrema excepto Galicia, Asturias, Cantabria y Navarra, en riesgo alto, y Canarias, en riesgo medio.\n\n<BREAK>\n\n\n\n<PARAGRAPH>\n\nNavarra y Andalucía han elevado su nivel de riesgo la última semana, según el último informe para el seguimiento de la pandemia publicado por el Ministerio de Sanidad, con datos hasta el 25 de enero.\n\n<PARAGRAPH>\n\nNo se puede pasar por alto que el mismo día en que Simón aseguraba que aquí no iba a pasar nada, la Organización Mundial de la Salud decretaba una «emergencia de salud pública de importancia internacional» en torno al coronavirus\n\n<PARAGRAPH>\n\nEl Gobierno PSOE-Podemos seguía insistiendo irresponsable en que no veía peligro alguno para la población, mientras grandes multinacionales se borraban del Mobile World Congress de Barcelona y obligaban a suspender el evento.\n\n<PARAGRAPH>\n\nY en las semanas posteriores, mientras otros países decretaban la alerta y procedían a suspender eventos masivos por recomendación de sus epidemiólogos, el propio Simón se pronunciaba a favor de mantener las marchas masivas del 8 de marzo, el Día de la Mujer.\n\n<PARAGRAPH>\n\n«Si mi hijo me pregunta si puede ir (al 8-M) le diré que haga lo que quiera».\n\n<PARAGRAPH>\n\nPues a día de hoy, un año después de una conducta que en el caso de Simón podría atribuirse a la mezcla de ignoracia y sumisión política, y que por lo que respecta al socialista Pedro Sánchez y sus ministros tiene tientes casi criminales, cerramos el primer mes de 2021 con la peor cifra de positivos jamás registrada desde que el Ministerio de Sanidad empezó a contar los datos de la epidemia.\n\n<PARAGRAPH>\n\nEn total, son 815.394 nuevos positivos, cifra que podría aumentar según se vaya consolidando la serie que publica el Instituto de Salud Carlos III (Isciii).\n\n<PARAGRAPH>\n\nLos más de 800.000 contagios incorporados este mes suponen casi un 30% de 2,74 millones que el ministerio que dirige Carolina Darias ha diagnosticado hasta la fecha.\n\n<PARAGRAPH>\n\nEl enero que termina este fin de semana, es el cuarto mes con más defuncion en  lo que llevamos de pandemia.\n\n<PARAGRAPH>\n\nEnero de 2021 comenzó con 11.500 ingresados por coronavirus en los hospitales españoles y unas 2.000 en las UCI.\n\n<BREAK>\n\n29 días más tarde, ya hay 30.800 pacientes con Covid en planta y otros 4.700 en cuidados intensivos.\n\n<PARAGRAPH>\n\nAdemás, el año empezó con una ocupación de las camas de hospital por pacientes con Covid por debajo del 10% y unas UCI al 21%.\n\n<PARAGRAPH>\n\nAhora están al 24% y al 44% respectivamente.\n\n<PARAGRAPH>\n\nMatías Prats somete a Fernando Simón a un escarnio público con el vídeo de sus meteduras de pata – Periodista Digital https://t.co/ALW3Ji077U\n\n<PARAGRAPH>\n\n— Alfonso Rojo López (@AlfonsoRojoPD) January 24, 2021\n\n<PARAGRAPH>\n",
        "TITLE": "Este domingo se cumple un año de que Simón vaticinase: «España no va a tener, como mucho, algún caso»",
        "ID": "NF_04-11-2021_20-45-48_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Este domingo se cumple un año de que Simón vaticinase: «España no va a tener, como mucho, algún caso»",
                "text_en": "This Sunday marks a year since Simon predicted: «Spain will not have, at best, some case»",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Este domingo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This Sunday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se cumple un año de que Simón vaticinase",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a year has passed since Simon predicted"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Simon"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En esos días y con dinero público, Irene Montero, la mujer de Pablo Iglesias, montaba carteles incitando a la gente a ir al aquelarre feminista en el que se contagio hasta la mujer de Sánchez",
                "text_en": "In those days and with public money, Irene Montero, Pablo Iglesias' wife, mounted posters inciting people to go to the feminist coven in which even Sanchez's woman is infected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En esos días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "In those days"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con dinero público",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with public money"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Irene Montero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Irene Montero"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "montaba carteles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "I was putting up posters."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "incitando a la gente a ir",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Instigating people to go"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al aquelarre feminista",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the feminist coven"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y ahí sigue el ‘experto’ Fernando Simón, presentándose en las ruedas de prensa como si viniera de una noche de copas o de dormir en el coche y soltando sin ruborizarse nuevas predicciones.",
                "text_en": "And there goes the ‘expert’ Fernando Simón, presenting himself at the press conferences as if he came from a night of drinks or sleeping in the car and releasing without blushing new predictions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el ‘experto’ Fernando Simón",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the ‘expert’ Fernando Simón"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "presentándose",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Presenting"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las ruedas de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at press conferences"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "como si viniera de una noche de copas o de dormir en el coche y soltando sin ruborizarse nuevas predicciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "as if it came from a night of drinks or sleeping in the car and letting go without blushing new predictions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Fue el 31 de enero de 2020 el controvertido director del Centro de Coordinación de Alertas y Emergencias Sanitarias dijo rotundo aquello de «España no tendrá, como mucho, más allá de algún caso diagnosticado».",
                "text_en": "He was on January 31, 2020 the controversial director of the Center for the Coordination of Health Alerts and Emergencies said emphatically that \"Spain will not have, at most, beyond any case diagnosed\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 31 de enero de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 31 January 2020"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el controvertido director",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the controversial director"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Centro de Coordinación de Alertas y Emergencias Sanitarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health Alert and Emergency Coordination Centre"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dijo rotundo aquello de «España no tendrá, como mucho, más allá de algún caso diagnosticado»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "said emphatically that \"Spain will not have, at most, beyond some case diagnosed\""
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pasados 365 días de la metida de pata más espeluznante que se recuerda, en España hay más de 2,5 millones de contagios y suma la friolera de más de 80.000 muertos.",
                "text_en": "After 365 days of the scariest mess that is remembered, in Spain there are more than 2.5 million contagions and it adds the coldness of more than 80,000 dead.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Pasados 365 días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "After 365 days"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay más de 2,5 millones de contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there are more than 2.5 million contagions"
                    }
                ],
                "evidences": [
                    {
                        "value": "Following the statement of the Health World Organization declaring coronavirus disease 2019 (COVID-19) a pandemic [1] , the rapidly increasing number of contagions and foreseeable saturation of the public and private health service intensive care units in Spain prompted the declaration of a nationwide State of Alarm on March 13, 2020, and a lockdown of all non-essential sectors was imposed on March 14, 2020. On April 28, 2020, the government announced a plan for easing lockdown restrictions consisting of four de-escalation phases to which different regions of Spain could progressively transition according to health indicators such as number of cases and capacity of the healthcare system. The State of Alarm ended on June 21, 2020. At the time of writing (August 13, 2020), the accumulated number of COVID-19 contagions in Spain is of 329.784, with a total death toll of 28.579 [2] , and new restrictions are being imposed or considered to curtail new local outbreaks of the disease.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9993446469
                    }
                ]
            },
            {
                "text": "Todas las comunidades autónomas están en alerta extrema excepto Galicia, Asturias, Cantabria y Navarra, en riesgo alto, y Canarias, en riesgo medio.",
                "text_en": "All the autonomous communities are on extreme alert except Galicia, Asturias, Cantabria and Navarre, at high risk, and the Canary Islands, at medium risk.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Todas las comunidades autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "All Autonomous Communities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están en alerta extrema",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're on extreme alert."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Galicia, Asturias, Cantabria y Navarra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Galicia, Asturias, Cantabria and Navarra"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en riesgo alto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at high risk"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Canarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Canary Islands"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en riesgo medio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at medium risk"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Navarra y Andalucía han elevado su nivel de riesgo la última semana, según el último informe para el seguimiento de la pandemia publicado por el Ministerio de Sanidad, con datos hasta el 25 de enero.",
                "text_en": "Navarra and Andalusia have raised their risk level last week, according to the latest report for the follow-up of the pandemic published by the Ministry of Health, with data until January 25.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Navarra y Andalucía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Navarre and Andalusia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han elevado su nivel de riesgo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have increased their level of risk"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "la última semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last week"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 25 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 25 January"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No se puede pasar por alto que el mismo día en que Simón aseguraba que aquí no iba a pasar nada, la Organización Mundial de la Salud decretaba una «emergencia de salud pública de importancia internacional» en torno al coronavirus",
                "text_en": "It cannot be overlooked that on the very day Simon claimed that nothing was going to happen here, the World Health Organization decreed a \"public health emergency of international importance\" around the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el mismo día",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on the same day"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "aquí",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Here."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Organización Mundial de la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the World Health Organization"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "decretaba una «emergencia de salud pública de importancia internacional»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "decreed a “public health emergency of international importance”"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "en torno al coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "around the coronavirus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Gobierno PSOE-Podemos seguía insistiendo irresponsable en que no veía peligro alguno para la población, mientras grandes multinacionales se borraban del Mobile World Congress de Barcelona y obligaban a suspender el evento.",
                "text_en": "The PSOE-Podemos government continued to insist irresponsiblely that it saw no danger to the population, while large multinationals were erasing themselves from the Barcelona Mobile World Congress and forcing the event to be suspended.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno PSOE-Podemos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The PSOE-We Can Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "seguía insistiendo irresponsable en que no veía peligro alguno",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I kept insisting irresponsible that I saw no danger at all."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y en las semanas posteriores, mientras otros países decretaban la alerta y procedían a suspender eventos masivos por recomendación de sus epidemiólogos, el propio Simón se pronunciaba a favor de mantener las marchas masivas del 8 de marzo, el Día de la Mujer.",
                "text_en": "And in the weeks that followed, while other countries decreed the alert and proceeded to suspend mass events on the recommendation of their epidemiologists, Simon himself was in favour of maintaining the March 8 mass marches, Women's Day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las semanas posteriores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in subsequent weeks"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "otros países",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "other countries"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "decretaban la alerta y procedían a suspender eventos masivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "decreed the alert and proceeded to suspend mass events"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por recomendación de sus epidemiólogos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on the recommendation of their epidemiologists"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el propio Simón",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Simon himself"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se pronunciaba a favor de mantener las marchas masivas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was in favour of maintaining the mass marches"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "8 de marzo, el Día de la Mujer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "8 March, Women's Day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Si mi hijo me pregunta si puede ir (al 8-M) le diré que haga lo que quiera».",
                "text_en": "«If my son asks me if he can go (to 8-M) I will tell him to do what he wants».",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mi hijo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "My son"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "(al 8-M)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "(at 8-M)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "le diré que haga lo que quiera",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I'll tell him to do whatever he wants."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pues a día de hoy, un año después de una conducta que en el caso de Simón podría atribuirse a la mezcla de ignoracia y sumisión política, y que por lo que respecta al socialista Pedro Sánchez y sus ministros tiene tientes casi criminales, cerramos el primer mes de 2021 con la peor cifra de positivos jamás registrada desde que el Ministerio de Sanidad empezó a contar los datos de la epidemia.",
                "text_en": "For today, a year after a conduct that in the case of Simon could be attributed to the mixture of ignorance and political submission, and that with regard to the socialist Pedro Sanchez and his ministers has almost criminal tempts, we closed the first month of 2021 with the worst number of positives ever recorded since the Ministry of Health began to count the data of the epidemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "una conducta que en el caso de Simón podría atribuirse",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a conduct that could be attributed to Simon"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Simon"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a la mezcla de ignoracia y sumisión política",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the mixture of ignorance and political submission"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al socialista Pedro Sánchez y sus ministros",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the socialist Pedro Sánchez and his ministers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cerramos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We're closed."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el primer mes de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the first month of 2021"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la peor cifra de positivos jamás registrada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with the worst number of positives ever recorded"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En total, son 815.394 nuevos positivos, cifra que podría aumentar según se vaya consolidando la serie que publica el Instituto de Salud Carlos III (Isciii).",
                "text_en": "In total, there are 815,394 new positives, which could increase as the series published by the Carlos III Health Institute (Isciii) consolidates.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "son 815.394 nuevos positivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "815,394 new positives"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Instituto de Salud Carlos III (Isciii)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Carlos III Health Institute (Isciii)"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El enero que termina este fin de semana, es el cuarto mes con más defuncion en  lo que llevamos de pandemia.",
                "text_en": "The January that ends this weekend, is the fourth month with the most death in what we carry from pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El enero que termina este fin de semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "January that ends this weekend"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es el cuarto mes con más defuncion",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It's the fourth month with the most death."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Enero de 2021 comenzó con 11.500 ingresados por coronavirus en los hospitales españoles y unas 2.000 en las UCI.",
                "text_en": "January 2021 began with 11,500 admitted by coronavirus in Spanish hospitals and about 2,000 in the ICU.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Enero de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "January 2021"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "comenzó con 11.500 ingresados por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "started with 11,500 admitted by coronavirus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los hospitales españoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Spanish hospitals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, el año empezó con una ocupación de las camas de hospital por pacientes con Covid por debajo del 10% y unas UCI al 21%.",
                "text_en": "In addition, the year began with an occupation of hospital beds by patients with Covid below 10% and about 21% ICU.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el año empezó con una ocupación de las camas de hospita",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the year began with an occupation of hospital beds"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "pacientes con Covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Covid patients"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por debajo del 10% y unas UCI al 21%.",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "below 10% and about 21% ICU."
                    }
                ],
                "evidences": [
                    {
                        "value": "We also collected information on the number of hospital beds in Wuhan. There were two designated hospitals with about 800 beds for COVID-19 patients before 23 January 2020, when hospital beds were gradually being expropriated for COVID-19 patients. The number of designated hospital beds from 31 January to 25 February (orange bars in Figure 1d ) and the number of hospital beds in Huoshenshan and Leishenshan hospitals (blue bars in Figure 1d ) were collected from the Wuhan Municipal Health Commission [25] , the number of Fangcang shelter hospital beds from 5 to 25 February (green bars in Figure 1d , note that Fangcang shelter hospitals were implemented for the first time on 5 February) were extracted from the reference [6] . Subsequently, we assumed that the number of hospital beds H c (t) is a constant H c 0 before 23 January, and it is an increasing function that satisfies the following logistic model (1) from then on. In model (1), r is the net increasing rate of hospital beds and M is the maximum number of hospital beds in Wuhan during the COVID-19 outbreak. Figure 1d shows the estimated number of hospital beds every day.",
                        "score": 0.5400000215
                    },
                    {
                        "value": "Of the 34 COVID-19 patients included in this study, 5 were admitted to the intensive care unit (ICU). Focusing on the total number of monocytes and the percentage of FSC-low and FSC-high, we observed a noticeable difference from the non-ICU patients. As shown in Fig. 6C,   3 representative ICU patients have lower number of total monocytes; of these, the FSC-high subsets are the majority. Moreover, the average length of hospital stay of the 5 ICU patients is 40.60 ± 7.89, significantly longer than the average 15.68 ± 2.67 days of the non-ICU patients (P < 0.0001).",
                        "score": 0.6399999857
                    },
                    {
                        "value": "The validation data set included 64 retrospective patients. These patients are independent of the development cohort. Majority of the patient's age ranges from 41 to 70 years old and about 4 out of 5 patients were male. In this cohort, the percentage of Omani national was 42% (n=27) and the percentage of ICU admission among laboratory-confirmed COVID-19 cases was 70% (n=45).",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9798179865
                    },
                    {
                        "label": "neutral",
                        "score": 0.9974415302
                    },
                    {
                        "label": "neutral",
                        "score": 0.9972579479
                    }
                ]
            },
            {
                "text": "Ahora están al 24% y al 44% respectivamente.",
                "text_en": "They are now 24 per cent and 44 per cent respectively.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Ahora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Now"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "al 24% y al 44% respectivamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "24 per cent and 44 per cent respectively"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "54": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 1,
            "What": 18,
            "WhatReliabilityReliable": 10,
            "WhatReliabilityUnreliable": 8,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 0,
            "Who": 18,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 9,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 3,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 6,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 3,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 17,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nInicialmente los nuevos medicamentos y vacunas se introducen en los países del Tercer Mundo en los que los que no hay un control eficaz de la seguridad de los fármacos.\n\n<BREAK>\n\nSi hay algún efecto adverso importante, importa menos que las consecuencias recaigan sobre los pobres y los explotados de este mundo.\n\n<PARAGRAPH>\n\nPara las multinacionales que los diseñan es importante analizar la información sobre los nuevos fármacos que se han obtenido en esos países donde los sistemas sanitarios carecen de las herramientas, la formación y la capacidad necesarias para controlar la seguridad.\n\n<PARAGRAPH>\n\nAunque se ha avanzado mucho y muchos países del Tercer Mundo son ahora miembros del Programa Internacional de Vigilancia de Medicamentos de la Organización Mundial de la Salud, la experiencia en la evaluación de los datos de reacciones adversas, así como en la planificación de la gestión de riesgos, es limitada.\n\n<PARAGRAPH>\n\nSin un control eficaz, los programas de salud pública corren peligro en los países más desarrollados y los pacientes ricos pueden verse afectados si sufren reacciones adversas a unos medicamentos mal diseñados y probados.\n\n<BREAK>\n\nPueden socavar el programa y conducir a un descenso de la confianza en los fármacos y vacunas.\n\n<PARAGRAPH>\n\nPor ello la OMS y la Fundación Gates han puesto en marcha el Proyecto de Vigilancia Inteligente de la Seguridad, también conocido como Proyecto Triple S, para mejorar el control de los experimentos farmacológicos en los países del Tercer Mundo.\n\n<PARAGRAPH>\n\nSe trata de un plan de tres años de duración, durante los cuales está previsto realizar tres ejercicios piloto en diferentes países del Tercer Mundo para evaluar adecuadamente los riesgos asociados a los nuevos fármacos y vacunas.\n\n<PARAGRAPH>\n\nLa MHRA, el instituto británico que autoriza los medicamentos y mercancías sanitarias del Reino Unido, se ha unido a la iniciativa para aportar su experiencia.\n\n<BREAK>\n\nEl doctor Ian Hudson, director ejecutivo de la MHRA, ha declarado: “Estamos encantados de participar en una iniciativa mundial tan importante.\n\n<BREAK>\n\nLos nuevos medicamentos y vacunas se comercializan por primera vez en el marco de programas de salud pública, en contextos en los que es necesario reforzar los sistemas de control de la seguridad y de regulación.\n\n<BREAK>\n\nLa experiencia que podemos aportar al proyecto ayudará a los centros nacionales de control de la seguridad a identificar rápidamente los riesgos y los beneficios y a tomar las medidas reglamentarias adecuadas para apoyar la salud mundial”.\n\n<PARAGRAPH>\n\nEl doctor Dan Hartman, de la Fundación Gates, añadió: “El Proyecto Triple S es de vital importancia para el éxito de los programas de salud pública destinados a combatir algunas de las principales enfermedades del mundo.\n\n<BREAK>\n\nCuando se utiliza un nuevo fármaco o vacuna, es esencial que los riesgos potenciales se identifiquen pronto y se comprendan.\n\n<BREAK>\n\nLa participación del MHRA en este proyecto contribuirá a desarrollar los conocimientos científicos y normativos de los centros nacionales”.\n\n<PARAGRAPH>\n\nLa OMS, la Fundación Gates y la MHRA, es decir, lo público y lo privado aparecen estrechamente imbricados en el mercado de la salud.\n\n<BREAK>\n\nLa Fundación Gates posee un importante paquete de acciones de la multinacional farmacéutica Pfizer, y la OMS y la MHRA son quienes tienen que autorizarlos.\n\n<PARAGRAPH>\n\nEsa unidad no sólo se produce a escala empresarial, sino también personal: los “expertos” pasan de la empresa privada a la OMS o a la MHRA sin solución de continuidad, y a la inversa.\n\n<BREAK>\n\nTodo queda en familia.\n\n<BREAK>\n\nSon los mismos perros con diferentes collares.\n\n<BREAK>\n\nNo tienen que romperse la cabeza para promover un mismo mensaje.\n\n<PARAGRAPH>\n",
        "TITLE": "Los ‘expertos’ pasan de las empresas farmacéuticas a la OMS y a las instituciones públicas, y a la inversa",
        "ID": "NF_NF_1198_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Los ‘expertos’ pasan de las empresas farmacéuticas a la OMS y a las instituciones públicas, y a la inversa",
                "text_en": "‘Experts’ move from pharmaceutical companies to WHO and public institutions, and vice versa",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los ‘expertos’",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The ‘experts’"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pasan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Come on in."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las empresas farmacéuticas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pharmaceutical companies"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to WHO"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las instituciones públicas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to public institutions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Inicialmente los nuevos medicamentos y vacunas se introducen en los países del Tercer Mundo en los que los que no hay un control eficaz de la seguridad de los fármacos.",
                "text_en": "Initially new medicines and vaccines are introduced in Third World countries where there is no effective control of drug safety.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Inicialmente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Initially"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los nuevos medicamentos y vacunas se introducen",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "new medicines and vaccines are introduced"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los países del Tercer Mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "countries of the Third World"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "no hay un control eficaz de la seguridad de los fármacos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "there is no effective control of drug safety"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si hay algún efecto adverso importante, importa menos que las consecuencias recaigan sobre los pobres y los explotados de este mundo.",
                "text_en": "If there are any significant adverse effects, it matters less that the consequences fall on the poor and exploited of this world.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Si hay algún efecto adverso importante",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "If there are any significant side effects"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "importa menos que las consecuencias recaigan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "matters less that the consequences fall"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los pobres y los explotados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the poor and exploited"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "este mundo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this world"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para las multinacionales que los diseñan es importante analizar la información sobre los nuevos fármacos que se han obtenido en esos países donde los sistemas sanitarios carecen de las herramientas, la formación y la capacidad necesarias para controlar la seguridad.",
                "text_en": "For multinationals who design them, it is important to analyse information on new drugs that have been obtained in those countries where health systems lack the tools, training and capacity to control safety.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las multinacionales que los diseñan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "multinationals that design them"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es importante analizar la información sobre los nuevos fármacos que se han obtenido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it is important to analyze the information about new drugs that have been obtained"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en esos países",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in those countries"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "los sistemas sanitarios carecen de las herramientas, la formación y la capacidad necesarias para controlar la seguridad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "health systems lack the tools, training and capacity to control safety"
                    }
                ],
                "evidences": [
                    {
                        "value": "All across the world, information technology is entering healthcare systems to illuminate issues that were only vaguely understood. Today though, a major problem arises when American multinationals swoop down on new foreign markets with suggested national policy changes to entrench their own interests (Human Development Network, 1993) . Thus, the paramount issue becomes who owns and controls the chosen analytics, for specifically questioning institutions that facilitate the influence of multinational health corporations present on new markets after privatization schemes gets encouraged to various governments.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9908837676
                    }
                ]
            },
            {
                "text": "Aunque se ha avanzado mucho y muchos países del Tercer Mundo son ahora miembros del Programa Internacional de Vigilancia de Medicamentos de la Organización Mundial de la Salud, la experiencia en la evaluación de los datos de reacciones adversas, así como en la planificación de la gestión de riesgos, es limitada.",
                "text_en": "Although much progress has been made and many Third World countries are now members of the International Drug Monitoring Programme of the World Health Organization, experience in assessing adverse reaction data, as well as in risk management planning, is limited.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchos países del Tercer Mundo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "many Third World countries"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "son ahora miembros del Programa Internacional de Vigilancia de Medicamentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are now members of the International Drug Monitoring Programme"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Organización Mundial de la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the World Health Organization"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sin un control eficaz, los programas de salud pública corren peligro en los países más desarrollados y los pacientes ricos pueden verse afectados si sufren reacciones adversas a unos medicamentos mal diseñados y probados.",
                "text_en": "Without effective control, public health programmes are at risk in the more developed countries and rich patients may be affected if they experience adverse reactions to poorly designed and tested medicines.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Sin un control eficaz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Without effective control"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los programas de salud pública corren peligro",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Public health programmes are at risk"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los países más desarrollados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the most developed countries"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los pacientes ricos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "rich patients"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "si sufren reacciones adversas a unos medicamentos mal diseñados y probados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "if you suffer from adverse reactions to poorly designed and tested medicines"
                    }
                ],
                "evidences": [
                    {
                        "value": "Similarly, public health programmes can hinder a community's health autonomy when, for example, they organise networks of community health workers to tackle health problems, say, common diarrhoeas or fevers, that the community effectively resolves without them. Africa is rife with such examples.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9988225102
                    }
                ]
            },
            {
                "text": "Pueden socavar el programa y conducir a un descenso de la confianza en los fármacos y vacunas.",
                "text_en": "They can undermine the program and lead to a decline in confidence in drugs and vaccines.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Pueden socavar el programa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They can undermine the programme"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "conducir a un descenso de la confianza en los fármacos y vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "lead to a decline in confidence in drugs and vaccines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por ello la OMS y la Fundación Gates han puesto en marcha el Proyecto de Vigilancia Inteligente de la Seguridad, también conocido como Proyecto Triple S, para mejorar el control de los experimentos farmacológicos en los países del Tercer Mundo.",
                "text_en": "That is why WHO and the Gates Foundation have launched the Intelligent Security Surveillance Project, also known as the Triple S Project, to improve the control of pharmacological experiments in Third World countries.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS y la Fundación Gates",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO and the Gates Foundation"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han puesto en marcha el Proyecto de Vigilancia Inteligente de la Seguridad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "launched the Intelligent Security Surveillance Project"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se trata de un plan de tres años de duración, durante los cuales está previsto realizar tres ejercicios piloto en diferentes países del Tercer Mundo para evaluar adecuadamente los riesgos asociados a los nuevos fármacos y vacunas.",
                "text_en": "This is a three-year plan, during which three pilot exercises are planned in different Third World countries to properly assess the risks associated with new drugs and vaccines.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "realizar tres ejercicios piloto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "carry out three pilot exercises"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en diferentes países del Tercer Mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in different Third World countries"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "evaluar adecuadamente los riesgos asociados a los nuevos fármacos y vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "adequately assess the risks associated with new drugs and vaccines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La MHRA, el instituto británico que autoriza los medicamentos y mercancías sanitarias del Reino Unido, se ha unido a la iniciativa para aportar su experiencia.",
                "text_en": "The MHRA, the British institute for authorizing medicines and health goods in the United Kingdom, has joined the initiative to contribute its expertise.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La MHRA, el instituto británico que autoriza los medicamentos y mercancías sanitarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "MHRA, the British Institute for the Authorization of Medicinal Products and Health Goods"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha unido a la iniciativa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has joined the initiative"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El doctor Ian Hudson, director ejecutivo de la MHRA, ha declarado: “Estamos encantados de participar en una iniciativa mundial tan importante.",
                "text_en": "Dr. Ian Hudson, executive director of MHRA, said: “We are delighted to participate in such an important global initiative.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El doctor Ian Hudson, director ejecutivo de la MHRA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Ian Hudson, MHRA Executive Director"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "“Estamos encantados de participar en una iniciativa mundial tan importante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "“We are delighted to participate in such an important global initiative"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los nuevos medicamentos y vacunas se comercializan por primera vez en el marco de programas de salud pública, en contextos en los que es necesario reforzar los sistemas de control de la seguridad y de regulación.",
                "text_en": "New medicines and vaccines are marketed for the first time in the framework of public health programmes, in contexts where there is a need to strengthen safety control and regulatory systems.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los nuevos medicamentos y vacunas se comercializan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "New medicines and vaccines are marketed"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por primera vez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the first time"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el marco de programas de salud pública",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "within the framework of public health programmes"
                    }
                ],
                "evidences": [
                    {
                        "value": "Discourse regarding vaccines in both the UK and US can be seen to have started to rise between 4th -10th December 2020, as different vaccines were certified for public use, and public health programmes got underway. From 14th February to 25th March 2021, there was increased discussion in both countries about the efficacy, safety and supply of different vaccines, as public health programmes rolled out vaccines. However, big peaks occurred between 25th March -1st April and 2nd -8th April, where there was increased discussion about the prospect of vaccine passports being made mandatory for global travel and large events (de Figueiredo, Larson and Reicher, 2021; Osama, Razai and Majeed, 2021). Overall, social media sentiment in terms of anti-mask and anti-vaccine attitudes across both countries was similar, with the UK being slightly more negative towards masks (28% compared to the US at 22% negative), and both having similar rates of negative sentiment towards vaccines with the US at 17% and the UK at 15% (Figure 3 , and Appendix b). ",
                        "score": 0.5500000119
                    },
                    {
                        "value": "Previously, we reported the efficacy of the simian adenoviral vectored vaccine ChAdOx1 nCoV-19 (AZD1222) in randomised controlled trials in Brazil and the UK, 3 in analyses done before the spread of the B.1.1.7 variant across the UK. In this study, we provide both an invitro analysis of vaccine-induced neutralising antibody responses against B.1.1.7 and an analysis of the clinical efficacy of ChAdOx1 nCoV-19 against disease caused by the B.1.1.7 variant of concern, using data from the UK. As novel variants are identified, new targeted vaccines might be needed in future public health programmes as booster doses. We also present data on the immune response to ChAdOx1 nCoV-19 in people who previously received other ChAdOx1-vectored vaccines.",
                        "score": 0.5
                    },
                    {
                        "value": "At the national level, the implementation and enforcement of the Bangladesh Government's National Drug Policy must be strengthened [23, 24, 26, 27] . The World Health Organization acknowledges the need to increase awareness and knowledge about antibiotic medicines and ABR more broadly in society. Specifically this means developing surveillance and research, enhancing infection control, optimizing the use of antimicrobials in human and animal health, and building sustainable investment in new medicines, diagnostic tools, and vaccines [51] .",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9642952681
                    },
                    {
                        "label": "neutral",
                        "score": 0.9995747209
                    },
                    {
                        "label": "neutral",
                        "score": 0.975640893
                    }
                ]
            },
            {
                "text": "El doctor Dan Hartman, de la Fundación Gates, añadió: “El Proyecto Triple S es de vital importancia para el éxito de los programas de salud pública destinados a combatir algunas de las principales enfermedades del mundo.",
                "text_en": "Dr. Dan Hartman of the Gates Foundation added: “The Triple S Project is of vital importance to the success of public health programs aimed at combating some of the world’s major diseases.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El doctor Dan Hartman, de la Fundación Gates",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Dan Hartman, Gates Foundation."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cuando se utiliza un nuevo fármaco o vacuna, es esencial que los riesgos potenciales se identifiquen pronto y se comprendan.",
                "text_en": "When a new drug or vaccine is used, it is essential that potential risks be identified soon and understood.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Cuando se utiliza un nuevo fármaco o vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "When a new drug or vaccine is used"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es esencial que los riesgos potenciales se identifiquen pronto y se comprendan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it is essential that potential risks be identified soon and understood"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La participación del MHRA en este proyecto contribuirá a desarrollar los conocimientos científicos y normativos de los centros nacionales”.",
                "text_en": "The participation of MHRA in this project will contribute to the development of the scientific and regulatory knowledge of the national centres.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La participación del MHRA en este proyecto contribuirá a desarrollar los conocimientos científicos y normativos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "MHRA's participation in this project will contribute to the development of scientific and regulatory knowledge"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "los centros nacionales”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "national centres”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La OMS, la Fundación Gates y la MHRA, es decir, lo público y lo privado aparecen estrechamente imbricados en el mercado de la salud.",
                "text_en": "WHO, the Gates Foundation and MHRA, that is, the public and private, are closely embedded in the health market.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La OMS, la Fundación Gates y la MHRA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO, Gates Foundation and MHRA"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "lo público y lo privado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "public and private"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aparecen estrechamente imbricados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are closely imbued"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el mercado de la salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the health market"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esa unidad no sólo se produce a escala empresarial, sino también personal: los “expertos” pasan de la empresa privada a la OMS o a la MHRA sin solución de continuidad, y a la inversa.",
                "text_en": "This unit is produced not only on a business scale, but also on a personal level: “experts” move from private enterprise to WHO or to MHRA without a solution of continuity, and vice versa.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los “expertos”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "“experts”"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pasan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Come on in."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la empresa privada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "private enterprise"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS o a la MHRA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO or MHRA"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin solución de continuidad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "no solution of continuity"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Son los mismos perros con diferentes collares.",
                "text_en": "They're the same dogs with different necklaces.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "on los mismos perros con diferentes collares",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on the same dogs with different necklaces"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No tienen que romperse la cabeza para promover un mismo mensaje.",
                "text_en": "You don't have to break your head to promote the same message.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No tienen que romperse la cabeza para promover un mismo mensaje",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "You don't have to break your head to promote the same message"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "55": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 12,
            "WhatReliabilityReliable": 8,
            "WhatReliabilityUnreliable": 4,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 5,
            "Who": 14,
            "WhoReliabilityReliable": 14,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 1,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 3,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 3,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 6,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLas cosas siguen sin estar claras con la vacuna de AstraZeneca para casi todo el mundo, excepto para el gobierno presidido por Pedro Sánchez al que parece darle igual las sospechas y los efectos secundarios que está provocando la inoculación de la misma.\n\n<PARAGRAPH>\n\nHoy mismo, el gobierno autonómico de Castilla y León, presidido por el servil Alfonso Fernández Mañueco, ha decidido suspender de forma inesperada la administración de esta vacuna por precaución.\n\n<BREAK>\n\nEn un comunicado de la Consejería de Sanidad de la Junta de Castilla y León se indica que “en aplicación del principio de precaución que ha de regir la gestión de alarmas y riesgos en cualquier medicamento”.\n\n<PARAGRAPH>\n\nAdemás, la consejería ha indicado que “la medida cautelar se adopta a la espera de conocer el informe de seguridad que se prevé que elaboré el Comité de Evaluación de Riesgos de Farmacovigilancia de la Agencia Europea del Medicamento (EMA), que se reúne hoy y de las decisiones que, en relación con este tema, puedan adoptarse próximamente por órganos ejecutivos de la Unión Europea y del Sistema Nacional de Salud”.\n\n<PARAGRAPH>\n\nHa sido esta misma mañana cuando se ha comunicado mientras eran varias las personas que esperaban en hospitales y centros de salud para ser vacunados.\n\n<BREAK>\n\nA través de magafonía y sin dar más explicaciones se ha dicho que “se suspende la vacunación hasta nueva orden”.\n\n<PARAGRAPH>\n\nEsta noticia ha pillado a la vicepresidente del gobierno, Carmen Calvo, en Extremadura y cuando ha sido preguntada sobre el asunto ha afirmado: “Las decisiones de qué vacunas, con qué criterios sanitarios, en qué tramos y con qué calendario corresponde al Consejo Interterritorial de Sanidad”, visiblemente molesta, Calvo ha añadido que considera esta suspensión un intento de “confrontación política” por parte de la Junta.\n\n<PARAGRAPH>\n\nCalvo añadía que “hay quién cree que puede tomar decisiones con criterios sanitarios o técnicos.\n\n<BREAK>\n\nEsas decisiones están tomadas.\n\n<BREAK>\n\nNo le corresponde a ninguna comunidad”.\n\n<PARAGRAPH>\n\nFíjense, con lo servil que es el gobierno de Fernández Mañueco, un impostor y una marioneta de Ciudadanos en Castilla y León, para una vez que se atreve a llevar la contraria al gobierno, llegan estos y dicen que busca “confrontación política”.\n\n<BREAK>\n\nPero señores del gobierno, si Mañueco es un perrito faldero que no se atreve ni a rechistar, no se enojen con él porque le tienen a su entero servicio.\n\n<PARAGRAPH>\n\nMientras nos siguen hablando exclusivamente de AstraZeneca, nosotros nos preguntamos por los destrozos que estarán causando el resto de vacunas y de los que ni siquiera nos enteramos.\n\n<PARAGRAPH>\n\nCOLABORA CON NOSOTROS CON PAYPAL\n\n<PARAGRAPH>\n\n",
        "TITLE": "Castilla y León suspende la vacunación con AstraZeneca y Carmen Calvo lo desautoriza en nombre del gobierno acusando al gobierno de la comunidad de “buscar confrontación política”",
        "ID": "NF_04-11-2021_20-42-33_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Castilla y León suspende la vacunación con AstraZeneca y Carmen Calvo lo desautoriza en nombre del gobierno acusando al gobierno de la comunidad de “buscar confrontación política”",
                "text_en": "Castilla y León suspends vaccination with AstraZeneca and Carmen Calvo disallows it on behalf of the government accusing the community government of “looking for political confrontation”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Castilla y León"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "suspende la vacunación con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Stop vaccination with AstraZeneca"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Carmen Calvo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Carmen Calvo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo desautoriza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Disauthorizes it."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en nombre del gobierno acusando al gobierno de la comunidad de “buscar confrontación política”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on behalf of the government accusing the community government of “seeking political confrontation”"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "gobierno de la comunidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "community governance"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las cosas siguen sin estar claras con la vacuna de AstraZeneca para casi todo el mundo, excepto para el gobierno presidido por Pedro Sánchez al que parece darle igual las sospechas y los efectos secundarios que está provocando la inoculación de la misma.",
                "text_en": "Things remain unclear with AstraZeneca's vaccine for almost everyone, except for the government presided over by Pedro Sánchez, which seems to give the same suspicions and side effects that the inoculation of the vaccine is causing.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las cosas siguen sin estar claras con la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Things are still unclear with the AstraZeneca vaccine."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el gobierno presidido por Pedro Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the government presided over by Pedro Sánchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "parece darle igual las sospechas y los efectos secundarios que está provocando la inoculación de la misma",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "seems to equal the suspicions and side effects that are causing the inoculation of the same"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hoy mismo, el gobierno autonómico de Castilla y León, presidido por el servil Alfonso Fernández Mañueco, ha decidido suspender de forma inesperada la administración de esta vacuna por precaución.",
                "text_en": "Today, the autonomous government of Castile and León, presided over by the servile Alfonso Fernández Mañueco, has decided to unexpectedly suspend the administration of this vaccine as a precaution.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hoy mismo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el gobierno autonómico de Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the autonomous government of Castile and León"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Alfonso Fernández Mañueco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Alfonso Fernández Mañueco"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha decidido suspender de forma inesperada la administración de esta vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has decided to suspend unexpectedly the administration of this vaccine"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por precaución",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as a precaution"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, la consejería ha indicado que “la medida cautelar se adopta a la espera de conocer el informe de seguridad que se prevé que elaboré el Comité de Evaluación de Riesgos de Farmacovigilancia de la Agencia Europea del Medicamento (EMA), que se reúne hoy y de las decisiones que, en relación con este tema, puedan adoptarse próximamente por órganos ejecutivos de la Unión Europea y del Sistema Nacional de Salud”.",
                "text_en": "In addition, the council has indicated that “the precautionary measure is adopted pending the receipt of the safety report that is expected to be prepared by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA), which meets today, and of decisions that may be taken in the near future by executive bodies of the European Union and the National Health System”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la consejería",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Counseling"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la medida cautelar se adopta a la espera de conocer el informe de seguridad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the precautionary measure is taken pending receipt of the security report"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Comité de Evaluación de Riesgos de Farmacovigilancia de la Agencia Europea del Medicamento (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA)"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A través de magafonía y sin dar más explicaciones se ha dicho que “se suspende la vacunación hasta nueva orden”.",
                "text_en": "Through magaphony and without further explanation, it has been said that “vaccination is suspended until further order”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "A través de magafonía y sin dar más explicaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Through magaphony and without further explanation"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha dicho que “se suspende la vacunación hasta nueva orden”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it has been said that “vaccination is suspended until further order”"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se suspende la vacunación hasta nueva orden",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccination is suspended until further notice"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta noticia ha pillado a la vicepresidente del gobierno, Carmen Calvo, en Extremadura y cuando ha sido preguntada sobre el asunto ha afirmado: “Las decisiones de qué vacunas, con qué criterios sanitarios, en qué tramos y con qué calendario corresponde al Consejo Interterritorial de Sanidad”, visiblemente molesta, Calvo ha añadido que considera esta suspensión un intento de “confrontación política” por parte de la Junta.",
                "text_en": "This news has caught the vice president of the government, Carmen Calvo, in Extremadura and when she has been asked about the issue she has said: “The decisions of which vaccines, with which health criteria, in which sections and with which calendar corresponds to the Interterritorial Health Council”, visibly annoying, Calvo has added that considers this suspension an attempt of “political confrontation” by the Board.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la vicepresidente del gobierno, Carmen Calvo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vice president of the government, Carmen Calvo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "considera esta suspensión un intento de “confrontación política”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "considers this suspension an attempt to “political confrontation”"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "confrontación política",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "political confrontation"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Junta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Board"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Fíjense, con lo servil que es el gobierno de Fernández Mañueco, un impostor y una marioneta de Ciudadanos en Castilla y León, para una vez que se atreve a llevar la contraria al gobierno, llegan estos y dicen que busca “confrontación política”.",
                "text_en": "Notice, with the servile government of Fernández Mañueco, an impostor and a puppet of Citizens in Castile and León, for once he dares to take the opposite to the government, these arrive and say he seeks “political confrontation.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fernández Mañueco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fernández Mañueco"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "un impostor y una marioneta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "an impostor and a puppet"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ciudadanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Citizens"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Castilla y León"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero señores del gobierno, si Mañueco es un perrito faldero que no se atreve ni a rechistar, no se enojen con él porque le tienen a su entero servicio.",
                "text_en": "But gentlemen of the government, if Mañueco is a lapdog who dares not even to laugh, do not get angry with him because they have him at their full service.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Mañueco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mañueco"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es un perrito faldero que no se atreve ni a rechistar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's a lapdog who doesn't even dare to squeal."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque le tienen a su entero servicio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because they have him at their full service."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "56": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 16,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 9,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 3,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 8,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 3,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 2,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 9,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 10,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nMás información sospechosa sobre la vacuna. \n\n<BREAK>\n\nComo muchos de ustedes sabrán, el Reino Unido fue el primer país en poner la campaña de vacunación contra el coronavirus en marcha. \n\n<BREAK>\n\nDe hecho, hubo una foto que dio la vuelta al mundo y fue la de una mujer británica de 90 años que había sido la primera en ponerse la citada vacuna. \n\n<BREAK>\n\nLa vacuna del Reino Unido es De Oxford.\n\n<BREAK>\n\nY tras esa puesta en marcha de la vacunación con carácter de urgencia, ¿con qué nos hemos encontrado? Con que el gobierno británico nos informa ahora de un suceso bastante curioso y preocupante: que el virus ha sufrido una mutación en Gran Bretaña que han calificado como más contagiosa y más letal, ¿cómo es posible todo esto? ¿Ahora resulta que el virus se está defendiendo de la vacuna o algo así? ¿Habrá fumigado Gran Bretaña el Partido Comunista Chino con una nueva cepa? ¿No les parece sorprendente, cuanto menos?\n\n<BREAK>\n\nEstamos viviendo desde hace muchos años en un mundo en el que los políticos y aquellos a quienes sirven, los malos, están haciéndolo todo de una forma cada vez más descarada, no hay disimulo. \n\n<BREAK>\n\nY parece que cuanto más descarados son, hay menos gente que los ve venir con claridad, como si fuera una especie de manual de defensa personal con el que ciertas personas pretenden protegerse de la realidad porque no les gusta.\n\n<BREAK>\n\nPero la realidad es la que es, aunque no nos guste, y si nos escondemos de ella, o nos hacemos los locos y no la vemos ponemos en riesgo nuestra salud e incluso nuestras vidas. \n\n<BREAK>\n\nRecurran a información alternativa, busquen y contrasten lo que lean, escuchen y vean. \n\n<BREAK>\n\nY que esto les sirva, sobre todo, para hacer despertar su espíritu crítico y sus ganas por conocer la verdad. \n\n<BREAK>\n\nLos grandes medios no les están diciendo la verdad y noticias como estas, por las que pasan como de soslayo, lo demuestran.\n\n<BREAK>\n\nPiénsenlo otra vez con calma: Son los primeros en ponerse la vacuna y es precisamente allí en donde nos encontramos con una mutación del virus más grave. \n\n<BREAK>\n\nLes preguntamos de nuevo: ¿No les parece raro?",
        "TITLE": "Qué curioso lo del Reino Unido: Son los primeros del mundo en vacunarse y ahora sufren una variante del virus más contagiosa y más letal; raro, ¿no?",
        "ID": "8-Eldiestro",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Qué curioso lo del Reino Unido: Son los primeros del mundo en vacunarse y ahora sufren una variante del virus más contagiosa y más letal; raro, ¿no?",
                "text_en": "Funny about the UK: They are the first in the world to get vaccinated and now suffer from a variant of the most contagious and lethal virus; rare, isn't it?",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Son los primeros del mundo en vacunarse y ahora sufren una variante del virus más contagiosa y más letal",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They are the first in the world to get vaccinated and now suffer from a variant of the most contagious and lethal virus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Más información sospechosa sobre la vacuna. ",
                "text_en": "More suspicious information about the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Más información sospechosa sobre la vacuna",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "More suspicious information about the vaccine"
                    }
                ],
                "evidences": [
                    {
                        "value": "Significant predictors of COVID-19 vaccine uptake intentions were education, having insurance, scoring high on subjective norms, a positive attitude toward the vaccine, as well as high perceived susceptibility to COVID-19, high perceived benefits of the vaccine, scoring low on barriers to the vaccine, and scoring high on self-efficacy. Predictors of willingness to take a COVID-19 vaccine under EUA were age, race/ethnicity, positive subjective norms, high perceived behavioral control, positive attitudes toward the vaccine, as well as high perceived susceptibility to COVID-19, high perceived benefits of the vaccine, low barriers to the vaccine, and scoring high on self-efficacy for getting the vaccine. Concerns about rushed vaccine development appear to reduce vaccine uptake intent, as well as willingness to get the vaccine under EUA.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "Vaccine Safety and Government Control: Figure 1 describes the top vaccine safety and government control concerns by country. Respondents from the US and Canada shared the same top vaccine safety and government control concern: the fast production of the vaccine compromised its safety. Respondents from Sweden (the vaccine can cause other diseases) and Italy (you can get COVID-19 from the vaccine) were both unique in their top vaccine safety and government control concerns. Among respondents who were not vaccine-hesitant, the US and Italy shared the same top concern (you can get COVID-19 from the vaccine), while Canada (the fast production of the vaccine compromised its safety) and Sweden (the vaccine can cause other diseases) were both unique. Among the hesitant, the US and Canada shared the same top concern (the fast production of the vaccine compromised its safety), while Sweden (there are toxic ingredients in the vaccine) and Italy (the vaccine can cause other diseases) were again unique.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9241889715
                    },
                    {
                        "label": "contradiction",
                        "score": 0.5916597247
                    }
                ]
            },
            {
                "text": "Como muchos de ustedes sabrán, el Reino Unido fue el primer país en poner la campaña de vacunación contra el coronavirus en marcha. ",
                "text_en": "As many of you will know, the UK was the first country to launch the vaccination campaign against coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue el primer país en poner la campaña de vacunación contra el coronavirus en marcha",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was the first country to launch the vaccination campaign against coronavirus"
                    }
                ],
                "evidences": [
                    {
                        "value": "The coronavirus disease 2019 (COVID-19) vaccination drive in Pakistan started in February 2021 after half a million doses of the COVID-19 vaccine (Sinopharm) supplied to the country by the People's Liberation Army of China [1] . The National Command and Control Center (NCOC) managed the vaccination program in the country; the frontline healthcare workers were vaccinated first when the mass vaccination campaign started on February 3, 2021 [2] . Later, on February 22, 2021, the government initiated a vaccination campaign for other healthcare workers. On March 16, April 3, April 25, April 28, May 12, May 29, and June 3, 2021, a mass vaccination campaign was introduced for populations above the age of 70, 65, 60, 50, 40, 30, and 18, respectively [3] .",
                        "score": 0.6600000262
                    },
                    {
                        "value": "The UK, despite having a single large-scale health care provider, the National Health Service, has also faced vaccine delivery challenges. One of those has been in clarity about which districts and which GPs were responsible for the health of each citizen. 21 In the UK's initial rollout, relative to the size of its population, and despite its larger geographic area, there were far fewer and often smaller sites for vaccine administration than in Israel. The UK relied on hospitals and relatively small, stand alone, or grouped, GP practices which seemed less suited than the one used by Israeli health plans to deliver a large-scale vaccination campaign [35] .",
                        "score": 0.5099999905
                    },
                    {
                        "value": "The UK began an ambitious vaccination programme to combat the COVID-19 pandemic on 8 December 2020; by 24 April 2021, 64% of the UK adult population have received their first of the dose. 1 Previous research demonstrates that vaccination rates tend to be lower among certain ethnic groups, and in areas of higher deprivation. [2] [3] [4] Existing evidence suggests that COVID-19 vaccination rates differ by level of area deprivation, certain underlying health conditions and ethnicity. 5 Far less is known about how COVID-19 vaccination uptake varies by sociodemographic factors, such as religious affiliation, individual socioeconomic status, living in multigenerational household or disability status, factors disproportionately associated with SARS-CoV-2 infection. Understanding which sociodemographic, economic and cultural factors are associated with low vaccination rates has major implications for designing policies that help maximise the vaccination campaign coverage.",
                        "score": 0.6499999762
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9543504715
                    },
                    {
                        "label": "neutral",
                        "score": 0.9957635403
                    },
                    {
                        "label": "neutral",
                        "score": 0.8239294887
                    }
                ]
            },
            {
                "text": "De hecho, hubo una foto que dio la vuelta al mundo y fue la de una mujer británica de 90 años que había sido la primera en ponerse la citada vacuna. ",
                "text_en": "In fact, there was a photo that went around the world and was that of a 90-year-old British woman who had been the first to get the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una mujer británica de 90 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a 90-year-old British woman"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "había sido la primera en ponerse la citada vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had been the first to get the said vaccine"
                    }
                ],
                "evidences": [
                    {
                        "value": "Due to these disparities, having medical professionals from Hispanic and Black communities discuss the vaccine may be particularly important. Sandra Lindsay, a Black medical professional, was the first person in the United States to receive the COVID-19 vaccine. She acknowledged the Black community's greater medical mistrust due to historical incidents like the Tuskegee experiments, and cited it as the primary reason she wanted to receive the vaccine publicly: \"That was the goal today. . . Not to be the first one to take the vaccine, but to inspire people who look like me, who are skeptical in general about taking vaccines [29] .\" The second person in the US to receive the vaccine, Dr. Yves Duroseau, was also Black and noted the importance of personally illustrating the vaccine's safety [29] . As the COVID-19 vaccine becomes more widely available to the general public, frequent salient examples of Black and Hispanic medical professionals receiving the vaccine and discussing its benefits could significantly reduce vaccine hesitancy among people of color. Furthermore, Paterson et al. [30] observed that healthcare providers are among the most trusted sources of vaccine information. Given this, healthcare providers' own vaccine status and attitudes are particularly important so that they can accurately inform their patients. However, healthcare worker COVID-19 vaccine hesitancy itself is a potential challenge. Lucia, Kelekar and Afonso [31] found that nearly a quarter of medical students were reluctant to receive the vaccine upon regulatory approval [also see 32, 33] . Paterson et al. [30] noted that making vaccination for healthcare providers convenient and inexpensive, as well as increased training about vaccines and patient communication strategies, can increase vaccine compliance among patients. Given the influential role that Black and Hispanic medical professionals play in encouraging vaccine uptake among Black and Hispanic patients, it is critically important to make it as easy as possible for them to receive the vaccine. US Blacks and Hispanics in this study were significantly more likely than Whites to state that more testing of the vaccine on their racial/ethnic group is needed. Researchers, too, have noted the challenge of achieving adequate representation of Black and Hispanic patients in medical research [e.g., 34, 35] . Our results suggest that the effectiveness and safety of the vaccines among minority study participants should be further highlighted. Promoting the dissemination of accurate research information, including the experiences of minority vaccine recipients, could demonstrate the positive effects of the vaccine in these groups, encouraging them to see the vaccine as safe and effective and increasing vaccination uptake.",
                        "score": 0.5600000024
                    },
                    {
                        "value": "On December 8, 2020, a 91-year-old woman made history as the first person to receive the COVID-19 vaccine in the United Kingdom. Worldwide vaccination coverage will take time, especially in lowmiddle-income countries (LMICs) where access to coronavirus vaccines is limited and health systems are ill equipped to deal with sustained pressures associated with COVID-19. Meanwhile, hospital and critical care capacity will remain strained and basic therapies, including oxygen, are in urgent short supply. 1 COVID-19 has disproportionately impacted the world's poorest and most vulnerable, posing additional challenges in achieving the Sustainable Development Goals. 2 In addition to basic supportive therapies, there are still not enough effective therapeutic interventions widely available. There remains an urgent need to develop efficacious COVID-19 therapeutics to prevent severity and mortality, and to forestall the collapse of overburdened health systems in resource-limited settings.",
                        "score": 0.7099999785
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9920707345
                    },
                    {
                        "label": "neutral",
                        "score": 0.9534367323
                    }
                ]
            },
            {
                "text": "La vacuna del Reino Unido es De Oxford.",
                "text_en": "The UK vaccine is De Oxford.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vacuna del Reino Unido es De Oxford",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The UK vaccine is De Oxford"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Oxford",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Oxford"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y tras esa puesta en marcha de la vacunación con carácter de urgencia, ¿con qué nos hemos encontrado? Con que el gobierno británico nos informa ahora de un suceso bastante curioso y preocupante: que el virus ha sufrido una mutación en Gran Bretaña que han calificado como más contagiosa y más letal, ¿cómo es posible todo esto? ¿Ahora resulta que el virus se está defendiendo de la vacuna o algo así? ¿Habrá fumigado Gran Bretaña el Partido Comunista Chino con una nueva cepa? ¿No les parece sorprendente, cuanto menos?",
                "text_en": "And after that start of vaccination as a matter of urgency, what have we met with? With which the British government now informs us of a rather curious and worrying event: that the virus has undergone a mutation in Britain that they have described as more contagious and more lethal, how is all this possible? Now it turns out that the virus is defending itself from the vaccine or something like that? Will Britain have sprayed the Chinese Communist Party with a new strain? Is it not surprising, at least?",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras esa puesta en marcha de la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "post-vaccination start-up"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con carácter de urgencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as a matter of urgency"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el gobierno británico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the British government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos informa ahora de un suceso bastante curioso y preocupante",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "informs us now of a rather curious and worrying event"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ahora",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Now"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el virus ha sufrido una mutación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the virus has undergone a mutation"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Gran Bretaña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Great Britain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Habrá fumigado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He must have fumigated."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Gran Bretaña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Great Britain"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Partido Comunista Chino",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the Chinese Communist Party"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con una nueva cepa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with a new strain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estamos viviendo desde hace muchos años en un mundo en el que los políticos y aquellos a quienes sirven, los malos, están haciéndolo todo de una forma cada vez más descarada, no hay disimulo. ",
                "text_en": "We have been living for many years in a world where politicians and those they serve, the bad ones, are doing everything in an increasingly brazen way, there is no dissimulation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los políticos y aquellos a quienes sirven, los malos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "politicians and those they serve, the bad ones"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están haciéndolo todo de una forma cada vez más descarada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're doing it all in an increasingly brazen way."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero la realidad es la que es, aunque no nos guste, y si nos escondemos de ella, o nos hacemos los locos y no la vemos ponemos en riesgo nuestra salud e incluso nuestras vidas. ",
                "text_en": "But reality is what it is, even if we don't like it, and if we hide from it, or become crazy and don't see it, we put our health and even our lives at risk.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la realidad es la que es",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "reality is what it is"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "si nos escondemos de ella, o nos hacemos los locos y no la vemos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "If we hide from her, or we play crazy and we don't see her"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ponemos en riesgo nuestra salud e incluso nuestras vidas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We put our health and even our lives at risk."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Recurran a información alternativa, busquen y contrasten lo que lean, escuchen y vean. ",
                "text_en": "Turn to alternative information, search and contrast what you read, listen and see.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "busquen y contrasten",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "search and contrast"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los grandes medios no les están diciendo la verdad y noticias como estas, por las que pasan como de soslayo, lo demuestran.",
                "text_en": "The big media are not telling you the truth and news like this, through which they pass like a slant, prove it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los grandes medios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The big media"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no les están diciendo la verdad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're not telling you the truth."
                    }
                ],
                "evidences": [
                    {
                        "value": "There are differences between news and rumours. News is an asserted claim, and rumours are shared claims among people. On platforms such as Twitter, a rumour can easily be started by a topic being shared, and since it triggers emotions (fear or disgust), it might be retweeted many times. Fake news also falls in this category. It is defined as a willful distortion of the truth. A study by Vosoughi et al. (2018) showed that even though people who had spread false news had fewer followers and spent less time on Twitter, their false news spread farther, faster, deeper, and more broadly than the active users who share the truth. In this regard, false news and rumours are overwhelmingly more novel than real news. To measure the novelty degree of true and false tweets, they compared the distributions of the experimental guided tweets for 60 days. False news can create many disadvantages for businesses, including misallocation of resources, misalignment of business strategies, and even loss of reputation (Vosoughi et al., 2018) .",
                        "score": 0.5199999809
                    },
                    {
                        "value": "Some scholars argue that the recent rise of fake news is a manifestation of a broader ongoing epistemological shift, where significant numbers of online information consumers move away from the standards of evidence-based reasoning and pursuit of objective truth toward \"alternative facts\" and partisan simplism-a malaise often labelled as the state of \"post-truth\" [17, 18] . Lewandowsky and colleagues identify large-scale trends such as declining social capital, rising economic inequality and political polarization, diminishing trust in science, and an increasingly fragmented media landscape as the processes underlying the shift toward the \"post-truth.\" In order to narrow the scope of this report, we specifically focus on the news media component of the larger \"post-truth\" puzzle. This leads us to consider only the studies that explore the effects of misinformation packaged in news-like formats, perforce leaving out investigations dealing with other forms of online deception-for example, messages coming from political figures and parties [19] or rumors [20] .",
                        "score": 0.6399999857
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9282952547
                    },
                    {
                        "label": "neutral",
                        "score": 0.9888185859
                    }
                ]
            },
            {
                "text": "Piénsenlo otra vez con calma: Son los primeros en ponerse la vacuna y es precisamente allí en donde nos encontramos con una mutación del virus más grave. ",
                "text_en": "Think again calmly: They are the first to get the vaccine and it is precisely there where we find a mutation of the most serious virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Son los primeros en ponerse la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're the first to get the vaccine."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "allí",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "There."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos encontramos con una mutación del virus más grave",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "we find a mutation of the most serious virus"
                    }
                ],
                "evidences": [
                    {
                        "value": "So, both Israel and the UK were quick to authorise their first vaccine against Covid-19 and to commence vaccine roll-out. Both countries had placed large advance orders for a number of potential vaccines, some of which have been authorised for use to date, with more in the pipeline. The early rollout was restricted to the Pfizer/BioNTech ('Pfizer') vaccine, the first vaccine to be authorised and made available in both Israel and the UK during December 2020.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9922069907
                    }
                ]
            },
            {
                "text": "Les preguntamos de nuevo: ¿No les parece raro?",
                "text_en": "We ask you again: Don't you think it's weird?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "parece raro",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It looks weird."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "57": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 15,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 8,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 5,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 13,
            "WhoReliabilityReliable": 9,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 5,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nPor Mente Alternativa\n\n<BREAK>\n\nPublicado 29 de mayo de 2020\n\n<BREAK>\n\n160 médicos reunidos en Londres desaprueban vacuna anticovid porque cambiará nuestro ADN. \n\n<BREAK>\n\nEl presentador de London Real, Brian Rose, ha publicado un video —censurado por YouTube— en el que presenta al Dr. Rashid Buttar en una mesa redonda con 160 médicos que se oponen a la vacuna contra el Covid-19. \n\n<BREAK>\n\nEl Dr. Rashid Buttar es un médico osteopático y autor que se ha popularizado por sus controvertidos puntos de vista sobre el manejo de la crisis de coronavirus. \n\n<BREAK>\n\nSu primer libro, “9 pasos para mantenerse alejado de los médicos” se convirtió en un bestseller y ha sido traducido a varios idiomas.\n\n<BREAK>\n\n“ — La vacuna que están fabricando es una vacuna de ácido ribonucleico (ARN), y sería la primera vez que se usa este tipo de vacuna. \n\n<BREAK>\n\nBásicamente el ARN sobreescribe nuestro ADN. \n\n<BREAK>\n\nPor lo que si la vacuna que seleccionan proviene del laboratorio Moderna, que es la opción preferida por el Dr. Anthony Fauci, tendríamos una vacuna de ARN mensajero que nunca ha sido probada en animales. \n\n<BREAK>\n\nAdemás, el laboratorio Moderna nunca antes ha desarrollado vacunas y nunca ha elaborado nada para humanos en el pasado. \n\n<BREAK>\n\nSin embargo, Moderna va a probar su vacuna directamente en humanos. \n\n<BREAK>\n\nY si esto sucede, nuestros hijos seguramente no podrán tener hijos. \n\n<BREAK>\n\nPero más allá de eso, no sabemos que podría ocurrirle a los hijos de nuestros hijos (segunda generación), pero lo que sí es seguro es que el genoma, el código genético, el ADN de la tercera generación (los hijos de nuestros hijos) no sería lo que es ahora. \n\n<BREAK>\n\nEs decir que ellos ya no serían humanos como nosotros ahora.\n\n<BREAK>\n\nDe los 160 médicos participantes en esta reunión, ¿cuántos apoyan el uso de la vacuna contra el COVID-19 dentro de los próximos 12 meses?\n\n<BREAK>\n\n— No veo ninguna mano levantada.\n\n<BREAK>\n\n— Ahora levanten la mano los que piensan que no existe una justificación para usar una vacuna en este caso.\n\n<BREAK>\n\n— Dr. Buttar, estoy asombrado. \n\n<BREAK>\n\nNo esperaba ver que tantos médicos estén en contra de la aplicación de esta vacuna en los próximos doce meses.”",
        "TITLE": "160 MÉDICOS REUNIDOS EN LONDRES DESAPRUEBAN VACUNA ANTICOVID PORQUE CAMBIARÁ NUESTRO ADN",
        "ID": "11-Mentealternativa",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "160 MÉDICOS REUNIDOS EN LONDRES DESAPRUEBAN VACUNA ANTICOVID PORQUE CAMBIARÁ NUESTRO ADN",
                "text_en": "160 MEDICALS MEETING IN LONDON DISAPPEARED VACANE ANTI-VID BECAUSE IT WILL CHANGE OUR DNA",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "160 MÉDICOS REUNIDOS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "160 MEDICALS MEETING"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "EN LONDRES",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "IN LONDON"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "DESAPRUEBAN VACUNA ANTICOVID",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "DISAPPEARING ANTI-VID VACCINE"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "PORQUE CAMBIARÁ NUESTRO ADN",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "WHY WILL CHANGE OUR DNA"
                    }
                ],
                "evidences": []
            },
            {
                "text": "160 médicos reunidos en Londres desaprueban vacuna anticovid porque cambiará nuestro ADN. ",
                "text_en": "160 doctors gathered in London disapprove of anti-covid vaccine because it will change our DNA.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "160 médicos reunidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "160 doctors assembled"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Londres",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in London"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desaprueban vacuna anticovid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "disapprove of anti-covid vaccine"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque cambiará nuestro ADN",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because it will change our DNA."
                    }
                ],
                "evidences": []
            },
            {
                "text": "El presentador de London Real, Brian Rose, ha publicado un video —censurado por YouTube— en el que presenta al Dr. Rashid Buttar en una mesa redonda con 160 médicos que se oponen a la vacuna contra el Covid-19. ",
                "text_en": "London Real host Brian Rose has released a video—censored by YouTube—in which he presents Dr. Rashid Buttar at a round table with 160 doctors opposing the Covid-19 vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El presentador de London Real, Brian Rose",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "London Real host Brian Rose"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha publicado un video",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has posted a video"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Dr. Rashid Buttar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Rashid Buttar"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "160 médicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "160 doctors"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se oponen a la vacuna contra el Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "oppose the Covid-19 vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Dr. Rashid Buttar es un médico osteopático y autor que se ha popularizado por sus controvertidos puntos de vista sobre el manejo de la crisis de coronavirus. ",
                "text_en": "Dr. Rashid Buttar is an osteopathic physician and author who has become popular because of his controversial views on the management of the coronavirus crisis.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Dr. Rashid Buttar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Rashid Buttar"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es un médico osteopático",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's an osteopathic doctor."
                    }
                ],
                "evidences": []
            },
            {
                "text": "“ — La vacuna que están fabricando es una vacuna de ácido ribonucleico (ARN), y sería la primera vez que se usa este tipo de vacuna. ",
                "text_en": "“ — The vaccine they are making is a ribonucleic acid (RNA) vaccine, and it would be the first time this type of vaccine is used.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vacuna que están fabricando es una vacuna de ácido ribonucleico (ARN)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The vaccine they're making is a ribonucleic acid (RNA) vaccine."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sería la primera vez que se usa este tipo de vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "would be the first time this type of vaccine is used"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Básicamente el ARN sobreescribe nuestro ADN. ",
                "text_en": "Basically RNA overwrites our DNA.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el ARN sobreescribe nuestro ADN",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "RNA overwrites our DNA"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por lo que si la vacuna que seleccionan proviene del laboratorio Moderna, que es la opción preferida por el Dr. Anthony Fauci, tendríamos una vacuna de ARN mensajero que nunca ha sido probada en animales. ",
                "text_en": "So if the vaccine they select comes from the Moderna laboratory, which is the preferred option for Dr. Anthony Fauci, we would have a messenger RNA vaccine that has never been tested on animals.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "del laboratorio Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the Moderna laboratory"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nunca ha sido probada en animales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has never been tested on animals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, el laboratorio Moderna nunca antes ha desarrollado vacunas y nunca ha elaborado nada para humanos en el pasado. ",
                "text_en": "In addition, the Moderna laboratory has never developed vaccines before and has never produced anything for humans in the past.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el laboratorio Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Moderna laboratory"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nunca antes ha desarrollado vacunas y nunca ha elaborado nada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's never developed vaccines before and he's never made anything."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "humanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "human rights"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en el pasado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the past"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y si esto sucede, nuestros hijos seguramente no podrán tener hijos. ",
                "text_en": "And if this happens, our children will surely not be able to have children.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nuestros hijos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "our children"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "seguramente no podrán tener hijos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Surely they won't be able to have children."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero más allá de eso, no sabemos que podría ocurrirle a los hijos de nuestros hijos (segunda generación), pero lo que sí es seguro es que el genoma, el código genético, el ADN de la tercera generación (los hijos de nuestros hijos) no sería lo que es ahora. ",
                "text_en": "But beyond that, we don't know what could happen to the children of our children (second generation), but what is certain is that the genome, the genetic code, the DNA of the third generation (the children of our children) would not be what it is now.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el ADN de la tercera generación (los hijos de nuestros hijos) no sería lo que es ahora",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "DNA of the third generation (the children of our children) would not be what it is now."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la tercera generación (los hijos de nuestros hijos)",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the third generation (the children of our children)"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ahora",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Now"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es decir que ellos ya no serían humanos como nosotros ahora.",
                "text_en": "That is to say, they would no longer be human like us now.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ellos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya no serían humanos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They wouldn't be human anymore."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nosotros",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "us."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ahora",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Now"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No esperaba ver que tantos médicos estén en contra de la aplicación de esta vacuna en los próximos doce meses.”",
                "text_en": "I did not expect to see so many doctors against the application of this vaccine in the next twelve months.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "tantos médicos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "so many doctors"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estén en contra de la aplicación de esta vacuna",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "against the application of this vaccine"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los próximos doce meses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the next 12 months"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "58": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 8,
            "WhatReliabilityReliable": 0,
            "WhatReliabilityUnreliable": 8,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 7,
            "WhoReliabilityReliable": 2,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 0,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 1,
            "WhereReliabilityReliable": 0,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 4,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 5,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nHay veces que muchas personas no ven lo que está pasando justamente delante de sus narices porque, simplemente, no se enteran, pero hay otras veces, y quizás esto sea más grave, que esas personas, simplemente, no lo quieren ver e incluso se enfadan e insultan a quiénes se lo muestren, como nos está pasando a nosotros últimamente.\n\n<PARAGRAPH>\n\nMostramos escandalosa información sobre las vacunas y sobre el virus que vamos encontrando en medios alternativos a nivel internacional y, simplemente, se nos insulta.\n\n<BREAK>\n\nPero lo grave es que esos que nos insultan no van más allá, no intentan ver las advertencias, las luces de peligro, no quieren que se les muestre la realidad, no quieren conocer la verdad incómoda puesto que viven mas felices con la mentira cómoda.\n\n<PARAGRAPH>\n\nEn el vídeo que mostramos a continuación, la Doctora Natalia Prego destapa toda la información y muestra los motivos por los que se ha vuelto a autorizar la vacuna de AstraZeneca y los condicionantes que se han “impuesto” con esa autorización.\n\n<BREAK>\n\nLo grave del asunto es que se nos dice desde organismos oficiales que esa vacuna está en fase de experimentación, es decir, que se está experimentando con todos nosotros y nos quedamos tan tranquilos.\n\n<PARAGRAPH>\n\nY no solo eso, se habla de hipótesis, en forma condicional y con esperanzas de que no cause daño.\n\n<BREAK>\n\nPor lo tanto, hemos de deducir que ni siquiera la Agencia Europea del Medicamento lo tiene claro y hemos de sospechar que se vuelve a autorizar por motivos políticos y económicos, no sanitarios.\n\n<PARAGRAPH>\n\nCOLABORA CON NOSOTROS CON PAYPAL\n\n<PARAGRAPH>\n\n",
        "TITLE": "La Dra. Natalia Prego destapa el escandaloso motivo y los preocupantes condicionantes con los que se ha vuelto a autorizar AstraZeneca",
        "ID": "NF_04-11-2021_20-35-07_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "La Dra. Natalia Prego destapa el escandaloso motivo y los preocupantes condicionantes con los que se ha vuelto a autorizar AstraZeneca",
                "text_en": "Dr. Natalia Prego exposes the scandalous motive and the worrying conditions with which AstraZeneca has been reauthorized",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Dra. Natalia Prego",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Natalia Prego"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "destapa el escandaloso motivo y los preocupantes condicionantes con los que se ha vuelto a autorizar AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "uncovers the scandalous motive and the worrying conditions with which AstraZeneca has been reauthorized"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hay veces que muchas personas no ven lo que está pasando justamente delante de sus narices porque, simplemente, no se enteran, pero hay otras veces, y quizás esto sea más grave, que esas personas, simplemente, no lo quieren ver e incluso se enfadan e insultan a quiénes se lo muestren, como nos está pasando a nosotros últimamente.",
                "text_en": "There are times when many people don't see what's going on right under their noses because they just don't find out, but there are other times, and maybe this is more serious, that those people just don't want to see it and even get angry and insult those who show it, as it's happening to us lately.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchas personas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "many people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no ven lo que está pasando justamente delante de sus narices",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They don't see what's going on right under their noses."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque, simplemente, no se enteran",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because they just don't know"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "no lo quieren ver",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They don't want to see him."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Mostramos escandalosa información sobre las vacunas y sobre el virus que vamos encontrando en medios alternativos a nivel internacional y, simplemente, se nos insulta.",
                "text_en": "We show scandalous information about the vaccines and the virus we are finding in alternative media internationally and are simply insulted.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Mostramos escandalosa información sobre las vacunas y sobre el virus que vamos encontrando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We show scandalous information about the vaccines and the virus we are finding"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en medios alternativos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in alternative media"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero lo grave es que esos que nos insultan no van más allá, no intentan ver las advertencias, las luces de peligro, no quieren que se les muestre la realidad, no quieren conocer la verdad incómoda puesto que viven mas felices con la mentira cómoda.",
                "text_en": "But the serious thing is that those who insult us don't go any further, they don't try to see the warnings, the danger lights, they don't want to be shown the reality, they don't want to know the uncomfortable truth since they live happier with the comfortable lie.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "esos que nos insultan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "those who insult us"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no quieren que se les muestre la realidad, no quieren conocer la verdad incómoda",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They don't want reality to be shown to them, they don't want to know the uncomfortable truth."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "puesto que viven mas felices con la mentira cómoda",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "since they live happier with the comfortable lie"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el vídeo que mostramos a continuación, la Doctora Natalia Prego destapa toda la información y muestra los motivos por los que se ha vuelto a autorizar la vacuna de AstraZeneca y los condicionantes que se han “impuesto” con esa autorización.",
                "text_en": "In the video below, Dr. Natalia Prego uncovers all the information and shows the reasons why the AstraZeneca vaccine has been reauthorized and the conditions that have been “taxed” with that authorization.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Doctora Natalia Prego",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Natalia Prego"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "destapa toda la información y muestra los motivos por los que se ha vuelto a autorizar la vacuna de AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Uncovers all information and shows the reasons why AstraZeneca vaccine has been re-authorised"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo grave del asunto es que se nos dice desde organismos oficiales que esa vacuna está en fase de experimentación, es decir, que se está experimentando con todos nosotros y nos quedamos tan tranquilos.",
                "text_en": "What is serious about the matter is that we are told from official bodies that this vaccine is in the experimental phase, that is, that it is being experimented with all of us and we remain so calm.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "organismos oficiales",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "official bodies"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se está experimentando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is being experimented"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "con todos nosotros",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with all of us"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por lo tanto, hemos de deducir que ni siquiera la Agencia Europea del Medicamento lo tiene claro y hemos de sospechar que se vuelve a autorizar por motivos políticos y económicos, no sanitarios.",
                "text_en": "Therefore, we must deduce that even the European Medicines Agency is not clear and we must suspect that it is being re-authorized for political and economic reasons, not for health reasons.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hemos de deducir que ni siquiera la Agencia Europea del Medicamento lo tiene claro",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We have to deduce that even the European Medicines Agency is not clear about this."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the European Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se vuelve a autorizar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is re-authorized"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por motivos políticos y económicos, no sanitarios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for political and economic reasons, non-health reasons"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "59": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 12,
            "WhatReliabilityReliable": 12,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 13,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 9,
            "WhenReliabilityReliable": 9,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nEFE Ámsterdam29 ene. 2021\n\n<BREAK>\n\nLa Agencia Europea del Medicamento (EMA) anunció este viernes que \"no se identificaron nuevos efectos secundarios\" durante el primer mes de vacunación con Pfizer/BioNTech en la Unión Europea (UE) y aseguró que el fármaco no está \"vinculado\" con ningún caso de muerte que haya ocurrido tras una inyección.\n\n<BREAK>\n\nEn su primer informe sobre la seguridad de la vacuna de Pfizer, conocida como Comirnaty, la EMA subrayó que, por los datos recopilados sobre el uso de este fármaco en las campañas de vacunación en todos los países europeos desde finales de diciembre, no se identificaron efectos secundarios adicionales a los que ya aparecieron durante los ensayos clínicos.\n\n<BREAK>\n\nLa Agencia también analizó los casos de muertes reportadas después de la vacunación con esta vacuna, teniendo en cuenta otras condiciones médicas y las tasas de mortalidad para grupos de edad en la población en general, y concluyó que ningún fallecimiento está directamente relacionado con un efecto de la inyección.\n\n<BREAK>\n\nEl comité de seguridad de la EMA (PRAC) estudió todas las muertes reportadas después de recibir una vacuna de Comirnaty, incluidos los fallecimientos de personas ancianas con una salud deteriorada, y aseguró que los casos no plantean un problema de seguridad de la propia vacuna, aunque promete “seguir supervisando atentamente” todos los casos.\n\n<BREAK>\n\nPRIMERA VACUNA EN SER APROBADA\n\n<BREAK>\n\nLa información sobre la seguridad de Pfizer incluye datos de EudraVigilance, la base de datos centralizada de la UE sobre efectos secundarias de los medicamentos, y los datos recibidos de otras fuentes, incluido el informe de seguridad mensual que elabora la farmacéutica por exigencia de la EMA, una condición impuesta junto a la licencia de comercialización.\n\n<BREAK>\n\nEl 6 de enero, la EMA y la Comisión Europea dieron luz verde a la vacuna de Moderna, y este mismo viernes se espera que los científicos europeos concluyan su evaluación sobre la seguridad y la eficacia del antídoto desarrollado por AstraZeneca, que se sumaría a las campañas de vacunación que los países europeos lanzaron a finales de diciembre.\n\n<BREAK>\n\nA través del sistema de farmacovigilancia de la UE, los estudios que realiza la empresa y los que realizan científicos independientes coordinados por las autoridades europeas son y seguirán siendo clave para la supervisión de la seguridad y la eficacia de Pfizer y Moderna, al igual que cualquier otra vacuna que se autorice en la UE contra el covid-19.\n\n<BREAK>\n\nEstá previsto que la EMA finalice hoy su evaluación científica de AstraZeneca, y anuncie en una rueda de prensa posterior sus conclusiones, y que en caso de ser positivas, recomendaría a la Comisión Europea otorgar una licencia a esta vacuna, la tercera en lo que va de pandemia en la UE.",
        "TITLE": "La vacuna de Pfizer, sin efectos secundarios nuevos tras un mes de uso en la UE",
        "ID": "7-Efe",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La vacuna de Pfizer, sin efectos secundarios nuevos tras un mes de uso en la UE",
                "text_en": "Pfizer vaccine, no new side effects after one month of use in the EU",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vacuna de Pfizer, sin efectos secundarios nuevos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer vaccine, no new side effects"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras un mes de uso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after one month of use"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the EU"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Agencia Europea del Medicamento (EMA) anunció este viernes que \"no se identificaron nuevos efectos secundarios\" durante el primer mes de vacunación con Pfizer/BioNTech en la Unión Europea (UE) y aseguró que el fármaco no está \"vinculado\" con ningún caso de muerte que haya ocurrido tras una inyección.",
                "text_en": "The European Medicines Agency (EMA) announced this Friday that \"no new side effects were identified\" during the first month of vaccination with Pfizer/BioNTech in the European Union (EU) and assured that the drug is not \"linked\" to any case of death that occurred after an injection.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Europea del Medicamento (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Friday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se identificaron nuevos efectos secundarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "no new side effects identified"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante el primer mes de vacunación con Pfizer/BioNTech",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the first month of vaccination with Pfizer/BioNTech"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Unión Europea (UE)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the European Union (EU)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el fármaco no está \"vinculado\" con ningún caso de muerte",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The drug is not \"linked\" to any case of death."
                    }
                ],
                "evidences": []
            },
            {
                "text": "En su primer informe sobre la seguridad de la vacuna de Pfizer, conocida como Comirnaty, la EMA subrayó que, por los datos recopilados sobre el uso de este fármaco en las campañas de vacunación en todos los países europeos desde finales de diciembre, no se identificaron efectos secundarios adicionales a los que ya aparecieron durante los ensayos clínicos.",
                "text_en": "In its first report on the safety of Pfizer vaccine, known as Comirnaty, the EMA stressed that due to the data collected on the use of Pfizer vaccine in vaccination campaigns in all European countries since the end of December, no additional side effects were identified to those that already appeared during clinical trials.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En su primer informe sobre la seguridad de la vacuna de Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In its first report on the safety of Pfizer vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se identificaron efectos secundarios adicionales a los que ya aparecieron",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "no additional side effects were identified to those that already appeared"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante los ensayos clínicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during clinical trials"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Agencia también analizó los casos de muertes reportadas después de la vacunación con esta vacuna, teniendo en cuenta otras condiciones médicas y las tasas de mortalidad para grupos de edad en la población en general, y concluyó que ningún fallecimiento está directamente relacionado con un efecto de la inyección.",
                "text_en": "The Agency also analysed the cases of deaths reported after vaccination with this vaccine, taking into account other medical conditions and mortality rates for age groups in the general population, and concluded that no death is directly related to an injection effect.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "también analizó los casos de muertes reportadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "also analyzed reported deaths"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de la vacunación con esta vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after vaccination with this vaccine"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "teniendo en cuenta otras condiciones médicas y las tasas de mortalidad para grupos de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "taking into account other medical conditions and mortality rates for age groups"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población en general",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the general population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El comité de seguridad de la EMA (PRAC) estudió todas las muertes reportadas después de recibir una vacuna de Comirnaty, incluidos los fallecimientos de personas ancianas con una salud deteriorada, y aseguró que los casos no plantean un problema de seguridad de la propia vacuna, aunque promete “seguir supervisando atentamente” todos los casos.",
                "text_en": "The EMA safety committee (PRAC) studied all deaths reported after receiving a Comirnaty vaccine, including deaths of elderly people with impaired health, and assured that the cases do not pose a safety problem for the vaccine itself, although it promises to “continue to monitor closely” all cases.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El comité de seguridad de la EMA (PRAC)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The EMA Security Committee (PRAC)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estudió todas las muertes reportadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "studied all reported deaths"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de recibir una vacuna de Comirnaty,",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after receiving a Comirnaty vaccine,"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aseguró que los casos no plantean un problema de seguridad de la propia vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "assured that the cases do not pose a safety problem of the vaccine itself"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El 6 de enero, la EMA y la Comisión Europea dieron luz verde a la vacuna de Moderna, y este mismo viernes se espera que los científicos europeos concluyan su evaluación sobre la seguridad y la eficacia del antídoto desarrollado por AstraZeneca, que se sumaría a las campañas de vacunación que los países europeos lanzaron a finales de diciembre.",
                "text_en": "On 6 January, the EMA and the European Commission gave the green light to the Moderna vaccine, and on Friday European scientists are expected to complete their assessment of the safety and efficacy of the antidote developed by AstraZeneca, which would be added to the vaccination campaigns launched by European countries at the end of December.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El 6 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "6 January"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA y la Comisión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA and the European Commission"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dieron luz verde a la vacuna de Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "gave the moderna vaccine green light"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este mismo viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this very Friday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se espera que los científicos europeos concluyan su evaluación sobre la seguridad y la eficacia del antídoto desarrollado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "European scientists are expected to complete their assessment of the safety and efficacy of the developed antidote"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los científicos europeos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "European scientists"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by AstraZeneca"
                    }
                ],
                "evidences": [
                    {
                        "value": "Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) is the Oxford-AstraZeneca vaccine designed to prevent COVID-19 infection. It was authorised by the European Medicines Agency (EMA) for use across the European Union (EU) following endorsement by the European Commission on 29 January 2021 [6] . The safety of the AstraZeneca vaccine was determined following a short-term analysis of data pooled from clinical trials that were conducted in the United Kingdom, Brazil, and South Africa [7] . Approximately 23,745 participants aged 18 years and older had been randomised and received either COVID-19 vaccine AstraZeneca or a control. The most frequently reported adverse reactions (ARs) from first vaccination were: injection site tenderness (63.7%), injection site pain (54.2%), fatigue (53.1%), headache (52.6%), malaise (44.2%), myalgia (44.0%), pyrexia (includes feverishness (33.6%) and fever >38°C (7.9%)) [6, 7] . The majority of ARs were mild to moderate in severity and resolved within a short period following the vaccination [6, 7] . Adverse reactions to second vaccinations were of the same nature but 'milder and less frequent' [6] .",
                        "score": 0.6600000262
                    },
                    {
                        "value": "Accordingly, some early commercial batches of the Pfizer-BioNTech's vaccine contained lower than expected levels of intact mRNA as shown by leaked EMA documents [6] . In an email dated November 23, an EMA official outlined a raft of issues on \"truncated and modified mRNA species present in the finished product,\" with unknown consequences on vaccine safety and efficacy. Two \"major objections\" were filed with Pfizer by EMA regulators who were tasked with ensuring good manufacturing production (GMP) practices. EMA authorized Pfizer-BioNTech's vaccine on December 21, noting that \"the quality of this medicinal product, submitted in the emergency context of the current (COVID-19) pandemic, is considered to be sufficiently consistent and acceptable.\" Approval of Moderna's vaccine, which is based on the same modality and subject to similar potential problems, followed.",
                        "score": 0.5500000119
                    },
                    {
                        "value": "On March 15th 2021, several European countries, including Italy, temporarily suspended the use of the COVID-19 vaccine developed by AstraZeneca, following sparse reports of serious side effects. Figure 6 reports the emotional profiles of \"vaccine\" and \"astrazeneca\" in popular tweets gathered in the next few days after the suspension. In comparison with the popular perceptions observed in December 2020 and in January 2021, as summarised in Figure 2 , the temporary suspension of the AstraZeneca vaccine had drastic effects over social discourse in the Italian twittersphere but not in the English one.",
                        "score": 0.6000000238
                    },
                    {
                        "value": "The healthcare workers who received the AstraZeneca COVID-19 vaccine during the early vaccination phase as priority groups (high-risk groups) were the target population of this study. Non-healthcare workers who received the AstraZeneca COVID-19 vaccine and healthcare workers who received the vaccine earlier than 29th January 2021 through phase 3 trials were excluded.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.809297502
                    },
                    {
                        "label": "neutral",
                        "score": 0.9994843006
                    },
                    {
                        "label": "neutral",
                        "score": 0.9972463846
                    },
                    {
                        "label": "entailment",
                        "score": 0.9974159002
                    }
                ]
            },
            {
                "text": "A través del sistema de farmacovigilancia de la UE, los estudios que realiza la empresa y los que realizan científicos independientes coordinados por las autoridades europeas son y seguirán siendo clave para la supervisión de la seguridad y la eficacia de Pfizer y Moderna, al igual que cualquier otra vacuna que se autorice en la UE contra el covid-19.",
                "text_en": "Through the EU pharmacovigilance system, studies conducted by the company and those conducted by independent scientists coordinated by the European authorities are and will remain key to the monitoring of the safety and efficacy of Pfizer and Moderna, as well as any other vaccine authorised in the EU against covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "A través del sistema de farmacovigilancia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Through the pharmacovigilance system"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la UE,",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EU,"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los estudios que realiza la empresa y los que realizan científicos independientes coordinados por las autoridades europeas son y seguirán siendo clave para la supervisión de la seguridad y la eficacia de Pfizer y Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the studies carried out by the company and those carried out by independent scientists coordinated by the European authorities are and will continue to be key to the monitoring of the safety and efficacy of Pfizer and Moderna"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la empresa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the company"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "científicos independientes coordinados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "co-ordinated independent scientists"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por las autoridades europeas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the European authorities"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Está previsto que la EMA finalice hoy su evaluación científica de AstraZeneca, y anuncie en una rueda de prensa posterior sus conclusiones, y que en caso de ser positivas, recomendaría a la Comisión Europea otorgar una licencia a esta vacuna, la tercera en lo que va de pandemia en la UE.",
                "text_en": "The EMA is expected to complete its scientific assessment of AstraZeneca today and announce its findings at a subsequent press conference, and if they are positive, it would recommend to the European Commission to issue a licence to this vaccine, the third in what is going on as a pandemic in the EU.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "finalice hoy su evaluación científica de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "conclude today its scientific evaluation of AstraZeneca"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la tercera en lo que va de pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the third in what goes from pandemic"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the EU"
                    }
                ],
                "evidences": [
                    {
                        "value": "In this regard, the process of vaccine approval in the EU by the European Medicines Agency (EMA) provides a good example: normally, vaccine candidates are successively evaluated for safety and efficacy in five clinical phases. In the case of the Coronavirus, some study phases were carried out simultaneously and the EMA was able to review them in parallel, so that the approval process could be shortened considerably to just a few months. Furthermore, the build-up of vaccine production capacity was associated with a high economic risk for the manufacturers -in case the vaccine eventually proved to be unsafe or ineffective in the course of the trials. In the case of the Coronavirus, governments have contributed to the 45 See 'Charles Michel says EU could invoke \"urgent measures\" in response to vaccine shortfall' (Politico, 28 January 2021) <https://www.po litico.eu/article/charles-michel-says-eu-could-invoke-urgent-measures-re sponse-coronavirus-vaccine-shortfall/> accessed 8 February 2021. cost of vaccine development, thereby reducing the risk to manufacturers.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "It was easier for the EMA to recommend the authorization of the AstraZeneca COVID-19 vaccine label as has been done. The EMA has helped national authorities willing to use this vaccine in adult and elderly populations. It is easier for national authorities to limit the indication than to broaden it. But it has created a lot of confusion and concern across many EU countries. Wouldn't the opposite situation have been better, in which a country decides to extend the administration of this vaccine to the elderly population and explaining the reasons supporting this decision to their own citizens? The issue would have been limited to few countries and for a given period: with a higher number and production of available vaccines, this situation will most likely be limited in time. For the EMA, it was also easier to follow the MHRA approved label than to recommend one that would have excluded older adults, something that would have prompted an open debate with the MHRA with uncertain consequences.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.999417305
                    },
                    {
                        "label": "neutral",
                        "score": 0.9911727309
                    }
                ]
            }
        ]
    },
    "60": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 1,
            "What": 18,
            "WhatReliabilityReliable": 3,
            "WhatReliabilityUnreliable": 15,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 16,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 9,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 2,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 6,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 5,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 7,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 7,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 10,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nImaginemos un sistema de clasificación que no solo nos categoriza según nuestro estado de salud, sino que también le permite al Estado clasificarnos de otras cien formas: por género, orientación, riqueza, condición médica, creencias religiosas, punto de vista político, estado legal, etc.\n\n<PARAGRAPH>\n\nEsta es la pendiente resbaladiza en la que estamos embarcados, una que comienza con los pasaportes de vacunas y termina con un sistema nacional de segregación.\n\n<PARAGRAPH>\n\nCada día que pasa, más y más empresas privadas y establecimientos están requiriendo a los usuarios prueba de una vacuna COVID-19 para poder trabajar, viajar, comprar, ir a la escuela y, en general, participar en la vida social.\n\n<PARAGRAPH>\n\nAl permitir que cualquier agente del Estado (policía, guardia civil, revisor de RENFE, etc.) establezcan una prueba de fuego para que las personas puedan participar en el comercio, la circulación y cualquier otro derecho que corresponda a la vida en una sociedad supuestamente libre, sienta las bases para una sociedad de «muéstrame tus papeles» en la que estamos obligados a identificarnos en cualquier momento ante cualquier funcionario público que lo exija por cualquier motivo.\n\n<BREAK>\n\nSi no hubiera «pandemia» de por medio, ninguna persona que se identifique «de izquierdas» dudaría en calificar este régimen como un régimen fascista.\n\n<PARAGRAPH>\n\nEstas prácticas estatales están escalando rápidamente a una toma de poder que faculta al Estado o a cualquier empresa a obligar a demostrar que se cumplen con todas las medidas aparentemente sanitarias.\n\n<BREAK>\n\nDecimos aparentemente porque tras cada Real Decreto o decreto autonómico relativo a la gestión de la «pandemia» contiene, adicionalmente, toda una panoplia de medidas económicas, fiscales o de vigilancia que ningún medio publica.\n\n<PARAGRAPH>\n\nAsí es también cómo el derecho a circular libremente ha sido socavado, suprimido y reescrito en un privilegio otorgado por el gobierno a aquellos ciudadanos que están dispuestos a seguir la línea o que gozan de una preeminencia social que, como no podría ser de otro modo en un Estado fascista, está asociada a su poder económico.\n\n<PARAGRAPH>\n\nAhora, los pasaportes de las vacunas, los requisitos de admisión en establecimientos públicos y las restricciones de viaje pueden parecer pasos pequeños y necesarios para ganar la guerra contra el virus, pero eso no es más que pura propaganda.\n\n<BREAK>\n\nPrincipalmente son medidas necesarias para el estado policial en sus esfuerzos por lavar aún más el cerebro a la población, para que crea que el gobierno tiene el derecho y el poder para hacer cumplir actos tan descarados de autoritarismo.\n\n<PARAGRAPH>\n\nAsí es como se encarcela y se encierra a toda una sociedad.\n\n<BREAK>\n\nEn otros tiempos tales tácticas de estado policial se llevaban a cabo en nombre de la seguridad nacional o en la lucha contra ETA, pero ahora, el poder que concentra el Estado se hace en nombre de la salud, porque el Estado siempre se preocupó de nuestra salud.\n\n<PARAGRAPH>\n\nLa lucha contra el terrorismo, donde el Estado se atribuyó y se dotó de leyes de excepción (Ley antiterrorista, Ley de Partidos), resultó ser una política que iba mucho más allá de la excusa terrorista; fue una concentración de poderes donde los casos de represión que hemos visto en las redes sociales durante el confinamiento no podrían concebirse sin esos antecedentes.\n\n<PARAGRAPH>\n\nLa militarización de la lucha contra la inmigración o la llamada Operación Balmis resultaron ser un ensayo de la futura participación de las fuerzas armadas en la vigilancia callejera.\n\n<BREAK>\n\nY esta «guerra» contra el COVID-19 (así lo calificó el ex JEMAD Miguel Ángel Villarroya en una de sus ruedas de prensa de abril de 2020) está resultando ser una guerra más contra el derecho de reunión, de expresión y de cualquier derecho civil, librada con todo el armamento de vigilancia y los mecanismos de rastreo a disposición del Estado.\n\n<PARAGRAPH>\n\nCuando se habla de «dotarnos de leyes que faculten a las Comunidades Autónomas para que examinen a la población a fin de controlar y prevenir la propagación de este virus», de lo que realmente se está hablando es de crear una sociedad en la que las tarjetas de identificación, las redadas, los puestos de control y los centros de detención se conviertan en una rutina.\n\n<PARAGRAPH>\n",
        "TITLE": "La nueva segregación: el ‘certificado covid’ es sólo el comienzo",
        "ID": "NF_NF_1236_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "La nueva segregación: el ‘certificado covid’ es sólo el comienzo",
                "text_en": "The new segregation: the ‘certificate covid’ is only the beginning",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nueva segregación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "new segregation"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "el ‘certificado covid’",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the ‘certificate covid’"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Imaginemos un sistema de clasificación que no solo nos categoriza según nuestro estado de salud, sino que también le permite al Estado clasificarnos de otras cien formas: por género, orientación, riqueza, condición médica, creencias religiosas, punto de vista político, estado legal, etc.",
                "text_en": "Imagine a classification system that not only categorizes us according to our state of health, but also allows the state to classify us in a hundred other ways: by gender, orientation, wealth, medical condition, religious beliefs, political viewpoint, legal status, etc.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Imaginemos un sistema de clasificación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Imagine a sorting system"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Estado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the State"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de otras cien formas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "of another 100 forms"
                    }
                ],
                "evidences": [
                    {
                        "value": "Consequently, if we start from the classification system with less operational criteria of \"transparency\" checked, to the classification system with a majority of operational criteria checked, we obtain: BPMLL, SMO, MLkNN, RIPPER, C4.5 and Naive Bayes. Accordingly, a classification system based on the Naive Bayes algorithm can be considered as the best alternative, from a \"transparency\" perspective, to treat our medical use case.",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9934101701
                    }
                ]
            },
            {
                "text": "Esta es la pendiente resbaladiza en la que estamos embarcados, una que comienza con los pasaportes de vacunas y termina con un sistema nacional de segregación.",
                "text_en": "This is the slippery slope on which we are embarked, one that begins with vaccine passports and ends with a national segregation system.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta es la pendiente resbaladiza en la que estamos embarcados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This is the slippery slope on which we are embarking."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "comienza con los pasaportes de vacunas y termina con un sistema nacional de segregación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "begins with vaccine passports and ends with a national segregation system"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cada día que pasa, más y más empresas privadas y establecimientos están requiriendo a los usuarios prueba de una vacuna COVID-19 para poder trabajar, viajar, comprar, ir a la escuela y, en general, participar en la vida social.",
                "text_en": "Every day that goes by, more and more private companies and establishments are requiring users to test a COVID-19 vaccine to be able to work, travel, buy, go to school and, in general, participate in social life.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "más y más empresas privadas y establecimientos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "more and more private companies and establishments"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están requiriendo a los usuarios prueba de una vacuna COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are requiring users to test a COVID-19 vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los usuarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "users"
                    }
                ],
                "evidences": [
                    {
                        "value": "Recombinant adenoviral vectors expressing SARS-CoV-2 spike protein/RBD A number of other institutions/companies in China, UK, Russia, and USA developed recombinant adenoviral vector expressing the COVID-19 genes as vaccines. China has a version based on the human adenovirus vector (rAd5 backbone). United Kingdom (Oxford University) has a version (code name AZD1222) that is based on a simian adenoviral vector. A multinational company also has a similar vaccine based on Ad26 backbone (code name Ad.26.CoV2.S or JNJ-78436725), which have data suggesting that one dose may be enough. Russia has a COVID-19 vaccine (code name Sputnik V) that uses two recombinant adenovirus backbone, with one dose using the rAd5 and the other dose using the rAd26 to reduce the interference by the host immunity against the 98 In this phase 2 trial, the vaccine was found to induce significant immune responses in the majority of the recipients after a single immunization. No data from their phase 3 study are available at the time that this review was prepared.",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9964495897
                    }
                ]
            },
            {
                "text": "Al permitir que cualquier agente del Estado (policía, guardia civil, revisor de RENFE, etc.) establezcan una prueba de fuego para que las personas puedan participar en el comercio, la circulación y cualquier otro derecho que corresponda a la vida en una sociedad supuestamente libre, sienta las bases para una sociedad de «muéstrame tus papeles» en la que estamos obligados a identificarnos en cualquier momento ante cualquier funcionario público que lo exija por cualquier motivo.",
                "text_en": "By allowing any State agent (police, civil guard, RENFE reviewer, etc.) to establish a test of fire so that people can participate in trade, movement and any other right that corresponds to life in a supposedly free society, it lays the foundation for a society of \"show me your roles\" in which we are obliged to identify ourselves at any time before any public official who demands it for any reason.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una sociedad supuestamente libre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in a supposedly free society"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estamos obligados a identificarnos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We're obliged to identify ourselves."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en cualquier momento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "at any time"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "cualquier funcionario público",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "any public official"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por cualquier motivo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for any reason"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si no hubiera «pandemia» de por medio, ninguna persona que se identifique «de izquierdas» dudaría en calificar este régimen como un régimen fascista.",
                "text_en": "If there were no “pandemy” involved, no one who identified himself as “leftist” would hesitate to call this regime a fascist regime.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Si no hubiera «pandemia» de por medio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "If there was no ‘pandemy’ involved"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ninguna persona que se identifique «de izquierdas»",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "no person identified as ‘left-wing’"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dudaría en calificar este régimen como un régimen fascista",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I would hesitate to call this regime a fascist regime."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estas prácticas estatales están escalando rápidamente a una toma de poder que faculta al Estado o a cualquier empresa a obligar a demostrar que se cumplen con todas las medidas aparentemente sanitarias.",
                "text_en": "These state practices are rapidly escalating into a seizure of power that empowers the State or any company to compel it to demonstrate compliance with all apparently sanitary measures.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estas prácticas estatales están escalando rápidamente a una toma de poder que faculta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "These state practices are rapidly climbing into a power grab that empowers"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Estado o a cualquier empresa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the State or any undertaking"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Decimos aparentemente porque tras cada Real Decreto o decreto autonómico relativo a la gestión de la «pandemia» contiene, adicionalmente, toda una panoplia de medidas económicas, fiscales o de vigilancia que ningún medio publica.",
                "text_en": "We say apparently that after each Royal Decree or autonomous decree concerning the management of pandemy it contains, in addition, a whole panoply of economic, fiscal or surveillance measures that no media publishes.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "toda una panoplia de medidas económicas, fiscales o de vigilancia que ningún medio publica",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a panoply of economic, fiscal or surveillance measures that no media publishes"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ningún medio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "no means"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así es también cómo el derecho a circular libremente ha sido socavado, suprimido y reescrito en un privilegio otorgado por el gobierno a aquellos ciudadanos que están dispuestos a seguir la línea o que gozan de una preeminencia social que, como no podría ser de otro modo en un Estado fascista, está asociada a su poder económico.",
                "text_en": "This is also how the right to move freely has been undermined, suppressed and rewritten in a privilege granted by the government to those citizens who are willing to follow the line or who enjoy a social preeminence that, as it could not otherwise be in a fascist state, is associated with its economic power.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el derecho a circular libremente ha sido socavado, suprimido y reescrito",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the right to freedom of movement has been undermined, deleted and rewritten"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en un privilegio otorgado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in a privilege granted"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por el gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the Government"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a aquellos ciudadanos que están dispuestos a seguir la línea o que gozan de una preeminencia social",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "citizens who are willing to follow the line or who enjoy a social preeminence"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un Estado fascista",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in a Fascist State"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "está asociada a su poder económico",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is associated with its economic power"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ahora, los pasaportes de las vacunas, los requisitos de admisión en establecimientos públicos y las restricciones de viaje pueden parecer pasos pequeños y necesarios para ganar la guerra contra el virus, pero eso no es más que pura propaganda.",
                "text_en": "Now, vaccine passports, admission requirements in public establishments and travel restrictions may seem like small and necessary steps to win the war against the virus, but that is nothing more than pure propaganda.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no es más que pura propaganda",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It's nothing but pure propaganda."
                    }
                ],
                "evidences": [
                    {
                        "value": "In order to address the aforementioned challenges, this paper presents an architecture for a Blockchain-based platform that creates and verifies digital COVID-19 vaccine passports. The platform makes use of IPFS for storing and distributing citizens' passport data securely. It also involves a smart contract factory to improve transparency, trust and data privacy of citizens.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "Participants overwhelmingly supported businesses requiring that customers be vaccinated. One summarized this shared sentiment as being ''like no shoes, no shirt, no service at the pub\" (or bar). (Sarah). As with 'gatherings mandates' or vaccine passports, participants considered that business mandates for clients imposed a logical consequence.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9994428754
                    },
                    {
                        "label": "neutral",
                        "score": 0.6685402989
                    }
                ]
            },
            {
                "text": "Principalmente son medidas necesarias para el estado policial en sus esfuerzos por lavar aún más el cerebro a la población, para que crea que el gobierno tiene el derecho y el poder para hacer cumplir actos tan descarados de autoritarismo.",
                "text_en": "They are mainly necessary measures for the police state in its efforts to further brainwash the population, so that it believes that the government has the right and the power to enforce such blatant acts of authoritarianism.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "son medidas necesarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "necessary measures"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el estado policial",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the police state"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "en sus esfuerzos por lavar aún más el cerebro",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in their efforts to further brainwash"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la población",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así es como se encarcela y se encierra a toda una sociedad.",
                "text_en": "This is how a whole society is imprisoned and locked up.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se encarcela y se encierra",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Imprisoned and Locked"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a toda una sociedad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to an entire society"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En otros tiempos tales tácticas de estado policial se llevaban a cabo en nombre de la seguridad nacional o en la lucha contra ETA, pero ahora, el poder que concentra el Estado se hace en nombre de la salud, porque el Estado siempre se preocupó de nuestra salud.",
                "text_en": "In other times such police state tactics were carried out in the name of national security or in the fight against ETA, but now, the power that concentrates the state is done in the name of health, because the state always cared about our health.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En otros tiempos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "In other times"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tales tácticas de estado policial se llevaban a cabo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "such police state tactics were carried out"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en nombre de la seguridad nacional o en la lucha contra ETA",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on behalf of national security or in the fight against ETA"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ahora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Now"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el poder que concentra",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the power that concentrates"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Estado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "State"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en nombre de la salud",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on behalf of health"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque el Estado siempre se preocupó de nuestra salud",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because the state always cared about our health"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La lucha contra el terrorismo, donde el Estado se atribuyó y se dotó de leyes de excepción (Ley antiterrorista, Ley de Partidos), resultó ser una política que iba mucho más allá de la excusa terrorista; fue una concentración de poderes donde los casos de represión que hemos visto en las redes sociales durante el confinamiento no podrían concebirse sin esos antecedentes.",
                "text_en": "The fight against terrorism, where the State attributed itself to itself and provided itself with emergency laws (Anti-Terrorism Act, Party Act), turned out to be a policy that went far beyond the terrorist excuse; it was a concentration of powers where the cases of repression we have seen on social networks during confinement could not be conceived without that background.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los casos de represión que hemos visto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the cases of repression that we have seen"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las redes sociales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on social networks"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante el confinamiento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during confinement"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y esta «guerra» contra el COVID-19 (así lo calificó el ex JEMAD Miguel Ángel Villarroya en una de sus ruedas de prensa de abril de 2020) está resultando ser una guerra más contra el derecho de reunión, de expresión y de cualquier derecho civil, librada con todo el armamento de vigilancia y los mecanismos de rastreo a disposición del Estado.",
                "text_en": "And this \"war\" against the COVID-19 (as the former JEMAD Miguel Angel Villarroya called it in one of his press conferences of April 2020) is proving to be another war against the right of assembly, of expression and of any civil right, waged with all the weapons of surveillance and the mechanisms of tracing available to the State.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está resultando ser una guerra más contra el derecho de reunión, de expresión y de cualquier derecho civil",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is proving to be another war against the right of assembly, expression and any civil right"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "librada con todo el armamento de vigilancia y los mecanismos de rastreo a disposición",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with all the surveillance weapons and tracking mechanisms at hand"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Estado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "State"
                    }
                ],
                "evidences": [
                    {
                        "value": "As expected, however, the number of new COVID-19 cases sharply increased soon after businesses reopened. This sharp increase has already occurred in some Iranian cities. According to the Institute for Health Metrics and Evaluation (IHME), an independent global health research center at the University of Washington, if Iranians continue with careless behaviors, the number of COVID-19 cases will begin to increase exponentially. 5 We were supposed F or the third time in the written history of humankind, a war has involved most countries of the globe: The world is at war with the coronavirus. 1 In this war, the soldiers are dedicated health care workers fighting tirelessly in the frontlines of the battle. \"Science\" is their only weapon. The generals writing the battle plans for this war must be scientists because every strategy for winning this war must be based on sound scientific evidence. Most world leaders are not scientists but they must listen to scientists.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9997575879
                    }
                ]
            },
            {
                "text": "Cuando se habla de «dotarnos de leyes que faculten a las Comunidades Autónomas para que examinen a la población a fin de controlar y prevenir la propagación de este virus», de lo que realmente se está hablando es de crear una sociedad en la que las tarjetas de identificación, las redadas, los puestos de control y los centros de detención se conviertan en una rutina.",
                "text_en": "When we talk about 'giving us laws that empower the Autonomous Communities to examine the population in order to control and prevent the spread of this virus', what we are really talking about is creating a society in which identification cards, raids, checkpoints and detention centres become routine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "leyes que faculten a las Comunidades Autónomas para que examinen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "laws empowering the Autonomous Communities to examine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las Comunidades Autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Autonomous Communities"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the population"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a fin de controlar y prevenir la propagación de este virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to control and prevent the spread of this virus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "crear una sociedad en la que las tarjetas de identificación, las redadas, los puestos de control y los centros de detención se conviertan en una rutina",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "create a society in which identification cards, raids, checkpoints and detention centres become routine"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "61": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 11,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 7,
            "WhoReliabilityReliable": 6,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 23,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 23,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nBogotá, 2 abr (EFE).- Colombia agregó este viernes 10.222 contagios y otras 163 muertes por coronavirus, cifras por las que las autoridades sanitarias consideran que el país está entrando a una tercera ola de la pandemia.\n\n<PARAGRAPH>\n\nColombia totaliza 2.428.048 infecciones, de las cuales 55.062 permanecen activas, que corresponden al 2,27 %, mientras que 2.300.887 han sido contabilizadas como recuperadas, es decir el 94,76 %.\n\n<PARAGRAPH>\n\nLos contagios por la covid-19 se han disparado en las últimas semanas principalmente en el departamento de Antioquia, que hoy sumó 3.008 casos, y en el Atlántico, que registró 2.147 en esta jornada.\n\n<PARAGRAPH>\n\nTambién hubo cifras altas en Bogotá (1.805), Valle del Cauca (592) y Magdalena (432).\n\n<PARAGRAPH>\n\nLas regiones en las que más infecciones han sido confirmadas siguen siendo Bogotá (690.844), Antioquia (380.298), Valle del Cauca (209.698), Atlántico (156.344) y Cundinamarca (111.526).\n\n<PARAGRAPH>\n\nSobre los fallecidos informados en esta jornada, con los que Colombia acumula 63.777 muertes, el Ministerio de Salud informó que 146 ocurrieron en días anteriores.\n\n<PARAGRAPH>\n\nLos decesos ocurrieron principalmente en Atlántico (42), Antioquia (30), Bogotá (16) y Valle del Cauca (13).\n\n<PARAGRAPH>\n\nHoy se procesaron 43.401 muestras, de las cuales 29.873 fueron de tipo PCR y otras 13.528 de antígenos, para un total de 12,83 millones de pruebas practicadas.\n\n<PARAGRAPH>\n\nSegún el informe del Ministerio de Salud, en la últimas 24 horas en el país fueron aplicadas 57.498 dosis de la vacuna contra el coronavirus, menos de la mitad de las más de 121.000 administradas en la jornada anterior.\n\n<PARAGRAPH>\n\nEn total en el país se han aplicado 2.300.890 dosis, de las cuales 334.955 personas han recibido las dos dosis.\n\n<BREAK>\n\nEFE\n\n<PARAGRAPH>\n\n",
        "TITLE": "Colombia agrega 10.222 contagios y otras 163 muertes por coronavirus",
        "ID": "NF_04-11-2021_22-11-06_www_eje21_com_co",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Colombia agrega 10.222 contagios y otras 163 muertes por coronavirus",
                "text_en": "Colombia adds 10,222 infections and another 163 deaths per coronavirus",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "agrega 10.222 contagios y otras 163 muertes por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "adds 10,222 contagions and another 163 deaths per coronavirus"
                    }
                ],
                "evidences": [
                    {
                        "value": "In a prospective study of respiratory viral infections among hospitalized patients, 5.7% had coronaviruses identified. 220 The 47 coronavirus infections represent 10.5% of all the respiratory viral infections. In 14 patients, coronaviruses were associated with another respiratory virus. Lower respiratory tract infections (bronchitis, bronchiolitis, and pneumonia) were far more common than upper respiratory tract (rhinitis, pharyngitis, and laryngitis) infections, 75 versus 25%, respectively. Over half of the infections were due to OC43-like strains. Approximately 20% were due to 229E-like strains and approximately 20% were due to NL63-strains. Coronavirus infections in the first year of life were associated predominantly with OC43-like strains.",
                        "score": 0.6800000072
                    },
                    {
                        "value": "As far as the seasonal distribution of coronavirus 229E infections is concerned, our results show that coronavirus 229E infections occur more frequently in Italy during the winter-spring period. This agrees with data previously reported for other countries [2, 3] .",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9979744554
                    },
                    {
                        "label": "neutral",
                        "score": 0.9237571359
                    }
                ]
            },
            {
                "text": "Bogotá, 2 abr (EFE).- Colombia agregó este viernes 10.222 contagios y otras 163 muertes por coronavirus, cifras por las que las autoridades sanitarias consideran que el país está entrando a una tercera ola de la pandemia.",
                "text_en": "Bogotá, 2 Apr (EFE).- Colombia added on Friday 10,222 infections and another 163 deaths due to coronaviruses, figures for which health authorities consider that the country is entering a third wave of the pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "agregó este viernes 10.222 contagios y otras 163 muertes por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "added on Friday 10,222 contagions and another 163 deaths per coronavirus"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Friday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las autoridades sanitarias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "health authorities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "consideran que el país está entrando a una tercera ola de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "consider that the country is entering a third wave of the pandemic"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Colombia totaliza 2.428.048 infecciones, de las cuales 55.062 permanecen activas, que corresponden al 2,27 %, mientras que 2.300.887 han sido contabilizadas como recuperadas, es decir el 94,76 %.",
                "text_en": "Colombia totals 2,428,048 infections, of which 55,062 remain active, accounting for 2.27%, while 2,300,887 have been accounted for as recovered, i.e. 94.76 %.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "totaliza 2.428.048 infecciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "total 2,428,048 infections"
                    }
                ],
                "evidences": [
                    {
                        "value": "On March 2, 2020, the first patient was detected in Argentina. Meanwhile, on March 6, the first case of COVID-19 was confirmed in Colombia. Nine months after the first infections, after more than 52.6 million infections worldwide and more than 1.29 million deaths worldwide. Specifically, Argentina and Colombia countries report similar figures for infection: 1.28 and 1.17 million cases, and 34,782 deaths in Argentina and 33,491 in Colombia.",
                        "score": 0.6499999762
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "entailment",
                        "score": 0.5068392754
                    }
                ]
            },
            {
                "text": "Los contagios por la covid-19 se han disparado en las últimas semanas principalmente en el departamento de Antioquia, que hoy sumó 3.008 casos, y en el Atlántico, que registró 2.147 en esta jornada.",
                "text_en": "Contagions from covid-19 have skyrocketed in recent weeks mainly in the department of Antioquia, which today totaled 3,008 cases, and in the Atlantic, which registered 2,147 on this day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los contagios por la covid-19 se han disparado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Covid-19 contagions have skyrocketed"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las últimas semanas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the last few weeks"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el departamento de Antioquia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the department of Antioquia"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Atlántico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Atlantic"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También hubo cifras altas en Bogotá (1.805), Valle del Cauca (592) y Magdalena (432).",
                "text_en": "There were also high figures in Bogotá (1.805), Valle del Cauca (592) and Magdalena (432).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "También hubo cifras altas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There were also high numbers"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Bogotá",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Bogotá"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Valle del Cauca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Valle del Cauca"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Magdalena",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Magdalena"
                    }
                ],
                "evidences": [
                    {
                        "value": "The seroprevalence in HCWs from Bogota was higher than in a previous study in one hospital in the city carried out in August 2020 (8.26%) [25] but similar to the seroprevalence reported in a cohort of airport workers in Bogotá (September 2020) [26] .",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9953101277
                    }
                ]
            },
            {
                "text": "Sobre los fallecidos informados en esta jornada, con los que Colombia acumula 63.777 muertes, el Ministerio de Salud informó que 146 ocurrieron en días anteriores.",
                "text_en": "On the deaths reported on this day, with which Colombia accumulates 63,777 deaths, the Ministry of Health reported that 146 occurred in previous days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "acumula 63.777 muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "amassing 63,777 deaths"
                    }
                ],
                "evidences": [
                    {
                        "value": "On March 2, 2020, the first patient was detected in Argentina. Meanwhile, on March 6, the first case of COVID-19 was confirmed in Colombia. Nine months after the first infections, after more than 52.6 million infections worldwide and more than 1.29 million deaths worldwide. Specifically, Argentina and Colombia countries report similar figures for infection: 1.28 and 1.17 million cases, and 34,782 deaths in Argentina and 33,491 in Colombia.",
                        "score": 0.5099999905
                    },
                    {
                        "value": "The physical isolation due to SARS CoV-2 in Colombia extended for 156 days from March 25 to August 30, 2020. As of November 13, 2020, Colombia has reported 1,198,746 COVID 19 cases, 1,104,956 recoveries, and 34.031 deaths (8) . Epidemiological reports have focused mainly on the notification and monitoring of the pandemic ignoring the direct and indirect health impacts in the country.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.6294156909
                    },
                    {
                        "label": "neutral",
                        "score": 0.9994194508
                    }
                ]
            },
            {
                "text": "Hoy se procesaron 43.401 muestras, de las cuales 29.873 fueron de tipo PCR y otras 13.528 de antígenos, para un total de 12,83 millones de pruebas practicadas.",
                "text_en": "Today, 43,401 samples were processed, of which 29,873 were PCR-type and another 13,528 antigens, for a total of 12.83 million tests performed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se procesaron 43.401 muestras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "43,401 samples were processed"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de tipo PCR",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "PCR type"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de antígenos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "antigens"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según el informe del Ministerio de Salud, en la últimas 24 horas en el país fueron aplicadas 57.498 dosis de la vacuna contra el coronavirus, menos de la mitad de las más de 121.000 administradas en la jornada anterior.",
                "text_en": "According to the report of the Ministry of Health, 57,498 doses of the coronavirus vaccine were applied in the last 24 hours in the country, less than half of the more than 121,000 given in the previous day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ministerio de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la últimas 24 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last 24 hours"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fueron aplicadas 57.498 dosis de la vacuna contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "57,498 doses of the coronavirus vaccine were administered"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En total en el país se han aplicado 2.300.890 dosis, de las cuales 334.955 personas han recibido las dos dosis.",
                "text_en": "A total of 2,300,890 doses have been applied in the country, of which 334,955 people have received both doses.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "e han aplicado 2.300.890 dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "and have applied 2,300,890 doses"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "334.955 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "334,955 persons"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han recibido las dos dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have received both doses"
                    }
                ],
                "evidences": [
                    {
                        "value": "While current supplies are limited, the Fijian government and MoH have managed at least 223,429 doses of COVID-19 vaccines so far. Considering that each individual requires two doses, which will be enough to vaccinate 12.6% of the country's population (see Fig. 1 ). MoH revealed that during the last weeks report, the country recorded an average of about 8,728 doses administered each day [6] . At this rate, administering enough doses for another 10% of the population will take another 21 days.",
                        "score": 0.5400000215
                    },
                    {
                        "value": "Although population of high-income countries makes up only 14% of the global, they had pledged to buy 51% of all pre-sold doses by 15 November 2020 (9) . According to the WHO director-general speech on 18th January 2021, only 25 doses have been administered in one lowest-income country; while more than 39 million doses of vaccine have been bought by at least 49 higher income countries (10) . Moreover, some high-income countries have bought vaccines more than their necessity to vaccinate their entire population (9) .",
                        "score": 0.5099999905
                    },
                    {
                        "value": "From week 52/2020 through week 31/2021 a total of 349,790,000 doses of COVID-19 vaccines were administered in the US and 496,518,433 doses of COVID-19 vaccines in Europe [7, 8] . Overall, 837,830,000 doses of COVID-19 vaccines have been delivered in the US and Europe during the study period, for which the vaccine name was known [7, 8] . Table 1 shows the numbers of administered COVID-19 vaccine doses and the numbers of anaphylactic reaction cases and anaphylactic shock cases per evaluated COVID-19 vaccine. In total there were 8940 notified anaphylactic cases reported to EudraVigilance and VAERS, including 7873 anaphylactic reactions cases and 1067 anaphylactic shock cases. The mean anaphylaxis rates per licensed COVID-19 vaccine were as follows: 8.58 per 10 6 vaccine doses for Spikevax, 10.44 per 10 6 vaccine doses for Comirnaty, 19 .39 per 10 6 vaccine doses for Vaxzevria, and 7.99 per 10 6 vaccine doses for Janssen. The mean anaphylaxis rate of the four licensed COVID-19 vaccines overall was estimated at 10.67 per 10 6 vaccine doses. Finally, there were 52 fatal anaphylaxis cases notified to VAERS and EudraVigilance, which corresponds to 0.06 fatal anaphylaxis cases per 10 6 vaccine doses. Fig. 1 shows the estimated anaphylaxis rates per studied vaccine in descending order. Rabies vaccine has by far the highest anaphylaxis rate among vaccines (70.77 anaphylaxis cases per 10 6 doses), followed by tick-borne encephalitis vaccine, measlesmumps-rubella-varicella vaccine, and human papillomavirus vaccine (20, 19.8, and 13 .65 anaphylaxis cases per 10 6 vaccine doses, respectively) [6, 12] . The estimated mean anaphylaxis rate of 10.67 among licensed COVID-19 vaccines rendered them fifth in this ranking, which is higher than the anaphylaxis rates of several routine or travel vaccines ( Fig. 1 ) but within the range of mean anaphylaxis rates of most commonly administered vaccines (1 per 10 6 vaccine doses to 10 per 10 6 vaccine doses depending on the vaccine) [13] .",
                        "score": 0.5199999809
                    },
                    {
                        "value": "In the EEA by 31 October 2021, the total number of doses administered of ChAdOx1 nCoV-19 was 68.8 million and of tozinameran 435.6 million. Approximately 5900 reports of suspected reactions per million doses had been logged for ChAdOx1 nCoV-19 and 1300 reports per million doses for tozinameran.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9773216844
                    },
                    {
                        "label": "neutral",
                        "score": 0.9074278474
                    },
                    {
                        "label": "neutral",
                        "score": 0.867177248
                    },
                    {
                        "label": "neutral",
                        "score": 0.9979588985
                    }
                ]
            }
        ]
    },
    "62": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 9,
            "WhatReliabilityReliable": 1,
            "WhatReliabilityUnreliable": 8,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 8,
            "WhoReliabilityReliable": 2,
            "WhoReliabilityUnreliable": 6,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 4,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 2,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 4,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 3,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 4,
            "Key-Verb": 0,
            "Orthotypography": 2,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEstamos dominados por el virus del miedo, no por ningún otro virus para el que se nos obligue a usar mascarillas.\n\n<BREAK>\n\nY ese virus está dominando esta sociedad de tal forma, que tiene a muchas mentes bloqueadas por el terror, mentes que no ven más allá de lo que les diga una vendida televisión, un rastrero medio de comunicación, un malísimo político o un médico traidor.\n\n<PARAGRAPH>\n\nDebido a ese terror, ya pánico absoluto, ya nadie piensa por sí mismo y espera que lo hagan por él.\n\n<BREAK>\n\nHoy mismo publicábamos la reacción que habían tenido alguna de las personas vacunadas con AstraZeneca y de qué forma se quejaban con los gobiernos, los responsables sanitarios e incluso los fabricantes de las vacunas.\n\n<PARAGRAPH>\n\nPero el problema también es suyo.\n\n<BREAK>\n\nY es que, estando las cosas como están, no se puede tomar una decisión tan sumamente importante como la de vacunarse con un líquido experimental, del que no se responsabiliza nadie, sin, al menos, informarse un poquito de qué es lo que le están metiendo en el cuerpo, más que nada porque, seguramente, el resto de su vida dependa de esa importante decisión.\n\n<PARAGRAPH>\n\nPor eso nos parece tan bueno este hilo que ha publicado un usuario de Twitter.\n\n<BREAK>\n\nSe podrá estar más o menos de acuerdo con alguno de los puntos pero hay mucha gente que, por culpa de toda esa basura que les hace vivir con un miedo permanente, no piensa, no disfruta y comete errores muy graves.\n\n<PARAGRAPH>\n\nEsta es, y otras cosas más que ha publicado este tuitero, deberían formar parte de “LA NUEVA SEPA”.\n\n<PARAGRAPH>\n\nCOLABORA CON NOSOTROS CON PAYPAL\n\n<PARAGRAPH>\n\n",
        "TITLE": "El fantástico hilo de Twitter que habla de \"LA NUEVA SEPA\" y que debería ser leído por todo aterrado \"tragacionista\"",
        "ID": "3_NF_04-11-2021_20-43-38_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "El fantástico hilo de Twitter que habla de \"LA NUEVA SEPA\" y que debería ser leído por todo aterrado \"tragacionista\"",
                "text_en": "The fantastic Twitter thread that talks about \"THE NEW SEPA\" and that should be read by all terrified \"tragationist\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hilo de Twitter que habla de \"LA NUEVA SEPA\" y que debería ser leído",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Twitter thread that talks about \"THE NEW SEPA\" and that should be read"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Twitter",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Twitter"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por todo aterrado \"tragacionista\"",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for all terrified \"tragationist\""
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estamos dominados por el virus del miedo, no por ningún otro virus para el que se nos obligue a usar mascarillas.",
                "text_en": "We are dominated by the virus of fear, not by any other virus for which we are forced to wear masks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dominados por el virus del miedo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "dominated by the fear virus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ningún otro virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "no other viruses"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y ese virus está dominando esta sociedad de tal forma, que tiene a muchas mentes bloqueadas por el terror, mentes que no ven más allá de lo que les diga una vendida televisión, un rastrero medio de comunicación, un malísimo político o un médico traidor.",
                "text_en": "And that virus is dominating this society in such a way, that it has many minds blocked by terror, minds that don't see beyond what a sold-out TV, a crawling media, a terrible politician or a traitoric doctor tells them.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ese virus está dominando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "That virus is dominating."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "esta sociedad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "this society"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por el terror",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by terror"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "no ven más allá de lo que les diga",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "they don't see beyond what I tell them."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una vendida televisión, un rastrero medio de comunicación, un malísimo político o un médico traidor",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a sold television, a crawling media, a terrible politician or a traitoric doctor"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Debido a ese terror, ya pánico absoluto, ya nadie piensa por sí mismo y espera que lo hagan por él.",
                "text_en": "Because of that terror, already absolute panic, no one thinks for themselves anymore and expects them to do it for him.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Debido a ese terror",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because of that terror"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nadie",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "No one."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "piensa por sí mismo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Think for yourself"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hoy mismo publicábamos la reacción que habían tenido alguna de las personas vacunadas con AstraZeneca y de qué forma se quejaban con los gobiernos, los responsables sanitarios e incluso los fabricantes de las vacunas.",
                "text_en": "Today we were publicizing the reaction of some of the people vaccinated with AstraZeneca and how they complained to governments, health officials and even vaccine manufacturers.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "publicábamos la reacción",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We advertised the reaction."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas vacunadas con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "people vaccinated with AstraZeneca"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los gobiernos, los responsables sanitarios e incluso los fabricantes de las vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Governments, health-care providers and even vaccine manufacturers"
                    }
                ],
                "evidences": [
                    {
                        "value": "The frequencies of each symptom with the three taken vaccine manufacturers are demonstrated in Table 2 , 66.9% of those who took Pfizer vaccine suffered from injection site reaction, which was more common when compared with AstraZeneca and Sinopharm one 54.2%, 54.5% respectively. Fever, fatigue, headache, myalgia and chills were more common among AstraZeneca vaccine. Three participants had allergic reaction after taking the vaccine by 5e15 min. One of them was an AstraZeneca recipient and two were Pfizer recipients. More details are shown in below table.",
                        "score": 0.5
                    },
                    {
                        "value": "The Italian authorities have used the following vaccination strategy, reserving the mRNA vaccines for health personnel and the population over 80 years old, and the administration of the COVID-19 Vaccine AstraZeneca for law enforcement personnel, school personnel and the population between 70 and 80 years old [9] . A strategy for monitoring adverse events of vaccines is based on the collaboration of local and national health structures, assisted by Italian Medicines Agency (AIFA) [10, 11] . On 15 March 2021, AIFA has decided to suspend temporarily the use of the AstraZeneca Covid19 vaccine throughout the country as a precaution, pending the rulings of the European Medicines Agency (EMA). This decision was taken in line with similar measures adopted by other European countries due to the death of some vaccinated people [10]. On 18 March 2021, EMA's safety committee concluded its preliminary review about thromboembolic events in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting [12] . The Committee confirmed that:",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9920766354
                    },
                    {
                        "label": "neutral",
                        "score": 0.9810040593
                    }
                ]
            },
            {
                "text": "Y es que, estando las cosas como están, no se puede tomar una decisión tan sumamente importante como la de vacunarse con un líquido experimental, del que no se responsabiliza nadie, sin, al menos, informarse un poquito de qué es lo que le están metiendo en el cuerpo, más que nada porque, seguramente, el resto de su vida dependa de esa importante decisión.",
                "text_en": "And it is that, when things are as they are, one cannot make such an extremely important decision as to get vaccinated with an experimental liquid, for which no one is responsible, without, at least, knowing a little bit about what they are getting into his body, more than anything else because, surely, the rest of his life depends on that important decision.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vacunarse con un líquido experimental",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "getting vaccinated with an experimental liquid"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin, al menos, informarse un poquito de qué es lo que le están metiendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "without, at least, finding out a little bit about what they're getting him into."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el cuerpo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the body"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "el resto de su vida dependa de esa importante decisión",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The rest of your life depends on that important decision."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por eso nos parece tan bueno este hilo que ha publicado un usuario de Twitter.",
                "text_en": "That's why we find this thread so good that a Twitter user has posted.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hilo que ha publicado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thread you have published"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "usuario",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "user"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Twitter",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Twitter"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se podrá estar más o menos de acuerdo con alguno de los puntos pero hay mucha gente que, por culpa de toda esa basura que les hace vivir con un miedo permanente, no piensa, no disfruta y comete errores muy graves.",
                "text_en": "You might agree more or less with one of the points but there are many people who, because of all that crap that makes them live with a permanent fear, do not think, do not enjoy and make very serious mistakes.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mucha gente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a lot of people"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por culpa de toda esa basura que les hace vivir con un miedo permanente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because of all that crap that makes them live in permanent fear"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "comete errores muy graves",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "makes very serious mistakes"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "63": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 9,
            "WhatReliabilityReliable": 4,
            "WhatReliabilityUnreliable": 5,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 9,
            "WhoReliabilityReliable": 9,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 1,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 4,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 7,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 3,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nLas pruebas de las vacunas Moderna y Pfizer se realizaron, como es habitual, con un grupo de control, es decir, con un grupo dentro del ensayo que recibió un placebo y no la vacuna de prueba.\n\n<BREAK>\n\nSin embargo, durante el ensayo, las farmacéuticas decidieron romper el protocolo y notificar al grupo de control que no estaban vacunados, por lo que a casi todo el grupo de control se le administró la vacuna.\n\n<PARAGRAPH>\n\nSegún ha informado la NPR, la radio pública de los Estados Unidos, la disolución intencional del grupo placebo viola el propósito científico de probar si la vacuna tiene alguna eficacia; cualquier beneficio real y/o problemas de seguridad no podrá ser evidenciado, ya que sin un grupo de control, no hay nada con lo que comparar al grupo vacunado.\n\n<PARAGRAPH>\n\nPara que quede clara la gravedad de la decisión adoptada y la metodología empleada, la autorización y aprobación final de la agencia norteamericana del medicamento (FDA) para las vacunas se basa en el resultado de estos ensayos, por lo que no hay forma de medir la eficacia, efectividad o seguridad de la vacuna en sí.\n\n<PARAGRAPH>\n\nNo queda nadie dentro del grupo de control, de un valor estadísticamente válido, para proporcionar una comparación adecuada de los resultados para personas vacunadas frente a las no vacunadas.\n\n<BREAK>\n\nEsto es una locura.\n\n<PARAGRAPH>\n\nDe acuerdo al artículo de NPR, ¿cómo puede considerarse eficaz la vacuna cuando no hay un grupo de personas no vacunadas con las que comparar los resultados?.\n\n<BREAK>\n\nDa igual, porque la FDA, al igual que la OMS, es otro de los organismos más corrompidos del sistema sanitario mundial.\n\n<PARAGRAPH>\n\nFuente: NPR\n\n<PARAGRAPH>\n",
        "TITLE": "Pfizer violó el protocolo y adulteró las pruebas para obtener la aprobación de la FDA",
        "ID": "NF_NF_1175_mpr21_info",
        "VALUE": "Fake",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Pfizer violó el protocolo y adulteró las pruebas para obtener la aprobación de la FDA",
                "text_en": "Pfizer violated protocol and adulterated evidence to obtain FDA approval",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "violó el protocolo y adulteró las pruebas para obtener la aprobación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "violated protocol and adulterated evidence to obtain approval"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la FDA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the FDA"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las pruebas de las vacunas Moderna y Pfizer se realizaron, como es habitual, con un grupo de control, es decir, con un grupo dentro del ensayo que recibió un placebo y no la vacuna de prueba.",
                "text_en": "Tests for the Moderna and Pfizer vaccines were, as usual, performed with a control group, i.e. with a group within the trial that received a placebo rather than the test vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las pruebas de las vacunas Moderna y Pfizer se realizaron",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Tests of the Moderna and Pfizer vaccines were performed"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con un grupo de control",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with a control group"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con un grupo dentro del ensayo que recibió un placebo y no la vacuna de prueba",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with a group within the trial that received placebo and not the test vaccine"
                    }
                ],
                "evidences": [
                    {
                        "value": "Within 3 weeks, 3 of 10 reported to have developed vaccines with 90%, 94.5%, and up to 90% efficacy, respectively (Moderna, 2020; Pfizer and BioNTech, 2020 ; 90% achieved in the smallest sample). 1 The first has challenging storing requirements (−70°C). Moderna has cooperated with the National Institute of Allergy and Infectious Diseases (NIAID), one of 27 institutes under the National Institute for Health (NIH, 2020) . AstraZeneca has cooperated with the Jenner Institute and Oxford Vaccine Group at the University of Oxford.",
                        "score": 0.6000000238
                    },
                    {
                        "value": "Recipients of the Pfizer and Moderna vaccines form Groups 1 and 2, respectively ( Figure 1A , B; Supplemental Figure 1A , B). For comparison, we also studied 2 other sub-groups of participants. Group-3 members were SARS-CoV-2 uninfected (n = 7) ( Figure 1C , Supplemental Figure 1C ), while Group 4 included people who had recovered from COVID-19 or became infected during participation in the NYP-WELCOME trial (n = 10). Among Group-4 members, 8 were vaccinated ( Figure 1D , Supplemental Figure 1D ).",
                        "score": 0.6999999881
                    },
                    {
                        "value": "The phase 2 randomized, double-blind placebo-controlled single centered trial of AD5-vectored vaccine for COVID-19 was conducted in China. Total 508 healthy adults, more than 18 years were enrolled with 382 in the two doses of test vaccine group (1 9 10 11 viral particles, n = 253; 5 9 10 10 viral particles, n = 129) and 126 in the placebo control group. The primary objective of this study was to evaluate the immunogenicity and safety of the test vaccine. The primary outcome for the safety evaluation was the incidence of adverse reactions within 14 days of immunization [17] .",
                        "score": 0.5600000024
                    },
                    {
                        "value": "In the phase 1 placebo control observer-blinded doseescalation study there were 195 participants were administered either of the two formulations of the test vaccine-BNT162b1 or BNT162b2 in the dose10 lg, 20 lg and 30 lg, and 100 lg in two age groups (18 to 55 and 65 to 85 years). Out of 195 participants, cohort 1 (N = 105) was assigned to receive BNT162b1 or placebo and cohort 2 was assigned to receive BNT162b2 or placebo. Each cohort was further divided into two groups based on age: group 1 had patients aged 18-55 years (N = 60 in cohort 1 and N = 45 in cohort 2) and group 2 had patients aged 65 to 85 (N = 45 in cohort 1 and N = 45 cohort 2).",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9990777969
                    },
                    {
                        "label": "neutral",
                        "score": 0.980167985
                    },
                    {
                        "label": "neutral",
                        "score": 0.9992081523
                    },
                    {
                        "label": "neutral",
                        "score": 0.9863633513
                    }
                ]
            },
            {
                "text": "Sin embargo, durante el ensayo, las farmacéuticas decidieron romper el protocolo y notificar al grupo de control que no estaban vacunados, por lo que a casi todo el grupo de control se le administró la vacuna.",
                "text_en": "However, during the trial, the pharmacists decided to break the protocol and notify the control group that they were not vaccinated, so almost the entire control group was given the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante el ensayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the test"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las farmacéuticas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pharmaceuticals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "decidieron romper el protocolo y notificar al grupo de control que no estaban vacunados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "decided to break the protocol and notify the control group that they were not vaccinated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a casi todo el grupo de control",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to almost the entire control group"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se le administró la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you were given the vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según ha informado la NPR, la radio pública de los Estados Unidos, la disolución intencional del grupo placebo viola el propósito científico de probar si la vacuna tiene alguna eficacia; cualquier beneficio real y/o problemas de seguridad no podrá ser evidenciado, ya que sin un grupo de control, no hay nada con lo que comparar al grupo vacunado.",
                "text_en": "As reported by the NPR, U.S. public radio, the intentional dissolution of the placebo group violates the scientific purpose of proving whether the vaccine has any efficacy; any real benefit and/or safety problems cannot be evidenced, as without a control group, there is nothing to compare with the vaccinated group.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la NPR, la radio pública",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "NPR, public radio"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "los Estados Unidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United States"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la disolución intencional del grupo placebo viola el propósito científico de probar si la vacuna tiene alguna eficacia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "intentional dissolution of the placebo group violates the scientific purpose of testing whether the vaccine has any efficacy"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que sin un grupo de control, no hay nada con lo que comparar al grupo vacunado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since without a control group, there is nothing to compare with the vaccinated group"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para que quede clara la gravedad de la decisión adoptada y la metodología empleada, la autorización y aprobación final de la agencia norteamericana del medicamento (FDA) para las vacunas se basa en el resultado de estos ensayos, por lo que no hay forma de medir la eficacia, efectividad o seguridad de la vacuna en sí.",
                "text_en": "In order to clarify the seriousness of the decision taken and the methodology used, the authorization and final approval of the US agency for the medicinal product (FDA) for vaccines is based on the results of these trials, so there is no way to measure the efficacy, effectiveness or safety of the vaccine itself.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la autorización y aprobación final de la agencia norteamericana del medicamento (FDA) para las vacunas se basa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the authorization and final approval of the US agency for the medicinal product (FDA) for vaccines is based"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la agencia norteamericana del medicamento (FDA) para las vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the US Drug Agency (FDA) for vaccines"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en el resultado de estos ensayos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the result of these tests"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No queda nadie dentro del grupo de control, de un valor estadísticamente válido, para proporcionar una comparación adecuada de los resultados para personas vacunadas frente a las no vacunadas.",
                "text_en": "There is no one left within the control group, of a statistically valid value, to provide an adequate comparison of the results for people vaccinated against those not vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No queda nadie dentro del grupo de control, de un valor estadísticamente válido, para proporcionar una comparación adecuada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "There is no one left within the control group, of a statistically valid value, to provide an adequate comparison"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de un valor estadísticamente válido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of a statistically valid value"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas vacunadas frente a las no vacunadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons vaccinated against non-vaccinated persons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto es una locura.",
                "text_en": "This is crazy.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esto es una locura",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This is crazy."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Da igual, porque la FDA, al igual que la OMS, es otro de los organismos más corrompidos del sistema sanitario mundial.",
                "text_en": "It doesn't matter, because the FDA, like the WHO, is another of the most corrupt organisms in the global health system.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la FDA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the FDA"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es otro de los organismos más corrompidos del sistema sanitario mundial",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is another of the most corrupt organisms in the global health system"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "64": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 10,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 5,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 10,
            "WhereReliabilityReliable": 10,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 3,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nMantiene también la limitación de las reuniones de no convivientes en los domicilios y los horarios en la hostelería.\n\n<PARAGRAPH>\n\nEl Boletín Oficial de la Comunidad de Madrid (BOCM) ha publicado este sábado las restricciones en 17 Zonas Básicas de Salud (ZBS) y 5 localidades a partir de este lunes, cuando se prorrogará además el toque de queda entre las 23.00 y las 6.00 horas y la prohibición de reuniones de no convivientes en domicilios durante 14 días más.\n\n<PARAGRAPH>\n\nA partir de las 00.00 horas del lunes 12 de abril y hasta las 00.00 horas del lunes 26 de abril quedarán restringidas las zonas básicas de salud de Villanueva del Pardillo; las zonas de La Princesa y Barcelona, en Móstoles; en Madrid capital las de Villa de Vallecas (distrito de Puente de Vallecas), Quinta de los Molinos (distrito de San Blas-Canillejas), Barajas (distrito de Barajas) y Silvano (en el distrito de Hortaleza); así como en el municipio de Manzanares El Real.\n\n<PARAGRAPH>\n\nAdemás, se mantienen las restricciones de movilidad una semana más, es decir hasta las 00.00 horas del lunes 19 de abril, las zonas básicas de salud de Las Margaritas, en Getafe; San Fernando, en San Fernando de Henares; en Madrid capital las de Alameda de Osuna (distrito de Barajas), Rejas (San Blas-Canillejas), Chopera (Arganzuela); Virgen de Begoña (Fuencarral-El Pardo); Vicálvaro-Artilleros y Valdebernardo (Vicálvaro); Valle de la Oliva (Majadahonda) y la zona básica de Villaviciosa de Odón.\n\n<PARAGRAPH>\n\nTambién quedarán limitadas durante una semana más las entradas y salidas, salvo por causas justificadas, en las localidades de La Cabrera, Moralzarzal, Colmenarejo y Paracuellos de Jarama.\n\n<PARAGRAPH>\n\nPor otro lado, se levantan las limitaciones de entrada y salida en la zona básica de Núñez Morgado (distrito de Chamartín), en Madrid capital, y en las localidades de Chapinería, Torrejón de Velasco, Villanueva de la Cañada, Navacerrada, Navas del Rey y Santos de la Humosa.\n\n<PARAGRAPH>\n\nLa Comunidad de Madrid mantiene también durante 14 días más la prohibición de las reuniones de no convivientes en domicilios, salvo que se trate de cuidados a terceras personas (mayores, dependientes, menores de edad o personas vulnerables).\n\n<PARAGRAPH>\n\nLa población afectada por las restricciones de entrada y salida salvo por causa justificada asciende a 427.809 ciudadanos, el 6,48% del total de la región, y concentran el 9,18% de los casos de los últimos 14 días.\n\n<PARAGRAPH>\n\nIgualmente, sigue siendo obligatorio, dentro de las medidas preventivas para hacer frente al Covid-19, asegurar la ventilación adecuada y permanente de los establecimientos; separación entre los grupos de mesas; que el número de comensales en las terrazas sea de un máximo de seis personas por mesa, y de cuatro en el interior de los establecimientos, y que está prohibido el consumo en barra.\n\n<PARAGRAPH>\n\nTambién se mantiene la obligatoriedad del uso de mascarilla de forma continuada, tanto en el interior como en terrazas, excepto en el momento concreto de la ingesta de bebida o comida.\n\n<PARAGRAPH>\n\n",
        "TITLE": "La Comunidad de Madrid cierra 17 zonas desde este lunes y mantiene el toque de queda en toda la región",
        "ID": "F_04-11-2021_21-04-59_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La Comunidad de Madrid cierra 17 zonas desde este lunes y mantiene el toque de queda en toda la región",
                "text_en": "The Community of Madrid closes 17 zones since this Monday and maintains curfew throughout the region",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Comunidad de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Community of Madrid"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cierra 17 zonas desde este lunes y mantiene el toque de queda",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "closes 17 zones since this Monday and maintains curfew"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since this Monday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en toda la región",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout the region"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Mantiene también la limitación de las reuniones de no convivientes en los domicilios y los horarios en la hostelería.",
                "text_en": "It also maintains the limitation of meetings of non-cohabitants at homes and times in the hotel.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Mantiene también la limitación de las reuniones de no convivientes en los domicilios y los horarios en la hostelería",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Also maintains the limitation of meetings of non-cohabitants in the homes and schedules in the hotel"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "no convivientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "non-cohabitants"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los domicilios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the residences"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Boletín Oficial de la Comunidad de Madrid (BOCM) ha publicado este sábado las restricciones en 17 Zonas Básicas de Salud (ZBS) y 5 localidades a partir de este lunes, cuando se prorrogará además el toque de queda entre las 23.00 y las 6.00 horas y la prohibición de reuniones de no convivientes en domicilios durante 14 días más.",
                "text_en": "The Official Gazette of the Community of Madrid (BOCM) published on Saturday the restrictions in 17 Basic Health Zones (ZBS) and 5 localities from this Monday, when the curfew will also be extended between 23.00 and 6.00 and the prohibition of meetings of non-residents in homes for 14 more days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Boletín Oficial de la Comunidad de Madrid (BOCM)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Official Gazette of the Community of Madrid (BOCM)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha publicado este sábado las restricciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has published the restrictions this Saturday"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este sábado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Saturday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en 17 Zonas Básicas de Salud (ZBS) y 5 localidades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in 17 Basic Health Areas (ZBS) and 5 localities"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir de este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from this Monday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A partir de las 00.00 horas del lunes 12 de abril y hasta las 00.00 horas del lunes 26 de abril quedarán restringidas las zonas básicas de salud de Villanueva del Pardillo; las zonas de La Princesa y Barcelona, en Móstoles; en Madrid capital las de Villa de Vallecas (distrito de Puente de Vallecas), Quinta de los Molinos (distrito de San Blas-Canillejas), Barajas (distrito de Barajas) y Silvano (en el distrito de Hortaleza); así como en el municipio de Manzanares El Real.",
                "text_en": "From 00.00 hours on Monday, 12 April, until 00.00 hours on Monday, 26 April, the basic health areas of Villanueva del Pardillo will be restricted; the areas of La Princesa and Barcelona, in Móstoles; in Madrid, the capital, those of Villa de Vallecas (district of Puente de Vallecas), Quinta de los Molinos (district of San Blas-Canillejas), Barajas (district of Barajas) and Silvano (district of Hortaleza); as well as in the municipality of Manzanares El Real.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "A partir de las 00.00 horas del lunes 12 de abril y hasta las 00.00 horas del lunes 26 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "From 00.00 a.m. on Monday, 12 April and until 00.00 a.m. on Monday, 26 April"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "quedarán restringidas las zonas básicas de salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "basic health areas will be restricted"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de Villanueva del Pardillo; las zonas de La Princesa y Barcelona, en Móstoles; en Madrid capital las de Villa de Vallecas (distrito de Puente de Vallecas), Quinta de los Molinos (distrito de San Blas-Canillejas), Barajas (distrito de Barajas) y Silvano (en el distrito de Hortaleza); así como en el municipio de Manzanares El Real",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of Villanueva del Pardillo; the areas of La Princesa and Barcelona, in Móstoles; in Madrid capital those of Villa de Vallecas (district of Puente de Vallecas), Quinta de los Molinos (district of San Blas-Canillejas), Barajas (district of Barajas) and Silvano (district of Hortaleza); as well as in the municipality of Manzanares El Real"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, se mantienen las restricciones de movilidad una semana más, es decir hasta las 00.00 horas del lunes 19 de abril, las zonas básicas de salud de Las Margaritas, en Getafe; San Fernando, en San Fernando de Henares; en Madrid capital las de Alameda de Osuna (distrito de Barajas), Rejas (San Blas-Canillejas), Chopera (Arganzuela); Virgen de Begoña (Fuencarral-El Pardo); Vicálvaro-Artilleros y Valdebernardo (Vicálvaro); Valle de la Oliva (Majadahonda) y la zona básica de Villaviciosa de Odón.",
                "text_en": "In addition, the mobility restrictions are maintained for another week, i.e. until 00.00 hours on Monday, 19 April, the basic health zones of Las Margaritas, in Getafe; San Fernando, in San Fernando de Henares; in Madrid the capital of Alameda de Osuna (district of Barajas), Rejas (San Blas-Canillejas), Chopera (Arganzuela); Virgen de Begoña (Fuencarral-El Pardo); Vicálvaro-Artilleros and Valdebernardo (Vicalvaro); Valle de la Oliva (Majadahonda) and the basic area of Villaviciosa de",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se mantienen las restricciones de movilidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mobility restrictions are maintained"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hasta las 00.00 horas del lunes 19 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "until 10 a.m. on Monday, 19 April"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "las zonas básicas de salud de Las Margaritas, en Getafe; San Fernando, en San Fernando de Henares; en Madrid capital las de Alameda de Osuna (distrito de Barajas), Rejas (San Blas-Canillejas), Chopera (Arganzuela); Virgen de Begoña (Fuencarral-El Pardo); Vicálvaro-Artilleros y Valdebernardo (Vicálvaro); Valle de la Oliva (Majadahonda) y la zona básica de Villaviciosa de Odón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the basic health areas of Las Margaritas, in Getafe; San Fernando, in San Fernando de Henares; in Madrid capital those of Alameda de Osuna (district of Barajas), Rejas (San Blas-Canillejas), Chopera (Arganzuela); Virgen de Begoña (Fuencarral-El Pardo); Vicálvaro-Artilleros and Valdebernardo (Vicalvaro); Valle de la Oliva (Majadahonda) and the basic area of Villaviciosa de Odon"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También quedarán limitadas durante una semana más las entradas y salidas, salvo por causas justificadas, en las localidades de La Cabrera, Moralzarzal, Colmenarejo y Paracuellos de Jarama.",
                "text_en": "The entrances and exits will also be limited for a week, except for justified reasons, in the towns of La Cabrera, Moralzarzal, Colmenarejo and Paracuellos de Jarama.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "También quedarán limitadas durante una semana más las entradas y salidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Inputs and departures will also be limited for one more week"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las localidades de La Cabrera, Moralzarzal, Colmenarejo y Paracuellos de Jarama",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the towns of La Cabrera, Moralzarzal, Colmenarejo and Paracuellos de Jarama"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por otro lado, se levantan las limitaciones de entrada y salida en la zona básica de Núñez Morgado (distrito de Chamartín), en Madrid capital, y en las localidades de Chapinería, Torrejón de Velasco, Villanueva de la Cañada, Navacerrada, Navas del Rey y Santos de la Humosa.",
                "text_en": "On the other hand, the limitations of entry and exit are raised in the basic area of Núñez Morgado (district of Chamartín), in Madrid capital, and in the localities of Chapinería, Torrejón de Velasco, Villanueva de la Cañada, Navacerrada, Navas del Rey and Santos de la Humosa.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se levantan las limitaciones de entrada y salida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "entry and exit limitations are lifted"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la zona básica de Núñez Morgado (distrito de Chamartín), en Madrid capital, y en las localidades de Chapinería, Torrejón de Velasco, Villanueva de la Cañada, Navacerrada, Navas del Rey y Santos de la Humosa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the basic area of Núñez Morgado (Chamartín district), in Madrid capital, and in the towns of Chapinería, Torrejón de Velasco, Villanueva de la Cañada, Navacerrada, Navas del Rey and Santos de la Humosa"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Comunidad de Madrid mantiene también durante 14 días más la prohibición de las reuniones de no convivientes en domicilios, salvo que se trate de cuidados a terceras personas (mayores, dependientes, menores de edad o personas vulnerables).",
                "text_en": "The Community of Madrid also maintains for 14 days the prohibition of meetings of non-residents in homes, except in the case of care of third persons (older, dependent, minor or vulnerable).",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Comunidad de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Community of Madrid"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mantiene también durante 14 días más la prohibición de las reuniones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "also maintains for 14 days the prohibition of meetings"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "no convivientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "non-cohabitants"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en domicilios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at home"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Igualmente, sigue siendo obligatorio, dentro de las medidas preventivas para hacer frente al Covid-19, asegurar la ventilación adecuada y permanente de los establecimientos; separación entre los grupos de mesas; que el número de comensales en las terrazas sea de un máximo de seis personas por mesa, y de cuatro en el interior de los establecimientos, y que está prohibido el consumo en barra.",
                "text_en": "Likewise, it remains mandatory, within the preventive measures to deal with Covid-19, to ensure adequate and permanent ventilation of the establishments; separation between the groups of tables; that the number of diners on the terraces is up to six persons per table, and four inside the establishments, and that bar consumption is prohibited.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "asegurar la ventilación adecuada y permanente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ensure adequate and permanent ventilation"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de los establecimientos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of establishments"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También se mantiene la obligatoriedad del uso de mascarilla de forma continuada, tanto en el interior como en terrazas, excepto en el momento concreto de la ingesta de bebida o comida.",
                "text_en": "The use of masks is also mandatory on a continuous basis, both indoors and on terraces, except at the specific time of the intake of drink or food.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se mantiene la obligatoriedad del uso de mascarilla de forma continuada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the obligatory use of mask is maintained on an ongoing basis"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el interior como en terrazas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "inside as on terraces"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "excepto en el momento concreto de la ingesta de bebida o comida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "except at the specific time of intake of drink or food"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "65": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 18,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 6,
            "Who": 11,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 7,
            "HowReliabilityReliable": 5,
            "HowReliabilityUnreliable": 2,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 5,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 5,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 4,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nTenían que empezar a pasar cosas como estás y ya han comenzado.\n\n<BREAK>\n\nTras las informaciones que salieron a la luz ayer con respecto a la vacuna de AstraZeneca empieza a haber preocupación entre los vacunados.\n\n<BREAK>\n\nRecuerden que ayer por la mañana, la Consejería de Sanidad de la Junta de Castilla y León suspendía repentinamente las vacunaciones con ese producto y por la tarde, la EMA decía que había vínculos entre las vacunas y los trombos, pero que eran “mayores los riesgos de morir por COVID a morir por los efectos secundarios de la vacuna”.\n\n<BREAK>\n\nComo verán eso no es nada tranquilizador para los vacunados.\n\n<PARAGRAPH>\n\nY ahora empieza a surgir la preocupación entre los vacunados, como es lógico.\n\n<BREAK>\n\nTal y como informa el digital ‘Burgos Conecta‘, vecinos de Aranda de Duero, recién vacunados con AstraZeneca afirman que lo que está sucediendo es una “tomadura de pelo”.\n\n<PARAGRAPH>\n\nAñaden, además, que les han tomado por “conejillos de indias” y ya empiezan a preguntarse “qué es lo que les han metido” en el cuerpo con esa vacuna.\n\n<BREAK>\n\n“¿Qué lleva esa inyección para que la prohiban solo un día después con tanta prisa?”\n\n<PARAGRAPH>\n\nPero también habría que decir que, aunque la principal responsabilidad recae sobre los gobiernos y los políticos, otra buena parte de la responsabilidad recae sobre quien no se informa correctamente y decide, a ciegas, vacunarse con un producto del que ha habido serias dudas de las que, en este caso, sí que se han hecho eco una buena parte de los medios de comunicación.\n\n<PARAGRAPH>\n\nNuestras dudas no son solo con AstraZeneca, son con todas y ahora mucho más con las demás, que parecen totalmente ocultas con todo lo que está sucediendo con esta vacuna.\n\n<BREAK>\n\n¿Alguien se compraría un televisor cuyo fabricante no diera los dos años de garantía legales? Pues los fabricantes de esa vacuna no dan garantías y no quieren hacerse responsables de las consecuencias, ¿no les resulta eso demasiado sospechoso para dejarse pinchar sin más?\n\n<PARAGRAPH>\n\nCOLABORA CON NOSOTROS CON PAYPAL\n\n<PARAGRAPH>\n\n",
        "TITLE": "Preocupación entre las personas vacunadas con AstraZeneca: \"Nos han utilizado como experimento... ¿qué nos han metido?\"",
        "ID": "8_NF_04-11-2021_22-12-15_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Preocupación entre las personas vacunadas con AstraZeneca: \"Nos han utilizado como experimento... ¿qué nos han metido?\"",
                "text_en": "Concern among people vaccinated with AstraZeneca: \"They have used us as an experiment... what have they put us into?\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Preocupación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Concern"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas vacunadas con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "people vaccinated with AstraZeneca"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Nos han utilizado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We've been used."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "como experimento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "as an experiment"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tras las informaciones que salieron a la luz ayer con respecto a la vacuna de AstraZeneca empieza a haber preocupación entre los vacunados.",
                "text_en": "After the information that came to light yesterday with regard to the AstraZeneca vaccine there is beginning to be concern among the vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ayer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "yesterday"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "preocupación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "concern"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Recuerden que ayer por la mañana, la Consejería de Sanidad de la Junta de Castilla y León suspendía repentinamente las vacunaciones con ese producto y por la tarde, la EMA decía que había vínculos entre las vacunas y los trombos, pero que eran “mayores los riesgos de morir por COVID a morir por los efectos secundarios de la vacuna”.",
                "text_en": "Remember that yesterday morning, the Health Department of the Junta de Castilla y León suddenly suspended vaccinations with that product and in the afternoon, the EMA said that there were links between vaccines and thrombi, but that “the risks of dying from COVID to die from the side effects of the vaccine were greater.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ayer por la mañana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "yesterday morning"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Consejería de Sanidad de la Junta de Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Department of Health of the Junta de Castilla y León"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "suspendía repentinamente las vacunaciones con ese producto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "suddenly stopped vaccinations with that product"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "repentinamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "All of a sudden."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "por la tarde",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "afternoon"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "había vínculos entre las vacunas y los trombos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There were links between vaccines and thrombus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mayores los riesgos de morir por COVID a morir por los efectos secundarios de la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "increased the risk of dying from COVID to die from the side effects of the vaccine"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por COVID",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by COVID"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por los efectos secundarios de la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to the side effects of the vaccine"
                    }
                ],
                "evidences": [
                    {
                        "value": "In Figure 4 we report a focus on the vaccine acceptance rate in correspondence of the EMA announcement (9 March 2021) about blood clots cases initially occurred in certain EU countries [27] . The empasse occurred after 9 March and lasted until 18 March 2021 when EMA declared that the benefits of As-traZeneca vaccination outweigh risks [28] . In the six considered countries the uncertainty about the side effects of vaccinations translated into a sudden drop of a few percentage points (3-4%). Thus, despite the great echo generated over the web (see Figure 2 ) by the news about AstraZeneca vaccinations, we do not observe any relevant variation in vaccination intentions.",
                        "score": 0.5600000024
                    },
                    {
                        "value": "Recent adverse events involving thrombocytopenia, thrombosis, and hemorrhage, that include a few cases of deaths, in temporal proximity to the administration of ChAdOx1 nCov-19 vaccine, promoted the temporary suspension of the administration of the vaccine by different European countries on March 15, 2021, and a reevaluation of the vaccine safety by EMA [7] . EMA concluded that although the causal link of very rare events of thrombosis and ChAdOx1 nCov-19 vaccine has not been proven, the connection cannot be excluded. Consequently, the safety information of the vaccine was updated including the warning on the rare events of thrombotic thrombocytopenia as a potential rare side effect. EMA highlighted that the benefits of the ChAdOx1 nCov-19 vaccine continue to outweigh the risks. However, the agency advised that the scientific bases of the potential side effects require investigation [8] . Cases of thrombosis in close temporary proximity to the administration of the vaccine Ad26.COV2.S have also been recently reported in the USA [9] [10] [11] , which prompted FDA to halt the administration of the vaccine and to stop its distribution in Europe in order to perform a reevaluation of the possible side effects linked with the cases of thrombosis. Recent scientific reports have deepened onto the possible link of the adverse events of ",
                        "score": 0.6600000262
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.5136474967
                    },
                    {
                        "label": "neutral",
                        "score": 0.995113194
                    }
                ]
            },
            {
                "text": "Como verán eso no es nada tranquilizador para los vacunados.",
                "text_en": "As you can see, that's nothing reassuring for the vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nada tranquilizador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Nothing reassuring."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y ahora empieza a surgir la preocupación entre los vacunados, como es lógico.",
                "text_en": "And now the concern among the vaccinated begins to arise, as is logical.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "preocupación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "concern"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tal y como informa el digital ‘Burgos Conecta‘, vecinos de Aranda de Duero, recién vacunados con AstraZeneca afirman que lo que está sucediendo es una “tomadura de pelo”.",
                "text_en": "As reported by the digital ‘Burgos Conecta’, neighbors of Aranda de Duero, recently vaccinated with AstraZeneca, claim that what is happening is a “hairing.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el digital ‘Burgos Conecta‘",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the digital ‘Burgos Connect‘"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "vecinos de Aranda de Duero, recién vacunados con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "neighbors of Aranda de Duero, newly vaccinated with AstraZeneca"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Aranda de Duero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Aranda de Duero"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "afirman que lo que está sucediendo es una “tomadura de pelo”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "claim that what is happening is a “feeling”"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tomadura de pelo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "taking of hair"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Añaden, además, que les han tomado por “conejillos de indias” y ya empiezan a preguntarse “qué es lo que les han metido” en el cuerpo con esa vacuna.",
                "text_en": "They add, moreover, that they have been taken as “rabbits of Indians” and are already beginning to wonder “what they have been put” in the body with that vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "qué es lo que les han metido",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "what they've been up to."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el cuerpo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the body"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con esa vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with that vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“¿Qué lleva esa inyección para que la prohiban solo un día después con tanta prisa?”",
                "text_en": "“What does that injection carry to be banned only a day later in such a hurry?”",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "prohiban",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "prohiban"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "un día después",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "one day later"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con tanta prisa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in such a hurry"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero también habría que decir que, aunque la principal responsabilidad recae sobre los gobiernos y los políticos, otra buena parte de la responsabilidad recae sobre quien no se informa correctamente y decide, a ciegas, vacunarse con un producto del que ha habido serias dudas de las que, en este caso, sí que se han hecho eco una buena parte de los medios de comunicación.",
                "text_en": "But it should also be said that, although the main responsibility lies with governments and politicians, a good part of the responsibility rests with those who are not properly informed and decide, blindly, to be vaccinated with a product of which there have been serious doubts which, in this case, a good part of the media has indeed echoed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la principal responsabilidad recae",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the main responsibility lies with"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los gobiernos y los políticos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Governments and politicians"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "otra buena parte de la responsabilidad recae",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a large part of the responsibility rests with"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "quien no se informa correctamente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "who is not properly informed"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "decide, a ciegas, vacunarse",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "decides, blindly, to get vaccinated"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con un producto del que ha habido serias dudas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with a product of which there have been serious doubts"
                    }
                ],
                "evidences": [
                    {
                        "value": "An eff ective global system for preventing and responding to outbreaks needs well coordinated and appropriately resourced actors to fulfi l clearly defi ned roles and responsibilities and to hold each other accountable for doing so (table). Many actors have crucial roles in this complex system: national governments have the main responsibility for their populations' health. National governments are also responsible for immediately sharing information with neighbouring countries and the international community in the event of a potential public health emergency of international concern. They also hold responsibility for calling for international assistance if domestic capabilities prove inadequate.",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9969161749
                    }
                ]
            },
            {
                "text": "Nuestras dudas no son solo con AstraZeneca, son con todas y ahora mucho más con las demás, que parecen totalmente ocultas con todo lo que está sucediendo con esta vacuna.",
                "text_en": "Our doubts are not only with AstraZeneca, they are with all and now much more with the others, who seem totally hidden with everything that is happening with this vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Nuestras dudas no son solo con AstraZeneca, son con todas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Our doubts are not only with AstraZeneca, they are with all"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ahora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Now"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mucho más con las demás",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "much more with the others"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "parecen totalmente ocultas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They look totally hidden."
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Alguien se compraría un televisor cuyo fabricante no diera los dos años de garantía legales? Pues los fabricantes de esa vacuna no dan garantías y no quieren hacerse responsables de las consecuencias, ¿no les resulta eso demasiado sospechoso para dejarse pinchar sin más?",
                "text_en": "Would anyone buy a television set whose manufacturer did not give the two years of legal guarantee? Because the manufacturers of that vaccine do not give guarantees and do not want to take responsibility for the consequences, is that not too suspicious for them to be just pricked?",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los fabricantes de esa vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "manufacturers of that vaccine"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no dan garantías y no quieren hacerse responsables de las consecuencias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "do not give guarantees and do not want to take responsibility for the consequences"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "demasiado sospechoso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "too suspicious."
                    }
                ],
                "evidences": [
                    {
                        "value": "It can be seen that countries that have entered into binding contractual agreements with vaccine manufacturers at a later date also tend to be supplied at a later date. With limited production capacities, it is rational for vaccine manufacturers to no longer offer binding quantity commitments (and dates) to demanders as soon as the production capacity available at a future delivery date has already been planned by earlier binding vaccine orders.",
                        "score": 0.5799999833
                    },
                    {
                        "value": "Overall, vaccine price needs to be equally sustainable for both countries and manufacturers [32] . Indeed, if, from the countries' point of view, prices should be affordable enough to ensure the system's economic sustainability, manufacturers need adequate compensation to guarantee uninterrupted production, vaccine security, and timely delivery [17] . This equilibrium is fundamental to ensure a plurality of suppliers, with stable and reliable production capacity, and to support sufficient innovation. Unrewarding vaccine prices might disincentivize manufacturers, causing them to reduce appropriate investments to ensure reliable supply and new vaccines [33] .",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.909781754
                    },
                    {
                        "label": "neutral",
                        "score": 0.8263226748
                    }
                ]
            }
        ]
    },
    "66": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 13,
            "WhatReliabilityReliable": 13,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 18,
            "WhoReliabilityReliable": 18,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 5,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 5,
            "WhyReliabilityReliable": 5,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 11,
            "WhoRoleTarget": 6,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nNuevos casos de trombosis en población menor de 60 años han hecho que las ciudades de Berlín y Múnich, en Alemania, paran la administración con la vacuna de AstraZeneca a menores de 60 años.La responsable de Sanidad de la capital alemana, Dilek Kalayci, ha dado a conocer esta decisión por los posibles efectos secundarios adversos en algunos pacientes que se habían administrado esta vacuna.\n\n<BREAK>\n\nSe ha sabido porque los hospitales públicos de la ciudad, Charité y Vivantes, anunciaron la pausa en la administración del fármaco la compañía.Es una medida de precaución por el aumento de casos de trombosis venosa cerebral y otros problemas de coagulación detectados.\n\n<BREAK>\n\nDe todas maneras, se están evaluando cada caso para saber la relación que estos pueden tener con la administración de la vacuna de AstraZeneca.El grupo Vivantes, que gestiona clínicas y residencias, ha decidido suspender la administración de tales vacunas en mujeres jóvenes como  medida de precaución.31 casos y 9 fallecidosEl Instituto Paul-Ehrlich para la vacunación en Alemania ha detectado 31 casos de trombosis en personas que recibieron esta vacuna.\n\n<BREAK>\n\nY tal como informa el medio Der Spiegel, nueve de estas personas fallecieron.Según Europa Press, en diecinueve casos se encontró un déficit de plaquetas en la sangre y el dos de los fallecidos eran hombres, de 36 y 57 años.\n\n<BREAK>\n\nEl resto de casos se refieren a mujeres con edades comprendidas entre los 20 y los 63 años.La vacuna se paró en otros países hace unas semanasA principios del mes de marzo, y por diversos casos de trombosis acontecidos en diferentes personas que se habían inoculado la dosis de Oxford, algunos países pararon la administración de la vacuna durante dos semanas.Esto hasta que el Comité para la Evaluación de Riesgos en Farmacovigilancia (PRAC) y la Agencia Europea de Medicamentos (EMA) evaluara los casos, cosa que se está realizando actualmente, aunque comentaron que la vacuna es segura.Así dijo que, pese a estos casos que se están siguiendo de cerca, los beneficios de la vacuna seguían superando con creces a sus riesgos.\n\n<BREAK>\n\nDe momento, no se ha concluido que los casos tromboembólicos estuvieran relacionados con la vacuna, pero no descartan completamente que exista una relación.Las ciudades de Berlín y Múnich no son las únicas que paran la administración con la vacuna de AstraZeneca a menores de 60 años, también lo está haciendo Canadá que anuncia que dejará de administrar la vacuna de AstraZeneca a los menores de 55 años. ",
        "TITLE": "Berlín y Múnich paran la administración con la vacuna de AstraZeneca a menores de 60 años",
        "ID": "NF_04-11-2021_21-51-07_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Berlín y Múnich paran la administración con la vacuna de AstraZeneca a menores de 60 años",
                "text_en": "Berlin and Munich stop administering AstraZeneca vaccine to children under 60 years of age",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Berlín y Múnich",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Berlin and Munich"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "paran la administración con la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stop administration with the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a menores de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to persons under 60 years of age"
                    }
                ],
                "evidences": [
                    {
                        "value": "Since the end of January 2021, mass vaccination of the population has been carried out in Berlin. However, the intensity of vaccination in its initial phase was very low [14] . In the first phase it was mainly the elderly over 80 years of age, followed by the 60+ age group and the \"risk group\". Young people aged 18 years and over were only vaccinated from the end of May, but we were unable to find specific information on the number of infected persons for each age group in Berlin. In [16] , statistical data on the dynamics of vaccination depending on age are given for a number of countries. By analysing these data for several European countries (Austria, Belgium, Denmark, France, Ireland, Italy, Spain, Sweden and Norway), an age-dependent estimate of the vaccinated population in Berlin (as of 25.06.2021) was calculated. For the age group over 60 years old the vaccinated part of the population is 70-90%. For populations aged between 19 and 60, the vaccination rate was assumed to be . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
                        "score": 0.5899999738
                    },
                    {
                        "value": "Other factors such as type of COVID-19 vaccine and dose received might also play an important role [14] [15] [16] . Those who received a chimpanzee adenovirus-vectored vaccine such as AstraZeneca/Vaxzevria reported more commonly adverse reactions than those who received a mRNA-based vaccine such as Pfizer or Moderna (and among these two vaccines, those who received Moderna experienced more adverse reactions than those who received Pfizer). We have to bear in mind that, in the case of AstraZeneca/Vaxzevria, during the first months of use (February and March and mid-April 2021), health authorities in Spain recommended inoculation in the population under 55 years of age. However, after some studies suggested a possible link of blood clots with low blood platelets due to the AstraZeneca/Vaxzevria vaccine [17] , health authorities in Spain prohibited it in people under 60 years old [18] . Those who had received AstraZeneca/Vaxzevria in the first dose could choose between being vaccinated with AstraZeneca/Vaxzevria or Pfizer in the second dose after the recommended period between doses (at least three months). This fact made side effects stronger after the first dose compared to those after the second dose, partly because only younger adults were eligible for receiving the former. Currently, only people who are 60 or older can be vaccinated with AstraZeneca/Vaxzevria. Hence, a lower number of people received vaccinated with AstraZeneca/Vaxzevria vaccine in both doses. Furthermore, regarding the age-based COVID-19 vaccine strategy, Spain started the vaccination with those at a higher risk of complications (>80 years old). Therefore, in the present study, mean age of people with both doses was higher compared to those who had only one dose. As younger people generally have a more a robust immune system, the immune response to the vaccine and the reported side effects are higher.",
                        "score": 0.6299999952
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9969854951
                    },
                    {
                        "label": "neutral",
                        "score": 0.8652299643
                    }
                ]
            },
            {
                "text": "Nuevos casos de trombosis en población menor de 60 años han hecho que las ciudades de Berlín y Múnich, en Alemania, paran la administración con la vacuna de AstraZeneca a menores de 60 años.La responsable de Sanidad de la capital alemana, Dilek Kalayci, ha dado a conocer esta decisión por los posibles efectos secundarios adversos en algunos pacientes que se habían administrado esta vacuna.",
                "text_en": "New cases of thrombosis in the population under the age of 60 have led the cities of Berlin and Munich, in Germany, to stop the administration of the AstraZeneca vaccine to children under the age of 60.The German capital's Health Officer, Dilek Kalayci, has made this decision known because of the possible adverse side effects in some patients who had been given this vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Nuevos casos de trombosis en población menor de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "New cases of thrombosis in the population below 60 years of age"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las ciudades de Berlín y Múnich",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the cities of Berlin and Munich"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Alemania",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Germany"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "paran la administración con la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stop administration with the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a menores de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to persons under 60 years of age"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la capital alemana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the German capital"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Dilek Kalayci",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dilek Kalayci"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha dado a conocer esta decisión",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "made known this decision"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por los posibles efectos secundarios adversos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "possible side effects"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en algunos pacientes que se habían administrado esta vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in some patients who had been given this vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se ha sabido porque los hospitales públicos de la ciudad, Charité y Vivantes, anunciaron la pausa en la administración del fármaco la compañía.Es una medida de precaución por el aumento de casos de trombosis venosa cerebral y otros problemas de coagulación detectados.",
                "text_en": "It has been known because the city's public hospitals, Charité and Vivantes, announced the company's pause in administering the drug.It is a precautionary measure due to the increase in cases of cerebral venous thrombosis and other clotting problems detected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los hospitales públicos de la ciudad, Charité y Vivantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the public hospitals of the city, Charité and Vivantes"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "anunciaron la pausa en la administración del fármaco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "announced the pause in the administration of the drug"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Es una medida de precaución",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's a precautionary measure."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por el aumento de casos de trombosis venosa cerebral y otros problemas de coagulación detectados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "increased cases of cerebral venous thrombosis and other coagulation problems detected"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De todas maneras, se están evaluando cada caso para saber la relación que estos pueden tener con la administración de la vacuna de AstraZeneca.El grupo Vivantes, que gestiona clínicas y residencias, ha decidido suspender la administración de tales vacunas en mujeres jóvenes como  medida de precaución.31 casos y 9 fallecidosEl Instituto Paul-Ehrlich para la vacunación en Alemania ha detectado 31 casos de trombosis en personas que recibieron esta vacuna.",
                "text_en": "However, each case is being evaluated to find out the relationship they may have with the administration of the AstraZeneca vaccine.The Vivantes group, which manages clinics and residences, has decided to suspend the administration of such vaccines in young women as a precautionary measure.31 cases and 9 deathsThe Paul-Ehrlich Institute for vaccination in Germany has detected 31 cases of thrombosis in people who received this vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El grupo Vivantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The group Vivantes"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha decidido suspender la administración de tales vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has decided to discontinue the administration of such vaccines"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en mujeres jóvenes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in young women"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "como  medida de precaución",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as a precautionary measure"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Instituto Paul-Ehrlich",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Paul-Ehrlich Institute"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Alemania",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Germany"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha detectado 31 casos de trombosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "detected 31 cases of thrombosis"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en personas que recibieron esta vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in people who received this vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y tal como informa el medio Der Spiegel, nueve de estas personas fallecieron.Según Europa Press, en diecinueve casos se encontró un déficit de plaquetas en la sangre y el dos de los fallecidos eran hombres, de 36 y 57 años.",
                "text_en": "And as reported by the media Der Spiegel, nine of these people died.According to Europa Press, in nineteen cases a platelet deficiency was found in the blood and two of the deceased were men, 36 and 57.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el medio Der Spiegel",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the medium Der Spiegel"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nueve de estas personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "nine of these persons"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fallecieron",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're dead."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Europa Press",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Europa Press"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "en diecinueve casos se encontró un déficit de plaquetas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in nineteen cases a platelet deficit was found"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la sangre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the blood"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El resto de casos se refieren a mujeres con edades comprendidas entre los 20 y los 63 años.La vacuna se paró en otros países hace unas semanasA principios del mes de marzo, y por diversos casos de trombosis acontecidos en diferentes personas que se habían inoculado la dosis de Oxford, algunos países pararon la administración de la vacuna durante dos semanas.Esto hasta que el Comité para la Evaluación de Riesgos en Farmacovigilancia (PRAC) y la Agencia Europea de Medicamentos (EMA) evaluara los casos, cosa que se está realizando actualmente, aunque comentaron que la vacuna es segura.Así dijo que, pese a estos casos que se están siguiendo de cerca, los beneficios de la vacuna seguían superando con creces a sus riesgos.",
                "text_en": "The remaining cases concern women aged between 20 and 63 years.The vaccine stopped in other countries a few weeks agoIn early March, and for various cases of thrombosis in different people who had inoculated the Oxford dose, some countries stopped administering the vaccine for two weeks.This until the Pharmacovigilance Risk Assessment Committee (PRAC) and the European Medicines Agency (EMA) assessed the cases, which is currently being done, although they commented that the vaccine is safe.He said that despite these cases being closely monitored, the benefits of the vaccine were still far beyond their risks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vacuna se paró",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The vaccine stopped."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en otros países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in other countries"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hace unas semanasA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A few weeks ago"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "principios del mes de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "early March"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por diversos casos de trombosis acontecidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to various cases of thrombosis"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en diferentes personas que se habían inoculado la dosis de Oxford",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in different people who had inoculated the Oxford dose"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "algunos países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "some countries"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pararon la administración de la vacuna durante dos semanas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stopped the administration of the vaccine for two weeks"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De momento, no se ha concluido que los casos tromboembólicos estuvieran relacionados con la vacuna, pero no descartan completamente que exista una relación.Las ciudades de Berlín y Múnich no son las únicas que paran la administración con la vacuna de AstraZeneca a menores de 60 años, también lo está haciendo Canadá que anuncia que dejará de administrar la vacuna de AstraZeneca a los menores de 55 años. ",
                "text_en": "At the moment, it has not been concluded that thromboembolic cases were related to the vaccine, but they do not completely rule out a relationship.The cities of Berlin and Munich are not the only ones stopping the administration of the AstraZeneca vaccine to children under the age of 60, so is Canada, which announces that it will stop administering the AstraZeneca vaccine to those under the age of 55.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "De momento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For the time being"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se ha concluido que los casos tromboembólicos estuvieran relacionados con la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thromboembolic cases have not been concluded to be related to the vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Canadá",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Canada"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "anuncia que dejará de administrar la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "announces that you will stop administering the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los menores de 55 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to persons under 55 years of age"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "67": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 11,
            "WhatReliabilityReliable": 9,
            "WhatReliabilityUnreliable": 2,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 0,
            "Who": 10,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 9,
            "WhenReliabilityReliable": 9,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 1,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 14,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 15,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nLos datos publicados por la Administración de Productos Terapéuticos (TGA) del Ministerio de Sanidad australiano confirman que, en un periodo de tan solo diez meses, se han notificado doce veces más muertes por reacciones adversas a las vacunas contra el coronavirus que por todas las demás vacunas disponibles combinadas en un periodo de 51 años.\n\n<PARAGRAPH>\n\nLa TGA regula la calidad, el suministro y la publicidad de los medicamentos, los dispositivos patológicos, los productos médicos, los productos sanguíneos y la mayoría de los demás productos terapéuticos.\n\n<PARAGRAPH>\n\nEn febrero del año pasado una solicitud de Médicos por la Ética del Covid reveló que la TGA autorizó la vacuna de Pfizer a ciegas.\n\n<BREAK>\n\nNo comprobó los datos extremadamente limitados de los ensayos clínicos y considerarla segura para ser inyectada.\n\n<PARAGRAPH>\n\nEn un principio la TGA intentó dilatar el suministros de la información solicitando una prórroga de 6 meses.\n\n<BREAK>\n\nLos demandantes tuvieron que presentar una queja ante la Oficina del Comisionado de Información y la TGA respondió confirmando que nunca había visto o solicitado los datos de los pacientes a Pfizer y que simplemente aceptaba el informe de Pfizer sobre su estudio como un hecho.\n\n<PARAGRAPH>\n\nLos datos de la TGA indican que en un periodo de 10 meses se han producido 8 veces más acontecimientos adversos y 12 veces más muertes por vacunas que las registradas para todas las demás vacunas disponibles combinadas desde el 1 de enero de 1971.\n\n<PARAGRAPH>\n\nLa TGA cuenta con una base de datos de efectos adversos notificados (*) que proceden de un amplio abanico de fuentes, como los ciudadanos, los médicos de cabecera, otros profesionales de la salud y la industria de productos terapéuticos.\n\n<PARAGRAPH>\n\nSi se busca “vaccine” en la base de datos y se seleccionan las cuatro vacunas disponibles en Australia, con parámetros de fecha del 1 de enero de 1971 a 27 de diciembre de 2021, se concluye que en esos 51 años se han puesto a disposición del público australiano 128 vacunas diferentes, excluyendo las del coronavirus, y se han producido 19.545 informes individuales para las 128 vacunas combinadas, incluyendo 62 muertes.\n\n<PARAGRAPH>\n\nSi se vuelve a buscar en la base de datos “vacuna covid-19” con el parámetro de fecha del 1 de enero de 2021 al 27 de noviembre de 2021, se encuentran 98.017 informes, incluyendo 725 muertes.\n\n<PARAGRAPH>\n\nEso significa que ha habido 12 veces más muertes, 5 veces más informes de efectos adversos y 8 veces más informes de efectos adversos debidos a las vacunas contra el coronavirus que los informados para todas las demás vacunas disponibles combinadas durante un período de 51 años.\n\n<PARAGRAPH>\n\n(*) https://apps.tga.gov.au/Prod/daen/daen-entry.aspx\n\n<PARAGRAPH>\n",
        "TITLE": "En diez meses las vacunas contra el coronavirus han causado 12 veces más muertes que todas las demás en 51 años",
        "ID": "NF_NF_604_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "En diez meses las vacunas contra el coronavirus han causado 12 veces más muertes que todas las demás en 51 años",
                "text_en": "In 10 months, coronavirus vaccines have caused 12 times more deaths than all others in 51 years.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En diez meses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In 10 months"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las vacunas contra el coronavirus han causado 12 veces más muertes que todas las demás",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Coronavirus vaccines have caused 12 times more deaths than all others"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los datos publicados por la Administración de Productos Terapéuticos (TGA) del Ministerio de Sanidad australiano confirman que, en un periodo de tan solo diez meses, se han notificado doce veces más muertes por reacciones adversas a las vacunas contra el coronavirus que por todas las demás vacunas disponibles combinadas en un periodo de 51 años.",
                "text_en": "Data published by the Australian Ministry of Health’s Therapeutic Products Administration (TGA) confirm that, over a period of just ten months, 12 times more deaths from adverse reactions to coronavirus vaccines have been reported than for all other vaccines available combined over a 51-year period.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Administración de Productos Terapéuticos (TGA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Administration of Therapeutic Products (TGA)"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ministerio de Sanidad australiano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Australian Ministry of Health"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en un periodo de tan solo diez meses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a period of only 10 months"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han notificado doce veces más muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "12 times more deaths have been reported"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por reacciones adversas a las vacunas contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for adverse reactions to coronavirus vaccines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La TGA regula la calidad, el suministro y la publicidad de los medicamentos, los dispositivos patológicos, los productos médicos, los productos sanguíneos y la mayoría de los demás productos terapéuticos.",
                "text_en": "TGA regulates the quality, supply and advertising of medicines, pathological devices, medical products, blood products and most other therapeutic products.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La TGA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The TGA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "regula la calidad, el suministro y la publicidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "regulates quality, supply and advertising"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En febrero del año pasado una solicitud de Médicos por la Ética del Covid reveló que la TGA autorizó la vacuna de Pfizer a ciegas.",
                "text_en": "In February last year a request from Doctors for the Ethics of Covid revealed that the TGA authorized the Pfizer vaccine blindly.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En febrero del año pasado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In February last year"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Médicos por la Ética del Covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Doctors for the Ethics of Covid"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la TGA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the TGA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "autorizó la vacuna de Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "authorised Pfizer vaccine"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a ciegas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "blind"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No comprobó los datos extremadamente limitados de los ensayos clínicos y considerarla segura para ser inyectada.",
                "text_en": "It did not check the extremely limited data from clinical trials and consider it safe to be injected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "No comprobó los datos extremadamente limitados de los ensayos clínicos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It did not check extremely limited clinical trial data"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En un principio la TGA intentó dilatar el suministros de la información solicitando una prórroga de 6 meses.",
                "text_en": "Initially the TGA tried to dilate the information supplies by requesting a six-month extension.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En un principio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the beginning"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la TGA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the TGA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "intentó dilatar el suministros de la información",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "tried to dilate the information supplies"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "solicitando una prórroga de 6 meses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "requesting an extension of 6 months"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los demandantes tuvieron que presentar una queja ante la Oficina del Comisionado de Información y la TGA respondió confirmando que nunca había visto o solicitado los datos de los pacientes a Pfizer y que simplemente aceptaba el informe de Pfizer sobre su estudio como un hecho.",
                "text_en": "The complainants had to file a complaint with the Office of the Information Commissioner and the TGA responded by confirming that it had never seen or requested Pfizer's patient data and that it simply accepted Pfizer's report on its study as a fact.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los demandantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The applicants"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tuvieron que presentar una queja",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had to file a complaint"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ante la Oficina del Comisionado de Información",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Office of the Information Commissioner"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los datos de la TGA indican que en un periodo de 10 meses se han producido 8 veces más acontecimientos adversos y 12 veces más muertes por vacunas que las registradas para todas las demás vacunas disponibles combinadas desde el 1 de enero de 1971.",
                "text_en": "TGA data indicate that over a 10-month period there have been 8 times more adverse events and 12 times more vaccine deaths than those recorded for all other vaccines available combined since 1 January 1971.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la TGA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the TGA"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en un periodo de 10 meses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "within 10 months"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han producido 8 veces más acontecimientos adversos y 12 veces más muertes por vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "8 times more adverse events and 12 times more vaccine deaths have occurred"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La TGA cuenta con una base de datos de efectos adversos notificados (*) que proceden de un amplio abanico de fuentes, como los ciudadanos, los médicos de cabecera, otros profesionales de la salud y la industria de productos terapéuticos.",
                "text_en": "The TGA has a database of reported adverse effects (*) from a wide range of sources such as citizens, family doctors, other health professionals and the therapeutic products industry.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La TGA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The TGA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cuenta con una base de datos de efectos adversos notificados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has a database of reported adverse events"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de un amplio abanico de fuentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from a wide range of sources"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si se busca “vaccine” en la base de datos y se seleccionan las cuatro vacunas disponibles en Australia, con parámetros de fecha del 1 de enero de 1971 a 27 de diciembre de 2021, se concluye que en esos 51 años se han puesto a disposición del público australiano 128 vacunas diferentes, excluyendo las del coronavirus, y se han producido 19.545 informes individuales para las 128 vacunas combinadas, incluyendo 62 muertes.",
                "text_en": "If you look for “vaccine” in the database and select the four vaccines available in Australia, with parameters dated from 1 January 1971 to 27 December 2021, it is concluded that in those 51 years 128 different vaccines have been made available to the Australian public, excluding those of the coronavirus, and 19,545 individual reports have been produced for the 128 combined vaccines, including 62 deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Australia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Australia"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "del 1 de enero de 1971 a 27 de diciembre de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "1 January 1971 to 27 December 2021"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en esos 51 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in those 51 years"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han puesto a disposición del público australiano 128 vacunas diferentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "128 different vaccines have been made available to the Australian public"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del público australiano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the Australian public"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si se vuelve a buscar en la base de datos “vacuna covid-19” con el parámetro de fecha del 1 de enero de 2021 al 27 de noviembre de 2021, se encuentran 98.017 informes, incluyendo 725 muertes.",
                "text_en": "If re-searched in the “covid-19 vaccine” database with the date parameter from 1 January 2021 to 27 November 2021, there are 98,017 reports, including 725 deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la base de datos “vacuna covid-19”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the “covid-19 vaccine” database"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "1 de enero de 2021 al 27 de noviembre de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "1 January 2021 to 27 November 2021"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se encuentran 98.017 informes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "98,017 reports are available"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Eso significa que ha habido 12 veces más muertes, 5 veces más informes de efectos adversos y 8 veces más informes de efectos adversos debidos a las vacunas contra el coronavirus que los informados para todas las demás vacunas disponibles combinadas durante un período de 51 años.",
                "text_en": "This means that there have been 12 times more deaths, 5 times more reports of adverse effects and 8 times more reports of adverse effects due to coronavirus vaccines than reported for all other vaccines available combined over a 51-year period.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha habido 12 veces más muertes, 5 veces más informes de efectos adversos y 8 veces más informes de efectos adversos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there have been 12 times more deaths, 5 times more reports of side effects and 8 times more reports of side effects"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "debidos a las vacunas contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to coronavirus vaccines"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante un período de 51 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for a period of 51 years"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "68": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 19,
            "WhatReliabilityReliable": 19,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 21,
            "WhoReliabilityReliable": 21,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 12,
            "WhenReliabilityReliable": 12,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 6,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 12,
            "WhoRoleTarget": 7,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 11,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 13,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nUn tribunal ordena retirar \"de inmediato\" el toque de queda nocturno contra la Covid en Holanda\n\n<PARAGRAPH>\n\nLo que nos faltaba.\n\n<BREAK>\n\nCasi a la misma hora en que nos enterábamos de que  tribunal de La Haya ha ordenado la retirada inmediata del toque de queda contra la covid-19 impuesto por el Gobierno holandés en el mes de enero y que suscitó varias noches consecutivas de protestas, salta la noticia de que a España van a llegar menos vacunas.\n\n<PARAGRAPH>\n\nLa farmacéutica Moderna ha anunciado que va a reducir la cantidad de las dosis de su vacuna contra la covid-19 que tenía previsto enviar al Gobierno PSOE-Podemos en febrero de 2021.\n\n<PARAGRAPH>\n\nEste cambio se debe a un problema con el rendimiento en la planta de producción de la sustancia activa y ha sido calificado como ajuste puesto que la compañía ha asegurado que cumplirá con su compromiso de distribuir 1.040.000 de aquí a finales de marzo.\n\n<PARAGRAPH>\n\nIgual que pasó con la distribución de Pfizer en enero, ahora es Moderna la que ha anunciado cambios la cantidad de dosis suministradas.\n\n<BREAK>\n\nSi la semana que viene deberían llegar a España 483.000 dosis, esta cantidad se verá reducida a la mitad, según informa Cadena Ser.\n\n<PARAGRAPH>\n\nEl Ministerio de Sanidad ha informado de estos cambios a las Comunidades Autónomas para que estas reorganicen su estrategia de vacunación en la medida que necesiten.\n\n<PARAGRAPH>\n\nLa Junta de Castilla y León ha emitido una nota de prensa en la que confirma este asunto: «El Ministerio de Sanidad ha comunicado a las comunidades autónomas la imposibilidad, trasladada por parte de la compañía Moderna, de suministrar sus vacunas esta semana, situación que pudiera prolongarse más tiempo; no obstante, es conveniente recordar que el plazo establecido, en el caso de la de Moderna, para la administración de la segunda inoculación es de veintiocho días», reza el comunicado.\n\n<PARAGRAPH>\n\nEl Ministerio de Sanidad que ahora dirige Carolina Darias informó este lunes que ha recibido 192.000 dosis de la vacuna de Moderna y que, de estas, se han inoculado 94.847.\n\n<BREAK>\n\nEstas cifras indican que las Comunidades se podrían estar creando una reserva estratégica para no quedarse sin la segunda dosis de esta compañía que las personas vacunadas con la primera necesiten una vez cumplido el plazo establecido (28 días), si bien Moderna se ha comprometido a que a lo largo del primer trimestre la cantidad total de dosis acordadas se entregará (1.040.000).\n\n<PARAGRAPH>\n\nEl pasado 7 de enero, el entonces ministro de Sanidad Salvador Illa anunció que Moderna enviaría un total de 600.000 dosis en las siguientes seis semanas, es decir, entre los meses de enero y finales de febrero.\n\n<BREAK>\n\nY, según el acuerdo con la UE, deberían llegar 1.040.000 dosis a España de aquí al 31 de marzo.\n\n<PARAGRAPH>\n\nLos datos publicados este lunes por el departamento que ahora encabeza Darias muestra que el ritmo de vacunaciones con las dos dosis de los sueros de Pfizer-BioNTech y Moderna se ha ralentizado desde el pasado viernes tras sumar 69.606 personas, frente a las más de 100.000 que se inmunizaron con la pauta completa durante el mismo período de la semana anterior (es decir 33.892 menos este fin de semana).\n\n<PARAGRAPH>\n\nEl recuento de Sanidad de este lunes, que incluye datos del viernes y del fin de semana, pone de manifiesto que los vacunados con las dos dosis ascienden a 1.070.091.\n\n<BREAK>\n\nEl pasado viernes se alcanzó la inmunización de 1.000.485 personas.\n\n<PARAGRAPH>\n\nEl número de dosis administradas de las tres vacunas autorizadas (Pzifer-BiONtech, Moderna y Astrazeneca) en las comunidades autónomas es de 2.561.608, el 87,9% de las 2.914.755 que Sanidad ha repartido hasta el momento.\n\n<BREAK>\n\nA estas se han de sumar las 483.000 de la farmacéutica Pfizer-BioNTech anunciadas este lunes por Sanidad.\n\n<PARAGRAPH>\n\nSanidad estima que en febrero se recibirán un total de 1.779.570 dosis de Pfizer-BioNTech y mantiene una previsión de 2.705.040 dosis para marzo.\n\n<PARAGRAPH>\n\nEn cuanto a la vacuna de AstraZeneca, 25.628 personas de entre 18 y 55 años, de los colectivos previstos en los planes de vacunación, han recibido ya su primera dosis.\n\n<PARAGRAPH>\n",
        "TITLE": "Moderna entregará en febrero al Gobierno Sánchez la mitad de las vacunas que le había prometido",
        "ID": "NF_04-11-2021_21-04-39_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Moderna entregará en febrero al Gobierno Sánchez la mitad de las vacunas que le había prometido",
                "text_en": "Moderna will deliver half of the vaccines promised to her to the Sánchez government in February",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Modern"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "entregará en febrero al Gobierno Sánchez la mitad de las vacunas que le había prometido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will deliver half of the vaccines promised to the Sánchez government in February"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en febrero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in February"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Gobierno Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Government of Sánchez"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Un tribunal ordena retirar \"de inmediato\" el toque de queda nocturno contra la Covid en Holanda",
                "text_en": "A court orders that the night curfew against the Covid in the Netherlands be withdrawn \"immediately\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Un tribunal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A court"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ordena retirar \"de inmediato\" el toque de queda nocturno contra la Covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "orders to withdraw \"immediately\" night curfew against the Covid"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Holanda",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Holland"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Casi a la misma hora en que nos enterábamos de que  tribunal de La Haya ha ordenado la retirada inmediata del toque de queda contra la covid-19 impuesto por el Gobierno holandés en el mes de enero y que suscitó varias noches consecutivas de protestas, salta la noticia de que a España van a llegar menos vacunas.",
                "text_en": "Almost at the same time as we realized that the court in The Hague has ordered the immediate withdrawal of the curfew against the covid-19 imposed by the Dutch Government in January and which provoked several consecutive nights of protests, the news is that fewer vaccines will arrive in Spain.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "tribunal de La Haya",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Hague court"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha ordenado la retirada inmediata del toque de queda contra la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has ordered the immediate withdrawal of the curfew against the covid-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Gobierno holandés",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Dutch Government"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en el mes de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in January"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "salta la noticia de que a España van a llegar menos vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The news is that fewer vaccines will arrive in Spain"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La farmacéutica Moderna ha anunciado que va a reducir la cantidad de las dosis de su vacuna contra la covid-19 que tenía previsto enviar al Gobierno PSOE-Podemos en febrero de 2021.",
                "text_en": "The pharmaceutical company Moderna has announced that it will reduce the amount of doses of its covid-19 vaccine that it planned to send to the PSOE-Podemos government in February 2021.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La farmacéutica Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The modern pharmaceutical company"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha anunciado que va a reducir la cantidad de las dosis de su vacuna contra la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has announced that you will reduce the amount of doses of your covid-19 vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Gobierno PSOE-Podemos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the PSOE-We can"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en febrero de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in February 2021"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este cambio se debe a un problema con el rendimiento en la planta de producción de la sustancia activa y ha sido calificado como ajuste puesto que la compañía ha asegurado que cumplirá con su compromiso de distribuir 1.040.000 de aquí a finales de marzo.",
                "text_en": "This change is due to a problem with the yield in the production plant of the active substance and has been qualified as an adjustment since the company has assured that it will meet its commitment to distribute 1,040,000 by the end of March.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "un problema con el rendimiento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a problem with performance"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la planta de producción de la sustancia activa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the production plant of the active substance"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la compañía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the company"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha asegurado que cumplirá con su compromiso de distribuir 1.040.000",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has assured that it will comply with its commitment to distribute 1,040,000"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "de aquí a finales de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the end of March"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Igual que pasó con la distribución de Pfizer en enero, ahora es Moderna la que ha anunciado cambios la cantidad de dosis suministradas.",
                "text_en": "As with the Pfizer distribution in January, it is now Moderna who has announced changes in the amount of doses supplied.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Modern"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha anunciado cambios la cantidad de dosis suministradas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has announced changes in the amount of doses supplied"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si la semana que viene deberían llegar a España 483.000 dosis, esta cantidad se verá reducida a la mitad, según informa Cadena Ser.",
                "text_en": "If 483,000 doses should arrive in Spain next week, this amount will be halved, according to Cadena Ser.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "la semana que viene",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Next week"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deberían llegar a España 483.000 dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "483,000 doses should reach Spain"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esta cantidad se verá reducida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this amount will be reduced"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a la mitad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the middle"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cadena Ser",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Chain Be"
                    }
                ],
                "evidences": [
                    {
                        "value": "Pfizer has committed to deliver to Spain 350,000 doses every week. That means we would need 95 weeks (1.8 years!) to reach the herd immunity in our country, which is definitely unacceptable. This excessively long-time frame could be improved by increasing the number of doses supplied to Spain by the laboratory (assuming that there is enough production capacity) and/or authorizing the administration in Spain of vaccines from other laboratories apart from Pfizer-BioNTech (as Moderna, AstraZeneca, J&J, Sanofi and Curevac), together with accelerating the negotiation process for their acquisition.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9989706278
                    }
                ]
            },
            {
                "text": "El Ministerio de Sanidad ha informado de estos cambios a las Comunidades Autónomas para que estas reorganicen su estrategia de vacunación en la medida que necesiten.",
                "text_en": "The Ministry of Health has informed the Autonomous Communities of these changes to reorganize their vaccination strategy as needed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Ministry of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha informado de estos cambios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has reported these changes"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las Comunidades Autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Autonomous Communities"
                    }
                ],
                "evidences": [
                    {
                        "value": "Although regional authorities and municipalities retained operational management of health and social care services, all were put under the direct orders of the Minister for Health, who had to guarantee territorial cohesion and equity in the provision of services. [23] Nevertheless, all decisions were discussed within the Interterritorial Council for the National Health System -the highest governance body of the health system comprising the Ministry of Health and the regional ministers of health. After the expiration of the state of alarm (21 June 2020), autonomous communities and municipalities recovered their competences in the areas of health and social care, although action is coordinated along with the Ministry of Health.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9969701767
                    }
                ]
            },
            {
                "text": "La Junta de Castilla y León ha emitido una nota de prensa en la que confirma este asunto: «El Ministerio de Sanidad ha comunicado a las comunidades autónomas la imposibilidad, trasladada por parte de la compañía Moderna, de suministrar sus vacunas esta semana, situación que pudiera prolongarse más tiempo; no obstante, es conveniente recordar que el plazo establecido, en el caso de la de Moderna, para la administración de la segunda inoculación es de veintiocho días», reza el comunicado.",
                "text_en": "The Junta de Castilla y León has issued a press release confirming this matter: \"The Ministry of Health has informed the Autonomous Communities of the impossibility, transferred by the Moderna company, of supplying their vaccines this week, a situation that could last longer; however, it is worth recalling that the deadline set, in the case of Moderna, for the administration of the second inoculation is 28 days\", the statement says.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Junta de Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Junta de Castilla y León"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha emitido una nota de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has issued a press release"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Ministerio de Sanidad que ahora dirige Carolina Darias informó este lunes que ha recibido 192.000 dosis de la vacuna de Moderna y que, de estas, se han inoculado 94.847.",
                "text_en": "The Ministry of Health now running Carolina Darias reported this Monday that it has received 192,000 doses of the Moderna vaccine and that, of these, 94,847 have been inoculated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Ministry of Health"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Carolina Darias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Carolina Darias"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha recibido 192.000 dosis de la vacuna de Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has received 192,000 doses of the Moderna vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estas cifras indican que las Comunidades se podrían estar creando una reserva estratégica para no quedarse sin la segunda dosis de esta compañía que las personas vacunadas con la primera necesiten una vez cumplido el plazo establecido (28 días), si bien Moderna se ha comprometido a que a lo largo del primer trimestre la cantidad total de dosis acordadas se entregará (1.040.000).",
                "text_en": "These figures indicate that the Communities could be creating a strategic reserve so as not to run out of the second dose of this company that people vaccinated with the first need after the deadline set (28 days), although Moderna has committed itself that during the first quarter the total amount of doses agreed will be delivered (1,040,000).",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Modern"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha comprometido a que a lo largo del primer trimestre la cantidad total de dosis acordadas se entregará",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has committed that during the first trimester the total quantity of agreed doses will be delivered"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a lo largo del primer trimestre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over the first quarter"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El pasado 7 de enero, el entonces ministro de Sanidad Salvador Illa anunció que Moderna enviaría un total de 600.000 dosis en las siguientes seis semanas, es decir, entre los meses de enero y finales de febrero.",
                "text_en": "On January 7, the then Minister of Health Salvador Illa announced that Moderna would send a total of 600,000 doses in the next six weeks, that is, between January and the end of February.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El pasado 7 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last January 7th"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el entonces ministro de Sanidad Salvador Illa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the then Minister of Health Salvador Illa"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "anunció que Moderna enviaría un total de 600.000 dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "announced that Moderna would send a total of 600,000 doses"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las siguientes seis semanas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over the next six weeks"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y, según el acuerdo con la UE, deberían llegar 1.040.000 dosis a España de aquí al 31 de marzo.",
                "text_en": "And, according to the agreement with the EU, 1,040,000 doses should be delivered to Spain by 31 March.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la UE",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EU"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deberían llegar 1.040.000 dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "should reach 1,040,000 doses"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Spain"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "de aquí al 31 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by 31 March"
                    }
                ],
                "evidences": [
                    {
                        "value": "Pfizer has committed to deliver to Spain 350,000 doses every week. That means we would need 95 weeks (1.8 years!) to reach the herd immunity in our country, which is definitely unacceptable. This excessively long-time frame could be improved by increasing the number of doses supplied to Spain by the laboratory (assuming that there is enough production capacity) and/or authorizing the administration in Spain of vaccines from other laboratories apart from Pfizer-BioNTech (as Moderna, AstraZeneca, J&J, Sanofi and Curevac), together with accelerating the negotiation process for their acquisition.",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9987078905
                    }
                ]
            },
            {
                "text": "El pasado viernes se alcanzó la inmunización de 1.000.485 personas.",
                "text_en": "Last Friday, 1,000,485 people were immunized.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El pasado viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last Friday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se alcanzó la inmunización",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Immunisation achieved"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "1.000.485 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "1,000,485 persons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El número de dosis administradas de las tres vacunas autorizadas (Pzifer-BiONtech, Moderna y Astrazeneca) en las comunidades autónomas es de 2.561.608, el 87,9% de las 2.914.755 que Sanidad ha repartido hasta el momento.",
                "text_en": "The number of doses administered of the three approved vaccines (Pzifer-Biontech, Moderna and Astrazeneca) in the autonomous communities is 2,561,608, 87.9% of the 2,914,755 that Health has so far distributed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El número de dosis administradas de las tres vacunas autorizadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The number of doses administered of the three approved vaccines"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las comunidades autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Autonomous Communities"
                    }
                ],
                "evidences": [
                    {
                        "value": "Vaccines included in the Colombian Expanded Program on Immunization during the study period for children <12 months were the BCG, hepatitis B, inactivated polio vaccine (IPV), oral polio vaccine (OPV)+IPV, pentavalent (three doses), rotavirus (two doses), seasonal influenza (two doses) and pneumococcal vaccines (two doses); the pentavalent vaccine, which contains diphtheria, pertussis and tetanus (DPT), Haemophilus influenzae type b and hepatitis B vaccines. The hepatitis B vaccine is first administered as a monovalent vaccine at birth and is subsequently given as part of the pentavalent vaccine at 2, 4 and 6 months of age. At 12-23 months, the vaccine schedule includes measles, mumps and rubella (MMR), varicella, pneumococcal reinforcement, hepatitis A and yellow fever vaccines, as well as OPV and DPT first doses. For 5-year-old children, the schedule includes boosters for MMR and second boosters for DPT and OPV. 16 Except for the two doses of the seasonal influenza vaccine, all vaccines were included in these analyses. The seasonal influenza vaccine was excluded since it is mainly delivered in yearly campaigns and not month by month. 17",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.4972130656
                    }
                ]
            },
            {
                "text": "Sanidad estima que en febrero se recibirán un total de 1.779.570 dosis de Pfizer-BioNTech y mantiene una previsión de 2.705.040 dosis para marzo.",
                "text_en": "Health estimates that a total of 1,779,570 doses of Pfizer-BioNTech will be received in February and maintains a forecast of 2,705,040 doses for March.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en febrero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in February"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se recibirán un total de 1.779.570 dosis de Pfizer-BioNTech",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a total of 1,779,570 doses of Pfizer-BioNTech will be received"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En cuanto a la vacuna de AstraZeneca, 25.628 personas de entre 18 y 55 años, de los colectivos previstos en los planes de vacunación, han recibido ya su primera dosis.",
                "text_en": "With regard to the AstraZeneca vaccine, 25,628 people aged 18 to 55, out of the groups provided for in the vaccination plans, have already received their first dose.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "25.628 personas de entre 18 y 55 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "25,628 persons aged 18 to 55"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han recibido ya su primera dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you have already received your first dose"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "69": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 27,
            "WhatReliabilityReliable": 19,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 0,
            "Who": 26,
            "WhoReliabilityReliable": 21,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 9,
            "WhenReliabilityReliable": 9,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 10,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 2,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 5,
            "HowReliabilityReliable": 5,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 21,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 5,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 7,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEspaña sufre 25.438 nuevos contagios de Covid, mientras PSOE y Podemos miran para otro lado\n\n<PARAGRAPH>\n\nGobierno PSOE-Podemos: caos con las vacunas, caos con Filomena y caos con el coronavirus,.\n\n<PARAGRAPH>\n\nEl drama no es sólo qué Pedro Sánchez, Pablo Iglesias y sus equipos mientan como bellacos, pacten con terroristas y hagan apaños con los golpistas catalanes, sino que además son unos inútiles.\n\n<PARAGRAPH>\n\nY capaces de cualquier cosa y a cuenta de quién sea, para seguir en el sillón.\n\n<PARAGRAPH>\n\nEspaña esta sumida ya en tercera ola de coronavirus,  tras registrar este 11 de enero de 2021 el mayor aumento de contagios en fin de semana desde el inicio de la pandemia.\n\n<BREAK>\n\ny el Ejecutivo mira ppara otro lado.\n\n<PARAGRAPH>\n\nTanto, que médicos y expertos han dado un paso adelante y piden abiertamente al al Gobierno Sánchez que deje de arrastrar los pies y decrete ya el confinamiento domiciliario\n\n<PARAGRAPH>\n\nA pesar que desde Sanidad califican como «preocupante» el pico de contagios, el ministro Illa -en realidad candidato del PSC en las elecciones autonómicas catalanas- todavía ven posible poder doblegar la curva sin tener que acudir al confinamiento domiciliario, como ya se hizo durante la segunda ola.\n\n<PARAGRAPH>\n\nLas comunidades autónomas ya han endurecido o tienen pensado endurecer sus restricciones, dirigidas fundamentalmente a la movilidad, los aforos y los toques de queda; mientras los médicos y expertos piden volver al confinamiento de marzo para atajar la situación y evitar agravar la saturación que ya sufren en los hospitales.\n\n<PARAGRAPH>\n\nEnero será un mes complicado, según el ministro de Sanidad Salvador Illa.\n\n<PARAGRAPH>\n\nNo obstante y, a pesar de que seis de cada diez españoles considera necesario endurecer considerablemente las restricciones, el Gobierno sigue descartando la posibilidad de establecer un confinamiento domiciliario y aboga por aplicar medidas lo «más quirúrgicamente posible».\n\n<PARAGRAPH>\n\nAlgunos gobiernos regionales, como el de Castilla y León, han pedido a sus ciudadanos que se autoconfinen en sus casas, pero ninguna comunidad se plantea todavía decretar el confinamiento domiciliario en sus territorios; relegando esta opción como la última posible.\n\n<PARAGRAPH>\n\nEn la Comunidad Valenciana, algunos consellers ya plantearon esta alternativa el 5 de enero, aunque «finalmente no se consideró que fuera algo que en este momento se tuviera que hacer», según reconoció la vicepresidenta portavoz de la Generalitat, Mónica Oltra.\n\n<PARAGRAPH>\n\nEl Colegio de Médicos de la Región de Murcia pidió este lunes al Gobierno autonómico que instara al central a establecer un confinamiento domiciliario de 15 días -o más, en función de la evolución- en la Región tras las últimas cifras notificadas.\n\n<BREAK>\n\nEntendiendo que «conlleva una privación de derechos no deseada por ningún ciudadano o institución», aseveran que la «grave realidad epidemiológica en la región y la situación límite de la sanidad regional para hacer frente a esta ola de la pandemia requieren de la toma de decisiones efectivas que frenen la propagación del virus».\n\n<PARAGRAPH>\n\nYa el 5 de enero, el Comité Expertos de Castilla y León que trabajan ante la pandemia generada por el Covid-19emitió un informe en el que recomendaban un confinamiento estricto para frenar el nivel de contagios y adelantaban la petición de herramientas jurídicas en el Consejo Interterritorial de Salud para acometer esta medida.\n\n<PARAGRAPH>\n\nOtros expertos han reconocido ser partidarios del confinamiento, según han confesado en varios medios.\n\n<BREAK>\n\nEn la Cadena Ser, el profesor de virología y epidemiología en la Universidad de Santiago de Compostela, Carlos Pereira, ha aseverado que las actuales medidas de control no son suficientes.\n\n<PARAGRAPH>\n\n«Opino que es necesario hacer un confinamiento domiciliario.\n\n<BREAK>\n\nLo dije hace tiempo, en noviembre, que teníamos que hacer una cuarentena igual a la de marzo antes de Navidad.\n\n<BREAK>\n\n¿No la hicimos entonces? ¡Pues hagámosla ahora! ¿Se va a hacer? No lo sé.\n\n<BREAK>\n\nYo creo que las autoridades tienen miedo y no quieren coger el toro por los cuernos».\n\n<PARAGRAPH>\n\nTres expertos -entre ellos el exdirector de Acción Sanitaria en Situaciones de Crisis de la OMS- han firmado un artículo en eldiario.es destacando la necesidad de establecer un confinamiento corto «de quince días a un mes» en todo el territorio; «dada la magnitud de los problemas que se avecinan con la tercera ola, el potencial impacto de la variante británica y la necesidad de priorizar la aplicación de las vacunas en las mejores condiciones».\n\n<PARAGRAPH>\n\nAunque es una medida muy temida por el azote que supone a la economía del país por la paralización de toda actividad, son muchos los países europeos que ya han acudido a ella para contener la incidencia de contagios.\n\n<PARAGRAPH>\n\nPortugal, que inicialmente se planteaba establecer el confinamiento general 15 días, lo ha alargado finalmente durante al menos un mes para frenar la tercera ola.\n\n<PARAGRAPH>\n\nEn Reino Unido, uno de los países más castigados por la pandemia tras la multiplicación de casos de la cepa británica, se decretó el confinamiento domiciliario el 5 de enero.\n\n<PARAGRAPH>\n\nAntes de las navidades, Alemania, previsora, volvió al confinamiento para evitar la transmisión.\n\n<BREAK>\n\nEste lunes, de hecho, iniciaba una fase más estricta, decretando el cierre de colegios hasta -al menos- finales de enero, así como el de la cultura, la gastronomía y los comercios no esenciales; y para los ciudadanos se ha establecido un radio máximo de 15 kilómetros como límite a la movilidad.\n\n<PARAGRAPH>\n\nItalia, por su parte, aunque ya va relajando sus medidas, viene de un duro confinamiento casi total que se prolongó durante todas las navidades.\n\n<PARAGRAPH>\n",
        "TITLE": "Los médicos piden al Gobierno Sánchez que deje de arrastrar los pies y decrete el confinamiento domiciliario",
        "ID": "NF_04-11-2021_21-32-00_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Los médicos piden al Gobierno Sánchez que deje de arrastrar los pies y decrete el confinamiento domiciliario",
                "text_en": "Doctors ask the Sánchez government to stop dragging their feet and decree house confinement",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los médicos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Doctors"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gobierno Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Gobierno Sánchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deje de arrastrar los pies y decrete el confinamiento domiciliario",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "stop dragging your feet and decree house confinement"
                    }
                ],
                "evidences": []
            },
            {
                "text": "España sufre 25.438 nuevos contagios de Covid, mientras PSOE y Podemos miran para otro lado",
                "text_en": "Spain suffers 25,438 new Covid infections, while PSOE and Podemos look the other way",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sufre 25.438 nuevos contagios de Covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is suffering from 25,438 new Covid contagions"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "PSOE y Podemos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "PSOE and Podemos"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "miran para otro lado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "look the other way."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Gobierno PSOE-Podemos: caos con las vacunas, caos con Filomena y caos con el coronavirus,.",
                "text_en": "PSOE-Cano government: chaos with vaccines, chaos with Filomena and chaos with the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gobierno PSOE-Podemos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government PSOE-We can"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "caos con las vacunas, caos con Filomena y caos con el coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "chaos with vaccines, chaos with Filomena and chaos with the coronavirus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El drama no es sólo qué Pedro Sánchez, Pablo Iglesias y sus equipos mientan como bellacos, pacten con terroristas y hagan apaños con los golpistas catalanes, sino que además son unos inútiles.",
                "text_en": "The drama is not only that Pedro Sánchez, Pablo Iglesias and their teams lie like bellacos, agree with terrorists and manage with Catalan coup plotters, but they are also useless.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pedro Sánchez, Pablo Iglesias y sus equipos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pedro Sánchez, Pablo Iglesias and their teams"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mientan como bellacos, pacten con terroristas y hagan apaños con los golpistas catalanes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They lie like bellacos, deal with terrorists and make a deal with the Catalan coup plotters."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y capaces de cualquier cosa y a cuenta de quién sea, para seguir en el sillón.",
                "text_en": "And capable of anything and whoever it is, to stay on the couch.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "capaces de cualquier cosa y a cuenta de quién sea, para seguir",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "capable of anything and on account of who it is, to continue"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el sillón",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on the couch"
                    }
                ],
                "evidences": []
            },
            {
                "text": "España esta sumida ya en tercera ola de coronavirus,  tras registrar este 11 de enero de 2021 el mayor aumento de contagios en fin de semana desde el inicio de la pandemia.",
                "text_en": "Spain is already in the third wave of coronavirus, after registering on January 11, 2021 the greatest increase in contagion in weekends since the beginning of the pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esta sumida ya en tercera ola de coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is already submerged in third wave of coronavirus"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras registrar este 11 de enero de 2021 el mayor aumento de contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after recording on January 11, 2021 the greatest increase in contagion"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este 11 de enero de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "11 January 2021"
                    }
                ],
                "evidences": []
            },
            {
                "text": "y el Ejecutivo mira ppara otro lado.",
                "text_en": "And the executive looks the other way.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ejecutivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Executive Committee"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mira ppara otro lado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Look at the other side."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tanto, que médicos y expertos han dado un paso adelante y piden abiertamente al al Gobierno Sánchez que deje de arrastrar los pies y decrete ya el confinamiento domiciliario",
                "text_en": "So much so that doctors and experts have taken a step forward and openly ask the Sánchez government to stop dragging their feet and now decree house confinement.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "médicos y expertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "doctors and experts"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al al Gobierno Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Government of Sánchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "que deje de arrastrar los pies y decrete ya el confinamiento domiciliario",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to stop dragging your feet and decree house confinement"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A pesar que desde Sanidad califican como «preocupante» el pico de contagios, el ministro Illa -en realidad candidato del PSC en las elecciones autonómicas catalanas- todavía ven posible poder doblegar la curva sin tener que acudir al confinamiento domiciliario, como ya se hizo durante la segunda ola.",
                "text_en": "Despite the fact that from Sanidad they qualify as \"concerning\" the peak of contagion, Minister Illa - actually candidate of the PSC in the Catalan regional elections - still see it possible to bend the curve without having to go to house confinement, as it was already done during the second wave.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el ministro Illa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Minister Illa"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "todavía ven posible poder doblegar la curva",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They still see it possible to bend the curve"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin tener que acudir al confinamiento domiciliario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "without having to go to house confinement"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las comunidades autónomas ya han endurecido o tienen pensado endurecer sus restricciones, dirigidas fundamentalmente a la movilidad, los aforos y los toques de queda; mientras los médicos y expertos piden volver al confinamiento de marzo para atajar la situación y evitar agravar la saturación que ya sufren en los hospitales.",
                "text_en": "The Autonomous Communities have already tightened or are planning to tighten their restrictions, mainly on mobility, capacity and curfews, while doctors and experts ask to return to the March confinement to address the situation and avoid aggravating the saturation they already suffer in hospitals.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Las comunidades autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Autonomous Communities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya han endurecido o tienen pensado endurecer sus restricciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have already hardened or planned to tighten their restrictions"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los médicos y expertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "doctors and experts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "piden volver al confinamiento de marzo para atajar la situación y evitar agravar la saturación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ask to return to the March confinement to stop the situation and avoid aggravating the saturation"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los hospitales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in hospitals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Enero será un mes complicado, según el ministro de Sanidad Salvador Illa.",
                "text_en": "January will be a complicated month, according to Health Minister Salvador Illa.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "January"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "será un mes complicado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It'll be a complicated month."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el ministro de Sanidad Salvador Illa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Minister of Health Salvador Illa"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No obstante y, a pesar de que seis de cada diez españoles considera necesario endurecer considerablemente las restricciones, el Gobierno sigue descartando la posibilidad de establecer un confinamiento domiciliario y aboga por aplicar medidas lo «más quirúrgicamente posible».",
                "text_en": "However, despite the fact that six out of ten Spaniards consider it necessary to tighten the restrictions considerably, the Government continues to rule out the possibility of house confinement and advocates the application of measures as \"surgically as possible\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sigue descartando la posibilidad de establecer un confinamiento domiciliario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "continues to rule out the possibility of house confinement"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Algunos gobiernos regionales, como el de Castilla y León, han pedido a sus ciudadanos que se autoconfinen en sus casas, pero ninguna comunidad se plantea todavía decretar el confinamiento domiciliario en sus territorios; relegando esta opción como la última posible.",
                "text_en": "Some regional governments, such as Castilla y León, have asked their citizens to self-confin themselves in their homes, but no community is yet planning to decree house confinement in their territories; relegating this option as the last possible option.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Algunos gobiernos regionales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Some regional governments"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Castilla y León"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han pedido a sus ciudadanos que se autoconfinen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have asked their citizens to define themselves"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en sus casas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in their homes"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En la Comunidad Valenciana, algunos consellers ya plantearon esta alternativa el 5 de enero, aunque «finalmente no se consideró que fuera algo que en este momento se tuviera que hacer», según reconoció la vicepresidenta portavoz de la Generalitat, Mónica Oltra.",
                "text_en": "In the Valencian Community, some consellers already proposed this alternative on 5 January, although \"finally it was not considered to be something that had to be done at the moment\", as acknowledged by the vice president spokesman of the Generalitat, Mónica Oltra.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En la Comunidad Valenciana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the Valencian Community"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "algunos consellers",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "some consellers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "plantearon esta alternativa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "raised this alternative"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 5 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 5 January"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Colegio de Médicos de la Región de Murcia pidió este lunes al Gobierno autonómico que instara al central a establecer un confinamiento domiciliario de 15 días -o más, en función de la evolución- en la Región tras las últimas cifras notificadas.",
                "text_en": "On Monday, the Murcia Region Medical Association asked the Autonomous Government to urge the central government to establish a house confinement of 15 days, or more, depending on the evolution, in the Region after the latest reported figures.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Colegio de Médicos de la Región de Murcia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The College of Doctors of the Region of Murcia"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Gobierno autonómico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Autonomous Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "instara al central a establecer un confinamiento domiciliario de 15 días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "urge the central to establish a 15-day house confinement"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Región",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Region"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras las últimas cifras notificadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after the latest reported figures"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ya el 5 de enero, el Comité Expertos de Castilla y León que trabajan ante la pandemia generada por el Covid-19emitió un informe en el que recomendaban un confinamiento estricto para frenar el nivel de contagios y adelantaban la petición de herramientas jurídicas en el Consejo Interterritorial de Salud para acometer esta medida.",
                "text_en": "Already on January 5, the Expert Committee of Castile and León working in response to the pandemic generated by the Covid-19 issued a report recommending strict confinement to curb the level of contagion and advancing the request for legal tools in the Interterritorial Health Council to undertake this measure.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Ya el 5 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Already on 5 January"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Comité Expertos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Committee of Experts"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Castilla y León",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Castilla y León"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "emitió un informe en el que recomendaban un confinamiento estricto para frenar el nivel de contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "issued a report recommending strict confinement to curb the level of contagion"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Otros expertos han reconocido ser partidarios del confinamiento, según han confesado en varios medios.",
                "text_en": "Other experts have acknowledged their support for confinement, as they have confessed in various media.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Otros expertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Other experts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han reconocido ser partidarios del confinamiento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recognized as supporters of confinement"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en varios medios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in various media"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En la Cadena Ser, el profesor de virología y epidemiología en la Universidad de Santiago de Compostela, Carlos Pereira, ha aseverado que las actuales medidas de control no son suficientes.",
                "text_en": "In Cadena Ser, the professor of virology and epidemiology at the University of Santiago de Compostela, Carlos Pereira, has stated that the current control measures are not enough.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el profesor de virología y epidemiología",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the professor of virology and epidemiology"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Universidad de Santiago de Compostela",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the University of Santiago de Compostela"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha aseverado que las actuales medidas de control no son suficientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has stated that the current control measures are not sufficient"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tres expertos -entre ellos el exdirector de Acción Sanitaria en Situaciones de Crisis de la OMS- han firmado un artículo en eldiario.es destacando la necesidad de establecer un confinamiento corto «de quince días a un mes» en todo el territorio; «dada la magnitud de los problemas que se avecinan con la tercera ola, el potencial impacto de la variante británica y la necesidad de priorizar la aplicación de las vacunas en las mejores condiciones».",
                "text_en": "Three experts – among them the former Director of Health Action in Crisis Situations of the WHO – have signed an article in the newspaper highlighting the need to establish a short confinement \"from fifteen days to one month\" throughout the territory; \"given the magnitude of the problems that are coming with the third wave, the potential impact of the British variant and the need to prioritize the application of vaccines under the best conditions\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Tres expertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Three experts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la necesidad de establecer un confinamiento corto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the need to establish a short confinement"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de quince días a un mes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "15 days to 1 month"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "dada la magnitud de los problemas que se avecinan con la tercera ola, el potencial impacto de la variante británica y la necesidad de priorizar la aplicación de las vacunas en las mejores condiciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "given the magnitude of the problems ahead with the third wave, the potential impact of the British variant and the need to prioritize the application of vaccines under the best conditions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aunque es una medida muy temida por el azote que supone a la economía del país por la paralización de toda actividad, son muchos los países europeos que ya han acudido a ella para contener la incidencia de contagios.",
                "text_en": "Although it is a measure greatly feared by the scourge of the country's economy due to the paralysis of all activities, many European countries have already come to it to contain the incidence of contagion.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es una medida muy temida por el azote que supone a la economía del país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is a measure greatly feared by the scourge of the country’s economy"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la paralización de toda actividad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the cessation of all activities"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Portugal, que inicialmente se planteaba establecer el confinamiento general 15 días, lo ha alargado finalmente durante al menos un mes para frenar la tercera ola.",
                "text_en": "Portugal, which initially intended to establish general confinement for 15 days, has finally extended it for at least one month to stop the third wave.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Portugal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Portugal"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo ha alargado finalmente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He's finally lengthened it."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "durante al menos un mes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for at least one month"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En Reino Unido, uno de los países más castigados por la pandemia tras la multiplicación de casos de la cepa británica, se decretó el confinamiento domiciliario el 5 de enero.",
                "text_en": "In the United Kingdom, one of the countries most affected by the pandemic following the multiplication of cases of the British strain, house confinement was decreed on 5 January.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se decretó el confinamiento domiciliario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "house confinement was decreed"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 5 de enero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 5 January"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Antes de las navidades, Alemania, previsora, volvió al confinamiento para evitar la transmisión.",
                "text_en": "Before Christmas, Germany, in anticipation, returned to confinement to avoid transmission.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Antes de las navidades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Before Christmas"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Alemania",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Germany"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "volvió al confinamiento para evitar la transmisión",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "returned to confinement to prevent transmission"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este lunes, de hecho, iniciaba una fase más estricta, decretando el cierre de colegios hasta -al menos- finales de enero, así como el de la cultura, la gastronomía y los comercios no esenciales; y para los ciudadanos se ha establecido un radio máximo de 15 kilómetros como límite a la movilidad.",
                "text_en": "This Monday, in fact, began a stricter phase, decreeing the closure of schools until - at least - the end of January, as well as that of culture, gastronomy and non-essential shops; and for citizens a maximum radius of 15 kilometers has been established as a limit to mobility.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This Monday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "iniciaba una fase más estricta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "began a stricter phase"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Italia, por su parte, aunque ya va relajando sus medidas, viene de un duro confinamiento casi total que se prolongó durante todas las navidades.",
                "text_en": "Italy, for its part, although it is already relaxing its measures, comes from an almost total hard confinement that lasted throughout all Christmas.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "viene de un duro confinamiento casi total",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "comes from an almost total hard confinement"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante todas las navidades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during all Christmas"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "70": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 21,
            "WhatReliabilityReliable": 2,
            "WhatReliabilityUnreliable": 18,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 11,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 6,
            "Who": 11,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 7,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 6,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 2,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 1,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 9,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 7,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 2,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 18,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 18,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 5,
            "Key-Verb": 0,
            "Orthotypography": 9,
            "Figure": 6,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 20,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nKen Frazier Vapor, recomendaciones para el rebrote por la pandemia covid-19 2021\n\n<BREAK>\n\nKen Frazier, director ejecutivo del principal productor de vacunas del mundo, la farmacéutica Merck & Co., en una entrevista con el profesor Tsedal Neeley, de la Escuela de Negocios de Harvard, dijo lo siguiente:\n\n<BREAK>\n\n“El agua caliente que se bebe ya sea con limón o con ramas u hojas de eucalipto, romero, laurel o malva, es muy buena para prevenir y ayudar a erradicar el virus de la garganta. \n\n<BREAK>\n\nPero el coronavirus se oculta detrás del seno paranasal de la nariz de 3 a 4 días.\n\n<BREAK>\n\nKen Frazier Vaporizaciones \n\n<BREAK>\n\nEl agua caliente que bebemos no llega allí.\n\n<BREAK>\n\nDespués de 4 a 5 días, el virus que estaba escondido detrás del seno paranasal se traslada a los pulmones. \n\n<BREAK>\n\nEs cuando comienzan los problemas para respirar, y puede provocar Neumonía.\n\n<BREAK>\n\nPor eso es muy importante inhalar vapor ya sea de eucalipto, romero, laurel, malva u otras ramas, o simplemente de mentol o vaporub, que llega a la parte posterior de su seno paranasal. \n\n<BREAK>\n\nTienes que atacar y matar este virus en la nariz y vías respiratorias con abundantes vaporizaciones.\n\n<BREAK>\n\nA 50 ° C, este virus se desactiva, es decir, se paraliza. \n\n<BREAK>\n\nA 60 ° C, este virus se debilita tanto que cualquier sistema inmunológico humano puede combatirlo. \n\n<BREAK>\n\nA 70 ° C este virus muere por completo.\n\n<BREAK>\n\nEsto es lo que hace el vapor. \n\n<BREAK>\n\nPero parece que existen muchas personas e instituciones, entre ellas algunos gobiernos del mundo y la industria farmacéutica, que por razones inconfesables quieren aprovechar esta pandemia. \n\n<BREAK>\n\nPor eso no comparten esta información abiertamente.\n\n<BREAK>\n\nKen Frazier Vaporizaciones, yo les doy el siguiente consejo:\n\n<BREAK>\n\nQuiénes están siempre en casa y no reciben visitas de ningún tipo, deben hacer la terapia de vapor (1) una vez al día. \n\n<BREAK>\n\nQuienes no salen de casa y reciben visitas y las que salen a hacer compras, deben hacer la terapia de vapor dos (2) veces al día. \n\n<BREAK>\n\nY quiénes tienen que ir a trabajar a una Oficina o Negocio, deben hacer la terapia de vapor tres (3) veces al día.\n\n<BREAK>\n\nLas inhalaciones se hacen de la siguiente manera: En una olla mediana se pone a hervir aproximadamente litro y medio de agua.\n\n<BREAK>\n\nCuando esté hirviendo, le agregas unas 6 hojas de eucalipto, y un poquito de romero u otra rama que vaya a usar, o una cucharadita de mentol o vaporub, lo apaga y lo tapa bien por unos 3 minutos. \n\n<BREAK>\n\nluego en su cuarto, donde no haya corrientes de aire, coloca la olla con el agua hirviendo sobre una mesa.\n\n<BREAK>\n\n1.- te pones una toalla grande sobre la cabeza, y cubres la olla con la toalla.\n\n<BREAK>\n\n2.-destapa la olla e inhalas el vapor cerca de la olla, por nariz y boca, lo que aguantes, respiras y llevas ese vapor a tus fosas nasales y a tu sistema respiratorio,durante 5 minutos, evitando quemarte.\n\n<BREAK>\n\n3.- Después de hacer estas vaporizaciones es recomendable no bañarse ni exponerse al aire acondicionado, ni a lugares donde corra mucha brisa.”\n\n<BREAK>\n\nSemana de Vapor\n\n<BREAK>\n\nSegún una gran cantidad de médicos de los más experimentados, el Covid -19 puede morir inhalando vapor por la nariz y la boca, eliminando el coronavirus.\n\n<BREAK>\n\nSi toda la gente iniciamos una campaña de inhalación de vapor durante una semana, la pandemia podría terminar pronto. \n\n<BREAK>\n\nKen Frazier sugiere\n\n<BREAK>\n\nInicie el proceso durante una semana por la mañana y por la noche, durante solo 5 minutos cada vez, para inhalar vapor. \n\n<BREAK>\n\nSi todos adoptan esta práctica durante una semana, el mortal Covid-19 se borrará. \n\n<BREAK>\n\nEsta práctica tampoco tiene efectos secundarios.",
        "TITLE": "Ken Frazier Vaporizaciones, Recomienda Vapor por Rebrote de Covid-19",
        "ID": "12-Mexicopublica",
        "VALUE": "Fake",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Ken Frazier Vaporizaciones, Recomienda Vapor por Rebrote de Covid-19",
                "text_en": "Ken Frazier Vaporizations, Recommends Vapor by Regrowth of Covid-19",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ken Frazier",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ken Frazier"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Recomienda Vapor por Rebrote de Covid-19",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Recommends Steam by Regrowth of Covid-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ken Frazier Vapor, recomendaciones para el rebrote por la pandemia covid-19 2021",
                "text_en": "Ken Frazier Vapor, recommendations for the outbreak of the pandemic covid-19 2021",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recomendaciones para el rebrote por la pandemia covid-19 2021",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "recommendations for the outbreak of the pandemic covid-19 2021"
                    }
                ],
                "evidences": [
                    {
                        "value": "With the outbreak of this pandemic, and foreseeing an uptake in suicide risks, the WHO and other agencies published recommendations on mental health and psychosocial considerations during the COVID-19 outbreak and the psychological effects of quarantine [11, 12] . A major impact of this pandemic was an increase in the rate of unemployment. Kawohl and Nordt had reported two scenarios in which the COVID-19 Pandemic and Uptake in Suicide Attempt J Med Cases. 2020;11 (12) :411-416 COVID-19 pandemic and unemployment could affect suicide.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.889618814
                    }
                ]
            },
            {
                "text": "Ken Frazier, director ejecutivo del principal productor de vacunas del mundo, la farmacéutica Merck & Co., en una entrevista con el profesor Tsedal Neeley, de la Escuela de Negocios de Harvard, dijo lo siguiente:",
                "text_en": "Ken Frazier, executive director of the world's leading vaccine producer, the pharmaceutical company Merck & Co., in an interview with Professor Tsedal Neeley, Harvard Business School, said:",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ken Frazier, director ejecutivo del principal productor de vacunas del mundo, la farmacéutica Merck & Co.",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ken Frazier, executive director of the world's leading vaccine producer, the pharmaceutical company Merck & Co."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una entrevista",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an interview"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el profesor Tsedal Neeley, de la Escuela de Negocios de Harvard",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Professor Tsedal Neeley, Harvard Business School"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“El agua caliente que se bebe ya sea con limón o con ramas u hojas de eucalipto, romero, laurel o malva, es muy buena para prevenir y ayudar a erradicar el virus de la garganta. ",
                "text_en": "“The hot water that is drunk with either lemon or with eucalyptus, rosemary, laurel or mauve branches or leaves, is very good to prevent and help eradicate the virus from the throat.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "El agua caliente que se bebe ya sea con limón o con ramas u hojas de eucalipto, romero, laurel o malva",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Hot water that is drunk either with lemon or with eucalyptus, rosemary, laurel or mauve branches or leaves"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "prevenir y ayudar a erradicar el virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "prevent and help eradicate the virus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de la garganta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throat"
                    }
                ],
                "evidences": [
                    {
                        "value": "The above analyses highlighted that temperature plays an important role in transmissions of coronavirus (Seung et al. 2007; Yuan et al. 2006; Casanova et al. 2010; Chan et al. 2011; Van Doremalen et al. 2013 ) that include COVID-19 (Paulo 2020; Demongeot et al. 2020; Scafetta 2020) . Warm temperature drastically reduced its impact. Hence, the following urgent measures (also mentioned earlier in Roy 2020a, b, c) inhaling hot air intermittently through the nose (keeping comfort level) even for five minutes, say two/three times a day, will be useful to kill the virus in the nasal cavity. (v) Hot Drinks: Hot drinks (could be tea, coffee, warm milk, hot water with lemon, etc.), hot soup, gargle with warm salt water few times a day to destroy virus in the mouth and throat.",
                        "score": 0.6700000167
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9832699299
                    }
                ]
            },
            {
                "text": "Pero el coronavirus se oculta detrás del seno paranasal de la nariz de 3 a 4 días.",
                "text_en": "But the coronavirus is hidden behind the paranoid sinus of the nose for 3 to 4 days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el coronavirus se oculta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the coronavirus is hidden"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "detrás del seno paranasal de la nariz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "behind the paranasal sinus of the nose"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "de 3 a 4 días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "3 to 4 days"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Después de 4 a 5 días, el virus que estaba escondido detrás del seno paranasal se traslada a los pulmones. ",
                "text_en": "After 4 to 5 days, the virus that was hidden behind the paranasal sinus moves into the lungs.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Después de 4 a 5 días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "After 4 to 5 days"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el virus que estaba escondido detrás del seno paranasal se traslada a los pulmones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the virus that was hidden behind the paranasal sinus moves into the lungs"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "detrás del seno paranasal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "behind the sinus paranasal"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a los pulmones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the lungs"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es cuando comienzan los problemas para respirar, y puede provocar Neumonía.",
                "text_en": "That's when breathing problems begin, and it can cause pneumonia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "problemas para respirar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "problems breathing"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por eso es muy importante inhalar vapor ya sea de eucalipto, romero, laurel, malva u otras ramas, o simplemente de mentol o vaporub, que llega a la parte posterior de su seno paranasal. ",
                "text_en": "Therefore it is very important to inhale steam either from eucalyptus, rosemary, laurel, mauve or other branches, or simply from menthol or vaporub, which reaches the back of your paranasal sinus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es muy importante inhalar vapor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's very important to inhale steam."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de eucalipto, romero, laurel, malva u otras ramas, o simplemente de mentol o vaporub",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "of eucalyptus, rosemary, laurel, mauve or other branches, or merely menthol or vaporub"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tienes que atacar y matar este virus en la nariz y vías respiratorias con abundantes vaporizaciones.",
                "text_en": "You have to attack and kill this virus in the nose and airways with abundant vaporizations.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "atacar y matar este virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "attack and kill this virus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la nariz y vías respiratorias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the nose and airways"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con abundantes vaporizaciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with abundant vaporizations"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A 70 ° C este virus muere por completo.",
                "text_en": "At 70 ° C this virus dies completely.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "A 70 ° C este virus muere por completo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "At 70 ° C this virus dies completely"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero parece que existen muchas personas e instituciones, entre ellas algunos gobiernos del mundo y la industria farmacéutica, que por razones inconfesables quieren aprovechar esta pandemia. ",
                "text_en": "But it seems that there are many people and institutions, including some governments in the world and the pharmaceutical industry, who, for unconfessable reasons, want to take advantage of this pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchas personas e instituciones, entre ellas algunos gobiernos del mundo y la industria farmacéutica",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "many people and institutions, including some governments around the world and the pharmaceutical industry"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "quieren aprovechar esta pandemia",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They want to take advantage of this pandemic."
                    }
                ],
                "evidences": [
                    {
                        "value": "At the beginning of 2020, governments across the globe proposed lockdowns in the name of public interest and the protection of public health and safety during the COVID-19 pandemic. Once infection rates decreased, often a phased approach was taken to re-open economies, facilitated by \"route maps\" and systems of \"alert levels\" (Cellan-Jones, 2020). A substantial effort was put into such planning exercises, as governments dealing with the pandemic faced a number of challenges around the re-opening of economies.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9956994057
                    }
                ]
            },
            {
                "text": "Por eso no comparten esta información abiertamente.",
                "text_en": "That is why they do not openly share this information.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no comparten esta información",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "do not share this information"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "abiertamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Outspokenly."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ken Frazier Vaporizaciones, yo les doy el siguiente consejo:",
                "text_en": "Ken Frazier Vaporizations, I give you the following advice:",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "yo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Me."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "les doy el siguiente consejo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I give you the following advice."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Quiénes están siempre en casa y no reciben visitas de ningún tipo, deben hacer la terapia de vapor (1) una vez al día. ",
                "text_en": "Those who are always at home and do not receive visits of any kind should do steam therapy (1) once a day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Quiénes están siempre en casa y no reciben visitas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Who are always at home and do not receive visitors"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en casa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at home"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deben hacer la terapia de vapor",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "You should do the steam therapy."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "(1) una vez al día",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "(1) once a day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Quienes no salen de casa y reciben visitas y las que salen a hacer compras, deben hacer la terapia de vapor dos (2) veces al día. ",
                "text_en": "Those who do not leave the house and receive visitors and those who go shopping should do steam therapy twice (2) times a day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Quienes no salen de casa y reciben visitas y las que salen a hacer compras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Those who do not leave the house and receive visitors and those who go shopping"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deben hacer la terapia de vapor",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "You should do the steam therapy."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "dos (2) veces al día",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "twice (2) times a day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y quiénes tienen que ir a trabajar a una Oficina o Negocio, deben hacer la terapia de vapor tres (3) veces al día.",
                "text_en": "And who has to go to work in an Office or Business, must do steam therapy three (3) times a day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "quiénes tienen que ir a trabajar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "who have to go to work"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a una Oficina o Negocio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to an Office or Business"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deben hacer la terapia de vapor",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "You should do the steam therapy."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tres (3) veces al día",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "three (3) times a day"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las inhalaciones se hacen de la siguiente manera: En una olla mediana se pone a hervir aproximadamente litro y medio de agua.",
                "text_en": "Inhalations are made as follows: In a medium pot it is boiled about a liter and a half of water.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las inhalaciones se hacen de la siguiente manera",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Inhalations are done as follows:"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "En una olla mediana se pone a hervir aproximadamente litro y medio de agua",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "In a medium pot it is put to boil approximately a liter and a half of water"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cuando esté hirviendo, le agregas unas 6 hojas de eucalipto, y un poquito de romero u otra rama que vaya a usar, o una cucharadita de mentol o vaporub, lo apaga y lo tapa bien por unos 3 minutos. ",
                "text_en": "When it's boiling, add about 6 eucalyptus leaves, and a little rosemary or another branch you're going to use, or a teaspoon of menthol or vaporub, turn it off and cover it well for about 3 minutes.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "le agregas unas 6 hojas de eucalipto, y un poquito de romero u otra rama que vaya a usar, o una cucharadita de mentol o vaporub, lo apaga y lo tapa bien por unos 3 minutos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "add about 6 leaves of eucalyptus, and a little rosemary or another branch you will use, or a teaspoon of menthol or vaporub, turn it off and cover it well for about 3 minutes"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según una gran cantidad de médicos de los más experimentados, el Covid -19 puede morir inhalando vapor por la nariz y la boca, eliminando el coronavirus.",
                "text_en": "According to a large number of doctors of the most experienced, Covid -19 can die by inhaling steam through the nose and mouth, eliminating the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una gran cantidad de médicos de los más experimentados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a lot of doctors of the most experienced"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el Covid -19 puede morir",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the Covid -19 can die"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "inhalando vapor por la nariz y la boca, eliminando el coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "inhaling steam through the nose and mouth, eliminating the coronavirus"
                    }
                ],
                "evidences": [
                    {
                        "value": "The main mechanism for person-to-person transmission of COVID-19 is through the droplets of saliva or discharge from the nose while the infected person sneezes or coughs. It can also be spread via direct or indirect contact with an infected person. Respiratory droplets or aerosols can penetrate the lungs via inhalation through the nose or mouth [1] . The spread of the organism can be halted by proper handwashing, maintaining physical distancing, avoiding touching faces with the hand, and covering mouth and nose with a face mask [5, 6] .",
                        "score": 0.5799999833
                    },
                    {
                        "value": "The participant's narratives showed that there was widespread use of a combination of local herbs, common tree leaves, and vegetables for the protection against suspected COVID-19 symptoms. From the interviews, a total of 19 plants were reported to be used against suspected COVID-19 symptoms ( Table 2) mlavumba (Tetradenia riparia (Hochst.)). Ginger (Zingiber officinale Roscoe), red onions (Allium cepa L.), garlic (Allium sativum L.), and lemons were also used in preparation of the remedies. Honey was also reported to be used in the preparation of the remedies. The concoctions were used in two main ways: either crushed and mixed with warm water or boiled in water and the product taken orally. Alternatively, the concoctions were boiled and the steam inhaled through the mouth and nose. From the interviews, inhaling the steam (kujifukiza or kupiga nyungu in Swahili) was the most popular way of administering the concoctions. A mixture of the tree leaves and local herbs was boiled in a huge cooking pot. At the point of boiling, the pot was taken off the cooker, and the covering lid removed. Then, the person needing treatment sat next to the pot and was covered with a bed sheet, blanket, or any other large piece of cloth to ensure that none of the medicinal steam escapes. They would inhale the steam and sweat for some time (for some, up to about 30 min). The sweating indicated that the medicine has entered into the body and taken the illness out of it. Respondents who steamed reported feeling relief and improvement after the sessions.",
                        "score": 0.5600000024
                    },
                    {
                        "value": "COVID-19 that is the name of the disease caused by the SARS-CoV2 virus remains to interrupt our lifes as pandemic in 2020 (1) . COVID-19 is usually noticed by fever, cough, sore throat, headache, muscle pain, diarrhea, and dyspnea, although neurological presentations of COVID-19 have also been defined (2, 3) . Some reports have published that COVID-19 could result cranial neuropathies such as anosmia and facial nerve palsy (4) (5) (6) .",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.6609694362
                    },
                    {
                        "label": "neutral",
                        "score": 0.9937048554
                    },
                    {
                        "label": "contradiction",
                        "score": 0.7188665867
                    }
                ]
            },
            {
                "text": "Si toda la gente iniciamos una campaña de inhalación de vapor durante una semana, la pandemia podría terminar pronto. ",
                "text_en": "If all the people started a steam inhalation campaign for a week, the pandemic could end soon.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "iniciamos una campaña de inhalación de vapor durante una semana",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We started a steam inhalation campaign for a week."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la pandemia podría terminar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the pandemic could end"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "pronto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Soon"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ken Frazier sugiere",
                "text_en": "Ken Frazier suggests",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ken Frazier",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ken Frazier"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Inicie el proceso durante una semana por la mañana y por la noche, durante solo 5 minutos cada vez, para inhalar vapor. ",
                "text_en": "Start the process for one week in the morning and at night, for only 5 minutes each time, to inhale steam.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Inicie el proceso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Start the process"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante una semana por la mañana y por la noche, durante solo 5 minutos cada vez",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for one week in the morning and at night, for only 5 minutes each time"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si todos adoptan esta práctica durante una semana, el mortal Covid-19 se borrará. ",
                "text_en": "If all adopt this practice for a week, the mortal Covid-19 will be erased.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "todos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "all"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "adoptan esta práctica durante una semana",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "adopt this practice for one week"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el mortal Covid-19 se borrará",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the mortal Covid-19 will be erased"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta práctica tampoco tiene efectos secundarios.",
                "text_en": "This practice also has no side effects.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta práctica tampoco tiene efectos secundarios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This practice also has no side effects."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "71": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 18,
            "WhatReliabilityReliable": 9,
            "WhatReliabilityUnreliable": 9,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 19,
            "WhoReliabilityReliable": 15,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 12,
            "WhereReliabilityReliable": 11,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 3,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 16,
            "WhoRoleTarget": 3,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 3,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLa misión concluye que saltó al humano en diciembre de 2019\n\n<PARAGRAPH>\n\nEstá la OMS (Organización Mundial de la Salud) para hacerle mucho caso de sus directrices y recomendaciones, pero ahí siguen.\n\n<PARAGRAPH>\n\nRecientemente, un equipo de expertos de este organismo se ha desplazado a Wuhan, el lugar donde se dio origen a la pandemia del coronavirus.\n\n<BREAK>\n\nLa conclusión de este equipo es que el SARS-CoV-2 tiene origen animal, descartando, por tanto, la teoría de la mano humana en algún laboratorio chino.\n\n<PARAGRAPH>\n\nEl comité desplazado a China ha sido incapaz de dilucidar si el maldito virus procede de alguna de las especies sospechosas, como el murciélago o el pangolín.\n\n<PARAGRAPH>\n\nLa comitiva llegó a Wuhan el pasado 14 de enero de 2021 y asegura que ha estudiado y visitado lugares como el mercado mayorista de mariscos de Huanan, donde se produjo el primer grupo de infecciones conocido, o el Instituto de Virología de Wuham, donde se investiga el origen del coronavirus.\n\n<BREAK>\n\nAseguran que el virus saltó al humano en diciembre de 2019.\n\n<PARAGRAPH>\n\nPara este viaje, no hacía falta estas alforjas, pensará más de uno al leer las conclusiones a las que ha llegado la OMS.\n\n<BREAK>\n\nEn la rueda de prensa han participado Peter Ben Embarek y Marion Koopmans.\n\n<PARAGRAPH>\n\nY es que los enviados de la Organización Mundial de la Salud se han visto incapaces de determinar de qué animal procede el virus, ya que incluso no han descartado a otras especies como «visones y gatos«.\n\n<PARAGRAPH>\n\nLiang Wannian insiste en la teoría de los congelados antes de empezar @Peterfoodsafety, que dice que la foto no ha cambiado dramáticamente tras su visita.\n\n<PARAGRAPH>\n\n— Pablo M.\n\n<BREAK>\n\nDíez (@PabloDiez_ABC) February 9, 2021\n\n<PARAGRAPH>\n\nEn el análisis, también se ha estudiado el salto del virus de los animales a los humanos.\n\n<BREAK>\n\nY se barajan cuatro hipótesis:\n\n<PARAGRAPH>\n\n– Salto directo de un animal a un humano\n\n<PARAGRAPH>\n\n– Desde un murciélago y a través de especies animales intermediarias\n\n<PARAGRAPH>\n\n– Productos congelados que actúen como superficie de transmisión del virus a la población humana\n\n<PARAGRAPH>\n\n– Orígen en un laboratorio, que es la posibilidad que la OMS ya ha descartado no sea que la dictadura china se pueda enfadar\n\n<PARAGRAPH>\n\nJuan Hidalgo, en Twitter, comentaba: «Por si a alguien le quedaban dudas, este viaje es una pantomima que no servirá de nada.\n\n<BREAK>\n\nPensar que en una visita así se puede descubrir algo es totalmente ridículo».\n\n<PARAGRAPH>\n\n«Desde el principio de la pandemia, la OMS está demostrando ser un organismo bastante poco acertado», añadía.\n\n<BREAK>\n\n«Sigue la misma línea que los políticos: postureo, muchos discursos y ruedas de prensa vacíos de contenido, hacer cosas no por su utilidad sino para generar bonitos titulares…»\n\n<PARAGRAPH>\n\n2/ Dicen que resulta imposible establecer cómo el virus entró en el mercado de carnes y mariscos de Wuhan.\n\n<BREAK>\n\nPor si a alguien le quedaban dudas, este viaje es una pantomima que no servirá para nada.\n\n<BREAK>\n\nPensar que en una visita así se puede descubrir algo es totalmente ridículo.\n\n<PARAGRAPH>\n\n— Juan Hidalgo (@juanhidalgocen) February 9, 2021\n\n<PARAGRAPH>\n\n3/ Desde el principio de la pandemia, la OMS está demostrando ser un organismo bastante poco acertado.\n\n<BREAK>\n\nSigue la misma línea que los políticos: postureo, muchos discursos y ruedas de prensa vacíos de contenido, hacer cosas no por su utilidad sino para generar bonitos titulares…\n\n<PARAGRAPH>\n\n— Juan Hidalgo (@juanhidalgocen) February 9, 2021\n\n<PARAGRAPH>\n\nEl analista Felipe Sahagún hablaba de una «nueva operación de propaganda de Pekín».\n\n<BREAK>\n\nY remachaba: «no deberíamos haberla llamado nunca ‘investigación’ ni calificado de ‘independiente’.\n\n<PARAGRAPH>\n\nLa rueda de prensa de hoy en Wuhan de la delegación de la #OMS, como todo el viaje, han sido otra gran operación de propaganda de Pekín.\n\n<BREAK>\n\nNo deberíamos haberla llamado nunca «investigación» ni calificado de «independiente».\n\n<PARAGRAPH>\n\n— Felipe Sahagún (@sahagunfelipe) February 9, 2021\n\n<PARAGRAPH>\n",
        "TITLE": "Para este viaje no hacían falta tantas alforjas: la OMS se va hasta China para concluir que el coronavirus tiene origen animal",
        "ID": "NF_04-11-2021_22-13-36_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Para este viaje no hacían falta tantas alforjas: la OMS se va hasta China para concluir que el coronavirus tiene origen animal",
                "text_en": "This trip did not take so many saddlebags: the WHO goes to China to conclude that the coronavirus has animal origin",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "hasta China",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to China"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "concluir que el coronavirus tiene origen animal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "conclude that coronavirus has animal origin"
                    }
                ],
                "evidences": [
                    {
                        "value": "In December of 2019 a new virus of zoonotic origin, called coronavirus (SARS-CoV-2), was reported in Wuhan, China; it expanded and quickly resulted in a global pandemic called Coronavirus Disease 2019 , declared by the WHO on 12 March 2020 [1, 2] .",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.5045418739
                    }
                ]
            },
            {
                "text": "La misión concluye que saltó al humano en diciembre de 2019",
                "text_en": "The mission concludes that it jumped the human in December 2019",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La misión concluye que saltó",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The mission concludes that it jumped"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al humano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the human person"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en diciembre de 2019",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in December 2019"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Está la OMS (Organización Mundial de la Salud) para hacerle mucho caso de sus directrices y recomendaciones, pero ahí siguen.",
                "text_en": "There is the WHO (World Health Organization) to pay close attention to its guidelines and recommendations, but they are still there.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS (Organización Mundial de la Salud)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO (World Health Organization)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hacerle mucho caso de sus directrices y recomendaciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "pay close attention to your guidelines and recommendations"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Recientemente, un equipo de expertos de este organismo se ha desplazado a Wuhan, el lugar donde se dio origen a la pandemia del coronavirus.",
                "text_en": "Recently, a team of experts from this agency has moved to Wuhan, where the coronavirus pandemic originated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Recientemente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Recently"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un equipo de expertos de este organismo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a team of experts from this body"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha desplazado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has moved"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a Wuhan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Wuhan"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La conclusión de este equipo es que el SARS-CoV-2 tiene origen animal, descartando, por tanto, la teoría de la mano humana en algún laboratorio chino.",
                "text_en": "The conclusion of this team is that SARS-CoV-2 has animal origin, thus discarding the theory of the human hand in some Chinese laboratory.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "este equipo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "this team"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el SARS-CoV-2 tiene origen animal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "SARS-CoV-2 has animal origin"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "descartando, por tanto, la teoría de la mano humana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "discarding, therefore, the theory of the human hand"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en algún laboratorio chino",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in some Chinese lab."
                    }
                ],
                "evidences": [
                    {
                        "value": "To investigate whether the mutation pattern between SARS-CoV-2 and RaTG13 is unique across all coronavirus species, we further compared their alterations of nucleotides and amino acids in comparison to other representative coronaviruses. Phylogenetic analysis of SARS-CoV-2 and its 20 closely related coronaviruses formed four well supported clades (Fig. 2) indicate that the relative level of synonymous substitutions between human SARS-CoV-2 and its possible animal origin (RaTG13) is much higher than that between other human coronaviruses and their potential animal sources.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.999425292
                    }
                ]
            },
            {
                "text": "El comité desplazado a China ha sido incapaz de dilucidar si el maldito virus procede de alguna de las especies sospechosas, como el murciélago o el pangolín.",
                "text_en": "The committee displaced to China has been unable to elucidate whether the damn virus comes from any of the suspicious species, such as bat or pangolin.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El comité desplazado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The displaced committee"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a China",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to China"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha sido incapaz de dilucidar si el maldito virus procede",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's been unable to figure out if the damn virus comes in."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de alguna de las especies sospechosas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "of any of the suspicious species"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La comitiva llegó a Wuhan el pasado 14 de enero de 2021 y asegura que ha estudiado y visitado lugares como el mercado mayorista de mariscos de Huanan, donde se produjo el primer grupo de infecciones conocido, o el Instituto de Virología de Wuham, donde se investiga el origen del coronavirus.",
                "text_en": "The entourage arrived in Wuhan on 14 January 2021 and says that it has studied and visited places such as the wholesale seafood market in Huanan, where the first known group of infections occurred, or the Institute of Virology in Wuham, where the origin of the coronavirus is investigated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La comitiva",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The motorcade"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a Wuhan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Wuhan"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado 14 de enero de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 14 January 2021"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha estudiado y visitado lugares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has studied and visited places"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "el mercado mayorista de mariscos de Huanan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the wholesale seafood market of Huanan"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "el Instituto de Virología de Wuham",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Institute of Virology of Wuham"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aseguran que el virus saltó al humano en diciembre de 2019.",
                "text_en": "They claim that the virus jumped the human in December 2019.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Aseguran que el virus saltó",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They say the virus jumped."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al humano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the human person"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en diciembre de 2019",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in December 2019"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En la rueda de prensa han participado Peter Ben Embarek y Marion Koopmans.",
                "text_en": "Peter Ben Embarek and Marion Koopmans participated in the press conference.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En la rueda de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "At the press conference"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han participado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have participated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Peter Ben Embarek y Marion Koopmans",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Peter Ben Embarek and Marion Koopmans"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y es que los enviados de la Organización Mundial de la Salud se han visto incapaces de determinar de qué animal procede el virus, ya que incluso no han descartado a otras especies como «visones y gatos«.",
                "text_en": "The World Health Organisation envoys have been unable to determine which animal the virus comes from, as they have not even ruled out other species such as ‘visons and cats’.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los enviados de la Organización Mundial de la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "World Health Organization envoys"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han visto incapaces de determinar de qué animal procede el virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "have been unable to determine from which animal the virus is derived"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que incluso no han descartado a otras especies",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since they have not even ruled out other species"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Liang Wannian insiste en la teoría de los congelados antes de empezar @Peterfoodsafety, que dice que la foto no ha cambiado dramáticamente tras su visita.",
                "text_en": "Liang Wannian insists on frozen theory before starting @Peterfoodsafety, which says the photo hasn't changed dramatically after his visit.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Liang Wannian",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Liang Wannian"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "insiste en la teoría de los congelados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "insists on frozen theory"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el análisis, también se ha estudiado el salto del virus de los animales a los humanos.",
                "text_en": "In the analysis, the leap from the animal virus to humans has also been studied.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En el análisis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the analysis"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha estudiado el salto del virus de los animales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "animal virus leap has been studied"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los humanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to human beings"
                    }
                ],
                "evidences": [
                    {
                        "value": "Major infectious disease epidemics and pandemics are often the result of pathogens that usually circulate in animals becoming capable of infecting humans [2] . Such jumps of pathogens from animals to humans are called zoonotic shifts. For viruses, especially those with RNA genome, such events happen when an animal virus adapts to human hosts, sometimes via an intermediate animal.",
                        "score": 0.6000000238
                    },
                    {
                        "value": "As people move out of metropolitan areas unwittingly encroaching on the wilderness, they are exposed to and come in contact with wildlife. Animals move into human neighborhoods or are brought in through wildlife trade. And this neighborliness back and forth is not without consequences. Humans are exposed to wildlife microbes, which sometimes make the leap from animal to human hosts. The role of bats and civet cats in SARS, wild waterfowl in avian influenza A(H5N1), and infected birds in West Nile virus infection points to community-wildlife interaction as an effective conduit for zoonotic microbes to enter new niches.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9953365922
                    },
                    {
                        "label": "neutral",
                        "score": 0.9952248335
                    }
                ]
            },
            {
                "text": "Y se barajan cuatro hipótesis:",
                "text_en": "And four hypotheses are dealt with:",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se barajan cuatro hipótesis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "four hypotheses are dealt with"
                    }
                ],
                "evidences": []
            },
            {
                "text": "– Orígen en un laboratorio, que es la posibilidad que la OMS ya ha descartado no sea que la dictadura china se pueda enfadar",
                "text_en": "– Origin in a laboratory, which is the possibility that the WHO has already ruled out unless the Chinese dictatorship can get angry",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un laboratorio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a laboratory"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es la posibilidad que la OMS ya ha descartado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is the possibility that the WHO has already ruled out"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "no sea que la dictadura china se pueda enfadar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "unless the Chinese dictatorship can get angry"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la dictadura china",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the Chinese dictatorship"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Juan Hidalgo, en Twitter, comentaba: «Por si a alguien le quedaban dudas, este viaje es una pantomima que no servirá de nada.",
                "text_en": "Juan Hidalgo, on Twitter, commented: \"In case anyone had any doubts, this trip is a pantomime that won't do any good.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Juan Hidalgo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Juan Hidalgo"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Twitter",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Twitter"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Por si a alguien le quedaban dudas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "In case anyone had any doubts."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "este viaje es una pantomima que no servirá de nada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This trip is a pantomime that won't do any good."
                    }
                ],
                "evidences": []
            },
            {
                "text": "3/ Desde el principio de la pandemia, la OMS está demostrando ser un organismo bastante poco acertado.",
                "text_en": "3/ From the beginning of the pandemic, WHO is proving to be a rather unwise body.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Desde el principio de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "From the beginning of the pandemic"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está demostrando ser un organismo bastante poco acertado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is proving to be a rather unwise organism"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sigue la misma línea que los políticos: postureo, muchos discursos y ruedas de prensa vacíos de contenido, hacer cosas no por su utilidad sino para generar bonitos titulares…",
                "text_en": "It follows the same line as politicians: postureo, many speeches and press conferences empty of content, doing things not for their usefulness but to generate beautiful headlines...",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Sigue la misma línea",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Follow the same line"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los políticos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "politicians"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por su utilidad sino para generar bonitos titulares",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for its usefulness but to generate beautiful headlines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La rueda de prensa de hoy en Wuhan de la delegación de la #OMS, como todo el viaje, han sido otra gran operación de propaganda de Pekín.",
                "text_en": "Today's press conference in Wuhan by the #WHO delegation, like the whole trip, has been another major Beijing propaganda operation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Wuhan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Wuhan"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la delegación de la #OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "#WHO delegation"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han sido otra gran operación de propaganda",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "have been another great propaganda operation"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pekín",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Beijing"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "72": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 17,
            "WhatReliabilityReliable": 17,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 5,
            "Who": 8,
            "WhoReliabilityReliable": 8,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nSabemos que vacunarse no es obligatorio.\n\n<BREAK>\n\nSi bien, ante la pandemia actual, los científicos y Gobiernos recomiendan que se haga para acabar con este virus cuanto antes.\n\n<BREAK>\n\nLos casos de trombosis acontecidos en personas que se habían administrado AstraZeneca (aunque no se demuestra relación alguna con la vacuna) han aumentado la desconfianza frente a ella.\n\n<BREAK>\n\n¿Es posible rechazar la vacuna de AstraZeneca y optar por otra?\n\n<PARAGRAPH>\n\nLa EMA ya dijo que la vacuna es segura y eficaz, pero, pese a ello, muchas personas están algo preocupadas y deciden no vacunarse, al menos con esta vacuna.\n\n<PARAGRAPH>\n\nVacunarse  no es obligatorio\n\n<PARAGRAPH>\n\nEn Italia, las personas pueden rechazar vacunarse con la dosis de AstraZeneca y cuando surja entonces hacerlo con otra más adelante.\n\n<BREAK>\n\nDesde el Ministerio de Sanidad en España se pone de manifiesto que la vacuna frente al nuevo coronavirus no es obligatoria.\n\n<PARAGRAPH>\n\nDe manera que, si queremos rechazar la vacuna de AstraZeneca, de igual forma que se puede decir que no a otras, no pasaría nada y podría hacerse, salvo la de no contar con inmunidad ante el virus SARS-CoV-2.\n\n<PARAGRAPH>\n\nYa nos dijeron desde un inicio que Sanidad recopilaría los datos de las personas que no quieren vacunarse y los motivos.\n\n<PARAGRAPH>\n\n¿Dos dosis de dos vacunas diferentes?\n\n<PARAGRAPH>\n\nAlgunas personas se preguntan si hay seguridad y efectividad al administrar dos dosis de dos vacunas diferentes.\n\n<BREAK>\n\nPero el caso es que no se sabe, por lo que desde Sanidad concluyen que si has recibido la primera dosis de AstraZeneca, no puedes ponerte una segunda dosis de otra vacuna diferente.\n\n<PARAGRAPH>\n\nY si rechazamos esta segunda dosis, entonces hay que espera qué nos dicen los médicos.\n\n<PARAGRAPH>\n\nNo podemos elegir vacuna en España\n\n<PARAGRAPH>\n\nRespecto a poder elegir la vacuna que yo quiera, esto no es posible.\n\n<BREAK>\n\nSanidad manifiesta que la campaña de vacunación es algo que se vive por la pandemia actual y que primero deben vacunarse los más vulnerables.\n\n<PARAGRAPH>\n\nAsí la elección de la vacuna a aplicar no puede ser una elección individual sino que debe basarse en la eficacia y la indicación de las vacunas para los diferentes grupos de población.\n\n<PARAGRAPH>\n\nY no es algo exclusivo de España, sino de casi todos los países.\n\n<BREAK>\n\nPues Italia sí permite que los  ciudadanos puedan elegir la vacuna contra el coronavirus, siempre que esté aprobada y disponible en el país.\n\n<PARAGRAPH>\n\n",
        "TITLE": "¿Es posible rechazar la vacuna de AstraZeneca y optar por otra?",
        "ID": "13_NF_04-11-2021_21-03-03_okdiario_com",
        "VALUE": "Fake",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "¿Es posible rechazar la vacuna de AstraZeneca y optar por otra?",
                "text_en": "Is it possible to reject the AstraZeneca vaccine and choose another one?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "rechazar la vacuna de AstraZeneca y optar por otra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reject the AstraZeneca vaccine and opt for another"
                    }
                ],
                "evidences": [
                    {
                        "value": "The Saudi Food and Drug Authority (SFDA) has approved two vaccines against coronavirus disease 2019 (COVID-19), Pfizer-BioNTech a messenger RNA-based vaccines, and COVID-19 vaccine AstraZeneca that encodes the spike protein antigen of SARS-CoV-2, encapsulated in lipid nanoparticles.",
                        "score": 0.5299999714
                    },
                    {
                        "value": "The COVID-19 Vaccine AstraZeneca vaccination course consists of two separate doses of 0.5 mL each, the second dose should be given 4 to 12 weeks (28 to 84 days) after the first dose.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "Note: Participants who favored the BioNTech (AstraZeneca) vaccine were randomly assigned the BioNTech (AstraZeneca) vaccine (assignment of preferred vaccine) or the AstraZeneca The results provide empirical support for the benefits of being able to choose a vaccine, which increases willingness to be vaccinated against COVID-19. This is clearly of particular relevance where strong preferences exist or where a preferred vaccine is scarce.",
                        "score": 0.5699999928
                    },
                    {
                        "value": "In sum, the understanding of factors that can contribute to COVID-19 vaccine hesitancy among college students is imperative in order to develop effective strategies to increase COVID-19 vaccination. However, none of the previous studies examined whether the rate of vaccine hesitancy among college students differed with respect to the vaccine typology. Although relevant authorities such as the European Medicines Agency and the WHO established that the benefits of COVID-19 vaccines far outweigh any possible risk [28, 29] , the safety of AstraZeneca vaccine has been concerned by mass media and social media as well [30] . It could be argued that the willingness to receive vaccination is lower with respect to the AstraZeneca vaccine, given the negative societal sentiment against it [31] [32] [33] . This issue seems especially relevant in the Italian context, given the repeated conflicting decisions about the use of the AstraZeneca vaccine during the first months of the Italian inoculation campaign. More specifically, after the European Union approved the use of the AstraZeneca vaccine in January, the Italian government recommended its use only for people under the age of 55. However, in March 2021, in accordance with other European countries, the Italian government briefly halted AstraZeneca inoculations over concerns of rare, severe thrombosis, mainly in young people. More than 20 countries stopped distributing that vaccine for a week or more. To our knowledge, only one experimental study in Germany [34] evidenced that the willingness to be vaccinated increased when the vaccine preferences (i.e., the BioNTech vaccine vs. the AstraZeneca vaccine) were taken into account. Moreover, when participants were asked which vaccine they would prefer (in February 2021), 46.2% of them favored the BioNTech vaccine, whereas only 2.3% chose the AstraZeneca vaccine, and 29.4% had no preferences.",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9988310933
                    },
                    {
                        "label": "neutral",
                        "score": 0.9967157841
                    },
                    {
                        "label": "neutral",
                        "score": 0.9642776251
                    },
                    {
                        "label": "neutral",
                        "score": 0.9945757389
                    }
                ]
            },
            {
                "text": "Sabemos que vacunarse no es obligatorio.",
                "text_en": "We know that vaccination is not mandatory.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vacunarse no es obligatorio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Vaccination is not compulsory"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si bien, ante la pandemia actual, los científicos y Gobiernos recomiendan que se haga para acabar con este virus cuanto antes.",
                "text_en": "While, in the face of the current pandemic, scientists and Governments recommend that it be done to end this virus as soon as possible.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ante la pandemia actual",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the face of the current pandemic"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los científicos y Gobiernos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "and Governments"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recomiendan que se haga para acabar con este virus cuanto antes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recommend that it be done to end this virus as soon as possible"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los casos de trombosis acontecidos en personas que se habían administrado AstraZeneca (aunque no se demuestra relación alguna con la vacuna) han aumentado la desconfianza frente a ella.",
                "text_en": "Cases of thrombosis in people who had been given AstraZeneca (although no link to the vaccine is shown) have increased mistrust of AstraZeneca.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "casos de trombosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "cases of thrombosis"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en personas que se habían administrado AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in people who had been given AstraZeneca"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desconfianza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mistrust"
                    }
                ],
                "evidences": [
                    {
                        "value": "This case series demonstrates rare thromboembolic events and thrombocytopenia after receiving the first dose of the ChAdOx1 nCoV-19 (AstraZeneca) vaccine. No thromboembolic events have been found in randomized safety studies of the AstraZeneca vaccine (1) (2) .",
                        "score": 0.6299999952
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9849258065
                    }
                ]
            },
            {
                "text": "La EMA ya dijo que la vacuna es segura y eficaz, pero, pese a ello, muchas personas están algo preocupadas y deciden no vacunarse, al menos con esta vacuna.",
                "text_en": "The EMA has already said that the vaccine is safe and effective, but despite this, many people are somewhat concerned and decide not to get vaccinated, at least with this vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dijo que la vacuna es segura y eficaz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "said the vaccine is safe and effective"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "muchas personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "many people"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "están algo preocupadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're kind of worried."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "deciden no vacunarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "decide not to get vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Vacunarse  no es obligatorio",
                "text_en": "Vaccination is not mandatory",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Vacunarse  no es obligatorio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Vaccination is not mandatory"
                    }
                ],
                "evidences": [
                    {
                        "value": "There are a lot of models of implementing vaccinations in European pharmacies. In 2019, flu vaccinations were offered in pharmacies in 40% of European countries, and in 17%, other vaccinations were also available (n = 30) [28] . Currently, in Europe, vaccinations are administered in pharmacies in 13 countries (Figure 1 ), yet it should be noted that conducting vaccinations by pharmacies is not obligatory in any country. For example, in Great Britain and Portugal, vaccinations are available in about 78% of the pharmacies, and in Norway, in 60%. In some countries, the Czech Republic, Belgium, Germany, and others, endeavors are being made to be able to administer vaccinations in pharmacies, but they face opposition from other medical professions conducting vaccinations [9, 10, 29] . Due to the fact that vaccinations are dispensed and administered on the basis of prescriptions, most vaccination models are based on doctor-pharmacist cooperation. Pharmacists are authorized to administer vaccinations in Portugal, Ireland, Great Britain, France, Switzerland, Denmark, and Greece. In many countries, vaccinations are not conducted by pharmacists but by nursing staff employed for this purpose-this is the case in Italy, the Netherlands, Sweden, Finland, and Estonia. In some countries, e.g., in Portugal, there is a mixed model.",
                        "score": 0.6000000238
                    },
                    {
                        "value": "There are a lot of models of implementing vaccinations in European pharmacies. In 2019, flu vaccinations were offered in pharmacies in 40% of European countries, and in 17%, other vaccinations were also available (n = 30) [28] . Currently, in Europe, vaccinations are administered in pharmacies in 13 countries (Figure 1 ), yet it should be noted that conducting vaccinations by pharmacies is not obligatory in any country. For example, in Great Britain and Portugal, vaccinations are available in about 78% of the pharmacies, and in Norway, in 60%. In some countries, the Czech Republic, Belgium, Germany, and others, endeavors are being made to be able to administer vaccinations in pharmacies, but they face opposition from other medical professions conducting vaccinations [9, 10, 29] . Due to the fact that vaccinations are dispensed and administered on the basis of prescriptions, most vaccination models are based on doctor-pharmacist cooperation. Pharmacists are authorized to administer vaccinations in Portugal, Ireland, Great Britain, France, Switzerland, Denmark, and Greece. In many countries, vaccinations are not conducted by pharmacists but by nursing staff employed for this purpose-this is the case in Italy, the Netherlands, Sweden, Finland, and Estonia. In some countries, e.g., in Portugal, there is a mixed model. The Portuguese Pharmaceutical Association developed guidelines on the implementation of services connected with administering vaccinations and medications in the form of injections in pharmacies, including minimum requirements for the provision of services and describing the process of basic and additional training sessions for pharmacists [31] . Having completed a basic training, Portuguese pharmacists are obliged to maintain the continuity of services and take part in a refresher training every five years. The guidelines regarding rooms, their equipment and vaccination reports were also developed. Currently, vaccinations are administered in 78% of all the pharmacies in Portugal [32] .",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "entailment",
                        "score": 0.7678863406
                    },
                    {
                        "label": "neutral",
                        "score": 0.700738728
                    }
                ]
            },
            {
                "text": "En Italia, las personas pueden rechazar vacunarse con la dosis de AstraZeneca y cuando surja entonces hacerlo con otra más adelante.",
                "text_en": "In Italy, people can refuse to be vaccinated with the dose of AstraZeneca and when it arises then do so with another later.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Italy"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pueden rechazar vacunarse con la dosis de AstraZeneca y cuando surja entonces hacerlo con otra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "may be refused vaccination with the dose of AstraZeneca and when it arises then do so with another dose of AstraZeneca."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "más adelante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "later"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desde el Ministerio de Sanidad en España se pone de manifiesto que la vacuna frente al nuevo coronavirus no es obligatoria.",
                "text_en": "The Spanish Ministry of Health has shown that vaccination against the new coronavirus is not compulsory.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la vacuna frente al nuevo coronavirus no es obligatoria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccination against the new coronavirus is not mandatory"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De manera que, si queremos rechazar la vacuna de AstraZeneca, de igual forma que se puede decir que no a otras, no pasaría nada y podría hacerse, salvo la de no contar con inmunidad ante el virus SARS-CoV-2.",
                "text_en": "So, if we want to reject the AstraZeneca vaccine, just as we can say no to others, nothing would happen and could be done, except that we do not have immunity from the SARS-CoV-2 virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "rechazar la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reject the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no contar con inmunidad ante el virus SARS-CoV-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "do not have immunity to SARS-CoV-2 virus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero el caso es que no se sabe, por lo que desde Sanidad concluyen que si has recibido la primera dosis de AstraZeneca, no puedes ponerte una segunda dosis de otra vacuna diferente.",
                "text_en": "But the fact is, it's not known, so from Sanidad they conclude that if you've received the first dose of AstraZeneca, you can't get a second dose of another vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "concluyen que si has recibido la primera dosis de AstraZeneca, no puedes ponerte una segunda dosis de otra vacuna diferente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "conclude that if you have received the first dose of AstraZeneca, you cannot get a second dose of another vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y si rechazamos esta segunda dosis, entonces hay que espera qué nos dicen los médicos.",
                "text_en": "And if we refuse this second dose, then we have to wait for what the doctors tell us.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "si rechazamos esta segunda dosis, entonces hay que espera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "If we refuse this second dose, then we have to wait"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No podemos elegir vacuna en España",
                "text_en": "We can't choose a vaccine in Spain",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No podemos elegir vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We can't choose a vaccine."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    }
                ],
                "evidences": [
                    {
                        "value": "According to the latest data for Spain (June 22, 2021), there are 50.8% of people received at least one dose of the COVID-19 vaccine (32). Although our data has shown low levels of COVID-19 vaccine rejection in Spain (1.5%), vaccine hesitancy among healthcare professionals is specially concerning.",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9845979214
                    }
                ]
            },
            {
                "text": "Sanidad manifiesta que la campaña de vacunación es algo que se vive por la pandemia actual y que primero deben vacunarse los más vulnerables.",
                "text_en": "Health says that the vaccination campaign is something that is lived by the current pandemic and that the most vulnerable must first be vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "primero deben vacunarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "must first be vaccinated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los más vulnerables",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the most vulnerable"
                    }
                ],
                "evidences": [
                    {
                        "value": "Vaccination by controlled exposure to an antigen or its precursor is a good strategy for prevention of full-blown infection. Such prior exposure activates the acquired immune system to produce antibodies against the pathogen. In vaccinated individuals, the pathogens will be controlled quickly, and symptoms of infection are alleviated. A common example is vaccination against the influenza virus. As the prevalent strains of influenza virus change frequently, annual vaccination of different influenza virus strains is a common practice. Of particular relevance is the current pandemic COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), against which a worldwide vaccination campaign is also underway.",
                        "score": 0.6100000143
                    },
                    {
                        "value": "provides insights on the immunological basis of the clinical efficacy of the current vaccination campaign and may instruct future vaccination strategies. . Furthermore, the study results have remarkable implications for policymakers in steering choices related to the promotion of the current vaccination campaign among the still unvaccinated health workers but also in the general population by enhancing evidence-based communication strategies.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9916309714
                    },
                    {
                        "label": "neutral",
                        "score": 0.9766586423
                    }
                ]
            },
            {
                "text": "Así la elección de la vacuna a aplicar no puede ser una elección individual sino que debe basarse en la eficacia y la indicación de las vacunas para los diferentes grupos de población.",
                "text_en": "Thus the choice of the vaccine to be applied cannot be an individual choice but must be based on the effectiveness and indication of the vaccines for the different population groups.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la elección de la vacuna a aplicar no puede ser una elección individual",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the choice of the vaccine to be applied cannot be an individual choice"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "debe basarse en la eficacia y la indicación de las vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "should be based on the efficacy and indication of vaccines"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los diferentes grupos de población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "different population groups"
                    }
                ],
                "evidences": [
                    {
                        "value": "Conventional vaccine methodologies tend to deal sequentially with the choice of adjuvant after the primary design work has been achieved. In contrast, we believe that the two aspects of design are indissoluble and that adjuvant choice is ab initio an essential aspect of a successful vaccine design. That is because it has been observed that with the right adjuvant there can be a valuable inverse correlation with infectivity, with morbidity and with fatality in published cohorts (Lam et al., 2017) .",
                        "score": 0.5799999833
                    },
                    {
                        "value": "Our study reports 16 key reasons for not accepting approved vaccines, with the main one being fear of side effects. Other studies have also identified safety as a key reason for vaccine hesitancy. 15 20 At the time of the survey circulation, news channels were publicising the Oxford-AstraZeneca trial being paused due to participants having side effects, and this was widely circulated in the media at the time. 28 Specifically, there were concerns of side effects of transverse myelitis that, although may not be directly linked to the vaccine, could also not be ruled out. 29 This could have influenced participants' view on the safety of vaccines.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.997035861
                    },
                    {
                        "label": "neutral",
                        "score": 0.9992021918
                    }
                ]
            },
            {
                "text": "Y no es algo exclusivo de España, sino de casi todos los países.",
                "text_en": "And it is not something exclusive to Spain, but to almost every country.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no es algo exclusivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's not something exclusive."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "73": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 8,
            "WhatReliabilityReliable": 3,
            "WhatReliabilityUnreliable": 5,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 4,
            "WhoReliabilityReliable": 2,
            "WhoReliabilityUnreliable": 2,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 0,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 1,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 4,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 1,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 4,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 8,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 10,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEsta que les vamos a mostrar a continuación es una de las noticias que más nos ha sorprendido y preocupado de todas las que hemos publicado sobre el tema de las vacunas y el virus porque nos parece ya absolutamente surrealista.\n\n<BREAK>\n\nY es que han tenido que ser paralizadas 15 millones de dosis de la vacuna Janssen (Johnson & Johnson) debido a una contaminación sufrida en el proceso de fabricación ya que han mezclado mal los ingredientes.\n\n<PARAGRAPH>\n\nY decimos que nos ha sorprendido y preocupado porque nos parece hasta mentira que en la fabricación de un producto tan delicado y peligroso, como es esta vacuna, puedan producirse errores de este tipo.\n\n<BREAK>\n\nAdemás, nos cuentan que desde la empresa aseguran que las dosis que han sido ya inoculadas y las que se están administrando en Estados Unidos no están afectadas.\n\n<PARAGRAPH>\n\n¿Quién se puede creer esta aseveración cuando todos somos conscientes del increíble oscurantismo que hay con todo lo relacionado con estas vacunas y, sobre todo, con sus efectos secundarios? ¿Les parece a alguno de ustedes que podamos fiarnos de algo de lo que ni siquiera sus fabricantes se quieren responsabilizar cuando nos enteramos, además, que se equivocan al mezclar los ingredientes?\n\n<PARAGRAPH>\n\nEs alucinante todo lo que está pasando pero todo nos lleva hacia la misma conclusión: no nos vamos a vacunar.\n\n<BREAK>\n\nQuien quiera poner en riesgo su vida, que lo haga, pero la verdad, aunque suene duro hemos de decir que después que no diga que no se le ha advertido por activa y por pasiva de los peligros.\n\n<PARAGRAPH>\n\nCOLABORA CON NOSOTROS CON PAYPAL\n\n<PARAGRAPH>\n\n",
        "TITLE": "Janssen (Johnson & Johnson) paraliza 15 millones de vacunas al mezclar erróneamente sus ingredientes en la fabricación",
        "ID": "NF_04-11-2021_21-33-26_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Janssen (Johnson & Johnson) paraliza 15 millones de vacunas al mezclar erróneamente sus ingredientes en la fabricación",
                "text_en": "Janssen (Johnson & Johnson) paralyzes 15 million vaccines by mismixing its ingredients in manufacturing",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Janssen (Johnson & Johnson)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Janssen (Johnson & Johnson)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "paraliza 15 millones de vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "paralyzes 15 million vaccines"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "al mezclar erróneamente sus ingredientes en la fabricación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by mismixing its ingredients in manufacturing"
                    }
                ],
                "evidences": [
                    {
                        "value": "All the vaccine companies begin to ramp up the production after the approval. CanSino proposed to supply 5 million vaccines during 2021, the highest production of the estimated supply. Janssen, Sinopharm/BIBP, Sinopharm/WIBP, and Sinovac stated that 1 million supply could be utilized in this year.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.916921556
                    }
                ]
            },
            {
                "text": "Esta que les vamos a mostrar a continuación es una de las noticias que más nos ha sorprendido y preocupado de todas las que hemos publicado sobre el tema de las vacunas y el virus porque nos parece ya absolutamente surrealista.",
                "text_en": "This one that we are going to show you below is one of the news that has surprised us most and worried about all those that we have published on the issue of vaccines and the virus because we already find it absolutely surreal.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "s una de las noticias que más nos ha sorprendido y preocupado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is one of the news that has surprised and worried us most"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque nos parece ya absolutamente surrealista",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because we already find it absolutely surreal."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y es que han tenido que ser paralizadas 15 millones de dosis de la vacuna Janssen (Johnson & Johnson) debido a una contaminación sufrida en el proceso de fabricación ya que han mezclado mal los ingredientes.",
                "text_en": "And it is that 15 million doses of the Janssen vaccine (Johnson & Johnson) have had to be paralyzed due to contamination suffered in the manufacturing process as they have mismixed the ingredients.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han tenido que ser paralizadas 15 millones de dosis de la vacuna Janssen (Johnson & Johnson)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "15 million doses of Janssen vaccine (Johnson & Johnson) have had to be paralyzed"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "debido a una contaminación sufrida en el proceso de fabricación ya que han mezclado mal los ingredientes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "due to contamination suffered in the manufacturing process as they have mismixed the ingredients"
                    }
                ],
                "evidences": [
                    {
                        "value": "Although many COVID-19 vaccines remain in clinical development, ≥8 vaccine candidates have completed phase 3 trials and received emergency authorization: Oxford-AstraZeneca (https://www.astrazeneca. com), Moderna (https://www.modernatx.com), Pfizer-BioNTech (https://www.pfizer.com), Gamaleya (Sputnik) (https://sputnikvaccine.com), Sinovac (CoronaVac) (http://www.sinovac.com), Sinopharm (http://www.sinopharm.com), Novavax (https:// www.novavax.com), and Janssen (Johnson & Johnson) (https://www.jnj.com). Moderna and Pfizer report >90% efficacy and Oxford-AstraZeneca 62%-90% when recipients have been fully vaccinated (9, (14) (15) (16) . Candidate vaccines are mainly being developed from mRNA (e.g., Pfizer-BioNTech and Moderna), nonreplicating viral vector (e.g., Oxford-AstraZeneca, Gamaleya, and Janssen), or inactivated virus (e.g., Sinovac and Sinopharm). The logistic requirements vary for distributing different vaccines. Except for the Janssen vaccine, which requires only 1 dose, all of the vaccines require 2 intramuscular doses administered several days apart (9) . The Pfizer-BioNTech and Moderna vaccines might be challenging to administer in Africa because each requires -70°C cold chain storage and transportation (14) .",
                        "score": 0.6000000238
                    },
                    {
                        "value": "The reported efficacy of the Johnson & Johnson COVID-19 vaccine is slightly lower than the mRNA-based options. However, the overall efficacy number equal to 72% against mild illness and a higher value, 86% against severe disease are reported for this vaccine.",
                        "score": 0.5
                    },
                    {
                        "value": "Johnson & Johnson has developed their vaccine candidate using Ad26 to fight against COVID-19. It has previously used recombinant adenovirus serotype 26 (Ad26) to create a vaccine for Ebola. Phase I/II trials that began in July yielded results that stated the vaccine had a good safety profile and immunogenicity after only a single dose [36] . The vaccine induced an immune response in the participants with a high seroconversion rate, and only mild to moderate side effects were reported [94] . This led to Phase III trials with 60,000 participants in September. The company declared on their company website that Johnson & Johnson will supply 100 million doses to the United States' federal government for USD 1 billion [95] and supply 200 million doses to the European Union members following approval or authorization from the regulators [96] . On October 12, the company announced that it would pause their clinical trials due to a participant experiencing an unexplained illness. It halted the trials to investigate the reaction's nature to determine whether it was related to the vaccine given [97] . Nevertheless, 11 days after the report, Johnson & Johnson resumed the trials after concluding that the medical event had no clear indication that it was related to the vaccine. This is because nobody knew if the vaccine or placebo was given to the patient [89] . Towards the end of January 2021, Johnson & Johnson announced that their Ad26.COV2.S vaccine was 66% effective in preventing moderate to severe COVD-19, 28 days after vaccination. The first onset of protection was observed on day 14 post immunization. This single-shot vaccine was reported to be safe for use as no significant safety concerns occurred during the trials. The company has plans to file for US emergency use authorization (EUA) and upon receiving the approval, it expects to have product available for shipment [95] .",
                        "score": 0.6100000143
                    },
                    {
                        "value": "Janssen Pharmaceutical Companies of Johnson & Johnson is developing Ad26.CoV2-S, an adenovirus-vectored vaccine. Johnson & Johnson can provide a large-scale production of vaccines through the AdVac ® and PER.C6 ® technologies, which are cost-effective manufacturing systems that were used for the Ebola vaccine [80, 81] . In the second half of July 2020, Johnson & Johnson initiated a phase 1/2a clinical trial with Ad26.CoV2-S in the U.S. and Belgium (NCT04436276) [82] . At the time of writing this review, phase 1 (NCT04509947), phase 2a (NCT04535453), and phase 3 (NCT04505722) clinical trials are on-going simultaneously [82] . On 12 October 2020, Johnson & Johnson temporarily stopped the phase 3 clinical trial, which had a target number of 60,000 healthy adults, due to an unexplained adverse event in one participant [83] . After a thorough evaluation of the adverse event, however, Johnson & Johnson resumed the trial [83] .",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9511637688
                    },
                    {
                        "label": "neutral",
                        "score": 0.9974065423
                    },
                    {
                        "label": "neutral",
                        "score": 0.7190569639
                    },
                    {
                        "label": "neutral",
                        "score": 0.6868097782
                    }
                ]
            },
            {
                "text": "Y decimos que nos ha sorprendido y preocupado porque nos parece hasta mentira que en la fabricación de un producto tan delicado y peligroso, como es esta vacuna, puedan producirse errores de este tipo.",
                "text_en": "And we say that it has surprised and worried us because it seems to us to be a lie that in the manufacture of such a delicate and dangerous product, such as this vaccine, errors of this kind can occur.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos ha sorprendido y preocupado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We've been surprised and worried."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque nos parece hasta mentira que en la fabricación de un producto tan delicado y peligroso, como es esta vacuna, puedan producirse errores de este tipo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because it seems to us to be a lie that errors of this kind may occur in the manufacture of such a delicate and dangerous product, such as this vaccine."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, nos cuentan que desde la empresa aseguran que las dosis que han sido ya inoculadas y las que se están administrando en Estados Unidos no están afectadas.",
                "text_en": "In addition, they tell us that from the company they assure that the doses that have already been inoculated and those that are being administered in the United States are not affected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la empresa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the company"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aseguran que las dosis que han sido ya inoculadas y las que se están administrando en Estados Unidos no están afectadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ensure that doses that have already been inoculated and those that are being administered in the United States are not affected"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Estados Unidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Restaurantes campestres en Estados Unidos"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Quién se puede creer esta aseveración cuando todos somos conscientes del increíble oscurantismo que hay con todo lo relacionado con estas vacunas y, sobre todo, con sus efectos secundarios? ¿Les parece a alguno de ustedes que podamos fiarnos de algo de lo que ni siquiera sus fabricantes se quieren responsabilizar cuando nos enteramos, además, que se equivocan al mezclar los ingredientes?",
                "text_en": "Who can believe this assertion when we are all aware of the incredible obscurantism that there is with everything related to these vaccines and, above all, their side effects? Does it seem to any of you that we can trust something that even your manufacturers do not want to take responsibility for when we find out, moreover, that they are wrong to mix the ingredients?",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "todos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "all"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "somos conscientes del increíble oscurantismo que hay con todo lo relacionado con estas vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "we are aware of the incredible obscurantism there is with everything related to these vaccines"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ni siquiera sus fabricantes se quieren responsabilizar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "even their manufacturers don't want to take responsibility"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "sus fabricantes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "their manufacturers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es alucinante todo lo que está pasando pero todo nos lleva hacia la misma conclusión: no nos vamos a vacunar.",
                "text_en": "Everything that's going on is amazing, but it all leads us to the same conclusion: we're not going to get vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "todo nos lleva hacia la misma conclusión: no nos vamos a vacunar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "everything leads us to the same conclusion: we are not going to vaccinate"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "74": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 17,
            "WhatReliabilityReliable": 17,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 5,
            "Who": 19,
            "WhoReliabilityReliable": 19,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 4,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 17,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nEl número 33 de la revista 'Physics of fluids' recoge el trabajo desarrollado a raíz de la pandemia del coronavirus SARS-CoV-2 por un equipo internacional de investigadores de Física de Partículas destinado a crear un respirador para tratar pacientes graves de la COVID-19 en el que han participado varias instituciones e investigadores aragoneses.\n\n<PARAGRAPH>\n\nEste respirador o ventilador posee licencia abierta lo que permite a países en desarrollo fabricar sus propias unidades de forma rápida y sencilla y uno de los prototipos se ha construido en el Laboratorio Subterráneo de Canfranc, ubicado en el Pirineo aragonés.\n\n<PARAGRAPH>\n\nEl investigador a cargo de la coordinación técnica del proyecto en España ha sido Vicente Pesudo, del Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), que desarrolla su actividad en el Laboratorio Subterráneo de Canfranc, instalación científico-técnica singular que, entre otras áreas, trabaja en la búsqueda de la materia oscura del universo.\n\n<PARAGRAPH>\n\nSegún ha precisado en declaraciones a Europa Press, la empresa Vexos, en Canadá, ha producido y entregado ya 6.000 unidades de este respirador, compañía que ha formado parte del proceso de desarrollo y validación del ventilador, junto a la italiana Elemaster.\n\n<PARAGRAPH>\n\nLa mayor parte del trabajo ha sido desarrollado por un equipo internacional de científicos, que durante el año pasado colaboró en este proyecto y que ha vuelto ya a sus tareas habituales, después de haber publicado los resultados del proyecto e iniciarse la producción.\n\n<PARAGRAPH>\n\nVENTILADOR MECÁNICO MILANO\n\n<PARAGRAPH>\n\nEste respirador se ha denominado Ventilador Mecánico Milano y el equipo interdisciplinar internacional que lo ha creado, llamado igualmente Mechanical Ventilator Milano (MVM), ha dado a conocer sus resultados en la revista científica 'Physics of Fluids', de AIP Publishing.\n\n<PARAGRAPH>\n\nEl artículo, titulado 'The novel Mechanical Ventilator Milano for the COVID-19 pandemic' (El novedoso Ventilador Mecánico Milano para la pandemia COVID-19), es de acceso abierto y lo firman más de cien autores, entre los que hay científicos del CIEMAT, de la Universidad de Zaragoza y del Laboratorio Subterráneo de Canfranc.\n\n<PARAGRAPH>\n\nEl proyecto ha estado liderado por Cristian Galbiati, profesor de Física en la Universidad de Princeton y el Gran Sasso Science Institute.\n\n<BREAK>\n\nSus otras dos cabezas más visibles han sido el premio Nobel de Física, Arthur McDonald, y el científico senior de INFN Cagliari, Walter Bonivento.\n\n<PARAGRAPH>\n\nEstos tres científicos son miembros de la colaboración Global Argon Dark Matter, en la que participan la mayoría de las personas que han llevado a cabo esta iniciativa, aportando el conocimiento de los físicos de partículas sobre los sistemas de manipulación de gases, que ha permitido diseñar este respirador de producción masiva y de bajo coste para ayudar a abordar la escasez mundial de estos aparatos generada por la pandemia.\n\n<PARAGRAPH>\n\nPor lo que respecta al prototipo desarrollado en el Laboratorio Subterráneo de Canfranc, además del CIEMAT han participado la Universidad de Zaragoza, la Universidad Católica de Valencia, médicos del servicio de emergencias de Aragón, el Hospital San Jorge de Huesca, el Instituto de Investigación Sanitaria de Aragón y el Hospital Fundación Jiménez Díaz de Madrid.\n\n<PARAGRAPH>\n\nMARZO DE 2020\n\n<PARAGRAPH>\n\nEl proyecto comenzó en marzo de 2020, poco después de que en Italia se decretara la situación de alarma y el confinamiento.\n\n<BREAK>\n\nTan solo una semana después, la colaboración MVM ya tenía un prototipo funcional.\n\n<PARAGRAPH>\n\nEl ventilador consiste en una válvula de entrada y otra de salida de gas, junto con una serie de controles y alarmas para garantizar una monitorización adecuada y la adaptación del modo de trabajo de un paciente a otro.\n\n<BREAK>\n\nSe construye a partir de piezas fácilmente disponibles y se presenta bajo una licencia abierta, lo que permite a los países en desarrollo fabricar sus propias unidades de forma rápida y sencilla.\n\n<PARAGRAPH>\n\nTras los primeros prototipos del MVM, se realizaron las pruebas para su caracterización y aprobación.\n\n<BREAK>\n\nSegún el profesor de Física en la Universidad de Princeton, Cristian Galbiati, el objetivo ha sido crear un diseño \"lo más simple posible\", con un sistema de suministro de aire a través de una sola válvula, así como de salida también a través de una sola válvula.\n\n<PARAGRAPH>\n\nDebido a que el MVM se ha desarrollado específicamente para pacientes con la COVID-19, tiene una funcionalidad reducida en comparación con los ventiladores habituales, con un diseño más simple que reduce el coste de producción hasta cinco veces, han precisado las citadas fuentes.\n\n<PARAGRAPH>\n\nEl premio Nobel de Física Arthur McDonald, de la Universidad de Queen, ha manifestado que la pandemia \"nos sobrevino\", contexto en el que la colaboración de físicos de partículas, ingenieros y especialistas en software de centros de investigación, academias e industria ha permitido \"aplicar su talento para crear un diseño nuevo y accesible y proporcionar una nueva capacidad de fabricación a nivel internacional para abordar los casos más graves durante la pandemia\".\n\n<PARAGRAPH>\n\nPor su parte el científico senior de INFN Cagliari, Walter Bonivento, ha comentado que para un científico comprometido con la investigación fundamental, como la búsqueda de la materia oscura del universo, \"es extremadamente importante dedicar tiempo y experiencia a construir dispositivos que puedan ayudar a mejorar la salud de las personas\".\n\n<PARAGRAPH>\n\nEste ventilador ha sido autorizado para uso de emergencia de la Food and Drug Administration de Estados Unidos y por la Health Canada Medical Device Directorate.\n\n<BREAK>\n\nHasta la fecha, se han entregado unas 6.000 unidades a este último país, contemplando la posibilidad de que sean donadas a países en desarrollo.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Una revista científica divulga el respirador COVID de licencia libre, en el que han colaborado investigadores aragoneses",
        "ID": "F_04-11-2021_20-48-23_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Una revista científica divulga el respirador COVID de licencia libre, en el que han colaborado investigadores aragoneses",
                "text_en": "A scientific journal publishes the free-licensed COVID respirator, in which Aragonese researchers have collaborated",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "revista científica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "scientific journal"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el respirador COVID de licencia libre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the free license COVID respirator"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "investigadores aragoneses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Aragonese researchers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El número 33 de la revista 'Physics of fluids' recoge el trabajo desarrollado a raíz de la pandemia del coronavirus SARS-CoV-2 por un equipo internacional de investigadores de Física de Partículas destinado a crear un respirador para tratar pacientes graves de la COVID-19 en el que han participado varias instituciones e investigadores aragoneses.",
                "text_en": "Issue 33 of the journal 'Physics of fluids' reflects the work carried out following the SARS-CoV-2 coronavirus pandemic by an international team of Particle Physics researchers to create a respirator to treat severe patients with COVID-19 in which several Aragonese institutions and researchers have participated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "El número 33 de la revista 'Physics of fluids",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Issue 33 of the magazine 'Physics of fluids"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "trabajo desarrollado a raíz de la pandemia del coronavirus SARS-CoV-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "work developed following the SARS-CoV-2 coronavirus pandemic"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un equipo internacional de investigadores de Física de Partículas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "an international team of Particle Physics researchers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "respirador para tratar pacientes graves de la COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "respirator to treat severe patients with COVID-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "pacientes graves de la COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "severe COVID-19 patients"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "varias instituciones e investigadores aragoneses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "various Aragonese institutions and researchers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este respirador o ventilador posee licencia abierta lo que permite a países en desarrollo fabricar sus propias unidades de forma rápida y sencilla y uno de los prototipos se ha construido en el Laboratorio Subterráneo de Canfranc, ubicado en el Pirineo aragonés.",
                "text_en": "This ventilator or fan has an open license which allows developing countries to manufacture their own units quickly and easily and one of the prototypes has been built in the Underground Laboratory of Canfranc, located in the Aragonese Pyrenees.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "uno de los prototipos se ha construido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "one of the prototypes has been built"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Laboratorio Subterráneo de Canfranc, ubicado en el Pirineo aragonés",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Underground Laboratory of Canfranc, located in the Aragonese Pyrenees"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El investigador a cargo de la coordinación técnica del proyecto en España ha sido Vicente Pesudo, del Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), que desarrolla su actividad en el Laboratorio Subterráneo de Canfranc, instalación científico-técnica singular que, entre otras áreas, trabaja en la búsqueda de la materia oscura del universo.",
                "text_en": "The researcher in charge of the technical coordination of the project in Spain has been Vicente Pesudo, of the Center for Energy, Environmental and Technological Research (CIEMAT), who develops his activity in the Underground Laboratory of Canfranc, a unique scientific-technical installation that, among other areas, works in the search for the dark matter of the universe.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "investigador a cargo de la coordinación técnica del proyecto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "researcher in charge of the technical coordination of the project"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Vicente Pesudo, del Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Vicente Pesudo, Center for Energy, Environmental and Technological Research (CIEMAT)"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Laboratorio Subterráneo de Canfranc",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Canfranc Underground Laboratory"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según ha precisado en declaraciones a Europa Press, la empresa Vexos, en Canadá, ha producido y entregado ya 6.000 unidades de este respirador, compañía que ha formado parte del proceso de desarrollo y validación del ventilador, junto a la italiana Elemaster.",
                "text_en": "As he has specified in statements to Europa Press, the company Vexos, in Canada, has already produced and delivered 6,000 units of this ventilator, a company that has been part of the process of development and validation of the fan, together with the Italian Elemaster.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la empresa Vexos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the company Vexos"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Canadá",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Canada"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha producido y entregado ya 6.000 unidades de este respirador",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has already produced and delivered 6,000 units of this respirator"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La mayor parte del trabajo ha sido desarrollado por un equipo internacional de científicos, que durante el año pasado colaboró en este proyecto y que ha vuelto ya a sus tareas habituales, después de haber publicado los resultados del proyecto e iniciarse la producción.",
                "text_en": "Most of the work has been developed by an international team of scientists, who over the past year collaborated in this project and who has already returned to their usual tasks, having published the results of the project and started production.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La mayor parte del trabajo ha sido desarrollado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Most of the work has been developed."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por un equipo internacional de científicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by an international team of scientists"
                    }
                ],
                "evidences": [
                    {
                        "value": "Finally, we note that this work was conducted by an interdisciplinary team that included computer and data scientists, a sociologist, an industrial psychologist, and an investigative journalist. This collaboration was both necessary and challenging, requiring us to reconcile our approaches and methodological toolkits, forging new methods for interdisciplinary collaboration.",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.998522222
                    }
                ]
            },
            {
                "text": "Este respirador se ha denominado Ventilador Mecánico Milano y el equipo interdisciplinar internacional que lo ha creado, llamado igualmente Mechanical Ventilator Milano (MVM), ha dado a conocer sus resultados en la revista científica 'Physics of Fluids', de AIP Publishing.",
                "text_en": "This respirator has been called Milano Mechanical Ventilator and the international interdisciplinary team that created it, also called Mechanical Ventilator Milano (MVM), has released its results in the scientific journal 'Physics of Fluids', of AIP Publishing.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el equipo interdisciplinar internacional que lo ha creado, llamado igualmente Mechanical Ventilator Milano (MVM)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the international interdisciplinary team that has created it, also called Mechanical Ventilator Milano (MVM)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha dado a conocer sus resultados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has released its results"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la revista científica 'Physics of Fluids', de AIP Publishing",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the scientific journal 'Physics of Fluids' by AIP Publishing"
                    }
                ],
                "evidences": [
                    {
                        "value": "The MVM collaboration has responded to this need by developing the Mechanical Ventilator Milano (MVM), a reliable, fail-safe, and easy to operate mechanical ventilator, built from a small number of readily available parts.",
                        "score": 0.7900000215
                    },
                    {
                        "value": "The imperative need to treat a large number of patients affected by SARS-CoV-2 has motivated the consideration of a reliable, fail-safe, and easy to operate mechanical ventilator that can be produced quickly on a massive scale. We introduce a novel mechanical ventilator (Mechanical Ventilator Milano, MVM), inspired by the Manley ventilator [11] . In 1961, Roger Manley \"suggested the possibility of using the pressure of the gases from the anaesthetic machine as the motive power for a simple apparatus to ventilate the lungs of the patients in the operating theatre\" [12] . We have tried to design the MVM with the same principle of simplicity in mind. The main difference is the use of electricallydriven pneumatic valves instead of mechanical switches to ease large scale production. The MVM does not include a system to measure the tidal volume provided to the patient with each breathing cycle, but rather a system to mea-sure the peak and average expiratory flow rate. The MVM adheres as much as possible to the guidelines for \"Rapidly Manufactured Ventilator System (RMVS)\" [13] recently released by the UK Medicine & Healthcare products Regulatory Agency.",
                        "score": 0.6600000262
                    },
                    {
                        "value": "The Mechanical Ventilator Milano, a novel intensive therapy mechanical ventilator designed for rapid, large-scale, low-cost production for the COVID-19 pandemic, was conceived, designed, prototyped, and tested by a unique international collaboration of scientists, medical specialists, and industrial partners. Within few months, it has received certification from U.S. and Canadian health agencies for interim use during the COVID-19 pandemic, representing an ",
                        "score": 0.75
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9995618463
                    },
                    {
                        "label": "neutral",
                        "score": 0.9994675517
                    },
                    {
                        "label": "neutral",
                        "score": 0.9814540148
                    }
                ]
            },
            {
                "text": "El artículo, titulado 'The novel Mechanical Ventilator Milano for the COVID-19 pandemic' (El novedoso Ventilador Mecánico Milano para la pandemia COVID-19), es de acceso abierto y lo firman más de cien autores, entre los que hay científicos del CIEMAT, de la Universidad de Zaragoza y del Laboratorio Subterráneo de Canfranc.",
                "text_en": "The article, entitled 'The novel Mechanical Ventilator Milano for the COVID-19 pandemic' (The novel Milano Mechanical Ventilator for the COVID-19 pandemic), is open access and is signed by more than a hundred authors, including scientists from the ICESAT, the University of Zaragoza and the Underground Laboratory of Canfranc.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "artículo, titulado 'The novel Mechanical Ventilator Milano for the COVID-19 pandemic' (El novedoso Ventilador Mecánico Milano para la pandemia COVID-19)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "article, entitled 'The novel Mechanical Ventilator Milano for the COVID-19 pandemic' (The novel Milano Mechanical Ventilator for the COVID-19 pandemic)"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de acceso abierto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "open access"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "más de cien autores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more than 100 authors"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "científicos del CIEMAT, de la Universidad de Zaragoza y del Laboratorio Subterráneo de Canfranc",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "scientists from ICESAT, the University of Zaragoza and the Underground Laboratory of Canfranc"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El proyecto ha estado liderado por Cristian Galbiati, profesor de Física en la Universidad de Princeton y el Gran Sasso Science Institute.",
                "text_en": "The project has been led by Cristian Galbiati, Professor of Physics at Princeton University and the Grand Sasso Science Institute.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El proyecto ha estado liderado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The project has been led"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cristian Galbiati, profesor de Física en la Universidad de Princeton y el Gran Sasso Science Institute.",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Cristian Galbiati, Professor of Physics at Princeton University and the Grand Sasso Science Institute."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sus otras dos cabezas más visibles han sido el premio Nobel de Física, Arthur McDonald, y el científico senior de INFN Cagliari, Walter Bonivento.",
                "text_en": "His other two most visible heads have been the Nobel Prize in Physics, Arthur McDonald, and the senior scientist of INFN Cagliari, Walter Bonivento.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Nobel de Física, Arthur McDonald",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Nobel of Physics, Arthur McDonald"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "científico senior de INFN Cagliari, Walter Bonivento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "senior scientist of INFN Cagliari, Walter Bonivento"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por lo que respecta al prototipo desarrollado en el Laboratorio Subterráneo de Canfranc, además del CIEMAT han participado la Universidad de Zaragoza, la Universidad Católica de Valencia, médicos del servicio de emergencias de Aragón, el Hospital San Jorge de Huesca, el Instituto de Investigación Sanitaria de Aragón y el Hospital Fundación Jiménez Díaz de Madrid.",
                "text_en": "With regard to the prototype developed in the Underground Laboratory of Canfranc, in addition to ICESAT, the University of Zaragoza, the Catholic University of Valencia, doctors of the emergency service of Aragon, the Hospital San Jorge de Huesca, the Institute of Health Research of Aragon and the Hospital Fundación Jiménez Díaz of Madrid have participated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "prototipo desarrollado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "prototype developed"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Laboratorio Subterráneo de Canfranc",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Underground Laboratory of Canfranc"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "CIEMAT",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ICESAT"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Universidad de Zaragoza, la Universidad Católica de Valencia, médicos del servicio de emergencias de Aragón, el Hospital San Jorge de Huesca, el Instituto de Investigación Sanitaria de Aragón y el Hospital Fundación Jiménez Díaz de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the University of Zaragoza, the Catholic University of Valencia, doctors of the emergency service of Aragon, the Hospital San Jorge de Huesca, the Institute of Health Research of Aragon and the Hospital Fundación Jiménez Díaz de Madrid"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El proyecto comenzó en marzo de 2020, poco después de que en Italia se decretara la situación de alarma y el confinamiento.",
                "text_en": "The project began in March 2020, shortly after Italy declared the situation of alarm and confinement.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El proyecto comenzó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The project began"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en marzo de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in March 2020"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El ventilador consiste en una válvula de entrada y otra de salida de gas, junto con una serie de controles y alarmas para garantizar una monitorización adecuada y la adaptación del modo de trabajo de un paciente a otro.",
                "text_en": "The fan consists of an inlet valve and a gas outlet valve, together with a series of controls and alarms to ensure proper monitoring and adaptation of the working mode of one patient to another.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El ventilador consiste en una válvula de entrada y otra de salida de gas, junto con una serie de controles y alarmas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The fan consists of an inlet valve and a gas outlet valve, along with a series of controls and alarms"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se construye a partir de piezas fácilmente disponibles y se presenta bajo una licencia abierta, lo que permite a los países en desarrollo fabricar sus propias unidades de forma rápida y sencilla.",
                "text_en": "It is built from readily available parts and presented under an open license, allowing developing countries to manufacture their own units quickly and easily.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "permite a los países en desarrollo fabricar sus propias unidades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "enables developing countries to manufacture their own units"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los países en desarrollo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to developing countries"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma rápida y sencilla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a quick and easy way"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según el profesor de Física en la Universidad de Princeton, Cristian Galbiati, el objetivo ha sido crear un diseño \"lo más simple posible\", con un sistema de suministro de aire a través de una sola válvula, así como de salida también a través de una sola válvula.",
                "text_en": "According to the professor of physics at Princeton University, Cristian Galbiati, the goal has been to create a \"simple design as possible\", with an air supply system through a single valve, as well as output through a single valve.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el profesor de Física en la Universidad de Princeton, Cristian Galbiati",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Professor of Physics at Princeton University, Cristian Galbiati"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el objetivo ha sido crear un diseño \"lo más simple posible\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the objective has been to create a design \"as simple as possible\""
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "lo más simple posible",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as simple as possible"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con un sistema de suministro de aire a través de una sola válvula, así como de salida también a través de una sola válvula",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with an air supply system through a single valve, as well as output through a single valve"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Debido a que el MVM se ha desarrollado específicamente para pacientes con la COVID-19, tiene una funcionalidad reducida en comparación con los ventiladores habituales, con un diseño más simple que reduce el coste de producción hasta cinco veces, han precisado las citadas fuentes.",
                "text_en": "Because MVM has been developed specifically for patients with COVID-19, it has a reduced functionality compared to the usual fans, with a simpler design that reduces the cost of production up to five times, they have specified the above sources.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "se ha desarrollado específicamente para pacientes con la COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has been developed specifically for patients with COVID-19"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tiene una funcionalidad reducida en comparación con los ventiladores habituales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has a reduced functionality compared to the usual fans"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este ventilador ha sido autorizado para uso de emergencia de la Food and Drug Administration de Estados Unidos y por la Health Canada Medical Device Directorate.",
                "text_en": "This fan has been authorized for emergency use by the Food and Drug Administration of the United States and by the Health Canada Medical Device Directore.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Este ventilador ha sido autorizado para uso de emergencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This fan has been authorized for emergency use"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Food and Drug Administration de Estados Unidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Food and Drug Administration of the United States"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Health Canada Medical Device Directorate",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Health Canada Medical Device Directorate"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "75": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 19,
            "WhatReliabilityReliable": 18,
            "WhatReliabilityUnreliable": 1,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 16,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 9,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 9,
            "HowReliabilityReliable": 8,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 1,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 13,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLos investigadores documentaron el caso de un hombre que perdió la escucha del oído izquierdo tras haberse contagiado con Covid-19\n\n<PARAGRAPH>\n\nUna pérdida repentina e irreversible de la escucha se suma al largo listado de efectos que puede causar la Covid-19 en las personas que lo contraen.\n\n<PARAGRAPH>\n\nAsí lo informó un equipo de expertos que difundió su investigación en la revista BMJ Case Reports.\n\n<PARAGRAPH>\n\nNo obstante, el estudio, señala que esta complicación es debida a la infección con el virus SARS-CoV-2, causante de la enfermedad, es bastante rara, pues solo se ha presentado en pocos casos.\n\n<BREAK>\n\n\n\n<PARAGRAPH>\n\nLa pérdida de la escucha se presenta luego de que una persona contrae Covid-19.\n\n<PARAGRAPH>\n\nSegún el estudio, a nivel general se desconoce la fisiopatología exacta de la Pérdida de audición neurosensorial (Ssnhl por sus siglas en inglés), pero se conoce que frecuentemente se presenta tras una infección viral.\n\n<PARAGRAPH>\n\nDe momento, señalaron únicamente varios casos en el mundo y los autores del estudio dan cuenta de un hombre de 45 años tratado por coronavirus en su hospital británico.\n\n<PARAGRAPH>\n\nEl paciente, que sufre además asma, fue admitido en cuidados intensivos, bajo respiración artificial.\n\n<PARAGRAPH>\n\nLos médicos le suministraron un tratamiento a base de remdesivir (un antivírico), esteroides y de un intercambio de plasma sanguíneo.\n\n<PARAGRAPH>\n\nSu estado mejoró pero una semana después de haber salido de la unidad de cuidados intensivos, se quedó sordo de forma repentina del oído izquierdo.\n\n<PARAGRAPH>\n\nLas pruebas determinaron que sus conductos no estaban obstruidos y que sus tímpanos estaban intactos.\n\n<PARAGRAPH>\n\n Fue tratado con corticoides pero solo se restableció parcialmente.\n\n<BREAK>\n\nTras descartar otras causas posibles, los médicos asociaron esta deficiencia auditiva a la Covid-19, según la revista.\n\n<PARAGRAPH>\n\nLos investigadores destacan que el SARS-CoV-2, que se instala en un tipo de célula particular que se halla en los pulmones, fue hallado recientemente en células similares en el oído.\n\n<PARAGRAPH>\n\nEste virus genera además una reacción inflamatoria y un aumento de la producción de citoquinas (un tipo de proteínas) implicadas en la pérdida de audición, según los autores.\n\n<PARAGRAPH>\n\nEn abril del 2020, especialistas de Tailandia reportaron una afección similar en otro paciente.\n\n<PARAGRAPH>\n\nSin embargo, en una consulta realizada por Infobae, la doctora Florencia Fernández, médica del servicio de Otorrinolaringología del Hospital Italiano señaló:\n\n<PARAGRAPH>\n\nLos investigadores realizaron una búsqueda exhaustiva para evidenciar la causa de la sordera súbita.\n\n<BREAK>\n\nTras no encontrar un origen claro de la misma y debido al conocido neurotropismo que da origen por ejemplo, al síntoma conocido como anosmia (pérdida de olfato), plantearon esa relación.\n\n<BREAK>\n\nAdemás, sugirieron realizar una evaluación mediante PCR de los pacientes que presenten diagnóstico de sordera súbita y en aquellos pacientes que estén cursando una internación por neumonía por dicho virus y en su evolución refieran disminución brusca de la audición o la aparición de un zumbido, una evaluación a cargo de un otorrinolaringólogo.\n\n<PARAGRAPH>\n\nDe esta manera, para la especialista, “se necesitan aún más estudios para demostrar esta asociación y por lo tanto -por ahora-, no se podría considerar un síntoma causado por la infección por COVID-19”.\n\n<PARAGRAPH>\n",
        "TITLE": "El coronavirus también podría causar sordera irreversible, alerta un estudio del Reino Unido",
        "ID": "NF_04-11-2021_21-38-12_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "El coronavirus también podría causar sordera irreversible, alerta un estudio del Reino Unido",
                "text_en": "Coronavirus could also cause irreversible deafness, alerting a UK study",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El coronavirus también podría causar sordera irreversible",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Coronavirus may also cause irreversible deafness"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "del Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los investigadores documentaron el caso de un hombre que perdió la escucha del oído izquierdo tras haberse contagiado con Covid-19",
                "text_en": "Investigators documented the case of a man who lost listening to his left ear after he had been infected with Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los investigadores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Investigators"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "documentaron el caso de un hombre que perdió la escucha del oído izquierdo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They documented the case of a man who lost listening to his left ear."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras haberse contagiado con Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after being infected with Covid-19"
                    }
                ],
                "evidences": [
                    {
                        "value": "52-year-old man with COVID-19 pneumonia. Axial CT images shows bilateral, multilobar, peripheral and central, patchy ground-glass opacities. COVID-19 chest CT severity score is \"7\" . Although the incidence is low, evidences show that SARS-CoV-2 can infect the ocular surface to cause conjunctivitis. Xia et al. (16) detected viral conjunctivitis in 1/30 COVID-19 patients (3.3%); the patient was a 53-year-old man with moderate COVID-19, conjunctival congestion, and aqueous secretion of the eyes, and SARS-CoV-2 nucleotides were detected in conjunctival swab samples. Zhang et al. (18) discovered that 2/72 COVID-19 patients (2.8%) had conjunctivitis; SARS-CoV-2 nucleotides were detected in the ocular discharges of one of these. The latter, a 29-year-old female nurse, working in an emergency department, presented with persistent bilateral conjunctival congestion, and watery discharges on day 2 with the onset of a moderate fever (day 1). Chen et al. (21) presented a case of a 30-year-old man with COVID-19 who had bilateral acute viral conjunctivitis of moderate hyperemia, a watery discharge, and inferior palpebral conjunctival follicles with a delayed onset (13 days after the onset of systemic disease), when conjunctival swab specimens were positive for SARS-CoV-2. The acute onset of the ocular manifestations with conjunctival hyperemia and watery discharges, and the positive virus testing of ocular samples indicated that it was viral conjunctivitis because of SARS-CoV-2 infection of the ocular surface.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9977036119
                    }
                ]
            },
            {
                "text": "Así lo informó un equipo de expertos que difundió su investigación en la revista BMJ Case Reports.",
                "text_en": "This was reported by a team of experts who disseminated their research in BMJ Case Reports.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un equipo de expertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a team of experts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "difundió su investigación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "disseminated his research"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la revista BMJ Case Reports",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in BMJ Case Reports"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No obstante, el estudio, señala que esta complicación es debida a la infección con el virus SARS-CoV-2, causante de la enfermedad, es bastante rara, pues solo se ha presentado en pocos casos.",
                "text_en": "However, the study notes that this complication is due to infection with the SARS-CoV-2 virus, which causes the disease, is quite rare, as it has only occurred in a few cases.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es bastante rara",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's pretty weird."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "pues solo se ha presentado en pocos casos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has only been reported in a few cases"
                    }
                ],
                "evidences": [
                    {
                        "value": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has recently emerged as a new cause of acute respiratory disease [1] [2] [3] , whose clinical spectrum encompasses asymptomatic infection, mild upper respiratory tract illness, and severe pneumonia with respiratory failure and even death [4] [5] [6] [7] .",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9668867588
                    }
                ]
            },
            {
                "text": "La pérdida de la escucha se presenta luego de que una persona contrae Covid-19.",
                "text_en": "The loss of listening occurs after a person contracts Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La pérdida de la escucha se presenta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The loss of listening occurs"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "luego de que una persona contrae Covid-19",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after a person contracts Covid-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una persona",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a person"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según el estudio, a nivel general se desconoce la fisiopatología exacta de la Pérdida de audición neurosensorial (Ssnhl por sus siglas en inglés), pero se conoce que frecuentemente se presenta tras una infección viral.",
                "text_en": "According to the study, the exact pathophysiology of neurosensory hearing loss (Ssnhl) is generally unknown, but is known to occur frequently after viral infection.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se desconoce la fisiopatología exacta de la Pérdida de audición neurosensorial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the exact pathophysiology of neurosensory hearing loss is unknown"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras una infección viral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after a viral infection"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De momento, señalaron únicamente varios casos en el mundo y los autores del estudio dan cuenta de un hombre de 45 años tratado por coronavirus en su hospital británico.",
                "text_en": "For the time being, only several cases were reported in the world and the authors of the study reported a 45-year-old man treated for coronavirus in his British hospital.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "De momento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For the time being"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "señalaron únicamente varios casos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reported only a number of cases"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los autores del estudio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "authors of the study"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dan cuenta de un hombre de 45 años tratado por coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "account of a 45-year-old man treated for coronavirus"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un hombre de 45 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a 45-year-old man"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su hospital británico",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in his British hospital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El paciente, que sufre además asma, fue admitido en cuidados intensivos, bajo respiración artificial.",
                "text_en": "The patient, who also suffers from asthma, was admitted to intensive care under artificial breathing.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El paciente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The patient"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue admitido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was admitted"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en cuidados intensivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in intensive care"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "bajo respiración artificial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "under artificial breathing"
                    }
                ],
                "evidences": [
                    {
                        "value": "Following a modified Delphi process, phase 2 of this process was to select a subset of the statements to gather the opinions of severe asthma patients, these were selected by the expert steering group and validated as being appropriate for patient consideration by a representative of Asthma UK (a patient group). Asthma UK engaged with anonymous severe asthma patients, in receipt of biological therapy, who were randomly sampled from the Asthma UK Volunteer mailing list to provide insight into the patient experience.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9966997504
                    }
                ]
            },
            {
                "text": "Los médicos le suministraron un tratamiento a base de remdesivir (un antivírico), esteroides y de un intercambio de plasma sanguíneo.",
                "text_en": "Doctors provided treatment based on remdesivir (an antiviral), steroids, and an exchange of blood plasma.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los médicos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Doctors"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "le suministraron un tratamiento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "they gave her a treatment"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a base de remdesivir (un antivírico), esteroides y de un intercambio de plasma sanguíneo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "based on remdesivir (an antiviral), steroids and a blood plasma exchange"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Su estado mejoró pero una semana después de haber salido de la unidad de cuidados intensivos, se quedó sordo de forma repentina del oído izquierdo.",
                "text_en": "His condition improved, but a week after leaving the intensive care unit, he suddenly became deaf in the left ear.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "una semana después de haber salido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a week after you left"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de la unidad de cuidados intensivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the intensive care unit"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se quedó sordo de forma repentina del oído izquierdo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "suddenly went deaf in the left ear"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma repentina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "suddenly"
                    }
                ],
                "evidences": []
            },
            {
                "text": " Fue tratado con corticoides pero solo se restableció parcialmente.",
                "text_en": "He was treated with corticosteroids but only partially restored.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Fue tratado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He was treated."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con corticoides",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with corticosteroids"
                    }
                ],
                "evidences": [
                    {
                        "value": "Corticosteroids have been used to treat lung inflammation. Animal studies indicate that the use of corticosteroids improved the outcomes in viral infections [4, 5] . Consequently, corticosteroids were used to manage lung inflammation during the outbreaks of the SARS and the Middle East respiratory syndrome (MERS) [6, 7] . Many studies have reported no evidence of the benefit of using corticosteroids in the treatment of viral-induced lung inflammation [6, 8, 9] . Some studies even reported that corticosteroids' use led to delayed viral clearance [10] and adverse outcomes [11] . WHO, in the interim guidelines on clinical management of COVID-19, released on 27 May 2020, recommended against using corticosteroids in COVID-19 cases unless indicated for other reasons [12] .",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "entailment",
                        "score": 0.8719694614
                    }
                ]
            },
            {
                "text": "Tras descartar otras causas posibles, los médicos asociaron esta deficiencia auditiva a la Covid-19, según la revista.",
                "text_en": "After discarding other possible causes, doctors associated this hearing deficiency with Covid-19, according to the magazine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Tras descartar otras causas posibles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "After discarding other possible causes"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los médicos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "doctors"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "asociaron esta deficiencia auditiva a la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "associated this hearing impairment to Covid-19"
                    }
                ],
                "evidences": [
                    {
                        "value": "► Profound and permanent bilateral sudden sensorineural hearing loss may occur as a result of COVID-19. ► There is evidence that COVID-19 may cause cochlear damage. ► Administration of intratympanic and oral steroids remains the mainstay of treatment, though outcomes are variable. ► Despite multimodal steroid treatment, this patient with bilateral COVID-19-related hearing loss has had very poor outcomes. ► The association between COVID-19 and hearing loss is yet to be clearly described, and work is needed to tackle this emerging phenomenon.",
                        "score": 0.7300000191
                    },
                    {
                        "value": "One patient reported conductive hearing loss in the right ear [24] , and eight patients reported sudden sensorineural hearing loss as a potential COVID-19-related symptom (total n = 12, 33%) [21, [23] [24] [25] [26] [27] [28] 30, 31] . Bilateral hearing loss was found in two patients [23, 27] , and 10 presented unilateral hearing loss, with 5 in the right ear [21, 25, 28] , 4 in the left ear [23, 25, 26, 30] , and one patient presented unspecified hearing loss [31] .",
                        "score": 0.6499999762
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9979384542
                    },
                    {
                        "label": "entailment",
                        "score": 0.4382981658
                    }
                ]
            },
            {
                "text": "Los investigadores destacan que el SARS-CoV-2, que se instala en un tipo de célula particular que se halla en los pulmones, fue hallado recientemente en células similares en el oído.",
                "text_en": "Researchers highlight that SARS-CoV-2, which is installed in a particular type of cell found in the lungs, was recently found in similar cells in the ear.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los investigadores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Investigators"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue hallado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was found"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "recientemente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "recently"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en células similares en el oído",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in similar cells in the ear"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En abril del 2020, especialistas de Tailandia reportaron una afección similar en otro paciente.",
                "text_en": "In April 2020, specialists from Thailand reported a similar condition in another patient.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En abril del 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In April 2020"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "especialistas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "specialists"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Tailandia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Thailand"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reportaron una afección similar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reported a similar condition"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en otro paciente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in another patient"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sin embargo, en una consulta realizada por Infobae, la doctora Florencia Fernández, médica del servicio de Otorrinolaringología del Hospital Italiano señaló:",
                "text_en": "However, in a consultation conducted by Infobae, Dr. Florencia Fernández, a physician at the Otorrinolaringology department of the Italian Hospital, said:",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la doctora Florencia Fernández, médica del servicio de Otorrinolaringología",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. Florencia Fernández, doctor of the Otorrinolaringology service"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Hospital Italiano",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italian Hospital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los investigadores realizaron una búsqueda exhaustiva para evidenciar la causa de la sordera súbita.",
                "text_en": "Researchers conducted a thorough search to show the cause of sudden deafness.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los investigadores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Investigators"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "realizaron una búsqueda exhaustiva para evidenciar la causa de la sordera súbita",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "conducted a thorough search to show the cause of sudden deafness"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tras no encontrar un origen claro de la misma y debido al conocido neurotropismo que da origen por ejemplo, al síntoma conocido como anosmia (pérdida de olfato), plantearon esa relación.",
                "text_en": "After not finding a clear origin of it and due to the well-known neurotropism that gives origin, for example, to the symptom known as anosmia (loss of smell), they raised that relationship.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Tras no encontrar un origen claro de la misma y debido al conocido neurotropismo que da origen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "After not finding a clear origin of it and due to the well-known neurotropism that gives origin"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "plantearon esa relación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "raised this relationship"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, sugirieron realizar una evaluación mediante PCR de los pacientes que presenten diagnóstico de sordera súbita y en aquellos pacientes que estén cursando una internación por neumonía por dicho virus y en su evolución refieran disminución brusca de la audición o la aparición de un zumbido, una evaluación a cargo de un otorrinolaringólogo.",
                "text_en": "In addition, they suggested conducting a PCR evaluation of patients with a diagnosis of sudden deafness and those patients who are undergoing hospitalization for pneumonia due to this virus and in its evolution report a sudden decrease in hearing or the appearance of a buzz, an evaluation by an otolaryngologist.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sugirieron realizar una evaluación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "suggested carrying out an evaluation"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "mediante PCR",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by PCR"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los pacientes que presenten diagnóstico de sordera súbita",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients diagnosed with sudden deafness"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "aquellos pacientes que estén cursando una internación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients who are undergoing hospitalization"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por neumonía por dicho virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pneumonia due to the said virus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De esta manera, para la especialista, “se necesitan aún más estudios para demostrar esta asociación y por lo tanto -por ahora-, no se podría considerar un síntoma causado por la infección por COVID-19”.",
                "text_en": "In this way, for the specialist, “even more studies are needed to demonstrate this association and therefore – for now – could not be considered a symptom caused by COVID-19 infection”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la especialista",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the specialist"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se necesitan aún más estudios para demostrar esta asociación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "further studies are needed to demonstrate this partnership"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "76": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 4,
            "WhatReliabilityUnreliable": 6,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 9,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 5,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 4,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 2,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 3,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 5,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEsto ya es impresionante.\n\n<BREAK>\n\nLo que está pasando en el mundo es absolutamente dantesco, inaudito y propio de una película de terror o de ciencia ficción increíble de creer.\n\n<PARAGRAPH>\n\nEl volcán La Soufriere, que ha estado inactivo durante décadas, entró en erupción el viernes temprano en el lado este de San Vicente, lanzando columnas de ceniza a casi 10 kilómetros de altura.\n\n<BREAK>\n\nLa isla de San Vicente y las Granadinas tiene una población de unas cien mil personas y dieciséis mil de ellas se encuentran viviendo en la zona cero de la erupción.\n\n<PARAGRAPH>\n\nSanta Lucía, Granada, Barbados y Antigua se ofrecieron como voluntarios para aceptar refugiados con la condición de que estuvieran completamente vacunados.\n\n<BREAK>\n\nVarias líneas de cruceros han enviado un total de cinco barcos para la misión de rescate, pero también con esta condición.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nY sorprendentemente, eso es lo que ha hecho el Primer Ministro de la isla, anunciar que solo podrán ser evacuadas las personas que estén vacunadas: “El médico jefe estará identificando a las personas ya vacunadas para que podamos subirlas al barco”, dijo Gonsalves, reiterando que “solo los que estén vacunados”.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nA los que no estén vacunados ya saben que se mueran de asco y con los efectos devastadores que provoque el volcán.\n\n<BREAK>\n\nYa lo tenemos claro, el mundo está absolutamente loco.\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Ante la erupción del volcán Le Soufriere, el Primer Ministro de la isla San Vicente y las Granadinas dice que solo serán evacuadas las personas vacunadas",
        "ID": "NF_04-11-2021_22-10-55_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Ante la erupción del volcán Le Soufriere, el Primer Ministro de la isla San Vicente y las Granadinas dice que solo serán evacuadas las personas vacunadas",
                "text_en": "Faced with the eruption of the Le Soufriere volcano, the Prime Minister of Saint Vincent and the Grenadines says that only vaccinated people will be evacuated",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Primer Ministro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Prime Minister"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la isla San Vicente y las Granadinas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Saint Vincent and the Grenadines"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dice que solo serán evacuadas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Says they'll only be evacuated."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas vacunadas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "persons vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto ya es impresionante.",
                "text_en": "This is already impressive.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esto ya es impresionante",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This is already impressive."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo que está pasando en el mundo es absolutamente dantesco, inaudito y propio de una película de terror o de ciencia ficción increíble de creer.",
                "text_en": "What is happening in the world is absolutely antithetical, unheard of and typical of a horror film or incredible science fiction to believe.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Lo que está pasando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "What's going on?"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the world"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de una película de terror o de ciencia ficción increíble de creer",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "from a horror movie or incredible science fiction to believe"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El volcán La Soufriere, que ha estado inactivo durante décadas, entró en erupción el viernes temprano en el lado este de San Vicente, lanzando columnas de ceniza a casi 10 kilómetros de altura.",
                "text_en": "The volcano La Soufriere, which has been inactive for decades, erupted early Friday on the east side of San Vicente, throwing ash columns at almost 10 kilometers high.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El volcán La Soufriere, que ha estado inactivo durante décadas, entró en erupción",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The volcano La Soufriere, which has been inactive for decades, erupted"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Friday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el lado este de San Vicente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on the east side of San Vicente"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "lanzando columnas de ceniza a casi 10 kilómetros de altura",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throwing ash columns about 10 kilometers high"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La isla de San Vicente y las Granadinas tiene una población de unas cien mil personas y dieciséis mil de ellas se encuentran viviendo en la zona cero de la erupción.",
                "text_en": "The island of Saint Vincent and the Grenadines has a population of about 100,000 people and sixteen thousand of them are living in the zero area of the eruption.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La isla de San Vicente y las Granadinas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The island of Saint Vincent and the Grenadines"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tiene una población de unas cien mil personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has a population of about 100,000 people"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "dieciséis mil de ellas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sixteen thousand of them"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la zona cero de la erupción",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the zero area of the eruption"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Santa Lucía, Granada, Barbados y Antigua se ofrecieron como voluntarios para aceptar refugiados con la condición de que estuvieran completamente vacunados.",
                "text_en": "Saint Lucia, Grenada, Barbados and Antigua volunteered to accept refugees on condition that they were fully vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Santa Lucía, Granada, Barbados y Antigua",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Saint Lucia, Grenada, Barbados and Antigua"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ofrecieron como voluntarios para aceptar refugiados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "volunteered to accept refugees"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con la condición de que estuvieran completamente vacunados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "on condition that they were fully vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Varias líneas de cruceros han enviado un total de cinco barcos para la misión de rescate, pero también con esta condición.",
                "text_en": "Several cruise lines have sent a total of five ships for the rescue mission, but also under this condition.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Varias líneas de cruceros han enviado un total de cinco barcos para la misión de rescate",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Several cruise lines have sent a total of five ships for the rescue mission"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con esta condición",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with this condition"
                    }
                ],
                "evidences": [
                    {
                        "value": "Norwegian Cruise Line Holdings Ltd. (NCLH) is a global cruise company and operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands, offering itineraries to more than 490 destinations worldwide. With a combined fleet of 28 ships, and nine ships to be added by 2027 with an average capacity of 3000 passengers per vessel it holds a cruise market share at 10%. The company was founded in 2010 and is headquartered in Miami, Florida.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9992663264
                    }
                ]
            },
            {
                "text": "Y sorprendentemente, eso es lo que ha hecho el Primer Ministro de la isla, anunciar que solo podrán ser evacuadas las personas que estén vacunadas: “El médico jefe estará identificando a las personas ya vacunadas para que podamos subirlas al barco”, dijo Gonsalves, reiterando que “solo los que estén vacunados”.",
                "text_en": "And surprisingly, that’s what the island’s Prime Minister has done, announcing that only people who are vaccinated can be evacuated: “The chief doctor will be identifying those already vaccinated so that we can get them on the boat,” Gonsalves said, reiterating that “only those who are vaccinated.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Primer Ministro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Prime Minister"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la isla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the island"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "anunciar que solo podrán ser evacuadas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "announce that they can only be evacuated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas que estén vacunadas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "people who are vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A los que no estén vacunados ya saben que se mueran de asco y con los efectos devastadores que provoque el volcán.",
                "text_en": "Those who are not vaccinated already know that they die of disgust and the devastating effects of the volcano.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "A los que no estén vacunados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Those who are not vaccinated"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya saben que se mueran de asco",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They know they're going to die of disgust."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con los efectos devastadores que provoque el volcán",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with the devastating effects of the volcano"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ya lo tenemos claro, el mundo está absolutamente loco.",
                "text_en": "We're clear, the world is absolutely crazy.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the world"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está absolutamente loco",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's absolutely crazy."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "77": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 18,
            "WhatReliabilityReliable": 2,
            "WhatReliabilityUnreliable": 16,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 3,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 5,
            "Who": 17,
            "WhoReliabilityReliable": 9,
            "WhoReliabilityUnreliable": 8,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 5,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 1,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 2,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 6,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 5,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 4,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 5,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 4,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 2,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 8,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 8,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 7,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 5,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 7,
            "Key-Verb": 0,
            "Orthotypography": 5,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 12,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nMétodo de médicos cubanos\n\n<BREAK>\n\nA nivel nacional, el Hospital Regional de Lambayeque, en Perú, es el único lugar donde ningún médico o personal de salud ha fallecido infectado con coronavirus, aplican un método que tiene resultados comprobados: el aseo bucal extremo.\n\n<BREAK>\n\nAsí lo sostiene el médico internista Stalin Vílchez Rivera, quien llegó a la conclusión de que los pacientes se pueden recuperar si realizan un correcto aseo bucal, esto ayuda a evitar que el virus se multiplique en la persona infectada.\n\n<BREAK>\n\n“Cuando nos infectamos, el virus no se mete al pulmón, eso se da al quinto día. \n\n<BREAK>\n\nEn los primeros 5 días el virus se replica en la nariz, la boca, la garganta, y en ese tiempo debemos desinfectarnos, extremar el aseo oral, y no perder el tiempo preocupándonos en medicamentos que no está comprobado su éxito”, señaló.\n\n<BREAK>\n\nEl médico indicó que, tras evaluar pacientes con Covid-19, comprobó que las personas que no cumplían las recomendaciones fallecían y las que sí lo hacían eran dados de alta.\n\n<BREAK>\n\nEsto lo plasmó en una investigación que ha enviado a una revista científica.\n\n<BREAK>\n\n“Tuve dos pacientes: Una señora diabética y otra sin factores de riesgo. \n\n<BREAK>\n\nA ambas les expliqué y le entregué a cada una un enjuague bucal, cepillo de dientes y pasta dental. \n\n<BREAK>\n\nA los dos días regresé y a la diabética la encontré mejor y fue dada de alta. \n\n<BREAK>\n\nEn cambio, la otra señora no se cuidó, no hizo caso y falleció.\n\n<BREAK>\n\n“Ahora tenemos pacientes ancianos que se recuperan por extremar el aseo”, indicó.\n\n<BREAK>\n\nIncluso, el médico internista compartió su peculiar método para prevenir el Covid-19: “Yo me cepillo y luego con tequila o vodka hago mi enjuague bucal, y después lo tiro, no lo tomo, no tiene sentido adentro como sí afuera, los antisépticos actúan al inicio”, acotó.\n\n<BREAK>\n\nPor tal motivo, el galeno sostiene que el Ministerio de Salud, debería incluir el aseo bucal en los protocolos para la prevención y el tratamiento del Covid-19. \n\n<BREAK>\n\n“Cuando yo no estoy de guardia, el médico que sigue, si quiere lo continúa, porque no está en ningún protocolo, hasta ahora, lo demostrado por microscopía electrónica que puede matar al virus, es el aseo”.\n\n<BREAK>\n\nDesde que empezó la pandemia, Vílchez Rivera atiende a pacientes severos y graves en el Servicio de Emergencia Covid del HRL. \n\n<BREAK>\n\nAdemás, demuestra su vocación de servicio y espíritu humanitario atendiendo a pacientes a través de su WhatsApp. \n\n<BREAK>\n\nEs por ello que cuestiona a los médicos que por radio o televisión recetan fármacos que pueden generar reacciones adversas a las personas.\n\n<BREAK>\n\n“Lo que estoy notando es que la gente está muriendo por los fármacos, se automedican sin razón y mueren por arritmia, trombosis, infartos. \n\n<BREAK>\n\nCuando son casos leves son contraindicados los fármacos. \n\n<BREAK>\n\nLos corticoides yo sí los uso pero sólo en pacientes graves. \n\n<BREAK>\n\nCada caso es diferente. \n\n<BREAK>\n\nLa Ivermectina y la Azitromicina no logran acabar con el virus ni reducir las muertes tanto al principio, en cambio con el aseo sí”, señala.\n\n<BREAK>\n\n“Se los comparto como mi hermano me lo compartió, porque si ayuda muchísimo hacer enjuagues o gárgaras con algún enjuague bucal o agua con sal o agua con bicarbonato, pero de preferencia y mucho mejor, antisépticos como el Vantal o el Isodine bucofaríngeos, se debe hacer primero el lavado de boca con pasta tres veces al día y luego las gárgaras, sobre todo con el Vantal o el Isodine, para desinfectar muy bien la garganta, es un medio muy efectivo de prevención, además del cubre bocas, la sana distancia y el lavado de manos constante.\n\n<BREAK>\n\n“Hagámoslo, es cierto, es una muy buena prevención y eso los médicos lo saben, mis padres se enfermaban de gripe o faringitis, solo cuando no lo hacían.\n\n<BREAK>\n\n“Les digo, es mejor prevenir, los aconsejo; yo lo hago y me ha funcionado muy bien”, concluye Vílchez Rivera.",
        "TITLE": "Aseo bucal extremo evita que coronavirus se multiplique en contagiados",
        "ID": "14-Diarioimagen",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Aseo bucal extremo evita que coronavirus se multiplique en contagiados",
                "text_en": "Extreme oral hygiene prevents coronavirus from multiplying in contagion",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Aseo bucal extremo evita que coronavirus se multiplique",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Extreme oral toilet prevents coronavirus from multiplying"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "contagiados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Contagious"
                    }
                ],
                "evidences": [
                    {
                        "value": "The coronavirus COVID-19 pandemic is an unprecedented health crisis that has forced nearly a third of the world population into lockdown (Kaplan et al., 2020) . Lockdowns are \"behavioral\" (non-pharmaceutical) measures involving forced isolation, movement restrictions, and active government surveillance. These measures effectively slow the virus's diffusion because they reduce contagion rates (Cowling et al., 2020; Ferguson et al., 2020; Flaxman et al., 2020) . Reducing contagion is an important objective, especially in the absence of effective antiviral drugs, vaccines, or widespread population immunity, all still unavailable in the context of the new pandemic.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.7645878196
                    }
                ]
            },
            {
                "text": "A nivel nacional, el Hospital Regional de Lambayeque, en Perú, es el único lugar donde ningún médico o personal de salud ha fallecido infectado con coronavirus, aplican un método que tiene resultados comprobados: el aseo bucal extremo.",
                "text_en": "At the national level, the Regional Hospital of Lambayeque, in Peru, is the only place where no doctor or health personnel has died infected with coronavirus, they apply a method that has proven results: the extreme mouthwash.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "el Hospital Regional de Lambayeque, en Perú",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Regional Hospital of Lambayeque, in Peru"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es el único lugar donde ningún médico o personal de salud ha fallecido infectado con coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is the only place where no doctor or health personnel has died infected with coronavirus"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ningún médico o personal de salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "no doctor or health personnel"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "aplican un método que tiene resultados comprobados: el aseo bucal extremo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "apply a method that has proven results: the extreme mouthwash"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así lo sostiene el médico internista Stalin Vílchez Rivera, quien llegó a la conclusión de que los pacientes se pueden recuperar si realizan un correcto aseo bucal, esto ayuda a evitar que el virus se multiplique en la persona infectada.",
                "text_en": "This is supported by the internist physician Stalin Vilchez Rivera, who concluded that patients can recover if they perform a proper oral lavage, which helps prevent the virus from multiplying in the infected person.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el médico internista Stalin Vílchez Rivera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the internist doctor Stalin Vilchez Rivera"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llegó a la conclusión de que los pacientes se pueden recuperar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "concluded that patients can recover"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "si realizan un correcto aseo bucal",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "if they perform a proper oral toilet"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "esto ayuda a evitar que el virus se multiplique",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this helps prevent the virus from multiplying"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la persona infectada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the infected person"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Cuando nos infectamos, el virus no se mete al pulmón, eso se da al quinto día. ",
                "text_en": "“When we get infected, the virus doesn’t get into the lung, that’s the fifth day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Cuando nos infectamos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "When we get infected"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el virus no se mete",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The virus doesn't get in."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al pulmón",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the lung"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En los primeros 5 días el virus se replica en la nariz, la boca, la garganta, y en ese tiempo debemos desinfectarnos, extremar el aseo oral, y no perder el tiempo preocupándonos en medicamentos que no está comprobado su éxito”, señaló.",
                "text_en": "In the first 5 days the virus replicates in the nose, mouth, throat, and in that time we must disinfect, extreme the oral toilet, and not waste time worrying about medicines that are not proven successful,” he said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En los primeros 5 días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "In the first 5 days"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el virus se replica",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the virus replicates"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la nariz, la boca, la garganta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the nose, mouth, throat"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en ese tiempo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "at that time"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "debemos desinfectarnos, extremar el aseo oral, y no perder el tiempo preocupándonos en medicamentos que no está comprobado su éxito",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We should disinfect, extort oral hygiene, and not waste time worrying about medicines that are not proven successful."
                    }
                ],
                "evidences": []
            },
            {
                "text": "El médico indicó que, tras evaluar pacientes con Covid-19, comprobó que las personas que no cumplían las recomendaciones fallecían y las que sí lo hacían eran dados de alta.",
                "text_en": "The doctor indicated that, after evaluating patients with Covid-19, he found that people who did not comply with the recommendations died and those who did were discharged.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El médico",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The doctor"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras evaluar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after evaluation"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "pacientes con Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Covid-19 patients"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "comprobó que las personas que no cumplían las recomendaciones fallecían y las que sí lo hacían eran dados de alta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "found that those who did not comply with the recommendations died and those who did were discharged"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas que no cumplían las recomendaciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "persons not complying with the recommendations"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las que sí lo hacían",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the ones who did."
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Ahora tenemos pacientes ancianos que se recuperan por extremar el aseo”, indicó.",
                "text_en": "“Now we have elderly patients who recover because of extreme cleaning,” he said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Ahora",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Now"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tenemos pacientes ancianos que se recuperan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We have elderly patients who recover"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "pacientes ancianos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "elderly patients"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por extremar el aseo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for extreme toilet"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Incluso, el médico internista compartió su peculiar método para prevenir el Covid-19: “Yo me cepillo y luego con tequila o vodka hago mi enjuague bucal, y después lo tiro, no lo tomo, no tiene sentido adentro como sí afuera, los antisépticos actúan al inicio”, acotó.",
                "text_en": "Even, the internist shared his peculiar method to prevent Covid-19: “I brush myself and then with tequila or vodka I make my mouth rinse, and then I throw it, I don’t take it, it doesn’t make sense inside as if outside, the antiseptics act at the beginning,” he said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el médico internista",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the internist doctor"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "compartió su peculiar método para prevenir el Covid-19",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "shared his peculiar method to prevent Covid-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Yo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Me."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con tequila o vodka",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with tequila or vodka"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hago mi enjuague bucal",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I do my mouthwash."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo tiro, no lo tomo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I throw it away, I don't take it."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "no tiene sentido adentro como sí afuera, los antisépticos actúan",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It doesn't make sense inside like it does outside, antiseptics act."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al inicio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "at the start"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por tal motivo, el galeno sostiene que el Ministerio de Salud, debería incluir el aseo bucal en los protocolos para la prevención y el tratamiento del Covid-19. ",
                "text_en": "For this reason, the galene maintains that the Ministry of Health should include oral lavage in the protocols for the prevention and treatment of Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "debería incluir el aseo bucal",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "should include the oral toilet"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los protocolos para la prevención y el tratamiento del Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "protocols for the prevention and treatment of Covid-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Cuando yo no estoy de guardia, el médico que sigue, si quiere lo continúa, porque no está en ningún protocolo, hasta ahora, lo demostrado por microscopía electrónica que puede matar al virus, es el aseo”.",
                "text_en": "“When I am not on duty, the doctor who follows, if he wants to continue, because he is not in any protocol, until now, what is demonstrated by electronic microscopy that can kill the virus, is the toilet.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo demostrado por microscopía electrónica que puede matar al virus, es el aseo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "what is demonstrated by electronic microscopy that can kill the virus, is the toilet"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por microscopía electrónica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by electronic microscopy"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Lo que estoy notando es que la gente está muriendo por los fármacos, se automedican sin razón y mueren por arritmia, trombosis, infartos. ",
                "text_en": "“What I’m noticing is that people are dying from drugs, self-medicating for no reason and dying from arrhythmia, thrombosis, heart attacks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la gente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "People"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está muriendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's dying."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por los fármacos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for drugs"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Se los comparto como mi hermano me lo compartió, porque si ayuda muchísimo hacer enjuagues o gárgaras con algún enjuague bucal o agua con sal o agua con bicarbonato, pero de preferencia y mucho mejor, antisépticos como el Vantal o el Isodine bucofaríngeos, se debe hacer primero el lavado de boca con pasta tres veces al día y luego las gárgaras, sobre todo con el Vantal o el Isodine, para desinfectar muy bien la garganta, es un medio muy efectivo de prevención, además del cubre bocas, la sana distancia y el lavado de manos constante.",
                "text_en": "“I share them as my brother shared it with me, because if it helps a lot to rinse or gargle with some mouthwash or water with salt or water with bicarbonate, but preferably and much better, antiseptics like Vantal or Isodine bucopharyngeals, you must first wash your mouth with pasta three times a day and then gargles, especially with Vantal or Isodine, to disinfect your throat very well, it is a very effective means of prevention, besides mouth covering, healthy distance and constant hand washing.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mi hermano",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "My brother."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "me lo compartió",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He shared it with me."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque si ayuda muchísimo hacer enjuagues o gárgaras",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because if it helps a lot to rinse or gargle"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con algún enjuague bucal o agua con sal o agua con bicarbonato",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with a mouthwash or water with salt or water with bicarbonate"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "antisépticos como el Vantal o el Isodine bucofaríngeos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "antiseptics such as Vantal or Isodine oropharyngeals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es un medio muy efectivo de prevención",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is a very effective means of prevention"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Hagámoslo, es cierto, es una muy buena prevención y eso los médicos lo saben, mis padres se enfermaban de gripe o faringitis, solo cuando no lo hacían.",
                "text_en": "“Let’s do it, it’s true, it’s a very good prevention and that doctors know, my parents got sick with flu or pharyngitis, only when they didn’t.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los médicos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "doctors"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo saben",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They know."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mis padres",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "My parents"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se enfermaban de gripe o faringitis",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "become sick with flu or pharyngitis"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "solo cuando no lo hacían",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Only when they didn't."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "78": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 10,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 11,
            "WhoReliabilityReliable": 11,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 5,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 2,
            "WhoRoleTarget": 9,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 24,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 24,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nEl riesgo de rebrote en la capital catalana se sitúa en 242, ocho más que el día anterior.\nHay 1.474 pacientes de Covid hospitalizados, 89 más que este domingo, de los que 403 están graves en la UCI, siete más.\n\n<PARAGRAPH>\n\nEl virus sigue escalando en Cataluña, que se encuentra a las puertas de una posible cuarta ola de coronavirus, con un aumento de contagios, de la velocidad de propagación del virus, del riesgo de rebrote y del número de personas hospitalizadas.\n\n<PARAGRAPH>\n\nSegún los datos epidemiológicos actualizados este lunes por el Departamento de Salud, hay 1.474 pacientes de Covid hospitalizados, 89 más que este domingo, de los que 403 están graves en la UCI, siete más, en el segundo día consecutivo en el que sube la presión hospitalaria. \n\n<PARAGRAPH>\n\nLa velocidad de propagación de la enfermedad (Rt) sigue creciendo y este lunes se ha situado en 1,13, dos centésimas más que la víspera, es decir, que cada 100 infectados contagian de media a 113 personas, lo que indica una expansión del virus lenta pero constante cuando se ha iniciado la Semana Santa, que conllevará un aumento de la movilidad y de las interacciones sociales. \n\n<PARAGRAPH>\n\nLa incidencia acumulada de casos por cada 100.000 habitantes a 14 días (IA14) también empeora y se ha situado en 215, cuatro casos más que el domingo, mientras que el riesgo de rebrote, índice que mide el crecimiento potencial de la pandemia, es de 242 puntos, ocho más.  \n\n<PARAGRAPH>\n\nVacunación\n\n<PARAGRAPH>\n\nCataluña ha administrado la vacuna contra el coronavirus a un total de 782.072 personas desde que empezó la campaña de vacunación --415.006 personas ya han recibido la segunda dosis--: se han administrado 7.125 primeras dosis de vacuna en las últimas 24 horas.\n\n<PARAGRAPH>\n\nDel total de personas vacunadas con la primera dosis, 573.257 son de la provincia de Barcelona, 74.016 de Girona, 52.281 de Lleida y 80.561 de Tarragona; y 59.037 del total son personas usuarias de residencias catalanas.\n\n<PARAGRAPH>\n\nEn porcentajes, se ha vacunado en primera dosis al 94,4% de usuarios de residencias; al 81,7% del personal de residencias; al 81,9% del personal de atención primaria y hospitalaria; al 55,3% del resto de profesionales sanitarios; al 80,2% de las personas con gran dependencia; al 34,8% de las personas de 80 años o más; al 60,5% de los trabajadores esenciales; y al 7,5% de las personas de 60 a 65 años.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Cataluña, a las puertas de una cuarta ola con un aumento de hospitalizaciones",
        "ID": "F_04-11-2021_20-55-24_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Cataluña, a las puertas de una cuarta ola con un aumento de hospitalizaciones",
                "text_en": "Catalonia, at the gates of a fourth wave with an increase in hospitalizations",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cuarta ola",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "fourth wave"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con un aumento de hospitalizaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with an increase in hospitalizations"
                    }
                ],
                "evidences": [
                    {
                        "value": "The first COVID-19 case in Catalonia was diagnosed on 25 February 2020. Since then, a total of 356,724 positive cases were diagnosed in 2020, with a mean effective reproduction number of 0.8 and a mean 14 day incidence of 1006.79 cases per 100,000 inhabitants [17, 18] . A total of 8723 deaths were notified, with 29,773 hospitalizations and 2426 ICU admissions [18] .",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9218642712
                    }
                ]
            },
            {
                "text": "El riesgo de rebrote en la capital catalana se sitúa en 242, ocho más que el día anterior.",
                "text_en": "The risk of resurgence in the Catalan capital is 242, eight more than the previous day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El riesgo de rebrote en la capital catalana se sitúa en 242",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The risk of resurgence in the Catalan capital is 242"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la capital catalana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Catalan capital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El virus sigue escalando en Cataluña, que se encuentra a las puertas de una posible cuarta ola de coronavirus, con un aumento de contagios, de la velocidad de propagación del virus, del riesgo de rebrote y del número de personas hospitalizadas.",
                "text_en": "The virus continues to climb in Catalonia, which is located at the gates of a possible fourth wave of coronavirus, with an increase in contagion, the rate of spread of the virus, the risk of regrowth and the number of people hospitalized.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "posible cuarta ola de coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "possible fourth wave of coronavirus"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con un aumento de contagios, de la velocidad de propagación del virus, del riesgo de rebrote y del número de personas hospitalizadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with increased contagion, the rate of spread of the virus, the risk of outbreak and the number of people hospitalized"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según los datos epidemiológicos actualizados este lunes por el Departamento de Salud, hay 1.474 pacientes de Covid hospitalizados, 89 más que este domingo, de los que 403 están graves en la UCI, siete más, en el segundo día consecutivo en el que sube la presión hospitalaria. ",
                "text_en": "According to epidemiological data updated this Monday by the Department of Health, there are 1,474 patients of Covid hospitalized, 89 more than this Sunday, of whom 403 are severe in the ICU, seven more, on the second consecutive day on which hospital pressure rises.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "datos epidemiológicos actualizados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "up-to-date epidemiological data"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Departamento de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Department of Health"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La velocidad de propagación de la enfermedad (Rt) sigue creciendo y este lunes se ha situado en 1,13, dos centésimas más que la víspera, es decir, que cada 100 infectados contagian de media a 113 personas, lo que indica una expansión del virus lenta pero constante cuando se ha iniciado la Semana Santa, que conllevará un aumento de la movilidad y de las interacciones sociales. ",
                "text_en": "The rate of spread of the disease (Rt) continues to grow and this Monday it has reached 1.13, two hundredths more than the eve, that is, every 100 infected people averaged 113 people, indicating a slow but constant expansion of the virus when the Holy Week has begun, which will lead to increased mobility and social interactions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La velocidad de propagación de la enfermedad (Rt) sigue creciendo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The rate of spread of the disease (Rt) continues to grow"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "expansión del virus lenta pero constante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "slow but steady virus expansion"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Holy Week"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "conllevará un aumento de la movilidad y de las interacciones sociales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will lead to increased mobility and social interactions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La incidencia acumulada de casos por cada 100.000 habitantes a 14 días (IA14) también empeora y se ha situado en 215, cuatro casos más que el domingo, mientras que el riesgo de rebrote, índice que mide el crecimiento potencial de la pandemia, es de 242 puntos, ocho más.  ",
                "text_en": "The cumulative incidence of cases per 100,000 inhabitants at 14 days (IA14) also worsens and has been in 215, four cases more than on Sunday, while the risk of regrowth, which measures the potential growth of the pandemic, is 242 points, eight more.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La incidencia acumulada de casos por cada 100.000 habitantes a 14 días (IA14) también empeora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The cumulative incidence of cases per 100,000 inhabitants at 14 days (IA14) also worsens"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cataluña ha administrado la vacuna contra el coronavirus a un total de 782.072 personas desde que empezó la campaña de vacunación --415.006 personas ya han recibido la segunda dosis--: se han administrado 7.125 primeras dosis de vacuna en las últimas 24 horas.",
                "text_en": "Catalonia has administered the coronavirus vaccine to a total of 782,072 people since the start of the vaccination campaign -- 415,006 people have already received the second dose -- with 7,125 first doses of the vaccine administered within the last 24 hours.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha administrado la vacuna contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has administered the coronavirus vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a un total de 782.072 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a total of 782,072 persons"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde que empezó la campaña de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since the vaccination campaign began"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han administrado 7.125 primeras dosis de vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "7,125 first doses of vaccine have been administered"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las últimas 24 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last 24 hours"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En porcentajes, se ha vacunado en primera dosis al 94,4% de usuarios de residencias; al 81,7% del personal de residencias; al 81,9% del personal de atención primaria y hospitalaria; al 55,3% del resto de profesionales sanitarios; al 80,2% de las personas con gran dependencia; al 34,8% de las personas de 80 años o más; al 60,5% de los trabajadores esenciales; y al 7,5% de las personas de 60 a 65 años.",
                "text_en": "In percentages, 94.4 per cent of residential users, 81.7 per cent of residential staff, 81.9 per cent of primary and hospital care staff, 55.3 per cent of other health professionals, 80.2 per cent of highly dependent persons, 34.8 per cent of persons aged 80 and over, 60.5 per cent of essential workers and 7.5 per cent of persons aged 60 to 65.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha vacunado en primera dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has been vaccinated in the first dose"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "94,4% de usuarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "94.4% of users"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "residencias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "residences"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "81,7% del personal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "81.7 per cent of staff"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "residencias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "residences"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "81,9% del personal de atención primaria y hospitalaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "81.9% of primary and hospital care staff"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "55,3% del resto de profesionales sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "55.3% of all other health professionals"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "80,2% de las personas con gran dependencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "80.2% of people with high dependency"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "34,8% de las personas de 80 años o más",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "34.8% of the population aged 80 and over"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "60,5% de los trabajadores esenciales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "60.5% of essential workers"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "7,5% de las personas de 60 a 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "7.5% of persons aged 60 to 65"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "79": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 24,
            "WhatReliabilityReliable": 16,
            "WhatReliabilityUnreliable": 8,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 20,
            "WhoReliabilityReliable": 19,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 3,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 1,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 17,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 1,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nAyer, en un comunicado de prensa, la Agencia Noruega del Medicamento informaba de dos nuevas muertes a causa de la vacuna de AstraZeneca: “Ya se han notificado cinco pacientes con una combinación de trombosis, hemorragia y bajo recuento de plaquetas ingresados en el OUS [Hospital Universitario de Oslo] tras la vacunación con la vacuna de AstraZeneca.\n\n<BREAK>\n\nUno murió a principios de esta semana, ahora se han reportado dos muertes más”.\n\n<PARAGRAPH>\n\nHasta la fecha el total de muertos en Noruega tras ser inoculados con la vacuna de AstraZeneca es de cuatro, todos ellos trabajadores de la sanidad, por lo que el país mantiene la suspensión con este tipo de vacunas, junto con otros países, como Suecia y Dinamarca.\n\n<PARAGRAPH>\n\nLa Agencia no excluye que las muertes estén relacionados con la vacuna de AstraZeneca.\n\n<BREAK>\n\nEl Comité de Seguridad de la EMA (PRAC) ha ordenado que estos efectos adversos se discutan en las características del fármaco y en su prospecto.\n\n<PARAGRAPH>\n\nEl Instituto Nacional de Salud Pública y el Hospital Universitario de Oslo colaborarán en la investigación de las muertes.\n\n<PARAGRAPH>\n\nNoruega vuelve a dejar en muy mal lugar a la Agencia Europea del Medicamento (EMA), sobre cuyas decisión de mantener este tipo de vacuna siguen recayendo toda clase de sospechas.\n\n<BREAK>\n\nA pesar de la autorización de emergencia, la EMA sigue estudiando los informes de reacciones adversas en Europa.\n\n<PARAGRAPH>\n\nNaturalmente que la OMS no se queda atrás, aunque la corrupción dentro de este organismo internacional es ya legendaria, lo que le ha privado de cualquier credibilidad.\n\n<BREAK>\n\nSon ya varios los estudios científicos que confirman que es esta vacuna la causa las trombosis.\n\n<PARAGRAPH>\n\nEl 15 de marzo la vacuna de AstraZeneca fue suspendida temporalmente en la Unión Europea, aunque la EMA volvió a autorizar su uso de nuevo, a pesar de los coágulos de sangre, hemorragias y bajo recuento de plaquetas que ocasiona.\n\n<PARAGRAPH>\n\nLa suspensión ha multiplicado el número de personas que rechazan las vacunas, tanto la de AstraZeneca como las demás.\n\n<BREAK>\n\nDespués de la suspensión, España reanudará mañana estas vacunaciones, pero en los países europeos no hay acuerdo sobre los tramos de edad en los que se puede administrar.\n\n<PARAGRAPH>\n\nAlgunos países europeos, como Francia, han decidido vacunar con AstraZeneca sólo a los mayores de 55 años, sin ningún líimite por encima de esa edad, mientras que otros, como España, vacunarán hasta los 65 años de edad a partir de mañana.\n\n<PARAGRAPH>\n\nOtros países, como Reino Unido y Bélgica, no tienen ningún límite de edad de edad para aplicar la vacuna.\n\n<PARAGRAPH>\n",
        "TITLE": "La vacuna de AstraZeneca tiene los días contados: otros dos muertos más en Noruega",
        "ID": "NF_NF_1668_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "La vacuna de AstraZeneca tiene los días contados: otros dos muertos más en Noruega",
                "text_en": "The AstraZeneca vaccine has the days counted: two more dead in Norway",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vacuna de AstraZeneca tiene los días contados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The AstraZeneca vaccine has the days counted"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "dos muertos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "two dead"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Noruega",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Norway"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ayer, en un comunicado de prensa, la Agencia Noruega del Medicamento informaba de dos nuevas muertes a causa de la vacuna de AstraZeneca: “Ya se han notificado cinco pacientes con una combinación de trombosis, hemorragia y bajo recuento de plaquetas ingresados en el OUS [Hospital Universitario de Oslo] tras la vacunación con la vacuna de AstraZeneca.",
                "text_en": "Yesterday, in a press release, the Norwegian Medicines Agency reported two new deaths due to the AstraZeneca vaccine: “Five patients with a combination of thrombosis, bleeding and low platelet counts admitted to the OUS [Oslo University Hospital] have already been reported after vaccination with the AstraZeneca vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Ayer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Yesterday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un comunicado de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a press release"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Noruega del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Norwegian Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "informaba de dos nuevas muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reported two new deaths"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a causa de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because of the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "cinco pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "five patients"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "con una combinación de trombosis, hemorragia y bajo recuento de plaquetas ingresados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with a combination of thrombosis, bleeding and low platelet count"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el OUS [Hospital Universitario de Oslo]",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the OUS [Oslo University Hospital]"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras la vacunación con la vacuna de AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after vaccination with the AstraZeneca vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Uno murió a principios de esta semana, ahora se han reportado dos muertes más”.",
                "text_en": "One died earlier this week, now two more deaths have been reported.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Uno",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "One"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "murió",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's dead."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a principios de esta semana",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "earlier this week"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ahora",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Now"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han reportado dos muertes más",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Two more deaths have been reported"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hasta la fecha el total de muertos en Noruega tras ser inoculados con la vacuna de AstraZeneca es de cuatro, todos ellos trabajadores de la sanidad, por lo que el país mantiene la suspensión con este tipo de vacunas, junto con otros países, como Suecia y Dinamarca.",
                "text_en": "To date the total number of deaths in Norway after being inoculated with the AstraZeneca vaccine is four, all of them health workers, so the country maintains the suspension with this type of vaccine, along with other countries, such as Sweden and Denmark.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Hasta la fecha",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "To date"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el total de muertos en Noruega tras ser inoculados con la vacuna de AstraZeneca es de cuatro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the total number of deaths in Norway after being inoculated with the AstraZeneca vaccine is four"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Noruega",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Norway"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras ser inoculados con la vacuna de AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after being inoculated with the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "trabajadores de la sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health workers"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mantiene la suspensión con este tipo de vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "maintain suspension with this type of vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Suecia y Dinamarca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sweden and Denmark"
                    }
                ],
                "evidences": [
                    {
                        "value": "Dear Editor, When many countries are busy with the rollout process of vaccine to tackle the COVID-19, the sudden death of 71 people after being immunized with Pfizer-BioNTech's COVID-19 vaccine (BNT162b2) in Europe [1] [2] [3] [4] led us to think critically on this issue. In Norway, over 2 million people received the first dose and 1.36 million people received the second dose of COVID-19 vaccines as of June 15, 2021, and the Norwegian Adverse Drug Reaction (ADR) registry recorded 1,472 reports of possible serious adverse events, including 185 fatality cases [3] . Norway dropped the Oxford-AstraZeneca vaccine from the immunization program [5] following a study by Pottegård et al. [6] reporting a small elevated risk of venous thromboembolic events among people who received the first dose of Oxford-AstraZeneca vaccine ChAdOx1-S in Norway and Denmark. Intriguingly, an expert review published on May 19, 2021 indicated a possible link between COVID-19 immunization and at least ten deaths among elderly frail patients living in Norwegian nursing homes [7] . It has been speculated that the common side effects might have been intensified by the comorbidities in these very old people aged more than 75 years; however, the available evidence is insufficient to draw any causal relationship. Investigations are underway in France, where five frail patients died, apparently coincidentally, after vaccination among 139 reported adverse events [8] . Ten similar death cases have also been reported in Germany. Although the clinical trial results demonstrate that the BNT162b2 vaccine is safe and effective [9] , it must not be outright rejected that previously unrecognized adverse reactions might occur during mass immunization using a modern mRNA vaccine. Deaths apparently linked to COVID-19 vaccination are very likely to negate confidence of mass people on vaccines and flag growing concerns that a careful strategy has to be devised for safe use of these vaccines.",
                        "score": 0.6700000167
                    },
                    {
                        "value": "Currently, only a few high-income countries (Canada, France, Germany, Denmark, Norway, Russia, South Korea, and Sweden) have advocated for the mixing of vaccines to their citizens in the light of rare thrombotic complications with the Oxford-AstraZeneca vaccine or due to its unavailability in their countries (18) . The UK's rationale to adopt the mix and match approach was born out of the urgent need to vaccinate more citizens in the absence of the Oxford-AstraZeneca vaccine as its COVID-19 burden increases especially with the emergence of the Delta variant (B.1.617.2) (19) .",
                        "score": 0.6200000048
                    },
                    {
                        "value": "The vaccine cohorts consisted of all people aged 18-65 years in Denmark and Norway who received a first vaccination with ChAdOx1-S from 9 February 2021 to 11 March 2021 (the date the Danish and Norwegian vaccination programmes were halted owing to safety concerns). We excluded vaccine recipients younger than 18 years and older than 65 years and those who immigrated to the countries within 365 days before their first vaccination (ascertained from the civil registration systems in the two countries). The general populations aged 18-65 years in Denmark during 2016-18 and in Norway during 2018-19 served as prespecified comparator cohorts.",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9992092252
                    },
                    {
                        "label": "neutral",
                        "score": 0.9187900424
                    },
                    {
                        "label": "entailment",
                        "score": 0.9007642269
                    }
                ]
            },
            {
                "text": "La Agencia no excluye que las muertes estén relacionados con la vacuna de AstraZeneca.",
                "text_en": "The Agency does not exclude that deaths are related to the AstraZeneca vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no excluye que las muertes estén relacionados con la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "does not exclude that the deaths are related to the AstraZeneca vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Comité de Seguridad de la EMA (PRAC) ha ordenado que estos efectos adversos se discutan en las características del fármaco y en su prospecto.",
                "text_en": "The EMA Safety Committee (PRAC) has ordered that these side effects be discussed in the drug's characteristics and in its package leaflet.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Comité de Seguridad de la EMA (PRAC)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The EMA Security Committee (PRAC)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha ordenado que estos efectos adversos se discutan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has ordered that these side effects be discussed"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en las características del fármaco y en su prospecto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the characteristics of the drug and in its package leaflet"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Instituto Nacional de Salud Pública y el Hospital Universitario de Oslo colaborarán en la investigación de las muertes.",
                "text_en": "The National Institute of Public Health and Oslo University Hospital will collaborate in the investigation of deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Instituto Nacional de Salud Pública y el Hospital Universitario de Oslo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The National Institute of Public Health and Oslo University Hospital"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "colaborarán en la investigación de las muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will collaborate in the investigation of the deaths"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Noruega vuelve a dejar en muy mal lugar a la Agencia Europea del Medicamento (EMA), sobre cuyas decisión de mantener este tipo de vacuna siguen recayendo toda clase de sospechas.",
                "text_en": "Norway once again leaves the European Medicines Agency (EMA) in a very bad place, on whose decision to maintain this type of vaccine continues to fall into all sorts of suspicions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Noruega",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Norway"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vuelve a dejar en muy mal lugar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Leaves him in a very bad place again."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la Agencia Europea del Medicamento (EMA)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "decisión de mantener este tipo de vacuna siguen recayendo toda clase de sospechas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "decision to maintain this type of vaccine continues to fall into all kinds of suspicions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A pesar de la autorización de emergencia, la EMA sigue estudiando los informes de reacciones adversas en Europa.",
                "text_en": "Despite the emergency authorisation, the EMA continues to study adverse reaction reports in Europe.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sigue estudiando los informes de reacciones adversas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "continue to study reports of adverse reactions"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Europa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Europe"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Naturalmente que la OMS no se queda atrás, aunque la corrupción dentro de este organismo internacional es ya legendaria, lo que le ha privado de cualquier credibilidad.",
                "text_en": "Of course, the WHO is not left behind, although corruption within this international body is already legendary, which has deprived it of any credibility.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la corrupción dentro de este organismo internacional es ya legendaria",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "corruption within this international body is already legendary"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "dentro de este organismo internacional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "within this international body"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Son ya varios los estudios científicos que confirman que es esta vacuna la causa las trombosis.",
                "text_en": "Several scientific studies have already confirmed that this vaccine is the cause of thrombosis.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "varios los estudios científicos que confirman que es esta vacuna la causa las trombosis",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "several scientific studies confirming that this vaccine is the cause of thrombosis"
                    }
                ],
                "evidences": [
                    {
                        "value": "Regarding COVID-19 vaccine related neurovascular thrombosis, the similar pathobiological process is possible. Vaccine might induce abnormal immune response and further cause problem [14, 15] . The underlying plays important role in determining occurrence of thrombotic event. As already noted, hyperviscosity and stasis might occur after COVID-19 vaccination. A patient with underlying neurological problem usually has a high blood viscosity, hence, that patient might have an increased risk of COVID-19 vaccination related neurovascular thrombosis. According to a recent study, the safety interval for thrombosis development is narrower in a vaccine recipient with underlying neurological disease [23] . It is recommended for a closed monitoring of possible thrombosis in a COVID-19 vaccine recipient who has an underlying neurological disease [23] .",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.715331614
                    }
                ]
            },
            {
                "text": "El 15 de marzo la vacuna de AstraZeneca fue suspendida temporalmente en la Unión Europea, aunque la EMA volvió a autorizar su uso de nuevo, a pesar de los coágulos de sangre, hemorragias y bajo recuento de plaquetas que ocasiona.",
                "text_en": "On 15 March, the AstraZeneca vaccine was temporarily suspended in the European Union, although the EMA again authorized its use, despite blood clots, bleeding and low platelet counts it causes.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "El 15 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "15 March"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la vacuna de AstraZeneca fue suspendida temporalmente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca vaccine was temporarily suspended"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Unión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the European Union"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "volvió a autorizar su uso de nuevo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reauthorized its use again"
                    }
                ],
                "evidences": [
                    {
                        "value": "Norwegian health authorities suspended the use of the Oxford-AstraZeneca (Vaxevria, hereafter referred to as AstraZeneca) vaccine on March 11th, 2021, after sudden reports of severe and sometimes fatal thromboembolic events following vaccination were announced earlier the same day [1] . In these announcements, it became clear that the European Medicines Agency (EMA) had received reports of 30 similar events among the five million individuals in the European Economic Area who had received the AstraZeneca vaccine [2] . While it was still not known whether the thromboembolic events could be linked to the vaccine, the severe cases and fatalities among otherwise healthy individuals received much media attention in the days that followed.",
                        "score": 0.7799999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9926245809
                    }
                ]
            },
            {
                "text": "La suspensión ha multiplicado el número de personas que rechazan las vacunas, tanto la de AstraZeneca como las demás.",
                "text_en": "The suspension has multiplied the number of people who reject vaccines, both from AstraZeneca and the others.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La suspensión ha multiplicado el número de personas que rechazan las vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The suspension has multiplied the number of people who reject vaccines"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Después de la suspensión, España reanudará mañana estas vacunaciones, pero en los países europeos no hay acuerdo sobre los tramos de edad en los que se puede administrar.",
                "text_en": "After the suspension, Spain will resume these vaccinations tomorrow, but in European countries there is no agreement on the age brackets in which it can be administered.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Después de la suspensión",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "After suspension"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reanudará mañana estas vacunaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will resume these vaccinations tomorrow"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "mañana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "tomorrow"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los países europeos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in European countries"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no hay acuerdo sobre los tramos de edad en los que se puede administrar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there is no agreement on the age brackets in which it can be administered"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Algunos países europeos, como Francia, han decidido vacunar con AstraZeneca sólo a los mayores de 55 años, sin ningún líimite por encima de esa edad, mientras que otros, como España, vacunarán hasta los 65 años de edad a partir de mañana.",
                "text_en": "Some European countries, such as France, have decided to vaccinate only those over 55 years of age with AstraZeneca, with no limit above that age, while others, such as Spain, will vaccinate up to 65 years of age from tomorrow.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Francia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "France"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han decidido vacunar con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have decided to vaccinate with AstraZeneca"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los mayores de 55 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 55 years of age"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin ningún líimite por encima de esa edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "without any limit above that age"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vacunarán hasta los 65 años de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccination until 65 years of age"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir de mañana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from tomorrow"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Otros países, como Reino Unido y Bélgica, no tienen ningún límite de edad de edad para aplicar la vacuna.",
                "text_en": "Other countries, such as the United Kingdom and Belgium, have no age limit for the application of the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Otros países, como Reino Unido y Bélgica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Other countries, such as the United Kingdom and Belgium"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no tienen ningún límite de edad de edad para aplicar la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have no age limit to apply the vaccine"
                    }
                ],
                "evidences": [
                    {
                        "value": "First-in-human dosing for vaccine candidates is typically in healthy young adult populations as these individuals generate the most robust responses. However, it will be important to demonstrate immunogenicity in those most at risk of severe disease. As this risk increases with age, the upper age limit for the expanded safety evaluation is 75 years, recognising that government guidance on strict social distancing of the over 70 may make it difficult for participants over 70 years old to attend trial sites. All participants will provide samples for immunogenicity assessment, including measurement of titres of serum binding and neutralising antibodies, induction of high levels of which is believed to be essential for an effective vaccine. Thus we will be able to confirm immunogenicity of the vaccine in older participants.",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9693370461
                    }
                ]
            }
        ]
    },
    "80": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 17,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 6,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 20,
            "WhoReliabilityReliable": 16,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 3,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 9,
            "HowReliabilityReliable": 8,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 6,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 6,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 18,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 5,
            "Key-Verb": 0,
            "Orthotypography": 2,
            "Figure": 7,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 14,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEl Gobierno PSOE-Podemos es responsable directo, por sectarismo e ineptitud, de buena parte de la crisis y de las muertes\n\n<PARAGRAPH>\n\nNo lo verán en RTVE, ni en LaSexta o las páginas de El País.\n\n<BREAK>\n\nTampoco lo oirán en la Cadena SER ni de la boca de los tertulianos de la Brunete Pedrete mediatica, pero duele saberlo.\n\n<PARAGRAPH>\n\nSi el confinamiento domiciliario de la primera ola de la pandemia de coronavirus, que entró en vigor el pasado 15 de marzo de 2020 a las 0:00 horas, se hubiera decretado siete días antes, se habrían evitado más de 20.000 muertes.\n\n<PARAGRAPH>\n\nSon los los resultados de un estudio realizado por un equipo de científicos del departamento de Ingeniería Informática y Matemáticas de la Universitat Rovira i Virgili, en colaboración con el departamento de Física de la Materia Condensada de la Universidad de Zaragoza publicado este 20 de febrero de 2021.\n\n<PARAGRAPH>\n\nHubiera bastado tomar medidas una semana antes, pero a esas alturas las terminales periodísticas del Gobierno PSOE-Podemos instaban a todas las formas a acudir en masa al akelarre feminista y desde la ministra Calvo, que se infectó en la manifestación, a la mujer de Sánchez, que también pilló allí el coronavirus, hacían propaganda a favor de las marchas, negando el peligro.\n\n<PARAGRAPH>\n\nEl propio Fernando Simón, supuesto experto en la materia, decía entonces que no desaconsejaría a su hijo asistir multitudinario al festival callejero de las feministas.\n\n<PARAGRAPH>\n\nLa cifra de fallecidos, que al final de esa primera ola se situó en 28.000, se habría quedado en 5.000.\n\n<PARAGRAPH>\n\n «Nos habríamos ahorrado 23.000 cadáveres si el confinamiento se hubiese avanzado una semana», ha explicado el físico Àlex Arenas, líder de la investigación.\n\n<PARAGRAPH>\n\nAunque cuadra perfectamente con su crónica desfachatez, a estas alturas -con casi 100.000 muertos- el socialista de Pedro Sánchez sigue eludiendo toda responsabilidad en la temeraria celebración de las manifestaciones feministas del 8-M.\n\n<PARAGRAPH>\n\nY con él y sus ministros, la mayor parte de la clase política y periodística, que alentó esas concentraciones por sectarismo y miopía.\n\n<PARAGRAPH>\n\nEs importante subrayar que el Ministerio de Sanidad, en aquellas fechas con Salvador Illa a la cabeza, desoyó las recomendaciones de la comunidad científica y de la Organización Mundial de la Salud (OMS), que elevaba ya el 28 de febrero de «alto» a «muy alto» el riesgo de propagación del coronavirus en España.\n\n<PARAGRAPH>\n\nTras analizar los datos de los primeros días de la pandemia en nuestro país los investigadores han concluido en sus estimaciones, para las que han reconstruido la evolución de la velocidad de propagación (Rt) teniendo en cuenta el periodo entre la aparición de los síntomas y el diagnóstico final para conocer la «incidencia real en esas fechas», que se produjo «un desfase» entre ambos.\n\n<PARAGRAPH>\n\n«Este desfase en la notificación, de 15 días de media, fue el gran problema en un momento en el que el número de pruebas era increíblemente pobre».\n\n<PARAGRAPH>\n\nAsí, los resultados finales han arrojado que se podría haber salvado la vida de miles de personas si se hubiera confinado antes.\n\n<PARAGRAPH>\n\nAl mismo tiempo, los investigadores han encontrado que «habría sido desastroso» si el confinamiento se hubiera impuesto una semana más tarde de lo que se hizo, pues el número de fallecimientos, según sus estimaciones, habría llegado hasta los 120.000.\n\n<PARAGRAPH>\n\nDurante la investigación, los científicos han averiguado que «la Rt empezó a bajar antes de que las medidas entraran en vigor, y eso fue gracias a la autorresponsabilidad de la gente», ha afirmado Arenas, que ha añadido que «hubo una especie de conciencia de la ciudadanía, que viendo lo que estaba pasando en Italia, tomó precauciones por su cuenta».\n\n<PARAGRAPH>\n\nEsta conclusión coincide, y queda «reflejado perfectamente» en este estudio, con los resultados de otras investigaciones relativas a la anticipación de la ciudadanía a la implementación de las medidas para frenar la expansión de la Covid-19.\n\n<PARAGRAPH>\n\nEn este sentido, los investigadores también han estudiado las búsquedas realizadas en Google por la población en ese periodo y han concluido que la ciudadanía entonces «ya estaba muy preocupada por la cuestión de la Covid» y que «jugó un papel muy importante, anticipándose al cierre.\n\n<BREAK>\n\nSu prudencia evitó un daño mucho mayor», ha subrayado el físico.\n\n<PARAGRAPH>\n\nArenas ha recalcado que la moraleja que se desprende de este estudio es que «tardar un día o dos en tomar una decisión tiene unas consecuencias importantes a nivel de mortalidad», así como lo importante que es «agilizar los procesos de diagnóstico y notificación» para que el análisis de la situación sea lo más exacta y real posible y poder tomar las medidas adecuadas.\n\n<PARAGRAPH>\n\nEl físico ha revelado también que su grupo de investigación derivó el pasado año «cuatro informes» al ministro de Sanidad, Salvador Illa, vía Miguel Hernán (epidemiólogo que asesoró al Gobierno en la primera ola):\n\n<PARAGRAPH>\n\n«A partir de los cuales el presidente Sánchez decidió el confinamiento total, como mínimo, dos semanas tarde».\n\n<PARAGRAPH>\n\nEste experto también se puso en contacto con el presidente de la Generalitat en aquel momento, Quim Torra, y los consellers de la Presidencia, Meritxell Budó, y de Interior, Miquel Buch, quienes «desde el minuto uno lo entendieron y pidieron el confinamiento un día después de saber» los datos.\n\n<PARAGRAPH>\n\n «El ministro Illa y Fernando Simón, con información aún más precisa que nos requirieron, tardaron dos semanas más».\n\n<PARAGRAPH>\n",
        "TITLE": "Si en vez de convocar al akelarre feminista del 8-M, Sánchez hubiera confinado, se habrían salvado 20.000 españoles",
        "ID": "NF_04-11-2021_21-52-26_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Si en vez de convocar al akelarre feminista del 8-M, Sánchez hubiera confinado, se habrían salvado 20.000 españoles",
                "text_en": "If instead of summoning the feminist akelarre of 8-M, Sánchez would have confined himself, 20,000 Spaniards would have been saved.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Si en vez de convocar al akelarre feminista del 8-M, Sánchez hubiera confinado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "If instead of summoning the feminist akelarre of 8-M, Sanchez would have confined"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sanchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se habrían salvado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "would have been saved."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "20.000 españoles",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "20,000 Spanish"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Gobierno PSOE-Podemos es responsable directo, por sectarismo e ineptitud, de buena parte de la crisis y de las muertes",
                "text_en": "The PSOE-Podemos government is directly responsible, for sectarianism and ineptitude, for much of the crisis and deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno PSOE-Podemos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The PSOE-We Can Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es responsable directo, por sectarismo e ineptitud, de buena parte de la crisis y de las muertes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is directly responsible, for sectarianism and ineptitude, for much of the crisis and deaths"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por sectarismo e ineptitud",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by sectarianism and ineptitude"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si el confinamiento domiciliario de la primera ola de la pandemia de coronavirus, que entró en vigor el pasado 15 de marzo de 2020 a las 0:00 horas, se hubiera decretado siete días antes, se habrían evitado más de 20.000 muertes.",
                "text_en": "If the house confinement of the first wave of the coronavirus pandemic, which came into force on 15 March 2020 at 0:00 hours, had been decreed seven days earlier, more than 20,000 deaths would have been prevented.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "el confinamiento domiciliario de la primera ola de la pandemia de coronavirus, que entró en vigor el pasado 15 de marzo de 2020 a las 0:00 horas, se hubiera decretado siete días antes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the house confinement of the first wave of the coronavirus pandemic, which came into force on 15 March 2020 at 0:00 hours, would have been decreed seven days earlier"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado 15 de marzo de 2020 a las 0:00 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 15 March 2020 at 0:00 a.m."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se habrían evitado más de 20.000 muertes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "more than 20,000 deaths would have been prevented"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Son los los resultados de un estudio realizado por un equipo de científicos del departamento de Ingeniería Informática y Matemáticas de la Universitat Rovira i Virgili, en colaboración con el departamento de Física de la Materia Condensada de la Universidad de Zaragoza publicado este 20 de febrero de 2021.",
                "text_en": "These are the results of a study carried out by a team of scientists from the Department of Computer Engineering and Mathematics of the Universitat Rovira i Virgili, in collaboration with the Department of Condensed Matter Physics of the University of Zaragoza published on February 20, 2021.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Son los los resultados de un estudio realizado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "These are the results of a study carried out"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un equipo de científicos del departamento de Ingeniería Informática y Matemáticas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a team of scientists from the Department of Computer Engineering and Mathematics"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la Universitat Rovira i Virgili",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Universitat Rovira i Virgili"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el departamento de Física de la Materia Condensada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Department of Condensed Matter Physics"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la Universidad de Zaragoza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "University of Zaragoza"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este 20 de febrero de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "20 February 2021"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hubiera bastado tomar medidas una semana antes, pero a esas alturas las terminales periodísticas del Gobierno PSOE-Podemos instaban a todas las formas a acudir en masa al akelarre feminista y desde la ministra Calvo, que se infectó en la manifestación, a la mujer de Sánchez, que también pilló allí el coronavirus, hacían propaganda a favor de las marchas, negando el peligro.",
                "text_en": "It would have been enough to take action a week earlier, but at that point the journalistic terminals of the PSOE-Podemos government urged all forms to go en masse to the feminist akelarre and from Minister Calvo, who infected herself in the demonstration, the woman of Sánchez, who also caught the coronavirus there, made propaganda in favor of the marches, denying the danger.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "una semana antes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "one week before"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las terminales periodísticas del Gobierno PSOE-Podemos instaban a todas las formas a acudir",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the journalistic terminals of the PSOE-Podemos government urged in all ways to go"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gobierno PSOE-Podemos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government PSOE-We can"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en masa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mass"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al akelarre feminista",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to feminist akelarre"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El propio Fernando Simón, supuesto experto en la materia, decía entonces que no desaconsejaría a su hijo asistir multitudinario al festival callejero de las feministas.",
                "text_en": "Fernando Simón himself, a supposed expert on the subject, said that he would not discourage his son from attending the street festival of feminists.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El propio Fernando Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fernando Simón himself"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "decía entonces que no desaconsejaría a su hijo asistir multitudinario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "said then that he would not advise his son to attend crowd"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al festival callejero de las feministas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the street festival of feminists"
                    }
                ],
                "evidences": []
            },
            {
                "text": " «Nos habríamos ahorrado 23.000 cadáveres si el confinamiento se hubiese avanzado una semana», ha explicado el físico Àlex Arenas, líder de la investigación.",
                "text_en": "\"We would have saved 23,000 corpses if the confinement had been advanced for a week,\" explained physicist Àlex Arenas, leader of the investigation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Nos habríamos ahorrado 23.000 cadáveres",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We'd have saved 23,000 dead bodies."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "si el confinamiento se hubiese avanzado una semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "if the confinement had been advanced for a week"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el físico Àlex Arenas, líder de la investigación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the physicist Àlex Arenas, leader of the investigation"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aunque cuadra perfectamente con su crónica desfachatez, a estas alturas -con casi 100.000 muertos- el socialista de Pedro Sánchez sigue eludiendo toda responsabilidad en la temeraria celebración de las manifestaciones feministas del 8-M.",
                "text_en": "Although it fits perfectly with his chronic weakness, at this point – with almost 100,000 dead – the socialist of Pedro Sánchez continues to evade all responsibility in the reckless celebration of the feminist demonstrations of 8-M.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el socialista de Pedro Sánchez",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the socialist of Pedro Sánchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sigue eludiendo toda responsabilidad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Continues to evade all responsibility"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la temeraria celebración de las manifestaciones feministas del 8-M",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the reckless celebration of the feminist demonstrations of 8-M"
                    }
                ],
                "evidences": [
                    {
                        "value": "The President of the Spanish Government, the Socialist Pedro Sánchez, has been another face of the crisis. He made lengthy speeches popularly known as \"Aló Presidente\" to explain the measures on television, which were the subject of many memes after each appearance. The memes offer a veiled criticism of the government's management, the perceived lack of foresight and organization and the lack of effectiveness of the measures adopted (Illustration 8 in the Supplementary Materials).",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9792822599
                    }
                ]
            },
            {
                "text": "Y con él y sus ministros, la mayor parte de la clase política y periodística, que alentó esas concentraciones por sectarismo y miopía.",
                "text_en": "And with him and his ministers, most of the political and journalistic class, who encouraged those rallies for sectarianism and myopia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la mayor parte de la clase política y periodística",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the majority of the political and journalistic class"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "alentó esas concentraciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "encouraged such concentrations"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por sectarismo y miopía",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by sectarianism and myopia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es importante subrayar que el Ministerio de Sanidad, en aquellas fechas con Salvador Illa a la cabeza, desoyó las recomendaciones de la comunidad científica y de la Organización Mundial de la Salud (OMS), que elevaba ya el 28 de febrero de «alto» a «muy alto» el riesgo de propagación del coronavirus en España.",
                "text_en": "It is important to stress that the Ministry of Health, at that time with Salvador Illa at the head, ignored the recommendations of the scientific community and the World Health Organization (WHO), which already raised the risk of the spread of coronavirus in Spain on 28 February from \"high\" to \"very high\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desoyó las recomendaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ignored the recommendations"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la comunidad científica y de la Organización Mundial de la Salud (OMS)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the scientific community and the World Health Organization (WHO)"
                    }
                ],
                "evidences": [
                    {
                        "value": "On 11 March 2020, the World Health Organization (WHO) [1] declared a global pandemic caused by severe acute respiratory syndrome coronavirus (SARS-Covid-2), which has become a public health emergency of international concern. During its first phase of expansion outside China, Italy and Spain were the most affected countries reporting most cases and deaths. Thus, they were the first nations to declare a state of emergency in Europe. In Spain it was declared on 17 March and the government ordered a lockdown to restrict travel and cancel non-essential services in order to stop the spread of coronavirus disease (COVID-19) [2] .",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9983276725
                    }
                ]
            },
            {
                "text": "Tras analizar los datos de los primeros días de la pandemia en nuestro país los investigadores han concluido en sus estimaciones, para las que han reconstruido la evolución de la velocidad de propagación (Rt) teniendo en cuenta el periodo entre la aparición de los síntomas y el diagnóstico final para conocer la «incidencia real en esas fechas», que se produjo «un desfase» entre ambos.",
                "text_en": "After analyzing the data of the first days of the pandemic in our country the researchers have concluded in their estimates, for which they have reconstructed the evolution of the propagation speed (Rt) taking into account the period between the appearance of symptoms and the final diagnosis to know the \"real incident at those dates\", which occurred \"a gap\" between the two.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Tras analizar los datos de los primeros días de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "After analyzing data from the early days of the pandemic"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en nuestro país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in our country"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los investigadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "researchers"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "han reconstruido la evolución de la velocidad de propagación (Rt) teniendo en cuenta el periodo entre la aparición de los síntomas y el diagnóstico final para conocer la «incidencia real en esas fechas»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have reconstructed the evolution of the propagation speed (Rt) taking into account the period between the onset of symptoms and the final diagnosis to know the \"real incidence at those dates\""
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se produjo «un desfase» entre ambos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "\"A gap\" occurred between the two"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Este desfase en la notificación, de 15 días de media, fue el gran problema en un momento en el que el número de pruebas era increíblemente pobre».",
                "text_en": "\"This 15-day notice lag was the big problem at a time when the number of tests was incredibly poor.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Este desfase en la notificación, de 15 días de media, fue el gran problema",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This 15-day notice lag was the big problem"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de 15 días de media",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of 15 days on average"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así, los resultados finales han arrojado que se podría haber salvado la vida de miles de personas si se hubiera confinado antes.",
                "text_en": "Thus, the final results have shown that thousands of people could have been saved if they had been confined earlier.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los resultados finales han arrojado que se podría haber salvado la vida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the final results have shown that you could have saved your life"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "de miles de personas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "of thousands of persons"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "si se hubiera confinado antes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "if he had been confined before"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Durante la investigación, los científicos han averiguado que «la Rt empezó a bajar antes de que las medidas entraran en vigor, y eso fue gracias a la autorresponsabilidad de la gente», ha afirmado Arenas, que ha añadido que «hubo una especie de conciencia de la ciudadanía, que viendo lo que estaba pasando en Italia, tomó precauciones por su cuenta».",
                "text_en": "During the research, scientists have found that \"the Rt started to fall before the measures came into effect, and that was thanks to the self-responsibility of the people\", said Arenas, who added that \"there was a kind of awareness of the citizenry, that seeing what was happening in Italy, took precautions on its own\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Durante la investigación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "During the investigation"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los científicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "scientists"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han averiguado que «la Rt empezó a bajar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have found out that \"the Rt started to come down"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "antes de que las medidas entraran en vigor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "before the measures entered into force"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "gracias a la autorresponsabilidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thanks to self-responsibility"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "People"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Arenas ha recalcado que la moraleja que se desprende de este estudio es que «tardar un día o dos en tomar una decisión tiene unas consecuencias importantes a nivel de mortalidad», así como lo importante que es «agilizar los procesos de diagnóstico y notificación» para que el análisis de la situación sea lo más exacta y real posible y poder tomar las medidas adecuadas.",
                "text_en": "Arenas stressed that the moral behind this study is that \"it takes a day or two to make a decision has important consequences at the level of mortality\", as well as how important it is to \"speed up the diagnostic and reporting processes\" so that the analysis of the situation is as accurate and real as possible and to be able to take the appropriate measures.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Arenas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sands"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de este estudio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of this study"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tardar un día o dos en tomar una decisión tiene unas consecuencias importantes a nivel de mortalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "taking a day or two to make a decision has important consequences at the level of mortality"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este experto también se puso en contacto con el presidente de la Generalitat en aquel momento, Quim Torra, y los consellers de la Presidencia, Meritxell Budó, y de Interior, Miquel Buch, quienes «desde el minuto uno lo entendieron y pidieron el confinamiento un día después de saber» los datos.",
                "text_en": "This expert also contacted the President of the Generalitat at that time, Quim Torra, and the President's consellers, Meritxell Budó, and Interior, Miquel Buch, who \"from the minute one understood it and asked for confinement a day after knowing\" the data.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Quim Torra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Quim Torra"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los consellers de la Presidencia, Meritxell Budó, y de Interior, Miquel Buch",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Presidents, Meritxell Budó, and Interior, Miquel Buch"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo entendieron y pidieron el confinamiento un día después de saber» los datos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "they understood it and asked for confinement the day after they knew» the data"
                    }
                ],
                "evidences": []
            },
            {
                "text": " «El ministro Illa y Fernando Simón, con información aún más precisa que nos requirieron, tardaron dos semanas más».",
                "text_en": "«Minister Illa and Fernando Simón, with even more precise information that we were required, took two more weeks».",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El ministro Illa y Fernando Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Minister Illa and Fernando Simón"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con información aún más precisa que nos requirieron",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with even more accurate information that we were required"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tardaron dos semanas más",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It took two more weeks."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "81": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 13,
            "WhatReliabilityReliable": 13,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 12,
            "WhoReliabilityReliable": 12,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 6,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 5,
            "HowReliabilityReliable": 5,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 6,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 6,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 7,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEspaña ha recibido hasta el momento 9.703.645 vacunas, de las que se han administrado 8.342.155 dosis, el 86,1%.Así queda el calendario de vacunación tras la actualización del Gobierno: ¿Cuándo me toca y con qué vacuna?DIRECTO | Sigue la última hora de la pandemia, de las restricciones y de la vacunación.\n\n<PARAGRAPH>\n\nLas comunidades autónomas han comenzado a recibir este viernes, 2 de abril, las 1.056.500 dosis de la vacuna de AstraZeneca contra el coronavirus que llegaron este jueves al Ministerio de Sanidad en su almacén central.\n\n<BREAK>\n\nLas dosis están ya en manos de Aragón, Navarra, Andalucía o Euskadi y a lo largo de la jornada se repartirán entre todas las comunidades y ciudades autónomas.\n\n<PARAGRAPH>\n\nLa incidencia acumulada sigue aumentando en España hasta los 154,7 casos con 7.041 contagios más de covid en 24 horas, en una jornada que ha registrado récord de vacunas administradas por segundo día consecutivo: 306.995 dosis el jueves y 298.549 este miércoles.\n\n<PARAGRAPH>\n\nLa ministra de Sanidad, Carolina Darias, anunció este jueves, además, la llegada el lunes de 1,2 millones de nuevas vacunas de Pfizer, que se sumarán a las más de un millón de dosis de AstraZeneca recibidas este jueves, y ha instado a todas las comunidades autónomas a seguir vacunando. De esta forma, aseguró que el objetivo de tener vacunado a 33 millones de españoles a lo largo del verano está \"al alcance de la mano\".\n\n<PARAGRAPH>\n\nEn total, España ha recibido hasta el momento 9.703.645 vacunas, de las que se han administrado 8.342.155 dosis, el 86,1% de las entregadas a las comunidades, según los datos de Sanidad de este jueves.\n\n<PARAGRAPH>\n\nEl número de personas que ya han recibido la pauta completa de alguna de las tres vacunas autorizadas asciende a 2.797.015 y la mayor parte de las vacunaciones ha sido con el suero de Pfizer (2.668.355).\n\n<PARAGRAPH>\n\nEl foco ahora está en cerrar por completo el grupo de mayores de 80 años aún en proceso de vacunación, así como los trabajadores sociosanitarios, esenciales -como policías y profesores-.\n\n<BREAK>\n\nY posteriormente alargar el calendario a las personas de entre 70 y 79, las de entre 60 y 69, también los menores de 60 con condiciones de riesgo, así como aquellas que tienen entre 56 y 59 y 45 y 55.\n\n<PARAGRAPH>\n\nEn la quinta edición de la estrategia de Sanidad, se contempla que los enfermos graves y crónicos sean vacunados ya por ser personas consideradas de \"muy alto riesgo\", por lo que se hará de manera simultánea a la franja de edad de 70 a 79 anos y con vacunas ARN mensajero, \"con la finalidad de alcanzar la mayor protección en un periodo de tiempo menor\".\n\n<PARAGRAPH>\n\nAdemás, Sanidad acordó la extensión de los 55 a los 65 años el límite de edad hasta el que se puede vacunar con AstraZeneca, con lo que personas entre 60 y 65 años recibirán la inmunidad antes que los que tiene setentaytantos, grupo al que pertenecen uno de cada cinco fallecidos por Covid-19 (21%).\n\n<PARAGRAPH>\n\nPor otra parte, el Gobierno ha decidido acelerar el proceso de vacunación quitando una de las dos dosis que hasta ahora se recibían de manera generala personas menores de 65 años que hayan pasado el coronavirus.\n\n<PARAGRAPH>\n",
        "TITLE": "España bate récord de vacunación por segundo día, envía un millón de dosis a las CC AA y otro más a partir del lunes",
        "ID": "F_04-11-2021_21-38-12_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "España bate récord de vacunación por segundo día, envía un millón de dosis a las CC AA y otro más a partir del lunes",
                "text_en": "Spain loses record vaccination per second day, sends a million doses to AACs and another one from Monday",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "envía un millón de dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "send a million doses"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las CC AA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AACs"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir del lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from Monday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "España ha recibido hasta el momento 9.703.645 vacunas, de las que se han administrado 8.342.155 dosis, el 86,1%.Así queda el calendario de vacunación tras la actualización del Gobierno: ¿Cuándo me toca y con qué vacuna?DIRECTO | Sigue la última hora de la pandemia, de las restricciones y de la vacunación.",
                "text_en": "Spain has so far received 9,703,645 vaccines, of which 8,342,155 doses have been administered, 86.1%.This is what the vaccination schedule is like after the government update: When is it my turn and with what vaccine?DIRECTO  Follow the last hour of the pandemic, restrictions and vaccination.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha recibido hasta el momento 9.703.645 vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has so far received 9,703,645 vaccines"
                    }
                ],
                "evidences": [
                    {
                        "value": "At a time when cases of the Delta variant are rising sharply worldwide and countries are lifting restrictions, it is key to know the concerns and doubts that people have about vaccination. In a recent survey of 1,050 subjects conducted in Spain between March 17 and 18, most Spaniards (52%) responded that the Vaxzevria vaccine was unsafe, twice as many as a month ago (25%). However, the perception of the safety of the other three vaccines administered in Spain, Pfizer-BioNTech, Moderna, and Janssen, increased. The same attitude was recorded in Italy, France, and Germany (12) . After the resumption of vaccination with Vaxzevria in Spain, official data showed that only 1% refused to receive it (12) . However, there have been more consultations in primary care centers about the effects of the vaccines, although these seem to dissipate after the information provided by health professionals. Thus, it is important to provide as much transparency as possible, generating a climate of trust between government, healthcare professionals, and regular citizens to be vaccinated.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9986644983
                    }
                ]
            },
            {
                "text": "Las comunidades autónomas han comenzado a recibir este viernes, 2 de abril, las 1.056.500 dosis de la vacuna de AstraZeneca contra el coronavirus que llegaron este jueves al Ministerio de Sanidad en su almacén central.",
                "text_en": "The Autonomous Communities have begun to receive on Friday, April 2, the 1,056,500 doses of AstraZeneca's Coronavirus vaccine that arrived this Thursday at the Ministry of Health in its central warehouse.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Las comunidades autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Autonomous Communities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han comenzado a recibir este viernes, 2 de abril, las 1.056.500 dosis de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have begun to receive this Friday, April 2, the 1,056,500 doses of the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este viernes, 2 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Friday, April 2nd"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Thursday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al Ministerio de Sanidad en su almacén central",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Ministry of Health in its central warehouse"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las dosis están ya en manos de Aragón, Navarra, Andalucía o Euskadi y a lo largo de la jornada se repartirán entre todas las comunidades y ciudades autónomas.",
                "text_en": "The doses are already in the hands of Aragon, Navarre, Andalusia or Euskadi and throughout the day will be distributed among all autonomous communities and cities.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las dosis están ya",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Doses are already in place."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en manos de Aragón, Navarra, Andalucía o Euskadi",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the hands of Aragon, Navarre, Andalusia or Euskadi"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a lo largo de la jornada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout the day"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "entre todas las comunidades y ciudades autónomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of all Autonomous Communities and Cities"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La incidencia acumulada sigue aumentando en España hasta los 154,7 casos con 7.041 contagios más de covid en 24 horas, en una jornada que ha registrado récord de vacunas administradas por segundo día consecutivo: 306.995 dosis el jueves y 298.549 este miércoles.",
                "text_en": "The cumulative incidence continues to increase in Spain to 154.7 cases with 7,041 more covid infections in 24 hours, in a day that has recorded a record of vaccines administered for the second consecutive day: 306,995 doses on Thursday and 298,549 on Wednesday.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La incidencia acumulada sigue aumentando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Cumulative incidence continues to increase"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    }
                ],
                "evidences": [
                    {
                        "value": "Since its origin in China, the SARS-CoV-2 infection has become a pandemic and spread to 209 countries. According to the latest WHO COVID-19 situation report (April 18, 2020), 2,160,207 cases and a total of 146,088 deaths have been reported so far. An overwhelming number of 6,710 new deaths were reported in the last 24 hours. The three countries with the highest number of cases (till April 18, 2020) are the United States, (665,330), Spain (188,068), and Italy (172,434) [3] . An increase in percentage mortality over time has been observed in the WHO COVID-19 status reports from January 21 to April 18, 2020 ( Figure 1) [3] .",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9933783412
                    }
                ]
            },
            {
                "text": "La ministra de Sanidad, Carolina Darias, anunció este jueves, además, la llegada el lunes de 1,2 millones de nuevas vacunas de Pfizer, que se sumarán a las más de un millón de dosis de AstraZeneca recibidas este jueves, y ha instado a todas las comunidades autónomas a seguir vacunando. De esta forma, aseguró que el objetivo de tener vacunado a 33 millones de españoles a lo largo del verano está \"al alcance de la mano\".",
                "text_en": "The Minister of Health, Carolina Darias, announced this Thursday, in addition, the arrival on Monday of 1.2 million new Pfizer vaccines, which will add to the more than a million doses of AstraZeneca received this Thursday, and has urged all the autonomous communities to continue to vaccinate. Thus, she assured that the goal of having vaccinated 33 million Spaniards throughout the summer is \"at hand\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La ministra de Sanidad, Carolina Darias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Minister of Health, Carolina Darias"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Thursday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la llegada el lunes de 1,2 millones de nuevas vacunas de Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "arrival on Monday of 1.2 million new Pfizer vaccines"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Monday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En total, España ha recibido hasta el momento 9.703.645 vacunas, de las que se han administrado 8.342.155 dosis, el 86,1% de las entregadas a las comunidades, según los datos de Sanidad de este jueves.",
                "text_en": "In total, Spain has so far received 9,703,645 vaccines, of which 8,342,155 doses have been administered, 86.1% of those delivered to the communities, according to the health data of this Thursday.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha recibido hasta el momento 9.703.645 vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has so far received 9,703,645 vaccines"
                    }
                ],
                "evidences": [
                    {
                        "value": "On the date on which the recruitment of patients from this study was closed, a total of 10,763,537 doses of vaccines had been administered in the Autonomous Community of Andalusia, at a vaccination rate similar to the rest of the Spain and similar to that of the rest of European countries. This is assuming, then, approximately 60% of the adult population [3] .",
                        "score": 0.7099999785
                    },
                    {
                        "value": "The quick and effective development of vaccines against COVID-19 has played an important role in the control of the pandemic [1] and represents one of the most meritorious and relevant advances of the history of science [2] . As of October 2021, the European Medicines Agency (EMA) has authorized the use of four vaccines against COVID-19 in Spain: BNT162b2 (Comirnaty ® ), mRNA-1273 (Moderna ® ), AZD1222 (Vaxzevria ® ), and Ad26.COV2.s (Janssen ® ). Although all these vaccines have proven their efficacy and safety, several studies during 2021 have reported adverse events in clinical series and post-authorization trials [3] [4] [5] .",
                        "score": 0.5799999833
                    },
                    {
                        "value": "At a time when cases of the Delta variant are rising sharply worldwide and countries are lifting restrictions, it is key to know the concerns and doubts that people have about vaccination. In a recent survey of 1,050 subjects conducted in Spain between March 17 and 18, most Spaniards (52%) responded that the Vaxzevria vaccine was unsafe, twice as many as a month ago (25%). However, the perception of the safety of the other three vaccines administered in Spain, Pfizer-BioNTech, Moderna, and Janssen, increased. The same attitude was recorded in Italy, France, and Germany (12) . After the resumption of vaccination with Vaxzevria in Spain, official data showed that only 1% refused to receive it (12) . However, there have been more consultations in primary care centers about the effects of the vaccines, although these seem to dissipate after the information provided by health professionals. Thus, it is important to provide as much transparency as possible, generating a climate of trust between government, healthcare professionals, and regular citizens to be vaccinated.",
                        "score": 0.7099999785
                    },
                    {
                        "value": "Since the outbreak of the SARS-CoV-2 epidemic, the world has accelerated the development process of vaccines (87) . At present, there are seven kinds of potential SARS-CoV-2 vaccines: inactivated vaccines, live attenuated vaccines, DNA vaccines, mRNA vaccines, viral vectored vaccines, protein subunit vaccines, and virus-like particle vaccines. As of 26 September 2021, a total of 6,078,264,761 doses of vaccine [https:// coronavirus.jhu.edu/map.html] have been administered worldwide. However, the emerging SARS-CoV-2 variants aroused great concern as a variety of vaccine sera showed weakened neutralization effect against variants ( Table 2) .",
                        "score": 0.5299999714
                    },
                    {
                        "value": "The results presented in Fig. 3 show that a total of 186,096,615 double-dose vaccines have been purchased from each of the five manufacturers, where 85,096,615 vaccines required ultra-cold refrigeration, 66,000,000 vaccines required very cold refrigeration, and the remainder required cold refrigeration. From the total purchased vaccine, 111,668,835 and 44,965,339 double-dose vaccines have been allocated to the Patna and Bhopal distribution centers, respectively. The remaining 29,462,441 doubledose vaccines have been allocated to the Hyderabad distribution center. In addition, the equitable vaccine distribution in Kerala State is depicted in this figure. 1,397 ,340 double-dose vaccines are transferred to this state from the Hyderabad distribution center in period 4, out of which 1,387,340 vaccines were assigned to group 1, and the remaining 9793 vaccines were allocated to group 2. Similarly, vaccines assigned to each group in periods 5 to 8 are shown in this figure. It is worth noting again some parameters, including transportation costs, vaccine prices, and manufacturing capacities, have Table 2 The optimal doses of vaccines delivered to distribution centers in each period ",
                        "score": 0.5600000024
                    },
                    {
                        "value": "By 30 March 2021, 268 COVID-19 candidate vaccines had been developed worldwide, 84 candidate vaccines had been evaluated clinically, and 184 candidate vaccines had been evaluated preclinically according to the WHO's draft landscape of COVID-19 candidate vaccines [11] . All known vaccine platforms have been used to develop vaccine candidates, including inactivated vaccines, live attenuated vaccines, subunit vaccines, virus-like particles, nucleic acid vaccines (mRNA vaccines and DNA vaccines), and viral vector vaccines. Inactivated viral vaccines have the advantages of a mature technology, high safety, high success probability and high public acceptance.",
                        "score": 0.5400000215
                    },
                    {
                        "value": "According to data obtained from the Ministry of Health at the time of writing this article, in Spain 39.9 million doses had been administered, with more than 24 million persons having received one dose (52.8%) and more than 16 million having completed the full vaccination schedule (35.4% of the population).",
                        "score": 0.7699999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "entailment",
                        "score": 0.4480662346
                    },
                    {
                        "label": "neutral",
                        "score": 0.9927275181
                    },
                    {
                        "label": "neutral",
                        "score": 0.9980717301
                    },
                    {
                        "label": "neutral",
                        "score": 0.9886566997
                    },
                    {
                        "label": "neutral",
                        "score": 0.9914854169
                    },
                    {
                        "label": "neutral",
                        "score": 0.9989948869
                    },
                    {
                        "label": "contradiction",
                        "score": 0.7712982893
                    }
                ]
            },
            {
                "text": "El número de personas que ya han recibido la pauta completa de alguna de las tres vacunas autorizadas asciende a 2.797.015 y la mayor parte de las vacunaciones ha sido con el suero de Pfizer (2.668.355).",
                "text_en": "The number of people who have already received the full schedule of one of the three approved vaccines is 2,797,015 and most of the vaccinations have been with Pfizer serum (2,668,355).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la mayor parte de las vacunaciones ha sido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "most vaccinations have been"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con el suero de Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with Pfizer serum"
                    }
                ],
                "evidences": [
                    {
                        "value": "To date, the Food and Drug Administration (FDA) approved three vaccines for their emergency use (Pfizer-BioNTech, Moderna, and Janssen), and other 14 vaccines were approved for their use in at least one country [7] . According to the Our World in Data website [8] , 272 million people were fully vaccinated (3.5% of the world's population). Unfortunately, the efficacy study of the vaccines against new variants, people from various age groups, and comorbidities is still ongoing and needs validation. In addition, the FDA had only emergency-approved antiviral drugs such as remdesivir, baricitinib, and the monoclonal antibody bamlanivimab [9] . However, due to their availability and cost, there are no accessible options for mass treatment [10] . In this sense, new drugs and accessible treatments worldwide against this novel virus remains a challenge [11] .",
                        "score": 0.5099999905
                    },
                    {
                        "value": "Whenever humanity faces a crisis from viral infections, effective vaccines contribute to protection against the virus [25] . Several vaccines have been developed against SARS-CoV-2 and, as of 18 May 2021, more than one billion COVID-19 vaccine doses have been administered worldwide [1] . Based on the results from clinical trials, the FDA approved three types of COVID-19 vaccine: Pfizer-BioNTech/BNT162b2 (mRNA) [26] , Moderna/mRNA 1273 (mRNA) [27] , and Janssen/Ad26.COV 2.S (viral vector) [28] . Meanwhile, the Korean Ministry of Food and Drug Safety approved Pfizer-BioNTech/BNT162b2 [26] and As-traZeneca/AZD1222 (viral vector) COVID-19 vaccines [29] in February, 2021. However, the drive for COVID-19 vaccination is slow in Korea: only 2.1 million people were completely vaccinated in the last three months (March-May) [30] .",
                        "score": 0.6600000262
                    },
                    {
                        "value": "Between December 2020 and January 2021, the UK approved three coronavirus vaccines Pfizer/BioNTech, Oxford/AstraZeneca and the Moderna vaccines. So far, nearly 20 million people have been given at least the first dose of the vaccine. The other vaccines including the Chinese (Sinopharm) and the Russians (Sputnik V) have also been approved in some countries and showed reasonable efficacy in protecting individuals against the severe form of COVID 19 disease.",
                        "score": 0.7099999785
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9727389812
                    },
                    {
                        "label": "neutral",
                        "score": 0.9098735452
                    },
                    {
                        "label": "neutral",
                        "score": 0.9992597699
                    }
                ]
            },
            {
                "text": "El foco ahora está en cerrar por completo el grupo de mayores de 80 años aún en proceso de vacunación, así como los trabajadores sociosanitarios, esenciales -como policías y profesores-.",
                "text_en": "The focus is now on shutting down completely the group of over 80 years of age still in the process of vaccination, as well as the essential socio-anital workers, such as police and teachers.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El foco ahora está en cerrar por completo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The focus is now on shutting down completely."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el grupo de mayores de 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the group of over 80 years"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "aún en proceso de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "still in the process of vaccination"
                    }
                ],
                "evidences": [
                    {
                        "value": "The initial vaccination rollout for age group 80+ years and health care workers in early 20201 coincided with the decline of the COVID-19 wave from December 2020 during which the elderly bore the major burden of COVID-19 mortality. Similarly, excess mortality during December 2020 was superseded by undermortality in the beginning of 2021 [1] , possibly due to mortality displacement effects.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9690313935
                    }
                ]
            },
            {
                "text": "Y posteriormente alargar el calendario a las personas de entre 70 y 79, las de entre 60 y 69, también los menores de 60 con condiciones de riesgo, así como aquellas que tienen entre 56 y 59 y 45 y 55.",
                "text_en": "And then extend the calendar to people between 70 and 79, those between 60 and 69, also those under 60 with risk conditions, as well as those between 56 and 59 and 45 and 55.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "posteriormente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "later"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "alargar el calendario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "lengthening the calendar"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las personas de entre 70 y 79, las de entre 60 y 69, también los menores de 60 con condiciones de riesgo, así como aquellas que tienen entre 56 y 59 y 45 y 55",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons between 70 and 79, those between 60 and 69, also those under 60 with risk conditions, as well as those between 56 and 59 and 45 and 55"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En la quinta edición de la estrategia de Sanidad, se contempla que los enfermos graves y crónicos sean vacunados ya por ser personas consideradas de \"muy alto riesgo\", por lo que se hará de manera simultánea a la franja de edad de 70 a 79 anos y con vacunas ARN mensajero, \"con la finalidad de alcanzar la mayor protección en un periodo de tiempo menor\".",
                "text_en": "In the fifth edition of the Health Strategy, it is envisaged that serious and chronic patients will be vaccinated already because they are considered to be \"very high risk\", so it will be done simultaneously with the age range of 70 to 79 years and with messenger RNA vaccines, \"with the aim of achieving the greatest protection in a shorter period of time\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En la quinta edición de la estrategia de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In the fifth edition of the Health Strategy"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se contempla que los enfermos graves y crónicos sean vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "serious and chronic patients are expected to be vaccinated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los enfermos graves y crónicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "severe and chronic patients"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por ser personas consideradas de \"muy alto riesgo\"",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as people considered to be \"very high-risk\""
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de manera simultánea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "simultaneously"
                    }
                ],
                "evidences": [
                    {
                        "value": "All dogs included in the study presented with gastrointestinal clinical signs consistent with parvoviral disease. The clinical history of the tested dogs showed that among 58 referred samples, 17 patients had a history of CPV vaccination and 41 patients were unvaccinated or of unknown CPV vaccination status. The age range for the vaccinated dogs was from 5 months to 6.5 years.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "For all vaccines, the number of administered doses in the different age ranges was obtained from the \"COVID-19 Vaccine rollout overview week 23rd, 2021\" data from the ECDC database for the available countries (25 out of 30) (Table S7) . Not all European countries provided these data. Hence, we created six simulations to extend the available data to all of Europe. One of these simulations, \"European mean\", considered the data of all 25 countries to calculate the percentage of administration in each age range. Each of the other five simulations considered the data of 5 of the 25 available countries chosen in a stochastic manner. For selecting the countries used in each of the five simulations, all 25 European countries were numbered using the \" = RAND()\" formula provided by Excel. Therefore, we selected only the five countries with the highest numbers to calculate the percentage of administration in each age range. The countries selected in the five simulations were: Austria, Croatia, the Czech Republic, Luxembourg, and Portugal (Simulation 1); Belgium, the Czech Republic, Ireland, Italy, and Romania (Simulation 2); Bulgaria, Iceland, Italy, Malta, and Romania (Simulation 3); Greece, Ireland, Malta, Romania, and Sweden (Simulation 4); and Estonia, Latvia, Romania, Slovakia, and Sweden (Simulation 5). For all vaccines, the overall number of doses administered was distributed in the age ranges using the fraction of administered doses in each age range obtained from the six simulations with the following formula:",
                        "score": 0.5799999833
                    },
                    {
                        "value": "This study was a cross-sectional study. The population of the study consisted of 23 patients vaccinated with COVID-19 mRNA vaccines between August 2021 and October 2021. The age range of the groups was from 18 to 38 years. The patients had no prior heart disease. 13 patients had vaccine-induced heart involvement, whereas other patients (10 patients) had no heart involvement (control group). The study protocol was accepted by Medicana International Ankara Hospital Human Research Ethic Committee (2021/24). Written informed consent was obtained from each patient. The principles of Declaration of Helsinki were followed in this study. The study data is available upon request.",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9990044236
                    },
                    {
                        "label": "neutral",
                        "score": 0.9966341853
                    },
                    {
                        "label": "neutral",
                        "score": 0.9987699389
                    }
                ]
            },
            {
                "text": "Además, Sanidad acordó la extensión de los 55 a los 65 años el límite de edad hasta el que se puede vacunar con AstraZeneca, con lo que personas entre 60 y 65 años recibirán la inmunidad antes que los que tiene setentaytantos, grupo al que pertenecen uno de cada cinco fallecidos por Covid-19 (21%).",
                "text_en": "In addition, Health agreed to extend from 55 to 65 years of age the age limit up to which AstraZeneca can be vaccinated, so that people between 60 and 65 years of age will receive immunity before those who are seventy-something, to which one in five died by Covid-19 (21%) belong.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "acordó la extensión de los 55 a los 65 años el límite de edad hasta el que se puede vacunar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "agreed to extend from 55 to 65 years the age limit until it can be vaccinated"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por otra parte, el Gobierno ha decidido acelerar el proceso de vacunación quitando una de las dos dosis que hasta ahora se recibían de manera generala personas menores de 65 años que hayan pasado el coronavirus.",
                "text_en": "In addition, the Government has decided to speed up the vaccination process by removing one of the two doses previously generally received by persons under 65 years of age who have passed the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha decidido acelerar el proceso de vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has decided to speed up the vaccination process"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "quitando una de las dos dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "removing one of the two doses"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "82": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 11,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 10,
            "WhoReliabilityReliable": 9,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 7,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 5,
            "HowReliabilityReliable": 5,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 3,
            "WhoRoleSubject": 7,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nBoris Johnson detalla un plan gradual que comienza con el regreso de los alumnos a las escuelas el 8 de marzo y la reapertura de los comercios minoristas no esenciales a partir del 12 de abril\n\n<PARAGRAPH>\n\nReino Unido se prepara para levantar gradualmente todas las restricciones por el COVID.\n\n<PARAGRAPH>\n\nBoris Johnson detalla el plan de cuatro pasos para aliviar las restricciones por el coronavirus, y expresó la esperanza de que la vida pueda volver a la normalidad a fines de junio.\n\n<PARAGRAPH>\n\nEl primer ministro británico anunció en la Cámara de los Comunes su hoja de ruta para reabrir la sociedad de forma “cauta pero irreversible”, que progresará siempre y cuando la campaña de vacunación siga su actual ritmo y no aparezcan nuevas variantes que alteren los planes.\n\n<PARAGRAPH>\n\n“La amenaza sigue siendo sustancial”, dijo Johnson al parlamento.\n\n<PARAGRAPH>\n\nJohnson, bajo presión para permitir más libertades a millones de personas encerradas en casa y ofrecer esperanza a negocios cerrados, dijo que la primera etapa daría prioridad a las escuelas que regresan el 8 de marzo cuando solo se permitiría una mínima socialización al aire libre.\n\n<PARAGRAPH>\n\nEl plan gradual continuará con la reapertura de los comercios minoristas no esenciales, pubs y restaurantes al exterior y museos actualmente cerrados a raíz de la pandemia a partir del 12 de abril.\n\n<PARAGRAPH>\n\nAlgunos fanáticos podrían asistir a partidos deportivos a partir del 17 de mayo, con un regreso de los espectadores a hasta un cuarto de la capacidad de los estadios, pero nunca por encima de las 10.000 personas.\n\n<BREAK>\n\nPara los eventos deportivos en recinto cerrado, se podrá llegar hasta la mitad de la capacidad del complejo, sin superar las 1.000 personas.\n\n<BREAK>\n\nLa medida llegaría a tiempo para la última jornada de la Premier League y el torneo de tenis de Wimbledon, que abre sus puertas el 28 de junio.\n\n<PARAGRAPH>\n\nFinalmente, todas las restricciones de distanciamiento social serán eliminadas a partir del 21 de junio, todas sujetas a cambios y dependiendo de los datos científicos.\n\n<PARAGRAPH>\n\n“Podemos tomar estos pasos gracias a la determinación del público británico y al extraordinario éxito de nuestro NHS (Servicio Nacional de Salud) al vacunar a más de 17,5 millones de personas en todo el Reino Unido”, dijo el primer ministro.\n\n<PARAGRAPH>\n\nCon casi 130.000 muertes, Gran Bretaña ha sufrido la quinta cifra oficial de muertos más alta del mundo por la pandemia y su economía ha experimentado su mayor caída en más de 300 años.\n\n<PARAGRAPH>\n",
        "TITLE": "Inglaterra levantará todas las restricciones por el COVID el 21 de junio",
        "ID": "NF_04-11-2021_20-34-32_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Inglaterra levantará todas las restricciones por el COVID el 21 de junio",
                "text_en": "England will lift all restrictions by COVID on 21 June",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Inglaterra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "England"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "levantará todas las restricciones por el COVID",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "lift all restrictions by the COVID"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 21 de junio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 21 June"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Boris Johnson detalla un plan gradual que comienza con el regreso de los alumnos a las escuelas el 8 de marzo y la reapertura de los comercios minoristas no esenciales a partir del 12 de abril",
                "text_en": "Boris Johnson details a phased plan that begins with the return of students to schools on 8 March and the reopening of non-essential retail outlets as of 12 April",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Boris Johnson",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Boris Johnson"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "detalla un plan gradual",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "details a phased plan"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con el regreso de los alumnos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with the return of the students"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a las escuelas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to schools"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 8 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 8 March"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "la reapertura de los comercios minoristas no esenciales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reopening of non-essential retail outlets"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir del 12 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from 12 April"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Reino Unido se prepara para levantar gradualmente todas las restricciones por el COVID.",
                "text_en": "The United Kingdom is preparing to gradually lift all restrictions by the COVID.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se prepara para levantar gradualmente todas las restricciones por el COVID",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "prepares to gradually lift all restrictions by the COVID"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Boris Johnson detalla el plan de cuatro pasos para aliviar las restricciones por el coronavirus, y expresó la esperanza de que la vida pueda volver a la normalidad a fines de junio.",
                "text_en": "Boris Johnson details the four-step plan to ease the restrictions by the coronavirus, and expressed the hope that life can return to normal by the end of June.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Boris Johnson",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Boris Johnson"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "detalla el plan de cuatro pasos para aliviar las restricciones por el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "details the four-step plan to ease the restrictions by the coronavirus"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "expresó la esperanza de que la vida pueda volver a la normalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "expressed the hope that life can return to normal"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a fines de junio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "end of June"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El primer ministro británico anunció en la Cámara de los Comunes su hoja de ruta para reabrir la sociedad de forma “cauta pero irreversible”, que progresará siempre y cuando la campaña de vacunación siga su actual ritmo y no aparezcan nuevas variantes que alteren los planes.",
                "text_en": "The British Prime Minister announced in the House of Commons his road map to reopen society in a “cautious but irreversible” way, which will progress as long as the vaccination campaign continues its current pace and no new variants appear that alter the plans.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El primer ministro británico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The British Prime Minister"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Cámara de los Comunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the House of Commons"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "su hoja de ruta para reabrir la sociedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "his road map to re-open society"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma “cauta pero irreversible”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a “cautual but irreversible” way"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“La amenaza sigue siendo sustancial”, dijo Johnson al parlamento.",
                "text_en": "“The threat remains substantial,” Johnson told parliament.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La amenaza sigue siendo sustancial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The threat remains substantial"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Johnson",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Johnson"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al parlamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Parliament"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El plan gradual continuará con la reapertura de los comercios minoristas no esenciales, pubs y restaurantes al exterior y museos actualmente cerrados a raíz de la pandemia a partir del 12 de abril.",
                "text_en": "The phased plan will continue with the reopening of non-essential retail outlets, pubs and restaurants abroad and museums currently closed in the wake of the pandemic as of 12 April.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El plan gradual continuará con la reapertura",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The gradual plan will continue with the reopening"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "comercios minoristas no esenciales, pubs y restaurantes al exterior y museos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "non-essential retail outlets, pubs and restaurants abroad and museums"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a raíz de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the aftermath of the pandemic"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir del 12 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from 12 April"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Algunos fanáticos podrían asistir a partidos deportivos a partir del 17 de mayo, con un regreso de los espectadores a hasta un cuarto de la capacidad de los estadios, pero nunca por encima de las 10.000 personas.",
                "text_en": "Some fans could attend sports matches starting on May 17, with a return of spectators to up to a quarter of the stadium capacity, but never above the 10,000 people.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Algunos fanáticos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Some fans"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "podrían asistir a partidos deportivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "could attend sports matches"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir del 17 de mayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from 17 May"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Finalmente, todas las restricciones de distanciamiento social serán eliminadas a partir del 21 de junio, todas sujetas a cambios y dependiendo de los datos científicos.",
                "text_en": "Finally, all social distancing restrictions will be removed from June 21, all subject to change and depending on scientific data.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "todas las restricciones de distanciamiento social serán eliminadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "all social distancing restrictions will be removed"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a partir del 21 de junio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from 21 June"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sujetas a cambios y dependiendo de los datos científicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "subject to change and depending on scientific data"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Con casi 130.000 muertes, Gran Bretaña ha sufrido la quinta cifra oficial de muertos más alta del mundo por la pandemia y su economía ha experimentado su mayor caída en más de 300 años.",
                "text_en": "With nearly 130,000 deaths, Britain has suffered the fifth-highest official death toll in the world from the pandemic and its economy has experienced its greatest decline in over 300 years.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Con casi 130.000 muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "With almost 130,000 deaths"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gran Bretaña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Great Britain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha sufrido la quinta cifra oficial de muertos más alta del mundo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has suffered the fifth highest official death toll in the world"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the pandemic"
                    }
                ],
                "evidences": [
                    {
                        "value": "Excess mortality. Additionally, we present the results from using excess mortality as an alternative Covid-related health outcome, estimating equation (3) . Figure 5 shows that by the end of June 2020, a one-standard-deviation increase in turnout is significantly associated with fewer accumulated excess deaths per 100,000 inhabitants in Italy, the Netherlands, Sweden and Great Britain. The effect size ranges from 6% in Italy to 35% in Sweden and stays relatively similar when including control variables (see Appendix  Table C5 ). The estimates imply that a one-standard-deviation increase in social capital could have prevented 1632 deaths in Sweden, 1787 deaths in the Netherlands, 2823 deaths in Italy, and 14,303 deaths in Great Britain. Reassuringly, excess mortality before the pandemic evolves in parallel between high-and low-social-capital micro-areas, which lends support to our identifying assumption. 22 In terms of dynamics, Figure 5 corroborates the evidence shown in Figures 1 and 2 : the number of excess deaths in high-socialcapital micro-areas starts to drop around the time of (or even before) the national lockdown. This decrease cannot be driven by the lockdown due to the incubation time and the duration of the disease before it leads to fatalities. Instead, we find that excess mortality drops in high-social-capital micro-areas about two to three weeks after the first community case. Moreover, effects stabilize about three weeks after the lockdown. This pattern is in line with evidence that deaths tend to occur around three weeks after the infection ( Yang et al., 2020 ) and points to the specific role of social capital in the absence of strict policy measures.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9338536263
                    }
                ]
            }
        ]
    },
    "83": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 1,
            "WhatReliabilityUnreliable": 9,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 7,
            "WhoReliabilityReliable": 3,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 3,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 7,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 7,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n¿Se dan cuenta que últimamente solo salen a la luz los problemas provocados por la vacuna AstraZeneca? ¿Se dan cuenta que, sorprendentemente, esos problemas son publicados incluso por las televisiones y los vendidos medios de comunicación? ¿No les sorprende que, mientras se habla de AstraZeneca, no se está hablando de los problemas provocados por otras vacunas?\n\n<PARAGRAPH>\n\nPues esto, que a todos nos resulta sospechoso, también tiene su explicación.\n\n<BREAK>\n\nY con gobiernos como los que sufrimos, de los que siempre hay que pensar mal para acertar, esto es, si cabe, todavía más sospechoso.\n\n<PARAGRAPH>\n\nY hoy nos hemos encontrado en la cuenta de Twitter del biólogo Fernando López-Mirones con una explicación que nos parece de lo más acertada y totalmente cargada de razón.\n\n<BREAK>\n\nY es que, mientras se nos habla de unas cosas, no se nos habla de otras y es como si las otras no existieran.\n\n<PARAGRAPH>\n\nEsto va de pasta, de comisiones y de estrategias ante la imposibilidad de parar las malas noticias, los efectos secundarios y las muertes que, desgraciadamente, estas vacunas están provocando en todo el mundo.\n\n<BREAK>\n\nPor lo tanto, la explicación de López-Mirones nos parece de lo más acertada.\n\n<BREAK>\n\nPiensen siempre mal y acertarán, tengan en cuenta que el gobierno que padecemos lo preside un tipo como Pedro Sánchez.\n\n<BREAK>\n\nCon eso debería estar todo dicho.\n\n<PARAGRAPH>\n\n#MIRONEWS El ataque a AstraZeneca es una estrategia comercial de libro.\n\n<BREAK>\n\nSacrifican un peón para que avance la reina.\n\n<BREAK>\n\nDe este modo el mensaje es “esta no pero LAS OTRAS SI”, pero son los mismos inversores.\n\n<BREAK>\n\nUn aullido\n\n<PARAGRAPH>\n\n— FERNANDO LÓPEZ-MIRONES (@FLMIRONES) April 7, 2021\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Fernando López-Mirones denuncia la descarada estrategia que se está llevando a cabo con AstraZeneca",
        "ID": "NF_04-11-2021_20-35-58_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Fernando López-Mirones denuncia la descarada estrategia que se está llevando a cabo con AstraZeneca",
                "text_en": "Fernando López-Mirones denounces the brazen strategy being carried out with AstraZeneca",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fernando López-Mirones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fernando López-Mirones"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "denuncia la descarada estrategia que se está llevando a cabo con AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "denounces the brazen strategy being carried out with AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Se dan cuenta que últimamente solo salen a la luz los problemas provocados por la vacuna AstraZeneca? ¿Se dan cuenta que, sorprendentemente, esos problemas son publicados incluso por las televisiones y los vendidos medios de comunicación? ¿No les sorprende que, mientras se habla de AstraZeneca, no se está hablando de los problemas provocados por otras vacunas?",
                "text_en": "Do you realize that recently only the problems caused by the AstraZeneca vaccine come to light? Do you realize that, surprisingly, these problems are published even by television and the sold media? Are you not surprised that, while talking about AstraZeneca, you are not talking about the problems caused by other vaccines?",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "últimamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Lately."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "solo salen a la luz los problemas provocados por la vacuna AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "only problems caused by the AstraZeneca vaccine come to light"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esos problemas son publicados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "these problems are published"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por las televisiones y los vendidos medios de comunicación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "by television and the sale of media"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y con gobiernos como los que sufrimos, de los que siempre hay que pensar mal para acertar, esto es, si cabe, todavía más sospechoso.",
                "text_en": "And with governments like those we suffer from, which we always have to think wrongly to get right, that is, if possible, even more suspicious.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con gobiernos como los que sufrimos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with governments like those we suffer"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "gobiernos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Governments"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esto es, si cabe, todavía más sospechoso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This is, if possible, even more suspicious."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y hoy nos hemos encontrado en la cuenta de Twitter del biólogo Fernando López-Mirones con una explicación que nos parece de lo más acertada y totalmente cargada de razón.",
                "text_en": "And today we have found ourselves on the Twitter account of biologist Fernando López-Mirones with an explanation that seems to us the most accurate and totally charged with reason.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la cuenta de Twitter",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on the Twitter account"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del biólogo Fernando López-Mirones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by biologist Fernando López-Mirones"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "una explicación que nos parece de lo más acertada y totalmente cargada de razón",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "an explanation that seems to us the most accurate and fully charged with reason"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto va de pasta, de comisiones y de estrategias ante la imposibilidad de parar las malas noticias, los efectos secundarios y las muertes que, desgraciadamente, estas vacunas están provocando en todo el mundo.",
                "text_en": "This is about money, commissions and strategies in the face of the impossibility of stopping the bad news, the side effects and deaths that, unfortunately, these vaccines are causing all over the world.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esto va de pasta, de comisiones y de estrategias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This is about money, commissions and strategies."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ante la imposibilidad de parar las malas noticias, los efectos secundarios y las muertes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the inability to stop bad news, side effects and deaths"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en todo el mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "all over the world"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por lo tanto, la explicación de López-Mirones nos parece de lo más acertada.",
                "text_en": "Therefore, López-Mirones' explanation seems to us to be the most accurate.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la explicación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "explanation"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "López-Mirones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "López-Mirones"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de lo más acertada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the right thing to do"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Piensen siempre mal y acertarán, tengan en cuenta que el gobierno que padecemos lo preside un tipo como Pedro Sánchez.",
                "text_en": "Always think wrong and you will be right, keep in mind that the government that we suffer is presided over by a guy like Pedro Sánchez.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el gobierno que padecemos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the government that we suffer"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lo preside",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He's presiding over it."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un tipo como Pedro Sánchez",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a guy like Pedro Sánchez"
                    }
                ],
                "evidences": []
            },
            {
                "text": "#MIRONEWS El ataque a AstraZeneca es una estrategia comercial de libro.",
                "text_en": "#MIRONEWS The attack on AstraZeneca is a commercial book strategy.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El ataque a AstraZeneca es una estrategia comercial de libro",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The attack on AstraZeneca is a commercial book strategy"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De este modo el mensaje es “esta no pero LAS OTRAS SI”, pero son los mismos inversores.",
                "text_en": "In this way the message is “this no but OTHER YES”, but they are the same investors.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "De este modo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "In this way"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "son los mismos inversores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "are the same investors"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "84": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 14,
            "WhatReliabilityReliable": 14,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 20,
            "WhoReliabilityReliable": 20,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 6,
            "HowReliabilityReliable": 6,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 12,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 7,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 7,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEsta es la APP gratuita para el diagnóstico predictivo del riesgo en pacientes COVID-19 para sanitarios.\n\n<BREAK>\n\nBajo el liderazgo médico del profesor Melchor Álvarez de Mon y del matemático Ferran Mazaira, ProA Capital y la Fundación Starlite son los promotores de la Cátedra COVID19.Esta app es el resultado práctico del estudio publicado en el el Journal of Personalised Medicine (MDPI), una de las revistas médicas especializadas más prestigiosas del mundo, titulado “A Predictive Model and Risk Factors for Case Fatality of COVID-19”.\n\n<BREAK>\n\nLa Cátedra ha elaborado este estudio a partir de una muestra de 2.000 pacientes de HM Hospitales y de otros 1.500 del UPA Hospital Universitario Príncipe de Asturias (asociado a la Universidad de Alcalá).Modelo PredictivoLo que este estudio analiza e identifica son las variables que determinan una evolución negativa (definida como acabar en la UCI o, peor aún, en fallecimiento) una vez el paciente se ha infectado por Covid-19.\n\n<BREAK>\n\nPara esto se han estudiado más de 60 variables en diferentes momentos de la infección de 3.500 pacientes de la primera oleada.\n\n<BREAK>\n\nEl análisis matemático-científico identifica y prioriza de manera precisa aquellas variables que más peso tienen en predecir la evolución del paciente.Más allá de una primera observación, la herramienta ayuda a los profesionales sanitarios a estimar con un alto grado de probabilidad el riesgo de ingreso en UCI o de muerte del paciente a partir de un simple análisis de sangre y obrar en consecuencia.\n\n<BREAK>\n\nEsta información puede ser de gran ayuda para tomar decisiones acertadas a tiempo.El estudio concluye con carácter científico (metodología de cohortes retrospectivas) y a partir del análisis de esa amplia muestra de pacientes, que las variables con mayor peso predictivo de la evolución de un paciente infectado son (entre paréntesis la relevancia de la variable en explicar la evolución):• Nivel de saturación de oxígeno en sangre (pulsiómetro): 20%• Edad: 18% • Ratio de linfocitos (sobre leucocitos): 14% • Nivel de proteína C-reactiva (es un marcador de la reacción inflamatoria): 13%• Comorbilidades o patologías previas del paciente: 13%• Número de leucocitos: 9% • Sexo (las mujeres presentan un menor riesgo de evolución negativa): 6,8%• Nivel de Dímero-D (otro potente marcador de la reacción inflamatoria): 6,2%2.000 pacientes de HM Hospitales en la primera ola de coronavirusEl estudio ha sido desarrollado gracias a los datos de 2.000 pacientes recogidos por HM Hospitales durante la primera ola.\n\n<BREAK>\n\nEl modelo resultante se testó contra los datos de otros 1.500 pacientes recogidos por el Hospital Príncipe de Asturias de Alcalá de Henares (también de la primera oleada) mostrando un 82% de grado de acierto (un grado muy elevado a nivel médico-científico).Finalmente, se refinó realizando el mismo trabajo sobre la muestra total de los 3.500 pacientes de ambos grupos hospitalarios.\n\n<BREAK>\n\nEsta Cátedra se creó en marzo del 2020 al inicio de la pandemia y su labor ha sido posible gracias a la coordinación del equipo de ProA Capital y de la Fundación Starlite y a las aportaciones realizadas por los mismos y por empresas de la órbita de ProA Capital, junto con el despacho de abogados Linklaters, las firmas de asesoramiento Arcano, Optima Corporate y otros empresarios y particulares como Cristina Oria o el Hotel Villa Magna.El objetivo de la Cátedra fue siempre práctico y de ahí la elaboración de una app gratuita que pueda servir como herramienta de diagnóstico predictivo para profesionales sanitarios.\n\n<BREAK>\n\nHerramienta En cuanto a la app, Ibermática ha sido la encargada del desarrollo de esta aplicación de uso gratuito vía web.\n\n<BREAK>\n\nLa app permite poner en práctica toda la capacidad predictiva del estudio a modo de “calculadora médica”.\n\n<BREAK>\n\nRecalcar que esta herramienta es de uso exclusivo por profesionales y sus conclusiones son sólo aplicables a pacientes ya infectados por Covid-19.",
        "TITLE": "Esta es la APP gratuita para el diagnóstico predictivo del riesgo en pacientes COVID-19 para sanitarios",
        "ID": "NF_04-11-2021_20-40-43_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Esta es la APP gratuita para el diagnóstico predictivo del riesgo en pacientes COVID-19 para sanitarios",
                "text_en": "This is the free APP for predictive risk diagnosis in patients COVID-19 for health care",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta es la APP gratuita para el diagnóstico predictivo del riesgo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This is free PPP for predictive risk diagnosis"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en pacientes COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in patients with COVID-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health services"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta es la APP gratuita para el diagnóstico predictivo del riesgo en pacientes COVID-19 para sanitarios.",
                "text_en": "This is the free APP for predictive risk diagnosis in patients COVID-19 for health care.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta es la APP gratuita para el diagnóstico predictivo del riesgo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This is free PPP for predictive risk diagnosis"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en pacientes COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in patients with COVID-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health services"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Bajo el liderazgo médico del profesor Melchor Álvarez de Mon y del matemático Ferran Mazaira, ProA Capital y la Fundación Starlite son los promotores de la Cátedra COVID19.Esta app es el resultado práctico del estudio publicado en el el Journal of Personalised Medicine (MDPI), una de las revistas médicas especializadas más prestigiosas del mundo, titulado “A Predictive Model and Risk Factors for Case Fatality of COVID-19”.",
                "text_en": "Under the medical leadership of Professor Melchor Álvarez de Mon and mathematician Ferran Mazaira, ProA Capital and the Starlite Foundation are the promoters of the COVID Chair.19 This app is the practical result of the study published in the Journal of Personalised Medicine (MDPI), one of the most prestigious specialized medical journals in the world, entitled “A Predictive Model and Risk Factors for Case Fatality of COVID-19”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "profesor Melchor Álvarez de Mon",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Professor Melchor Álvarez de Mon"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "matemático Ferran Mazaira",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mathematician Ferran Mazaira"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "ProA Capital y la Fundación Starlite",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ProA Capital and Starlite Foundation"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "son los promotores de la Cátedra COVID19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are the promoters of the COVID Chair19"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta app es el resultado práctico del estudio publicado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This app is the practical result of the published study"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el el Journal of Personalised Medicine",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Journal of Personalised Medicine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Cátedra ha elaborado este estudio a partir de una muestra de 2.000 pacientes de HM Hospitales y de otros 1.500 del UPA Hospital Universitario Príncipe de Asturias (asociado a la Universidad de Alcalá).Modelo PredictivoLo que este estudio analiza e identifica son las variables que determinan una evolución negativa (definida como acabar en la UCI o, peor aún, en fallecimiento) una vez el paciente se ha infectado por Covid-19.",
                "text_en": "The Chair has prepared this study from a sample of 2,000 patients from HM Hospitals and another 1,500 from the UPA University Hospital Príncipe de Asturias (associated with the University of Alcalá).Predictive ModelWhat this study analyzes and identifies are the variables that determine a negative evolution (defined as ending up in the ICU or, worse still, in death) once the patient has been infected by Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Cátedra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Chair"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha elaborado este estudio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has prepared this study"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a partir de una muestra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from a sample"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "2.000 pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "2,000 patients"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "HM Hospitales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "HM Hospitals"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "otros 1.500",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "another 1,500"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "del UPA Hospital Universitario Príncipe de Asturias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the UPA University Hospital Príncipe de Asturias"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para esto se han estudiado más de 60 variables en diferentes momentos de la infección de 3.500 pacientes de la primera oleada.",
                "text_en": "For this purpose, more than 60 variables have been studied at different times of infection of 3,500 patients in the first wave.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han estudiado más de 60 variables",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more than 60 variables have been studied"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en diferentes momentos de la infección",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at different times of infection"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "3.500 pacientes de la primera oleada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "3,500 first wave patients"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El análisis matemático-científico identifica y prioriza de manera precisa aquellas variables que más peso tienen en predecir la evolución del paciente.Más allá de una primera observación, la herramienta ayuda a los profesionales sanitarios a estimar con un alto grado de probabilidad el riesgo de ingreso en UCI o de muerte del paciente a partir de un simple análisis de sangre y obrar en consecuencia.",
                "text_en": "The mathematical-scientific analysis accurately identifies and prioritizes those variables that have the most weight in predicting the evolution of the patient.Beyond a first observation, the tool helps healthcare professionals to estimate with a high degree of probability the risk of admission to ICU or death of the patient from a simple blood test and act accordingly.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "identifica y prioriza de manera precisa aquellas variables que más peso tienen en predecir la evolución del paciente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "precisely identifies and prioritizes those variables that have the most weight in predicting the evolution of the patient"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los profesionales sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health professionals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estimar con un alto grado de probabilidad el riesgo de ingreso en UCI o de muerte",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "estimate with a high degree of probability the risk of admission to ICU or death"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en UCI",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in ICU"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "paciente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patient"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a partir de un simple análisis de sangre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from a simple blood test"
                    }
                ],
                "evidences": [
                    {
                        "value": "Beyond predicting specific outcomes, one should expect advances in the direction of predicting the entire temporal evolution of a patient. Techniques such as structured output prediction or latent embedding have been successfully used both in the ICU and elsewhere [16, 17] . This approach can be used for developing personalised patient management and treatment plans, based on the success on previous patients with similar prognosis.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9995779395
                    }
                ]
            },
            {
                "text": "Esta información puede ser de gran ayuda para tomar decisiones acertadas a tiempo.El estudio concluye con carácter científico (metodología de cohortes retrospectivas) y a partir del análisis de esa amplia muestra de pacientes, que las variables con mayor peso predictivo de la evolución de un paciente infectado son (entre paréntesis la relevancia de la variable en explicar la evolución):• Nivel de saturación de oxígeno en sangre (pulsiómetro): 20%• Edad: 18% • Ratio de linfocitos (sobre leucocitos): 14% • Nivel de proteína C-reactiva (es un marcador de la reacción inflamatoria): 13%• Comorbilidades o patologías previas del paciente: 13%• Número de leucocitos: 9% • Sexo (las mujeres presentan un menor riesgo de evolución negativa): 6,8%• Nivel de Dímero-D (otro potente marcador de la reacción inflamatoria): 6,2%2.000 pacientes de HM Hospitales en la primera ola de coronavirusEl estudio ha sido desarrollado gracias a los datos de 2.000 pacientes recogidos por HM Hospitales durante la primera ola.",
                "text_en": "This information can be of great help in making accurate decisions in time.The study concludes with a scientific character (retrospective cohort methodology) and from the analysis of this large sample of patients, that the variables with the highest predictive weight of the evolution of an infected patient are (in parentheses the relevance of the variable in explaining the evolution):• Level of oxygen saturation in blood (pulsiometer): 20%• Age: 18% • Lymphocyte ratio (on leukocytes): 14% • Level of C-reactive protein (is a marker of the inflammatory reaction): 13%• Comorbidities or previous pathologies of the patient: 13%• Number of leukocytes: 9%",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta información puede ser de gran ayuda para tomar decisiones acertadas a tiempo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This information can be of great help in making wise decisions in time"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El estudio ha sido desarrollado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The study has been developed"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "gracias a los datos de 2.000 pacientes recogidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thanks to data from 2,000 patients collected"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "HM Hospitales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "HM Hospitals"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante la primera ola",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the first wave"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El modelo resultante se testó contra los datos de otros 1.500 pacientes recogidos por el Hospital Príncipe de Asturias de Alcalá de Henares (también de la primera oleada) mostrando un 82% de grado de acierto (un grado muy elevado a nivel médico-científico).Finalmente, se refinó realizando el mismo trabajo sobre la muestra total de los 3.500 pacientes de ambos grupos hospitalarios.",
                "text_en": "The resulting model was tested against the data of another 1,500 patients collected by the Hospital Príncipe de Asturias de Alcalá de Henares (also from the first wave) showing an 82% degree of success (a very high degree at the medical-scientific level).Finally, the same work was refined on the total sample of 3,500 patients in both hospital groups.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El modelo resultante se testó contra los datos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The resulting model was tested against the data"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "otros 1.500 pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "1,500 other patients"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por el Hospital Príncipe de Asturias de Alcalá de Henares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the Hospital Príncipe de Asturias de Alcalá de Henares"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta Cátedra se creó en marzo del 2020 al inicio de la pandemia y su labor ha sido posible gracias a la coordinación del equipo de ProA Capital y de la Fundación Starlite y a las aportaciones realizadas por los mismos y por empresas de la órbita de ProA Capital, junto con el despacho de abogados Linklaters, las firmas de asesoramiento Arcano, Optima Corporate y otros empresarios y particulares como Cristina Oria o el Hotel Villa Magna.El objetivo de la Cátedra fue siempre práctico y de ahí la elaboración de una app gratuita que pueda servir como herramienta de diagnóstico predictivo para profesionales sanitarios.",
                "text_en": "This Chair was created in March 2020 at the beginning of the pandemic and its work has been made possible thanks to the coordination of the ProA Capital team and the Starlite Foundation and the contributions made by them and by companies of the ProA Capital orbit, together with the law firm Linklaters, Arcano consulting firms, Optima Corporate and other entrepreneurs and individuals such as Cristina Oria or Hotel Villa Magna.The objective of the Chair was always practical and hence the development of a free app that can serve as a predictive diagnostic tool for healthcare professionals.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta Cátedra se creó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This Chair was created"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en marzo del 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in March 2020"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "equipo de ProA Capital y de la Fundación Starlite",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ProA Capital and Starlite Foundation team"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Herramienta En cuanto a la app, Ibermática ha sido la encargada del desarrollo de esta aplicación de uso gratuito vía web.",
                "text_en": "Tool As for the app, Ibermatica has been responsible for the development of this application for free use via web.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ibermática",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ibermatic"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha sido la encargada del desarrollo de esta aplicación de uso gratuito",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has been in charge of the development of this application for free use"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "vía web",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "via web"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La app permite poner en práctica toda la capacidad predictiva del estudio a modo de “calculadora médica”.",
                "text_en": "The app allows you to implement all the predictive capacity of the study as a “medical calculator”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La app permite poner en práctica toda la capacidad predictiva del estudio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The app allows you to implement all the predictive capacity of the study"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a modo de “calculadora médica”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as a “medical calculator”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Recalcar que esta herramienta es de uso exclusivo por profesionales y sus conclusiones son sólo aplicables a pacientes ya infectados por Covid-19.",
                "text_en": "To stress that this tool is exclusively used by professionals and its conclusions are only applicable to patients already infected with Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esta herramienta es de uso exclusivo por profesionales y sus conclusiones son sólo aplicables",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this tool is for exclusive use by professionals and its conclusions are only applicable"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "profesionales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "professionals"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a pacientes ya infectados por Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients already infected with Covid-19"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "85": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 6,
            "WhatReliabilityReliable": 5,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 2,
            "WhoReliabilityReliable": 2,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 2,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nLos principios activos que contiene el organismo 'Aplidium albicans' han demostrado ser efectivos inhibiendo la replicación del coronavirus.\n\n<BREAK>\n\nLas profundidades marinas de Ibiza podrían tener la cura contra el coronavirus, pues allí había un minúsculo ser invertebrado del que se extraen los principios activos para la fabricación de medicamentos antitumorales y antivirales.\n\n<BREAK>\n\nAntena 3 Noticias se ha adentrado en los laboratorios de la empresa 'PharmaMar', encargada de investigar el organismo marino conocido como 'Aplidium albicans' y que se encuentra en las aguas de Ibiza y Formentera.\n\n<BREAK>\n\nA partir del principio activo plitidepsina, extraído de este invertebrado, nace el medicamento 'Aplidin', un medicamento antitumoral y antiviral que podría ser altamente efectivo en la lucha contra el coronavirus SARS-CoV-2, cuyos ensayos están actualmente en fase III.\n\n<BREAK>\n\nSantiago Bueno, jefe del departamento de Organismo Marinos de 'Pharmamar' ha indicado que \"el coronavirus necesita de una maquinaria como si de una fotocopiadora se tratase, y a través de la cual consigue multiplicarse y que avance la enfermedad\", por lo que la plitidepsina, principio activo que se extrae de este organismo marino, serviría para \"desenchufar esa fotocopiadora\", es decir, frenar la carga viral de la Covid-19.\n\n<BREAK>\n\nYa en 1988, un grupo de biólogos del Centre d’Estudis Avançats de Blanes (CEAB-CSIC) zarparon en el García del Cid, un buque de investigación oceanográfica del CSIC, para recoger organismos marinos de las Baleares y estudiarlos. \n\n<BREAK>\n\nFue en el marco de esa expedición, financiada por PharmaMar, cuando se encontraron, a 52 metros de profundidad, cerca de la isla de Ibiza, abundantes colonias de este pequeño organismo\n\n<BREAK>\n\nAunque este organismo marino puede hallarse en varias zonas del mundo, se cree que tiene sus orígenes en las aguas del mar Caribe y que llegó al Mediterráneo pegado a los barcos que conectaban Europa con América.",
        "TITLE": "Desarrollan un antiviral basado en un organismo marino hallado en Ibiza que podría curar el coronavirus",
        "ID": "10-Antena3",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Desarrollan un antiviral basado en un organismo marino hallado en Ibiza que podría curar el coronavirus",
                "text_en": "They develop an antiviral based on a marine organism found in Ibiza that could cure the coronavirus",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Desarrollan un antiviral basado en un organismo marino hallado en Ibiza que podría curar el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They develop an antiviral based on a marine organism found in Ibiza that could cure the coronavirus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Ibiza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Ibiza"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los principios activos que contiene el organismo 'Aplidium albicans' han demostrado ser efectivos inhibiendo la replicación del coronavirus.",
                "text_en": "The active substances contained in the organism 'Aplidium albicans' have been shown to be effective by inhibiting the replication of the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los principios activos que contiene el organismo 'Aplidium albicans' han demostrado ser efectivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The active substances contained in the organism 'Aplidium albicans' have been shown to be effective."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "inhibiendo la replicación del coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "inhibiting the replication of the coronavirus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las profundidades marinas de Ibiza podrían tener la cura contra el coronavirus, pues allí había un minúsculo ser invertebrado del que se extraen los principios activos para la fabricación de medicamentos antitumorales y antivirales.",
                "text_en": "The sea depths of Ibiza could have the cure against coronavirus, because there was a tiny invertebrate from which the active substances for the manufacture of antitumor and antiviral drugs are extracted.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Las profundidades marinas de Ibiza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The deep sea of Ibiza"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "podrían tener la cura contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "could have the cure against the coronavirus"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "había un minúsculo ser invertebrado del que se extraen los principios activos para la fabricación de medicamentos antitumorales y antivirales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there was a tiny invertebrate from which the active substances for the manufacture of antitumor and antiviral medicinal products were removed"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Antena 3 Noticias se ha adentrado en los laboratorios de la empresa 'PharmaMar', encargada de investigar el organismo marino conocido como 'Aplidium albicans' y que se encuentra en las aguas de Ibiza y Formentera.",
                "text_en": "Antena 3 News has entered the laboratories of the company 'PharmaMar', in charge of investigating the marine organism known as 'Aplidium albicans' and located in the waters of Ibiza and Formentera.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "empresa 'PharmaMar'",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "company 'PharmaMar'"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "encargada de investigar el organismo marino conocido como 'Aplidium albicans' y que se encuentra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in charge of investigating the marine organism known as 'Aplidium albicans' which is"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las aguas de Ibiza y Formentera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the waters of Ibiza and Formentera"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A partir del principio activo plitidepsina, extraído de este invertebrado, nace el medicamento 'Aplidin', un medicamento antitumoral y antiviral que podría ser altamente efectivo en la lucha contra el coronavirus SARS-CoV-2, cuyos ensayos están actualmente en fase III.",
                "text_en": "From the active substance plitidepsin, extracted from this invertebrate, is born the medicine 'Aplidin', an antitumor and antiviral medicine that could be highly effective in the fight against SARS-CoV-2 coronavirus, whose trials are currently in phase III.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "A partir del principio activo plitidepsina, extraído de este invertebrado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "From the active substance plitidepsin, extracted from this invertebrate"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nace el medicamento 'Aplidin', un medicamento antitumoral y antiviral que podría ser altamente efectivo en la lucha contra el coronavirus SARS-CoV-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is born the medicine 'Aplidin', an antitumor and antiviral medicine that could be highly effective in the fight against the coronavirus SARS-CoV-2"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Fue en el marco de esa expedición, financiada por PharmaMar, cuando se encontraron, a 52 metros de profundidad, cerca de la isla de Ibiza, abundantes colonias de este pequeño organismo",
                "text_en": "It was in the framework of this expedition, financed by PharmaMar, that they found, at 52 meters depth, near the island of Ibiza, abundant colonies of this small organism",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en el marco de esa expedición",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "within the framework of that expedition"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por PharmaMar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by PharmaMar"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a 52 metros de profundidad, cerca de la isla de Ibiza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "52 meters deep, near the island of Ibiza"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "abundantes colonias de este pequeño organismo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "abundant colonies of this small organism"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "86": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 17,
            "WhatReliabilityReliable": 17,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 5,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 4,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 2,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 5,
            "HowReliabilityReliable": 5,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 2,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nInvestigadores de la Universidad de Surrey, en Guildford, Reino Unido, desarrollaron un nuevo método para detectar la COVID-19.\n\n<BREAK>\n\nSe trata de una prueba de las secreciones de sebo, llamada prueba de frotis cutáneo o hisopado de sebo que utiliza un hisopo de piel, un método que, además de ser mínimamente invasivo, mostró diversas características que lo hacen sumamente atractivo para combatir la pandemia actual.\n\n<BREAK>\n\nAdemás, los resultados del test han mostrado ser muy precisos.Estudian el hisopado de sebo para detectar la COVID-19El equipo de investigadores publicó recientemente un artículo The Lancet, en donde explican cómo funciona esta prueba para detectar el virus.\n\n<BREAK>\n\nSu método utiliza hisopos de piel en lugar de emplear muestras de sangre o de moco y analiza el sebo, una sustancia producida por las glándulas sebáceas.\n\n<BREAK>\n\nEsta no es una prueba nueva, sino que se ha estudiado con anterioridad para la enfermedad de Parkinson y diabetes del tipo 1.Matt Spick, el autor principal del estudio, anunció que, mediante este trabajo, se mostró que los cambios en el lipidoma de la piel es un síntoma detectable de la enfermedad en sí y podrían tener implicaciones para la función de barrera de la piel.\n\n<BREAK>\n\nLa muestra, según esto, puede satisfacer ambas necesidades, pues observa lo que nos hace el virus, en lugar de detectar al virus en sí.Además, indicó que, desafortunadamente, la posibilidad de nuevas pandemias es un tema que se encuentra en la cima de la agenda de la comunidad científica mundial.\n\n<BREAK>\n\nY el estudio sugiere que es posible utilizar métodos no invasivos para detectar enfermedades como la COVID-19 en el futuro, un desarrollo que será bien recibido por todos.El hisopado de sebo es más eficaz y menos invasivoDesde hace mucho tiempo que los investigadores intentan mejorar las pruebas de COVID-19 existentes, pues estas tienen algunas limitaciones.\n\n<BREAK>\n\nLas pruebas de antígenos pueden ser poco sensibles, mientras que las moleculares demoran mucho tiempo.\n\n<BREAK>\n\nPero la prueba de hisopado de sebo no cuenta con ninguna de estas desventajas.En el desarrollo de los test para coronavirus, se ha priorizado el objetivo de que los métodos de prueba fueran mínimamente invasivos.\n\n<BREAK>\n\nCuanto menos dolorosos y más sencillos de hacer sean, más posibilidades existen de que las personas se sometan a las pruebas.Esto, sumado a los resultados extremadamente precisos de las pruebas de hisopado de sebo, contribuiría a reducir la propagación del virus.Deja tus comentarios y opiniones sobre esta posible nueva prueba para la COVID-19.\n\n<BREAK>\n\nComparte en tus redes, informa a tus amigos y transmite esta buena noticia: probablemente, pronto podamos contar con un test más efectivo y menos invasivo.",
        "TITLE": "Hisopos de piel podrían ser las nuevas pruebas para coronavirus",
        "ID": "NF_04-11-2021_21-44-27_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Hisopos de piel podrían ser las nuevas pruebas para coronavirus",
                "text_en": "Skin swabs could be the new tests for coronavirus",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Hisopos de piel podrían ser las nuevas pruebas para coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Skin swabs could be the new tests for coronavirus"
                    }
                ],
                "evidences": [
                    {
                        "value": "The pandemic associated with the severe acute respiratory coronavirus type 2 (SARS-CoV-2) has spread around the globe with massive impact on humankind. By now, coronavirus disease 2019 has infected and killed millions (https://covid19.who. int/). Thanks to the tremendous efforts of the global scientific community, the virus has been extensively investigated, and new tests for pathogen detection and potential treatments have been rapidly developed (Wiersinga et al, 2020) .",
                        "score": 0.5099999905
                    },
                    {
                        "value": "The pandemic associated with the severe acute respiratory coronavirus type 2 (SARS-CoV-2) has spread around the globe with massive impact on mankind. By now, coronavirus disease 2019 (COVID-19) has infected and killed millions (https://covid19.who.int/). Thanks to the tremendous efforts of the global scientific community, the virus has been extensively investigated and new tests for pathogen detection and potential treatments have been rapidly developed (Wiersinga et al., 2020) .",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9980081916
                    },
                    {
                        "label": "neutral",
                        "score": 0.9969909191
                    }
                ]
            },
            {
                "text": "Investigadores de la Universidad de Surrey, en Guildford, Reino Unido, desarrollaron un nuevo método para detectar la COVID-19.",
                "text_en": "Researchers at the University of Surrey, Guildford, UK, developed a new method for detecting COVID-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Investigadores de la Universidad de Surrey",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Researchers at the University of Surrey"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Guildford, Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Guildford, United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desarrollaron un nuevo método para detectar la COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "developed a new method for detecting COVID-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se trata de una prueba de las secreciones de sebo, llamada prueba de frotis cutáneo o hisopado de sebo que utiliza un hisopo de piel, un método que, además de ser mínimamente invasivo, mostró diversas características que lo hacen sumamente atractivo para combatir la pandemia actual.",
                "text_en": "This is a test of sebum secretions, called a skin smear or sebum hyssop test, which uses a skin swab, a method that, in addition to being minimally invasive, showed various characteristics that make it extremely attractive to combat the current pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Se trata de una prueba de las secreciones de sebo, llamada prueba de frotis cutáneo o hisopado de sebo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This is a test of sebum secretions, called a skin smear or sebum swab test."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "utiliza un hisopo de piel",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "uses a skin swab"
                    }
                ],
                "evidences": [
                    {
                        "value": "Studies have demonstrated that some cutaneous biophysical properties vary with the part of the body. The results to date of skin conditions in human skin of multiple parts of the body have not yet been well established. In this study, we assessed the differences in the skin's sebum, moisture, pores, wrinkles, pigmentation, and elasticity of each body part in Korean men in their 20s. A total of healthy 32 men were enrolled. A Skin Diagnosis Meter was used to measure the skin's surface sebum, moisture, pores, wrinkles, pigmentation, and elasticity of each body part. The sebum content was significantly higher on the face than at other sites. Moisture was significantly high on the feet. Pores were significantly high on the face. Wrinkles were significantly high on the face. Pigmentation was high on the face and neck, but not significantly. Elasticity was significantly high on the hands. For nearly the first time, this study resulted in systematic reference values for standardized biophysical measuring methods and body parts reflecting the skin physiology of men. The results show that skin's surface sebum, moisture, pores, wrinkles, pigmentation, and elasticity vary with the part of the body.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9913314581
                    }
                ]
            },
            {
                "text": "Además, los resultados del test han mostrado ser muy precisos.Estudian el hisopado de sebo para detectar la COVID-19El equipo de investigadores publicó recientemente un artículo The Lancet, en donde explican cómo funciona esta prueba para detectar el virus.",
                "text_en": "In addition, the results of the test have been shown to be very accurate.They study sebum hyssoping to detect COVID-19The team of researchers recently published an article The Lancet, which explains how this test works to detect the virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los resultados del test han mostrado ser muy precisos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the results of the test have been shown to be very precise"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El equipo de investigadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The team of researchers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "publicó recientemente un artículo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recently published an article"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "The Lancet",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Lancet"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Su método utiliza hisopos de piel en lugar de emplear muestras de sangre o de moco y analiza el sebo, una sustancia producida por las glándulas sebáceas.",
                "text_en": "Its method uses skin swabs instead of using blood or mucus samples and analyzes the sebum, a substance produced by the sebaceous glands.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Su método utiliza hisopos de piel",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Your method uses skin swabs"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "analiza el sebo, una sustancia producida por las glándulas sebáceas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "analyzes sebum, a substance produced by the sebaceous glands"
                    }
                ],
                "evidences": [
                    {
                        "value": "Human blood and skin swabs were obtained from Dr. Chun-Ming Huang with an approved protocol (no. 121230) (Wang et al., 2018) by the institutional review board at University of California, San Diego (UCSD).",
                        "score": 0.5500000119
                    },
                    {
                        "value": "Approaches that measure the indirect effect of the virus on the host (as opposed to direct measurement of the virus itself) may offer a complementary solution in clinical or mass testing settings; for example, one feasibility study has recently identified derangement of breath biochemistry in COVID-19 patients [6] . As the coronavirus requires lipids for reproduction, COVID-19 can be expected to disrupt the lipidome [7] . Evidence of a dysregulated lipidome has been observed in patients with COVID-19; triglyceride levels have been found to be significantly increased in the serum and plasma of COVID-19 patients, alongside changes in lipoprotein particle size and distribution. This has been characterised as pathogenic in nature and consistent with increased atherosclerotic risk; [8, 9] lipidomics therefore offers a promising route to better understanding of -and potentially diagnosis for -COVID-19. Sebum is a biofluid secreted by the sebaceous glands and is rich in lipids. A sample can be collected easily and non-invasively via a gentle swab of skin areas rich in sebum (for example the face, neck or back). Characteristic features have previously been identified from sebum for a limited number of conditions such as Parkinson's Disease and Type 1 Diabetes Mellitus; [10, 11, 12] sebum changes have also been reported in pregnancy [13] . In addition, whilst the mechanisms for the role of sebum in barrier function are not fully described, sebum lipids provide this function directly and also through commensal bacteria interactions; lipid dysregulation would have implications for skin health [14] . In this work, we explore differences in sebum lipid profiles for patients with and without COVID-19, with a view to exploring sebum's future use as a non-invasive sampling medium, as well as expanding the understanding of sebum as a sampling matrix.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9991882443
                    },
                    {
                        "label": "neutral",
                        "score": 0.8601112366
                    }
                ]
            },
            {
                "text": "Esta no es una prueba nueva, sino que se ha estudiado con anterioridad para la enfermedad de Parkinson y diabetes del tipo 1.Matt Spick, el autor principal del estudio, anunció que, mediante este trabajo, se mostró que los cambios en el lipidoma de la piel es un síntoma detectable de la enfermedad en sí y podrían tener implicaciones para la función de barrera de la piel.",
                "text_en": "This is not a new test, but has been previously studied for Parkinson’s disease and type 1 diabetes. Matt Spick, the lead author of the study, announced that, through this paper, it was shown that changes in skin lipidoma is a detectable symptom of the disease itself and could have implications for the barrier function of the skin.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha estudiado con anterioridad para la enfermedad de Parkinson y diabetes del tipo 1",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has previously been studied for Parkinson’ s disease and type 1 diabetes"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "con anterioridad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "earlier"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Matt Spick, el autor principal del estudio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Matt Spick, the lead author of the study"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "mediante este trabajo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "through this work"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se mostró que los cambios en el lipidoma de la piel es un síntoma detectable de la enfermedad en sí",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "changes in skin lipidoma are shown to be a detectable symptom of the disease itself"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La muestra, según esto, puede satisfacer ambas necesidades, pues observa lo que nos hace el virus, en lugar de detectar al virus en sí.Además, indicó que, desafortunadamente, la posibilidad de nuevas pandemias es un tema que se encuentra en la cima de la agenda de la comunidad científica mundial.",
                "text_en": "The sample, according to this, can satisfy both needs, because it observes what the virus does to us, rather than detecting the virus itself.In addition, it indicated that, unfortunately, the possibility of new pandemics is a topic that is at the top of the agenda of the world scientific community.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La muestra, según esto, puede satisfacer ambas necesidades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The sample, according to this, can meet both needs"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "pues observa lo que nos hace el virus, en lugar de detectar al virus en sí.",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "See what the virus does to us, instead of detecting the virus itself."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y el estudio sugiere que es posible utilizar métodos no invasivos para detectar enfermedades como la COVID-19 en el futuro, un desarrollo que será bien recibido por todos.El hisopado de sebo es más eficaz y menos invasivoDesde hace mucho tiempo que los investigadores intentan mejorar las pruebas de COVID-19 existentes, pues estas tienen algunas limitaciones.",
                "text_en": "And the study suggests that it is possible to use non-invasive methods to detect diseases such as COVID-19 in the future, a development that will be well received by all.Sebum hyssopping is more effective and less invasiveFor a long time, researchers have been trying to improve existing COVID-19 tests, as these have some limitations.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el estudio sugiere que es posible utilizar métodos no invasivos para detectar enfermedades como la COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the study suggests that it is possible to use non-invasive methods to detect diseases such as COVID-19"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en el futuro",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the future"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El hisopado de sebo es más eficaz y menos invasivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sebum hyssopping is more effective and less invasive"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Desde hace mucho tiempo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "For a long time"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los investigadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "researchers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "intentan mejorar las pruebas de COVID-19 existentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "try to improve existing COVID-19 tests"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "pues estas tienen algunas limitaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for these have some limitations"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las pruebas de antígenos pueden ser poco sensibles, mientras que las moleculares demoran mucho tiempo.",
                "text_en": "Antigen testing can be unsensitive, while molecular testing takes a long time.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las pruebas de antígenos pueden ser poco sensibles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Antigen tests can be unsensitive."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero la prueba de hisopado de sebo no cuenta con ninguna de estas desventajas.En el desarrollo de los test para coronavirus, se ha priorizado el objetivo de que los métodos de prueba fueran mínimamente invasivos.",
                "text_en": "But the sebum hysoping test does not have any of these disadvantages.In the development of the coronavirus tests, the goal of minimally invasive testing methods has been prioritized.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la prueba de hisopado de sebo no cuenta con ninguna de estas desventajas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the sebum hyssoping test does not have any of these disadvantages"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha priorizado el objetivo de que los métodos de prueba fueran",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "priority has been given to the objective that the test methods should be"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "mínimamente invasivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "minimally invasive"
                    }
                ],
                "evidences": [
                    {
                        "value": "Mirror, \"16,000 coronavirus tests went missing because of Excel spreadsheet blunder,\" 2020, https://www.mirror.co.uk/news/politics/16000-coronavirus-tests-wentmissing-22794820 (accessed: Nov 13, 2020). . Delays in getting results for the thousands of coronavirus tests commissioned daily could hinder efforts to track the number of coronavirus tests performed nationwide and the spread of the disease, warned HHS Secretary Alex Azar, in the face of criticisms of the medical system's antiquated tracking systems, which is expected to reduce some healthcare providers to faxes or phone calls to report data. Brian Dixon of the Regenstrief Institute health research organisation complains that \"there is no infrastructure in the USA for tracking the number of tests ordered for just about anything,\" and even if communications are sorted out between labs and doctors, gaps will remain with public health agencies [18] , which have completely different pipelines, governance and reporting rules.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9987302423
                    }
                ]
            },
            {
                "text": "Cuanto menos dolorosos y más sencillos de hacer sean, más posibilidades existen de que las personas se sometan a las pruebas.Esto, sumado a los resultados extremadamente precisos de las pruebas de hisopado de sebo, contribuiría a reducir la propagación del virus.Deja tus comentarios y opiniones sobre esta posible nueva prueba para la COVID-19.",
                "text_en": "The less painful and easier to do, the more likely people are to be tested.This, along with the extremely accurate results of the sebum swab tests, would help reduce the spread of the virus.Leave your comments and opinions on this possible new test for COVID-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Cuanto menos dolorosos y más sencillos de hacer sean",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The less painful and the easier they are to do"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "más posibilidades existen de que las personas se sometan a las pruebas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there are more possibilities for people to be tested"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Comparte en tus redes, informa a tus amigos y transmite esta buena noticia: probablemente, pronto podamos contar con un test más efectivo y menos invasivo.",
                "text_en": "Share on your networks, inform your friends and share this good news: we will probably soon be able to count on a more effective and less invasive test.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "pronto",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Soon"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "podamos contar con un test más efectivo y menos invasivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We can count on a more effective and less invasive test"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "87": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 9,
            "WhatReliabilityReliable": 0,
            "WhatReliabilityUnreliable": 9,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 11,
            "WhoReliabilityReliable": 8,
            "WhoReliabilityUnreliable": 3,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 1,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 5,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 3,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 7,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nParece que, por suerte, no todos los médicos que hay en España son como el televisivo doctor César Carballo y tienen más en cuenta el juramento hipocrático que realizaron al final su carrera, de lo que lo tienen doctores como Carballo más interesados en la fama y el dinero que en preocuparse por el futuro de sus pacientes.\n\n<PARAGRAPH>\n\nHoy tenemos noticia de una doctora de Urgencias del Hospital Mateu Orfila de Menorca, Nadiya Popel, quien afirma, en una entrevista concedida a ‘Menorca Info‘, estar tremendamente preocupada por los efectos secundarios de la vacuna de AstraZeneca ya que afirma que en el último mes ha atendido a 19 personas con diferentes dolencias tras serles administrada esta vacuna.\n\n<PARAGRAPH>\n\nPopel afirma en esa entrevista que no pretende “crear polémica, ni criticar, ni enfrentarme a nadie, pero creo que es necesario dar información a la gente para que reflexione y decida”.\n\n<BREAK>\n\nAdemás añade, entre otras cosas, no entender “entonces qué sentido tiene vacunar a la gente cuando no hay ningún caso si hacerlo puede provocar efectos secundarios relacionados con AstraZeneca”.\n\n<PARAGRAPH>\n\nAdemás de relatar los efectos secundarios que está viendo provocados por esa vacuna, Popel afirma estar afligida por el sufrimiento del ser humano que está viendo en su hospital.\n\n<PARAGRAPH>\n\n¿Se dan cuenta de lo diferente que sería todo si hubiera más doctores valientes que contaran sus experiencias y lo que están viendo a causa de las vacunas y menos Carballo o Margarita del Val? ¿Se dan cuenta la falta de información que estamos teniendo y que, a pesar de ello, hay mucha gente que está tomando la peligrosa decisión de vacunarse porque se le está incitando a ello desde las televisiones como si fueran un martillo pilón? Busquen información antes de tomar decisiones tan arriesgadas.\n\n<PARAGRAPH>\n\nCOLABORA CON NOSOTROS CON PAYPAL\n\n<PARAGRAPH>\n\n",
        "TITLE": "Una valiente doctora de Urgencias alza la voz: “Qué sentido tiene vacunar a la gente cuando no hay ningún caso si hacerlo puede provocar efectos secundarios”",
        "ID": "NF_04-11-2021_21-41-51_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Una valiente doctora de Urgencias alza la voz: “Qué sentido tiene vacunar a la gente cuando no hay ningún caso si hacerlo puede provocar efectos secundarios”",
                "text_en": "A courageous ER doctor raises her voice: “What’s the point of vaccinating people when there’s no case if doing so can cause side effects”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Una valiente doctora de Urgencias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "A brave ER doctor."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "alza la voz",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Raise your voice"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vacunar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "vaccination"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the people"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando no hay ningún caso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "when there is no case"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Parece que, por suerte, no todos los médicos que hay en España son como el televisivo doctor César Carballo y tienen más en cuenta el juramento hipocrático que realizaron al final su carrera, de lo que lo tienen doctores como Carballo más interesados en la fama y el dinero que en preocuparse por el futuro de sus pacientes.",
                "text_en": "It seems that, fortunately, not all the doctors in Spain are like the television doctor César Carballo and take more into account the Hippocratic oath they took at the end of their career, than they have doctors like Carballo more interested in fame and money than in worrying about the future of their patients.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no todos los médicos que hay en España son como el televisivo doctor César Carballo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Not all the doctors in Spain are like the television doctor César Carballo"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "doctor César Carballo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr. César Carballo"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hoy tenemos noticia de una doctora de Urgencias del Hospital Mateu Orfila de Menorca, Nadiya Popel, quien afirma, en una entrevista concedida a ‘Menorca Info‘, estar tremendamente preocupada por los efectos secundarios de la vacuna de AstraZeneca ya que afirma que en el último mes ha atendido a 19 personas con diferentes dolencias tras serles administrada esta vacuna.",
                "text_en": "Today we have news of an ER doctor from the Mateu Orfila Hospital in Menorca, Nadiya Popel, who claims, in an interview with ‘Menorca Info‘, to be tremendously concerned about the side effects of the AstraZeneca vaccine because she claims that in the last month she has treated 19 people with different ailments after being given this vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una doctora de Urgencias del Hospital Mateu Orfila de Menorca, Nadiya Popel",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "an ER doctor from the Mateu Orfila Hospital in Menorca, Nadiya Popel"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Hospital Mateu Orfila de Menorca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mateu Orfila de Menorca Hospital"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una entrevista concedida a ‘Menorca Info‘",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an interview with ‘Menorca Info‘"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estar tremendamente preocupada por los efectos secundarios de la vacuna de AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "be extremely concerned about the side effects of the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que afirma que en el último mes ha atendido a 19 personas con diferentes dolencias tras serles administrada esta vacuna",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "since he claims that in the last month he has treated 19 people with different ailments after being given this vaccine"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en el último mes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last month"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a 19 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "19 persons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Popel afirma en esa entrevista que no pretende “crear polémica, ni criticar, ni enfrentarme a nadie, pero creo que es necesario dar información a la gente para que reflexione y decida”.",
                "text_en": "Popel states in that interview that he does not intend to “create controversy, criticize, or confront anyone, but I think it is necessary to give information to people to reflect and decide.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Popel",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Popel"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en esa entrevista",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in that interview"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "creo que es necesario dar información a la gente para que reflexione y decida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "I think it's necessary to give information to people to reflect and decide."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the people"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además añade, entre otras cosas, no entender “entonces qué sentido tiene vacunar a la gente cuando no hay ningún caso si hacerlo puede provocar efectos secundarios relacionados con AstraZeneca”.",
                "text_en": "He adds, among other things, that he does not understand “then what’s the point of vaccinating people when there is no case if doing so can cause side effects related to AstraZeneca.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no entender “entonces qué sentido tiene vacunar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "not understand “then what’s the point of vaccinating"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the people"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando no hay ningún caso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "when there is no case"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "puede provocar efectos secundarios relacionados con AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "may cause side effects related to AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además de relatar los efectos secundarios que está viendo provocados por esa vacuna, Popel afirma estar afligida por el sufrimiento del ser humano que está viendo en su hospital.",
                "text_en": "In addition to reporting the side effects he is seeing caused by this vaccine, Popel claims to be afflicted by the suffering of the human being he is seeing in his hospital.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Popel",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Popel"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "afirma estar afligida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "claims to be distressed"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por el sufrimiento del ser humano que está viendo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the suffering of the human being you are seeing"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su hospital",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in your hospital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Se dan cuenta de lo diferente que sería todo si hubiera más doctores valientes que contaran sus experiencias y lo que están viendo a causa de las vacunas y menos Carballo o Margarita del Val? ¿Se dan cuenta la falta de información que estamos teniendo y que, a pesar de ello, hay mucha gente que está tomando la peligrosa decisión de vacunarse porque se le está incitando a ello desde las televisiones como si fueran un martillo pilón? Busquen información antes de tomar decisiones tan arriesgadas.",
                "text_en": "Do you realize how different it would be if there were more courageous doctors to tell about your experiences and what you are seeing because of the vaccines and less Carballo or Margarita del Val? Do you realize the lack of information we are having and that, despite this, there are many people who are making the dangerous decision to get vaccinated because they are being encouraged to do so from the television stations as if they were a pylon hammer? Look for information before making such risky decisions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "si hubiera más doctores valientes que contaran sus experiencias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "if there were more brave doctors to tell their experiences"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "doctores valientes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Brave doctors"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "hay mucha gente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "There's a lot of people."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "que está tomando la peligrosa decisión de vacunarse",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "who is making the dangerous decision to get vaccinated"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque se le está incitando a ello",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because he is being encouraged to do so."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "88": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 8,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 12,
            "WhoReliabilityReliable": 12,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 4,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLetizia asiste la reunión de trabajo de la Federación de Enfermedades Raras en la que se han analizado los efectos de la pandemia en los afectados\n\n<PARAGRAPH>\n\nDesde hace varios años, la lucha de las familias y afectados por las llamadas enfermedades raras es una de las causas que abandera la reina Letizia.\n\n<BREAK>\n\nEste miércoles, ha vuelto a dar visibilidad a este colectivo con su asistencia a la reunión de la La Federación Española de Enfermedades Raras (FEDER) donde se ha puesto sobre la mesa los problemas de los enfermos a quienes la pandemia ha agravado su situación y, también, ha supuesto una ralentización en las investigaciones.\n\n<BREAK>\n\nEn el curso de la reunión, la Reina se ha interesado por el proceso de suministración de vacunas a los afectados y por los problemas en la asistencia hospitalaria debido a la saturación de los centros sanitarios.\n\n<BREAK>\n\nLa Reina mantuvo un encuentro en septiembre del pasado año, en el que conoció los primeros datos sobre el impacto de la covid en las familias que conviven con estas patología.\n\n<PARAGRAPH>\n\nLa FEDER se creó en 1990 por iniciativa de padres y familiares de niños afectados y, a lo largo de estos más de 20 años, han pasado de ser siete a más de 370 las entidades y asociaciones que han aunado esfuerzos.\n\n<BREAK>\n\nJuntos, representan a más de 1.300 patologías y a casi 97.000 personas, la mayoría niños y adolescentes dado que la mayor parte de los enfermos no alcanza la edad adulta.  La federación y en eso ha tenido mucho que ver el compromiso y presencia de la Reina está actualmente aliada con otras asociaciones de afectados en todo el mundo principalmente a las alianzas europea e iberoamericana (EURORDIS y ALIBER, respectivamente) y la Red Internacional de Enfermedades Raras (RDI).\n\n<PARAGRAPH>\n",
        "TITLE": "La Reina se interesa por el impacto de la covid en las enfermedades raras",
        "ID": "F_04-11-2021_20-49-33_www_lavanguardia_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La Reina se interesa por el impacto de la covid en las enfermedades raras",
                "text_en": "The Queen is interested in the impact of covid on rare diseases",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Reina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Queen"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se interesa por el impacto de la covid en las enfermedades raras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is interested in the impact of covid on rare diseases"
                    }
                ],
                "evidences": [
                    {
                        "value": "This research studied the impact on health and psychological wellbeing in patients with rare diseases during the COVID-19 pandemic. More specifically, it focused on the evaluation of the degree of anxiety and/or depression that patients with rare diseases may have experienced during the pandemic. Patients with rare diseases are patients with high requirements of healthcare; however, throughout the pandemic, access to healthcare services has been limited and, in many cases, non-existent [18] .",
                        "score": 0.5199999809
                    },
                    {
                        "value": "The impact of the COVID-19 pandemic on rare disease communities is asymmetrical in different contexts. While even in a \"normal\" world, they often face isolation and anxiety due to their uncertain condition and must navigate through several clinicians to obtain the care they need, the additional anxiety due to COVID-19, triggered by the worldwide emergency health protocol and the loaded pressure on health systems, research, development, and the pharma industry, has made the challenges more extravagant than ever. While facing the current challenges, it is essential to keep in mind that access to therapies and continued government and private funding of drug development, translational research, and basic research is crucial to saving rare disease patients' lives. The COVID-19 pandemic experience regarding health emergencies and rare disease management represents the basis for establishing healthcare policies to ensure preparedness for providing adequate care for people with rare diseases.",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9968762398
                    },
                    {
                        "label": "neutral",
                        "score": 0.985896647
                    }
                ]
            },
            {
                "text": "Letizia asiste la reunión de trabajo de la Federación de Enfermedades Raras en la que se han analizado los efectos de la pandemia en los afectados",
                "text_en": "Letizia attends the working meeting of the Federation of Rare Diseases at which the effects of the pandemic on those affected have been analyzed",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Letizia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Letizia"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la reunión de trabajo de la Federación de Enfermedades Raras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the working meeting of the Federation of Rare Diseases"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han analizado los efectos de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the impact of the pandemic has been analysed"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los afectados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "affected persons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desde hace varios años, la lucha de las familias y afectados por las llamadas enfermedades raras es una de las causas que abandera la reina Letizia.",
                "text_en": "For several years now, the struggle of families and affected by so-called rare diseases has been one of the causes of Queen Letizia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Desde hace varios años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For several years"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la lucha de las familias y afectados por las llamadas enfermedades raras es una de las causas que abandera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the struggle of families and affected by the so-called rare diseases is one of the causes that"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la reina Letizia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Queen Letizia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este miércoles, ha vuelto a dar visibilidad a este colectivo con su asistencia a la reunión de la La Federación Española de Enfermedades Raras (FEDER) donde se ha puesto sobre la mesa los problemas de los enfermos a quienes la pandemia ha agravado su situación y, también, ha supuesto una ralentización en las investigaciones.",
                "text_en": "This Wednesday, he returned to give visibility to this collective with his attendance at the meeting of the Spanish Federation of Rare Diseases (FEDER) where the problems of the sick have been put on the table to whom the pandemic has aggravated their situation and, also, has led to a slowdown in the investigations.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Este miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This Wednesday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha vuelto a dar visibilidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has returned to give visibility"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a este colectivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to this collective"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con su asistencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with your assistance"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a la reunión de la La Federación Española de Enfermedades Raras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the meeting of the Spanish Federation of Rare Diseases"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el curso de la reunión, la Reina se ha interesado por el proceso de suministración de vacunas a los afectados y por los problemas en la asistencia hospitalaria debido a la saturación de los centros sanitarios.",
                "text_en": "In the course of the meeting, the Queen has been interested in the process of providing vaccinations to those affected and in the problems in hospital care due to the saturation of health centres.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En el curso de la reunión",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "During the meeting"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Reina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Queen"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha interesado por el proceso de suministración de vacunas a los afectados y por los problemas en la asistencia hospitalaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "interested in the process of providing vaccines to those affected and problems in hospital care"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los afectados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to those affected"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "debido a la saturación de los centros sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to saturation of health facilities"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Reina mantuvo un encuentro en septiembre del pasado año, en el que conoció los primeros datos sobre el impacto de la covid en las familias que conviven con estas patología.",
                "text_en": "The Queen held a meeting in September last year, in which she learned the first data on the impact of covid on families living with these diseases.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Reina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Queen"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en septiembre del pasado año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in September of last year"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "conoció los primeros datos sobre el impacto de la covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "first data on the impact of covid"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en las familias que conviven con estas patología",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in families living with these pathologies"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La FEDER se creó en 1990 por iniciativa de padres y familiares de niños afectados y, a lo largo de estos más de 20 años, han pasado de ser siete a más de 370 las entidades y asociaciones que han aunado esfuerzos.",
                "text_en": "The ERDF was established in 1990 on the initiative of parents and family members of affected children and, over these more than 20 years, it has grown from seven to more than 370 entities and associations that have joined forces.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La FEDER",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The ERDF"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se creó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was created"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en 1990",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in 1990"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por iniciativa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by initiative"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "padres y familiares de niños afectados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "parents and family members of affected children"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Juntos, representan a más de 1.300 patologías y a casi 97.000 personas, la mayoría niños y adolescentes dado que la mayor parte de los enfermos no alcanza la edad adulta.  La federación y en eso ha tenido mucho que ver el compromiso y presencia de la Reina está actualmente aliada con otras asociaciones de afectados en todo el mundo principalmente a las alianzas europea e iberoamericana (EURORDIS y ALIBER, respectivamente) y la Red Internacional de Enfermedades Raras (RDI).",
                "text_en": "Together, they represent more than 1,300 pathologies and almost 97,000 people, most of them children and adolescents, since most of the sick do not reach adulthood. The federation and in this has had much to do with the Queen’s commitment and presence is currently allied with other affected associations around the world, mainly with the European and Ibero-American alliances (EURORDIS and ALIBER, respectively) and the International Network of Rare Diseases (RDI).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "representan a más de 1.300 patologías y a casi 97.000 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "represent more than 1,300 pathologies and almost 97,000 people"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la mayoría niños y adolescentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "most children and adolescents"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "dado que la mayor parte de los enfermos no alcanza la edad adulta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since most of the sick do not reach adulthood"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "89": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 7,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 11,
            "WhoReliabilityReliable": 11,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 1,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 3,
            "WhoRoleTarget": 7,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 8,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nPfizer y BioNTech han solicitado este viernes a las autoridades reguladoras estadounidenses que amplíen la Autorización de Uso de Emergencia (EUA, por sus siglas en inglés) de su vacuna contra la Covid-19 para ampliar el uso en adolescentes de 12 a 15 años.\n\n<PARAGRAPH>\n\nSegún han informado en un comunicado, las compañías tienen previsto solicitar resoluciones similares a otras autoridades reguladoras de todo el mundo en los próximos días, como la Agencia Europea del Medicamento (EMA, por sus siglas en inglés).\n\n<PARAGRAPH>\n\nEstas solicitudes se basan en los datos del ensayo pivotal de fase 3 en adolescentes de 12 a 15 años de edad con o sin evidencia previa de infección por SARS-CoV-2, que demostró una eficacia del 100% y una sólida respuesta de anticuerpos tras la vacunación con la vacuna contra la Covid-19.\n\n<PARAGRAPH>\n\nEn este análisis, la vacuna fue bien tolerada con efectos secundarios generalmente consistentes con los observados en participantes de 16 a 25 años de edad. \n\n<PARAGRAPH>\n\nTodos los participantes en el ensayo seguirán siendo controlados en cuanto a la protección y seguridad a largo plazo durante dos años más después de su segunda dosis.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Pfizer y BioNTech solicitan en Estados Unidos que su vacuna se apruebe en adolescentes de 12 a 15 años",
        "ID": "F_04-11-2021_21-05-39_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Pfizer y BioNTech solicitan en Estados Unidos que su vacuna se apruebe en adolescentes de 12 a 15 años",
                "text_en": "Pfizer and BioNTech request in the United States that their vaccine be approved in adolescents aged 12 to 15 years",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer y BioNTech",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer and BioNTech"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "solicitan en Estados Unidos que su vacuna se apruebe",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "request in the United States that your vaccine be approved"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Estados Unidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Restaurantes campestres en Estados Unidos"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en adolescentes de 12 a 15 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in adolescents aged 12 to 15 years"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pfizer y BioNTech han solicitado este viernes a las autoridades reguladoras estadounidenses que amplíen la Autorización de Uso de Emergencia (EUA, por sus siglas en inglés) de su vacuna contra la Covid-19 para ampliar el uso en adolescentes de 12 a 15 años.",
                "text_en": "Pfizer and BioNTech have asked US regulatory authorities this Friday to extend the Emergency Use Authorisation (EUA) of their Covid-19 vaccine to expand use in adolescents aged 12 to 15.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer y BioNTech",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer and BioNTech"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Friday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las autoridades reguladoras estadounidenses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the US regulatory authorities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "amplíen la Autorización de Uso de Emergencia (EUA, por sus siglas en inglés) de su vacuna contra la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "expand the Emergency Use Authorization (EUA) of your Covid-19 vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en adolescentes de 12 a 15 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in adolescents aged 12 to 15 years"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según han informado en un comunicado, las compañías tienen previsto solicitar resoluciones similares a otras autoridades reguladoras de todo el mundo en los próximos días, como la Agencia Europea del Medicamento (EMA, por sus siglas en inglés).",
                "text_en": "As reported in a statement, companies plan to request similar resolutions from other regulatory authorities around the world in the coming days, such as the European Medicines Agency (EMA).",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un comunicado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in a statement"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las compañías",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "companies"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tienen previsto solicitar resoluciones similares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "plan to request similar resolutions"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a otras autoridades reguladoras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "other regulatory authorities"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de todo el mundo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from all over the world"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los próximos días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the next few days"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estas solicitudes se basan en los datos del ensayo pivotal de fase 3 en adolescentes de 12 a 15 años de edad con o sin evidencia previa de infección por SARS-CoV-2, que demostró una eficacia del 100% y una sólida respuesta de anticuerpos tras la vacunación con la vacuna contra la Covid-19.",
                "text_en": "These applications are based on data from the pivotal phase 3 trial in adolescents aged 12 to 15 years with or without previous evidence of SARS-CoV-2 infection, which demonstrated 100% efficacy and a solid antibody response after vaccination with the Covid-19 vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estas solicitudes se basan en los datos del ensayo pivotal de fase 3",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "These requests are based on data from the pivotal phase 3 test."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en adolescentes de 12 a 15 años de edad con o sin evidencia previa de infección por SARS-CoV-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in adolescents aged 12 to 15 years with or without previous evidence of SARS-CoV-2 infection"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "demostró una eficacia del 100% y una sólida respuesta de anticuerpos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "demonstrated 100% efficacy and a strong antibody response"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras la vacunación con la vacuna contra la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after vaccination with Covid-19 vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En este análisis, la vacuna fue bien tolerada con efectos secundarios generalmente consistentes con los observados en participantes de 16 a 25 años de edad. ",
                "text_en": "In this analysis, the vaccine was well tolerated with side effects generally consistent with those observed in participants between 16 and 25 years of age.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la vacuna fue bien tolerada con efectos secundarios generalmente consistentes con los observados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the vaccine was well tolerated with side effects generally consistent with those observed"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en participantes de 16 a 25 años de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "participants between 16 and 25 years of age"
                    }
                ],
                "evidences": [
                    {
                        "value": "In a phase 3 trial with more than 30 000 volunteers, the mRNA-1273 COVID-19 vaccine (Moderna Biotech, Madrid, Spain) showed 94·1% efficacy in protecting against COVID-19. 4 Local and systemic side-effects were common but mainly low grade and of short duration.",
                        "score": 0.5899999738
                    },
                    {
                        "value": "Thus, the overall proportion of COVID-19 vaccine acceptance was 69.3%. This finding is slightly higher than a previous study conducted in United Kingdom in which 64% of participants had good vaccine acceptance against COVID-19. 8 This might be due to difference in the study population.",
                        "score": 0.6100000143
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9992117882
                    },
                    {
                        "label": "neutral",
                        "score": 0.9997499585
                    }
                ]
            },
            {
                "text": "Todos los participantes en el ensayo seguirán siendo controlados en cuanto a la protección y seguridad a largo plazo durante dos años más después de su segunda dosis.",
                "text_en": "All participants in the trial will continue to be monitored for long-term safety and safety for two more years after their second dose.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Todos los participantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "All participants"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el ensayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the test"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "seguirán siendo controlados en cuanto a la protección y seguridad a largo plazo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will continue to be monitored for long-term safety and security"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante dos años más después de su segunda dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for two more years after your second dose"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "90": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 9,
            "WhatReliabilityReliable": 4,
            "WhatReliabilityUnreliable": 5,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 8,
            "WhoReliabilityReliable": 3,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 0,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 1,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 6,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 5,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 2,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 7,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 12,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 12,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEn Chile están sufriendo un auténtico drama tras lograr “el privilegio” de ser el tercer país que más vacuna.\n\n<BREAK>\n\nSegún indican varios medios, en su principal puerto, Valparaíso, la morgue del Hospital Carlos Van Buren ya no tiene espacio para más cadáveres.\n\n<BREAK>\n\nLas autoridades sanitarias han tenido que habilitar la instalación de contenedores refrigerados para depositar los cuerpos de los fallecidos por Covid-19.\n\n<PARAGRAPH>\n\nPero por otro lado, en esos mismos medios en los que se nos cuenta todo esto, califican lo que está sucediendo en ese país con las vacunas como el “milagro chileno” ya que más de una tercera parte de la población ya se encuentra vacunada.\n\n<BREAK>\n\nY ahora, tras esas vacunaciones, nos encontramos con que en Chile se han ordenado nuevos y estrictos confinamientos, el número de fallecidos y contagiados está subiendo de una forma tan alarmante, que está provocando incluso nuevos y más estrictos confinamientos, de hecho, durante dos días la población no podía salir de sus casas ni para comprar productos básicos y la nueva noticia de la que nos hemos enterado es de que el Gobierno de solicitar al Congreso una reforma para postergar por seis semanas las elecciones originalmente previstas para el 10 y 11 de abril.\n\n<PARAGRAPH>\n\nPero, ¿qué conclusión se nos intenta vender desde los grandes medios de comunicación españoles sobre lo que está sucediendo en Chile? Que es algo “paradójico” lo que está pasando.\n\n<BREAK>\n\nQue es una paradoja que, tras vacunar a una tercera parte de la población esté pasando lo que está pasando.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nY hacer eso es mentir, manipular y tratarnos de idiotas porque lo que está sucediendo en Chile es que los efectos secundarios de las vacunas están provocando un auténtico drama sanitario con miles de contagios y cientos de fallecimientos.\n\n<BREAK>\n\nPero eso no lo van a decir nunca.\n\n<BREAK>\n\nEllos están absolutamente vendidos.\n\n<BREAK>\n\nDicen lo que se les ordena que diga y les da igual que en unos meses, en España nos podamos encontrar en la misma situación.\n\n<PARAGRAPH>\n\nOjalá llegue algún día en el que los responsables de todo lo que está pasando y sus altavoces mediáticos y sanitarios respondan de todo lo que están haciendo en los tribunales.\n\n<BREAK>\n\nEs vergonzoso todo esto.\n\n<BREAK>\n\nCobardes y vendidos que juegan con la vida de las personas a cambio de dinero.\n\n<BREAK>\n\n¡Gentuza!\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Vergonzoso lo de los medios de comunicación españoles: Nos “venden” el drama que está sufriendo Chile por la vacunación como algo “paradójico”",
        "ID": "NF_04-11-2021_21-02-34_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Vergonzoso lo de los medios de comunicación españoles: Nos “venden” el drama que está sufriendo Chile por la vacunación como algo “paradójico”",
                "text_en": "Shameful about the Spanish media: We “sell” the drama that Chile is suffering from vaccination as something “paradoxic”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los medios de comunicación españoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Spanish media"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Nos “venden” el drama que está sufriendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They “sell” us the drama they are suffering"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Chile",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Chile"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for vaccination"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "como algo “paradójico”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "as something “paradoxical”"
                    }
                ],
                "evidences": [
                    {
                        "value": "Although the Spanish language media produces similar content to English language news outlets, it is delivered within the Latinx context (Gomez-Aguinaga 2020). Unfortunately, assessments about the media messages communicated to Latinx Spanish-speaking IPV survivors seem to be limited. This lack of knowledge is disconcerting because a vast majority of Latinx individuals (68%) consume their news in Spanish, despite English language proficiency (Lopez and González-Barrera 2013) . The large percentage of Latinx people engaging in Spanish media consumption is not surprising since almost 38 million Latinx individuals speak Spanish at home, not counting unauthorized immigrants (Hernández-Nieto et al. 2017) . The most popular platform for news in the Latinx community is the television (Lopez and González-Barrera 2013) . Univision's network, a Spanish-language media company, has the largest nationwide Latinx viewership (Hernández-Nieto et al. 2017) . In 2020, their network averaged 1.4 million viewers during primetime (Univision Communications Inc. 2020a). Between the week of March 16 and March 20, 2020, Univision's audience totaled 1.7 million, becoming the leading Latinx media company (Univision Communications Inc. 2020b) . Despite this network's extensive reach, little is known about the messages they provide to assist those experiencing IPV during a national crisis such as the COVID-19 pandemic.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9311752915
                    }
                ]
            },
            {
                "text": "En Chile están sufriendo un auténtico drama tras lograr “el privilegio” de ser el tercer país que más vacuna.",
                "text_en": "In Chile they are suffering a real drama after achieving “the privilege” of being the third most vaccinated country.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En Chile",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Chile"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están sufriendo un auténtico drama",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're suffering a real drama."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras lograr “el privilegio” de ser el tercer país que más vacuna",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after achieving “the privilege” of being the third country with the most vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según indican varios medios, en su principal puerto, Valparaíso, la morgue del Hospital Carlos Van Buren ya no tiene espacio para más cadáveres.",
                "text_en": "According to several media outlets, in its main port, Valparaiso, the morgue of the Hospital Carlos Van Buren no longer has room for more corpses.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "varios medios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "various media"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su principal puerto, Valparaíso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in its main port, Valparaíso"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la morgue del Hospital Carlos Van Buren",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the morgue of the Hospital Carlos Van Buren"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya no tiene espacio para más cadáveres",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He doesn't have room for any more corpses anymore."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las autoridades sanitarias han tenido que habilitar la instalación de contenedores refrigerados para depositar los cuerpos de los fallecidos por Covid-19.",
                "text_en": "The sanitary authorities have had to enable the installation of refrigerated containers to deposit the bodies of those killed by Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Las autoridades sanitarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health authorities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han tenido que habilitar la instalación de contenedores refrigerados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have had to enable the installation of refrigerated containers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero por otro lado, en esos mismos medios en los que se nos cuenta todo esto, califican lo que está sucediendo en ese país con las vacunas como el “milagro chileno” ya que más de una tercera parte de la población ya se encuentra vacunada.",
                "text_en": "But on the other hand, in those same media in which we are told all this, they describe what is happening in that country with vaccines as the “Chilean miracle” since more than a third of the population is already vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "esos mismos medios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the same means"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "califican lo que está sucediendo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "qualify what is happening"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en ese país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in that country"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "como el “milagro chileno”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "as the “Chilean Miracle”"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que más de una tercera parte de la población ya se encuentra vacunada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since more than a third of the population is already vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y ahora, tras esas vacunaciones, nos encontramos con que en Chile se han ordenado nuevos y estrictos confinamientos, el número de fallecidos y contagiados está subiendo de una forma tan alarmante, que está provocando incluso nuevos y más estrictos confinamientos, de hecho, durante dos días la población no podía salir de sus casas ni para comprar productos básicos y la nueva noticia de la que nos hemos enterado es de que el Gobierno de solicitar al Congreso una reforma para postergar por seis semanas las elecciones originalmente previstas para el 10 y 11 de abril.",
                "text_en": "And now, after these vaccinations, we find that new and strict confinements have been ordered in Chile, the number of dead and infected is rising so alarmingly, that it is causing even new and stricter confinements, in fact, for two days the population could not leave their homes or buy basic goods and the new news that we have learned is that the Government is asking Congress for a reform to postpone the elections originally scheduled for April 10 and 11.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Chile",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Chile"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el número de fallecidos y contagiados está subiendo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the number of dead and infected is rising"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de una forma tan alarmante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in such an alarming way"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero, ¿qué conclusión se nos intenta vender desde los grandes medios de comunicación españoles sobre lo que está sucediendo en Chile? Que es algo “paradójico” lo que está pasando.",
                "text_en": "But what conclusion is we trying to sell from the great Spanish media about what is happening in Chile? That it is something “paradoxical” what is happening.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los grandes medios de comunicación españoles",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the great Spanish media"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Chile",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Chile"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es algo “paradójico” lo que está pasando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is something “paradoxical” what is happening"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Que es una paradoja que, tras vacunar a una tercera parte de la población esté pasando lo que está pasando.",
                "text_en": "That it is a paradox that, after vaccinating a third of the population, what is happening is happening.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "es una paradoja que, tras vacunar a una tercera parte de la población esté pasando lo que está pasando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It is a paradox that, after vaccinating a third of the population, what is happening is happening."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y hacer eso es mentir, manipular y tratarnos de idiotas porque lo que está sucediendo en Chile es que los efectos secundarios de las vacunas están provocando un auténtico drama sanitario con miles de contagios y cientos de fallecimientos.",
                "text_en": "And to do that is to lie, manipulate and treat us as idiots because what is happening in Chile is that the side effects of vaccines are causing a real health drama with thousands of infections and hundreds of deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hacer eso es mentir, manipular y tratarnos de idiotas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "To do that is to lie, manipulate and treat us as idiots."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Chile",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Chile"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "los efectos secundarios de las vacunas están provocando un auténtico drama sanitario",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the side effects of vaccines are causing a real health drama"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con miles de contagios y cientos de fallecimientos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with thousands of contagions and hundreds of deaths"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Cobardes y vendidos que juegan con la vida de las personas a cambio de dinero.",
                "text_en": "Cowards and sellers who play with people's lives in exchange for money.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cobardes y vendidos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Cowards and sellers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "juegan con la vida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "play with life"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "persons"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a cambio de dinero",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in exchange for money"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "91": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 7,
            "WhatReliabilityReliable": 0,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 7,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 2,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 0,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 2,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 4,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n“No perdamos nuestra cultura, nuestra religión”… Así se dirigía un sacerdote a sus feligreses en Honduras hasta que, dirigiéndose a varios de los que llevaban mascarilla, les dice “quítense esta babosada”, “mierda, ¿ve?” Y dirigiéndose a una de las mujeres le arranca la mascarilla y se la tira.\n\n<PARAGRAPH>\n\nAsí, así es como debería actuar la Iglesia con esta tomadura de pelo que estamos sufriendo en todo el mundo.\n\n<BREAK>\n\nEso es lo que debería decir el Papa Francisco, en lugar de asumir el discurso globalista en el que está instalado y recomendar a los católicos que participen en ese experimento peligroso que son las vacunas.\n\n<PARAGRAPH>\n\n¿Creen que Bergoglio hará algo así alguna vez? No lo hará nunca porque participa del negocio.\n\n<BREAK>\n\nOlvídense de que haga lo que debería como líder religioso que es de millones de personas.\n\n<BREAK>\n\nÉl solo esta donde está para proteger su puesto y su cartera, todo lo demás le da igual.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n",
        "TITLE": "Un sacerdote le quita a sus feligreses la mascarilla: “Quítense esta babosada, mi..da, ¿ve?”",
        "ID": "NF_04-11-2021_20-40-33_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Un sacerdote le quita a sus feligreses la mascarilla: “Quítense esta babosada, mi..da, ¿ve?”",
                "text_en": "A priest takes away the mask from his parishioners: “Take off this slug, my..da, see?”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Un sacerdote",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "A priest"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "le quita a sus feligreses la mascarilla",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Removes the mask from his parishioners"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“No perdamos nuestra cultura, nuestra religión”… Así se dirigía un sacerdote a sus feligreses en Honduras hasta que, dirigiéndose a varios de los que llevaban mascarilla, les dice “quítense esta babosada”, “mierda, ¿ve?” Y dirigiéndose a una de las mujeres le arranca la mascarilla y se la tira.",
                "text_en": "“Let’s not lose our culture, our religion”... So a priest went to his parishioners in Honduras until, addressing several of those wearing masks, he told them “get off this slug,” “shit, see?” And going to one of the women, he ripped off his mask and threw it away.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un sacerdote",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a priest"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a sus feligreses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to their parishioners"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Honduras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Honduras"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dirigiéndose a una de las mujeres le arranca la mascarilla y se la tira",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Heading to one of the women, he rips off his mask and throws it at her."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así, así es como debería actuar la Iglesia con esta tomadura de pelo que estamos sufriendo en todo el mundo.",
                "text_en": "Thus, this is how the Church should act with this tease that we are suffering all over the world.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "así es como debería actuar la Iglesia con esta tomadura de pelo que estamos sufriendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "That's how the Church should act with this tease we're suffering from."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Iglesia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Church"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en todo el mundo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "all over the world"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Eso es lo que debería decir el Papa Francisco, en lugar de asumir el discurso globalista en el que está instalado y recomendar a los católicos que participen en ese experimento peligroso que son las vacunas.",
                "text_en": "That is what Pope Francis should say, instead of taking up the globalist discourse in which he is installed and recommending Catholics to participate in that dangerous experiment that vaccines are.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Eso es lo que debería decir",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "That's what I should say."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Papa Francisco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pope Francis"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recomendar a los católicos que participen en ese experimento peligroso que son las vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "recommend to Catholics to participate in that dangerous experiment that vaccines are"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los católicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catholics"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Creen que Bergoglio hará algo así alguna vez? No lo hará nunca porque participa del negocio.",
                "text_en": "Do you think Bergoglio will ever do something like that? He never will because he participates in the business.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Bergoglio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Bergoglio"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No lo hará nunca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He'll never do it."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque participa del negocio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because it participates in the business"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Olvídense de que haga lo que debería como líder religioso que es de millones de personas.",
                "text_en": "Forget about me doing what I should do as a religious leader who is from millions of people.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Olvídense de que haga lo que debería",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Forget about me doing what I should do."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "como líder religioso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "as a religious leader"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Él solo esta donde está para proteger su puesto y su cartera, todo lo demás le da igual.",
                "text_en": "He's just where he is to protect his position and his wallet, everything else doesn't matter.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Él solo esta donde está para proteger su puesto y su cartera",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's just where he is to protect his position and his wallet."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "92": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 8,
            "WhatReliabilityReliable": 8,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 1,
            "WhoReliabilityReliable": 1,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 1,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 4,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 1,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 8,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEn el día mundial de la tuberculosis, que se celebra este 24 de marzo, hay que conocer más esta enfermedad y ser conscientes de que, de igual forma que otras afecciones, se alerta de una peor atención a la tuberculosis por la pandemia.Y es que en un año casi todos los meses han estado centrados en la Covid-19 y esto ha hecho dejar de lado tratamientos, diagnósticos y atenciones a otro tipo de afecciones que también están ahí.La Sociedad Española de Neumología y Cirugía Torácica (SEPAR) explica que tanto la Covid como la tuberculosis son dos epidemias respiratorias muy relevantes.\n\n<BREAK>\n\n“La actual coexistencia de ambas ha influido en una merma en la calidad y la continuidad de la atención a la tuberculosis durante el año 2020, así como menos inversión en investigación, y casos de coinfección de ambas enfermedades”.Datos sobre esta enfermedadEn cifras, es de destacar que hubo 10,0 millones de personas que enfermaron de tuberculosis en 2019 y se registraron 1,2 millones de muertes de tuberculosis entre las personas VIH negativas y 208.000 muertes entre personas VIH positivas.Entre los afectados de quince años o más, el 56% fueron hombres y el 32% mujeres y, por debajo de los quince años, hubo un 12% de niños con tuberculosis.Entre estos hubo un 8,2% de personas que además tenían VIH, según el Informe Global de Tuberculosis de la OMS, que recoge los últimos datos de la TB en el mundo, que datan de 2020.¿Cómo está la investigación de tuberculosis en España?Desde Separ explican que los esfuerzos se han centrado en la lucha contra la Covid-19.\n\n<BREAK>\n\nLos recursos en investigación pueden disminuir en el caso de la tuberculosis, contra la que se ha de investigar en nuevos fármacos y vacunas.Actualmente hay varias vacunas en desarrollo en España, una de ellas en la Universidad de Zaragoza y la Ruti en Barcelona.\n\n<BREAK>\n\nY hay más datos: después de los tres primeros meses de pandemia, se envió una encuesta a 165 países, de los cuales el 42% informó de interrupciones parciales en la detección y el tratamiento de los casos de TB.Y en otros estudios se ha observado una peor atención a la tuberculosis por la pandemia y decremento de los servicios sanitarios para esta afección durante los primeros cuatro meses de la pandemia, en que muchos países declararon el confinamiento de la población, respecto a los primeros cuatro meses de 2019.Algunas de las causas de ello son la reasignación de los recursos humanos que atendían a los pacientes con tuberculosis a la atención a la Covid-19; el temor de los pacientes a acudir a los servicios sanitarios para no contagiarse o bien por dificultades para acceder a los servicios médicos.",
        "TITLE": "Alertan de una peor atención a la tuberculosis por la pandemia",
        "ID": "NF_04-11-2021_21-15-06_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Alertan de una peor atención a la tuberculosis por la pandemia",
                "text_en": "Warn of worse attention to tuberculosis due to pandemic",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Alertan de una peor atención a la tuberculosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Warn of worse attention to tuberculosis"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the pandemic"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el día mundial de la tuberculosis, que se celebra este 24 de marzo, hay que conocer más esta enfermedad y ser conscientes de que, de igual forma que otras afecciones, se alerta de una peor atención a la tuberculosis por la pandemia.Y es que en un año casi todos los meses han estado centrados en la Covid-19 y esto ha hecho dejar de lado tratamientos, diagnósticos y atenciones a otro tipo de afecciones que también están ahí.La Sociedad Española de Neumología y Cirugía Torácica (SEPAR) explica que tanto la Covid como la tuberculosis son dos epidemias respiratorias muy relevantes.",
                "text_en": "On the world tuberculosis day, which is celebrated on March 24, we must learn more about this disease and be aware that, like other conditions, we are alerted to a worse attention to tuberculosis due to the pandemic.It is that in almost every year they have been focused on Covid-19 and this has caused to leave aside treatments, diagnoses and attentions to other types of conditions that are also there.The Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) explains that both Covid and tuberculosis are two very important respiratory epidemics.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "En el día mundial de la tuberculosis, que se celebra este 24 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "On the World Tuberculosis Day, which is being celebrated on 24 March"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se alerta de una peor atención a la tuberculosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Better attention to tuberculosis is being alerted"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the pandemic"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "han estado centrados en la Covid-19 y esto ha hecho dejar de lado tratamientos, diagnósticos y atenciones a otro tipo de afecciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have been focused on Covid-19 and this has left aside treatments, diagnoses and attentions to other types of conditions"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Sociedad Española de Neumología y Cirugía Torácica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Spanish Society of Pneumology and Thoracic Surgery"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "explica que tanto la Covid como la tuberculosis son dos epidemias respiratorias muy relevantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "explains that both Covid and tuberculosis are two very important respiratory epidemics"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“La actual coexistencia de ambas ha influido en una merma en la calidad y la continuidad de la atención a la tuberculosis durante el año 2020, así como menos inversión en investigación, y casos de coinfección de ambas enfermedades”.Datos sobre esta enfermedadEn cifras, es de destacar que hubo 10,0 millones de personas que enfermaron de tuberculosis en 2019 y se registraron 1,2 millones de muertes de tuberculosis entre las personas VIH negativas y 208.000 muertes entre personas VIH positivas.Entre los afectados de quince años o más, el 56% fueron hombres y el 32% mujeres y, por debajo de los quince años, hubo un 12% de niños con tuberculosis.Entre estos hubo un 8,2% de personas que además tenían VIH, según el Informe Global de Tuberculosis de la OMS, que recoge los últimos datos de la TB en el mundo, que datan de 2020.¿Cómo está la investigación de tuberculosis en España?Desde Separ explican que los esfuerzos se han centrado en la lucha contra la Covid-19.",
                "text_en": "\"The current coexistence of the two has influenced a decrease in the quality and continuity of tuberculosis care during 2020, as well as less investment in research, and cases of co-infection of both diseases.\"Data on this diseaseIn figures, it is worth noting that there were 10.0 million people who became infected with tuberculosis in 2019 and 1.2 million deaths of tuberculosis were recorded among HIV-negative people and 208,000 deaths among HIV-positive people.Among those affected 15 years of age or older, 56% were men and 32% women and, below 15 years of age, 12% of children with tuberculosis.Among these, there were 8.2% of people who also had HIV, according to the WHO Global Tuberculosis Report, which collects the",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La actual coexistencia de ambas ha influido en una merma en la calidad y la continuidad de la atención a la tuberculosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The current coexistence of the two has affected the quality and continuity of tuberculosis care."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante el año 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the year 2020"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los recursos en investigación pueden disminuir en el caso de la tuberculosis, contra la que se ha de investigar en nuevos fármacos y vacunas.Actualmente hay varias vacunas en desarrollo en España, una de ellas en la Universidad de Zaragoza y la Ruti en Barcelona.",
                "text_en": "Research resources may decrease in the case of tuberculosis, against which new drugs and vaccines must be investigated.There are currently several vaccines in development in Spain, one of them at the University of Zaragoza and the Ruti in Barcelona.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los recursos en investigación pueden disminuir en el caso de la tuberculosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Research resources may decrease in the case of tuberculosis"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en nuevos fármacos y vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in new drugs and vaccines"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Actualmente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Currently"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay varias vacunas en desarrollo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there are several vaccines in development"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Universidad de Zaragoza y la Ruti en Barcelona",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the University of Zaragoza and the Ruti in Barcelona"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y hay más datos: después de los tres primeros meses de pandemia, se envió una encuesta a 165 países, de los cuales el 42% informó de interrupciones parciales en la detección y el tratamiento de los casos de TB.Y en otros estudios se ha observado una peor atención a la tuberculosis por la pandemia y decremento de los servicios sanitarios para esta afección durante los primeros cuatro meses de la pandemia, en que muchos países declararon el confinamiento de la población, respecto a los primeros cuatro meses de 2019.Algunas de las causas de ello son la reasignación de los recursos humanos que atendían a los pacientes con tuberculosis a la atención a la Covid-19; el temor de los pacientes a acudir a los servicios sanitarios para no contagiarse o bien por dificultades para acceder a los servicios médicos.",
                "text_en": "And there are more data: after the first three months of the pandemic, a survey was sent to 165 countries, of which 42 per cent reported partial interruptions in the detection and treatment of TB cases.And other studies have shown a worse attention to tuberculosis due to the pandemic and a decrease in health services for this condition during the first four months of the pandemic, in which many countries declared population confinement, compared to the first four months of 2019.Some of the causes of this are the reallocation of human resources that treat patients with tuberculosis to care for Covid-19; the fear of patients to go to health services to avoid becoming infected or for difficulties in accessing medical services.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de los tres primeros meses de pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after the first three months of the pandemic"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se envió una encuesta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a survey was sent"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a 165 países",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "165 countries"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en otros estudios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in other studies"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha observado una peor atención a la tuberculosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Better attention to tuberculosis has been observed"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la pandemia y decremento de los servicios sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the pandemic and the decline of health services"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "93": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 12,
            "WhatReliabilityReliable": 3,
            "WhatReliabilityUnreliable": 9,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 11,
            "WhoReliabilityReliable": 4,
            "WhoReliabilityUnreliable": 7,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 2,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 1,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 1,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 8,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 9,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 9,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nAcabamos de tener noticia de una nueva muestra de lo miserables que son en la red social Facebook y sobre todo, de lo miserables que son los vendidos censores, llamados verificadores, que trabajan para ellos.\n\n<PARAGRAPH>\n\nUna mujer llamada Desirée Penrod, de 25 años, había sido inoculada con la vacuna.\n\n<BREAK>\n\nDías más tarde empezó a sufrir los efectos secundarios de la misma y comenzó a contar a través de su cuenta de Facebook todo por lo que estaba pasando.\n\n<BREAK>\n\nPenrod, profesora de preescolar, publicaba el pasado 10 de marzo lo siguiente: “La vacuna me está matando.\n\n<BREAK>\n\nMe duele el brazo, más allá del cansancio, dolor de cabeza, calambres de estómago y dolores de oído.\n\n<BREAK>\n\nVarias personas me han dicho que hoy me veían pálida.\n\n<BREAK>\n\nAyer estaba bien, pero hoy me está pasando factura ”.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nComo observarán en la publicación, los verificadores, los Ana Pastor de Estados Unidos, colocaron un mensaje en la parte inferior de la publicación de Penrod en el que se puede leer: “Las vacunas Covid-19 pasan por muchas pruebas de seguridad y efectividad antes de ser aprobadas” y añaden, “obtenga más información en la OMS”.\n\n<PARAGRAPH>\n\nEsto fue escrito un 10 de marzo, justo a la semana de hacerlo, el día 17 de marzo, Desirée Penrod fallecía como consecuencia de todo lo que estaba denunciando sufrir tras haberse vacunado.\n\n<BREAK>\n\nLa gentuza de Facebook y sus verificadores estarán tan contentos de ser unos rastreros miserables como han demostrado ser, una vez más.\n\n<PARAGRAPH>\n\nNo hay mejor información que la que pueda proporcionar alguien que está sufriendo las consecuencias de este mejunje experimental que están intentando administrarnos.\n\n<BREAK>\n\nEsto se lo tenían que pasar a la gentuza de Newtrola y compañía en bucle hasta que les surgiera un mínimo de arrepentimiento y de vergüenza, aunque lo dudamos, ellos son más de dinerito fresco, todo lo demás les da igual.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Los “verificadores” de Facebook censuraron una publicación en la que una mujer de 25 años denunciaba los efectos secundarios que estaba sufriendo por la vacuna, a la semana siguiente falleció",
        "ID": "NF_04-11-2021_20-57-44_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Los “verificadores” de Facebook censuraron una publicación en la que una mujer de 25 años denunciaba los efectos secundarios que estaba sufriendo por la vacuna, a la semana siguiente falleció",
                "text_en": "Facebook’s “verifiers” censored a post in which a 25-year-old woman denounced the side effects she was suffering from the vaccine, the following week she died.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los “verificadores”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The “verifiers”"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Facebook",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Facebook"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "censuraron una publicación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "censored a publication"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una mujer de 25 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a 25-year-old woman"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "denunciaba los efectos secundarios que estaba sufriendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "reported the side effects he was suffering from"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Acabamos de tener noticia de una nueva muestra de lo miserables que son en la red social Facebook y sobre todo, de lo miserables que son los vendidos censores, llamados verificadores, que trabajan para ellos.",
                "text_en": "We have just heard of a new sample of how miserable they are on the social network Facebook and above all, of how miserable the sold censors, called verifiers, are working for them.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Acabamos de tener noticia de una nueva muestra de lo miserables que son",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We just got word of a new sample of how miserable they are."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la red social Facebook",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on the social network Facebook"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los vendidos censores, llamados verificadores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "sold censors, called verifiers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una mujer llamada Desirée Penrod, de 25 años, había sido inoculada con la vacuna.",
                "text_en": "A woman named Desirée Penrod, 25, had been inoculated with the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Una mujer llamada Desirée Penrod, de 25 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A woman named Desirée Penrod, 25 years old"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "había sido inoculada con la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had been inoculated with the vaccine"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Días más tarde empezó a sufrir los efectos secundarios de la misma y comenzó a contar a través de su cuenta de Facebook todo por lo que estaba pasando.",
                "text_en": "Days later he began to suffer the side effects of it and began to tell through his Facebook account everything he was going through.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Días más tarde",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Days later"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "empezó a sufrir los efectos secundarios de la misma y comenzó a contar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "began to suffer the side effects of it and began to count"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a través de su cuenta de Facebook",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "through your Facebook account"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Penrod, profesora de preescolar, publicaba el pasado 10 de marzo lo siguiente: “La vacuna me está matando.",
                "text_en": "On March 10, Penrod, a preschool teacher, published the following: “The vaccine is killing me.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Penrod, profesora de preescolar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Penrod, preschool teacher"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado 10 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last March 10"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vacuna me está matando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The vaccine is killing me."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Varias personas me han dicho que hoy me veían pálida.",
                "text_en": "Several people told me that I was pale today.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Varias personas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Several persons"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hoy",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "me veían pálida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They saw me pale."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Como observarán en la publicación, los verificadores, los Ana Pastor de Estados Unidos, colocaron un mensaje en la parte inferior de la publicación de Penrod en el que se puede leer: “Las vacunas Covid-19 pasan por muchas pruebas de seguridad y efectividad antes de ser aprobadas” y añaden, “obtenga más información en la OMS”.",
                "text_en": "As you will see in the publication, the verifiers, the Ana Pastor of the United States, put a message at the bottom of Penrod’s publication in which you can read: “Covid-19 vaccines go through many tests of safety and effectiveness before they are approved” and add, “get more information at the WHO.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los verificadores, los Ana Pastor",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the verifiers, the Ana Pastor"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Estados Unidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United States"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "colocaron un mensaje",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "put a message"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la parte inferior de la publicación de Penrod",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the bottom of Penrod’s publication"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto fue escrito un 10 de marzo, justo a la semana de hacerlo, el día 17 de marzo, Desirée Penrod fallecía como consecuencia de todo lo que estaba denunciando sufrir tras haberse vacunado.",
                "text_en": "This was written on March 10, just a week after doing so, on March 17, Desirée Penrod died as a result of everything he was claiming to suffer after he had been vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el día 17 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 17 March"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Desirée Penrod",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Desirée Penrod"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fallecía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "passed away."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "como consecuencia de todo lo que estaba denunciando sufrir tras haberse vacunado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "as a result of everything he was claiming to suffer after he had been vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La gentuza de Facebook y sus verificadores estarán tan contentos de ser unos rastreros miserables como han demostrado ser, una vez más.",
                "text_en": "The Facebook mob and their verifiers will be as happy to be miserable creeps as they have proven to be, once again.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La gentuza de Facebook y sus verificadores",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The Facebook mob and their verifiers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estarán tan contentos de ser unos rastreros miserables",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They'll be so happy to be miserable creeps."
                    }
                ],
                "evidences": []
            },
            {
                "text": "No hay mejor información que la que pueda proporcionar alguien que está sufriendo las consecuencias de este mejunje experimental que están intentando administrarnos.",
                "text_en": "There is no better information than can be provided by someone who is suffering the consequences of this experimental mejunge who are trying to administer us.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No hay mejor información que la que pueda proporcionar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "There's no better information than you can provide."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "alguien que está sufriendo las consecuencias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "someone who is suffering the consequences"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto se lo tenían que pasar a la gentuza de Newtrola y compañía en bucle hasta que les surgiera un mínimo de arrepentimiento y de vergüenza, aunque lo dudamos, ellos son más de dinerito fresco, todo lo demás les da igual.",
                "text_en": "This had to be passed on to Newtrola's mobster and loop company until a minimum of regret and shame arose, although we doubt it, they are more of fresh money, everything else they don't care.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esto se lo tenían que pasar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This had to be passed on to him."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la gentuza de Newtrola y compañía",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the Newtrola mob and company"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "94": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 19,
            "WhatReliabilityReliable": 9,
            "WhatReliabilityUnreliable": 10,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 13,
            "WhoReliabilityReliable": 12,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 3,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 3,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 2,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 11,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 6,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLas señales estaban ahí: la identificación de un nuevo coronavirus, la declaración de Emergencia de Salud Pública de la OMS, las muertes en China, la aparición de casos en distintos países de nuestro entorno...\n\n<PARAGRAPH>\n\nLo tremendo, lo más indignante, lo vomitivo es que el socialista Pedro Sánchez, su compinche Pablo Iglesias, los dirigentes del PSOE y toda la patulea operan encimo como si no fuera con ellos, siguen mintiendo sobre la cifra real de muertos por coronavirus y no parecen sentir la mínima preocupación por la tragedia sanitaria, económica y social que se bate sobre España y en que gran medida se debe a su sectarismo e ineptitud.\n\n<PARAGRAPH>\n\nSe cumple estos días un año desde el estallido ‘oficial’ de la pandemia del Covid-19, originada en la ciudad china de Wuhan y causante de la peor emergencia sanitaria del último siglo.\n\n<PARAGRAPH>\n\nLas señales estaban ahí: la identificación de un nuevo coronavirus, la declaración de Emergencia de Salud Pública de la OMS, las muertes en China, la aparición de casos en distintos países de nuestro entorno…\n\n<PARAGRAPH>\n\nPero Gobierno PSOE-Podemos infravaloró el riesgo, desatendió las advertencias y permitió la vida social hasta el punto negligente de alentar las marchas del 8-M del pasado año.\n\n<PARAGRAPH>\n\nFracasó en la tarea de garantizar la provisión de suministros y lo ha vuelto a hacer con la vacunación, sin un plan nacional y con un volumen de dosis adquiridas a todas luces insuficiente.\n\n<PARAGRAPH>\n\nLa inédita presión asistencial sufrida por el sistema sanitaria solo se ha podido salvar por la entrega y la profesionalidad del personal médico y de enfermería, en contraste con la incompetencia del ex ministro Illa y del resto de autoridades sanitarias.\n\n<PARAGRAPH>\n\nEspaña, según datos oficiales que ya sabemos que están por muy debajo de las cifras de exceso de mortalidad, suma más de 71.000 fallecidos por coronavirus y más de tres millones de contagiados.\n\n<BREAK>\n\nEs uno de los países europeos con más víctimas y más sanitarios infectados.\n\n<PARAGRAPH>\n\nEl Gobierno, una calamidad como subraya el diario ‘El Mundo’ en su editorial de este 7 de marzo de 2021, se mantuvo impávido hasta la declaración del estado de alarma, que restringió la movilidad en todo el territorio nacional e impuso el confinamiento domiciliario.\n\n<PARAGRAPH>\n\nLa dureza de este encierro fue consecuencia de la pasividad del Ejecutivo, incapaz de ofrecer datos fiables, con un ministro sobrepasado y con el director del centro de emergencias, Fernando Simón, convertido en vocero gubernamental.\n\n<PARAGRAPH>\n\nLa descoordinación y los cambios de criterio se tradujeron luego en una desescalada caótica y en una obscena dejación de responsabilidades al traspasar el peso de la sucesivas olas a las CCAA.\n\n<BREAK>\n\nSánchez ha pasado de retener poderes especiales y aplicar severas restricciones a inhibirse después de sacar adelante la alarma hasta mayo sin apenas tener que rendir cuentas en el Parlamento.\n\n<PARAGRAPH>\n\nA ello se unen los cebos ideológicos, como la regulación de la eutanasia, lanzados para desviar la atención.\n\n<BREAK>\n\nAún hoy, cuando los fallecidos siguen contándose por centenares, el debate público sigue maniatado por la propaganda de La Moncloa, lo que también pone de relieve la impotencia de la oposición a la hora de subrayar las responsabilidades de un Gobierno dividido y sin crédito internacional.\n\n<PARAGRAPH>\n\nDesde el punto de vista económico, el confinamiento paralizó el consumo y la actividad productiva, causando un daño severo en el sector servicios.\n\n<PARAGRAPH>\n\nEspaña ya supera los cuatro millones de parados, la deuda pública ha escalado hasta el 117% del PIB y los negocios en concurso de acreedores indican la onda sísmica de un cataclismo al que el Gobierno responde de forma errática.\n\n<BREAK>\n\nLos efectos dramáticos de la crisis ahondan en la desigualdad y amenazan con generar un estallido social sin precedentes.\n\n<BREAK>\n\nNo basta con el auxilio de créditos o del necesario mecanismo de los ERTE.\n\n<PARAGRAPH>\n\nUrge inyectar ayudas directas a las empresas y diseñar una gestión independiente, técnica y eficaz del fondo europeo, que Sánchez pretende tutelar saltándose los dictámenes del Consejo de Estado.\n\n<PARAGRAPH>\n\nLa recuperación depende del ritmo de vacunación y de mantener a raya al virus.\n\n<BREAK>\n\nSin embargo, un año después del estrepitoso fiasco de la escalada, el Gobierno continúa mostrándose incapaz de liderar una respuesta eficaz a la emergencia sanitaria y de infundir la certidumbre necesaria para rescatar la economía.\n\n<PARAGRAPH>\n",
        "TITLE": "Un año de coronavirus: 100.000 muertos, 5 millones de españoles sin empleo y Sánchez disfrutando",
        "ID": "NF_04-11-2021_21-14-02_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Un año de coronavirus: 100.000 muertos, 5 millones de españoles sin empleo y Sánchez disfrutando",
                "text_en": "One year of coronavirus: 100,000 dead, 5 million Spanish unemployed and Sánchez enjoying",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "100.000 muertos, 5 millones de españoles sin empleo y Sánchez disfrutando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "100,000 dead, 5 million Spanish unemployed and Sánchez enjoying"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "5 millones de españoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "5 million Spanish"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sanchez"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las señales estaban ahí: la identificación de un nuevo coronavirus, la declaración de Emergencia de Salud Pública de la OMS, las muertes en China, la aparición de casos en distintos países de nuestro entorno...",
                "text_en": "The signs were there: the identification of a new coronavirus, the WHO declaration of Public Health Emergency, deaths in China, the appearance of cases in different countries of our environment...",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la declaración de Emergencia de Salud Pública de",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the declaration of Public Health Emergency of"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la OMS",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "WHO"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las muertes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Deaths"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en China",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in China"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la aparición de casos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the occurrence of cases"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en distintos países de nuestro entorno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in different countries of our environment"
                    }
                ],
                "evidences": [
                    {
                        "value": "Chinese health officials officially announced the discovery on 7th January, 2020. On 30th January, the World Health Organization (WHO) declared a public health emergency of international concern. On February 11, WHO gave a name to the disease caused by this new coronavirus: Covid-19. On 11th March, WHO upgraded the epidemic to a pandemic, the first triggered by a coronavirus [1, 2] .",
                        "score": 0.6999999881
                    },
                    {
                        "value": "Initial name of this new coronavirus was 2019-nCoV. Later on, it was termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [4] . This virus is a member of respiratory tract viruses group which is related to Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV). The World Health Organization (WHO) termed it as coronavirus disease 2019 (COVID-19) [5] .",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9990642667
                    },
                    {
                        "label": "contradiction",
                        "score": 0.4923676848
                    }
                ]
            },
            {
                "text": "Lo tremendo, lo más indignante, lo vomitivo es que el socialista Pedro Sánchez, su compinche Pablo Iglesias, los dirigentes del PSOE y toda la patulea operan encimo como si no fuera con ellos, siguen mintiendo sobre la cifra real de muertos por coronavirus y no parecen sentir la mínima preocupación por la tragedia sanitaria, económica y social que se bate sobre España y en que gran medida se debe a su sectarismo e ineptitud.",
                "text_en": "The tremendous, the most outrageous, the vomitive thing is that the socialist Pedro Sánchez, his crony Pablo Iglesias, the leaders of the PSOE and all the patulea operate as if it were not with them, they continue to lie about the real number of deaths by coronaviruses and they do not seem to feel the slightest concern for the health, economic and social tragedy that is being fought over Spain and to what extent it is due to their sectarianism and ineptitude.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el socialista Pedro Sánchez, su compinche Pablo Iglesias, los dirigentes del PSOE y toda la patulea",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the socialist Pedro Sánchez, his crony Pablo Iglesias, the leaders of the PSOE and all the patulea"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "operan encimo como si no fuera con ellos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They operate as if they weren't with them."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "siguen mintiendo sobre la cifra real de muertos por coronavirus y no parecen sentir la mínima preocupación por la tragedia sanitaria, económica y social",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "continue to lie about the actual number of deaths due to coronaviruses and do not seem to feel the slightest concern about the health, economic and social tragedy"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se cumple estos días un año desde el estallido ‘oficial’ de la pandemia del Covid-19, originada en la ciudad china de Wuhan y causante de la peor emergencia sanitaria del último siglo.",
                "text_en": "These days are one year since the ‘official’ outbreak of the Covid-19 pandemic, originating in the Chinese city of Wuhan and causing the worst health emergency of the last century.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el estallido ‘oficial’ de la pandemia del Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the ‘official’ outbreak of the Covid-19 pandemic"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la ciudad china de Wuhan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Chinese city of Wuhan"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las señales estaban ahí: la identificación de un nuevo coronavirus, la declaración de Emergencia de Salud Pública de la OMS, las muertes en China, la aparición de casos en distintos países de nuestro entorno…",
                "text_en": "The signs were there: the identification of a new coronavirus, the WHO declaration of Public Health Emergency, deaths in China, the appearance of cases in different countries of our environment...",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las señales estaban ahí",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The signs were there."
                    }
                ],
                "evidences": [
                    {
                        "value": "Chinese health officials officially announced the discovery on 7th January, 2020. On 30th January, the World Health Organization (WHO) declared a public health emergency of international concern. On February 11, WHO gave a name to the disease caused by this new coronavirus: Covid-19. On 11th March, WHO upgraded the epidemic to a pandemic, the first triggered by a coronavirus [1, 2] .",
                        "score": 0.6999999881
                    },
                    {
                        "value": "Initial name of this new coronavirus was 2019-nCoV. Later on, it was termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [4] . This virus is a member of respiratory tract viruses group which is related to Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV). The World Health Organization (WHO) termed it as coronavirus disease 2019 (COVID-19) [5] .",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9990642667
                    },
                    {
                        "label": "contradiction",
                        "score": 0.4923676848
                    }
                ]
            },
            {
                "text": "Pero Gobierno PSOE-Podemos infravaloró el riesgo, desatendió las advertencias y permitió la vida social hasta el punto negligente de alentar las marchas del 8-M del pasado año.",
                "text_en": "But the PSOE-Podemos government underestimated the risk, ignored the warnings and allowed social life to the point of neglecting to encourage the marches of 8-M last year.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Gobierno PSOE-Podemos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government PSOE-We can"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "infravaloró el riesgo, desatendió las advertencias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Undervalued the risk, ignored the warnings"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Fracasó en la tarea de garantizar la provisión de suministros y lo ha vuelto a hacer con la vacunación, sin un plan nacional y con un volumen de dosis adquiridas a todas luces insuficiente.",
                "text_en": "He failed in the task of ensuring the provision of supplies and has done so again with vaccination, without a national plan and with a volume of doses acquired clearly insufficient.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Fracasó en la tarea de garantizar la provisión de suministros y lo ha vuelto a hacer con la vacunación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He failed in the task of ensuring the provision of supplies and has done so again with vaccination"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin un plan nacional y con un volumen de dosis adquiridas a todas luces insuficiente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "without a national plan and with a clearly insufficient volume of doses"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La inédita presión asistencial sufrida por el sistema sanitaria solo se ha podido salvar por la entrega y la profesionalidad del personal médico y de enfermería, en contraste con la incompetencia del ex ministro Illa y del resto de autoridades sanitarias.",
                "text_en": "The unprecedented health-care pressure suffered by the health system has been saved only by the delivery and professionalism of medical and nursing personnel, in contrast to the incompetence of former Minister Illa and other health authorities.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La inédita presión asistencial sufrida por el sistema sanitaria solo se ha podido salvar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The unprecedented health-care pressure suffered by the health system has only been saved."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por la entrega y la profesionalidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for delivery and professionalism"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personal médico y de enfermería",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "medical and nursing personnel"
                    }
                ],
                "evidences": []
            },
            {
                "text": "España, según datos oficiales que ya sabemos que están por muy debajo de las cifras de exceso de mortalidad, suma más de 71.000 fallecidos por coronavirus y más de tres millones de contagiados.",
                "text_en": "Spain, according to official data we already know that they are well below the figures of excess mortality, totals more than 71,000 deaths by coronavirus and more than three million infected.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "suma más de 71.000 fallecidos por coronavirus y más de tres millones de contagiados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "more than 71,000 deaths due to coronavirus and more than 3 million people infected"
                    }
                ],
                "evidences": [
                    {
                        "value": "The ongoing coronavirus disease 2019 (COVID-19) pandemic has tested healthcare systems all around the world, taking some of them on the brink of collapse. Spain has been one of the European countries most affected by the pandemic. The first case of SARS-CoV-2 infection was diagnosed in Spain on January 31, 2020. On July 17, 2020, the epidemic had left in the country a total of 260,255 confirmed cases and 28,420 deaths from the novel coronavirus [1] .",
                        "score": 0.6000000238
                    },
                    {
                        "value": "Spain is one of the countries most affected by the coronavirus pandemic in the world, with 28,628 deaths as of today May 23, 2020. This figure, the highest after the USA, Italy and UK, underestimates the actual number of deaths attributable to the virus, since it only counts the polymerase chain reaction + cases (and Spain has not been an exception to the scarcity of these diagnostic tests). These data, like any other epidemiological data, must be interpreted in its sociodemographic, cultural and political context.",
                        "score": 0.7799999714
                    },
                    {
                        "value": "The novel coronavirus SARS-CoV-2 was reported for the first time in China, in Hubei province, in December 2019 and has rapidly spread around the world [1] [2] [3] . As of 10 May 2020, there have been 3,917,366 confirmed cases of the novel coronavirus disease globally and 274,361 deaths [4] . Most of the cases (1, 245, 775) and deaths (75,364) were reported in the U.S.A., followed by Spain (223,578 cases and 26,478 deaths), Italy (218,268 cases and 30,395 deaths), the United Kingdom (215,264 cases and 31,587 deaths), the Russian Federation (209,688 cases and 1915 deaths), Germany (169,218 cases and 7395 deaths), Turkey (137,115 cases and 3739 deaths) and France (137,008 cases and 26,268 deaths) [4] . At the time of submission of this manuscript, there have been, globally, 70,476,836 confirmed cases and 1,599,922 deaths; in particular, in Italy, 1,825,775 confirmed cases with 64,036 deaths have been reported [5] .",
                        "score": 0.5899999738
                    },
                    {
                        "value": "Coronavirus disease 2019 (COVID-19), which is caused by severe adult respiratory syndrome coronavirus 2 (SARS-CoV-2), quickly spread from China to the rest of the world and, as of 22 May 2020, had led to 5,168,433 confirmed cases and 335,936 deaths (www.worldometers.info/coronavirus). 1, 2 Italy was the first western country to be hit by the initial wave of SARSCoV-2 infection and, by 22 May 2020, it was the country with the sixth highest number of cases and deaths (respectively 228,658 and 32,616). The local spread of the disease was heterogeneous, with the northern regions of the country recording 80.4% of the cases and 86.7% of the deaths. In the province of Trento, which has a population of 540,000 inhabitants, 5444 cases and 541 deaths had been recorded as of 22 May 2020.",
                        "score": 0.5099999905
                    },
                    {
                        "value": "The first death officially related to COVID-19 in Quebec occurred on March 18, 2020, and the province crossed the threshold of 5,000 deaths on June 8, 2020. As of December 5, 2020, the number of deaths due to coronavirus in Quebec was 7255 (with 12,613 deaths across Canada) (INSPQ, 2020) . In Canada, Quebec is the province with the most coronavirus cases and deaths.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9992181063
                    },
                    {
                        "label": "neutral",
                        "score": 0.860170126
                    },
                    {
                        "label": "neutral",
                        "score": 0.9596366286
                    },
                    {
                        "label": "neutral",
                        "score": 0.9992140532
                    },
                    {
                        "label": "neutral",
                        "score": 0.9935280681
                    }
                ]
            },
            {
                "text": "El Gobierno, una calamidad como subraya el diario ‘El Mundo’ en su editorial de este 7 de marzo de 2021, se mantuvo impávido hasta la declaración del estado de alarma, que restringió la movilidad en todo el territorio nacional e impuso el confinamiento domiciliario.",
                "text_en": "The government, a calamity as the daily newspaper ‘El Mundo’ emphasizes in its editorial of March 7, 2021, remained unsuspected until the declaration of the state of alarm, which restricted mobility throughout the national territory and imposed house confinement.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Government"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este 7 de marzo de 2021",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "7 March 2021"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se mantuvo impávido hasta la declaración del estado de alarma",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "remained undisturbed until the state of alarm was declared."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en todo el territorio nacional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout the national territory"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La dureza de este encierro fue consecuencia de la pasividad del Ejecutivo, incapaz de ofrecer datos fiables, con un ministro sobrepasado y con el director del centro de emergencias, Fernando Simón, convertido en vocero gubernamental.",
                "text_en": "The harshness of this confinement was the result of the passiveness of the Executive, unable to provide reliable data, with a minister overtaken and with the director of the emergency centre, Fernando Simón, who became a government spokesman.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La dureza de este encierro fue consecuencia de la pasividad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The hardness of this confinement was a consequence of passivity"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "del Ejecutivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Executive Committee"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "incapaz de ofrecer datos fiables",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "unable to provide reliable data"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sánchez ha pasado de retener poderes especiales y aplicar severas restricciones a inhibirse después de sacar adelante la alarma hasta mayo sin apenas tener que rendir cuentas en el Parlamento.",
                "text_en": "Sánchez has moved from retaining special powers and applying severe restrictions to inhibiting himself after moving the alarm forward until May without just having to be held accountable in Parliament.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sanchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha pasado de retener poderes especiales y aplicar severas restricciones a inhibirse",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has moved from retaining special powers and applying severe restrictions to inhibiting"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de sacar adelante la alarma hasta mayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after raising the alarm until May"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin apenas tener que rendir cuentas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "without just having to be held accountable"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Parlamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Parliament"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aún hoy, cuando los fallecidos siguen contándose por centenares, el debate público sigue maniatado por la propaganda de La Moncloa, lo que también pone de relieve la impotencia de la oposición a la hora de subrayar las responsabilidades de un Gobierno dividido y sin crédito internacional.",
                "text_en": "Even today, when the dead continue to be counted by hundreds, the public debate continues to be manipulated by the propaganda of La Moncloa, which also highlights the impotence of the opposition in highlighting the responsibilities of a divided Government without international credit.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el debate público sigue maniatado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The public debate is still tied up."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la propaganda de La Moncloa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for the propaganda of La Moncloa"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Desde el punto de vista económico, el confinamiento paralizó el consumo y la actividad productiva, causando un daño severo en el sector servicios.",
                "text_en": "From an economic point of view, confinement paralysed consumption and productive activity, causing severe damage to the services sector.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el confinamiento paralizó el consumo y la actividad productiva, causando un daño severo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the confinement paralysed consumption and productive activity, causing severe damage"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en el sector servicios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the services sector"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Urge inyectar ayudas directas a las empresas y diseñar una gestión independiente, técnica y eficaz del fondo europeo, que Sánchez pretende tutelar saltándose los dictámenes del Consejo de Estado.",
                "text_en": "There is an urgent need to inject direct aid to companies and to design an independent, technical and effective management of the European fund, which Sánchez intends to protect by ignoring the opinions of the Council of State.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sánchez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Sanchez"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pretende tutelar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is intended to protect"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "saltándose los dictámenes del Consejo de Estado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the opinions of the Council of State"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "del Consejo de Estado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the Council of State"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La recuperación depende del ritmo de vacunación y de mantener a raya al virus.",
                "text_en": "Recovery depends on the rate of vaccination and keeping the virus at bay.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La recuperación depende del ritmo de vacunación y de mantener a raya al virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Recovery depends on the rate of vaccination and keeping the virus at bay"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sin embargo, un año después del estrepitoso fiasco de la escalada, el Gobierno continúa mostrándose incapaz de liderar una respuesta eficaz a la emergencia sanitaria y de infundir la certidumbre necesaria para rescatar la economía.",
                "text_en": "However, one year after the shocking fiasco of the escalation, the Government continues to be unable to lead an effective response to the health emergency and to instill the necessary certainty to rescue the economy.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "un año después del estrepitoso fiasco de la escalada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "one year after the shocking fiasco of climbing"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "continúa mostrándose incapaz de liderar una respuesta eficaz a la emergencia sanitaria",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "continues to be unable to lead an effective response to the health emergency"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "95": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 29,
            "WhatReliabilityReliable": 29,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 6,
            "Who": 8,
            "WhoReliabilityReliable": 8,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 11,
            "WhereReliabilityReliable": 11,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 9,
            "WhyReliabilityReliable": 9,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 4,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 1,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 4,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "04/04/2021-20:03:57\n\n<TEXT>\n\n\"Siempre y cuando se coloquen correctamente\" sería el matiz que habría que añadir. No obstante, en nuestro contexto, puede no ser necesario, sino incluso contraproducente\n\n<PARAGRAPH>\n\nLa semana pasada el Dr.\n\n<BREAK>\n\nFauci, el principal asesor de la Casa Blanca durante la pandemia, hizo unas declaraciones en las que afirmaba que llevar dos mascarillas a la vez podría ser más eficaz que llevar solo una y puntualizó: \"Siempre y cuando se coloquen correctamente\".\n\n<BREAK>\n\nLamentablemente, solo la primera parte de sus declaraciones ha acaparado los titulares y es importante hacer algún matiz porque, en nuestro contexto, usar \"doble mascarilla\" puede no solo no ser necesario, sino incluso contraproducente.\n\n<PARAGRAPH>\n\nEspaña, un paso por delante\n\n<PARAGRAPH>\n\nEn España, a diferencia de otros países donde no cuentan con una normativa específica para las mascarillas higiénicas (las de tela), disponemos de la norma UNE0065, que garantiza no solo una filtración adecuada (similar a la de las mascarillas quirúrgicas, que es superior al 90 %), sino también una correcta respirabilidad.\n\n<BREAK>\n\nEs decir, en nuestro país, a diferencia de otros, fuimos pioneros en implementar una normativa que regula que las mascarillas de tela reutilizables nos protejan y nos dejen respirar al mismo tiempo.\n\n<BREAK>\n\nUna vez que el tejido y la forma de la mascarilla cumplen los requisitos ya establecidos por nuestras autoridades sanitarias y ensayados en los laboratorios pertinentes, ¿tiene sentido usar una segunda capa y generar unas nuevas condiciones que no han sido ensayadas en el laboratorio? Si esto fuera necesario, se hubiera incluido en los estándares.\n\n<PARAGRAPH>\n\nPongamos un ejemplo: si llueve y nos tapamos la cabeza con una manta estaremos algo más protegidos, pero por el mero hecho de ponernos dos mantas en la cabeza no estaremos el doble de protegidos.\n\n<BREAK>\n\nSi una manta cala, la segunda también lo acabará haciendo.\n\n<BREAK>\n\nAhora bien, si bajo la lluvia usamos un buen impermeable no nos mojaremos, ya usemos uno solo o usemos dos.\n\n<BREAK>\n\nCon las mascarillas, como con muchas otras cosas en la vida, también es cuestión de calidad, no de cantidad.\n\n<PARAGRAPH>\n\nEl ajuste debe ser una prioridad\n\n<PARAGRAPH>\n\nQuizá lo más importante de las declaraciones del Dr.\n\n<BREAK>\n\nFauci ha sido precisamente aquello que puntualizó y sin embargo para la gran mayoría de los medios ha pasado desapercibido: su énfasis en la importancia del buen ajuste de la mascarilla.\n\n<BREAK>\n\nY es que de poco servirá llevar puesto el \"Ferrari\" de las mascarillas si quedan espacios entre la mascarilla y el rostro dejando que los virus \"se escapen\" por la parte superior (nariz) o por los laterales antes de pasar por el filtro.\n\n<BREAK>\n\nDel mismo modo, de nada servirá usar el mejor impermeable si nos dejamos partes del cuerpo sin cubrir.\n\n<BREAK>\n\nRecordemos: es fundamental que las mascarillas dispongan de un clip nasal y que nos aseguremos del correcto ajuste con las gomas.\n\n<PARAGRAPH>\n\nDoble mascarilla: ¿en qué casos sí y en qué casos no?\n\n<PARAGRAPH>\n\nA pesar de todo, existen algunos escenarios en los que por causas concretas puede ser útil utilizar una doble mascarilla.\n\n<BREAK>\n\nEstas son algunas de las posibilidades y analizamos cuándo sí sería útil y cuándo no.\n\n<PARAGRAPH>\n\nMascarilla quirúrgica sobre FFP2\n\n<PARAGRAPH>\n\nEsta \"modalidad\" es habitual entre los profesionales sanitarios para evitar salpicaduras y aerosoles que provengan de los pacientes.\n\n<BREAK>\n\nDe este modo la mascarilla quirúrgica actúa como una barrera, como un paraguas que preserva la FFP2, más costosa, alargando su vida útil.\n\n<BREAK>\n\nPor poner un ejemplo cotidiano: si un paciente estornuda encima al profesional con \"doble mascarilla\", este puede retirar la quirúrgica y desecharla, alargando la vida útil de la FFP2, que es más costosa.\n\n<PARAGRAPH>\n\nMascarilla FFP2 sobre quirúrgica\n\n<PARAGRAPH>\n\nUsar una mascarilla FFP2 sobre una mascarilla quirúrgica es un error ya que puede empeorar el ajuste.\n\n<BREAK>\n\nHaced la prueba si disponéis de estos dos tipos de mascarilla en casa y comprobaréis como al poner primero la quirúrgica y después la FFP2, la FFP2, que es la que ofrece mayor protección y cuyo ajuste ha sido ensayado, no se ajusta directamente a la cara perdiendo de este modo parte de su efectividad.\n\n<PARAGRAPH>\n\nMascarilla de tela + mascarilla de tela que no cumple la norma UNE0065\n\n<PARAGRAPH>\n\nEn el caso de las mascarillas de tela que no cumplan la normativa y de las que desconocemos su filtración, es decir, en el caso de ponernos en la boca un trozo de tela \"random\" que tengamos por casa, es posible que usar dos mascarillas pudiera ser mejor que solo una.\n\n<BREAK>\n\nPodría ser...\n\n<BREAK>\n\npero la realidad es que no lo sabemos.\n\n<BREAK>\n\nSi con ello conseguimos al menos un mejor ajuste, algo habremos ganado.\n\n<BREAK>\n\nLa pregunta es si ahora mismo es responsable usar mascarillas \"de andar por casa\" en un punto crítico de la pandemia, con una alta incidencia y teniendo abastecimiento suficiente de todos los tipos, higiénicas, quirúrgicas y FFP2 acordes a la normativa.\n\n<PARAGRAPH>\n\nMascarilla quirúrgica + mascarilla quirúrgica o mascarilla quirúrgica más mascarilla higiénica que cumple la norma UNE0065\n\n<PARAGRAPH>\n\nEn este caso, depende.\n\n<BREAK>\n\nCon estas modalidades no se mejora tanto el porcentaje de filtración como podría pensarse, sin embargo, en algunos casos sí se podría conseguir un mejor ajuste, algo que también es interesante y en lo que incide el Dr Fauci.\n\n<BREAK>\n\nLo que sí podrían empeorar estas opciones es la respirabilidad y esto importante valorarlo de manera individual.\n\n<BREAK>\n\nEs probable que, si empeora la respirabilidad, además de la evidente pérdida de seguridad, notemos cierto disconfort, empecemos a sudar (el típico \"sudor de bigotillo\") y que en consecuencia se moje la mascarilla perdiendo efectividad.\n\n<BREAK>\n\nSi todo esto sucede también es posible que nos la toquemos más de la cuenta intentando estar cómodos, algo no deseable.\n\n<PARAGRAPH>\n\nInsisto: si alguien emplea estas \"modalidades\" de doble mascarilla porque se siente más seguro en transporte público o en espacios concurridos poco ventilados, mi consejo es que, si su bolsillo se lo permite, utilice una FFP2.\n\n<PARAGRAPH>\n\nEn resumen...\n\n<PARAGRAPH>\n\n- Quirúrgica sobre FFP2 SÍ, para protegerla de salpicaduras especialmente en el entorno sanitario o de cuidados a terceros.\n\n<PARAGRAPH>\n\n- FFP2 sobre quirúrgica NO, porque se pierde ajuste de la FFP2, que es una parte fundamental al valorar su eficacia.\n\n<PARAGRAPH>\n\n- Quirúrgica + quirúrgica o quirúrgica + higiénica no es necesario en general.\n\n<BREAK>\n\nSolo debe hacerse si se respira adecuadamente con ellas y se consigue un mejor ajuste.\n\n<BREAK>\n\nEn espacios donde el riesgo sea elevado, mejor evitar estos \"apaños\" y utilizar FFP2.\n\n<PARAGRAPH>\n\n¿Mascarillas FFP2 obligatorias?\n\n<PARAGRAPH>\n\nLa Unión Europea dice \"no\".\n\n<BREAK>\n\nAnte la polémica generada en las últimas semanas sobre si su uso debería ser obligatorio, tal y como ocurre en algunas zonas de Europa, el pasado miércoles la Comisión Europea se pronunció indicando que no las recomienda para el gran público en línea con los criterios de los Centros Europeos para la Prevención y control de Enfermedades (ECDC).\n\n<BREAK>\n\nNo parece que, por el momento, vayan a ser obligatorias en nuestro país, aunque sí es interesante emplearlas en transporte público o espacios concurridos y poco ventilados, especialmente en personas de riesgo, tal y como hablamos la pasada semana.\n\n<PARAGRAPH>\n\nConforme a los criterios de\n\n<PARAGRAPH>\n\nSaber más\n\n<PARAGRAPH>\n\n",
        "TITLE": "¿Realmente es más eficaz llevar dos mascarillas?",
        "ID": "14_F_04-11-2021_21-09-10_www_elmundo_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "¿Realmente es más eficaz llevar dos mascarillas?",
                "text_en": "Is it really more effective to wear two masks?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llevar dos mascarillas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "wear two masks"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"Siempre y cuando se coloquen correctamente\" sería el matiz que habría que añadir. No obstante, en nuestro contexto, puede no ser necesario, sino incluso contraproducente",
                "text_en": "\"As long as they are correctly placed\" would be the nuance to be added. However, in our context, it may not be necessary, but even counterproductive.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "se coloquen correctamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are correctly placed"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en nuestro contexto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in our context"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puede no ser necesario, sino incluso contraproducente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "may not be necessary, but even counterproductive"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La semana pasada el Dr.",
                "text_en": "Last week Dr.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "La semana pasada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last week"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Dr.",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dr."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Fauci, el principal asesor de la Casa Blanca durante la pandemia, hizo unas declaraciones en las que afirmaba que llevar dos mascarillas a la vez podría ser más eficaz que llevar solo una y puntualizó: \"Siempre y cuando se coloquen correctamente\".",
                "text_en": "Fauci, the White House's main advisor during the pandemic, made statements stating that wearing two masks at once could be more effective than carrying only one and stating, \"As long as they are correctly placed.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fauci, el principal asesor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fauci, the main adviser"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la Casa Blanca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the White House"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the pandemic"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "afirmaba que llevar dos mascarillas a la vez podría ser más eficaz que llevar solo una",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "claimed that wearing two masks at once could be more effective than carrying only one"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a la vez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the same time"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "se coloquen correctamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are correctly placed"
                    }
                ],
                "evidences": [
                    {
                        "value": "Buzzfeed notes that Dr. Fauci responded to Sivia Burwell, who had emailed him a query on 5 February 2020 about the efficacy of wearing a mask, with the comment: \"Masks are really for infected people to prevent them from spreading infection to people who are not infected rather than protecting uninfected people from acquiring infection.\" It does appear that Dr. Fauci's advice about masks did change, with his endorsement of the wearing of one or two masks increasing over time.",
                        "score": 0.6299999952
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9975568056
                    }
                ]
            },
            {
                "text": "Lamentablemente, solo la primera parte de sus declaraciones ha acaparado los titulares y es importante hacer algún matiz porque, en nuestro contexto, usar \"doble mascarilla\" puede no solo no ser necesario, sino incluso contraproducente.",
                "text_en": "Unfortunately, only the first part of his statements has captured the headlines and it is important to make some shade because, in our context, using \"double mask\" may not only not be necessary, but even counterproductive.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "solo la primera parte de sus declaraciones ha acaparado los titulares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Only the first part of his statements has captured the headlines"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es importante hacer algún matiz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's important to make some nuance"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque, en nuestro contexto, usar \"doble mascarilla\" puede no solo no ser necesario, sino incluso contraproducente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because, in our context, using \"double mask\" may not only not be necessary, but even counterproductive."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en nuestro contexto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in our context"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En España, a diferencia de otros países donde no cuentan con una normativa específica para las mascarillas higiénicas (las de tela), disponemos de la norma UNE0065, que garantiza no solo una filtración adecuada (similar a la de las mascarillas quirúrgicas, que es superior al 90 %), sino también una correcta respirabilidad.",
                "text_en": "In Spain, unlike other countries where they do not have specific regulations for hygienic masks (cloth masks), we have the standard UNE0065, which guarantees not only an adequate filtration (similar to that of surgical masks, which is more than 90 %), but also a correct respiration.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "disponemos de la norma UNE0065",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "we have the UNE0065 standard"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es decir, en nuestro país, a diferencia de otros, fuimos pioneros en implementar una normativa que regula que las mascarillas de tela reutilizables nos protejan y nos dejen respirar al mismo tiempo.",
                "text_en": "That is, in our country, unlike others, we were pioneers in implementing a regulation that regulates that reusable fabric masks protect us and allow us to breathe at the same time.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en nuestro país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in our country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "normativa que regula que las mascarillas de tela reutilizables nos protejan y nos dejen respirar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "regulation that regulates that reusable fabric masks protect us and let us breathe"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una vez que el tejido y la forma de la mascarilla cumplen los requisitos ya establecidos por nuestras autoridades sanitarias y ensayados en los laboratorios pertinentes, ¿tiene sentido usar una segunda capa y generar unas nuevas condiciones que no han sido ensayadas en el laboratorio? Si esto fuera necesario, se hubiera incluido en los estándares.",
                "text_en": "Once the tissue and the shape of the mask meet the requirements already established by our health authorities and tested in the relevant laboratories, does it make sense to use a second layer and generate new conditions that have not been tested in the laboratory? If this were necessary, it would have been included in the standards.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el tejido y la forma de la mascarilla cumplen los requisitos ya establecidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the fabric and shape of the mask meet the requirements already established"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "nuestras autoridades sanitarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "our health authorities"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los laboratorios pertinentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the relevant laboratories"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Con las mascarillas, como con muchas otras cosas en la vida, también es cuestión de calidad, no de cantidad.",
                "text_en": "With masks, as with many other things in life, it is also a matter of quality, not quantity.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es cuestión de calidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's a matter of quality."
                    }
                ],
                "evidences": [
                    {
                        "value": "However, according to WHO guidelines, 5 protective material is essential for all healthcare providers. The shortage of filtering facepiece 2 (FFP2)/FFP3 protective face masks for healthcare professionals such as doctors, nurses, dentists, carers, and paramedics in hospitals and other healthcare settings is the main problem in this situation.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9984588623
                    }
                ]
            },
            {
                "text": "El ajuste debe ser una prioridad",
                "text_en": "Adjustment should be a priority",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El ajuste debe ser una prioridad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Adjustment should be a priority"
                    }
                ],
                "evidences": [
                    {
                        "value": "For interventions that can be ethically and practically investigated in a clinical trial, evidence generated from trials with a randomized control is rightly given priority over evidence from observational studies. Even the best adjustment methods used in observational studies can miss major systematic biases, especially in the midst of a response to a pandemic with a high infection rate and associated with such rapid and high mortality. Despite this, it is difficult to ignore the accumulating and potentially valuable observational data from large medical centers and other care settings around the world. Treatment decisions are being made today without clear guidance from trial results. It is unclear when reports from highquality controlled trials will be available.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9903715253
                    }
                ]
            },
            {
                "text": "Fauci ha sido precisamente aquello que puntualizó y sin embargo para la gran mayoría de los medios ha pasado desapercibido: su énfasis en la importancia del buen ajuste de la mascarilla.",
                "text_en": "Fauci has been precisely what he pointed out and yet for the vast majority of the media has gone unnoticed: his emphasis on the importance of the good fit of the mask.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fauci",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fauci"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la importancia del buen ajuste de la mascarilla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the importance of the good fit of the mask"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Recordemos: es fundamental que las mascarillas dispongan de un clip nasal y que nos aseguremos del correcto ajuste con las gomas.",
                "text_en": "Remember: it is essential that the masks have a nasal clip and that we ensure the correct fit with the rubbers.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es fundamental que las mascarillas dispongan de un clip nasal y que nos aseguremos del correcto ajuste con las gomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It is essential that the masks have a nasal clip and that we ensure the correct fit with the rubbers"
                    }
                ],
                "evidences": [
                    {
                        "value": "Due to the global supply shortages of PPE, almost all of the guidelines revised their initial recommendations related to PPE use. Of the 6 guidelines, 5 now recommend reuse of PPE following the manufacturers' instructions. Considering the global scarcity of PPE supplies, the WHO, CDC, ECDC, Australian, and UK updated guidelines recommend surgical masks as an acceptable alternative to N95 respirators for HCPs during routine care, and N95 or equivalent respirators have been prioritized during AGPs. However, the recommendations around the type of face mask vary; for example, some guidelines recommend fluidrepellent surgical face masks, whereas others recommend general surgical masks. 82 The CDC also recommends homemade cloth masks or homemade masks when a face mask is totally unavailable. 81 As contact and droplet precautions, PPE measures, including wearing a surgical mask, and a gown, gloves, face shield, goggles and/or visors, and hand hygiene, have been recommended upon entering the patient's room as well as removal of PPE upon leaving (Table 1 ). In all guidelines, alcohol-based hand sanitizers have been prioritized whenever available (Table 1) . Fit testing and seal checks are an essential part of respirator use, but fit testing is recommended in 5 guidelines and a seal check is recommended in 3 guidelines. Precautions during donning and doffing are recommended in all guidelines. If an autopsy is required for a patient, the WHO, CDC, ECDC, and UK guidelines recommend the use of contact and airborne precautions during the autopsy. However, the WHO recommends performing autopsies in an adequately ventilated room, whereas the CDC recommends performing this procedure in airborne infection isolation room 85, 86 Engineering control Physical separation is efficient in reducing transmission of respiratory virus in hospital settings. The Australian, CDC, and WHO guidelines emphasize engineering control as an IPC measure. These guidelines recommend the following engineering control measures: spatial barriers or partitions to manage patients in triage areas, curtains around each bed in inpatient wards, closed suctioning systems for airway suctioning in intubated patients, and airflow management. The CDC guidelines also recommend installing physical barriers using glass or plastic windows in the hospital reception area.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9961147308
                    }
                ]
            },
            {
                "text": "A pesar de todo, existen algunos escenarios en los que por causas concretas puede ser útil utilizar una doble mascarilla.",
                "text_en": "Despite everything, there are some scenarios in which for specific reasons it may be useful to use a double mask.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "algunos escenarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "some scenarios"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por causas concretas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by specific causes"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puede ser útil utilizar una doble mascarilla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it may be useful to use a double mask"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Mascarilla quirúrgica sobre FFP2",
                "text_en": "Surgical mask on FFP2",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Mascarilla quirúrgica sobre FFP2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Surgical mask on FFP2"
                    }
                ],
                "evidences": [
                    {
                        "value": "The protection offered by masks and respirators against particles larger than 0.3 μm is a surgical mask: 80%, FFP2: 94%, N95: 95%, FFP3: 99.9%, N100: 99.9%. It is strongly recommended to verify the National Institute for Occupational Safety and Health (NIOSH) quality certification, it must be written on the front of the device.",
                        "score": 0.5199999809
                    },
                    {
                        "value": "The protection factor of cloth, surgical and FFP-2 masks were evaluated by one study 32 which showed that cloth masks presented a considerably lower protection factor (1.9, CI95% 1.5,2.3) especially in children. Protection offered by a surgical mask and FFP2 respirator did not differ.",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9898758531
                    },
                    {
                        "label": "neutral",
                        "score": 0.9586440325
                    }
                ]
            },
            {
                "text": "Esta \"modalidad\" es habitual entre los profesionales sanitarios para evitar salpicaduras y aerosoles que provengan de los pacientes.",
                "text_en": "This \"modality\" is common among healthcare professionals to avoid splashes and sprays that come from patients.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los profesionales sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health professionals"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "evitar salpicaduras y aerosoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "avoid splashes and sprays"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los pacientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "patients"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De este modo la mascarilla quirúrgica actúa como una barrera, como un paraguas que preserva la FFP2, más costosa, alargando su vida útil.",
                "text_en": "In this way the surgical mask acts as a barrier, like an umbrella that preserves the most expensive FFP2, extending its service life.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la mascarilla quirúrgica actúa como una barrera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The surgical mask acts as a barrier"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "preserva la FFP2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "preserves FFP2"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "alargando su vida útil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "lengthening your service life"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Usar una mascarilla FFP2 sobre una mascarilla quirúrgica es un error ya que puede empeorar el ajuste.",
                "text_en": "Using a FFP2 mask on a surgical mask is a mistake as it may make adjustment worse.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Usar una mascarilla FFP2 sobre una mascarilla quirúrgica es un error",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Using a FFP2 mask on a surgical mask is a mistake"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que puede empeorar el ajuste",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because it can make the adjustment worse"
                    }
                ],
                "evidences": [
                    {
                        "value": "Loose-fitting surgical masks with straps allow profound inward leakage through gaps along the mask edges. Research has shown that surgical masks allow 8-12 times more penetration than N95 FFRs, with 86% of this penetration caused by lack of faceseal . One study using infectious influenza virus-containing aerosols found that a poorly fitted N95 FFR performed similarly to a loosefitting surgical mask; however, when the surgical mask was sealed over the mouth of the manikin with silicone caulk, the filtration efficiency increased from 56 to 95%, comparable to the minimum efficiency seen with a sealed N95 FFR (Noti et al., 2012) . This suggests that eliminating faceseal leakage in high quality surgical masks could substantially increase their aerosol filtration efficiency; however, this cannot be generalized to all surgical masks. Grinshpun et al. (2009) suggested that priority in the development of respiratory protection devices should be shifted from improving the efficiency of the filter medium to establishing a better fit that would eliminate or minimize faceseal leakage.",
                        "score": 0.5500000119
                    },
                    {
                        "value": "The overall FFs measured for nine models of surgical masks are presented in Fig. 4 . Based on these results, the nine surgical masks were divided into three classes, representing different levels of protection as tested by the ANOVA: high (Surgical masks 1, 2, 3 and 4), medium (Surgical masks 5, 6 and 7) and low (Surgical masks 8 and 9). Three surgical Fig. 3 . The comparison of PFs against particles in bacterial and viral size ranges between respirators without (N95 Respirator C) and with (N95 Respirator D) exhalation valves. The tests were performed when the N95 respirators were donned on human subjects. Each data point represents an average and standard deviation of 36 observations for N95 Respirator C and 9 observations for N95 Respirator D. Fig. 4 . Overall FFs measured for nine models of surgical masks with the PortaCount (with N95-Companion). The mask was donned on a human subject. Each bar represents an average and standard deviation of three replicate measurements performed by one human subject. Each replicate was done with the same type of unused surgical mask. mask models were chosen by randomly drawing one model from each class. As a result, Surgical masks 1, 5 and 8 were selected; they are labeled A, B and C, respectively, in the following text and figures. The PFs for these three models of surgical masks are shown in Fig. 5 . The overall GM of PFs was 2.4 (3 models Â 8 size classes Â 12 subjects Â 3 repeats 5 864 data points). The minimum PFs were found to be approximately between d a 5 0.04 and 0.32 lm for Surgical masks A and B and in a somewhat wider range for Surgical mask C. With respect to the geometric mean of PFs, the PF provided by surgical masks was nine times lower than that provided by N95 respirators.",
                        "score": 0.6000000238
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8834628463
                    },
                    {
                        "label": "neutral",
                        "score": 0.5337556005
                    }
                ]
            },
            {
                "text": "Haced la prueba si disponéis de estos dos tipos de mascarilla en casa y comprobaréis como al poner primero la quirúrgica y después la FFP2, la FFP2, que es la que ofrece mayor protección y cuyo ajuste ha sido ensayado, no se ajusta directamente a la cara perdiendo de este modo parte de su efectividad.",
                "text_en": "Do the test if you have these two types of mask at home and you will check how when you first put the surgical and then the FFP2, the FFP2, which is the one that offers the most protection and whose adjustment has been tested, does not fit directly to the face thus losing part of its effectiveness.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "perdiendo de este modo parte de su efectividad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "thus losing part of its effectiveness"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En el caso de las mascarillas de tela que no cumplan la normativa y de las que desconocemos su filtración, es decir, en el caso de ponernos en la boca un trozo de tela \"random\" que tengamos por casa, es posible que usar dos mascarillas pudiera ser mejor que solo una.",
                "text_en": "In the case of cloth masks that do not comply with the regulations and of which we do not know their filtration, that is, in the case of putting in our mouth a piece of cloth \"random\" that we have at home, it is possible that using two masks could be better than just one.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "las mascarillas de tela que no cumplan la normativa y de las que desconocemos su filtración",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "cloth masks that do not comply with the regulations and of which we do not know their filtration"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es posible que usar dos mascarillas pudiera ser mejor que solo una",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it's possible that using two masks could be better than just one."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Mascarilla quirúrgica + mascarilla quirúrgica o mascarilla quirúrgica más mascarilla higiénica que cumple la norma UNE0065",
                "text_en": "Surgical mask + surgical mask or surgical mask plus hygienic mask that meets UNE0065 standard",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Mascarilla quirúrgica + mascarilla quirúrgica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Surgical mask + surgical mask"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mascarilla quirúrgica más mascarilla higiénica que cumple la norma UNE0065",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "surgical mask plus hygienic mask that meets UNE0065 standard"
                    }
                ],
                "evidences": [
                    {
                        "value": "All hospital staff and the patients wore a surgical mask. A KN95 mask was worn under the surgical mask in the operating room by anesthetists, surgeons, and instrumentalist nurses. 3 Moreover, they wore protective glasses or face shields. No relatives could visit the patients during hospital stay. Daily phone calls were performed to inform patients' relatives.",
                        "score": 0.5099999905
                    },
                    {
                        "value": "At our institution, specialty team members practice social distancing and have been instructed to wear, at minimum, surgical masks (standard 3-ply) for all patient encounters throughout the hospital, regardless of patients' known COVID-19 status.",
                        "score": 0.5400000215
                    },
                    {
                        "value": "About 62.5% (n = 30) of the surgical team used regular surgical masks only covering nose and mouth, while only 12.5% (n = 6) used regular surgical mask and goggle, and only 6.3% (n = 3) of the surgeons used regular surgical mask with protective shield, regular surgical mask, protective shield, and N95 mask, regular surgical mask and N95 mask, or N95 mask only [ Figure 3a ]. All of the surgeons used ",
                        "score": 0.6299999952
                    },
                    {
                        "value": "Patients who accessed the clinic had to wear a surgical mask and gloves. For otological examinations, the staff wore a surgical mask, and gloves, since no aerosol production was involved. Instead, for oncological visits, pharynx and larynx evaluations, the medical staff wore an FFP2 mask, a surgical mask, face protection, a disposable gown, gloves and a cap (for risky aerosol producing procedures).",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9953665733
                    },
                    {
                        "label": "neutral",
                        "score": 0.931604445
                    },
                    {
                        "label": "contradiction",
                        "score": 0.9697480798
                    },
                    {
                        "label": "neutral",
                        "score": 0.8315374255
                    }
                ]
            },
            {
                "text": "Con estas modalidades no se mejora tanto el porcentaje de filtración como podría pensarse, sin embargo, en algunos casos sí se podría conseguir un mejor ajuste, algo que también es interesante y en lo que incide el Dr Fauci.",
                "text_en": "With these modalities the percentage of filtration is not as much improved as one might think, however, in some cases a better adjustment could be achieved, something that is also interesting and in what Dr Fauci affects.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se podría conseguir un mejor ajuste",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a better adjustment could be achieved"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo que sí podrían empeorar estas opciones es la respirabilidad y esto importante valorarlo de manera individual.",
                "text_en": "What could make these options worse is respiration, and this is important to evaluate individually.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "podrían empeorar estas opciones es la respirabilidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They could make these options worse. It's respirability."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si todo esto sucede también es posible que nos la toquemos más de la cuenta intentando estar cómodos, algo no deseable.",
                "text_en": "If all this happens it is also possible that we touch it more than the count trying to be comfortable, something undesirable.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "es posible que nos la toquemos más de la cuenta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's possible we'll touch her more than we know."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no deseable",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "undesirable"
                    }
                ],
                "evidences": []
            },
            {
                "text": "- Quirúrgica sobre FFP2 SÍ, para protegerla de salpicaduras especialmente en el entorno sanitario o de cuidados a terceros.",
                "text_en": "- Surgical on FFP2 YES, to protect it from splashing especially in the health or care environment to third parties.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Quirúrgica sobre FFP2 S",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Surgical on FFP2 S"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "protegerla de salpicaduras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "protect it from splashes"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el entorno sanitario o de cuidados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the health or care environment"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a terceros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to third parties"
                    }
                ],
                "evidences": [
                    {
                        "value": "The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21258080 doi: medRxiv preprint transesophageal echocardiography, reanimation, non-invasive ventilation, and suction of tracheal secretions. Participants had the choice among \"Use of surgical mask only\"; \"Mostly use of surgical mask\"; \"Equal use of both mask types\"; \"Mostly use of FFP2\"; \"Use of FFP2 only\". For the purpose of this analysis, the two latter categories were classified as \"Mostly FFP2\", whereas the first three categories were merged into the group \"Not mostly FFP2\" (for better comprehensibility termed \"Mostly surgical masks\"). For HCW involved in AGPs, we also asked whether they always used FFP2 during AGPs, irrespective of the patient's COVID-19 status (i.e. termed \"universal FFP2 use\"). Furthermore, use of other PPE including gowns, gloves and goggles while caring for COVID-19 patients was asked, as well as the number of COVID-19 patients and of positive co-workers HCW had been knowingly exposed since March 2020 (for description and categorisation of variables, see Table S1 ). ",
                        "score": 0.5600000024
                    },
                    {
                        "value": "Of the 175 batches of FFP2/N95 masks and 31 batches of surgical masks tested by our laboratory in thirty-six days, 81% of FFP2 mask batches and 97% of surgical mask batches were released for use. The testing prevented 19% of defective batches of FFP2/N95 masks and 3% of defective batches of surgical masks being delivered to health care personnel. Even in a health crisis context, it is vital to take the time to perform the quality checks that guarantee the safety of personal.",
                        "score": 0.5699999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.9391770363
                    },
                    {
                        "label": "neutral",
                        "score": 0.9960108995
                    }
                ]
            },
            {
                "text": "- FFP2 sobre quirúrgica NO, porque se pierde ajuste de la FFP2, que es una parte fundamental al valorar su eficacia.",
                "text_en": "- FFP2 on surgical NO, because adjustment of FFP2 is lost, which is an essential part when assessing its efficacy.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "FFP2 sobre quirúrgica NO",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "FFP2 on surgical NO"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque se pierde ajuste de la FFP2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because FFP2 adjustment is lost"
                    }
                ],
                "evidences": [
                    {
                        "value": "Only one FFP2 respirator brand was used in this study. Similar findings are expected with other FFP2 respirators undergoing UVGI treatment because the filter media are typically polypropylene. There are, however, some caution needed in extrapolating these results to other FFP2 respirator brands, in particular during periods of respiratory supply shortage. Respirators that have not undergone testing and can be of lower quality will then likely appear on the market. For this reason, recycling should be limited to respirators with particularly low penetration rates, typically around 1%. This gives a larger margin of safety with respect to the minimum requirements of the FFP2 and N95 standards.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9989218712
                    }
                ]
            },
            {
                "text": "- Quirúrgica + quirúrgica o quirúrgica + higiénica no es necesario en general.",
                "text_en": "- Surgical + surgical + hygienic is not generally necessary.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Quirúrgica + quirúrgica o quirúrgica + higiénica no es necesario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Surgical + surgical + hygienic is not necessary"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Solo debe hacerse si se respira adecuadamente con ellas y se consigue un mejor ajuste.",
                "text_en": "It should only be done if you breathe properly with them and get a better fit.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "si se respira adecuadamente con ellas y se consigue un mejor ajuste",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "if you breathe properly with them and you get a better fit"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En espacios donde el riesgo sea elevado, mejor evitar estos \"apaños\" y utilizar FFP2.",
                "text_en": "In areas where the risk is high, it is better to avoid these \"steps\" and use FFP2.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En espacios donde el riesgo sea elevado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In spaces where the risk is high"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "utilizar FFP2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "use FFP2"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Mascarillas FFP2 obligatorias?",
                "text_en": "Mandatory FFP2 masks?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Mascarillas FFP2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "FFP2 masks"
                    }
                ],
                "evidences": [
                    {
                        "value": "Only 57.3% of the family doctors have received relevant training on PPE use, including surgical masks, gloves, gowns, N95\\Filtering Face Pieces 2 (FFP2) masks, face shields, and protective glass. However, all participants used a surgical mask and 98.4% used gloves. In comparison to a study done in Singapore published in 2020, all medical staff was trained on how to use the PPE appropriately. Furthermore, PPE use was mandatory for all patients at the counter, reception staff, and doctors during patients' consultation either in isolation or standard consultation rooms [19] .",
                        "score": 0.5199999809
                    },
                    {
                        "value": "A recently published meta-analysis comparing different types of masks versus no mask reported better protection against MERS, SARS and COVID-19 in studies using FFP2 (96% protection rate) compared to surgical masks (77% protection rate) [48] . This conclusion should be seen with caution, as they are based on in-between study rather than within-study comparisons. Furthermore, studies in a healthcare setting, which more frequently used FFP2 masks, have been shown to generally perform better than studies performed in the community. Direct comparisons between the two mask types are mandatory.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9943695664
                    },
                    {
                        "label": "neutral",
                        "score": 0.9826678634
                    }
                ]
            },
            {
                "text": "No parece que, por el momento, vayan a ser obligatorias en nuestro país, aunque sí es interesante emplearlas en transporte público o espacios concurridos y poco ventilados, especialmente en personas de riesgo, tal y como hablamos la pasada semana.",
                "text_en": "It does not seem that, for the time being, they will be mandatory in our country, although it is interesting to use them in public transport or crowded and poorly ventilated spaces, especially in people at risk, as we talked about last week.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No parece que, por el momento, vayan a ser obligatorias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It does not seem that, for the time being, they will be mandatory."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "por el momento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the time being"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en nuestro país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in our country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es interesante emplearlas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's interesting to use them."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en transporte público o espacios concurridos y poco ventilados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by public transport or crowded and poorly ventilated spaces"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas de riesgo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons at risk"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "96": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 20,
            "WhatReliabilityReliable": 20,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 20,
            "WhoReliabilityReliable": 20,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 12,
            "WhenReliabilityReliable": 11,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 5,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 4,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 6,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 6,
            "WhoRoleSubject": 13,
            "WhoRoleTarget": 6,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 12,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 12,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nKlarem Valoyes Gutiérrez\n\n<PARAGRAPH>\n\nBogotá, 2 abr (EFE).- Las autoridades colombianas volvieron a apretar las restricciones a la población en plena Semana Santa ante el aumento de la ocupación de las UCI pese a que el número de casos diarios de covid-19 está lejos del pico alcanzado en enero pasado, cuando el país llegó a tener más de 20.000 contagios al día.\n\n<PARAGRAPH>\n\nEl aumento de las infecciones y muertes por el coronavirus en las últimas semanas tiene en alerta a varias regiones del país donde, anticipándose a un tercer pico de la pandemia, las autoridades han decretado medidas como toques de queda y ley seca.\n\n<PARAGRAPH>\n\nCon esas disposiciones el país espera frenar la velocidad de propagación del virus y bajar las cifras de contagios que se han duplicado y hasta triplicado, con respecto a las de hace tres semanas, en regiones como Antioquia, Bogotá, Atlántico y el Valle del Cauca.\n\n<PARAGRAPH>\n\n«Desde mediados de marzo estamos observando un incremento paulatino del número de casos, fallecimientos, ocupación hospitalaria y de cuidados intensivos», explica a Efe el médico epidemiólogo de la Universidad del Rosario Carlos Enrique Trillos, al advertir que «todo esto refleja un aumento de la dinámica de transmisión viral».\n\n<PARAGRAPH>\n\nEl aumento de las cifras en lugares como la ciudad caribeña de Barranquilla sugiere, según Trillos, que «estamos entrando en un nuevo pico» de la pandemia cuyo impacto será menor o mayor al de los dos anteriores dependiendo «del refuerzo de medidas restrictivas por parte de las autoridades sanitarias».\n\n<PARAGRAPH>\n\nColombia sumó el miércoles 8.646 contagios, la cifra de infecciones más alta desde el 4 de febrero, y 167 muertes, con lo que acumula 2.406.377 casos y 63.422 fallecidos.\n\n<PARAGRAPH>\n\nEL CARIBE, EN ALERTA MÁXIMA\n\n<PARAGRAPH>\n\nBarranquilla, capital del departamento del Atlántico, tuvo su primer pico de contagios en junio del año pasado y hoy experimenta un incremento pronunciado en la curva de casos, al registrar 17.190 nuevos infectados en apenas 23 días, periodo en el que la covid-19 se cobró además la vida de 228 personas.\n\n<PARAGRAPH>\n\nPara las autoridades de esa ciudad es preocupante la alta cifra de positividad ya que de cada 100 pruebas practicadas 26 dan positivo.\n\n<PARAGRAPH>\n\nEsto se refleja en la ocupación de unidades de cuidados intensivos (UCI), lo que se agrava con la llegada de pacientes remitidos de otras ciudades de la región.\n\n<PARAGRAPH>\n\nCon una capacidad instalada de 749 camas UCI, la ocupación está en el 86 %, de los cuales el 64 % son pacientes de Barranquilla y el 22 % de otros municipios del Atlántico y del resto de la región Caribe, especialmente de la vecina ciudad de Santa Marta, que también sufre el ascenso de las cifras.\n\n<PARAGRAPH>\n\nSEMANA SANTA, PUNTO DE INFLEXIÓN\n\n<PARAGRAPH>\n\nLas autoridades temen que las muertes y contagios se disparen después de Semana Santa, pues como señala Trillos, «los picos de covid-19 en muchos países se relacionan con temporadas vacacionales y festivos, con aumentos de reuniones familiares y de amigos».\n\n<PARAGRAPH>\n\nPara anticiparse a un tercer pico, Bogotá prepara un plan de expansión hospitalaria para pacientes críticos por coronavirus.\n\n<PARAGRAPH>\n\nLa capital colombiana, cuya ocupación de las UCI está en el 64,4 %, de las cuales el 56,8 % corresponde a pacientes con coronavirus, es el foco principal de la emergencia con 687.382 contagios y 14.409 muertes.\n\n<PARAGRAPH>\n\nAnte esas cifras, la Alcaldía impuso desde ayer y hasta el próximo 5 de abril un toque de queda que restringe la movilidad entre la medianoche y las cinco de la mañana, medida similar a la decretada hasta el próximo lunes y durante 12 horas diarias en el departamento de Antioquia, que acumula 374.623 infecciones.\n\n<PARAGRAPH>\n\nAunque estas restricciones tienen un carácter preventivo, el epidemiólogo Javier Idrovo, de la Universidad Industrial de Santander, explica a Efe que ha pasado un año desde que empezaron a implementarse con regularidad y «nadie ha hecho una evaluación real de si funcionan o no».\n\n<PARAGRAPH>\n\n«Hay unas medidas que se toman sin ningún sustento en sentido cuantitativo.\n\n<BREAK>\n\nDespués de un año ya deberíamos tener una evidencia para saber cuáles de ellas se deben aplicar porque parece que creemos que el virus solo se propaga de noche», señala.\n\n<PARAGRAPH>\n\nLA VACUNACIÓN AVANZA\n\n<PARAGRAPH>\n\nMientras tanto, Colombia avanza en su Plan Nacional de Vacunación contra la covid-19 y terminó marzo con 2.243.392 dosis aplicadas, aunque el proceso comenzó el pasado 17 de febrero de manera lenta.\n\n<PARAGRAPH>\n\nEsta semana ha sido aplicada una media de 141.000 dosis diarias, con lo que de continuar a este ritmo el número de vacunados igualará en los próximos días el de infectados.\n\n<PARAGRAPH>\n\nLa meta del Gobierno colombiano es vacunar a lo largo de este año a 35,2 millones de personas, equivalentes al 70 % de la población nacional, para alcanzar la inmunidad de rebaño.\n\n<PARAGRAPH>\n\nSin embargo, Idrovo advierte que el ritmo de la vacunación, que depende principalmente de la disponibilidad de dosis, debe aumentar porque la lentitud «genera una sensación de tranquilidad» y «una posibilidad biológica de que comiencen a aparecer nuevas formas del virus con capacidad de contagio más fuerte».\n\n<BREAK>\n\nEFE\n\n<PARAGRAPH>\n",
        "TITLE": "La Semana Santa, punto de inflexión de la pandemia, pone en alerta a Colombia",
        "ID": "NF_04-11-2021_22-14-26_www_eje21_com_co",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La Semana Santa, punto de inflexión de la pandemia, pone en alerta a Colombia",
                "text_en": "Holy Week, the turning point of the pandemic, alerts Colombia",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "La Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Holy Week"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pone en alerta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "puts on alert"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Colombia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Bogotá, 2 abr (EFE).- Las autoridades colombianas volvieron a apretar las restricciones a la población en plena Semana Santa ante el aumento de la ocupación de las UCI pese a que el número de casos diarios de covid-19 está lejos del pico alcanzado en enero pasado, cuando el país llegó a tener más de 20.000 contagios al día.",
                "text_en": "Bogotá, 2 Apr (EFE).- The Colombian authorities tightened the restrictions on the population in the middle of Holy Week in the face of the increase in the occupation of the ICUs despite the fact that the number of daily cases of covid-19 is far from the peak reached last January, when the country came to have more than 20,000 infections per day.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Las autoridades colombianas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombian authorities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "volvieron a apretar las restricciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "again tightened the restrictions"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the population"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en plena Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the middle of Holy Week"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ante el aumento de la ocupación de las UCI",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "against the increase in the occupation of the ICUs"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El aumento de las infecciones y muertes por el coronavirus en las últimas semanas tiene en alerta a varias regiones del país donde, anticipándose a un tercer pico de la pandemia, las autoridades han decretado medidas como toques de queda y ley seca.",
                "text_en": "The increase in infections and deaths from the coronavirus in recent weeks has alerted several regions of the country where, anticipating a third peak of the pandemic, authorities have decreed measures such as curfews and dry law.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El aumento de las infecciones y muertes por el coronavirus en las últimas semanas tiene en alerta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Increased infections and deaths from coronavirus in recent weeks have been on alert"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en las últimas semanas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the last few weeks"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a varias regiones del país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to various regions of the country"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las autoridades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "authorities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han decretado medidas como toques de queda y ley seca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have decreed measures such as curfews and dry law"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Con esas disposiciones el país espera frenar la velocidad de propagación del virus y bajar las cifras de contagios que se han duplicado y hasta triplicado, con respecto a las de hace tres semanas, en regiones como Antioquia, Bogotá, Atlántico y el Valle del Cauca.",
                "text_en": "With these provisions, the country hopes to slow down the rate of spread of the virus and reduce the number of infections that have doubled and even tripled, compared to those of three weeks ago, in regions such as Antioquia, Bogotá, Atlántico and Valle del Cauca.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Con esas disposiciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "With these provisions"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "espera frenar la velocidad de propagación del virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "expects to slow down the rate of spread of the virus"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "hace tres semanas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Three weeks ago"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en regiones como Antioquia, Bogotá, Atlántico y el Valle del Cauca.",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in regions such as Antioquia, Bogotá, Atlántico and Valle del Cauca."
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Desde mediados de marzo estamos observando un incremento paulatino del número de casos, fallecimientos, ocupación hospitalaria y de cuidados intensivos», explica a Efe el médico epidemiólogo de la Universidad del Rosario Carlos Enrique Trillos, al advertir que «todo esto refleja un aumento de la dinámica de transmisión viral».",
                "text_en": "«Since mid-March we have seen a gradual increase in the number of cases, deaths, hospital and intensive care occupations», explains the epidemiologist of the University of Rosario Carlos Enrique Trillos to Efe, warning that «all this reflects an increase in the dynamics of viral transmission».",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Desde mediados de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Since mid-March"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "estamos observando un incremento paulatino del número de casos, fallecimientos, ocupación hospitalaria y de cuidados intensivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We are seeing a gradual increase in the number of cases, deaths, hospital and intensive care occupations."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a Efe",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a Efe"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el médico epidemiólogo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the epidemiologist doctor"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Universidad del Rosario Carlos Enrique Trillos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Universidad del Rosario Carlos Enrique Trillos"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El aumento de las cifras en lugares como la ciudad caribeña de Barranquilla sugiere, según Trillos, que «estamos entrando en un nuevo pico» de la pandemia cuyo impacto será menor o mayor al de los dos anteriores dependiendo «del refuerzo de medidas restrictivas por parte de las autoridades sanitarias».",
                "text_en": "The increase in figures in places such as the Caribbean city of Barranquilla suggests, according to Trillos, that \"we are entering a new peak\" of the pandemic whose impact will be less or more than that of the previous two depending \"on the reinforcement of restrictive measures by the health authorities\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aumento de las cifras",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "increase in numbers"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en lugares como la ciudad caribeña de Barranquilla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in places like the Caribbean city of Barranquilla"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Colombia sumó el miércoles 8.646 contagios, la cifra de infecciones más alta desde el 4 de febrero, y 167 muertes, con lo que acumula 2.406.377 casos y 63.422 fallecidos.",
                "text_en": "Colombia added up on Wednesday 8.646 infections, the highest number of infections since February 4, and 167 deaths, resulting in 2,406,377 cases and 63,422 deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sumó el miércoles 8.646 contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "added up on Wednesday 8,646 contagions"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Wednesday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Barranquilla, capital del departamento del Atlántico, tuvo su primer pico de contagios en junio del año pasado y hoy experimenta un incremento pronunciado en la curva de casos, al registrar 17.190 nuevos infectados en apenas 23 días, periodo en el que la covid-19 se cobró además la vida de 228 personas.",
                "text_en": "Barranquilla, capital of the department of the Atlantic, had its first peak of contagion in June of last year and today experiences a pronounced increase in the curve of cases, registering 17,190 new infected in just 23 days, period in which the covid-19 also took the lives of 228 people.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Barranquilla, capital del departamento del Atlántico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Barranquilla, capital of the Atlantic department"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tuvo su primer pico de contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had its first peak of contagion"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en junio del año pasado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in June of last year"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para las autoridades de esa ciudad es preocupante la alta cifra de positividad ya que de cada 100 pruebas practicadas 26 dan positivo.",
                "text_en": "For the authorities of that city, the high number of positivity is worrying, since out of every 100 tests carried out 26 are positive.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las autoridades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "authorities"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "esa ciudad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "that city"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es preocupante la alta cifra de positividad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the high number of positivity is worrying"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que de cada 100 pruebas practicadas 26 dan positivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since out of every 100 tests performed 26 are positive"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto se refleja en la ocupación de unidades de cuidados intensivos (UCI), lo que se agrava con la llegada de pacientes remitidos de otras ciudades de la región.",
                "text_en": "This is reflected in the occupation of intensive care units (ICUs), which is aggravated by the arrival of referrals from other cities in the region.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esto se refleja en la ocupación de unidades de cuidados intensivos (UCI)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This is reflected in the occupation of intensive care units (ICUs)"
                    }
                ],
                "evidences": [
                    {
                        "value": "In the backdrop of the COVID-19 pandemic, intensive care resources are in high demand but are not always available. In addition to the great demand for intensive care beds, the long occupation of intensive care units by severely-ill patients in intensive care units and specific mechanical ventilation methods, creates further challenges in availing more intensive care beds and the reallocation of used beds to new patients. How does one decide who has more priority to receive intensive care and invasive mechanical ventilation assistance (6)?",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9973326921
                    }
                ]
            },
            {
                "text": "Las autoridades temen que las muertes y contagios se disparen después de Semana Santa, pues como señala Trillos, «los picos de covid-19 en muchos países se relacionan con temporadas vacacionales y festivos, con aumentos de reuniones familiares y de amigos».",
                "text_en": "The authorities fear that deaths and contagions will spread after Holy Week, because as Trillos points out, \"the peaks of covid-19 in many countries are related to holiday and holiday seasons, with increases in family and friends meetings\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Las autoridades",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The authorities"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "temen que las muertes y contagios se disparen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "fear that deaths and contagions will spread"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after Easter"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para anticiparse a un tercer pico, Bogotá prepara un plan de expansión hospitalaria para pacientes críticos por coronavirus.",
                "text_en": "To anticipate a third peak, Bogotá prepares a hospital expansion plan for critical patients by coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Bogotá",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Bogotá"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "prepara un plan de expansión hospitalaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "prepares a hospital expansion plan"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "pacientes críticos por coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "critical patients by coronavirus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ante esas cifras, la Alcaldía impuso desde ayer y hasta el próximo 5 de abril un toque de queda que restringe la movilidad entre la medianoche y las cinco de la mañana, medida similar a la decretada hasta el próximo lunes y durante 12 horas diarias en el departamento de Antioquia, que acumula 374.623 infecciones.",
                "text_en": "In view of these figures, the Mayor's office imposed a curfew from yesterday until April 5 which restricts mobility between midnight and five in the morning, a measure similar to that decreed until next Monday and for 12 hours daily in the department of Antioquia, which accumulates 374,623 infections.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Alcaldía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Mayor’s Office"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "impuso desde ayer y hasta el próximo 5 de abril un toque de queda",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "imposed a curfew from yesterday until April 5th"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde ayer y hasta el próximo 5 de abril",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from yesterday until April 5th"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aunque estas restricciones tienen un carácter preventivo, el epidemiólogo Javier Idrovo, de la Universidad Industrial de Santander, explica a Efe que ha pasado un año desde que empezaron a implementarse con regularidad y «nadie ha hecho una evaluación real de si funcionan o no».",
                "text_en": "Although these restrictions are of a preventive nature, epidemiologist Javier Idrovo of the Industrial University of Santander explains to Efe that it has been a year since they began to be implemented regularly and \"no one has made a real evaluation of whether they work or not\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el epidemiólogo Javier Idrovo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "epidemiologist Javier Idrovo"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Universidad Industrial de Santander",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Universidad Industrial de Santander"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a Efe",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a Efe"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha hecho una evaluación real de si funcionan o no",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has made a real assessment of whether or not they work"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Después de un año ya deberíamos tener una evidencia para saber cuáles de ellas se deben aplicar porque parece que creemos que el virus solo se propaga de noche», señala.",
                "text_en": "After a year we should already have some evidence to know which of them should be applied because it seems that we believe that the virus only spreads at night,\" he says.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Después de un año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "After a year"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ya deberíamos tener una evidencia para saber cuáles de ellas se deben aplicar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We should already have some evidence to know which of them should be applied."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque parece que creemos que el virus solo se propaga de noche",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Because it looks like we think the virus only spreads at night."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de noche",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "night"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Mientras tanto, Colombia avanza en su Plan Nacional de Vacunación contra la covid-19 y terminó marzo con 2.243.392 dosis aplicadas, aunque el proceso comenzó el pasado 17 de febrero de manera lenta.",
                "text_en": "Meanwhile, Colombia is advancing its National Covid-19 Vaccination Plan and ended March with 2,243,392 doses applied, although the process began on February 17th slowly.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "avanza en su Plan Nacional de Vacunación contra la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "progress in its National Plan for Vaccination against Covid-19"
                    }
                ],
                "evidences": [
                    {
                        "value": "The national vaccination register contains information on vaccination for COVID-19 since 1 January 2021. The information includes personal identifier and date of vaccination. The vaccine products are specified by a unique identifier based on a combination of brand name, substance, formulation, additionally batch number and dose number (for repeated doses). The completeness of registration within the child immunisation program is high, where 98.4% of children had at least one vaccination recorded; however, completeness for vaccination for COVID-19 has not been published (9) . The register is held by the Public Health Agency of Sweden.",
                        "score": 0.5099999905
                    },
                    {
                        "value": "On 17 February 2021, the national COVID-19 vaccination plan started in Colombia, with the arrival, on previous days, of the first doses of the Pfizer-BioNTech (New York, NY, USA) COVID-19 vaccine (BNT162b2). Nevertheless, so far, up to 15 March 2021, only 913,961 doses have been applied, mainly in healthcare workers and the population ≥80-year-old. Colombia has a population of 51,049,498 people, with approximately 1.8 physicians per 1000 people (2021).",
                        "score": 0.8199999928
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8913372755
                    },
                    {
                        "label": "neutral",
                        "score": 0.998867631
                    }
                ]
            },
            {
                "text": "Esta semana ha sido aplicada una media de 141.000 dosis diarias, con lo que de continuar a este ritmo el número de vacunados igualará en los próximos días el de infectados.",
                "text_en": "This week, an average of 141,000 daily doses have been applied, so that if the number of vaccinated will continue at this rate, the number of infected will be equal in the next few days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Esta semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This week"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha sido aplicada una media de 141.000 dosis diarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has been applied on average 141,000 daily doses"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La meta del Gobierno colombiano es vacunar a lo largo de este año a 35,2 millones de personas, equivalentes al 70 % de la población nacional, para alcanzar la inmunidad de rebaño.",
                "text_en": "The goal of the Colombian Government is to immunize 35.2 million people, equivalent to 70% of the national population, this year in order to achieve herd immunity.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La meta del Gobierno colombiano es vacunar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombian government’s goal is to vaccinate"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a lo largo de este año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout this year"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a 35,2 millones de personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "35.2 million persons"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sin embargo, Idrovo advierte que el ritmo de la vacunación, que depende principalmente de la disponibilidad de dosis, debe aumentar porque la lentitud «genera una sensación de tranquilidad» y «una posibilidad biológica de que comiencen a aparecer nuevas formas del virus con capacidad de contagio más fuerte».",
                "text_en": "However, Idrovo warns that the pace of vaccination, which depends mainly on the availability of doses, should increase because the slowness \"generates a sense of tranquility\" and \"a biological possibility that new forms of the virus with stronger contagion will begin to appear\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Idrovo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Idrovo"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el ritmo de la vacunación, que depende principalmente de la disponibilidad de dosis, debe aumentar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the rate of vaccination, which depends mainly on the availability of doses, should increase"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque la lentitud «genera una sensación de tranquilidad» y «una posibilidad biológica de que comiencen a aparecer nuevas formas del virus con capacidad de contagio más fuerte»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "because slowness “generates a sense of tranquility” and “a biological possibility for new forms of the virus to begin to appear with a stronger contagion capacity”"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "97": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 7,
            "WhatReliabilityReliable": 3,
            "WhatReliabilityUnreliable": 4,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 5,
            "WhoReliabilityReliable": 4,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 1,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 3,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 1,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 3,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 2,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nNo podemos evitar preguntarnos en infinidad de ocasiones si Fernando Simón es una persona demasiado lista o demasiado tonta porque a lo largo de todo este año nos ha dejado unos momentos en los que ha hecho tanto el ridículo, que ya no sabemos ni qué pensar de él.\n\n<PARAGRAPH>\n\nY en una entrevista que ha publicado ‘El Diario de Mallorca‘ nos vuelve a despistar puesto que, con las declaraciones que realiza, nos viene a decir que, a lo largo de toda esta “pandemia”, se han tomado decisiones por impulsos, con graves consecuencias para todos nosotros que se han tomado sin ninguna meditación y porque no se les ocurría otra cosa.\n\n<PARAGRAPH>\n\nDecir cosas como que “se confinó a la población porque no sabíamos qué hacer” es una nueva prueba que nos deja claro un hecho casi incontestable: a este tipo le da todo igual y no mide nunca las consecuencias de sus palabras, algo que dice mucho de él, aunque nada bueno.\n\n<PARAGRAPH>\n\nPorque venir a decirnos a estas alturas, cuando todavía estamos sufriendo un estado de alarma interminable que ni se enteran, ni se han enterado de nada, es absolutamente lamentable: “Sí que creo que podríamos haber presionado mucho mas a nivel internacional, en concreto a la OMS y a China, para tener mas información antes y de mayor calidad.\n\n<BREAK>\n\nYo creo que China no ocultó demasiada información.\n\n<BREAK>\n\nAlgo seguro que ocultaría, algo que querrían verificar y eso retrasa la información, pero yo creo que no ocultaron demasiada.\n\n<BREAK>\n\nSí que creo que en algunos casos no tenían suficiente y en momentos claves no se hizo el esfuerzo internacional.\n\n<BREAK>\n\nCreo que en eso fallamos un poco”.\n\n<PARAGRAPH>\n\nY este, señores, es el responsable del gobierno y la cara visible en la situación que estamos viviendo.\n\n<BREAK>\n\nLo raro es que todavía no haya habido un juez con el suficiente valor como para haberlo sentado delante de él, a pesar de las múltiples denuncias y querellas que ha recibido.\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Fernando Simón sigue haciendo gala de su ignorancia y su irresponsabilidad, pero de marcharse a su casa no dice nada",
        "ID": "NF_04-11-2021_21-35-21_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Fernando Simón sigue haciendo gala de su ignorancia y su irresponsabilidad, pero de marcharse a su casa no dice nada",
                "text_en": "Fernando Simón continues to show his ignorance and irresponsibility, but to go home says nothing",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fernando Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fernando Simón"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sigue haciendo gala de su ignorancia y su irresponsabilidad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "continues to show ignorance and irresponsibility"
                    }
                ],
                "evidences": []
            },
            {
                "text": "No podemos evitar preguntarnos en infinidad de ocasiones si Fernando Simón es una persona demasiado lista o demasiado tonta porque a lo largo de todo este año nos ha dejado unos momentos en los que ha hecho tanto el ridículo, que ya no sabemos ni qué pensar de él.",
                "text_en": "We cannot avoid asking ourselves on countless occasions whether Fernando Simón is a person too smart or too silly because throughout this year he has left us a few moments in which he has made so much of a fool, that we no longer know what to think of him.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Fernando Simón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fernando Simón"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es una persona demasiado lista o demasiado tonta",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "is a person too smart or too silly"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque a lo largo de todo este año nos ha dejado unos momentos en los que ha hecho tanto el ridículo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because throughout this year he has left us a few moments in which he has made so much of a fool"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y en una entrevista que ha publicado ‘El Diario de Mallorca‘ nos vuelve a despistar puesto que, con las declaraciones que realiza, nos viene a decir que, a lo largo de toda esta “pandemia”, se han tomado decisiones por impulsos, con graves consecuencias para todos nosotros que se han tomado sin ninguna meditación y porque no se les ocurría otra cosa.",
                "text_en": "And in an interview he has published ‘El Diario de Mallorca‘ we are once again lost since, with the statements he makes, he tells us that, throughout all this ‘pandemy’, decisions have been made by impulses, with serious consequences for all of us who have been taken without any meditation and because they could not think of anything else.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una entrevista que ha publicado ‘El Diario de Mallorca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in an interview he has published ‘El Diario de Mallorca"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a lo largo de toda esta “pandemia”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout this “pandemy”"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se han tomado decisiones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "decisions have been taken"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin ninguna meditación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "without any meditation"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque no se les ocurría otra cosa",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because they couldn't think of anything else."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Decir cosas como que “se confinó a la población porque no sabíamos qué hacer” es una nueva prueba que nos deja claro un hecho casi incontestable: a este tipo le da todo igual y no mide nunca las consecuencias de sus palabras, algo que dice mucho de él, aunque nada bueno.",
                "text_en": "Saying things like “the people were confined to it because we didn’t know what to do” is a new test that makes clear to us an almost incontestable fact: this guy doesn’t care about everything and never measures the consequences of his words, something that says a lot about him, although nothing good.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se confinó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was defined"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the population"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque no sabíamos qué hacer",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because we didn't know what to do."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a este tipo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "This guy."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "le da todo igual y no mide nunca las consecuencias de sus palabras",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "gives everything the same and never measures the consequences of his words"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sí que creo que en algunos casos no tenían suficiente y en momentos claves no se hizo el esfuerzo internacional.",
                "text_en": "I do believe that in some cases they did not have enough and at key times the international effort was not made.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en algunos casos no tenían suficiente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in some cases they did not have enough"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en momentos claves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at key times"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no se hizo el esfuerzo internacional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the international effort was not made"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Lo raro es que todavía no haya habido un juez con el suficiente valor como para haberlo sentado delante de él, a pesar de las múltiples denuncias y querellas que ha recibido.",
                "text_en": "The strange thing is that there has not yet been a judge brave enough to have sat him in front of him, despite the many complaints and complaints he has received.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Lo raro es que todavía no haya habido un juez con el suficiente valor como para haberlo sentado delante de él",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The weird thing is, there hasn't been a judge brave enough to sit in front of him yet."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un juez",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a judge"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a pesar de las múltiples denuncias y querellas que ha recibido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "despite the multiple complaints and complaints received"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "98": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 23,
            "WhatReliabilityReliable": 23,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 11,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 9,
            "WhenReliabilityReliable": 9,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 11,
            "WhereReliabilityReliable": 10,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 3,
            "WhyReliabilityReliable": 3,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 11,
            "HowReliabilityReliable": 11,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 3,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 4,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 4,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nSe tendría que aplicar en la primera fase de la enfermedad y reduce la carga antiviral.\n\n<BREAK>\n\nSe ha demostrado ser seguro en los primeros ensayos clínicos en humanos\n\n<PARAGRAPH>\n\nEl Aplidin es un fármaco anticancerígeno que se basa en la molécula plitidepsina y podría convertirse en el primer medicamento con una efectividad probada al momento de reducir la carga viral en la primera semana de la infección por Covid-19.\n\n<PARAGRAPH>\n\nLa fase 2 del ensayo con Aplidin contra el coronavirus ha concluido con resultados esperanzadores.\n\n<PARAGRAPH>\n\nAsí lo han indicado los especialistas que han participado en esta investigación en hospitales de la Comunidad de Madrid.\n\n<PARAGRAPH>\n\nEntre un 80% y un 90% de los 24 pacientes hospitalizados por Covid que participaron en la fase 2 de los ensayos clínicos, realizados en 13 hospitales españoles, fueron dados de alta en los primeros 14 días y un 37%, lo consiguieron antes del octavo día, según han informado este martes los propios investigadores participantes en el estudio en rueda de prensa.\n\n<PARAGRAPH>\n\nAdemás, este fármaco podría reducir los efectos secundarios que provoca la enfermedad.\n\n<PARAGRAPH>\n\n«Si curamos la infección de raíz, es probable que no se desarrolle ningún efecto secundarios, aunque habrá que esperar», ha apuntado uno de los expertos en rueda de prensa.\n\n<PARAGRAPH>\n\nLos especialistas han apuntado que este fármaco se tendría que aplicar en la primera fase de la enfermedad, cuando comienzan a manifestarse los síntomas, para que tenga una efectividad mayor.\n\n<PARAGRAPH>\n\nEl medicamento tendría menos efecto si se suministra en la fase 2, cuando los pacientes ya manifiestan un estado inflamatorio.\n\n<PARAGRAPH>\n\nDe esta manera y, siempre que se confirmen los resultados en la última fase de ensayos clínicos, el fármaco se convertiría en un complemento a corticoides como la dexametasona, de probada eficacia en la segunda semana de infección grave, cuando comienza la inflamación provocada por la respuesta descontrolada del propio sistema inmunológico.\n\n<PARAGRAPH>\n\n«Hay que elegir bien al paciente y hay que elegirlo pronto», ha señalado Pedro Landete, neumólogo de La Princesa.\n\n<BREAK>\n\n«La replicación viral en estos pacientes cae de manera drástica, y sobre todo cuánto más al inicio de los síntomas damos este tratamiento».\n\n<PARAGRAPH>\n\nEl equipo de investigadores del estudio impulsado por la compañía biofarmacéutica española PharmaMar están ahora a la espera de la autorización, por parte de la Agencia Española del Medicamento, para poder empezar con la fase 3 y se mostraron convencidos de que los resultados serán positivos también en esas pruebas.\n\n<PARAGRAPH>\n\nPara eso, en las próximas semanas, Pharmamar discutirá «de una manera lineal, honesta, ética y directa» con las agencias reguladoras, como la Agencia Española del Medicamento y la FDA estadounidense, para que se apruebe un ensayo con más pacientes que permita comparar los resultados del fármaco con los tratamientos actuales contra el coronavirus.\n\n<PARAGRAPH>\n\nEl consejero de Sanidad de la Comunidad de Madrid, Enrique Ruiz Escudero, ha acompañado a los investigadores y se ha mostrado esperanzado en que en «un futuro no muy lejano» podría contarse «con un tratamiento eficaz contra la enfermedad».\n\n<PARAGRAPH>\n\nLa plitidepsina, administrada por vía oral durante tres días consecutivos, se ha mostrado eficaz durante la primera fase de la enfermedad, en la que se produce la replicación viral.\n\n<PARAGRAPH>\n\nEste fármaco impide al virus replicarse en el interior de la célula humana uniéndose a una proteína humana, la EF1A, esencial para que el virus se pueda replicar, y bloqueándola.\n\n<BREAK>\n\nEso inhibe la capacidad del virus de propagarse por el organismo.\n\n<PARAGRAPH>\n\nAplidin secuestraría el virus, formando un complejo estable que haga que el virus no sea viable.\n\n<PARAGRAPH>\n\nEste antiviral podría ser especialmente útil en los primeros días de la infección, que es cuando el virus prolifera rápidamente, y evitar que los pacientes progresen hacia formas graves de Covid, como las neumonías bilaterales y los procesos de inflamación graves, que requieren cuidados intensivos.\n\n<PARAGRAPH>\n\nAplidin es un medicamento para el cáncer hematológico que ya está aprobado en Australia y en fase de aprobación en Taiwán, Nueva Zelanda y Corea del Sur.\n\n<PARAGRAPH>\n",
        "TITLE": "Aplidin: El fármaco anticancerígeno probado en España que cura la Covid en 14 días",
        "ID": "NF_04-11-2021_22-10-31_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Aplidin: El fármaco anticancerígeno probado en España que cura la Covid en 14 días",
                "text_en": "Aplidin: The anticancer drug tested in Spain that cures Covid in 14 days",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fármaco anticancerígeno probado en España que cura la Covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "anticancer drug tested in Spain that cures Covid"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en 14 días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in 14 days"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se tendría que aplicar en la primera fase de la enfermedad y reduce la carga antiviral.",
                "text_en": "It would have to be applied in the first phase of the disease and reduce the antiviral load.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Se tendría que aplicar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It would have to be implemented"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la primera fase de la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the first stage of the disease"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reduce la carga antiviral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reduces antiviral load"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se ha demostrado ser seguro en los primeros ensayos clínicos en humanos",
                "text_en": "It has been shown to be safe in the first human clinical trials",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Se ha demostrado ser seguro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's proven to be safe."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en los primeros ensayos clínicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the first clinical trials"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en humanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in humans"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Aplidin es un fármaco anticancerígeno que se basa en la molécula plitidepsina y podría convertirse en el primer medicamento con una efectividad probada al momento de reducir la carga viral en la primera semana de la infección por Covid-19.",
                "text_en": "Aplidin is an anticancer drug that is based on the plitidepsin molecule and could become the first drug with proven effectiveness at the time of reducing viral load in the first week of Covid-19 infection.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El Aplidin es un fármaco anticancerígeno que se basa en la molécula plitidepsina",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Aplidin is an anticancer drug based on the plitidepsin molecule."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "podría convertirse en el primer medicamento con una efectividad probada al momento de reducir la carga viral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "could become the first drug with proven effectiveness when reducing viral load"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la primera semana de la infección por Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the first week of Covid-19 infection"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La fase 2 del ensayo con Aplidin contra el coronavirus ha concluido con resultados esperanzadores.",
                "text_en": "Phase 2 of the trial with Aplidin against coronavirus has concluded with hopeful results.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La fase 2 del ensayo con Aplidin contra el coronavirus ha concluido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Phase 2 of the Aplidin anti-coronavirus test has been completed"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con resultados esperanzadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with encouraging results"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así lo han indicado los especialistas que han participado en esta investigación en hospitales de la Comunidad de Madrid.",
                "text_en": "This has been indicated by specialists who have participated in this research in hospitals in the Community of Madrid.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los especialistas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "specialists"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han participado en esta investigación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have participated in this investigation"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en hospitales de la Comunidad de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Hospitals in the Community of Madrid"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Entre un 80% y un 90% de los 24 pacientes hospitalizados por Covid que participaron en la fase 2 de los ensayos clínicos, realizados en 13 hospitales españoles, fueron dados de alta en los primeros 14 días y un 37%, lo consiguieron antes del octavo día, según han informado este martes los propios investigadores participantes en el estudio en rueda de prensa.",
                "text_en": "Between 80% and 90% of the 24 patients hospitalized by Covid who participated in phase 2 of the clinical trials, carried out in 13 Spanish hospitals, were discharged in the first 14 days and 37%, they achieved it before the eighth day, according to the researchers participating in the study at a press conference this Tuesday.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Entre un 80% y un 90% de los 24 pacientes hospitalizados por Covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "80% to 90% of the 24 patients hospitalized by Covid"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en 13 hospitales españoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in 13 Spanish hospitals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fueron dados de alta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "were discharged"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los primeros 14 días",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the first 14 days"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este martes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Tuesday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los propios investigadores participantes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the participating researchers themselves"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en rueda de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at a press conference"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, este fármaco podría reducir los efectos secundarios que provoca la enfermedad.",
                "text_en": "In addition, this drug may reduce the side effects caused by the disease.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "este fármaco podría reducir los efectos secundarios que provoca la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this drug could reduce the side effects that the disease causes"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Si curamos la infección de raíz, es probable que no se desarrolle ningún efecto secundarios, aunque habrá que esperar», ha apuntado uno de los expertos en rueda de prensa.",
                "text_en": "\"If we cure the root infection, it is likely that no side effects will develop, although we will have to wait,\" said one of the experts at a press conference.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Si curamos la infección de raíz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "If we cure the root infection"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es probable que no se desarrolle ningún efecto secundarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is likely not to develop any side effects"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "uno de los expertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "one of the experts"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en rueda de prensa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at a press conference"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los especialistas han apuntado que este fármaco se tendría que aplicar en la primera fase de la enfermedad, cuando comienzan a manifestarse los síntomas, para que tenga una efectividad mayor.",
                "text_en": "Specialists have pointed out that this drug would have to be applied in the first phase of the disease, when symptoms begin to manifest, in order to have a greater effectiveness.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los especialistas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Specialists"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han apuntado que este fármaco se tendría que aplicar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have pointed out that this drug would have to be applied"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la primera fase de la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the first stage of the disease"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El medicamento tendría menos efecto si se suministra en la fase 2, cuando los pacientes ya manifiestan un estado inflamatorio.",
                "text_en": "The medicine would have less effect if supplied in phase 2, when patients already exhibit an inflammatory state.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El medicamento tendría menos efecto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The medicine would have less effect"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "si se suministra en la fase 2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "if supplied in phase 2"
                    }
                ],
                "evidences": [
                    {
                        "value": "The major challenge facing the advancement of an anti-inflammatory (AI) from a phase 2 to a phase 3 CF trial is that the standard clinical outcome measures that are typically explored in phase 2, most notably a beneficial change (increase) in FEV1, and to some extent a beneficial trend in number of or time to pulmonary exacerbation (PEx) may not be impacted by an AI during the typical size and length of a phase 2 study (eg, 2-3 months). Thus, design of a phase 3 trial (choosing an appropriate outcome measure, effect size, and sample size) has proved challenging.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9892457128
                    }
                ]
            },
            {
                "text": "De esta manera y, siempre que se confirmen los resultados en la última fase de ensayos clínicos, el fármaco se convertiría en un complemento a corticoides como la dexametasona, de probada eficacia en la segunda semana de infección grave, cuando comienza la inflamación provocada por la respuesta descontrolada del propio sistema inmunológico.",
                "text_en": "In this way and, provided the results are confirmed in the last phase of clinical trials, the drug would become a complement to corticosteroids such as dexamethasone, proven effective in the second week of severe infection, when inflammation caused by the uncontrolled response of the immune system itself begins.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el fármaco se convertiría en un complemento a corticoides",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the drug would become a complement to corticosteroids"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "cuando comienza la inflamación provocada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when the caused inflammation begins"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la respuesta descontrolada del propio sistema inmunológico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the uncontrolled response of the immune system itself"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Hay que elegir bien al paciente y hay que elegirlo pronto», ha señalado Pedro Landete, neumólogo de La Princesa.",
                "text_en": "\"The patient must be chosen well and he must be chosen soon,\" said Pedro Landete, a pulmonologist for The Princess.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pedro Landete, neumólogo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pedro Landete, pulmonologist"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "La Princesa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Princess"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«La replicación viral en estos pacientes cae de manera drástica, y sobre todo cuánto más al inicio de los síntomas damos este tratamiento».",
                "text_en": "\"Viral replication in these patients falls dramatically, and especially how much more at the beginning of the symptoms we give this treatment.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La replicación viral en estos pacientes cae de manera drástica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Viral replication in these patients falls dramatically"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al inicio de los síntomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at onset of symptoms"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El equipo de investigadores del estudio impulsado por la compañía biofarmacéutica española PharmaMar están ahora a la espera de la autorización, por parte de la Agencia Española del Medicamento, para poder empezar con la fase 3 y se mostraron convencidos de que los resultados serán positivos también en esas pruebas.",
                "text_en": "The team of researchers of the study promoted by the Spanish biopharmaceutical company PharmaMar are now waiting for authorization, by the Spanish Medicines Agency, to be able to start with phase 3 and were convinced that the results will also be positive in those tests.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El equipo de investigadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The team of researchers"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la compañía biofarmacéutica española PharmaMar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Spanish biopharmaceutical company PharmaMar"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "están ahora a la espera de la autorización",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "are now awaiting authorization"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Española del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Spanish Medicines Agency"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El consejero de Sanidad de la Comunidad de Madrid, Enrique Ruiz Escudero, ha acompañado a los investigadores y se ha mostrado esperanzado en que en «un futuro no muy lejano» podría contarse «con un tratamiento eficaz contra la enfermedad».",
                "text_en": "The Minister of Health of the Community of Madrid, Enrique Ruiz Escudero, accompanied the researchers and expressed hope that in “a not too distant future” “effective treatment of the disease” could be counted.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "la Comunidad de Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Community of Madrid"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Enrique Ruiz Escudero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Enrique Ruiz Escudero"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha acompañado a los investigadores y se ha mostrado esperanzado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has accompanied the researchers and has shown hope"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en «un futuro no muy lejano»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in “a not too distant future”"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "dría contarse «con un tratamiento eficaz contra la enfermedad»",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "□ ‘effective treatment of the disease’ should be taken into account."
                    }
                ],
                "evidences": []
            },
            {
                "text": "La plitidepsina, administrada por vía oral durante tres días consecutivos, se ha mostrado eficaz durante la primera fase de la enfermedad, en la que se produce la replicación viral.",
                "text_en": "Plitidepsin, administered orally for three consecutive days, has been shown to be effective during the first phase of the disease, in which viral replication occurs.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La plitidepsina, administrada por vía oral durante tres días consecutivos, se ha mostrado eficaz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Plitidepsin, administered orally for three consecutive days, has been shown to be effective"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por vía oral durante tres días consecutivos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by mouth for three consecutive days"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante la primera fase de la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "during the first stage of the disease"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este fármaco impide al virus replicarse en el interior de la célula humana uniéndose a una proteína humana, la EF1A, esencial para que el virus se pueda replicar, y bloqueándola.",
                "text_en": "This drug prevents the virus from replicating within the human cell by joining a human protein, EF1A, which is essential for the virus to replicate and block.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Este fármaco impide al virus replicarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This drug prevents the virus from replicating"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el interior de la célula humana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "inside the human cell"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "uniéndose a una proteína humana, la EF1A",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "binding to a human protein, EF1A"
                    }
                ],
                "evidences": [
                    {
                        "value": "In addition to playing a role in protein translation, EF1A, a pleiotropic protein, is involved in actin bundling in cells (Kurasawa et al., 1996; Abbas et al., 2015) . During cytokinesis, EF1A localizes to the division furrow instead of being diffusely distributed in the cytoplasm, and it is involved in the formation of F-actin bundles in the contractile ring (Kurasawa et al., 1996; Numata et al., 2000) . There is evidence that the proteins of some viruses interact with EF1A to block F-actin bundling. For example, the interaction of HBx of hepatitis B virus (HBV) with EF1A results in blockade of actin bundling . In addition, the E7 protein of cutaneous human papilloma virus type 38 (HPV38) has been shown to directly interact with EF1A and induce actin stress fiber disruption (Yue et al., 2011) . The findings of our study confirm the interaction of EF1A with MERS-CoV N and reveal that this interaction blocks the association between EF1A and actin bundling; in turn, this effect causes cytokinesis blockade in cells infected with MERS-CoV, resulting in abnormal mitosis and multiple nuclei formation.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8226935267
                    }
                ]
            },
            {
                "text": "Eso inhibe la capacidad del virus de propagarse por el organismo.",
                "text_en": "This inhibits the ability of the virus to spread through the body.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Eso inhibe la capacidad del virus de propagarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This inhibits the ability of the virus to spread"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "por el organismo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the organism"
                    }
                ],
                "evidences": [
                    {
                        "value": "Present analyses highlighted the major uncertainty regarding the outcomes of the current pandemic associated with the potential of the SCARS-CoV-2 virus for the expansion of the cellular tropism (Walls et al., 2020) based on access to genetically vulnerable host cells due to nearly ubiquitous expression of the ACE2 and FURIN genes in the human body. Particularly dangerous seems the potential ability of the the SCARS-CoV-2 virus to infect the immune cells.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9919695258
                    }
                ]
            },
            {
                "text": "Aplidin secuestraría el virus, formando un complejo estable que haga que el virus no sea viable.",
                "text_en": "Aplidin would hijack the virus, forming a stable complex that would make the virus not viable.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Aplidin secuestraría el virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Aplidin would kidnap the virus"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "formando un complejo estable que haga que el virus no sea viable",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "forming a stable complex that makes the virus not viable"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Este antiviral podría ser especialmente útil en los primeros días de la infección, que es cuando el virus prolifera rápidamente, y evitar que los pacientes progresen hacia formas graves de Covid, como las neumonías bilaterales y los procesos de inflamación graves, que requieren cuidados intensivos.",
                "text_en": "This antiviral may be especially useful in the early days of the infection, which is when the virus proliferates rapidly, and prevent patients from progressing to severe forms of Covid, such as bilateral pneumonias and severe inflammation processes, which require intensive care.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Este antiviral podría ser especialmente útil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This antiviral may be especially useful"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los primeros días de la infección",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the first days of infection"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "es cuando el virus prolifera rápidamente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is when the virus proliferates rapidly"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "evitar que los pacientes progresen hacia formas graves de Covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "prevent patients from progressing to severe forms of Covid"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aplidin es un medicamento para el cáncer hematológico que ya está aprobado en Australia y en fase de aprobación en Taiwán, Nueva Zelanda y Corea del Sur.",
                "text_en": "Aplidin is a hematological cancer medicine that is already approved in Australia and in the approval phase in Taiwan, New Zealand and South Korea.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es un medicamento para el cáncer hematológico que ya está aprobado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is a hematological cancer medicine that is already approved"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Australia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Australia"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en fase de aprobación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "under approval"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Taiwán, Nueva Zelanda y Corea del Sur",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Taiwan, New Zealand and South Korea"
                    }
                ],
                "evidences": [
                    {
                        "value": "Plitidepsin is a cyclic depsipeptide discovered in a sea tunicate Aplidium albicans, already marketed as Aplidin ® (PharmaMar, Colmenar Viejo, Spain) in Australia for the treatment of MM, but under investigation in phase III as anti-COVID agent, since its potent inhibition of the eukaryotic translation elongation factor eEF1A determines inhibition of viral replication [71] .",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9982560277
                    }
                ]
            }
        ]
    },
    "99": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 11,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 21,
            "WhoReliabilityReliable": 20,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 2,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 6,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 1,
            "WhoRoleTarget": 19,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 26,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 26,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEl 81,1% de las personas mayores de 80 años han recibido la primera dosis de la vacuna contra la Covid-19 en Cataluña.\n\n<BREAK>\n\nAdemás, hay un 26,8% que ya tiene también al segunda dosis y, por lo tanto, ya están inmunizados del todo. \n\n<PARAGRAPH>\n\nEn líneas generales, el 15,9% de los ciudadanos de Cataluña han recibido una primera dosis –el 18,8% si se tiene en cuenta la población a partir de 16 años-, el 5,9% también tienen la segunda y el 6,1% tiene la pauta completa. \n\n<PARAGRAPH>\n\nEl Departament de Salut entiende por pauta completa el haber recibido las dos dosis o bien solo una en el caso de ser menor de 56 años y haber pasado la Covid-19.\n\n<BREAK>\n\nEn total, este viernes hay 1.235.290 de catalanes con la primera dosis, 70.875 más que este jueves, y 456.058 con la segunda, 3.902 más que hace 24 horas.\n\n<PARAGRAPH>\n\nCasi el 100% de los residentes vacunados\n\n<PARAGRAPH>\n\nTambién han recibido una primera dosis el 94,6% de las personas que viven en residencias, el 79,4% del personal de geriátricos, el 82,4% del personal de atención primaria y hospitalaria, el 61,2% del resto de personal sanitario y sociosanitario, el 80,7% de las personas con gran dependencia, el 66,1% de los trabajadores esenciales y el 42,7% de las personas de 60 a 65 años.\n\n<PARAGRAPH>\n\nEn cuanto a la pauta completa, la tienen el 92% de las personas que viven en residencias, el 76,1% de su personal, el 76,7% del personal de atención primaria y hospitalaria, el 10,1% del resto de personal sanitario y sociosanitario, el 67,1% de los grandes dependientes, el 26,8% de los de 80 años o más, el 2,1% de los trabajadores esenciales y el 1,1% de personas de entre 60 y 65 años.\n\n<PARAGRAPH>\n\n",
        "TITLE": "El 81% de los mayores de 80 años ya tienen la primera dosis de la vacuna contra el coronavirus en Cataluña",
        "ID": "3_F_04-11-2021_21-33-20_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "El 81% de los mayores de 80 años ya tienen la primera dosis de la vacuna contra el coronavirus en Cataluña",
                "text_en": "81% of those over 80 already have the first dose of the coronavirus vaccine in Catalonia",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El 81% de los mayores de 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "81% of those over 80 years of age"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tienen la primera dosis de la vacuna contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have the first dose of the coronavirus vaccine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El 81,1% de las personas mayores de 80 años han recibido la primera dosis de la vacuna contra la Covid-19 en Cataluña.",
                "text_en": "81.1% of people over 80 have received the first dose of Covid-19 vaccine in Catalonia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El 81,1% de las personas mayores de 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "81.1% of people over 80 years of age"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han recibido la primera dosis de la vacuna contra la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have received the first dose of Covid-19 vaccine"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, hay un 26,8% que ya tiene también al segunda dosis y, por lo tanto, ya están inmunizados del todo. ",
                "text_en": "In addition, there are 26.8% who already have the second dose and are therefore immunized at all.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un 26,8%",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "26.8%"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tiene también al segunda dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "you also have the second dose"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En líneas generales, el 15,9% de los ciudadanos de Cataluña han recibido una primera dosis –el 18,8% si se tiene en cuenta la población a partir de 16 años-, el 5,9% también tienen la segunda y el 6,1% tiene la pauta completa. ",
                "text_en": "Overall, 15.9% of the citizens of Catalonia have received a first dose – 18.8% if the population is 16 years of age or older – 5.9% also have the second dose and 6.1% have the complete pattern.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 15,9% de los ciudadanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "15.9 per cent of citizens"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han recibido una primera dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have received a first dose"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 5,9%",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "5.9%"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tienen la segunda",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They have the second one."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "6,1%",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "6.1 per cent"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tiene la pauta completa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has the complete schedule"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Departament de Salut entiende por pauta completa el haber recibido las dos dosis o bien solo una en el caso de ser menor de 56 años y haber pasado la Covid-19.",
                "text_en": "The Department of Salut understands the complete pattern to have received both doses or only one in the case of being under 56 years of age and having passed Covid-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Departament de Salut",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Department of Salut"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "entiende por pauta completa el haber recibido las dos dosis o bien solo una",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the complete regimen is defined as having received either the two doses or only one dose."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "en el caso de ser menor de 56 años y haber pasado la Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the case of being under 56 years of age and having passed the Covid-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En total, este viernes hay 1.235.290 de catalanes con la primera dosis, 70.875 más que este jueves, y 456.058 con la segunda, 3.902 más que hace 24 horas.",
                "text_en": "In total, this Friday there are 1,235,290 Catalans with the first dose, 70,875 more than this Thursday, and 456,058 with the second, 3,902 more than 24 hours ago.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este viernes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Friday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "1.235.290 de catalanes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "1,235,290 Catalans"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la primera dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the first dose"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Casi el 100% de los residentes vacunados",
                "text_en": "Nearly 100 per cent of vaccinated residents",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Casi el 100% de los residentes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Nearly 100 per cent of residents"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También han recibido una primera dosis el 94,6% de las personas que viven en residencias, el 79,4% del personal de geriátricos, el 82,4% del personal de atención primaria y hospitalaria, el 61,2% del resto de personal sanitario y sociosanitario, el 80,7% de las personas con gran dependencia, el 66,1% de los trabajadores esenciales y el 42,7% de las personas de 60 a 65 años.",
                "text_en": "A first dose has also been given to 94.6 per cent of persons living in residential homes, 79.4 per cent of geriatric staff, 82.4 per cent of primary and hospital care staff, 61.2 per cent of other health and social workers, 80.7 per cent of highly dependent persons, 66.1 per cent of essential workers and 42.7 per cent of persons aged 60-65.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han recibido una primera dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have received a first dose"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 94,6% de las personas que viven",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "94.6 per cent of the population"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en residencias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in residences"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 79,4% del personal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "79.4 per cent of staff"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "geriátricos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "geriatrics"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 82,4% del personal de atención primaria y hospitalaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "82.4 per cent of primary and hospital care staff"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 61,2% del resto de personal sanitario y sociosanitario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "61.2 per cent of all other health and social workers"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En cuanto a la pauta completa, la tienen el 92% de las personas que viven en residencias, el 76,1% de su personal, el 76,7% del personal de atención primaria y hospitalaria, el 10,1% del resto de personal sanitario y sociosanitario, el 67,1% de los grandes dependientes, el 26,8% de los de 80 años o más, el 2,1% de los trabajadores esenciales y el 1,1% de personas de entre 60 y 65 años.",
                "text_en": "In terms of the complete pattern, 92 per cent of persons living in residential homes, 76.1 per cent of their staff, 76.7 per cent of primary and hospital care staff, 10.1 per cent of other health and social workers, 67.1 per cent of large dependants, 26.8 per cent of those aged 80 and over, 2.1 per cent of essential workers and 1.1 per cent of persons aged 60 to 65 years.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la pauta completa, la tienen",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the whole pattern, they have it"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 92% de las personas que viven",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "92 per cent of the population"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en residencias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in residences"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 76,1% de su personal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "76.1 per cent of its staff"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 76,7% del personal de atención primaria y hospitalaria",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "76.7 per cent of primary and hospital care staff"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 10,1% del resto de personal sanitario y sociosanitario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "10.1% of all other health and social workers"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 67,1% de los grandes dependientes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "67.1% of large dependants"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 26,8% de los de 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "26.8% of 80-year-olds"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 2,1% de los trabajadores esenciales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "2.1 per cent of essential workers"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el 1,1% de personas de entre 60 y 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "1.1 per cent of persons aged 60 to 65"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "100": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 10,
            "WhatReliabilityReliable": 10,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 7,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 7,
            "HowReliabilityReliable": 7,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nUna mayor exposición a la luz solar también está relacionada con una mejor salud cardiovascular.\n\n<PARAGRAPH>\n\nLa exposición a los rayos del sol puede reducir el riesgo de muerte por Covid-19, según ha puesto de manifiesto un estudio llevado a cabo por investigadores de la Universidad de Edimburgo (Escocia) y que ha sido publicado en el British Journal of Dermatology.\n\n<PARAGRAPH>\n\nPara alcanzar esta conclusión, los expertos compararon todas las muertes registradas por Covid-19 en los Estados Unidos de enero a abril de 2020 con los niveles de radiación ultravioleta de 2.474 condados estadounidenses durante el mismo período de tiempo.\n\n<PARAGRAPH>\n\nAsí, observaron que las personas que viven en áreas con el nivel más alto de exposición a los rayos UVA, que constituye el 95% de la luz ultravioleta del sol, tenían un menor riesgo de morir por Covid-19 en comparación con aquellas con niveles más bajos.\n\n<BREAK>\n\nEl análisis se repitió en Inglaterra e Italia con los mismos resultados.\n\n<PARAGRAPH>\n\nLos investigadores tomaron en cuenta factores que se sabe están asociados con una mayor exposición al virus y el riesgo de muerte, como la edad, el origen étnico, el estado socioeconómico, la densidad de población, la contaminación del aire, la temperatura y los niveles de infección en las áreas locales.\n\n<PARAGRAPH>\n\nUna explicación del menor número de muertes, que los investigadores están siguiendo, es que la exposición a la luz solar hace que la piel libere óxido nítrico, lo que puede reducir la capacidad del coronavirus para replicarse, como se ha encontrado en algunos estudios de laboratorio.\n\n<PARAGRAPH>\n\nInvestigaciones anteriores del mismo grupo han demostrado que una mayor exposición a la luz solar está relacionada con una mejor salud cardiovascular, con una presión arterial más baja y menos ataques cardíacos.\n\n<BREAK>\n\nComo la enfermedad cardiaca es un factor de riesgo conocido para morir por Covid-19, esto también podría explicar los últimos hallazgos.\n\n<PARAGRAPH>\n\n",
        "TITLE": "La exposición a los rayos del sol puede reducir el riesgo de muerte por Covid-19",
        "ID": "29_F_04-11-2021_21-38-59_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "La exposición a los rayos del sol puede reducir el riesgo de muerte por Covid-19",
                "text_en": "Exposure to sun rays can reduce the risk of death by Covid-19",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "La exposición a los rayos del sol",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Exposure to the sun’s rays"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "puede reducir el riesgo de muerte por Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "may reduce the risk of death from Covid-19"
                    }
                ],
                "evidences": [
                    {
                        "value": "Using the Poisson generalized additive model for time series analysis, the correlation between the daily log of COVID-19 mortality and temperature and 15 lag days was visualized (Fig. 3a) . From the figure, the correlation is U-shaped, and the delayed effect is non-linear. Besides, compared with the average temperature, when the temperature is lower, COVID-19 mortality is higher. As the ambient temperature increases, the Log (mortality) of COVID-19 patients due to temperature initially decreases rapidly and then slowly increases. Figure 3b displays the overall correlation between cumulative relative risk of COVID-19 death and temperature, which is L-shaped. A significant negative association was shown between the temperature and the daily risk of COVID-19 death, in other words, a 1.0°C increase in temperature was associated with a 12.3% (95% CI [3.4, 20 .4%]) reduction in daily cumulative relative risk of COVID-19 death. When the temperature was lower than 20.0°C, the relative risk of death is approaching 0 while it was close to 20.0°C. Overall, the cumulative relative death risk of COVID-19 decreased with increasing temperature. Figure 4 shows the general pattern of the relative risk death as a function of temperature and lag, by showing a three-dimensional plots of relative death risk along with temperature and lag 15 days. Overall, the effect of temperature on the daily mortality risk of COVID-19 was non-linear, with higher temperatures leading to lower relative risk. Figure 5 shows the relative mortality for the lag-specific effects (0, 5, 10, 15 days) and temperatures-specific effects (− 5.0, 2.0, 10.0, 20.0°C). The death risk of COVID-19 at low temperature presented acute and short-term effects, and it showed a trend of first strong and then weak, with the greatest risk occurring in 5-7 days of exposure. The delayed effects of the high temperature appeared quickly, then decrease rapidly, and increased sharply 15 days of exposure, the ",
                        "score": 0.5699999928
                    },
                    {
                        "value": "Significant differences in COVID-19-related death rates were found according to sex, age, region of residence, health insurance premiums, CCI score and mental illness. The risk of COVID-19-related death was lower for women (OR 0.40, 95% CI 0.30-0.54, p-value < 0.001) and increased with age. A statistical difference in the risk of COVID-19-related death was found between Seoul and Gyeonggi-do (OR 4.12; 95% CI 1.24-13.68, p-value = 0.021). The risk of COVID-19-related death was higher in Gyeonggi-do than in Seoul. Among patients with health insurance, those in the 1st quintile (OR 0.52, 95% CI 0.31-0.85, p-value = 0.009), 4th quintile (OR 0.56, 95% CI 0.34-0.93, p-value = 0.024) and 5th quintile (OR 0.60, 95% CI 0.39-0.94, p-value = 0.026) showed significant differences in COVID-19-related mortality risk. The risk of COVID-19-related death was relatively low in patients with health insurance compared to those receiving medical aid. Patients with CCI scores of 1 (OR 2.10, 95% CI 1.35-3.28, p-value = 0.001) were at a higher risk of COVID-19 than those with CCI scores of 0. The OR for COVID-19-related death in patients with mental illness was high at 2.18 (95% CI 1.57-3.04, p-value < 0.001), showing that patients with mental illness had a higher risk of COVID-19-related death.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.8194115162
                    },
                    {
                        "label": "contradiction",
                        "score": 0.7125751972
                    }
                ]
            },
            {
                "text": "Una mayor exposición a la luz solar también está relacionada con una mejor salud cardiovascular.",
                "text_en": "Greater exposure to sunlight is also related to improved cardiovascular health.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "mayor exposición a la luz solar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "increased exposure to sunlight"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mejor salud cardiovascular",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "improved cardiovascular health"
                    }
                ],
                "evidences": [
                    {
                        "value": "The authors claimed that they have analyzed data of 64,553,275 French citizens to explore the correlation between Sunlight exposure and Mortality. The main finding is a correlation between mortality rate and Sunlight exposure (that is considered as a surrogate marker of Vit-D) with an impressive \"p-value of 1.532x10-32) correlated to the COVID-19 mortality rate, with a Pearson coefficient of -0.636\".",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9990021586
                    }
                ]
            },
            {
                "text": "La exposición a los rayos del sol puede reducir el riesgo de muerte por Covid-19, según ha puesto de manifiesto un estudio llevado a cabo por investigadores de la Universidad de Edimburgo (Escocia) y que ha sido publicado en el British Journal of Dermatology.",
                "text_en": "Exposure to sun rays can reduce the risk of death by Covid-19, as evidenced by a study conducted by researchers at the University of Edinburgh (Scotland) and published in the British Journal of Dermatology.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "La exposición a los rayos del sol",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Exposure to the sun’s rays"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reducir el riesgo de muerte por Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reduce the risk of death by Covid-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "investigadores de la Universidad de Edimburgo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "researchers at the University of Edinburgh"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Escocia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Scotland"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el British Journal of Dermatology",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the British Journal of Dermatology"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para alcanzar esta conclusión, los expertos compararon todas las muertes registradas por Covid-19 en los Estados Unidos de enero a abril de 2020 con los niveles de radiación ultravioleta de 2.474 condados estadounidenses durante el mismo período de tiempo.",
                "text_en": "To reach this conclusion, experts compared all deaths recorded by Covid-19 in the United States from January to April 2020 with ultraviolet radiation levels in 2,474 U.S. counties over the same period of time.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los expertos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "experts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "compararon todas las muertes registradas por Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "compared all deaths recorded by Covid-19"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los Estados Unidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in the United States"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "de enero a abril de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "from January to April 2020"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con los niveles de radiación ultravioleta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with ultraviolet radiation levels"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "2.474 condados estadounidenses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "2,474 United States counties"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante el mismo período de tiempo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the same period of time"
                    }
                ],
                "evidences": [
                    {
                        "value": "The research that appears to have generated the most attention in the media during the COVID-19 pandemic is an unpublished ecological study that considered as the unit of observation data from a total of 3,080 counties in the United States (Wu et al. 2020) . We found two versions of this manuscript online that used slightly different methods (Table 1) , and in our view, it is important to provide details on both versions, given that the original analyses generated considerable media attention, and the latter version provided a lower risk estimate. The aim of the study was to investigate whether chronic exposure to ambient pollution, over 17 y, was associated with increased risk of COVID-19 mortality. Deaths from COVID-19 were obtained from the Johns Hopkins University Center for Systems Science and Engineering Coronavirus Resource (Xu and Kraemer 2020) . The first report comprised mortality data up to 4 April 2020, and the second incorporated additional data until 22 April 2020. Reported counts of deaths from COVID-19 and total estimates of the population for each county were used. The summary county data provided only aggregated COVID-19 death data and therefore did not allow for these deaths to be tabulated by age group, sex, race, or other sociodemographic characteristics. In the first report, concentrations of PM 2:5 were derived for the period from 2000 to 2016 using an exposure prediction model that conjoins satellite, modeled, and monitored and has a resolution of about 0:01 × 0:01 (van Donkelaar et al. 2019) . These values were combined to represent county-level averages. County-specific rates of mortality attributed to COVID-19 were regressed against average county-specific concentrations of PM 2:5 using a zero-inflated Poisson model with a random effect for state. Adjustments included 16 county-level variables and the number of COVID-19 tests performed in each state (Table 1 ). In the first version of the paper, a number of counties were excluded because they lacked covariable data or had a small number of identified COVID-19 deaths. Specifically, the main analyses derived risk estimates using 1,783 counties, which represented 90% of all COVID-19 deaths identified in the United States as of 4 April 2020. The authors reported that for an increase of 1 lg=m 3 of PM 2:5 , the rate ratio for COVID-19 mortality was 1.15 (95% CI: 1.05, 1.25).",
                        "score": 0.6899999976
                    },
                    {
                        "value": "T he severe acute respiratory syndrome coronavirus (SARS-CoV-2 or COVID- 19) was first reported in the United States in January 2020 and by mid November 2020 had caused over 250,000 deaths nationwide. 1 Local health departments have reported that COVID-19 is disproportionately impacting people of color, 2 and ecological studies suggest that counties with high poverty rates have higher rates of COVID-19 mortality than low poverty counties. 3, 4 While minority race/ethnicity and low socioeconomic status (SES) are both correlated with higher rates of chronic diseases associated with increased risk of COVID-19 mortality and severe disease (eg, diabetes, coronary heart disease, and obesity), 5,6 these pre-existing conditions likely do not fully explain documented COVID-19 disparities.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9685949683
                    },
                    {
                        "label": "neutral",
                        "score": 0.9989983439
                    }
                ]
            },
            {
                "text": "Así, observaron que las personas que viven en áreas con el nivel más alto de exposición a los rayos UVA, que constituye el 95% de la luz ultravioleta del sol, tenían un menor riesgo de morir por Covid-19 en comparación con aquellas con niveles más bajos.",
                "text_en": "Thus, they observed that people living in areas with the highest level of exposure to UVA, which constitutes 95% of ultraviolet sunlight, had a lower risk of dying from Covid-19 compared to those with the lowest levels.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "áreas con el nivel más alto de exposición a los rayos UVA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "areas with the highest level of exposure to UVA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tenían un menor riesgo de morir por Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had a lower risk of dying for Covid-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "aquellas con niveles más bajos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "those with lower levels"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El análisis se repitió en Inglaterra e Italia con los mismos resultados.",
                "text_en": "The analysis was repeated in England and Italy with the same results.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El análisis se repitió",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The analysis was repeated"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Inglaterra",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in England"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Italia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Italy"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con los mismos resultados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with the same results"
                    }
                ],
                "evidences": [
                    {
                        "value": "The analysis of respondents across the national territory highlighted a response rate equal to 39% (55 out of 142 laboratories/units have completed in the survey) in northern Italy, 16% (11 out of 70 laboratories/units have completed in the survey) in central Italy, and 23% (10 out of 43 laboratories/units have completed in the survey) in southern Italy.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9633609653
                    }
                ]
            },
            {
                "text": "Los investigadores tomaron en cuenta factores que se sabe están asociados con una mayor exposición al virus y el riesgo de muerte, como la edad, el origen étnico, el estado socioeconómico, la densidad de población, la contaminación del aire, la temperatura y los niveles de infección en las áreas locales.",
                "text_en": "Researchers took into account factors known to be associated with increased exposure to the virus and the risk of death, such as age, ethnicity, socio-economic status, population density, air pollution, temperature and infection levels in local areas.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los investigadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Investigators"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "tomaron en cuenta factores que se sabe están asociados con una mayor exposición al virus y el riesgo de muerte",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "factors known to be associated with increased exposure to the virus and risk of death"
                    }
                ],
                "evidences": [
                    {
                        "value": "The excess of deaths due to COVID-19 in men is possibly associated with a greater number of comorbidities and exposure to risk factors (alcoholism, smoking, and occupational exposures) which are risk factors related to male behavior [24] . In addition, there seems to be an interaction between gender and age, with males of advanced age having the highest risk of death by COVID-19. This association should be studied further in order to understand the clinical evolution of the disease.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9987988472
                    }
                ]
            },
            {
                "text": "Una explicación del menor número de muertes, que los investigadores están siguiendo, es que la exposición a la luz solar hace que la piel libere óxido nítrico, lo que puede reducir la capacidad del coronavirus para replicarse, como se ha encontrado en algunos estudios de laboratorio.",
                "text_en": "An explanation for the lower number of deaths, which researchers are following, is that exposure to sunlight causes the skin to release nitric oxide, which may reduce the ability of the coronavirus to replicate, as has been found in some laboratory studies.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los investigadores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "researchers"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "la exposición a la luz solar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "exposure to sunlight"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la piel libere óxido nítrico, lo que puede reducir la capacidad del coronavirus para replicarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the skin releases nitric oxide, which may reduce the ability of the coronavirus to replicate"
                    }
                ],
                "evidences": [
                    {
                        "value": "Nitric oxide levels are locally and systemically regulated by multiple pathways. Nitric oxide is produced via the activity of nitric oxide synthases [NOS; e.g., induced (iNOS); endothelial (e)NOS], which convert oxygen and L-arginine into nitric oxide and L-citrulline. There are also dietary sources of inorganic nitric oxide precursors, nitrite (NO − 2 ) and nitrate (NO − 3 ), which occurring naturally in green leafy vegetables, beetroot and seaweed (268) . Nitrate is reduced to nitrite through the activity of tongue microflora and enters the circulation via saliva and for further reduction to nitric oxide in various tissues, including the lung (269) . Impaired production of local nitric oxide, through endothelial dysfunction, and reduced expression of eNOS, and decreased bioavailability of nitric oxide occurs in older men and people with comorbidities such as obesity and hypertension, and is hypothesized to increase mortality due to COVID-19 (270) . Genetic differences in the expression of eNOS may underpin ethnic differences in susceptibility for severe COVID-19 (271) . However, nitric oxide can have more direct anti-viral effects, including inhibition of the replication of a number of viruses at an early stage and activating innate immune pathways for more generalized anti-viral functions (152) . Exposure to UV radiation is also another means of increasing the bioavailability of nitric oxide through photo-release from stores in the skin (272) . Nitric oxide \"bioactivity\" is then mobilized to the systemic circulation (as nitrite) to potentially promote vasodilation and reductions in blood pressure (136) . Below we describe in more detail potential mechanisms of action of nitric oxide that could reduce severity of COVID-19, including anti-viral effects, as well as anti-inflammatory and cardiometabolic benefits. We then discuss other ways of improving nitric oxide bioavailability that are being considered for prevention or treatment of COVID-19, including provision of inhaled nitric oxide or via dietary supplementation (with nitrate/nitrite) and other methods.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.6939341426
                    }
                ]
            },
            {
                "text": "Investigaciones anteriores del mismo grupo han demostrado que una mayor exposición a la luz solar está relacionada con una mejor salud cardiovascular, con una presión arterial más baja y menos ataques cardíacos.",
                "text_en": "Previous research from the same group has shown that increased exposure to sunlight is related to improved cardiovascular health, lower blood pressure, and fewer heart attacks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Investigaciones anteriores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Previous investigations"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mismo grupo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "same group"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "una mayor exposición a la luz solar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "increased exposure to sunlight"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "mejor salud cardiovascular, con una presión arterial más baja y menos ataques cardíacos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "improved cardiovascular health, with lower blood pressure and fewer heart attacks"
                    }
                ],
                "evidences": [
                    {
                        "value": "Given the disinfection effect of sunlight, it could be expected that areas of BE with greater sunlight exposure would have lower microbial activity, which is a desirable outcome when microbial control is a priority. BE design and operation can take advantage of the disinfection capacity of sunlight by strategically enhancing sunlight exposure in areas with greater risks of microbial contamination and transmission, such as conference rooms and bathrooms. The effectiveness of the strategy to exploit sunlight for the control of MoBE, however, needs to be further validated in field studies.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.7092000842
                    }
                ]
            },
            {
                "text": "Como la enfermedad cardiaca es un factor de riesgo conocido para morir por Covid-19, esto también podría explicar los últimos hallazgos.",
                "text_en": "Since heart disease is a known risk factor for dying from Covid-19, this could also explain the latest findings.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la enfermedad cardiaca es un factor de riesgo conocido para morir por Covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "heart disease is a known risk factor for dying from Covid-19"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "esto también podría explicar los últimos hallazgos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This could also explain the latest findings"
                    }
                ],
                "evidences": [
                    {
                        "value": "A third and rather surprising finding is the inconsistent and mostly weak association between individual behavior change and the respondents' age. Against the background that higher age is a known risk factor for a more severe COVID-19-associated illness and death (18, 19) , which has also been widely reported in media, we would have assumed that higher age groups show more protective behavior.",
                        "score": 0.5400000215
                    },
                    {
                        "value": "As reported in earlier studies 1-3 , a prior history of CVD was common in patients admitted with COVID-19, and the burden of CVD was more prevalent in patients with mildly and severely elevated troponin. However, in multivariate regression, CVD did not independently predict survival, with the exception of diabetes mellitus, a known risk factor for poor outcomes with COVID-19 17 . The incidence of myocardial injury increased with age and was disproportionately associated with male sex.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9987521172
                    },
                    {
                        "label": "neutral",
                        "score": 0.9793551564
                    }
                ]
            }
        ]
    },
    "101": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 13,
            "WhatReliabilityReliable": 9,
            "WhatReliabilityUnreliable": 4,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 5,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 15,
            "WhoReliabilityReliable": 14,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 1,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 1,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 3,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nRospotrebnadzor, el organismo encargado de la protección del consumidor, hizo el comunicado a favor de la vacuna rusa, pero sin decir cuántas personas han sido analizadas en el estudio.\n\n<PARAGRAPH>\n\nTras encerrar en prisión al líder de la oposición, Rusia retoma la campaña internacional a favor de la Sputnik V.\n\n<PARAGRAPH>\n\nEl Gobierno ruso afirma que la primera vacuna rusa, Sputnik V, y la segunda, denominada EpiVacCorona son eficaces contra la cepa británica del coronavirus. \n\n<BREAK>\n\nUna información que fue transmitida desde el organismo encargado de la protección del consumidor, Rospotrebnadzor.\n\n<PARAGRAPH>\n\n“El efecto protector ha sido demostrado por reacciones neutralizadoras utilizando suero de personas que recibieron la Sputnik V y la EpiVacCorona y desarrollaron anticuerpos al SARS-CoV-2”, indicó en su cuenta de Facebook Rospotrebnadzor.\n\n<PARAGRAPH>\n\n“Los sueros de las personas vacunadas neutralizaron eficazmente tanto la variante británica del coronavirus como el coronavirus en sí, que no contiene el conjunto de mutaciones características de la cepa británica”, indicó la agencia federal rusa.\n\n<PARAGRAPH>\n\nRospotrebnadzor no revela cuántas personas han sido analizadas en este estudio efectuado por el Centro Estatal de Virología y Biotegnología “Véktor”, desarrollador además de la EpiVacCorona.\n\n<PARAGRAPH>\n\nTambién indicó a la agencia oficial TASS que la segunda vacuna rusa era eficaz también contra las cepas sudafricana y brasileña, sin ofrecer más datos.\n\n<PARAGRAPH>\n\nEl presidente ruso, Vladimir Putin, instruyó ayer al Gobierno a analizar la eficacia de las vacunas rusas contra las nuevas variantes del coronavirus y en caso necesario a llevar a cabo más investigaciones para adaptarlas.\n\n<PARAGRAPH>\n\nEl plazo fijado para el primer informe es el 15 de marzo y después uno nuevo cada medio año, pero Rospotrebnadzor ya se adelantó a hoy.\n\n<PARAGRAPH>\n\nEn Rusia antes de Año Nuevo se detectó la presencia de la cepa británica en un paciente, que ya está recuperado, según la agencia Interfax.\n\n<PARAGRAPH>\n\nEl Centro “Véktor” aisló la cepa británica en diciembre pasado y ha estudiado esta variante del coronavirus.\n\n<PARAGRAPH>\n\n PERIODISTA DIGITAL, SL CIF B82785809 Avenida de Asturias, 49, bajo 28029 Madrid (España) Tlf.\n\n<BREAK>\n\n(+34) 91 732 19 05 \n\n<PARAGRAPH>\n\n sugerencias@periodistadigital.com \n\n<PARAGRAPH>\n\n",
        "TITLE": "Rusia retoma la campaña a favor de la Sputnik V: ahora dice que es eficaz contra la cepa británica del COVID",
        "ID": "2_NF_04-11-2021_21-25-00_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Rusia retoma la campaña a favor de la Sputnik V: ahora dice que es eficaz contra la cepa británica del COVID",
                "text_en": "Russia resumes campaign in favour of Sputnik V: now says it is effective against the British strain of COVID",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Rusia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Russia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "retoma la campaña a favor de la Sputnik V",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "resumes the campaign in favor of Sputnik V"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es eficaz contra la cepa británica del COVID",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is effective against the British strain of COVID"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Rospotrebnadzor, el organismo encargado de la protección del consumidor, hizo el comunicado a favor de la vacuna rusa, pero sin decir cuántas personas han sido analizadas en el estudio.",
                "text_en": "Rospotrebnadzor, the consumer protection agency, made the statement in favor of the Russian vaccine, but without saying how many people have been analyzed in the study.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Rospotrebnadzor, el organismo encargado de la protección del consumidor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Rospotrebnadzor, the consumer protection body"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hizo el comunicado a favor de la vacuna rusa, pero sin decir cuántas personas han sido analizadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "made the statement in favor of the Russian vaccine, but without saying how many people have been analyzed"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el estudio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the study"
                    }
                ],
                "evidences": [
                    {
                        "value": "An analysis of COVID-19 regulatory documents, including in medical organizations, has shown that the first recommendations, instructions, and decisions of the Russian Federal State Agency for Health and Consumer Rights (Rospotrebnadzor) were published from 21 to 25 January 2020. By the end of January 2020, testing systems for SARS-Cov-2 detection were developed, and their production had begun. The National Plan for the Prevention of the Import and Spread of COVID-19 was approved [29] .",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9959362745
                    }
                ]
            },
            {
                "text": "Tras encerrar en prisión al líder de la oposición, Rusia retoma la campaña internacional a favor de la Sputnik V.",
                "text_en": "After jailing the leader of the opposition, Russia resumes the international campaign for Sputnik V.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Tras encerrar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "After I locked up"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en prisión",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in prison"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al líder de la oposición",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the leader of the opposition"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Rusia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Russia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "retoma la campaña internacional a favor de la Sputnik V",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "resumes the international campaign for Sputnik V"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Gobierno ruso afirma que la primera vacuna rusa, Sputnik V, y la segunda, denominada EpiVacCorona son eficaces contra la cepa británica del coronavirus. ",
                "text_en": "The Russian Government states that the first Russian vaccine, Sputnik V, and the second, called EpiVacCorona, are effective against the British strain of the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Gobierno ruso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Russian Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la primera vacuna rusa, Sputnik V, y la segunda, denominada EpiVacCorona son eficaces contra la cepa británica del coronavirus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the first Russian vaccine, Sputnik V, and the second, called EpiVacCorona, are effective against the British strain of coronavirus"
                    }
                ],
                "evidences": [
                    {
                        "value": "In June 2020, a clinical trial of the first Russian vaccine against COVID-19 was started, and several more vaccine variants are on the way. Assessing the preliminary results of the fight against SARS-CoV-2, we come to the following conclusions. First, that quick, decisive adoption of public health measures, based on the opinion of specialists, is the main weapon in the fight against this infection. Second, that new schemes for the provision of medical care and social services must be implemented, with the understanding that it is the behaviour of citizens that determines the trajectory of a pandemic. Third, the best ideas of the theory and practice of immunology, virology and epidemiology should become the basis for all decision-making in order to combat the pandemic. Going forwards, the Russian Scientific Society of Immunologists will be involved in supporting all of these aims.",
                        "score": 0.6600000262
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9996165037
                    }
                ]
            },
            {
                "text": "Una información que fue transmitida desde el organismo encargado de la protección del consumidor, Rospotrebnadzor.",
                "text_en": "This information was transmitted from the consumer protection agency, Rospotrebnadzor.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Una información que fue transmitida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Information that was transmitted"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el organismo encargado de la protección del consumidor, Rospotrebnadzor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the consumer protection body, Rospotrebnadzor"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“El efecto protector ha sido demostrado por reacciones neutralizadoras utilizando suero de personas que recibieron la Sputnik V y la EpiVacCorona y desarrollaron anticuerpos al SARS-CoV-2”, indicó en su cuenta de Facebook Rospotrebnadzor.",
                "text_en": "“The protective effect has been demonstrated by neutralizing reactions using serum from people who received Sputnik V and EpiVacCorona and developed antibodies to SARS-CoV-2,” Rospotrebnadzor said in his Facebook account.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El efecto protector ha sido demostrado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Protective effect has been demonstrated"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "por reacciones neutralizadoras utilizando suero",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by neutralizing reactions using serum"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas que recibieron la Sputnik V y la EpiVacCorona y desarrollaron anticuerpos al SARS-CoV-2",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "people who received Sputnik V and EpiVacCorona and developed antibodies to SARS-CoV-2"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en su cuenta de Facebook",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on your Facebook account"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Rospotrebnadzor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Rospotrebnadzor"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Los sueros de las personas vacunadas neutralizaron eficazmente tanto la variante británica del coronavirus como el coronavirus en sí, que no contiene el conjunto de mutaciones características de la cepa británica”, indicó la agencia federal rusa.",
                "text_en": "“The serums of the vaccinated people effectively neutralized both the British variant of the coronavirus and the coronavirus itself, which does not contain the set of mutations characteristic of the British strain,” the Russian federal agency said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los sueros de las personas vacunadas neutralizaron eficazmente tanto la variante británica del coronavirus como el coronavirus en sí",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The serums of the vaccinated people effectively neutralized both the British variant of the coronavirus and the coronavirus itself"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "personas vacunadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "people vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Rospotrebnadzor no revela cuántas personas han sido analizadas en este estudio efectuado por el Centro Estatal de Virología y Biotegnología “Véktor”, desarrollador además de la EpiVacCorona.",
                "text_en": "Rospotrebnadzor does not reveal how many people have been analyzed in this study carried out by the State Center of Virology and Biotegnology “Véktor”, developer in addition to the EpiVacCorona.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Rospotrebnadzor",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Rospotrebnadzor"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no revela cuántas personas han sido analizadas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "does not reveal how many people have been analyzed"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en este estudio",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in this study"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Centro Estatal de Virología y Biotegnología “Véktor”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the State Center of Virology and Biotechnology “Véktor”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También indicó a la agencia oficial TASS que la segunda vacuna rusa era eficaz también contra las cepas sudafricana y brasileña, sin ofrecer más datos.",
                "text_en": "He also told the official TASS agency that the second Russian vaccine was also effective against South African and Brazilian strains, without providing more data.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la segunda vacuna rusa era eficaz también contra las cepas sudafricana y brasileña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the second Russian vaccine was also effective against South African and Brazilian strains"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El presidente ruso, Vladimir Putin, instruyó ayer al Gobierno a analizar la eficacia de las vacunas rusas contra las nuevas variantes del coronavirus y en caso necesario a llevar a cabo más investigaciones para adaptarlas.",
                "text_en": "Russian President Vladimir Putin instructed the government yesterday to analyse the effectiveness of Russian vaccines against new variants of the coronavirus and, if necessary, to carry out further research to adapt them.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El presidente ruso, Vladimir Putin",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Russian President Vladimir Putin"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "instruyó ayer al Gobierno a analizar la eficacia de las vacunas rusas contra las nuevas variantes del coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "yesterday instructed the government to analyze the effectiveness of Russian vaccines against new variants of the coronavirus"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ayer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "yesterday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al Gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the Government"
                    }
                ],
                "evidences": [
                    {
                        "value": "Overall, pandemic policies in Russia and Armenia appear similar. Both Armenia and Russia denied the seriousness of the virus for a long time by playing down its possible health impacts. Vladimir Putin, the president of Russia, continued to hold meetings without masks, and similarly in Armenia Prime Minister Nikol Pashinyan held mass meetings for a constitutional referendum (MassisPost, 2020). However, both Russia and Armenia changed their approach and started taking the pandemic more seriously since March 2020: both countries declared a state of emergency since March 2020, mainly coordinating their actions with the standards of the World Health Organization. The fight against coronavirus was conducted through the following mechanisms: isolation, wearing masks, disinfection of hands, maintenance of physical distance, restriction of free movement, and prohibition of large events. Although the Armenian government initially implemented strict control mechanisms, the large influx of labor migrants (mostly from Russia) allowed the virus to spread (Aslanyan & Mirzoyan, 2020) . As a result, Armenia was among the top ten countries in the world in terms of COVID-19 cases per capita (World Health Organization, 2020a, b). Due to gradual improvements, the state of emergency was replaced with a state of quarantine on September 11, 2020. Restrictive measures were relaxed due to the outbreak of war over Nagorno-Karabakh on September 27, 2020 and haven't been reinstated since then (Aslanyan et al., 2021) .",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9617601037
                    }
                ]
            },
            {
                "text": "En Rusia antes de Año Nuevo se detectó la presencia de la cepa británica en un paciente, que ya está recuperado, según la agencia Interfax.",
                "text_en": "In Russia before the New Year the presence of the British strain was detected in a patient, who is already recovered, according to the Interfax agency.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En Rusia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Russia"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "antes de Año Nuevo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "before New Year"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se detectó la presencia de la cepa británica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the presence of the British strain was detected"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en un paciente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a patient"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Centro “Véktor” aisló la cepa británica en diciembre pasado y ha estudiado esta variante del coronavirus.",
                "text_en": "The Véktor Center isolated the British strain last December and has studied this variant of the coronavirus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Centro “Véktor”",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The “Véktor” Centre"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aisló la cepa británica en diciembre pasado y ha estudiado esta variante del coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "isolated the British strain last December and studied this variant of coronavirus"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en diciembre pasado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last December"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "102": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 22,
            "WhatReliabilityReliable": 10,
            "WhatReliabilityUnreliable": 12,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 4,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 24,
            "WhoReliabilityReliable": 19,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 5,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 2,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 2,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 1,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 19,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 1,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nPfizer entregó vacunas con ARNm defectuoso a la Unión Europea y la EMA (Agencia Europea del Medicamento) está encubriendo el fraude, según la revista científica British Medical Journal (1).\n\n<PARAGRAPH>\n\nLa revista comenta los datos y correos electrónicos de los funcionarios de la EMA pirateados durante un ataque informático el pasado mes de diciembre (2).\n\n<PARAGRAPH>\n\nAlgunos de los primeros lotes de la vacuna de Pfizer eran defectuosos, lo que alarmó a los funcionarios de la EMA, según se desprende claramente del contenido de los correos electrónicos capturados por los piratas.\n\n<PARAGRAPH>\n\nDichos lotes tenían niveles de ARNm intactos inferiores a los esperados, lo que plantea cuestiones más amplias sobre cómo evaluar esta nueva vacuna.\n\n<PARAGRAPH>\n\nMientras realizaba su análisis de la vacuna en diciembre, la EMA fue víctima de un ataque informático.\n\n<BREAK>\n\nMás de 40 megabytes de información confidencial de la Agencia acabaron en internet, y varios periodistas y académicos de todo el mundo, incluido el British Medical Journal, recibieron copias de las filtraciones.\n\n<BREAK>\n\nProcedían de cuentas de correo electrónico anónimas y la mayoría de los esfuerzos por hablar con los remitentes fueron infructuosos.\n\n<BREAK>\n\nNinguno de los remitentes ha revelado su identidad y la EMA dice que está llevando a cabo una investigación.\n\n<PARAGRAPH>\n\nEl British Medical Journal ha revisado los documentos, que muestran que su preocupación por las cantidades inesperadamente bajas de ARNm intacto en los lotes de la vacuna desarrollada para su producción comercial.\n\n<PARAGRAPH>\n\nLos expertos de la EMA se encargaron de garantizar la calidad de la producción -los aspectos de química, fabricación y control de la presentación de Pfizer a la EMA- preocupados por las “especies de ARNm truncadas y modificadas presentes en el producto final”.\n\n<BREAK>\n\nEntre los numerosos archivos filtrados, un correo electrónico del 23 de noviembre de un alto funcionario de la EMA esbozaba una serie de problemas.\n\n<PARAGRAPH>\n\nLa fabricación comercial no estaba produciendo vacunas con las especificaciones esperadas y los reguladores no estaban seguros de las consecuencias.\n\n<BREAK>\n\nLa EMA respondió presentando dos objeciones importantes a Pfizer, junto con una serie de otras cuestiones que quería resolver.\n\n<PARAGRAPH>\n\nEl correo electrónico identificó una diferencia significativa en el porcentaje de integridad/especie de ARN truncado entre los lotes clínicos y los comerciales propuestos, del 78 al 55 por ciento.\n\n<BREAK>\n\nLa causa principal es desconocida, y el impacto de la pérdida de integridad del ARN en la seguridad y eficacia de la vacuna aún está aún por determinar, decía el correo electrónico.\n\n<PARAGRAPH>\n\nFinalmente, el 21 de diciembre, la EMA autorizó la vacuna de Pfizer.\n\n<BREAK>\n\nEl informe público de evaluación de la Agencia, un documento técnico colgado en su página web, asegura que “la calidad de este medicamento, presentado en el contexto de emergencia de la pandemia actual, se considera suficientemente consistente y aceptable”.\n\n<PARAGRAPH>\n\nNo está claro cómo Pfizer ha respondido a las preocupaciones de la Agencia.\n\n<BREAK>\n\nSegún uno de los correos electrónicos filtrados el 25 de noviembre, una fuente no identificada de Estados Unidos difundió noticias positivas: “Los últimos lotes indican que el porcentaje de ARN intacto vuelve a estar en torno al 70-75 por ciento, lo que nos hace ser cautelosamente optimistas respecto a la posibilidad de obtener más datos”, decía el correo electrónico.\n\n<PARAGRAPH>\n\n(1) https://www.bmj.com/content/372/bmj.n627\n\n<PARAGRAPH>\n\n(2) https://www.reuters.com/article/us-ema-cyber/pfizer-biontech-say-hackers-accessed-covid-19-vaccine-data-attack-on-eu-regulator-idUSKBN28J2Q7\n\n<PARAGRAPH>\n",
        "TITLE": "Pfizer entregó vacunas con ARNm defectuoso a la Unión Europea y la Agencia Europea del Medicamento encubre el fraude",
        "ID": "NF_NF_1704_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Pfizer entregó vacunas con ARNm defectuoso a la Unión Europea y la Agencia Europea del Medicamento encubre el fraude",
                "text_en": "Pfizer delivered vaccines with defective mRNA to the European Union and the European Medicines Agency covers up fraud",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "entregó vacunas con ARNm defectuoso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "delivered vaccines with defective mRNA"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la Unión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the European Union"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia Europea del Medicamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the European Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "encubre el fraude",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Covers fraud"
                    }
                ],
                "evidences": [
                    {
                        "value": "In less than 12 months after the beginning of the COVID-19 pandemic, scientific research 45 succeeded in developing multiple vaccines against a previously unknown viral pathogen, severe 46 acute respiratory coronavirus 2 (SARS-CoV-2). The mRNA-based Pfizer-BioNTech vaccine (BNT162b2) has been the first authorized, and on 27 December 2020, the European Union 48 countries launched a co-ordinated vaccination campaign that initially was prioritized for individuals 49 at high risk of SARS-CoV-2 exposure, such as the health-care workers (HCW), and for those at 50 high risk of severe COVID-19, including elderly and residents of assisted living facilities. One key 51 point is to identify and follow up post-vaccine infections and to assess vaccine effectiveness in 52 reducing disease severity and limiting infection transmission to unvaccinated individuals. As 53 expected due to the fact that COVID-19 vaccines do not offer 100% protection against the SARS-54",
                        "score": 0.6100000143
                    },
                    {
                        "value": "On 21 st December 2020, the mRNA vaccine from BioNTech / Pfizer (Comirnaty®) was approved in the European Union (EU) as the first vaccine against the SARS-CoV-2 virus.",
                        "score": 0.6700000167
                    },
                    {
                        "value": "Limiting the vaccines to a few; groups, populations, or nations will defeat the very purpose for which the vaccine has been developed. The pandemic has been global so should be the vaccine. As the \"Pharmacy capital\" of the world, India needs to stand up to the challenge in delivering safe and cost-effective vaccines across the world, and on its part, India is living up to its reputation. [4] Given the way, the different vaccines are placed, with respect to the use of vaccine platforms, the cold chain maintenance, and eventual delivery to each corner of the world, vaccines manufactured and to be delivered by India are the best options to tackle the vaccine requirement and target the COVID-19 pandemic. What also makes the Indian Vaccines more important on the world's vaccine canvas is the fact that nations including Britain, European Union members, the United States, Switzerland, and Israel have been at the front of the queue for vaccine deliveries from companies including Pfizer and partner BioNTech, Moderna, and AstraZeneca. As per available reports, the European Union (EU) has entered into a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine. [5] This deal will help the EU secure nearly half of the firms' global output for 2021 making their vaccine almost unavailable to a large number of poor and developing countries.",
                        "score": 0.6200000048
                    },
                    {
                        "value": "The rapid development and deployment of COVID-19 vaccines has put the safety of these vaccines in the spot light. So far four COVID-19 vaccines are approved in the European Union: mRNA vaccines from Pfizer-BioNTech (Comirnaty®) (1) and Moderna (Spikevax®)(2) and viral vector vaccines from AstraZeneca (Vaxzevria®) (3) and Janssen(4). The vaccines had been tested for efficacy and safety in large clinical trials (5) (6) (7) . During the vaccination campaign in the Netherlands, a large amount of vaccines were administered in a time-period of months. This made large scale near real time safety surveillance possible during the vaccine roll-out.",
                        "score": 0.6800000072
                    },
                    {
                        "value": "The European Medicines Agency (EMA) has authorized four vaccines in Europe: Pfizer-BioNTech/Cominarty, Moderna/Spikevax, AstraZeneca/Vaxzevria and Johnson&Johnson /COVID-19 vaccine Janssen. The first three are given in two doses some weeks apart, whereas Janseen vaccine is administered as single dose [3] [4] [5] .",
                        "score": 0.6600000262
                    },
                    {
                        "value": "We conducted a cross sectional survey to study the attitude of hospital employees towards Covid-19 vaccination from December 12th to 21st, 2020. At this time, the mRNA vaccine BNT162b2 from BioNTech/Pfizer was on the verge of authorization in the European Union as its first Covid-19 vaccine and intended to be used in our institution.",
                        "score": 0.5699999928
                    },
                    {
                        "value": "Pfizer/BioNTech vaccine has been used in many countries and regions, such as European Union, France, Australia et al. According to Pfizer and BioNTech, the phase three trial of Pfizer/BioNTech vaccine involved 43,000 volunteers from approximately 150 clinical trial sites in the United States, Germany, Turkey, South Africa, Brazil and Argentina. The overall effective rate was 95%, and the effective rate of people over 65 years old was 94%.",
                        "score": 0.6299999952
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9983416796
                    },
                    {
                        "label": "neutral",
                        "score": 0.9909959435
                    },
                    {
                        "label": "neutral",
                        "score": 0.998165071
                    },
                    {
                        "label": "neutral",
                        "score": 0.9751509428
                    },
                    {
                        "label": "neutral",
                        "score": 0.9879171252
                    },
                    {
                        "label": "neutral",
                        "score": 0.9450270534
                    },
                    {
                        "label": "neutral",
                        "score": 0.936950922
                    }
                ]
            },
            {
                "text": "Pfizer entregó vacunas con ARNm defectuoso a la Unión Europea y la EMA (Agencia Europea del Medicamento) está encubriendo el fraude, según la revista científica British Medical Journal (1).",
                "text_en": "Pfizer delivered vaccines with defective mRNA to the European Union and the EMA (European Medicines Agency) is covering up fraud, according to the British Medical Journal (1).",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "entregó vacunas con ARNm defectuoso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "delivered vaccines with defective mRNA"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la Unión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the European Union"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA (Agencia Europea del Medicamento)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA (European Medicines Agency)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está encubriendo el fraude",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "He's covering up the fraud."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la revista científica British Medical Journal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the British Medical Journal"
                    }
                ],
                "evidences": [
                    {
                        "value": "Limiting the vaccines to a few; groups, populations, or nations will defeat the very purpose for which the vaccine has been developed. The pandemic has been global so should be the vaccine. As the \"Pharmacy capital\" of the world, India needs to stand up to the challenge in delivering safe and cost-effective vaccines across the world, and on its part, India is living up to its reputation. [4] Given the way, the different vaccines are placed, with respect to the use of vaccine platforms, the cold chain maintenance, and eventual delivery to each corner of the world, vaccines manufactured and to be delivered by India are the best options to tackle the vaccine requirement and target the COVID-19 pandemic. What also makes the Indian Vaccines more important on the world's vaccine canvas is the fact that nations including Britain, European Union members, the United States, Switzerland, and Israel have been at the front of the queue for vaccine deliveries from companies including Pfizer and partner BioNTech, Moderna, and AstraZeneca. As per available reports, the European Union (EU) has entered into a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine. [5] This deal will help the EU secure nearly half of the firms' global output for 2021 making their vaccine almost unavailable to a large number of poor and developing countries.",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9988042116
                    }
                ]
            },
            {
                "text": "La revista comenta los datos y correos electrónicos de los funcionarios de la EMA pirateados durante un ataque informático el pasado mes de diciembre (2).",
                "text_en": "The magazine comments on the data and emails of EMA officials hacked during a computer attack last December (2).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La revista comenta los datos y correos electrónicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The magazine comments on data and emails"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los funcionarios de la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EMA officials"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "pirateados durante un ataque informático",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "hacked during a computer attack"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado mes de diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last December"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Algunos de los primeros lotes de la vacuna de Pfizer eran defectuosos, lo que alarmó a los funcionarios de la EMA, según se desprende claramente del contenido de los correos electrónicos capturados por los piratas.",
                "text_en": "Some of the first batches of the Pfizer vaccine were defective, which alarmed EMA officials, as is clear from the content of emails captured by pirates.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Algunos de los primeros lotes de la vacuna de Pfizer eran defectuosos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Some of the first batches of Pfizer vaccine were defective"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los funcionarios de la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EMA officials"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se desprende claramente del contenido de los correos electrónicos capturados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "clear from the contents of the captured emails"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los piratas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "pirates"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Dichos lotes tenían niveles de ARNm intactos inferiores a los esperados, lo que plantea cuestiones más amplias sobre cómo evaluar esta nueva vacuna.",
                "text_en": "These batches had intact mRNA levels lower than expected, raising broader questions about how to evaluate this new vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tenían niveles de ARNm intactos inferiores a los esperados,",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had intact mRNA levels lower than expected,"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Mientras realizaba su análisis de la vacuna en diciembre, la EMA fue víctima de un ataque informático.",
                "text_en": "While performing his vaccine analysis in December, the EMA was the victim of a computer attack.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Mientras realizaba su análisis de la vacuna en diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "While performing her vaccine test in December"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue víctima de un ataque informático",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was the victim of a computer attack"
                    }
                ],
                "evidences": [
                    {
                        "value": "In December 2020, documents relating to COVID-19 vaccines and, in particular, to one from Pfizer/BioNTech were stolen from the EMA agency, which, after Brexit, is located in the Netherlands. EMA confirmed the cyber-attack, and criminal investigations are ongoing to clarify whether the stolen data are up for sale or if they have been published for anyone to access.",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9997857213
                    }
                ]
            },
            {
                "text": "Más de 40 megabytes de información confidencial de la Agencia acabaron en internet, y varios periodistas y académicos de todo el mundo, incluido el British Medical Journal, recibieron copias de las filtraciones.",
                "text_en": "More than 40 megabytes of confidential information from the Agency ended up on the Internet, and several journalists and academics from around the world, including the British Medical Journal, received copies of the leaks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Más de 40 megabytes de información confidencial de la Agencia acabaron",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "More than 40 megabytes of Agency confidential information have ended"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en internet",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on the Internet"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "varios periodistas y académicos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "various journalists and academics"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el British Medical Journal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the British Medical Journal"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recibieron copias de las filtraciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "received copies of the leaks"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Procedían de cuentas de correo electrónico anónimas y la mayoría de los esfuerzos por hablar con los remitentes fueron infructuosos.",
                "text_en": "They came from anonymous email accounts and most of the efforts to talk to senders were fruitless.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de cuentas de correo electrónico anónimas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "of anonymous email accounts"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ninguno de los remitentes ha revelado su identidad y la EMA dice que está llevando a cabo una investigación.",
                "text_en": "None of the senders have revealed their identity and the EMA says it is conducting an investigation.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Ninguno de los remitentes",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "None of the senders"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha revelado su identidad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "has revealed his identity"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dice que está llevando a cabo una investigación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Says he's conducting an investigation."
                    }
                ],
                "evidences": []
            },
            {
                "text": "El British Medical Journal ha revisado los documentos, que muestran que su preocupación por las cantidades inesperadamente bajas de ARNm intacto en los lotes de la vacuna desarrollada para su producción comercial.",
                "text_en": "The British Medical Journal has reviewed the documents, which show that its concern over unexpectedly low amounts of mRNA intact in the batches of vaccine developed for commercial production.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El British Medical Journal",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The British Medical Journal"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "preocupación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "concern"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por las cantidades inesperadamente bajas de ARNm",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by unexpectedly low amounts of mRNA"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los lotes de la vacuna desarrollada para su producción comercial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in batches of vaccine developed for commercial production"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los expertos de la EMA se encargaron de garantizar la calidad de la producción -los aspectos de química, fabricación y control de la presentación de Pfizer a la EMA- preocupados por las “especies de ARNm truncadas y modificadas presentes en el producto final”.",
                "text_en": "EMA experts were in charge of ensuring the quality of production - the chemical, manufacturing and control aspects of the presentation of Pfizer to the EMA - concerned about the “truncated and modified mRNA species present in the final product”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los expertos de la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EMA experts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se encargaron de garantizar la calidad de la producción",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "were in charge of guaranteeing the quality of the production"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "preocupados por las “especies de ARNm truncadas y modificadas presentes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "concerned about “truncated and modified mRNA species present"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el producto final",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the final product"
                    }
                ],
                "evidences": [
                    {
                        "value": "EMA contributed to the design of the work and analysis, revised the draft, approved the final version of the manuscript, and agreed to be responsible for the quality and accuracy of all parts of the work.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9959799051
                    }
                ]
            },
            {
                "text": "Entre los numerosos archivos filtrados, un correo electrónico del 23 de noviembre de un alto funcionario de la EMA esbozaba una serie de problemas.",
                "text_en": "Among the numerous leaked files, an email of 23 November from a senior EMA official outlined a number of problems.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "un correo electrónico",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "an email"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "23 de noviembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "23 November"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "un alto funcionario de la EMA",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a senior official of the EMA"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La fabricación comercial no estaba produciendo vacunas con las especificaciones esperadas y los reguladores no estaban seguros de las consecuencias.",
                "text_en": "Commercial manufacturing was not producing vaccines with the expected specifications and regulators were not sure of the consequences.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La fabricación comercial no estaba produciendo vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Commercial manufacturing was not producing vaccines"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con las especificaciones esperadas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with the expected specifications"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La EMA respondió presentando dos objeciones importantes a Pfizer, junto con una serie de otras cuestiones que quería resolver.",
                "text_en": "The EMA responded by raising two major objections to Pfizer, along with a number of other issues that it wanted to resolve.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "respondió",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "answered"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "presentando dos objeciones importantes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by submitting two major objections"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a Pfizer"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El correo electrónico identificó una diferencia significativa en el porcentaje de integridad/especie de ARN truncado entre los lotes clínicos y los comerciales propuestos, del 78 al 55 por ciento.",
                "text_en": "The email identified a significant difference in the percentage of truncated RNA integrity/species between the proposed clinical and commercial batches, from 78 to 55 percent.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El correo electrónico identificó una diferencia significativa en el porcentaje de integridad/especie de ARN truncado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The email identified a significant difference in the percentage of truncated RNA integrity/species"
                    }
                ],
                "evidences": [
                    {
                        "value": "Total RNA was isolated using the mirVana miRNA PARIS kit (Ambion), according to the protocol of the manufacturer. RNA concentration and RNA integrity were determined by capillary electrophoresis on an Agilent 2100 Bioanalyzer (Agilent Technologies); only the samples with RNA integrity number > 7 were used. RNA samples were stored at −80°C until further processing.",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9991357923
                    }
                ]
            },
            {
                "text": "La causa principal es desconocida, y el impacto de la pérdida de integridad del ARN en la seguridad y eficacia de la vacuna aún está aún por determinar, decía el correo electrónico.",
                "text_en": "The main cause is unknown, and the impact of the loss of RNA integrity on the safety and efficacy of the vaccine is still to be determined, the email said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La causa principal es desconocida",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The main cause is unknown."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Finalmente, el 21 de diciembre, la EMA autorizó la vacuna de Pfizer.",
                "text_en": "Finally, on 21 December, the EMA authorised the Pfizer vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 21 de diciembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 21 December"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "autorizó la vacuna de Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "authorised Pfizer vaccine"
                    }
                ],
                "evidences": [
                    {
                        "value": "On 21 December 2020, the European Medicines Agency (EMA) announced their decision on the conditional marketing authorization for the first coronavirus disease 2019 vaccine in the European Union (EU) [1] . This decision allowed the implementation of vaccination programs against COVID-19 in the EU Member States. According to the EU Vaccines Strategy, the EU Member States launched the joint purchase of COVID-19 vaccines to secure supplies and facilitate the rollout of vaccines [2] . The European Commission has signed the Advance Purchase Agreements with individual COVID-19 vaccine producers on behalf of Member States, wherein the volume of orders was proportional to the number of inhabitants of individual EU Member States [3] . According to the EU Vaccines Strategy, by summer 2021, Member States should have vaccinated a minimum of 70% of the entire adult population, in order to achieve herd immunity [2] [3] [4] . While vaccine deliveries depended on the EU Agreements, the organization of COVID-19 vaccination programs, methods of promotion as well as priority groups for COVID-19 vaccination differed between EU Member States [2, 4] .",
                        "score": 0.5099999905
                    },
                    {
                        "value": "On 21 December 2020, the European Medicines Agency (EMA) recommended the first COVID-19 vaccine, Comirnaty, for conditional marketing authorisation across the Aversion to post-vaccination side effects was described by the Strategic Advisory Group of Experts on Immunization (SAGE) of the World Health Organization (WHO) as a key promoter for vaccine hesitancy among different population groups [15] . Not only can the life-threatening side effects trigger vaccine hesitancy, but the minor side effects that are usually self-limiting can also prevent individuals from making the decision to receive a vaccine, as even these minor side effects can lead to interruption of daily routine and absence from work/school [16] . Therefore, one of the effective approaches to counter vaccine hesitancy is to continuously and transparently monitor the safety of vaccines to enhance public confidence [17, 18] .",
                        "score": 0.5799999833
                    },
                    {
                        "value": "The European Medicines Agency (EMA) is the agency of the European Union (EU) responsible for the evaluation and supervision of medicinal products. As of the end of May 2021, the EMA had approved four COVID-19 vaccines: two of them are mRNA vaccines and two are viral vector vaccines. The other major stringent regulatory authority is the US Food and Drug Administration (FDA) that had approved, as of the end of May 2021, three vaccines: two are the same mRNA-based vaccines approved by EMA, while one is a viral vector vaccine. Table I shows the main characteristics of the EMA and FDA approved vaccines as of the end of May 2021.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9834318757
                    },
                    {
                        "label": "neutral",
                        "score": 0.9757900238
                    },
                    {
                        "label": "neutral",
                        "score": 0.9987216592
                    }
                ]
            },
            {
                "text": "No está claro cómo Pfizer ha respondido a las preocupaciones de la Agencia.",
                "text_en": "It is not clear how Pfizer has responded to the concerns of the Agency.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "No está claro cómo Pfizer ha respondido a las preocupaciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It is unclear how Pfizer has responded to concerns"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Agencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Agency"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según uno de los correos electrónicos filtrados el 25 de noviembre, una fuente no identificada de Estados Unidos difundió noticias positivas: “Los últimos lotes indican que el porcentaje de ARN intacto vuelve a estar en torno al 70-75 por ciento, lo que nos hace ser cautelosamente optimistas respecto a la posibilidad de obtener más datos”, decía el correo electrónico.",
                "text_en": "According to one of the emails leaked on November 25, an unidentified source from the United States spread positive news: “The latest batches indicate that the percentage of RNA intact is around 70-75 percent again, making us cautiously optimistic about the possibility of obtaining more data,” the email said.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 25 de noviembre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 25 November"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "una fuente no identificada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "an unidentified source"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Estados Unidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United States"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "difundió noticias positivas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "disseminated positive news"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "103": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 10,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 11,
            "WhoReliabilityReliable": 11,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 8,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 7,
            "WhyReliabilityReliable": 7,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLa Policía Local del municipio localizó a la mujer, una anciana de 78 años, el jueves por la tarde tras el aviso de un vecino.\n\n<BREAK>\n\nPodría enfrentarse a una sanción de 600 euros.\n\n<PARAGRAPH>\n\nUna madrileña de 78 años ha sido denunciada por la policía local de Alicante al descubrir que se había saltado el cierre perimetral decretado en la Comunidad Valenciana para acudir a su segunda residencia en la playa de San Juan.\n\n<PARAGRAPH>\n\nSegún el Ayuntamiento de Alicante, esta mujer fue localizada e identificada el jueves sobre las 17.30 horas tras un aviso recibido por parte de un vecino, y ahora se enfrenta a una sanción que puede conllevar una multa de hasta 600 euros. La denunciada se había desplazado con motivo de la Semana Santa a su segunda vivienda situada en la avenida de Santander.\n\n<PARAGRAPH>\n\nEl concejal de Seguridad de Alicante, José Ramón González, ha recordado la importancia de \"cumplir estrictamente las normas en esta Semana Santa para frenar una posible cuarta ola de la pandemia\".\n\n<PARAGRAPH>\n\nEn un comunicado, ha añadido que habrá el \"máximo control policial en estas fiestas para protegernos de nuevos contagios y evitar que la incidencia del virus vuelva a incrementarse\", para lo cual se vigilarán los incumplimientos del cierre perimetral, las reuniones de más de cuatro personas, las fiestas ilegales y los botellones y el uso de mascarillas.\n\n<PARAGRAPH>\n\nLos agentes de la Policía Local de Alicante cerraron el operativo anticovid para hacer frente a la pandemia organizado en la tarde y noche del pasado jueves, con 53 personas denunciadas por incumplir el estado de alarma, de ellas 14 actas son por no llevar las obligatorias mascarillas y 5 por estar reunidas en grupos.\n\n<PARAGRAPH>\n\nDurante la noche se disolvieron y denunciaron cuatro fiestas ilegales en viviendas, a un establecimientos por incumplir el horario de cierre en el centro, y a cuatro personas que estaban fumando sin mantener las distancias.\n\n<BREAK>\n\nAdemás, en el control situado en la la avenida del Doctor Jiménez Díaz se interceptaron a 10 vehículos con personas incumpliendo el toque de queda, y uno de ellos dio positivo en las pruebas de alcoholemia y fue denunciado por conducir bajo los efectos del alcohol. \n\n<PARAGRAPH>\n",
        "TITLE": "Denuncian a una madrileña por saltarse el cierre perimetral para ir a su apartamento en Alicante",
        "ID": "F_04-11-2021_21-48-17_www_lavanguardia_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Denuncian a una madrileña por saltarse el cierre perimetral para ir a su apartamento en Alicante",
                "text_en": "A Madrid woman is denounced for skipping the perimeter closure to go to her apartment in Alicante",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Denuncian",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Complaint"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a una madrileña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to a Madrid woman"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por saltarse el cierre perimetral para ir",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for skipping the perimeter closure to go"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a su apartamento en Alicante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to your apartment in Alicante"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Policía Local del municipio localizó a la mujer, una anciana de 78 años, el jueves por la tarde tras el aviso de un vecino.",
                "text_en": "The municipal local police located the woman, a 78-year-old elderly woman, on Thursday afternoon after a neighbor's notice.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Policía Local",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Local Police"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "municipio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "municipality"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "localizó",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "localized"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la mujer, una anciana de 78 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the woman, an old woman of 78 years"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el jueves por la tarde",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Thursday afternoon"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras el aviso de un vecino",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after the warning of a neighbor"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Podría enfrentarse a una sanción de 600 euros.",
                "text_en": "It could face a penalty of 600 euros.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Podría enfrentarse a una sanción de 600 euros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Could face a sanction of 600 euros"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una madrileña de 78 años ha sido denunciada por la policía local de Alicante al descubrir que se había saltado el cierre perimetral decretado en la Comunidad Valenciana para acudir a su segunda residencia en la playa de San Juan.",
                "text_en": "A 78-year-old Madrid woman has been denounced by the local police of Alicante when they discovered that she had skipped the perimeter closure decreed in the Valencian Community to go to her second residence on the beach of San Juan.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Una madrileña de 78 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A 78-year-old Madrid woman"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha sido denunciada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has been reported"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la policía local",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "local police"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Alicante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Alicante"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "al descubrir que se había saltado el cierre perimetral decretado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "finding that the perimeter closure decreed had been skipped"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la Comunidad Valenciana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Valencian Community"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Según el Ayuntamiento de Alicante, esta mujer fue localizada e identificada el jueves sobre las 17.30 horas tras un aviso recibido por parte de un vecino, y ahora se enfrenta a una sanción que puede conllevar una multa de hasta 600 euros. La denunciada se había desplazado con motivo de la Semana Santa a su segunda vivienda situada en la avenida de Santander.",
                "text_en": "According to the City Council of Alicante, this woman was located and identified on Thursday at around 5.30 p.m. after a notice received from a neighbor, and now faces a penalty that can carry a fine of up to 600 euros. The complaint had been moved on the occasion of Holy Week to her second house located on Santander Avenue.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "esta mujer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This woman."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue localizada e identificada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was located and identified"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el jueves sobre las 17.30 horas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Thursday at 5.30 p.m."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "tras un aviso recibido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after a notice received"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "de un vecino",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of a neighbor"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La denunciada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The complaint"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se había desplazado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had moved"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "con motivo de la Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on the occasion of Holy Week"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a su segunda vivienda situada en la avenida de Santander",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to his second house located in the avenue of Santander"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El concejal de Seguridad de Alicante, José Ramón González, ha recordado la importancia de \"cumplir estrictamente las normas en esta Semana Santa para frenar una posible cuarta ola de la pandemia\".",
                "text_en": "Security Councillor José Ramón González of Alicante recalled the importance of \" strictly complying with the norms in this Holy Week to stop a possible fourth wave of the pandemic.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El concejal de Seguridad de Alicante, José Ramón González",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Security Councillor of Alicante, José Ramón González"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha recordado la importancia de \"cumplir estrictamente las normas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recalled the importance of \"close compliance with the rules"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en esta Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on this Holy Week"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "para frenar una posible cuarta ola de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to stop a possible fourth wave of the pandemic"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los agentes de la Policía Local de Alicante cerraron el operativo anticovid para hacer frente a la pandemia organizado en la tarde y noche del pasado jueves, con 53 personas denunciadas por incumplir el estado de alarma, de ellas 14 actas son por no llevar las obligatorias mascarillas y 5 por estar reunidas en grupos.",
                "text_en": "The agents of the local police of Alicante closed the anti-covid operation to deal with the pandemic organized in the afternoon and night of last Thursday, with 53 people denounced for failing to comply with the state of alarm, of which 14 minutes are for not wearing the obligatory masks and 5 for being gathered in groups.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los agentes de la Policía Local",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Local Police officers"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Alicante",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Alicante"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cerraron el operativo anticovid para hacer frente a la pandemia organizado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "they closed the anti-covid operation to deal with the organized pandemic"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la tarde y noche del pasado jueves",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the afternoon and night of last Thursday"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por incumplir el estado de alarma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for breaching the state of alarm"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Durante la noche se disolvieron y denunciaron cuatro fiestas ilegales en viviendas, a un establecimientos por incumplir el horario de cierre en el centro, y a cuatro personas que estaban fumando sin mantener las distancias.",
                "text_en": "During the night, four illegal house parties were dissolved and denounced, one establishments for failing to comply with the closing hours in the center, and four people who were smoking without maintaining distances.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Durante la noche",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "During the night"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se disolvieron y denunciaron cuatro fiestas ilegales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dissolved and reported four illegal parties"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en viviendas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in housing"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por incumplir el horario de cierre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for failing to comply with closing hours"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "cuatro personas que estaban fumando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "four people who were smoking"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin mantener las distancias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "without keeping the distances"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además, en el control situado en la la avenida del Doctor Jiménez Díaz se interceptaron a 10 vehículos con personas incumpliendo el toque de queda, y uno de ellos dio positivo en las pruebas de alcoholemia y fue denunciado por conducir bajo los efectos del alcohol. ",
                "text_en": "In addition, 10 vehicles were intercepted with people in breach of curfew at the control located on Dr. Jiménez Díaz Avenue, and one of them was positive in alcohol tests and was reported to be driving under the influence of alcohol.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el control situado en la la avenida del Doctor Jiménez Díaz",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the control located on the avenue of Dr. Jiménez Díaz"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se interceptaron a 10 vehículos con personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "10 vehicles were intercepted with persons"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "incumpliendo el toque de queda",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "breaching curfew"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "104": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 18,
            "WhatReliabilityReliable": 2,
            "WhatReliabilityUnreliable": 16,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 1,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 3,
            "Who": 7,
            "WhoReliabilityReliable": 2,
            "WhoReliabilityUnreliable": 5,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 5,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 8,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 6,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 6,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 1,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 3,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 9,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 9,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nPara darse cuenta de la manipulación de las cosas y cómo se nos va llevando, poco a poco, a acabar convencidos de que después de la Semana Santa llegará una cuarta ola de coronavirus con la que se aprovechará para restringir, aún más, nuestras libertades y acabar sufriendo una nueva y artificial ampliación del estado de alarma, no hay más que darse una vuelta por la portada de medios como ‘Redacción Médica’ de hoy.\n\n<BREAK>\n\nSe la vamos a mostrar aquí y verán como todo encaja.\n\n<BREAK>\n\nAtentos a cómo se nos prepara para la próxima tomadura de pelo.\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nSi se dan cuenta y observan los artículos que les hemos marcado de esa portada, el relato para una cuarta ola ya está absolutamente diseñado.\n\n<BREAK>\n\nEn primer lugar van a aprovechar los efectos secundarios que provoquen las vacunas para colarnos, con esa excusa, la llegada de esa cuarta ola.\n\n<BREAK>\n\nPero también van a culparnos a todos de ello, en la Semana Santa, como todos somos muy irresponsables cuando se nos deja un poco de libertad, vamos a sufrir una cuarta ola de la que seremos culpables.\n\n<BREAK>\n\nResulta curioso, con lo difícil que les resultó detectarla el 8 de marzo de 2020.\n\n<PARAGRAPH>\n\nPero hay más, también llegan turistas irresponsables a España que nos van a traer nuevas cepas y más peligrosas.\n\n<BREAK>\n\nY también es importante colarnos noticias internacionales en las que nos hablen de más restricciones que las que ahora sufrimos nosotros, como las de Francia.\n\n<BREAK>\n\nAsí nos quedaremos más tranquilos cuando nos recorten de nuevo libertades, como también les pasa a los demás.\n\n<PARAGRAPH>\n\nPero después está su defensa a ultranza de las vacunas y aunque nos dicen que hay mucho irresponsable que no se vacuna nos cuentan, por otro lado, que se han batido récords de vacunación y que va a llegar otra millonada de vacunas de Pfizer.\n\n<PARAGRAPH>\n\nEs decir, estos serviles no cuentan nada de lo que está sucediendo en otros países, de las denuncias que se están produciendo en países como Israel o Noruega, donde se están denunciando a los gobiernos, o en países como Finlandia, donde el Parlamento ha tumbado la ley de confinamiento del gobierno por inconstitucional.\n\n<PARAGRAPH>\n\nEllos están instalados en el relato oficial, con el que están ganando mucho dinero, y sobre todo en defender y justificar a un colectivo, el médico, que está quedando, en general salvo excepciones, bastante mal con todo lo que está sucediendo.\n\n<BREAK>\n\nSon una decepción.\n\n<PARAGRAPH>\n\nTodo esto nos llevará a convencernos de que, por nuestra irresponsabilidad ya que no nos vacunamos y pretendemos disfrutar de libertad, vendrá una nueva ola.\n\n<BREAK>\n\nRecuerden que nos acercamos al 9 de mayo, fecha en la que debería levantarse el estado de alarma.\n\n<BREAK>\n\nEstamos absolutamente seguros de que ese estado de alarma se ampliará porque, casualmente, todo esto coincide a, prácticamente, un mes de que este finalice.\n\n<BREAK>\n\nCon lo falsos, mentirosos y manipuladores que son todos estos, no les cuesta nada estar otro mes más diciéndonos que todo está horrible.\n\n<BREAK>\n\nY además por nuestra culpa.\n\n<PARAGRAPH>\n\nY como aquí en España nunca pasa nada seguirán haciendo lo que les de la gana.\n\n<BREAK>\n\n¿Hacemos apuestas?\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Así se prepara el relato para una “supuesta cuarta ola” que nos lleve a perder más libertades y a justificar la ampliación del estado de alarma",
        "ID": "NF_04-11-2021_22-13-11_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Así se prepara el relato para una “supuesta cuarta ola” que nos lleve a perder más libertades y a justificar la ampliación del estado de alarma",
                "text_en": "This is how the story is prepared for a “supposed fourth wave” that leads us to lose more freedoms and justify the expansion of the state of alarm",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "una “supuesta cuarta ola” que nos lleve a perder más libertades",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "a “supposed fourth wave” that leads us to lose more freedoms"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para darse cuenta de la manipulación de las cosas y cómo se nos va llevando, poco a poco, a acabar convencidos de que después de la Semana Santa llegará una cuarta ola de coronavirus con la que se aprovechará para restringir, aún más, nuestras libertades y acabar sufriendo una nueva y artificial ampliación del estado de alarma, no hay más que darse una vuelta por la portada de medios como ‘Redacción Médica’ de hoy.",
                "text_en": "To realize the manipulation of things and how it is taking us, little by little, to end up convinced that after Holy Week there will come a fourth wave of coronavirus with which it will take advantage to restrict, even more, our freedoms and end up suffering a new and artificial expansion of the state of alarm, there is only one turn around the cover of media like ‘Medical Writing’ of today.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después de la Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after Holy Week"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "llegará una cuarta ola de coronavirus con la que se aprovechará para restringir, aún más, nuestras libertades",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "There will come a fourth wave of coronavirus with which it will take advantage to restrict, even more, our freedoms"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "por la portada de medios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the media cover"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "‘Redacción Médica’",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "‘Medical Writing’"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Atentos a cómo se nos prepara para la próxima tomadura de pelo.",
                "text_en": "Watch out for how we're getting ready for the next haircut.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Atentos a cómo se nos prepara para la próxima tomadura de pelo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Watch out for how we're getting ready for the next haircut."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Si se dan cuenta y observan los artículos que les hemos marcado de esa portada, el relato para una cuarta ola ya está absolutamente diseñado.",
                "text_en": "If you notice and observe the articles that we have marked you on that cover, the story for a fourth wave is already absolutely designed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "esa portada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "that cover"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el relato para una cuarta ola ya está absolutamente diseñado",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the story for a fourth wave is already absolutely designed"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En primer lugar van a aprovechar los efectos secundarios que provoquen las vacunas para colarnos, con esa excusa, la llegada de esa cuarta ola.",
                "text_en": "First, they are going to take advantage of the side effects of vaccines to strain us, with that excuse, the arrival of that fourth wave.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "aprovechar los efectos secundarios que provoquen las vacunas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "taking advantage of the side effects of vaccines"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "colarnos, con esa excusa, la llegada de esa cuarta ola",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to sneak in, with that excuse, the arrival of that fourth wave"
                    }
                ],
                "evidences": [
                    {
                        "value": "Compared to the first three waves (8, 9) , the fourth wave of Covid-19 has been extremely lethal (10), causing a severe strain on the already burdened healthcare system in the country. Hesitancy toward the Covid-19 vaccine, driven by various factors ranging from cultural and religious beliefs (2) and concerns about vaccines' side effects (11) to many half-baked conspiracy theories and social media rumors about the vaccine's reliability, origin, and efficacy, further adds to the strain (1, 2). Consequently, the country has been able to vaccinate only 18.2% of its population, as per the recent statistics shared by the Government of Pakistan (10). If the vaccine hesitancy is not countered, it will take a long period to return to a state of normalcy from the pandemic.",
                        "score": 0.5299999714
                    },
                    {
                        "value": "The distribution and acceptability of vaccines to the public remains uncertain. We therefore simulated the vaccine scenarios in Nevertheless, at slower roll out, a fourth wave of infections (Fig 5a) , diagnosed cases (Fig 5b) , 315 hospitalization (Fig 5c) and deaths (Fig 5b) occurred among all scenarios. The peak (Fig 5 top row) was blunted and delayed under scenarios with VESUSC=90% (blue lines) or VEINF=90% (dark red, green and blue) with ~100,000 fewer cumulative cases and ~300 fewer deaths (Fig 5 middle and bottom rows) indicating that VEINF would take on added importance under less optimal roll out scenarios with low VESUSC. Only the scenario with limited effects on secondary 320 transmission VESUSC=10% and VEINF=10% allowed a severe enough wave to necessitate another round of physical distancing (Fig 5e,f) .",
                        "score": 0.6000000238
                    },
                    {
                        "value": "Concern about side effects and ingredients of the influenza vaccines were two of the top five reasons to not receive an influenza vaccine annually (16.6% and 17.0% respectively). Perceived safety of a vaccine has proven to be an indicator of uptake, and both side effects and ingredients of a vaccine can influence an individual's perception of that vaccine's safety. 54, 55 The COVID-19 vaccines, especially the second shot of the Pfizer vaccine, are known for relatively severe side effects, especially fever, chills, muscle aches, and fatigue. Concern about vaccine side effects and ingredients could affect uptake of a particularly novel and comparatively \"rushed\" COVID-19 vaccine, even though it has passed all safety protocols. HCP reassurance for the safety and rigorous testing of the COVID-19 vaccines could help alleviate some of these concerns.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9971767664
                    },
                    {
                        "label": "neutral",
                        "score": 0.9565468431
                    },
                    {
                        "label": "neutral",
                        "score": 0.9599086642
                    }
                ]
            },
            {
                "text": "Pero también van a culparnos a todos de ello, en la Semana Santa, como todos somos muy irresponsables cuando se nos deja un poco de libertad, vamos a sufrir una cuarta ola de la que seremos culpables.",
                "text_en": "But they are also going to blame us all for this, in Holy Week, as we are all very irresponsible when we are left with a little freedom, we are going to suffer a fourth wave of which we will be guilty.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a todos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to all"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la Semana Santa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Holy Week"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "como todos somos muy irresponsables cuando se nos deja un poco de libertad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Like we're all very irresponsible when we're left with a little freedom."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vamos a sufrir una cuarta ola de la que seremos culpables",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We're going to suffer a fourth wave of which we'll be guilty."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Resulta curioso, con lo difícil que les resultó detectarla el 8 de marzo de 2020.",
                "text_en": "It is curious, with how difficult they found it on March 8, 2020.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Resulta curioso",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It's funny."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "con lo difícil que les resultó detectarla",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with how difficult it was for them to detect"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 8 de marzo de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on 8 March 2020"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero hay más, también llegan turistas irresponsables a España que nos van a traer nuevas cepas y más peligrosas.",
                "text_en": "But there are more, irresponsible tourists also arrive in Spain that will bring us new and more dangerous strains.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "turistas irresponsables",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "irresponsible tourists"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "a España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos van a traer nuevas cepas y más peligrosas",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're going to bring us new and more dangerous strains."
                    }
                ],
                "evidences": [
                    {
                        "value": "For instance, in Spain, tourism is the cornerstone of the economy: 2020 Spanish National Statistics Institute (INE) data show the total tourism-sector contribution to GDP in 2019 was near 180€ billion (real prices); figures to which spending by foreign tourists contributed significantly (upwards of 90€ billion). In 2019 alone, Spain welcomed 83.5 million tourists-ranking 2nd in the world (Statista, 2021) . Just one year later, inbound tourism had fallen by 71%; a mere 19 million tourists graced Spain's GDP in 2020, according to the same source. Clearly, the COVID-19 pandemic has had a sweeping, historic impact on the Spanish economy, with more impact in leader regions such as Catalonia, the Canary Islands, Andalusia, the Balearic Islands and Madrid.",
                        "score": 0.6200000048
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9961374402
                    }
                ]
            },
            {
                "text": "Y también es importante colarnos noticias internacionales en las que nos hablen de más restricciones que las que ahora sufrimos nosotros, como las de Francia.",
                "text_en": "And it is also important to get international news that tells us more about restrictions than we now have, such as those in France.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es importante colarnos noticias internacionales en las que nos hablen de más restricciones",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "It's important to get international news to talk about more restrictions."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ahora",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Now"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Francia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "France"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Así nos quedaremos más tranquilos cuando nos recorten de nuevo libertades, como también les pasa a los demás.",
                "text_en": "This will make us more comfortable when we are cut back on our freedoms, just as it does for others.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos quedaremos más tranquilos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We'll stay calmer."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "cuando nos recorten de nuevo libertades",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "when we are cut back from liberties"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los demás",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to others"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es decir, estos serviles no cuentan nada de lo que está sucediendo en otros países, de las denuncias que se están produciendo en países como Israel o Noruega, donde se están denunciando a los gobiernos, o en países como Finlandia, donde el Parlamento ha tumbado la ley de confinamiento del gobierno por inconstitucional.",
                "text_en": "That is to say, these servants do not tell anything about what is happening in other countries, about the complaints that are taking place in countries such as Israel or Norway, where they are denouncing governments, or in countries such as Finland, where Parliament has overthrown the law of government confinement as unconstitutional.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "estos serviles",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "these serviles"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no cuentan nada de lo que está sucediendo",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They don't tell anything about what's going on."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en otros países",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in other countries"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en países como Israel o Noruega",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in countries such as Israel or Norway"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Finlandia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Finland"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Parlamento",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Parliament"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha tumbado la ley de confinamiento del gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has overthrown the government’s confinement law"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por inconstitucional",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "unconstitutional"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Son una decepción.",
                "text_en": "They're a disappointment.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Son una decepción",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're a disappointment."
                    }
                ],
                "evidences": [
                    {
                        "value": "There is a clear feeling of disappointment among health personnel, which overlaps the fatigue of several months of intense work and exhausting days. This disappointment is also directed to the behavior of political and institutional leaders.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9969606996
                    }
                ]
            },
            {
                "text": "Todo esto nos llevará a convencernos de que, por nuestra irresponsabilidad ya que no nos vacunamos y pretendemos disfrutar de libertad, vendrá una nueva ola.",
                "text_en": "All this will lead us to convince ourselves that, because of our irresponsibility because we do not get vaccinated and pretend to enjoy freedom, a new wave will come.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por nuestra irresponsabilidad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for our irresponsibility"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que no nos vacunamos y pretendemos disfrutar de libertad",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "since we don't get vaccinated and pretend to enjoy freedom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vendrá una nueva ola",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "A new wave will come"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Recuerden que nos acercamos al 9 de mayo, fecha en la que debería levantarse el estado de alarma.",
                "text_en": "Remember that we are approaching May 9, when the state of alarm should be lifted.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "al 9 de mayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "as at 9 May"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "debería levantarse el estado de alarma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The state of alarm should be lifted."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estamos absolutamente seguros de que ese estado de alarma se ampliará porque, casualmente, todo esto coincide a, prácticamente, un mes de que este finalice.",
                "text_en": "We are absolutely certain that this state of alarm will be extended because, incidentally, all this coincides with practically one month after the end of this year.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estamos absolutamente seguros de que ese estado de alarma se ampliará",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We are absolutely sure that this state of alarm will be extended."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "porque, casualmente, todo esto coincide",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Because, incidentally, all this coincides."
                    }
                ],
                "evidences": [
                    {
                        "value": "In view of the new pandemic, the Spanish government declared a state of alarm on 14th March for a fortnight, the maximum allowed by the Spanish Constitution. But subsequently the Congress of Deputies has twice extended this state of alarm, and it will most likely have to continue to be extended. The state of alarm, among other measures, forces the population to be confined to their homes, being able to go out only to go to the health services if it is essential, to supermarkets or pharmacies and to go to work if they are working in activities considered essential for society.",
                        "score": 0.5699999928
                    },
                    {
                        "value": "An important element to keep in mind is that the pandemic led the Spanish government to declare a state of alarm (estado de alarma) on 14 March 2020 for an initial period of 15 days, 1 which was subsequently extended every fortnight until 21 June 2020 with the approval of the lower chamber of the Spanish Parliament (Congreso de los Diputados). 2 According to Article 116 of the Spanish Constitution (Constitución Española, \"CE\"), the state of alarm is the least restrictive of the three states of emergency under Spanish lawstate of alarm (estado de alarma), state of exception (estado de excepción), and martial law (estado de sitio). The state of alarm means there can be a temporary and partial (i) strengthening of executive powers to impose restrictive measures, and (ii) centralisation of competences for the executive branch of the Spanish government, though the extent of such centralisation is not predetermined and it is unclear whether there can be different degrees of temporary centralisation under a state of alarm. During the pandemic the Spanish government was empowered, as part of the state of alarm of March to June 2020, to quarantine citizens nationwide and to adopt other restrictive measures based on public health concerns. However, any matter of regional competence that was not expressly exercised by the state remained under the regulatory competences of the Autonomous Communities.",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9994377494
                    },
                    {
                        "label": "neutral",
                        "score": 0.9699402452
                    }
                ]
            },
            {
                "text": "Con lo falsos, mentirosos y manipuladores que son todos estos, no les cuesta nada estar otro mes más diciéndonos que todo está horrible.",
                "text_en": "With the fakes, liars and manipulators that are all these, it's not hard for them to be another month telling us that everything is horrible.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Con lo falsos, mentirosos y manipuladores que son",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "With how false, lying, and manipulative they are"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "todos estos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "all these"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no les cuesta nada estar otro mes más diciéndonos que todo está horrible",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They don't have a problem with another month telling us everything's awful."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y como aquí en España nunca pasa nada seguirán haciendo lo que les de la gana.",
                "text_en": "And as here in Spain nothing ever happens, they will continue to do whatever they want.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "aquí en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "here in Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "seguirán haciendo lo que les de la gana",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They'll keep doing whatever they want."
                    }
                ],
                "evidences": []
            }
        ]
    },
    "105": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 16,
            "WhatReliabilityReliable": 16,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 5,
            "Who": 11,
            "WhoReliabilityReliable": 11,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 5,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 3,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 3,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nLa EMA ya dijo que la vacuna de Oxford es segura y que los casos de trombosis acontecidos con las personas que se habían vacunado con esta dosis no estaban relacionados con ello.\n\n<BREAK>\n\nAún así, hay que conocer cuáles son las recomendaciones de AstraZeneca para los sanitarios ante síntomas de los vacunados.\n\n<PARAGRAPH>\n\nEn concreto, el laboratorio farmacéutico ha manifestado a los sanitarios que deben prestar atención ante posibles signos y síntomas sugestivos de tromboembolismo y/o trombocitopenia en aquellas personas vacunadas con AstraZeneca.\n\n<PARAGRAPH>\n\nSignos de alerta\n\n<PARAGRAPH>\n\nEn una carta, que está aprobada por la Agencia Europea de Medicamentos (EMA) y la Agencia Española de Medicamentos y Productos Sanitarios (Aemps), AstraZeneca manifiesta que se debe instruir a los vacunados para que soliciten atención médica inmediata, en el que caso de que tenga algunos de los síntomas que detallamos a continuación.\n\n<PARAGRAPH>\n\nDisnea, o falta de aire, dolor precordial, edema de miembros inferiores, dolor abdominal persistente, sintomatología neurológica (incluyendo cefalea intensa o persistente y visión borrosa), hematomas cutáneos, y petequias en lugares diferentes al sitio donde ha sido administrada la vacuna.\n\n<PARAGRAPH>\n\nVacuna segura\n\n<PARAGRAPH>\n\nDe igual forma, y a pesar de las recomendaciones de AstraZeneca a los sanitarios, la compañía defiende que su vacuna es segura y que los casos acontecidos de trombosis son realmente escasos y no son un número identificativo para establecer conexiones y relaciones de la vacuna.\n\n<PARAGRAPH>\n\nEs por ello que tanto la compañía como la EMA recomiendan su inoculación, algo que se ha reanudado ya en prácticamente todos los países que pararon la vacunación por este tema.\n\n<BREAK>\n\nEn España se sigue vacunando con AstraZeneca desde el miércoles 24 de marzo.\n\n<PARAGRAPH>\n\nEn estudio\n\n<PARAGRAPH>\n\nLos casos de trombosis se están todavía estudiando para saber cuál es su origen y determinar que, según las causas, haya un grupo de población que no pueda vacunarse con la de Oxford.\n\n<PARAGRAPH>\n\nDesde la EMA han explicado que se debe lanzar una investigación adicional para entender más y también analizar estudios observacionales específicos, por lo que no está claro del todo.\n\n<PARAGRAPH>\n\nVacunados en España\n\n<PARAGRAPH>\n\nHasta el momento, en España se han vacunado con 6,6 millones de dosis en total, y más de 2 millones de personas han recibido la pauta completa con ambas inyecciones.\n\n<BREAK>\n\nSi bien hay que resaltar que hay algo de desconfianza por parte de la población frente a la vacunación con la de AstraZeneca.\n\n<PARAGRAPH>\n\nAdemás se ha extendido la edad de personas que pueden vacunarse con ella, ahora a mayores de 55 años, para poder acelerar el proceso de vacunación en España, tal como lo ha hecho el resto de países.\n\n<PARAGRAPH>\n\n",
        "TITLE": "AstraZeneca: Las recomendaciones para los sanitarios ante posibles síntomas de vacunados",
        "ID": "21_NF_04-11-2021_22-09-46_okdiario_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "AstraZeneca: Las recomendaciones para los sanitarios ante posibles síntomas de vacunados",
                "text_en": "AstraZeneca: Recommendations for health care professionals for possible symptoms of vaccinations",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recomendaciones para los sanitarios ante posibles síntomas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recommendations for health care professionals for possible symptoms"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health care services"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La EMA ya dijo que la vacuna de Oxford es segura y que los casos de trombosis acontecidos con las personas que se habían vacunado con esta dosis no estaban relacionados con ello.",
                "text_en": "The EMA already said that the Oxford vaccine is safe and that the cases of thrombosis with people who had been vaccinated with this dose were not related to it.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "dijo que la vacuna de Oxford es segura",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He said the Oxford vaccine is safe."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "los casos de trombosis acontecidos con las personas que se habían vacunado con esta dosis no estaban relacionados con ello",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the cases of thrombosis with people who had been vaccinated with this dose were not related to this"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las personas que se habían vacunado con esta dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "people who had been vaccinated with this dose"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aún así, hay que conocer cuáles son las recomendaciones de AstraZeneca para los sanitarios ante síntomas de los vacunados.",
                "text_en": "Still, we need to know what AstraZeneca's recommendations are for health care workers in the event of symptoms of the vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "las recomendaciones de AstraZeneca para los sanitarios ante síntomas de los vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the recommendations of AstraZeneca for health care professionals for symptoms of the vaccinated"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health care services"
                    }
                ],
                "evidences": [
                    {
                        "value": "In Norway, AstraZeneca was administered to more than 100,000 health care workers (HCWs, including cleaners in the health care sector) under the age of 65 until March 11th, 2021. Multiple cases of thromboembolism and four deaths among vaccinated HCWs, predominately young women, were discovered after March 11th, which eventually resulted in the permanent removal of AstraZeneca from the Norwegian COVID-19 vaccination program on May 10th, 2021 [3] . Along the fatal events, recent survey studies based on selfreporting, conducted after March 11th, have also reported minor bleeding episodes such as skin and nose bleedings following vaccination with AstraZeneca [4] .",
                        "score": 0.6700000167
                    },
                    {
                        "value": "Following the European Medicines Agency (EMA) recommendation, the European Commission has granted conditional marketing authorization for AstraZeneca COVID-19 vaccine for one year. As in the UK, it is indicated for adults (18- year-olds) [1] . This decision has been accompanied by statements from 22 EU countries ─all except 5─ recommending not to use this vaccine in individuals between 55 and 70-year-old ( Table 1 ). The national health authorities of 22 countries had to explain to their citizens that the decision was based on the lack of vaccine efficacy data (see below). This undermined the confidence in the EU vaccine review and assessment process and adds to the growing issue of vaccine hesitancy in countries that account to close to 95% of total EU population. Could a different EMA recommendation have helped to mitigate vaccine hesitancy?",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9979945421
                    },
                    {
                        "label": "neutral",
                        "score": 0.9987643957
                    }
                ]
            },
            {
                "text": "En concreto, el laboratorio farmacéutico ha manifestado a los sanitarios que deben prestar atención ante posibles signos y síntomas sugestivos de tromboembolismo y/o trombocitopenia en aquellas personas vacunadas con AstraZeneca.",
                "text_en": "In particular, the pharmaceutical laboratory has told health care providers to pay attention to possible signs and symptoms suggestive of thromboembolism and/or thrombocytopenia in people vaccinated with AstraZeneca.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "prestar atención ante posibles signos y síntomas sugestivos de tromboembolismo y/o trombocitopenia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pay attention to possible signs and symptoms suggestive of thromboembolism and/or thrombocytopenia"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "aquellas personas vacunadas con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "those vaccinated with AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Disnea, o falta de aire, dolor precordial, edema de miembros inferiores, dolor abdominal persistente, sintomatología neurológica (incluyendo cefalea intensa o persistente y visión borrosa), hematomas cutáneos, y petequias en lugares diferentes al sitio donde ha sido administrada la vacuna.",
                "text_en": "Dyspnoea, or shortness of breath, precordial pain, lower limb oedema, persistent abdominal pain, neurological symptomatology (including severe or persistent headache and blurred vision), skin bruising, and petechiae in places other than the site where the vaccine has been administered.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Disnea, o falta de aire, dolor precordial, edema de miembros inferiores, dolor abdominal persistente, sintomatología neurológica (incluyendo cefalea intensa o persistente y visión borrosa), hematomas cutáneos, y petequias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Dyspnoea, or shortness of breath, precordial pain, lower limb oedema, persistent abdominal pain, neurological symptomatology (including severe or persistent headache and blurred vision), skin bruising, and petechiae"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en lugares diferentes al sitio donde ha sido administrada la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in places other than the site where the vaccine has been administered"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De igual forma, y a pesar de las recomendaciones de AstraZeneca a los sanitarios, la compañía defiende que su vacuna es segura y que los casos acontecidos de trombosis son realmente escasos y no son un número identificativo para establecer conexiones y relaciones de la vacuna.",
                "text_en": "Likewise, and despite AstraZeneca's recommendations to health care providers, the company defends that its vaccine is safe and that the cases of thrombosis are really scarce and are not an identification number to establish connections and relationships of the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la compañía defiende que su vacuna es segura",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the company defends that its vaccine is safe"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los casos acontecidos de trombosis son realmente escasos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Thrombosis cases are really rare"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Es por ello que tanto la compañía como la EMA recomiendan su inoculación, algo que se ha reanudado ya en prácticamente todos los países que pararon la vacunación por este tema.",
                "text_en": "This is why both the company and the EMA recommend its inoculation, something that has already resumed in virtually all the countries that stopped vaccination due to this issue.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la compañía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the company"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recomiendan su inoculación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recommend inoculation"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha reanudado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "resumed"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en prácticamente todos los países que pararon la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in virtually all countries that stopped vaccination"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por este tema",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for this topic"
                    }
                ],
                "evidences": [
                    {
                        "value": "The Budapest district mayors in the Democratic Coalition led by former PM Ferenc Gyurcsány have sent a letter to Minister of Human Resources Miklós Kásler requesting that only EMA-approved vaccines be administered in their districts because they are the ones to be trusted. 88 The Democratic Coalition also launched a petition for free vaccine choice following reports of the Sinopharm vaccine as the only option. 89 Gyurcsány has even ventured to insinuate that Orbán was probably given a different vaccine, not the \"worse Chinese one lacking European approval\". 90 The opposition parties seem to agree that no vaccine should be administered without EMA approval or a Hungarian review process. In late January they issued a joint demand for withdrawal of the new governmental decree that made way for the Chinese vaccine. 91 The Hungarian population has also shown general distrust in the Chinese vaccine. According to a mid-January survey by Publicus Research, only 27% of those who want a COVID-19 vaccine would accept the Sinopharm product, while 63% would reject it. (The yes-no ratio among the same group for Pfizer is 91%-4%, for Moderna 77-15%, and for Sputnik V 35%-55%.) 92 This is probably the reason why not just Orbán himself but also Hungarian President János Áder and Zsolt Bayer, a journalist and very influential Orbán supporter, have decided to take the Sinopharm jab-and become live promotion for it.",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9968478084
                    }
                ]
            },
            {
                "text": "En España se sigue vacunando con AstraZeneca desde el miércoles 24 de marzo.",
                "text_en": "In Spain, AstraZeneca has been vaccinated since Wednesday, March 24.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "In Spain"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "vacunando con AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccinating with AstraZeneca"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde el miércoles 24 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since Wednesday, 24 March"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los casos de trombosis se están todavía estudiando para saber cuál es su origen y determinar que, según las causas, haya un grupo de población que no pueda vacunarse con la de Oxford.",
                "text_en": "Cases of thrombosis are still being studied to determine their origin and determine that, depending on the causes, there is a population group that cannot be vaccinated with that of Oxford.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los casos de trombosis se están todavía estudiando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Cases of thrombosis are still being studied"
                    }
                ],
                "evidences": [
                    {
                        "value": "Rather than identifying thrombotic phenomena as a byproduct of pulmonary embolism, ever-increasing evidence points to a direct origin of thrombosis in arterial lung vasculature [14, 32, 33] , highlighting the need for a more accurate characterization of these phenomena in their true location [34] .",
                        "score": 0.5099999905
                    },
                    {
                        "value": "In this nationwide analysis of hospitalizations for viral pneumonias, thrombosis occurred in 5% of cases. Although substantial, this is significantly lower than thrombosis observed in patients hospitalized with COVID-19. Investigations into mechanisms of thrombosis and risk reduction strategies in COVID-19 and other viral respiratory infections are necessary. ",
                        "score": 0.5099999905
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9899474978
                    },
                    {
                        "label": "neutral",
                        "score": 0.9987816215
                    }
                ]
            },
            {
                "text": "Desde la EMA han explicado que se debe lanzar una investigación adicional para entender más y también analizar estudios observacionales específicos, por lo que no está claro del todo.",
                "text_en": "Since the EMA have explained that additional research should be launched to understand more and also analyze specific observational studies, so it is not entirely clear.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "EMA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "lanzar una investigación adicional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "launch an additional investigation"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "analizar estudios observacionales específicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "analyze specific observational studies"
                    }
                ],
                "evidences": [
                    {
                        "value": "In the specific setting of the COVID-19 pandemic with a number of highly relevant risk factors, high heterogeneity with respect to the severity of the disease and the onset of treatment, a good characterization of the population that would profit from treatment is crucial. Obviously, an extensive search for the optimal subgroup and subsequent confirmation may not be compatible with the need for rapid development. Regulatory principles of subgroup selection are given in the EMA guideline on the investigation of subgroups in confirmatory clinical trials (EMA, 2019), to be applied in case a positive effect has been established in the overall population but plausible heterogeneity with respect to efficacy and severe side effects asks for a refinement of the population.",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9973281622
                    }
                ]
            },
            {
                "text": "Si bien hay que resaltar que hay algo de desconfianza por parte de la población frente a la vacunación con la de AstraZeneca.",
                "text_en": "While it should be noted that there is some mistrust on the part of the population about vaccination with AstraZeneca.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "desconfianza",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Mistrust"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "por parte de la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the population"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además se ha extendido la edad de personas que pueden vacunarse con ella, ahora a mayores de 55 años, para poder acelerar el proceso de vacunación en España, tal como lo ha hecho el resto de países.",
                "text_en": "In addition, the age of people who can be vaccinated with it has been extended to over 55 years of age in order to accelerate the vaccination process in Spain, as has been done by the other countries.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se ha extendido la edad de personas que pueden vacunarse con ella",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the age of people who can be vaccinated with it has been extended"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a mayores de 55 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 55 years of age"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "106": {
        "DATA": {
            "Title": 1,
            "Subtitle": 3,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 21,
            "WhatReliabilityReliable": 21,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 5,
            "Who": 5,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 1,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 9,
            "WhereReliabilityReliable": 9,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 1,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 1,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 2,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 5,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 2,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 2,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<BREAK>\n\nLa acrilamida está presente en nuestra dieta desde que el hombre empezó a cocinar los alimentos y se crea cuando sometemos a alimentos ricos en hidratos de carbono a altas temperaturas.\n\n<BREAK>\n\nLas mayores fuentes de acrilamida son las patatas fritas, el pan tostado, las galletas y el café.\n\n<BREAK>\n\nLa OCU alerta de cinco productos que superan los límites recomendados de acrilamida\n\n<BREAK>\n\nLa Agencia Internacional de Investigación sobre el Cáncer (IARC), de la Organización Mundial de la Salud (OMS), califica a la acrilamida como ‘probable carcinógeno humano’. \n\n<BREAK>\n\nEsto significa que, tras realizar algunos ensayos en animales, se puede concluir que esta sustancia puede causar daños neurológicos y en el ADN y conllevar la aparición de cáncer. \n\n<BREAK>\n\nPor este motivo, las autoridades sanitarias, tanto europeas como españolas, recomiendan reducir nuestra exposición a esta sustancia, minimizando su presencia en los alimentos.\n\n<BREAK>\n\n¿Qué es la acrilamida?\n\n<BREAK>\n\nLa acrilamida está presente en nuestra dieta desde que el hombre empezó a cocinar los alimentos. \n\n<BREAK>\n\nSe trata de una sustancia soluble en agua que se forma al cocinar alimentos ricos en hidratos de carbono -como cereales o patatas- a temperaturas superiores a 120 grados y en ambientes de baja humedad, sobre todo cuando freímos, tostamos u horneamos. \n\n<BREAK>\n\nDurante la cocción, se produce lo que se conoce como la 'Reación de Maillard', cuando algunos azúcares, como la glucosa o la fructosa, reaccionan químicamente con un aminoácido llamado asparagina. \n\n<BREAK>\n\nLa sustancia resultante, la acrilamida, confiere a los alimentos ese color dorado y textura crujiente tan atrayente para el paladar.\n\n<BREAK>\n\nAdemás de en los alimentos, la acrilamida también está presente en una gran concentración en el humo del tabaco y en la industria química para la fabricación de papel, de tintes y plásticos, en el tratamiento del agua potable y residual, y en algunos productos de consumo, tales como selladores, envases de alimentos o algunos adhesivos.\n\n<BREAK>\n\n¿Por qué puede llegar a ser peligrosa?\n\n<BREAK>\n\nLa acrilamida, una vez en el organismo, se transforma en glicidamida. \n\n<BREAK>\n\nTras realizar varias pruebas en animales de laboratorio, se concluyó que esta sustancia en altas concentraciones fue la responsable de la aparición de algunos tipos de cáncer en ratones -mama, ovarios, endometrio, riñón o estómago- y de provocarles de efectos nocivos en el sistema nervioso. \n\n<BREAK>\n\nAunque no existen pruebas concluyentes de que se produjera el mismo efecto en humanos y se insiste en que aún se necesitan más investigaciones, dado el resultado en animales, se decidió calificarlo como ‘probable carcinógeno’ y establecer una serie de medidas para reducir su exposición.\n\n<BREAK>\n\nPor un lado, desde 2013 desde la UE, a través de la Autoridad Europea de Seguridad Alimentaria (EFSA) y los gobiernos nacionales (el Ministerio de Sanidad y AECOSAN en España) se llevan a cabo campañas para que la población general sepa cómo reducir la exposición, y por otra, se insta a las empresas de la industria alimentaria a controlar la presencia de esta sustancia en los distintos procesos de fabricación.\n\n<BREAK>\n\nCómo evitarla\n\n<BREAK>\n\nLos precursores de la acrilamida (hidratos de carbono y asparagina) están presentes de forma natural en los alimentos que consumimos, por lo que evitarla al 100% es casi imposible. \n\n<BREAK>\n\nLo que sí podemos hacer es controlar la que consumimos dentro de límites seguros. \n\n<BREAK>\n\nPara ello, AECOSAN (Agencia Española de Consumo, Seguridad Alimentaria y Nutrición) ha elaborado una serie de recomendaciones destinadas a la reducción de acrilamida que se deberán llevar a cabo en los alimentos implicados: las patatas, el pan, las galletas y los empanados o rebozados. \n\n<BREAK>\n\nEstas precauciones son:\n\n<BREAK>\n\n•Controlar la temperatura a la que cocinamos los alimentos (nunca más de 170 grados) y el tiempo de cocción.\n\n<BREAK>\n\n•Para asegurarnos de que el nivel de acrilamida no es demasiado alto, el mejor indicador es el dolor, así que, ante cualquier frito y horneado, hay que vigilar que esté dorado, ni tostado ni, por supuesto, quemado. \n\n<BREAK>\n\nHay que evitar comerse siempre las partes más oscuras. \n\n<BREAK>\n\nComo reza el eslogan de AECOSAN, “frito, tostado y empanado, mejor que marrón, dorado”.\n\n<BREAK>\n\nCon las patatas en particular, debemos tomar las siguientes recomendaciones:\n\n<BREAK>\n\n•Comprarlas en su punto óptimo de maduración, sin brotes y que no sean muy pequeñas, pues concentran más azúcares.\n\n<BREAK>\n\n•Conservarlas fuera de la nevera, en un lugar fresco y seco y evitar que germinen.\n\n<BREAK>\n\n•Antes de freírlas: hacer un corte grueso, lavarlas y secarlas bien.\n\n<BREAK>\n\n•Cocinarlas al microondas, cocidas o al horno en vez de fritas. \n\n<BREAK>\n\nDe elegir freírlas, a menos de 175 grados y durante poco tiempo para que no se tuesten demasiado. \n\n<BREAK>\n\nSi no reutilizamos el aceite, mejor.\n\n<BREAK>\n\nEn cuanto a los productos industriales, se debe reducir el consumo de los que más acrilamida contienen, que son: las galletas, las patatas frías u otros aperitivos a base de patatas, los productos de bollería y pastelería, cereales del desayuno y café. \n\n<BREAK>\n\nEste último se recomienda comprar el natural frente al torrefacto y al soluble y la variedad arábica frente a la robusta, más rica en acrilamida.\n\n<BREAK>\n\nDespués de toda esta información, ¡que no cunda el pánico! Pues, según la EFSA, el nivel de exposición que tenemos actualmente a través de la alimentación no es peligrosa para la salud. \n\n<BREAK>\n\nSólo hay que prestar atención a no consumir demasiada y a evitarla, sobre, todo entre los bebés y los niños, los colectivos más vulnerables.\n\n<BREAK>\n\nY, por supuesto, huir del humo de tabaco.",
        "TITLE": "Acrilamida, dónde está, cómo evitarla y por qué puede ser perjudicial ",
        "ID": "5-20minutos",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Acrilamida, dónde está, cómo evitarla y por qué puede ser perjudicial ",
                "text_en": "Acrylamide, where it is, how to avoid it and why it can be harmful",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Acrilamida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Acrylamide"
                    }
                ],
                "evidences": [
                    {
                        "value": "To develop an understanding of the impact of environmental exposures on male reproductive function, we have previously used acrylamide as a reproductive toxicant to assess its impact on germ cell populations in the testes and in epididymis (22) (23) (24) . In these former studies, we demonstrated that acrylamide exposure leads to elevated levels of DNA damage throughout sperm development and maturation, with subtle changes in Sertoli cell structure following long-term acrylamide exposure. Specifically, exposure of testicular germ cells to acrylamide leads to enhanced levels of DNA damage that fail to be resolved during sperm maturation, yet do not appear to affect fertility or fetal development. Comparable levels of DNA damage are also characteristic of sperm exclusively exposed to acrylamide during epididymal transit. However, exposure timed to coincide with the developmental window of epididymal transit and ejaculation leads to substantially increased rates of fetal loss. These data indicate that the male transfers the burden of acrylamide stress to the female through mechanisms that are independent of sperm DNA damage. These results gave us the impetus to utilize this acute exposure model to assess acrylamide impact on the seminal vesicles, to better understand the contribution of this understudied tissue to a male's response to reproductive insults.",
                        "score": 0.5600000024
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9956889749
                    }
                ]
            },
            {
                "text": "La acrilamida está presente en nuestra dieta desde que el hombre empezó a cocinar los alimentos y se crea cuando sometemos a alimentos ricos en hidratos de carbono a altas temperaturas.",
                "text_en": "Acrylamide is present in our diet since man started cooking food and is created when we submit to foods rich in carbohydrates at high temperatures.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La acrilamida está presente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Acrylamide is present"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en nuestra dieta",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in our diet"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde que el hombre empezó a cocinar los alimentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since the man started cooking the food"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el hombre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the man"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se crea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "created"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "cuando sometemos a alimentos ricos en hidratos de carbono a altas temperaturas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when we submit to foods rich in carbohydrates at high temperatures"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las mayores fuentes de acrilamida son las patatas fritas, el pan tostado, las galletas y el café.",
                "text_en": "The main sources of acrylamide are fries, toast, biscuits and coffee.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las mayores fuentes de acrilamida son las patatas fritas, el pan tostado, las galletas y el café",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The main sources of acrylamide are fries, toast, biscuits and coffee."
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Agencia Internacional de Investigación sobre el Cáncer (IARC), de la Organización Mundial de la Salud (OMS), califica a la acrilamida como ‘probable carcinógeno humano’. ",
                "text_en": "The International Agency for Cancer Research (IARC), of the World Health Organization (WHO), calls acrylamide ‘probable human carcinogen’.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Internacional de Investigación sobre el Cáncer (IARC), de la Organización Mundial de la Salud (OMS)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "International Agency for Research on Cancer (IARC), World Health Organization (WHO)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "califica a la acrilamida como ‘probable carcinógeno humano’",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "qualifies acrylamide as ‘probable human carcinogen’"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esto significa que, tras realizar algunos ensayos en animales, se puede concluir que esta sustancia puede causar daños neurológicos y en el ADN y conllevar la aparición de cáncer. ",
                "text_en": "This means that, after some animal trials, it can be concluded that this substance can cause neurological and DNA damage and lead to cancer.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "tras realizar algunos ensayos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after some tests"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en animales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in animals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se puede concluir que esta sustancia puede causar daños neurológicos y en el ADN y conllevar la aparición de cáncer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it can be concluded that this substance can cause neurological and DNA damage and lead to cancer"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Por este motivo, las autoridades sanitarias, tanto europeas como españolas, recomiendan reducir nuestra exposición a esta sustancia, minimizando su presencia en los alimentos.",
                "text_en": "For this reason, the health authorities, both European and Spanish, recommend reducing our exposure to this substance, minimizing its presence in food.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "Por este motivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "For this reason"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las autoridades sanitarias, tanto europeas como españolas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health authorities, both European and Spanish"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recomiendan reducir nuestra exposición a esta sustancia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recommend reducing our exposure to this substance"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "minimizando su presencia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "minimizing their presence"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los alimentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in food"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Se trata de una sustancia soluble en agua que se forma al cocinar alimentos ricos en hidratos de carbono -como cereales o patatas- a temperaturas superiores a 120 grados y en ambientes de baja humedad, sobre todo cuando freímos, tostamos u horneamos. ",
                "text_en": "It is a water-soluble substance that is formed when cooking foods rich in carbohydrates - such as cereals or potatoes - at temperatures above 120 degrees and in low humidity environments, especially when frying, roasting or baking.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sustancia soluble en agua que se forma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "water-soluble substance forming"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "al cocinar alimentos ricos en hidratos de carbono -como cereales o patatas- a temperaturas superiores a 120 grados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when cooking foods rich in carbohydrates - such as cereals or potatoes - at temperatures above 120 degrees"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "cuando freímos, tostamos u horneamos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "when we fry, toast, or bake"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La sustancia resultante, la acrilamida, confiere a los alimentos ese color dorado y textura crujiente tan atrayente para el paladar.",
                "text_en": "The resulting substance, acrylamide, gives food that golden color and crispy texture so appealing to the palate.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la acrilamida, confiere a los alimentos ese color dorado y textura crujiente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "acrylamide, gives food that golden color and crispy texture"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Además de en los alimentos, la acrilamida también está presente en una gran concentración en el humo del tabaco y en la industria química para la fabricación de papel, de tintes y plásticos, en el tratamiento del agua potable y residual, y en algunos productos de consumo, tales como selladores, envases de alimentos o algunos adhesivos.",
                "text_en": "In addition to food, acrylamide is also present in a high concentration in tobacco smoke and in the chemical industry for the manufacture of paper, dyes and plastics, in the treatment of drinking and residual water, and in some consumer products, such as sealants, food containers or some adhesives.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la acrilamida también está presente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "acrylamide is also present"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el humo del tabaco y en la industria química para la fabricación de papel, de tintes y plásticos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in tobacco smoke and in the chemical industry for the manufacture of paper, dyes and plastics"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La acrilamida, una vez en el organismo, se transforma en glicidamida. ",
                "text_en": "Acrylamide, once in the body, is transformed into glycidamide.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el organismo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the body"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se transforma en glicidamida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "transforms into glycidamide"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Tras realizar varias pruebas en animales de laboratorio, se concluyó que esta sustancia en altas concentraciones fue la responsable de la aparición de algunos tipos de cáncer en ratones -mama, ovarios, endometrio, riñón o estómago- y de provocarles de efectos nocivos en el sistema nervioso. ",
                "text_en": "After several tests in laboratory animals, it was concluded that this substance at high concentrations was responsible for the appearance of some types of cancer in mice - mom, ovaries, endometrial, kidney or stomach - and causing harmful effects on the nervous system.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Tras realizar varias pruebas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "After several tests"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en animales de laboratorio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in laboratory animals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se concluyó que esta sustancia en altas concentraciones fue la responsable de la aparición de algunos tipos de cáncer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "it was concluded that this substance in high concentrations was responsible for the appearance of some types of cancer"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en ratones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in mice"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aunque no existen pruebas concluyentes de que se produjera el mismo efecto en humanos y se insiste en que aún se necesitan más investigaciones, dado el resultado en animales, se decidió calificarlo como ‘probable carcinógeno’ y establecer una serie de medidas para reducir su exposición.",
                "text_en": "Although there is no conclusive evidence of the same effect on humans and it is stressed that further research is still needed, given the result in animals, it was decided to qualify it as ‘probable carcinogen’ and to establish a number of measures to reduce its exposure.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no existen pruebas concluyentes de que se produjera el mismo efecto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "there is no conclusive evidence of the same effect"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en humanos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in humans"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aún se necesitan más investigaciones",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "further investigations are still needed"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "dado el resultado en animales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "given the result in animals"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se decidió calificarlo como ‘probable carcinógeno’ y establecer una serie de medidas para reducir su exposición",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "decided to qualify it as ‘probable carcinogen’ and to establish a series of measures to reduce its exposure"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los precursores de la acrilamida (hidratos de carbono y asparagina) están presentes de forma natural en los alimentos que consumimos, por lo que evitarla al 100% es casi imposible. ",
                "text_en": "Precursors of acrylamide (carbohydrates and asparagina) are naturally present in the foods we consume, so avoiding it at 100% is almost impossible.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los precursores de la acrilamida (hidratos de carbono y asparagina) están presentes de forma natural",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Precursors of acrylamide (carbohydrates and asparagina) are naturally present"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en los alimentos que consumimos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the food we consume"
                    }
                ],
                "evidences": [
                    {
                        "value": "Acrylamide has cytotoxic, antiproliferative and apoptotic effects on human lung adeno carcinoma cell line A549 Acrylamide (AA), a widespread substance in many fields, forms in foods during high temperature processing such as baking, roasting, frying. AA is a potent neurotoxic, genotoxic and clastogenic agent being a strong electrophile and forming adduct with biological molecules or potent nucleophiles. Up to now, several studies confirmed the toxicity of acrylamide to several organs. On the other hand, AA is reported to have inhibition effects both on proliferation and differentiation of different cancer cells in a time and dose-dependent manner. In addition, natural and synthetic acrylamide derivatives are also used as potent anti-cancer agents. Moreover, inhibition concentration (IC50) values of AA against these cancer cells have not been investigated in detail yet. Thus, the goal of this study is to investigate the cytotoxicity of AA on A549 cells including with ultrastructural and morphological effects.",
                        "score": 0.5299999714
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9984474778
                    }
                ]
            },
            {
                "text": "Lo que sí podemos hacer es controlar la que consumimos dentro de límites seguros. ",
                "text_en": "What we can do is control what we consume within safe limits.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Lo que sí podemos hacer es controlar la que consumimos dentro de límites seguros",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "What we can do is control what we consume within safe limits."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para ello, AECOSAN (Agencia Española de Consumo, Seguridad Alimentaria y Nutrición) ha elaborado una serie de recomendaciones destinadas a la reducción de acrilamida que se deberán llevar a cabo en los alimentos implicados: las patatas, el pan, las galletas y los empanados o rebozados. ",
                "text_en": "To this end, AECOSAN (Spanish Agency for Consumer Affairs, Food Safety and Nutrition) has drawn up a series of recommendations for the reduction of acrylamide to be carried out in the foods involved: potatoes, bread, biscuits and pastries.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "AECOSAN (Agencia Española de Consumo, Seguridad Alimentaria y Nutrición)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AECOSAN (Spanish Agency for Consumer Affairs, Food Safety and Nutrition)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha elaborado una serie de recomendaciones destinadas a la reducción de acrilamida",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has drawn up a series of recommendations aimed at reducing acrylamide"
                    }
                ],
                "evidences": []
            },
            {
                "text": "•Controlar la temperatura a la que cocinamos los alimentos (nunca más de 170 grados) y el tiempo de cocción.",
                "text_en": "•Control the temperature at which we cook the food (never more than 170 degrees) and the cooking time.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Controlar la temperatura a la que cocinamos los alimentos (nunca más de 170 grados) y el tiempo de cocción",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Control the temperature at which we cook food (never more than 170 degrees) and cooking time"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Después de toda esta información, ¡que no cunda el pánico! Pues, según la EFSA, el nivel de exposición que tenemos actualmente a través de la alimentación no es peligrosa para la salud. ",
                "text_en": "After all this information, do not panic! Well, according to EFSA, the level of exposure we currently have through food is not dangerous to health.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "según la EFSA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "according to EFSA"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el nivel de exposición que tenemos actualmente a través de la alimentación no es peligrosa para la salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the level of exposure that we currently have through food is not dangerous to health"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Sólo hay que prestar atención a no consumir demasiada y a evitarla, sobre, todo entre los bebés y los niños, los colectivos más vulnerables.",
                "text_en": "Only care must be taken not to consume too much and to avoid it, especially among babies and children, the most vulnerable groups.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hay que prestar atención a no consumir demasiada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pay attention to not consuming too much"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y, por supuesto, huir del humo de tabaco.",
                "text_en": "And, of course, running away from tobacco smoke.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "huir del humo de tabaco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Fleeing from tobacco smoke"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "107": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 13,
            "WhatReliabilityReliable": 13,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 15,
            "WhoReliabilityReliable": 15,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 9,
            "WhenReliabilityReliable": 9,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 6,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 13,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 6,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 6,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nEl departamento de Salud empezó este miércoles a inocular dosis de AstraZeneca\n\n<PARAGRAPH>\n\nUnas 100.000 personas de entre 60 y 65 años han pedido cita para recibir la vacuna de AstraZeneca a lo largo de esta semana en Cataluña, según datos del departamento de Salud a través de la web vacunacovid.cat.\n\n<BREAK>\n\nLa consejería empezó a principios de semana a activar el censo de este colectivo para inocular de nuevo las dosis de AstraZeneca, y este miércoles unas 14.000 personas recibieron su primer pinchazo.\n\n<PARAGRAPH>\n\nSalud anunció que enviaría mensajes de texto a las personas citadas, como ha hecho hasta ahora con los profesionales esenciales de menos de 55 años, pero la web permite apuntarse sin esperar el aviso de los servicios sanitarios.\n\n<BREAK>\n\nLa falta de dosis y el éxito de la inmunización en las residencias ha disparado el interés para recibir las vacunas, y la web recibió a lo largo de los primeros días miles de visitas.\n\n<BREAK>\n\nA lo largo del día se vieron colas en diferentes puntos de vacunación, como en el CAP Casernes de Barcelona.\n\n<PARAGRAPH>\n\nLa vacuna de AstraZeneca se retoma después del parón decretado por la Organización Mundial de la Salud para estudiar su vinculación con trombos sufridos en distintos países de Europa y de que el Ministerio de Sanidad aumentara la edad máxima para recibir las dosis de los 55 años a los 65.\n\n<PARAGRAPH>\n\nEl sistema, sin embargo, limita la inscripción a las personas que no sufran trasplantes de órganos o estén en la lista de espera, enfermedades oncohematológicas, cáncer en tratamiento de quimioterapia o cualquier tratamiento inmunosupresor.\n\n<BREAK>\n\nLa vacunación se realiza actualmente en uno de los puntos habilitados y los usuarios pueden reservar día y hora en el centro elegido.\n\n<BREAK>\n\nLas reservas, sin embargo, están casi al máximo hasta la semana que viene.\n\n<PARAGRAPH>\n\nActualmente Cataluña también está vacunando a los mayores de 80 años y los profesionales esenciales.\n\n<BREAK>\n\nEn vista de terminar este proceso a mediados de mayo, Cataluña habilitará 500 puntos de vacunación para acelerar la administración masiva de dosis, entre los que destacan los espacios del Camp Nou y Fira de Barcelona.\n\n<BREAK>\n\nLa Generalitat, que contempla mantener estos espacios “unos seis meses”, presentó este martes la planificación para los próximos meses, cuando la distribución de las dosis aumente considerablemente.\n\n<BREAK>\n\nLa consejera de Salud, Alba Vergés, avanzó que el departamento está preparado para administrar 500.000 vacunas semanales y terminar a mediados de mayo la vacunación de los mayores de 80 años y los profesionales esenciales.\n\n<PARAGRAPH>\n",
        "TITLE": "Unas 100.000 personas de entre 60 y 65 años han pedido cita para vacunarse en Cataluña a través de una web",
        "ID": "F_04-11-2021_21-19-01_elpais_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Unas 100.000 personas de entre 60 y 65 años han pedido cita para vacunarse en Cataluña a través de una web",
                "text_en": "About 100,000 people aged 60 to 65 have requested an appointment to get vaccinated in Catalonia through a website",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Unas 100.000 personas de entre 60 y 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "About 100,000 persons aged 60 to 65"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han pedido cita para vacunarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have asked for an appointment to get vaccinated"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a través de una web",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "through a website"
                    }
                ],
                "evidences": [
                    {
                        "value": "A total of 667 participants from the general population participated (30.9% were men and 69.1% were women). All of them were of legal age (mean = 32.46; standard deviation = 10.373). A total of 34.5% resided in the community of Catalonia, 28% in Madrid, 19.8% in Castilla-La Mancha and 17.7% resided in Andalusia. All participants were asked the number of people they had lived with during the 57 days of confinement (mean = 2.07; standard deviation = 1.486). Given ",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.983079195
                    }
                ]
            },
            {
                "text": "El departamento de Salud empezó este miércoles a inocular dosis de AstraZeneca",
                "text_en": "The Department of Health began this Wednesday to inoculate doses of AstraZeneca",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El departamento de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Department of Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "empezó este miércoles a inocular dosis de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "started this Wednesday to inoculate doses of AstraZeneca"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Wednesday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Unas 100.000 personas de entre 60 y 65 años han pedido cita para recibir la vacuna de AstraZeneca a lo largo de esta semana en Cataluña, según datos del departamento de Salud a través de la web vacunacovid.cat.",
                "text_en": "Some 100,000 people between the ages of 60 and 65 have requested an appointment to receive the AstraZeneca vaccine throughout this week in Catalonia, according to data from the Department of Health through the website vaccinacovid.cat.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Unas 100.000 personas de entre 60 y 65 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "About 100,000 persons aged 60 to 65"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han pedido cita para recibir la vacuna de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "have asked for an appointment to receive the AstraZeneca vaccine"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a lo largo de esta semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout this week"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Catalonia"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "departamento de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Department of Health"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a través de la web vacunacovid.cat",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "through the website vaccinacovid.cat"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La consejería empezó a principios de semana a activar el censo de este colectivo para inocular de nuevo las dosis de AstraZeneca, y este miércoles unas 14.000 personas recibieron su primer pinchazo.",
                "text_en": "The counseling began at the beginning of the week to activate the census of this collective to inoculate again the doses of AstraZeneca, and on Wednesday about 14,000 people received their first puncture.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La consejería",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Counseling"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a principios de semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at the beginning of the week"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "activar el censo de este colectivo para inocular de nuevo las dosis de AstraZeneca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "activate the census of this group to inoculate again the doses of AstraZeneca"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "de este colectivo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of this collective"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Wednesday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "unas 14.000 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "about 14,000 people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recibieron su primer pinchazo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "received their first puncture"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Salud anunció que enviaría mensajes de texto a las personas citadas, como ha hecho hasta ahora con los profesionales esenciales de menos de 55 años, pero la web permite apuntarse sin esperar el aviso de los servicios sanitarios.",
                "text_en": "Health announced that it would send text messages to the mentioned people, as it has done so far with essential professionals under 55 years old, but the website allows to sign up without waiting for the notice of the health services.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la web permite apuntarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the web allows you to sign up"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin esperar el aviso",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "without waiting for notice"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los servicios sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "health services"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La falta de dosis y el éxito de la inmunización en las residencias ha disparado el interés para recibir las vacunas, y la web recibió a lo largo de los primeros días miles de visitas.",
                "text_en": "The lack of doses and the success of immunization in residences has triggered interest in getting the vaccines, and the web received thousands of visits over the first few days.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "La falta de dosis y el éxito de la inmunización",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Lack of doses and successful immunization"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en las residencias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in residences"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la web recibió a lo largo de los primeros días miles de visitas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the web received over the first few days thousands of visits"
                    }
                ],
                "evidences": [
                    {
                        "value": "The COVID-19 pandemic highlights the urgent need for efficient vaccines, and the increased interest in vaccines of all varieties among the general population does offer excitement. We note that much like with the SARS-CoV-2 vaccines, providing availability to remote areas while maintaining affordability remains a challenge.",
                        "score": 0.5199999809
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9827961326
                    }
                ]
            },
            {
                "text": "La vacuna de AstraZeneca se retoma después del parón decretado por la Organización Mundial de la Salud para estudiar su vinculación con trombos sufridos en distintos países de Europa y de que el Ministerio de Sanidad aumentara la edad máxima para recibir las dosis de los 55 años a los 65.",
                "text_en": "The AstraZeneca vaccine is resumed after the stoppage decreed by the World Health Organization to study its association with thrombi in different countries of Europe and that the Ministry of Health increased the maximum age to receive doses from 55 years to 65.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vacuna de AstraZeneca se retoma",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca vaccine is resumed"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "después del parón",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after the stoppage"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Organización Mundial de la Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the World Health Organization"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en distintos países de Europa",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in different European countries"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La vacunación se realiza actualmente en uno de los puntos habilitados y los usuarios pueden reservar día y hora en el centro elegido.",
                "text_en": "Vaccination is currently carried out at one of the designated points and users can book day and time in the chosen centre.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La vacunación se realiza actualmente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Vaccination is currently taking place"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en uno de los puntos habilitados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at one of the enabled points"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Actualmente Cataluña también está vacunando a los mayores de 80 años y los profesionales esenciales.",
                "text_en": "Currently Catalonia is also vaccinating those over 80 years of age and essential professionals.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Actualmente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Currently"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "está vacunando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He's vaccinating."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los mayores de 80 años y los profesionales esenciales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 80 years of age and essential professionals"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En vista de terminar este proceso a mediados de mayo, Cataluña habilitará 500 puntos de vacunación para acelerar la administración masiva de dosis, entre los que destacan los espacios del Camp Nou y Fira de Barcelona.",
                "text_en": "In view of the completion of this process in mid-May, Catalonia will enable 500 vaccination points to accelerate the massive administration of doses, among which are the Camp Nou and Fira areas of Barcelona.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a mediados de mayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mid-May"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Cataluña",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Catalonia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "habilitará 500 puntos de vacunación para acelerar la administración masiva de dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "enable 500 vaccination points to accelerate mass dose administration"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "los espacios del Camp Nou y Fira de Barcelona",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the spaces of the Camp Nou and Fira of Barcelona"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Generalitat, que contempla mantener estos espacios “unos seis meses”, presentó este martes la planificación para los próximos meses, cuando la distribución de las dosis aumente considerablemente.",
                "text_en": "The Generalitat, which plans to maintain these spaces “about six months”, presented Tuesday the planning for the coming months, when the distribution of the doses increases considerably.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Generalitat",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Generalitat"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "presentó este martes la planificación para los próximos meses",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "presented this Tuesday the planning for the next months"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este martes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Tuesday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La consejera de Salud, Alba Vergés, avanzó que el departamento está preparado para administrar 500.000 vacunas semanales y terminar a mediados de mayo la vacunación de los mayores de 80 años y los profesionales esenciales.",
                "text_en": "Health Advisor Alba Verges said the department is ready to administer 500,000 vaccines a week and to complete the vaccination of 80-year-olds and essential professionals by mid-May.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La consejera de Salud, Alba Vergés",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Health Counselor, Alba Verges"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "avanzó que el departamento está preparado para administrar 500.000 vacunas semanales y terminar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "progressed that the department is ready to administer 500,000 vaccines weekly and finish"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a mediados de mayo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "mid-May"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los mayores de 80 años y los profesionales esenciales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 80 years of age and essential professionals"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "108": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 12,
            "WhatReliabilityReliable": 9,
            "WhatReliabilityUnreliable": 3,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 12,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 2,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 3,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 6,
            "WhereReliabilityReliable": 6,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 4,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 1,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 2,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 1,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 11,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n \n\n<PARAGRAPH>\n\nUna enfermera falleció ayer en Georgia a causa de un choque anafiláctico dos días después de ser vacunada con AstraZeneca, lo que representa la primera muerte por esa causa tras la inoculación de dicho fármaco.\n\n<PARAGRAPH>\n\nEl fallecimiento de la enfermera georgiana de 27 años, Megi Bakradze, fue confirmada por el Ministerio de Salud de Georgia a través de un comunicado.\n\n<PARAGRAPH>\n\n“Podemos afirmar, de forma preliminar que lo ocurrido es el resultado de una reacción alérgica severa a la vacunación, pero próximamente los expertos emitirán su veredicto oficial”, expresó el inmunólogo Bidzina Kulumbegov, uno de los asesores médicos del gobierno georgiano.\n\n<PARAGRAPH>\n\nBakradze fue vacunada el pasado 18 de marzo a las 12:15 hora local y luego concedió una entrevista en la que manifestó que “se necesitan vacunas, somos impotentes contra el virus, debemos vacunarnos para evitar enfermedades o no enfermarnos de forma grave.\n\n<BREAK>\n\nAunque la gente tiene miedo, no hay nada peligroso en vacunarse.\n\n<BREAK>\n\nInsto a todos a que se vacunen”.\n\n<PARAGRAPH>\n\nAl día siguiente de haber recibido la inyección, la joven enfermera cayó en coma en un hospital de la ciudad georgiana de Ajaltsije, a 200 kilómetros al sur de Tiflis, la capital de Georgia y, a pesar de que esa noche se estabilizó, ayer su corazón se detuvo y los médicos no lograron reanimarla.\n\n<PARAGRAPH>\n\nGeorgia inició su campaña de inmunización masiva contra el coronavirus el 15 de marzo de este año y hasta ahora solo cuenta con dicho fármaco de origen británico para el proceso.\n\n<PARAGRAPH>\n\nA pesar del fallecimiento de la enfermera, y poco después de que científicos noruegos relacionaran esta vacuna AstraZeneca, con la formación de coágulos de sangre; el Ministerio de Salud de Georgia afirmó que el proceso de vacunación contra el coronavirus con el preparado británico continuaría en el país solo en los centros médicos especializados.\n\n<PARAGRAPH>\n\nLa Unión Europea detuvo durante varios días la vacunación con este fármaco tras varios episodios trombóticos notificados en el Viejo Continente.\n\n<PARAGRAPH>\n",
        "TITLE": "Una enfermera fallece en Georgia tras ser vacunada con AstraZeneca a causa de un choque anafiláctico",
        "ID": "NF_NF_1680_mpr21_info",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Una enfermera fallece en Georgia tras ser vacunada con AstraZeneca a causa de un choque anafiláctico",
                "text_en": "A nurse dies in Georgia after being vaccinated with AstraZeneca due to anaphylactic shock",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Una enfermera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A nurse"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fallece",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "passed away."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Georgia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Georgia"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras ser vacunada con AstraZeneca a causa de un choque anafiláctico",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "after being vaccinated with AstraZeneca due to anaphylactic shock"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Una enfermera falleció ayer en Georgia a causa de un choque anafiláctico dos días después de ser vacunada con AstraZeneca, lo que representa la primera muerte por esa causa tras la inoculación de dicho fármaco.",
                "text_en": "A nurse died yesterday in Georgia from an anaphylactic shock two days after being vaccinated with AstraZeneca, which represents the first death from that cause after inoculation of the drug.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Una enfermera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A nurse"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "falleció",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He passed away."
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ayer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "yesterday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Georgia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Georgia"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a causa de un choque anafiláctico",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "due to anaphylactic shock"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "dos días después de ser vacunada con AstraZeneca",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "two days after being vaccinated with AstraZeneca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El fallecimiento de la enfermera georgiana de 27 años, Megi Bakradze, fue confirmada por el Ministerio de Salud de Georgia a través de un comunicado.",
                "text_en": "The death of the 27-year-old Georgian nurse, Megi Bakradze, was confirmed by the Georgian Ministry of Health through a statement.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "El fallecimiento de la enfermera georgiana de 27 años, Megi Bakradze, fue confirmada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The death of 27-year-old Georgian nurse Megi Bakradze was confirmed"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la enfermera georgiana de 27 años, Megi Bakradze",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Georgian nurse, age 27, Megi Bakradze"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Salud",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Georgia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Georgia"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "a través de un comunicado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "through a statement"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Podemos afirmar, de forma preliminar que lo ocurrido es el resultado de una reacción alérgica severa a la vacunación, pero próximamente los expertos emitirán su veredicto oficial”, expresó el inmunólogo Bidzina Kulumbegov, uno de los asesores médicos del gobierno georgiano.",
                "text_en": "“We can state, in a preliminary way, that what happened is the result of a severe allergic reaction to vaccination, but the experts will soon issue their official verdict,” said immunologist Bidzina Kulumbegov, one of the Georgian government’s medical advisors.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "el resultado de una reacción alérgica severa a la vacunación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the result of a severe allergic reaction to vaccination"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "próximamente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Soon"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los expertos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "experts"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "emitirán su veredicto oficial",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "will issue their official verdict"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el inmunólogo Bidzina Kulumbegov",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "immunologist Bidzina Kulumbegov"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Bakradze fue vacunada el pasado 18 de marzo a las 12:15 hora local y luego concedió una entrevista en la que manifestó que “se necesitan vacunas, somos impotentes contra el virus, debemos vacunarnos para evitar enfermedades o no enfermarnos de forma grave.",
                "text_en": "Bakradze was vaccinated on March 18 at 12:15 local time and then gave an interview in which she said that “vaccinations are needed, we are powerless against the virus, we must get vaccinated to avoid disease or not get seriously ill.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Bakradze",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Bakradze"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "fue vacunada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "was vaccinated"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el pasado 18 de marzo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "last March 18"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "debemos vacunarnos para evitar enfermedades o no enfermarnos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "We have to get vaccinated to avoid disease or not get sick."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de forma grave",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "severely"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Aunque la gente tiene miedo, no hay nada peligroso en vacunarse.",
                "text_en": "Although people are afraid, there is nothing dangerous about getting vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "no hay nada peligroso en vacunarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "There's nothing dangerous about getting vaccinated."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Al día siguiente de haber recibido la inyección, la joven enfermera cayó en coma en un hospital de la ciudad georgiana de Ajaltsije, a 200 kilómetros al sur de Tiflis, la capital de Georgia y, a pesar de que esa noche se estabilizó, ayer su corazón se detuvo y los médicos no lograron reanimarla.",
                "text_en": "The day after receiving the injection, the young nurse fell into a coma in a hospital in the Georgian city of Ajaltsije, 200 kilometres south of Tbilisi, the capital of Georgia, and, although she stabilized that night, her heart stopped yesterday and the doctors failed to revive her.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Al día siguiente de haber recibido la inyección",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The day after receiving the injection"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la joven enfermera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the young nurse"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cayó en coma",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "fell into a coma"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en un hospital de la ciudad georgiana de Ajaltsije",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a hospital in the Georgian city of Ajaltsije"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ayer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "yesterday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "su corazón se detuvo y los médicos no lograron reanimarla",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "her heart stopped and the doctors failed to revive her"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Georgia inició su campaña de inmunización masiva contra el coronavirus el 15 de marzo de este año y hasta ahora solo cuenta con dicho fármaco de origen británico para el proceso.",
                "text_en": "Georgia started its mass immunization campaign against the coronavirus on March 15 of this year and so far only has this drug of British origin for the process.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Georgia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Georgia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "inició su campaña de inmunización masiva contra el coronavirus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "started its mass immunization campaign against the coronavirus"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el 15 de marzo de este año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on March 15 of this year"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A pesar del fallecimiento de la enfermera, y poco después de que científicos noruegos relacionaran esta vacuna AstraZeneca, con la formación de coágulos de sangre; el Ministerio de Salud de Georgia afirmó que el proceso de vacunación contra el coronavirus con el preparado británico continuaría en el país solo en los centros médicos especializados.",
                "text_en": "Despite the death of the nurse, and shortly after Norwegian scientists linked this AstraZeneca vaccine to the formation of blood clots; the Ministry of Health of Georgia stated that the process of vaccination against the coronavirus with the British preparation would continue in the country only in specialized medical centers.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "A pesar del fallecimiento de la enfermera, y poco después de que científicos noruegos relacionaran esta vacuna AstraZeneca, con la formación de coágulos de sangre",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Despite the death of the nurse, and shortly after Norwegian scientists related this AstraZeneca vaccine to the formation of blood clots"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "científicos noruegos",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Norwegian scientists"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Salud de Georgia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health of Georgia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "afirmó que el proceso de vacunación contra el coronavirus con el preparado británico continuaría",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "said that the process of vaccination against the coronavirus with the British preparation would continue"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el país solo en los centros médicos especializados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the country only in specialized medical centres"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Unión Europea detuvo durante varios días la vacunación con este fármaco tras varios episodios trombóticos notificados en el Viejo Continente.",
                "text_en": "The European Union stopped vaccination with this drug for several days after several thrombotic episodes reported in the Old Continent.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Unión Europea",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European Union"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "detuvo durante varios días la vacunación con este fármaco",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "stopped vaccination with this drug for several days"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "durante varios días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for several days"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "tras varios episodios trombóticos notificados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "after several thrombotic events reported"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Viejo Continente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the Old Continent"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "109": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 10,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 14,
            "WhoReliabilityReliable": 14,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 2,
            "WhereReliabilityReliable": 1,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 2,
            "HowReliabilityReliable": 2,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 6,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 8,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nLos primeros en ser citados serán los nacidos en 1942 y 1943, un grupo de más de 677.000 personas.\n\nMoreno asegura que queda un 8% de mayores de 80 años por localizar para administrarles la vacuna.\n\n<PARAGRAPH>\n\nLa Consejería de Salud y Familias de la Junta de Andalucía adelanta a este lunes la vacunación a la población general de 79 a 70 años, cuyo inicio estaba previsto para el 15 de este mes, una vez que se encuentra muy avanzada la vacunación de los mayores de 80, habiendo concluido en muchas provincias.\n\n<PARAGRAPH>\n\nEsta nueva citación se hará siguiendo un orden descendente por edad, comenzando por los nacidos en 1942 y 1943 en toda Andalucía.\n\n<BREAK>\n\nEste grupo está compuesto por 677.542 personas, según señala en un comunicado la Consejería de Salud y Familias.\n\n<BREAK>\n\nEstas primeras dosis para este grupo de edad serán con el preparado de Pfizer y Moderna.\n\n<PARAGRAPH>\n\nEn paralelo, ha apuntado que Andalucía va a comenzar a citar a los pacientes vulnerables o de muy alto riesgo que contempla la estrategia de vacunación consensuada por el Consejo Interterritorial: personas con trasplante de progenitores hematopoyéticos, trasplante de órgano sólido y lista de espera para este, personas en hemodiálisis y diálisis peritoneal, enfermedad oncohematológica, cáncer de órgano sólido en tratamiento con quimioterapia citotóxica, cáncer de pulmón en tratamiento con quimioterapia o inmunoterapia y personas con Síndrome de Down mayores de 40 años.\n\n<PARAGRAPH>\n\nMayores de 80\n\n<PARAGRAPH>\n\nEl presidente de la Junta, Juanma Moreno, ha asegurado que el 92% de mayores de 80 años ya se han vacunado y que \"queda por localizar un 8%\" para vacunar contra la Covid-19 \"en tiempo y forma\", toda vez que ha asegurado que se intentará esta semana localizar a estas personas y que \"a lo largo de los próximos diez días estén todos vacunados\".\n\n<PARAGRAPH>\n\n\"No es fácil localizar a algunas personas que son mayores, muchos de ellos no tiene móvil o viven en zonas aisladas, y estamos haciendo digamos un cribado para poder localizarlos y vacunar en tiempo y forma\", ha indicado Moreno, quien ha insistido en que \"hacen falta vacunas\".\n\n<BREAK>\n\n\"Quiero tener la posibilidad de sufrir poniendo vacunas, que nos critiquen si no somos capaces de poner tantas vacunas como nos llegan, eso es lo que quiero\", ha manifestado, para añadir que Andalucía \"es líder en la puesta de vacunas de España, en términos relativos y absolutos, y somos los que más vacunas hemos puesto a mayores de 80 años\". \n\n<PARAGRAPH>\n\n",
        "TITLE": "Andalucía adelanta a este lunes la vacunación de mayores de 70 a 79 años",
        "ID": "F_04-11-2021_20-46-38_www_20minutos_es",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Andalucía adelanta a este lunes la vacunación de mayores de 70 a 79 años",
                "text_en": "Andalusia anticipates Monday the vaccination of over 70 to 79 years of age",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Andalucía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Andalusia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "adelanta a este lunes la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "advance to this Monday the vaccination"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mayores de 70 a 79 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 70 to 79 years of age"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los primeros en ser citados serán los nacidos en 1942 y 1943, un grupo de más de 677.000 personas.",
                "text_en": "The first to be cited will be those born in 1942 and 1943, a group of more than 677,000 people.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los primeros en ser citados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The first to be cited"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los nacidos en 1942 y 1943, un grupo de más de 677.000 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "born in 1942 and 1943, a group of more than 677,000 people"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en 1942 y 1943",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in 1942 and 1943"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Moreno asegura que queda un 8% de mayores de 80 años por localizar para administrarles la vacuna.",
                "text_en": "Moreno says that there are 8% of those over 80 years of age left to locate to give them the vaccine.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Moreno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Moreno"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "asegura que queda un 8% de mayores de 80 años por localizar para administrarles la vacuna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "ensures that 8% of people over 80 years of age still have to be found to give them the vaccine"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "mayores de 80 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "over 80 years of age"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Consejería de Salud y Familias de la Junta de Andalucía adelanta a este lunes la vacunación a la población general de 79 a 70 años, cuyo inicio estaba previsto para el 15 de este mes, una vez que se encuentra muy avanzada la vacunación de los mayores de 80, habiendo concluido en muchas provincias.",
                "text_en": "The Council of Health and Families of the Junta de Andalucía advances to this Monday the vaccination to the general population of 79 to 70 years, whose beginning was planned for the 15 of this month, once the vaccination of those over 80 is very advanced, having concluded in many provinces.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Consejería de Salud y Familias de la Junta de Andalucía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Department of Health and Families of the Junta de Andalucía"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "adelanta a este lunes la vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "advance to this Monday the vaccination"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la población general de 79 a 70 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the general population aged 79-70"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Esta nueva citación se hará siguiendo un orden descendente por edad, comenzando por los nacidos en 1942 y 1943 en toda Andalucía.",
                "text_en": "This new citation will be made following a descending order by age, beginning with those born in 1942 and 1943 throughout Andalusia.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Esta nueva citación se hará",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "This new subpoena will be made"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "siguiendo un orden descendente por edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "following a descending order by age"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los nacidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "born"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en 1942 y 1943",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in 1942 and 1943"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en toda Andalucía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "throughout Andalusia"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estas primeras dosis para este grupo de edad serán con el preparado de Pfizer y Moderna.",
                "text_en": "These first doses for this age group will be with the preparation of Pfizer and Moderna.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estas primeras dosis",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "These first doses"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "este grupo de edad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this age group"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con el preparado de Pfizer y Moderna",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with the preparation of Pfizer and Moderna"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En paralelo, ha apuntado que Andalucía va a comenzar a citar a los pacientes vulnerables o de muy alto riesgo que contempla la estrategia de vacunación consensuada por el Consejo Interterritorial: personas con trasplante de progenitores hematopoyéticos, trasplante de órgano sólido y lista de espera para este, personas en hemodiálisis y diálisis peritoneal, enfermedad oncohematológica, cáncer de órgano sólido en tratamiento con quimioterapia citotóxica, cáncer de pulmón en tratamiento con quimioterapia o inmunoterapia y personas con Síndrome de Down mayores de 40 años.",
                "text_en": "In parallel, it has pointed out that Andalusia is going to begin to cite vulnerable or very high-risk patients that contemplate the strategy of vaccination agreed by the Interterritorial Council: people with hematopoietic parents transplant, solid organ transplant and waiting list for it, people on hemodialysis and peritoneal dialysis, oncohematology disease, solid organ cancer being treated with cytotoxic chemotherapy, lung cancer being treated with chemotherapy or immunotherapy and people with Down syndrome over 40 years of age.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Andalucía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Andalusia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "va a comenzar a citar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He's going to start quoting."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los pacientes vulnerables o de muy alto riesgo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to vulnerable or very high-risk patients"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El presidente de la Junta, Juanma Moreno, ha asegurado que el 92% de mayores de 80 años ya se han vacunado y que \"queda por localizar un 8%\" para vacunar contra la Covid-19 \"en tiempo y forma\", toda vez que ha asegurado que se intentará esta semana localizar a estas personas y que \"a lo largo de los próximos diez días estén todos vacunados\".",
                "text_en": "The president of the Board, Juanma Moreno, has assured that 92% of those over 80 years of age have already been vaccinated and that \"it remains to locate 8%\" to vaccinate against the Covid-19 \"in time and form\", since he has assured that it will be attempted this week to locate these people and that \"over the next ten days they will all be vaccinated\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El presidente de la Junta, Juanma Moreno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The President of the Board, Juanma Moreno"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha asegurado que el 92% de mayores de 80 años ya se han vacunado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "has assured that 92% of those over 80 years of age have already been vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"No es fácil localizar a algunas personas que son mayores, muchos de ellos no tiene móvil o viven en zonas aisladas, y estamos haciendo digamos un cribado para poder localizarlos y vacunar en tiempo y forma\", ha indicado Moreno, quien ha insistido en que \"hacen falta vacunas\".",
                "text_en": "\"It's not easy to locate some people who are older, many of them have no motive or live in isolated areas, and we're doing a screening so we can locate them and vaccinate them in time and form,\" said Moreno, who has insisted that \"vaccines are needed.\"",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Moreno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Moreno"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "hacen falta vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "vaccines are needed"
                    }
                ],
                "evidences": []
            },
            {
                "text": "\"Quiero tener la posibilidad de sufrir poniendo vacunas, que nos critiquen si no somos capaces de poner tantas vacunas como nos llegan, eso es lo que quiero\", ha manifestado, para añadir que Andalucía \"es líder en la puesta de vacunas de España, en términos relativos y absolutos, y somos los que más vacunas hemos puesto a mayores de 80 años\". ",
                "text_en": "\"I want to have the possibility to suffer by putting vaccines, that criticize us if we are not able to put as many vaccines as we get, that's what I want,\" he said, adding that Andalusia \"is leader in the laying of vaccines in Spain, in relative and absolute terms, and we are the ones that have put more vaccines to over 80 years of age\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Andalucía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Andalusia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es líder en la puesta de vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is a leader in the introduction of vaccines"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "110": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 13,
            "WhatReliabilityReliable": 13,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 13,
            "WhoReliabilityReliable": 10,
            "WhoReliabilityUnreliable": 3,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 5,
            "WhenReliabilityReliable": 4,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 5,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 1,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 1,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 1,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 4,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 4,
            "WhoRoleSubject": 10,
            "WhoRoleTarget": 1,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 7,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 7,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nCasi 260.000 personas han muerto en la nación sudamericana a causa de la enfermedad\n\n<PARAGRAPH>\n\nBrasil sigue enfrentándose a la difícil batalla de vencer al COVID-19.\n\n<PARAGRAPH>\n\nLos secretarios de Salud de los 27 estados de Brasil exigieron, mediante un comunicado, que el Gobierno imponga un toque de queda nocturno y nacional en todo el país para evitar el colapso de la red hospitalaria en las principales ciudades.\n\n<PARAGRAPH>\n\n“Brasil atraviesa, perplejo, por el peor momento de la crisis provocada por la covid-19, con índices muy elevados en todas las regiones”, alertó el Consejo Nacional de Secretarios de Salud (Conass), que reúne a los responsables sanitarios de los 27 estados.\n\n<PARAGRAPH>\n\n“La ausencia de una conducción nacional unificada y coherente dificultó la adopción de medidas” para restringir la movilidad de personas, agregan los secretarios, en una clara alusión al presidente del país, Jair Bolsonaro, líder una negacionista ultraderecha brasileña y que insiste en minimizar la gravedad de la pandemia.\n\n<PARAGRAPH>\n\nEn su documento, la Conass recomendó la inmediata “prohibición de eventos presenciales como espectáculos, congresos, actividades religiosas, deportivas o similares en todo el territorio nacional”.\n\n<PARAGRAPH>\n\nTambién pidió “la suspensión de las actividades presenciales en todos los niveles de la educación del país”, el “cierre de playas y bares” y la implantación de “un toque de queda nacional entre las 20.00 horas y las seis de la mañana, y durante los fines de semana”.\n\n<PARAGRAPH>\n\nEl jefe de Estado, por el contrario, volvió a criticar en los últimos días las medidas de distanciamiento social y afirmó que se debe dar prioridad al mantenimiento de la actividad económica, pues el desempleo causado por esas restricciones “mata más” que el virus.\n\n<PARAGRAPH>\n\nPese a la aparente reducción de las cifras en los dos últimos días, el promedio de muertes en la última semana se ubicó este lunes en 1.225 diarias, el mayor registrado desde el inicio de la pandemia y una media en un 15,35 % superior a la de hace un mes (1.062 fallecimientos diarios el 1 de febrero).\n\n<PARAGRAPH>\n\nDe la misma forma, el promedio de contagios en la última semana subió hasta 55.977 diarios este lunes, igualmente el mayor desde el inicio de la pandemia y en un 9,47 % superior a la media de hace exactamente un mes (51.133 casos diarios el 1 de febrero).\n\n<PARAGRAPH>\n\nLa subida de los promedios diarios a niveles récords demuestra que Brasil enfrenta una segunda ola de la pandemia más virulenta y mortal que la primera, que al parecer se ha recrudecido por la circulación de nuevas cepas del virus, entre las cuales la llamada variante brasileña, que, según el Ministerio de Salud, es tres veces más contagiosa que la original.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Presionan a Bolsonaro para imponer un toque de queda nacional que evite el colapso hospitalario",
        "ID": "NF_04-11-2021_20-36-46_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Presionan a Bolsonaro para imponer un toque de queda nacional que evite el colapso hospitalario",
                "text_en": "Bolsonaro is pressured to impose a national curfew to prevent hospital collapse",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Presionan a Bolsonaro para imponer un toque de queda nacional que evite el colapso hospitalario",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Bolsonaro is pressured to impose a national curfew to prevent hospital collapse"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Bolsonaro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Bolsonaro"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Casi 260.000 personas han muerto en la nación sudamericana a causa de la enfermedad",
                "text_en": "Nearly 260,000 people have died in the South American nation from the disease",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Casi 260.000 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Nearly 260,000 people"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han muerto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're dead."
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en la nación sudamericana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the South American nation"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "a causa de la enfermedad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "caused by the disease"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Brasil sigue enfrentándose a la difícil batalla de vencer al COVID-19.",
                "text_en": "Brazil continues to face the difficult battle of defeating COVID-19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Brazil"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "sigue enfrentándose a la difícil batalla de vencer al COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "continues to face the difficult battle of defeating the COVID-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los secretarios de Salud de los 27 estados de Brasil exigieron, mediante un comunicado, que el Gobierno imponga un toque de queda nocturno y nacional en todo el país para evitar el colapso de la red hospitalaria en las principales ciudades.",
                "text_en": "The health secretaries of the 27 states of Brazil demanded, in a statement, that the government impose a night and national curfew throughout the country to prevent the collapse of the hospital network in the main cities.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los secretarios de Salud",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The Health Secretaries"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de los 27 estados de Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the 27 states of Brazil"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "exigieron, mediante un comunicado, que el Gobierno imponga un toque de queda nocturno y nacional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "demanded, by a communiqué, that the Government impose a night and national curfew"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "mediante un comunicado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by means of a communiqué"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en todo el país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "all over the country"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Brasil atraviesa, perplejo, por el peor momento de la crisis provocada por la covid-19, con índices muy elevados en todas las regiones”, alertó el Consejo Nacional de Secretarios de Salud (Conass), que reúne a los responsables sanitarios de los 27 estados.",
                "text_en": "“Brazil goes through, perplexed, the worst moment of the crisis caused by covid-19, with very high rates in all regions,” warned the National Council of Health Secretaries (Conass), which brings together health officials from all 27 states.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Brazil"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "atraviesa, perplejo, por el peor momento de la crisis provocada por la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "through, perplexed, the worst moment of the crisis caused by the covid-19"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Consejo Nacional de Secretarios de Salud (Conass)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "National Council of Health Secretaries (Conass)"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "reúne",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "meets"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a los responsables sanitarios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to health-care providers"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "de los 27 estados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "of the 27 states"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“La ausencia de una conducción nacional unificada y coherente dificultó la adopción de medidas” para restringir la movilidad de personas, agregan los secretarios, en una clara alusión al presidente del país, Jair Bolsonaro, líder una negacionista ultraderecha brasileña y que insiste en minimizar la gravedad de la pandemia.",
                "text_en": "“The absence of a unified and coherent national leadership made it difficult to adopt measures” to restrict the mobility of people, the secretaries add, in a clear allusion to the country’s president, Jair Bolsonaro, leader of an ultra-right Brazilian denialist who insists on minimizing the seriousness of the pandemic.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La ausencia de una conducción nacional unificada y coherente dificultó la adopción de medidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The absence of unified and coherent national leadership made action difficult"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los secretarios",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Secretaries"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "presidente del país, Jair Bolsonaro",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "President of the country, Jair Bolsonaro"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "insiste en minimizar la gravedad de la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "insists on minimizing the seriousness of the pandemic"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En su documento, la Conass recomendó la inmediata “prohibición de eventos presenciales como espectáculos, congresos, actividades religiosas, deportivas o similares en todo el territorio nacional”.",
                "text_en": "In its document, the Conass recommended the immediate “prohibition of face-to-face events such as shows, congresses, religious, sporting or similar activities throughout the national territory”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "En su documento",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "In your document"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la Conass",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the Conass"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recomendó la inmediata “prohibición de eventos presenciales como espectáculos, congresos, actividades religiosas, deportivas o similares en todo el territorio nacional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "recommended the immediate “prohibition of face-to-face events such as shows, congresses, religious, sporting or similar activities throughout the national territory"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El jefe de Estado, por el contrario, volvió a criticar en los últimos días las medidas de distanciamiento social y afirmó que se debe dar prioridad al mantenimiento de la actividad económica, pues el desempleo causado por esas restricciones “mata más” que el virus.",
                "text_en": "The head of State, on the other hand, again criticized measures of social distancing in recent days and stated that priority should be given to maintaining economic activity, as unemployment caused by such restrictions “kills more” than the virus.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El jefe de Estado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Head of State"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "volvió a criticar en los últimos días las medidas de distanciamiento social y afirmó que se debe dar prioridad al mantenimiento de la actividad económica,",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "once again criticized measures of social distancing in recent days and stated that priority should be given to maintaining economic activity,"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en los últimos días",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in the last few days"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "pues el desempleo causado por esas restricciones “mata más” que el virus",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because unemployment caused by these restrictions “kills more” than the virus"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pese a la aparente reducción de las cifras en los dos últimos días, el promedio de muertes en la última semana se ubicó este lunes en 1.225 diarias, el mayor registrado desde el inicio de la pandemia y una media en un 15,35 % superior a la de hace un mes (1.062 fallecimientos diarios el 1 de febrero).",
                "text_en": "Despite the apparent reduction in numbers over the last two days, the average number of deaths in the last week was 1,225 per day on Monday, the highest since the start of the pandemic and an average of 15.35 per cent higher than a month ago (1,062 deaths per day on 1 February).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el promedio de muertes en la última semana se ubicó este lunes en 1.225 diarias",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the average of deaths in the last week was placed this Monday in 1,225 daily"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la última semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last week"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De la misma forma, el promedio de contagios en la última semana subió hasta 55.977 diarios este lunes, igualmente el mayor desde el inicio de la pandemia y en un 9,47 % superior a la media de hace exactamente un mes (51.133 casos diarios el 1 de febrero).",
                "text_en": "Similarly, the average number of infections in the last week rose to 55,977 daily on Monday, the largest since the start of the pandemic and by 9.47 % more than the average exactly one month ago (51,133 cases per day on 1 February).",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el promedio de contagios en la última semana subió hasta 55.977 diarios este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the average contagion last week rose to 55,977 daily this Monday"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la última semana",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last week"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este lunes",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Monday"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La subida de los promedios diarios a niveles récords demuestra que Brasil enfrenta una segunda ola de la pandemia más virulenta y mortal que la primera, que al parecer se ha recrudecido por la circulación de nuevas cepas del virus, entre las cuales la llamada variante brasileña, que, según el Ministerio de Salud, es tres veces más contagiosa que la original.",
                "text_en": "The rise in daily averages to record levels shows that Brazil faces a second wave of the pandemic more virulent and deadly than the first, which appears to have been exacerbated by the circulation of new strains of the virus, among which the so-called Brazilian variant, which, according to the Ministry of Health, is three times more contagious than the original one.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "La subida de los promedios diarios a niveles récords demuestra que Brasil enfrenta una segunda ola de la pandemia más virulenta y mortal que la primera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The rise in daily averages to record levels shows that Brazil faces a second wave of the pandemic more virulent and deadly than the first"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Brasil",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Brazil"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "111": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 10,
            "WhatReliabilityReliable": 10,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 15,
            "WhoReliabilityReliable": 14,
            "WhoReliabilityUnreliable": 1,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 1,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 4,
            "WhenReliabilityReliable": 3,
            "WhenReliabilityUnreliable": 1,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 0,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 3,
            "HowReliabilityReliable": 3,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 2,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 2,
            "WhoRoleSubject": 9,
            "WhoRoleTarget": 4,
            "WhoRoleBoth": 2,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 5,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 5,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nBogotá, 4 de abril de 2021.\n\n<BREAK>\n\nA través de su cuenta de twitter, el Presidente Iván Duque informó que este sábado llegaron al país 280.800 nuevas dosis de la vacuna contra el covid-19, de la farmacéutica Pfizer, lo que permite seguir avanzando en el Plan Nacional de Vacunación puesto en marcha por el Gobierno Nacional.\n\n<PARAGRAPH>\n\n“Colombia avanza hacia inmunización colectiva.\n\n<BREAK>\n\nHoy recibimos nuevo lote de 280.800 vacunas, adquiridas en negociación bilateral con Pfizer y que llegaron al Aeropuerto El Dorado, a las 5:09 a.m., procedentes de Bruselas, en vuelo DAE305, operado por aerolínea LAS”, precisó el Mandatario.\n\n<PARAGRAPH>\n\nLas vacunas que arribaron hacen parte de las negociaciones bilaterales que adelantó el Gobierno Nacional con Pfizer, en las cuales se acordó la compra de 10 millones de dosis.\n\n<PARAGRAPH>\n\nAl respecto, el Jefe de Gabinete del Ministerio de Salud, Germán Escobar, explicó que los biológicos serán empleados para seguir inmunizando al talento humano y a adultos de más de 60 años.\n\n<PARAGRAPH>\n\n“Se destinarán para continuar reforzando la vacunación de esta segunda etapa, tanto para profesionales de la salud como adultos mayores de 60 años, que se continuarán cubriendo progresivamente, como lo hemos venido haciendo”, agregó el funcionario.\n\n<PARAGRAPH>\n\nProcedimiento de recibo de vacunas\n\n<PARAGRAPH>\n\nA su llegada al país, el desembarco de las vacunas se realiza en la plataforma de pasajeros del Aeropuerto El Dorado de Bogotá, tras lo cual se da cumplimiento a los procedimientos de nacionalización de los envíos.\n\n<PARAGRAPH>\n\nActo seguido, los biológicos son trasladados a la bodega del Ministerio de Salud, en la Zona Franca, donde se inicia el proceso del ingreso a los ultracongeladores.\n\n<PARAGRAPH>\n\nPlan Nacional de Vacunación\n\n<PARAGRAPH>\n\nCon el Plan Nacional de Vacunación, el Gobierno Nacional busca reducir la mortalidad e incidencia de casos graves por covid-19, así como proteger a los trabajadores de la salud y avanzar en la disminución del contagio para generar inmunidad colectiva.\n\n<PARAGRAPH>\n\nDe acuerdo con el DANE, a 2021 Colombia tendrá 51’049.498 habitantes.\n\n<BREAK>\n\nPara poder generar inmunidad colectiva, según evidencia científica, es necesario vacunar al 70% de la población, es decir, 35’734.649 colombianos.\n\n<PARAGRAPH>\n\nBiológicos adquiridos por Colombia\n\n<PARAGRAPH>\n\nPara la adquisición de vacunas contra el covid-19, el Gobierno ejecutó una estrategia que combinó negociaciones multilaterales, a través del mecanismo Covax, y bilaterales, con las farmacéuticas que producen los biológicos.\n\n<PARAGRAPH>\n\nDe esta manera, el país logró adquirir las vacunas necesarias, así:\n\n<PARAGRAPH>\n\n—Covax: 20 millones de dosis, para 10 millones de personas\n\n<PARAGRAPH>\n\n—Pfizer: 10 millones de dosis, para 5 millones de personas\n\n<PARAGRAPH>\n\n—AstraZeneca: 10 millones de dosis, para 5 millones de personas\n\n<PARAGRAPH>\n\n—Janssen: 9 millones de dosis, para 9 millones de personas\n\n<PARAGRAPH>\n\n—Sinovac: 7,5 millones de dosis, para 3’750.000 personas\n\n<PARAGRAPH>\n\n—Moderna: 10 millones de dosis, para 5 millones de personas.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Colombia recibió este sábado nuevo lote de 280.800 vacunas de Pfizer, confirma Presidente Duque",
        "ID": "0_NF_04-11-2021_20-50-54_www_eje21_com_co",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Colombia recibió este sábado nuevo lote de 280.800 vacunas de Pfizer, confirma Presidente Duque",
                "text_en": "Colombia received a new batch of 280,800 Pfizer vaccines this Saturday, confirms President Duque",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este sábado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Saturday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nuevo lote de 280.800 vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "new batch of 280,800 vaccines"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Presidente Duque",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "President Duque"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A través de su cuenta de twitter, el Presidente Iván Duque informó que este sábado llegaron al país 280.800 nuevas dosis de la vacuna contra el covid-19, de la farmacéutica Pfizer, lo que permite seguir avanzando en el Plan Nacional de Vacunación puesto en marcha por el Gobierno Nacional.",
                "text_en": "Through his twitter account, President Iván Duque reported that 280,800 new doses of the Covid-19 vaccine from the pharmaceutical company Pfizer arrived in the country this Saturday, allowing further progress to be made on the National Vaccine Plan launched by the National Government.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Presidente Iván Duque",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the President Iván Duque"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "informó que este sábado llegaron al país 280.800 nuevas dosis de la vacuna contra el covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reported that 280,800 new doses of covid-19 vaccine arrived in the country this Saturday"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este sábado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "this Saturday"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al país",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "country"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la farmacéutica Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the pharmaceutical company Pfizer"
                    }
                ],
                "evidences": []
            },
            {
                "text": "“Colombia avanza hacia inmunización colectiva.",
                "text_en": "“Colombia is moving towards collective immunization.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Colombia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Colombia"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "avanza hacia inmunización colectiva",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "progress towards collective immunization"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Hoy recibimos nuevo lote de 280.800 vacunas, adquiridas en negociación bilateral con Pfizer y que llegaron al Aeropuerto El Dorado, a las 5:09 a.m., procedentes de Bruselas, en vuelo DAE305, operado por aerolínea LAS”, precisó el Mandatario.",
                "text_en": "Today we received a new batch of 280,800 vaccines, purchased in bilateral negotiations with Pfizer and arriving at El Dorado Airport, at 5:09 a.m., coming from Brussels, in flight DAE305, operated by airline LAS,” said the President.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "Hoy",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Today"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "recibimos nuevo lote de 280.800 vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "receive new batch of 280,800 vaccines"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "adquiridas en negociación bilateral",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Acquired in bilateral negotiations"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Aeropuerto El Dorado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "El Dorado Airport"
                    }
                ],
                "evidences": [
                    {
                        "value": "As of 20 February 2021, two vaccines are approved by the Australian TGA: Pfizer/BioNTech BNT162b2 and AstraZeneca AZD1222 vaccines. Both vaccines require administration of two doses, 21 days apart for the Pfizer vaccine and 12 weeks apart for the AstraZeneca vaccine. 22 In people due to commence anti-cancer therapy, both doses should ideally be completed at least 2 weeks prior to starting treatment. 20 The commencement of anti-cancer therapy should not be delayed for COVID-19 vaccination.",
                        "score": 0.5500000119
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9978888631
                    }
                ]
            },
            {
                "text": "Las vacunas que arribaron hacen parte de las negociaciones bilaterales que adelantó el Gobierno Nacional con Pfizer, en las cuales se acordó la compra de 10 millones de dosis.",
                "text_en": "The vaccines that arrived are part of the bilateral negotiations that the National Government advanced with Pfizer, in which the purchase of 10 million doses was agreed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Las vacunas que arribaron hacen parte de las negociaciones bilaterales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The vaccines that arrived are part of the bilateral negotiations"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Gobierno Nacional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the National Government"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Pfizer",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Pfizer"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Al respecto, el Jefe de Gabinete del Ministerio de Salud, Germán Escobar, explicó que los biológicos serán empleados para seguir inmunizando al talento humano y a adultos de más de 60 años.",
                "text_en": "In this regard, the Chief of Staff of the Ministry of Health, Germán Escobar, explained that biologicals will be employed to continue immunizing human talent and adults over 60 years of age.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Jefe de Gabinete del Ministerio de Salud, Germán Escobar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Chief of Staff of the Ministry of Health, Germán Escobar"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "los biológicos serán empleados para seguir inmunizando",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "biologicals will be used to continue immunizing"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "al talento humano y a adultos de más de 60 años",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to human talent and adults over 60 years of age"
                    }
                ],
                "evidences": []
            },
            {
                "text": "A su llegada al país, el desembarco de las vacunas se realiza en la plataforma de pasajeros del Aeropuerto El Dorado de Bogotá, tras lo cual se da cumplimiento a los procedimientos de nacionalización de los envíos.",
                "text_en": "Upon arrival in the country, the vaccinations are landed on the passenger platform of El Dorado Airport in Bogotá, after which the procedures for nationalization of shipments are followed.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "A su llegada al país",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Upon arrival in the country"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "el desembarco de las vacunas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "landing of vaccines"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Aeropuerto El Dorado de Bogotá",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "El Dorado Airport of Bogotá"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Con el Plan Nacional de Vacunación, el Gobierno Nacional busca reducir la mortalidad e incidencia de casos graves por covid-19, así como proteger a los trabajadores de la salud y avanzar en la disminución del contagio para generar inmunidad colectiva.",
                "text_en": "With the National Vaccination Plan, the National Government seeks to reduce mortality and incidence of severe covid-19 cases, as well as to protect health workers and to advance the reduction of contagion to generate collective immunity.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Con el Plan Nacional de Vacunación",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "With the National Vaccination Plan"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Gobierno Nacional",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the National Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "avanzar en la disminución del contagio para generar inmunidad colectiva",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "progress in reducing contagion to generate collective immunity"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Para poder generar inmunidad colectiva, según evidencia científica, es necesario vacunar al 70% de la población, es decir, 35’734.649 colombianos.",
                "text_en": "In order to generate collective immunity, according to scientific evidence, it is necessary to vaccinate 70% of the population, that is, 35’734,649 Colombians.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "según evidencia científica",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "according to scientific evidence"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "es necesario vacunar al 70% de la población",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "70% of the population need to be vaccinated"
                    }
                ],
                "evidences": [
                    {
                        "value": "Currently, several COVID-19 vaccines are publicly available in the SR. Achieving collective immunity is a necessary step to end the pandemic. Mathematical models show that if the COVID-19 vaccine is 80% effective, then the coverage must be at least 75% to eliminate an ongoing pandemic [6] . Globally, there have been 3,223,744,666 persons fully vaccinated, and in the SR there have been 2,426,386 persons [4] .",
                        "score": 0.6000000238
                    },
                    {
                        "value": "Currently, several COVID-19 vaccines are publicly available in the SR. Achieving collective immunity is a necessary step to end the pandemic. Mathematical models show Int. J. Environ. Res. Public Health 2021, 18 , 12695 2 of 9 that if the COVID-19 vaccine is 80% effective, then the coverage must be at least 75% to eliminate an ongoing pandemic [6] . Globally, there have been 3,223,744,666 persons fully vaccinated, and in the SR there have been 2,426,386 persons [4] .",
                        "score": 0.5899999738
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.9217832088
                    },
                    {
                        "label": "neutral",
                        "score": 0.952888906
                    }
                ]
            },
            {
                "text": "Para la adquisición de vacunas contra el covid-19, el Gobierno ejecutó una estrategia que combinó negociaciones multilaterales, a través del mecanismo Covax, y bilaterales, con las farmacéuticas que producen los biológicos.",
                "text_en": "For the purchase of vaccines against covid-19, the Government implemented a strategy that combined multilateral negotiations, through the Covax mechanism, and bilateral ones, with the pharmaceuticals that produce the biologicals.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Gobierno",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ejecutó una estrategia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "implemented a strategy"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "combinó negociaciones multilaterales, a través del mecanismo Covax, y bilaterales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "combined multilateral negotiations, through the Covax mechanism, and bilateral negotiations"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las farmacéuticas que producen los biológicos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "pharmaceuticals produced by biologicals"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "112": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 0,
            "Body": 1,
            "Conclusion": 0,
            "What": 15,
            "WhatReliabilityReliable": 15,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 13,
            "WhoReliabilityReliable": 13,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 1,
            "WhenReliabilityReliable": 1,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 4,
            "WhereReliabilityReliable": 4,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 2,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 4,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 13,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 7,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 8,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nArmengol frena la apertura de la actividad por la delicada situación de las UCI\n\n<PARAGRAPH>\n\nLas autoridades sanitarias de Baleares se resisten a iniciar la desescalada en Mallorca a pesar del desplome de los nuevos contagios.\n\n<BREAK>\n\nCon apenas 75 nuevos casos notificados este jueves, una incidencia acumulada a 14 días de 155,80 casos por cada 100.000 habitantes y una incidencia a 7 días de 57,92 casos, el Govern balear ha decidido mantener toda la hostelería cerrada al menos dos semanas más.\n\n<BREAK>\n\nSiete de los ocho indicadores de riesgo que ha marcado el Ministerio de Sanidad apuntan a que la isla se encuentra en un nivel de riesgo medio con tendencia a la baja.\n\n<BREAK>\n\nLos datos epidemiológicos son muy parecidos a los de agosto del año pasado, cuando turistas alemanes disfutaban sin trabas de sus vacaciones en los hoteles de la Platja de Palma o de la zona norte de la isla.\n\n<PARAGRAPH>\n\n¿Qué ha cambiado con respecto a ese atípico verano de 2020 para que el Govern de Francina Armengol se resista a abrir la hostelería y los grandes centros comerciales? La explicación está en ese octavo indicador que sigue en rojo: el relativo a la ocupación de las UCI.\n\n<BREAK>\n\nEl Ministerio considera que hay riesgo extremo cuando se supera el 25 % y la ocupación en Mallorca es, en estos momentos, del 34 %.\n\n<BREAK>\n\nLa experta que asesora al Govern en la desescalada, Marga Frontera, alerta de que un aumento de la movilidad traerá consigo un aumento de loscontagios y, con ellos, de los ingresos , por lo que corre el riesgo de que los nuevos ingresos en la UCI se solapen con los actuales y el sistema colapse.\n\n<BREAK>\n\nY además está la cepa británica, más contagiosa y letal, que ya circula por las islas y supone el 17 % de los nuevos casos.\n\n<PARAGRAPH>\n\nEl Govern de Armengol afronta la desescalada de la tercera ola con un temor muy superior al de las anteriores.\n\n<BREAK>\n\nSe acerca la temporada de verano y hay miedo a que una nueva apertura provoque más contagios, abra la puerta de una nueva ola -la cuarta en la isla- y ponga en peligro el inicio de la temporada turística en mayo.\n\n<BREAK>\n\nBaleares busca contener los contagios, inmunizar rápidamente a la población y poder mostrarse al mundo como territorio libre de Covid para poder empezar a recibir turistas.  Armengol ha llegado a asegurar que, cuando lleguen las vacunas, hay capacidad para administrar la dosis a 80.000 personas a la semana e inmunizar a toda la población balear, 1,2 millones de habitantes, en tres meses.\n\n<PARAGRAPH>\n\nSin embargo, un sector de los empresarios de hostelería no lo ve así.\n\n<BREAK>\n\nSu situación es muy complicada y algunos están a punto de cumplir dos meses con la persiana bajada.\n\n<BREAK>\n\nConsideran que se les está perjudicando con una decisión arbitraria que no está justificada en los datos epidemiológicos y piden que se les permita ir abriendo poco a poco.  Ya han portagonizado tres sonadas protestas por las calles de Palma.\n\n<BREAK>\n\nDe momento, las patronales oficiales aceptan a regañadientes el cierre de la actividad durante 15 días más, aunque urgen a que se paguen las ayudas prometidas: 1.500 euros al mes para cada establecimiento afectado por las restricciones.\n\n<PARAGRAPH>\n\nLa presidenta balear ha convocado a la Mesa de Diálogo Social para consensuar las nuevas medidas encaminadas a una flexibilización de las restricciones, que afectan básicamente al comercio, pero insiste en que la desescalada debe ser prudente.\n\n<BREAK>\n\nLos departamentos económicos del Govern balear alertan de que las islas no pueden permitirse un segundo año sin temporada turística y apuntan a los nefastos datos económicos del año pasado, con una caída del PIB del 27 % según el Banco de España, la mayor de  todas las comunidades autónomas.\n\n<PARAGRAPH>\n",
        "TITLE": "Mallorca: miedo escénico a la desescalada",
        "ID": "F_04-11-2021_21-48-46_www_lavanguardia_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Mallorca: miedo escénico a la desescalada",
                "text_en": "Mallorca: scenic fear of desiccation",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Mallorca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Majorca"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "miedo escénico a la desescalada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "scenic fear of desiccation"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Armengol frena la apertura de la actividad por la delicada situación de las UCI",
                "text_en": "Armengol slows down the opening of the activity due to the delicate situation of the ICUs",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Armengol",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Armengol"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "frena la apertura de la actividad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "slows down the opening of the activity"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por la delicada situación de las UCI",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the delicate situation of the ICUs"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Las autoridades sanitarias de Baleares se resisten a iniciar la desescalada en Mallorca a pesar del desplome de los nuevos contagios.",
                "text_en": "The health authorities of the Balearic Islands are reluctant to start the desiccation in Mallorca despite the collapse of the new contagions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Las autoridades sanitarias de Baleares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health authorities in the Balearic Islands"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se resisten a iniciar la desescalada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "they resist to start descaling"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Mallorca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Mallorca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Con apenas 75 nuevos casos notificados este jueves, una incidencia acumulada a 14 días de 155,80 casos por cada 100.000 habitantes y una incidencia a 7 días de 57,92 casos, el Govern balear ha decidido mantener toda la hostelería cerrada al menos dos semanas más.",
                "text_en": "With just 75 new cases reported on Thursday, a 14-day cumulative incidence of 155.80 cases per 100,000 inhabitants and a 7-day incidence of 57.92 cases, the Balearic Government has decided to keep the entire hotel shop closed for at least two more weeks.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Govern balear",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Balearic Govern"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha decidido mantener toda la hostelería cerrada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "He's decided to keep the whole hotel store closed."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "al menos dos semanas más",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "at least two more weeks"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Siete de los ocho indicadores de riesgo que ha marcado el Ministerio de Sanidad apuntan a que la isla se encuentra en un nivel de riesgo medio con tendencia a la baja.",
                "text_en": "Seven of the eight risk indicators identified by the Ministry of Health indicate that the island is at an average risk level with a downward trend.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Ministry of Health"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la isla",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the island"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se encuentra en un nivel de riesgo medio con tendencia a la baja",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "is at an average risk level with a downward trend"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los datos epidemiológicos son muy parecidos a los de agosto del año pasado, cuando turistas alemanes disfutaban sin trabas de sus vacaciones en los hoteles de la Platja de Palma o de la zona norte de la isla.",
                "text_en": "Epidemiological data are very similar to those of August last year, when German tourists unfetteredly enjoyed their holidays in the hotels of Platja de Palma or in the northern part of the island.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los datos epidemiológicos son muy parecidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Epidemiological data are very similar"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "agosto del año pasado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "August of last year"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Qué ha cambiado con respecto a ese atípico verano de 2020 para que el Govern de Francina Armengol se resista a abrir la hostelería y los grandes centros comerciales? La explicación está en ese octavo indicador que sigue en rojo: el relativo a la ocupación de las UCI.",
                "text_en": "What has changed with regard to this atypical summer of 2020 so that the Government of Francina Armengol will resist opening the hotel and the large shopping centres? The explanation is in that eighth indicator that follows in red: the one regarding the occupation of the ICUs.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el Govern de Francina Armengol",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the Government of Francina Armengol"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se resista a abrir la hostelería y los grandes centros comerciales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "resists opening the hotel and the big shopping malls"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "la ocupación de las UCI",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "occupation of the ICUs"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Ministerio considera que hay riesgo extremo cuando se supera el 25 % y la ocupación en Mallorca es, en estos momentos, del 34 %.",
                "text_en": "The Ministry considers that there is an extreme risk when 25% is exceeded and the occupation in Mallorca is currently 34%.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Ministerio",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Ministry"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "considera que hay riesgo extremo cuando se supera el 25 %",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "considers that there is an extreme risk when it exceeds 25%"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Mallorca",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in Mallorca"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La experta que asesora al Govern en la desescalada, Marga Frontera, alerta de que un aumento de la movilidad traerá consigo un aumento de loscontagios y, con ellos, de los ingresos , por lo que corre el riesgo de que los nuevos ingresos en la UCI se solapen con los actuales y el sistema colapse.",
                "text_en": "The expert who advises the Govern in the descalada, Marga Frontera, warns that an increase in mobility will bring with it an increase of the contagions and, with them, of the revenues, so runs the risk that the new revenues in the ICU will overlap with the current ones and the collapse system.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Marga Frontera",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Marga Frontera"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "alerta de que un aumento de la movilidad traerá consigo un aumento de loscontagios y, con ellos, de los ingresos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "a warning that an increase in mobility will lead to an increase in the numbers and, with them, in income."
                    }
                ],
                "evidences": []
            },
            {
                "text": "Y además está la cepa británica, más contagiosa y letal, que ya circula por las islas y supone el 17 % de los nuevos casos.",
                "text_en": "And there is also the British strain, the most contagious and lethal, which already circulates on the islands and accounts for 17% of new cases.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la cepa británica, más contagiosa y letal, que ya circula",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the British strain, more contagious and lethal, which already circulates"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "por las islas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for the Islands"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Govern de Armengol afronta la desescalada de la tercera ola con un temor muy superior al de las anteriores.",
                "text_en": "The Government of Armengol faces the desalination of the third wave with a fear far superior to that of the previous ones.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Govern de Armengol",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Government of Armengol"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "afronta la desescalada de la tercera ola",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "facing the desalination of the third wave"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con un temor muy superior al de las anteriores",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "with a fear far superior to that of the previous ones"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Baleares busca contener los contagios, inmunizar rápidamente a la población y poder mostrarse al mundo como territorio libre de Covid para poder empezar a recibir turistas.  Armengol ha llegado a asegurar que, cuando lleguen las vacunas, hay capacidad para administrar la dosis a 80.000 personas a la semana e inmunizar a toda la población balear, 1,2 millones de habitantes, en tres meses.",
                "text_en": "Baleares seeks to contain the contagions, immunize the population quickly and be able to show itself to the world as a territory free of Covid in order to start receiving tourists. Armengol has come to ensure that, when vaccines arrive, there is capacity to administer the dose to 80,000 people a week and immunize the entire Balearic population, 1.2 million inhabitants, in three months.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Baleares",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Balearic Islands"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "busca contener los contagios, inmunizar rápidamente a la población y poder mostrarse al mundo como territorio libre de Covid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "seeks to contain the contagions, immunize the population quickly and be able to show the world as a territory free of Covid"
                    }
                ],
                "evidences": []
            },
            {
                "text": "De momento, las patronales oficiales aceptan a regañadientes el cierre de la actividad durante 15 días más, aunque urgen a que se paguen las ayudas prometidas: 1.500 euros al mes para cada establecimiento afectado por las restricciones.",
                "text_en": "For the time being, the official employers reluctantly accept the closure of the activity for another 15 days, although they urge that the promised aid be paid: 1,500 euros per month for each establishment affected by the restrictions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "las patronales oficiales",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the official employers"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "aceptan a regañadientes el cierre de la actividad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "reluctantly accept the closure of the activity"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "durante 15 días más",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for 15 more days"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La presidenta balear ha convocado a la Mesa de Diálogo Social para consensuar las nuevas medidas encaminadas a una flexibilización de las restricciones, que afectan básicamente al comercio, pero insiste en que la desescalada debe ser prudente.",
                "text_en": "The president of the Balearic Islands has called the Social Dialogue Bureau to agree on the new measures aimed at making restrictions more flexible, which basically affect trade, but insists that the desalination should be prudent.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La presidenta balear",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The President Ballear"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha convocado a la Mesa de Diálogo Social para consensuar las nuevas medidas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "convened the Social Dialogue Bureau to agree on new measures"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los departamentos económicos del Govern balear alertan de que las islas no pueden permitirse un segundo año sin temporada turística y apuntan a los nefastos datos económicos del año pasado, con una caída del PIB del 27 % según el Banco de España, la mayor de  todas las comunidades autónomas.",
                "text_en": "The economic departments of the Govern balear warn that the islands cannot afford a second year without tourist season and point to the bad economic data of last year, with a fall in GDP of 27% according to the Banco de España, the largest of all the autonomous communities.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los departamentos económicos del Govern balear",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The economic departments of the Balearic Government"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "alertan de que las islas no pueden permitirse un segundo año",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "warn that the islands cannot afford a second year"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "sin temporada turística",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "no tourist season"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "113": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 10,
            "WhatReliabilityReliable": 3,
            "WhatReliabilityUnreliable": 7,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 1,
            "Who": 9,
            "WhoReliabilityReliable": 5,
            "WhoReliabilityUnreliable": 4,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 0,
            "WhenReliabilityReliable": 0,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 3,
            "WhereReliabilityReliable": 3,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 2,
            "WhyReliabilityReliable": 0,
            "WhyReliabilityUnreliable": 2,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 4,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 4,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 3,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 3,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 6,
            "WhoRoleTarget": 3,
            "WhoRoleBoth": 0,
            "TitleStyleObjective": 0,
            "TitleStyleSubjective": 1,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 9,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 1,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 10,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\nNos hemos quedado absolutamente alucinados con una miserable noticia que ha publicado el diario ‘El Mundo’.\n\n<BREAK>\n\nEl titular ya de por sí es bochornoso y escandaloso: “Un brote con 21 positivos en una residencia de Segura se inició por una trabajadora que se negó a vacunarse”.\n\n<BREAK>\n\nAtentos porque el desarrollo de la noticia que viene después tiene lo suyo.\n\n<BREAK>\n\nVean de qué forma se miente y se manipula: “Los 18 ancianos que sí habían sido inmunizados permanecen asintomáticos y han sido trasladados al hospital de Eibar”.\n\n<PARAGRAPH>\n\nPero vamos a ver, señores de El Mundo, ¿cómo es posible que nos tomen a todos por imbéciles de una forma tan descarada? ¿Cómo pueden decir en una misma noticia que los ancianos habían sido inmunizados, si después dicen que han sido contagiados por una persona que no había querido vacunarse y que, a pesar de ello, se encuentran “asintomáticos”?\n\n<PARAGRAPH>\n\n¿Se dan cuenta de la tomadura de pelo y la manipulación en tan solo dos frases? Los “inmunizados” se “contagian” de algo que no les produce ningún síntoma ya que se encuentran “asintomáticos”.\n\n<BREAK>\n\nPero, ¿es posible que esta gente haya leído con tranquilidad lo que han escrito? ¿Es posible que alguien pueda tragarse este tipo de noticias tan carentes de sentido y con una intención tan descaradamente manipuladora?\n\n<PARAGRAPH>\n\nAnalicen, analicen, ¡por Dios! ¿No será, más bien, que los ancianos vacunados han contagiado a la única persona que no se había querido vacunar? ¿Cómo se puede tener tanta caradura y tan poca vergüenza? ¿Cómo se puede engañar y manipular a la gente de esta forma?\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n \n\n<PARAGRAPH>\n",
        "TITLE": "Mintiendo y manipulando, así pretenden marcar los miserables medios de comunicación de España a las personas que decidan no vacunarse",
        "ID": "NF_04-11-2021_20-29-17_www_eldiestro_es",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Mintiendo y manipulando, así pretenden marcar los miserables medios de comunicación de España a las personas que decidan no vacunarse",
                "text_en": "Lying and manipulating, they intend to mark the miserable media in Spain to people who choose not to get vaccinated.",
                "5w1h_value": [
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "Mintiendo y manipulando",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Lying and Manipulating"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "pretenden marcar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They're trying to mark."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los miserables medios de comunicación",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "the miserable media"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Spain"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a las personas que decidan no vacunarse",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "persons who decide not to be vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Nos hemos quedado absolutamente alucinados con una miserable noticia que ha publicado el diario ‘El Mundo’.",
                "text_en": "We have been absolutely shocked by a miserable news story published in the newspaper ‘The World’.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Nos hemos quedado absolutamente alucinados",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "We've been absolutely hallucinated."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "con una miserable noticia",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "with a miserable news"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "el diario ‘El Mundo’",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the daily newspaper ‘The World’"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El titular ya de por sí es bochornoso y escandaloso: “Un brote con 21 positivos en una residencia de Segura se inició por una trabajadora que se negó a vacunarse”.",
                "text_en": "The headline is already embarrassing and scandalous: “An outbreak with 21 positives in a residence in Segura was started by a worker who refused to vaccinate herself.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Un brote con 21 positivos en una residencia de Segura se inició",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "An outbreak with 21 positives in a residence in Segura began"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en una residencia de Segura",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in a residence in Segura"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por una trabajadora que se negó a vacunarse",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "for a worker who refused to get vaccinated"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Vean de qué forma se miente y se manipula: “Los 18 ancianos que sí habían sido inmunizados permanecen asintomáticos y han sido trasladados al hospital de Eibar”.",
                "text_en": "See how you lie and manipulate yourself: “The 18 elderly who had been immunized remain asymptomatic and have been taken to Eibar hospital.”",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Vean de qué forma se miente y se manipula",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "See how you lie and manipulate yourself"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los 18 ancianos que sí habían sido inmunizados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The 18 elders who had been immunized"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "permanecen asintomáticos y han sido trasladados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "remain asymptomatic and have been transferred"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "al hospital de Eibar",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to Eibar hospital"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero vamos a ver, señores de El Mundo, ¿cómo es posible que nos tomen a todos por imbéciles de una forma tan descarada? ¿Cómo pueden decir en una misma noticia que los ancianos habían sido inmunizados, si después dicen que han sido contagiados por una persona que no había querido vacunarse y que, a pesar de ello, se encuentran “asintomáticos”?",
                "text_en": "But let's see, gentlemen of The World, how is it possible that we are all taken for imbecile in such a brazen way? How can you say in the same news that the elders had been immunized, if they later say that they have been infected by a person who had not wanted to get vaccinated and that, despite this, they are “asymptomatic”?",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "nos tomen a todos por imbéciles",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "They take us all for fools."
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de una forma tan descarada",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in such a brazen way"
                    }
                ],
                "evidences": []
            },
            {
                "text": "¿Se dan cuenta de la tomadura de pelo y la manipulación en tan solo dos frases? Los “inmunizados” se “contagian” de algo que no les produce ningún síntoma ya que se encuentran “asintomáticos”.",
                "text_en": "Do you realize that the “immunized” are “contagious” to something that does not give them any symptoms since they are “asymptomatic”.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Los “inmunizados”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "The “immunized”"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "se “contagian” de algo que no les produce ningún síntoma",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "“contagious” of something that doesn’t give them any symptoms"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "ya que se encuentran “asintomáticos”",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "because they are “asymptomatic”"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Pero, ¿es posible que esta gente haya leído con tranquilidad lo que han escrito? ¿Es posible que alguien pueda tragarse este tipo de noticias tan carentes de sentido y con una intención tan descaradamente manipuladora?",
                "text_en": "But is it possible that these people have quietly read what they have written? Is it possible that someone can swallow this kind of meaningless news with such blatantly manipulative intent?",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "esta gente",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "These people."
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "haya leído con tranquilidad lo que han escrito",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "have read with peace of mind what they have written"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Analicen, analicen, ¡por Dios! ¿No será, más bien, que los ancianos vacunados han contagiado a la única persona que no se había querido vacunar? ¿Cómo se puede tener tanta caradura y tan poca vergüenza? ¿Cómo se puede engañar y manipular a la gente de esta forma?",
                "text_en": "Analyze, analyze, for God's sake! Won't it be, rather, that the vaccinated elders have infected the only person who hasn't wanted to vaccinate? How can you have so much nerve and so little shame? How can you deceive and manipulate people in this way?",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "los ancianos vacunados",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the elderly vaccinated"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han contagiado",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They've been infected."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la única persona que no se había querido vacunar",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "to the only person who had not wanted to vaccinate"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "engañar y manipular",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "cheating and manipulating"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "a la gente",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "to the people"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "de esta forma",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "in this way"
                    }
                ],
                "evidences": []
            }
        ]
    },
    "114": {
        "DATA": {
            "Title": 1,
            "Subtitle": 1,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 0,
            "What": 12,
            "WhatReliabilityReliable": 11,
            "WhatReliabilityUnreliable": 1,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 4,
            "Who": 3,
            "WhoReliabilityReliable": 3,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 7,
            "WhenReliabilityReliable": 7,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 7,
            "WhereReliabilityReliable": 7,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 0,
            "HowReliabilityReliable": 0,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 0,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 0,
            "WhoRoleSubject": 2,
            "WhoRoleTarget": 0,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 1,
            "Figure": 12,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 13,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\nEn cuanto a la incidencia acumulada, vuelve a subir, y se sitúa en los 255,55 casos por cada 100.000 habitantes\n\n<PARAGRAPH>\n\nMalas noticias en la última semana de 2020.\n\n<PARAGRAPH>\n\nA pesar de los deseos de la población por dejar atrás ya este ‘annus horribilis’, la realidad dice que esto, cambie el año o no, está lejos de terminar.\n\n<PARAGRAPH>\n\nEl Ministerio de Sanidad ha informado este martes 29 de diciembre de 20202 de la suma de un total de 14.089 contagios y ha notificado 320 fallecidos.\n\n<PARAGRAPH>\n\nEste dato de los contagios diarios es el peor desde el del 20 de noviembre de 2020, cuando la cifra ascendió a 15.156.\n\n<PARAGRAPH>\n\nEn cuanto a la incidencia acumulada, vuelve a subir, y se sitúa en los 255,55 casos por cada 100.000 habitantes, mientras que ayer, lunes 28 de diciembre de 2020, era de 246,19.\n\n<PARAGRAPH>\n\nLos casos se disparan en Reino Unido\n\n<PARAGRAPH>\n\nY mientras, los británicos siguen para récord.\n\n<PARAGRAPH>\n\nLos casos se disparan en el Reino Unido y marcan un tremendo dato en un solo día: 53.135 nuevos contagios.\n\n<PARAGRAPH>\n\nSegún fuentes oficiales,  también han crecido los fallecidos: 414 decesos frente a los 357 de ayer 28 de diciembre de 2020.\n\n<BREAK>\n\nEn total, 71.567 personas han muerto por el virus en el Reino Unido desde que comenzó la pandemia.\n\n<PARAGRAPH>\n\nLa cepa británica\n\n<PARAGRAPH>\n\nPrecisamente el Reino Unido sigue siendo protagonista por la existencia de una variante del Covid que ya se conoce como ‘cepa británica’ y que sería más contagiosa.\n\n<PARAGRAPH>\n\nLa Comunidad de Madrid ha confirmado este martes 29 de diciembre de 2020 el diagnóstico de un total de seis casos positivos de la cepa británica de la covid-19 tras sumar dos nuevos en la región, y continúa estudiando «al menos otros 13 posibles casos».\n\n<PARAGRAPH>\n\nEstos diagnósticos elevan a 11 el total de casos confirmados de la cepa británica en España, dado que a los seis de Madrid se añaden los cinco reportados hasta el momento por Andalucía.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Los contagios por coronavirus se disparan por Navidad: Sanidad notifica 14.089 nuevos casos y 320 fallecidos",
        "ID": "30_NF_04-11-2021_21-23-06_www_periodistadigital_com",
        "VALUE": "True",
        "VALUE_reliability": 1,
        "annotation_values": [
            {
                "text": "Los contagios por coronavirus se disparan por Navidad: Sanidad notifica 14.089 nuevos casos y 320 fallecidos",
                "text_en": "Contagion by coronavirus triggers by Christmas: Health reports 14,089 new cases and 320 deaths",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los contagios por coronavirus se disparan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Coronavirus contagions are triggered"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "por Navidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "for Christmas"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Health"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "notifica 14.089 nuevos casos y 320 fallecidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "notifies 14,089 new cases and 320 deaths"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En cuanto a la incidencia acumulada, vuelve a subir, y se sitúa en los 255,55 casos por cada 100.000 habitantes",
                "text_en": "As for the cumulative incidence, it rises again, and stands at 255.55 cases per 100,000 inhabitants.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "la incidencia acumulada, vuelve a subir",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the accumulated incidence, rises again"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Malas noticias en la última semana de 2020.",
                "text_en": "Bad news in the last week of 2020.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Malas noticias",
                        "5w1h_reliability": "Unreliable",
                        "5w1h_text_en": "Bad news"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en la última semana de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in the last week of 2020"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El Ministerio de Sanidad ha informado este martes 29 de diciembre de 20202 de la suma de un total de 14.089 contagios y ha notificado 320 fallecidos.",
                "text_en": "The Ministry of Health reported on Tuesday 29 December 20202 the sum of a total of 14,089 infections and reported 320 deaths.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El Ministerio de Sanidad",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The Ministry of Health"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este martes 29 de diciembre de 20202",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Tuesday, 29 December 20202"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "14.089 contagios y ha notificado 320 fallecidos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "14,089 infections and reported 320 deaths"
                    }
                ],
                "evidences": [
                    {
                        "value": "By the end of 2019, the COVID-19 outbreak in Wuhan, China made global headlines and continued to spread globally at a rapid speed (Zhu, Wei & Niu, 2020) . The World Health Organization (WHO) had declared the COVID-19 outbreak, a pandemic on the 11th of March 2020 (Cucinotta & Vanelli, 2020) . Currently, the virus has affected 221 countries and territories with approximately, 102 million individuals have been infected with the virus worldwide, with a mortality rate of 2.1% (World Health Organization, 2020) . The Saudi Ministry of Health reported the first COVID-19 case on 2nd March 2020, when an individual returning from Iran was tested positive (Ministry of Health, 2020) . As of 1st February 2021, the Kingdom of Saudi Arabia has reported about 368,074 confirmed cases. The total recovered patients are 359,573, with 6375 deaths in the kingdom. Overall, the positive cases to PCR test, (12,295,687 tests) ratio are around 3% (Ministry of Health, 2020) .",
                        "score": 0.5299999714
                    },
                    {
                        "value": "The epidemiological data studied, consisting of 381 laboratory confirmed 80 COVID-19 cases, has been obtained from the epidemiological investigation reports 81 that were released by the Israeli Ministry of Health (Israeli Ministry of Health, 2020). 82",
                        "score": 0.5500000119
                    },
                    {
                        "value": "Approval was sought from the ethics committee at each hospital. The requirement for informed consent was waived by each centre in the light of the retrospective and anonymous nature of the study. Using Israeli Ministry of Health diagnostic codes 47-47.19 based on the ICD-9 codes for appendicitis, all consecutive patients between 31 December 2019 and 07 April 2020 were identified via a search of each hospital's electronic databases which are kept in real time. The incidence of confirmed COVID-19 infections was extrapolated from the Israeli Ministry of Health figures which are published daily on their website.",
                        "score": 0.5
                    },
                    {
                        "value": "The Indonesian Ministry of Health recorded an increase in positive cases of COVID-19 on 5 November 2021, bringing the total to 4,246,802. The Ministry of Health has examined 47,709,218 specimens, with a cure rate of 84.0%. The cases of death with confirmed COVID-19 increased to 143,500 cases [4] .",
                        "score": 0.5400000215
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.6941324472
                    },
                    {
                        "label": "neutral",
                        "score": 0.9665035605
                    },
                    {
                        "label": "neutral",
                        "score": 0.9988176227
                    },
                    {
                        "label": "neutral",
                        "score": 0.7868027687
                    }
                ]
            },
            {
                "text": "En cuanto a la incidencia acumulada, vuelve a subir, y se sitúa en los 255,55 casos por cada 100.000 habitantes, mientras que ayer, lunes 28 de diciembre de 2020, era de 246,19.",
                "text_en": "As for the cumulative incidence, it rises again, and stands at 255.55 cases per 100,000 inhabitants, while yesterday, Monday, December 28, 2020, it was 246.19.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "a incidencia acumulada, vuelve a subir",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "At cumulative incidence, it rises again"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "ayer, lunes 28 de diciembre de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "yesterday, Monday, December 28, 2020"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los casos se disparan en Reino Unido",
                "text_en": "Cases are skyrocketing in the UK",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Los casos se disparan",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Cases are skyrocketing"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in United Kingdom"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Los casos se disparan en el Reino Unido y marcan un tremendo dato en un solo día: 53.135 nuevos contagios.",
                "text_en": "Cases are skyrocketing in the UK and mark a tremendous figure in a single day: 53,135 new contagions.",
                "5w1h_value": [
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "en un solo día",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in one day"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "53.135 nuevos contagios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "53.135 new contagions"
                    }
                ],
                "evidences": []
            },
            {
                "text": "En total, 71.567 personas han muerto por el virus en el Reino Unido desde que comenzó la pandemia.",
                "text_en": "In total, 71,567 people have died of the virus in the United Kingdom since the pandemic began.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "71.567 personas",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "71,567 persons"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "han muerto",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "They're dead."
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "por el virus",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "by the virus"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in the United Kingdom"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "desde que comenzó la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "since the pandemic began"
                    }
                ],
                "evidences": [
                    {
                        "value": "Corona virus (COVID-19) which allegedly started to spread from the Wuhan 5 district in China has now been declared as global pandemic by the World Health Organisation (WHO) [3, 4] . To Date (1 st June 2020) it has infected over 7961307 people and has been a cause for the death of 434471 people. In total 213 countries and territories have been infected by . Although all parts of the world have been affected by this virus the major impact has been seen in 10 countries like USA, Italy, India, China, Spain, Brazil, Russia, United Kingdom, Peru, Iran, Turkey where cases are more than 1,00,000 [5] .",
                        "score": 0.5799999833
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "neutral",
                        "score": 0.8119778633
                    }
                ]
            },
            {
                "text": "Precisamente el Reino Unido sigue siendo protagonista por la existencia de una variante del Covid que ya se conoce como ‘cepa británica’ y que sería más contagiosa.",
                "text_en": "It is precisely the United Kingdom that continues to play a leading role in the existence of a variant of the Covid that is already known as the ‘British strain’ and would be more contagious.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "el Reino Unido",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "United Kingdom"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "variante del Covid que ya se conoce como ‘cepa británica’",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "variant of the Covid already known as ‘British strain’"
                    }
                ],
                "evidences": []
            },
            {
                "text": "La Comunidad de Madrid ha confirmado este martes 29 de diciembre de 2020 el diagnóstico de un total de seis casos positivos de la cepa británica de la covid-19 tras sumar dos nuevos en la región, y continúa estudiando «al menos otros 13 posibles casos».",
                "text_en": "The Community of Madrid confirmed on Tuesday, 29 December 2020, the diagnosis of a total of six positive cases of the British covid-19 strain after adding two new cases in the region, and continues to study \"at least 13 other possible cases\".",
                "5w1h_value": [
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Madrid"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "este martes 29 de diciembre de 2020",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Tuesday, 29 December 2020"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "seis casos positivos de la cepa británica de la covid-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "six positive cases of the British strain of covid-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estos diagnósticos elevan a 11 el total de casos confirmados de la cepa británica en España, dado que a los seis de Madrid se añaden los cinco reportados hasta el momento por Andalucía.",
                "text_en": "These diagnoses bring to 11 the total number of confirmed cases of the British strain in Spain, since the five reported so far by Andalusia are added to the six in Madrid.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "11 el total de casos confirmados de la cepa británica",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "11 the total number of confirmed cases of the British strain"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "en España",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "correspondent in Spain"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Madrid",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Madrid"
                    },
                    {
                        "5w1h_label": "Where",
                        "5w1h_text": "Andalucía",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Andalusia"
                    }
                ],
                "evidences": [
                    {
                        "value": "According to the WHO data updated on March 23, 2020 [37] , 190countriesor areas have reported 332,218 laboratory confirmed cases including 14,510 deaths. The total case-fatality rate of global cases outside China is 4.5%. More attention should be paid to Italy, Spain, the USA, Germany, France, and Iran with more severe outbreaks [37] . The top five countries with the highest cumulative confirmed cases in the world are China (24.6%), Italy (17.8%), USA (9.5%), Spain (8.6%), and Germany (7.5%). Higher case-fatality rates were found in Italy (9.3%), Iran (7.8%), and Spain (6.0%) [37] .",
                        "score": 0.5
                    }
                ],
                "entailment_predict": [
                    {
                        "label": "contradiction",
                        "score": 0.9659241438
                    }
                ]
            }
        ]
    },
    "115": {
        "DATA": {
            "Title": 1,
            "Subtitle": 0,
            "Lead": 1,
            "Body": 1,
            "Conclusion": 1,
            "What": 7,
            "WhatReliabilityReliable": 7,
            "WhatReliabilityUnreliable": 0,
            "WhatReliabilityUnknown": 0,
            "WhatLack-Of-InformationYes": 0,
            "WhatLack-Of-InformationNo": 0,
            "WhatLack-Of-Information-": 0,
            "WhatMain-Event": 2,
            "Who": 7,
            "WhoReliabilityReliable": 7,
            "WhoReliabilityUnreliable": 0,
            "WhoReliabilityUnknown": 0,
            "WhoLack-Of-InformationYes": 0,
            "WhoLack-Of-InformationNo": 0,
            "WhoLack-Of-Information-": 0,
            "WhoMain-Event": 0,
            "When": 2,
            "WhenReliabilityReliable": 2,
            "WhenReliabilityUnreliable": 0,
            "WhenReliabilityUnknown": 0,
            "WhenLack-Of-InformationYes": 0,
            "WhenLack-Of-InformationNo": 0,
            "WhenLack-Of-Information-": 0,
            "WhenMain-Event": 0,
            "Where": 0,
            "WhereReliabilityReliable": 0,
            "WhereReliabilityUnreliable": 0,
            "WhereReliabilityUnknown": 0,
            "WhereLack-Of-InformationYes": 0,
            "WhereLack-Of-InformationNo": 0,
            "WhereLack-Of-Information-": 0,
            "WhereMain-Event": 0,
            "Why": 1,
            "WhyReliabilityReliable": 1,
            "WhyReliabilityUnreliable": 0,
            "WhyReliabilityUnknown": 0,
            "WhyLack-Of-InformationYes": 0,
            "WhyLack-Of-InformationNo": 0,
            "WhyLack-Of-Information-": 0,
            "WhyMain-Event": 0,
            "How": 1,
            "HowReliabilityReliable": 1,
            "HowReliabilityUnreliable": 0,
            "HowReliabilityUnknown": 0,
            "HowLack-Of-InformationYes": 0,
            "HowLack-Of-InformationNo": 0,
            "HowLack-Of-Information-": 0,
            "HowMain-Event": 0,
            "Quote": 1,
            "QuoteReliabilityReliable": 0,
            "QuoteReliabilityUnreliable": 0,
            "QuoteReliabilityUnknown": 0,
            "QuoteLack-Of-InformationYes": 0,
            "QuoteLack-Of-InformationNo": 0,
            "QuoteLack-Of-Information-": 0,
            "QuoteMain-Event": 0,
            "QuoteAuthor-StanceAgree": 0,
            "QuoteAuthor-StanceDisagree": 0,
            "QuoteAuthor-StanceUnknown": 1,
            "WhoRoleSubject": 4,
            "WhoRoleTarget": 2,
            "WhoRoleBoth": 1,
            "TitleStyleObjective": 1,
            "TitleStyleSubjective": 0,
            "TitleStyleUnknown": 0,
            "TitleTitle-StanceAgree": 1,
            "TitleTitle-StanceDisagree": 0,
            "TitleTitle-StanceUnrelated": 0,
            "Key-Term": 0,
            "Key-Syntax": 0,
            "Key-Expression": 0,
            "Key-Verb": 0,
            "Orthotypography": 0,
            "Figure": 0,
            "Ambiguity": 0,
            "Exageration": 0,
            "Lack-Of-Information": 0,
            "Reliable": 0,
            "Unreliable": 0,
            "Key-ExpressionExpression-TypeSubjective": 0,
            "Key-ExpressionExpression-TypePersuasive": 0,
            "Key-ExpressionExpression-TypeExhortative": 0,
            "Key-ExpressionExpression-TypeRhetoric": 0,
            "Key-ExpressionExpression-TypeOther": 0,
            "HAS_ELEMENT_OF_INTEREST": 0,
            "HAS_QUOTE": 0
        },
        "TEXT": "\n<TEXT>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\n\n\n<PARAGRAPH>\n\nÁmsterdam, 8 abr (Reuters) – La Agencia Europea de Medicamentos (EMA, por sus siglas en inglés) informó el miércoles de una posible relación entre la vacuna de COVID-19 de AstraZeneca y unos pocos casos de coagulación de la sangre registrados en adultos que habían recibido la inyección, afirmando haber tenido en cuenta todas las pruebas actualmente disponibles.\n\n<PARAGRAPH>\n\n«Una explicación plausible para la combinación de coágulos de sangre y plaquetas bajas es una respuesta inmune, que conduce a una condición similar a la que se ve a veces en pacientes tratados con heparina», dijo la EMA.\n\n<PARAGRAPH>\n\nEstas conclusiones suponen un importante obstáculo en la lucha mundial contra la pandemia y un cambio en la postura del regulador europeo, que la semana pasada había expresado su respaldo a la vacuna y afirmado que no había un mayor riesgo de coágulos sanguíneos en general por su inyección.\n\n<PARAGRAPH>\n\nTambién supone un golpe para AstraZeneca, uno de los principales candidatos a fabricar una vacuna eficaz contra la COVID-19 desde que empezó a trabajar en su desarrollo junto con la Universidad de Oxford.\n\n<PARAGRAPH>\n\nEl comité de seguridad de la EMA, que estaba evaluando la vacuna, ha solicitado que se lleven a cabo más estudios y que se realicen cambios en los actuales para obtener más información.\n\n<PARAGRAPH>\n\n",
        "TITLE": "Agencia de Medicamentos encuentra relación entre vacuna COVID de AstraZeneca y coágulos",
        "ID": "NF_04-11-2021_21-42-11_www_eje21_com_co",
        "VALUE": "True",
        "VALUE_reliability": 0,
        "annotation_values": [
            {
                "text": "Agencia de Medicamentos encuentra relación entre vacuna COVID de AstraZeneca y coágulos",
                "text_en": "Medicines Agency Finds Relationship Between AstraZeneca COVID Vaccine and Clots",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "Agencia de Medicamentos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Medicines Agency"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "encuentra relación entre vacuna COVID de AstraZeneca y coágulos",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "found a relationship between AstraZeneca COVID vaccine and clots"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Ámsterdam, 8 abr (Reuters) – La Agencia Europea de Medicamentos (EMA, por sus siglas en inglés) informó el miércoles de una posible relación entre la vacuna de COVID-19 de AstraZeneca y unos pocos casos de coagulación de la sangre registrados en adultos que habían recibido la inyección, afirmando haber tenido en cuenta todas las pruebas actualmente disponibles.",
                "text_en": "Amsterdam, 8 Apr (Reuters) – The European Medicines Agency (EMA) reported on Wednesday a possible relationship between AstraZeneca’s COVID-19 vaccine and a few reported cases of blood clotting in adults who had received the injection, claiming to have taken into account all the tests currently available.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "La Agencia Europea de Medicamentos (EMA, por sus siglas en inglés)",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The European Medicines Agency (EMA)"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "el miércoles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "on Wednesday"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "posible relación entre la vacuna de COVID-19 de AstraZeneca y unos pocos casos de coagulación de la sangre",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "possible relationship between AstraZeneca’s COVID-19 vaccine and a few cases of blood clotting"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "en adultos que habían recibido la inyección",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "in adults who had received the injection"
                    },
                    {
                        "5w1h_label": "How",
                        "5w1h_text": "afirmando haber tenido en cuenta todas las pruebas actualmente disponibles",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "claiming to have taken into account all evidence currently available"
                    }
                ],
                "evidences": []
            },
            {
                "text": "«Una explicación plausible para la combinación de coágulos de sangre y plaquetas bajas es una respuesta inmune, que conduce a una condición similar a la que se ve a veces en pacientes tratados con heparina», dijo la EMA.",
                "text_en": "\"A plausible explanation for the combination of low blood clots and platelets is an immune response, leading to a condition similar to that sometimes seen in patients treated with heparin,\" said the EMA.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Una explicación plausible para la combinación de coágulos de sangre y plaquetas bajas es una respuesta inmune",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "A plausible explanation for the combination of low blood clots and platelets is an immune response"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "the EMA"
                    }
                ],
                "evidences": []
            },
            {
                "text": "Estas conclusiones suponen un importante obstáculo en la lucha mundial contra la pandemia y un cambio en la postura del regulador europeo, que la semana pasada había expresado su respaldo a la vacuna y afirmado que no había un mayor riesgo de coágulos sanguíneos en general por su inyección.",
                "text_en": "These conclusions represent a major obstacle to the global fight against the pandemic and a change in the position of the European regulator, who last week had expressed support for the vaccine and stated that there was no increased risk of blood clots in general due to its injection.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "Estas conclusiones suponen un importante obstáculo en la lucha mundial contra la pandemia",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "These findings represent a major obstacle to the global fight against the pandemic"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "cambio en la postura",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "change in posture"
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "regulador europeo",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "European regulator"
                    },
                    {
                        "5w1h_label": "When",
                        "5w1h_text": "a semana pasada",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "Last week"
                    },
                    {
                        "5w1h_label": "Why",
                        "5w1h_text": "había expresado su respaldo a la vacuna y afirmado que no había un mayor riesgo de coágulos sanguíneos en general por su inyección",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "had expressed support for the vaccine and claimed that there was no increased risk of blood clots in general due to its injection"
                    }
                ],
                "evidences": []
            },
            {
                "text": "También supone un golpe para AstraZeneca, uno de los principales candidatos a fabricar una vacuna eficaz contra la COVID-19 desde que empezó a trabajar en su desarrollo junto con la Universidad de Oxford.",
                "text_en": "It is also a blow to AstraZeneca, one of the main candidates to make an effective vaccine against COVID-19 since he began working on its development together with Oxford University.",
                "5w1h_value": [
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "supone un golpe",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "It's a blow."
                    },
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "AstraZeneca, uno de los principales candidatos a fabricar una vacuna eficaz contra la COVID-19",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "AstraZeneca, one of the main candidates to make an effective vaccine against COVID-19"
                    }
                ],
                "evidences": []
            },
            {
                "text": "El comité de seguridad de la EMA, que estaba evaluando la vacuna, ha solicitado que se lleven a cabo más estudios y que se realicen cambios en los actuales para obtener más información.",
                "text_en": "The EMA safety committee, which was evaluating the vaccine, has requested further studies and changes in the current ones for further information.",
                "5w1h_value": [
                    {
                        "5w1h_label": "Who",
                        "5w1h_text": "El comité de seguridad de la EMA",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "The EMA Security Committee"
                    },
                    {
                        "5w1h_label": "What",
                        "5w1h_text": "ha solicitado que se lleven a cabo más estudios",
                        "5w1h_reliability": "Reliable",
                        "5w1h_text_en": "requested further studies"
                    }
                ],
                "evidences": []
            }
        ]
    }
}